{"meta":{"query_hash":"eac09bd1f6b0","filters":{"venue":"Multiple Sclerosis and Related Disorders"},"cohort_total":487,"direct_labels_cover":4,"predictions_cover":487,"exported":487,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/eac09bd1f6b0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+and+Related+Disorders"},"results":[{"id":"W1535513754","doi":"10.1016/j.msard.2015.05.008","title":"Clinical decision-making in multiple sclerosis: Challenges reported internationally with emerging treatment complexity","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Psychological intervention; Health care; Alternative medicine; Family medicine; Adverse effect; Nursing","score_opus":0.22303808730265753,"score_gpt":0.3674495509594118,"score_spread":0.14441146365675425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535513754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855721,0.0071110073,0.00023146938,0.0030166507,0.0003272283,0.0014538653,0.000025706986,0.00021276144,0.0020492384],"genre_scores_gemma":[0.96050453,0.033644553,0.005303019,0.000089075,0.00007375541,0.00018813554,0.000048516304,0.00007751175,0.0000708801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551433,0.00027997734,0.0013607212,0.0011515891,0.00095174095,0.00074163405],"domain_scores_gemma":[0.996882,0.0012068205,0.00037756097,0.00063522154,0.00036795167,0.0005304086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013082301,0.000530277,0.0010339473,0.00049058546,0.0002974352,0.00007455569,0.0002056399,0.00030815916,0.000052223873],"category_scores_gemma":[0.0029651844,0.00038690065,0.0002549098,0.0005624255,0.0007361931,0.000266968,0.0002545318,0.0005980955,0.000025398567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020891612,0.0015864349,0.625878,0.00004563639,0.0007660201,0.00004104981,0.0027114055,0.0005574441,0.00024431647,0.00004417645,0.0001773047,0.36585906],"study_design_scores_gemma":[0.021915222,0.0011698531,0.942183,0.002235808,0.00012845964,0.000024344805,0.00424688,0.02597071,0.000028085937,0.00030039522,0.0013478138,0.00044938238],"about_ca_topic_score_codex":0.0008073274,"about_ca_topic_score_gemma":0.00794931,"teacher_disagreement_score":0.36540967,"about_ca_system_score_codex":0.0003673811,"about_ca_system_score_gemma":0.00020372563,"threshold_uncertainty_score":0.9998583},"labels":[],"label_agreement":null},{"id":"W1551155942","doi":"10.1016/j.msard.2015.05.009","title":"Neurologists׳ accuracy in predicting cognitive impairment in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Cognitive impairment; Cognition; Physical medicine and rehabilitation; Psychiatry","score_opus":0.08852712692423444,"score_gpt":0.2958466182721283,"score_spread":0.2073194913478939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551155942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080694,0.0027155017,0.000018864555,0.0023988995,0.0002525125,0.002386084,0.0000535476,0.00018693603,0.0011807266],"genre_scores_gemma":[0.9901637,0.008692775,0.00023237169,0.0002485646,0.000046222412,0.00040035625,0.00007583907,0.000078111385,0.00006207144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956099,0.00038369247,0.001031824,0.0010607535,0.00075457484,0.0011592752],"domain_scores_gemma":[0.997108,0.0014789442,0.00023066867,0.00039246786,0.00020516056,0.0005847972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001205283,0.0005347912,0.0008617697,0.00071165065,0.0002384301,0.00008085917,0.00020507754,0.00039252944,0.000047051268],"category_scores_gemma":[0.007751945,0.00046498838,0.0001889206,0.0011938827,0.000599799,0.00037846036,0.0004302593,0.0011319268,0.00004329299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015210477,0.0012233049,0.9570152,0.00009414134,0.0001314974,0.000028071669,0.004058935,0.00061092613,0.002496491,0.0000036006304,0.00024281813,0.03257397],"study_design_scores_gemma":[0.027738268,0.00078040716,0.9302762,0.0011248054,0.00005747971,0.000008922497,0.005162875,0.033944167,0.00028465994,0.000048884627,0.00015081596,0.00042250508],"about_ca_topic_score_codex":0.004467925,"about_ca_topic_score_gemma":0.0045032445,"teacher_disagreement_score":0.033333242,"about_ca_system_score_codex":0.0002801784,"about_ca_system_score_gemma":0.00016029325,"threshold_uncertainty_score":0.9997802},"labels":[],"label_agreement":null},{"id":"W1676731399","doi":"10.1016/j.msard.2015.09.002","title":"Relapses in multiple sclerosis: Relationship to disability","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Biogen; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Clinical trial; Intensive care medicine; Pediatrics; Physical disability; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.18619970594508337,"score_gpt":0.35030000335067557,"score_spread":0.1641002974055922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1676731399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009186916,0.98051673,0.000008826918,0.0010135369,0.000511007,0.0069013876,0.00029787957,0.00033062007,0.0012330645],"genre_scores_gemma":[0.082882285,0.9136903,0.00061193295,0.00006551727,0.00010799648,0.0015111892,0.00040792106,0.0002497448,0.00047308273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918543,0.0009181414,0.0023822142,0.0021388938,0.0012253524,0.0014810879],"domain_scores_gemma":[0.9940447,0.0024055513,0.000494356,0.0015225508,0.0002667111,0.0012660911],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0020199437,0.0013814962,0.0041143275,0.0009645455,0.0005489322,0.0001523878,0.00052217644,0.0014362637,0.0001029559],"category_scores_gemma":[0.008871927,0.0011066296,0.0009885024,0.0027443003,0.0010307238,0.00030951353,0.0008110743,0.002402661,0.00037654012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024288759,0.001116693,0.071319245,0.0068980446,0.0004976164,0.000007603252,0.0011219403,0.00005441546,0.000010611084,0.0000214118,0.0026207073,0.9160888],"study_design_scores_gemma":[0.009836145,0.0006117394,0.2669837,0.05008424,0.0013303965,0.000021875745,0.0013130637,0.0004904257,0.0000018729926,0.00012221055,0.66723347,0.001970893],"about_ca_topic_score_codex":0.001084292,"about_ca_topic_score_gemma":0.0020253942,"teacher_disagreement_score":0.91411793,"about_ca_system_score_codex":0.0010831539,"about_ca_system_score_gemma":0.00043488434,"threshold_uncertainty_score":0.99989885},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"grok","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W1740897416","doi":"10.1016/j.msard.2015.07.013","title":"Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Demyelinating disease; Differential diagnosis; Dilemma; Multiple sclerosis; Reading (process); Demyelinating Disorder; Intervention (counseling); Intensive care medicine; Disease; Pathology; Psychiatry","score_opus":0.15526152833495424,"score_gpt":0.37498763200266777,"score_spread":0.21972610366771353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740897416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081674074,0.99210215,0.000013093162,0.00077275035,0.0005574976,0.003646779,0.0001333427,0.0002727951,0.0016848461],"genre_scores_gemma":[0.0045712614,0.9932267,0.00046527004,0.00006865206,0.00017926811,0.0005140903,0.00026567694,0.00023457369,0.00047449503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99425125,0.00080233853,0.0015055948,0.0014460312,0.0008854164,0.0011093817],"domain_scores_gemma":[0.9954036,0.0020803574,0.0007586788,0.00059431687,0.00039468415,0.0007683962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010664745,0.0011044346,0.0038551793,0.00066696346,0.000598225,0.00008968717,0.0003424884,0.0012147871,0.00014714237],"category_scores_gemma":[0.0048947698,0.000717274,0.00079619477,0.0010403985,0.0006284883,0.00020622197,0.0007504102,0.0022205266,0.00016951688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023200817,0.00041116503,0.00029197056,0.0051200446,0.00079625007,0.000045911787,0.00042953432,0.0000066761327,0.000076367745,0.000006793197,0.00316468,0.9894186],"study_design_scores_gemma":[0.0057715965,0.0010252747,0.0017781962,0.0142516,0.0017274836,0.00011437375,0.0007301833,0.0007588659,0.0000035094647,0.00002168758,0.97297,0.0008472048],"about_ca_topic_score_codex":0.00026532487,"about_ca_topic_score_gemma":0.00014718082,"teacher_disagreement_score":0.9885714,"about_ca_system_score_codex":0.00058934285,"about_ca_system_score_gemma":0.00090232113,"threshold_uncertainty_score":0.9995278},"labels":[],"label_agreement":null},{"id":"W1963477604","doi":"10.1016/j.msard.2015.07.014","title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; McGill University; University of British Columbia; Dalhousie University; St. Francis Xavier University; University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Health Research Foundation","keywords":"Medicine; Multiple sclerosis; Comorbidity; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.15926200120024797,"score_gpt":0.2815926175422206,"score_spread":0.12233061634197262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963477604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882729,0.0011597555,0.00006352055,0.005167462,0.0001755037,0.0017787168,0.000103611696,0.0003231607,0.0029553648],"genre_scores_gemma":[0.9931265,0.005139639,0.00030653755,0.00026277025,0.000020759975,0.00024088591,0.00014332938,0.00010938904,0.00065020594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953987,0.00070151937,0.00078105077,0.0010312855,0.0010222363,0.0010652305],"domain_scores_gemma":[0.99599725,0.0018793249,0.00031554914,0.00060815946,0.0004498653,0.00074987864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018541843,0.00061902276,0.0010129,0.00054882024,0.0005216337,0.00010699722,0.00022048809,0.00055948796,0.000079408994],"category_scores_gemma":[0.0073292293,0.0005087025,0.00023501682,0.0017801774,0.0008627956,0.00041688627,0.00022237262,0.0011578462,0.000050605824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011940264,0.0029623548,0.88098943,0.0000981139,0.0011688718,0.000021899034,0.0069981953,0.00087260536,0.009312894,0.000014994695,0.004246923,0.092119694],"study_design_scores_gemma":[0.018579397,0.0008364737,0.9277326,0.000951698,0.00015217648,0.0000049237365,0.002674374,0.04699682,0.00057064294,0.000108434426,0.0007513185,0.00064112816],"about_ca_topic_score_codex":0.0020860757,"about_ca_topic_score_gemma":0.0067858845,"teacher_disagreement_score":0.09147857,"about_ca_system_score_codex":0.00043088323,"about_ca_system_score_gemma":0.00023046068,"threshold_uncertainty_score":0.9997365},"labels":[],"label_agreement":null},{"id":"W1964237140","doi":"10.1016/j.msard.2012.08.004","title":"Substantial burden of dizziness in multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Interquartile range; Confidence interval; Odds ratio; Quality of life (healthcare); Physical therapy; Multiple sclerosis; Internal medicine; Psychiatry","score_opus":0.04611344163085638,"score_gpt":0.22958104881448974,"score_spread":0.18346760718363336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964237140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586004,0.001493316,0.00012867355,0.000265209,0.0008901461,0.00043947043,0.000044592103,0.00009216647,0.00078638946],"genre_scores_gemma":[0.9971629,0.002448219,0.00009796024,0.000057024496,0.00006415308,0.000033829387,0.000011558137,0.00005271761,0.00007166748],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99762213,0.00020330386,0.0005864472,0.00051887246,0.0003555375,0.0007136978],"domain_scores_gemma":[0.9988423,0.00038451268,0.00021248066,0.00032225664,0.000028286551,0.00021013993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029417567,0.00032253415,0.00041406666,0.0002646332,0.000246705,0.00003887624,0.000274387,0.0002568804,0.000111754685],"category_scores_gemma":[0.0007463057,0.0002952535,0.00014532408,0.00079186965,0.0004884932,0.00049743004,0.00012612533,0.00032698183,0.000040060506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021308307,0.0009338381,0.3063423,0.00008552669,0.000034998957,0.0000018704409,0.0048562693,0.008049707,0.65182793,0.00027732024,0.00021743207,0.027159726],"study_design_scores_gemma":[0.017533464,0.0002860505,0.8255183,0.00081117457,0.00013037522,0.000011818367,0.004284588,0.032927513,0.1128801,0.0004826644,0.003283259,0.0018506936],"about_ca_topic_score_codex":0.0006471672,"about_ca_topic_score_gemma":0.00018662415,"teacher_disagreement_score":0.5389478,"about_ca_system_score_codex":0.000029367558,"about_ca_system_score_gemma":0.000025712177,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W1966050297","doi":"10.1016/j.msard.2015.02.002","title":"Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Dysautonomia; Medicine; Multiple sclerosis; Meta-analysis; Internal medicine; Cardiology; Physical therapy; Disease; Immunology","score_opus":0.18933934262164684,"score_gpt":0.31559233959242977,"score_spread":0.12625299697078293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966050297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068694295,0.9929586,0.000035131277,0.00019166559,0.00030330775,0.0046279905,0.00039213453,0.00027707493,0.00052715244],"genre_scores_gemma":[0.016881745,0.9789607,0.0003665793,0.000040483417,0.00008273673,0.0020700465,0.000921384,0.00025612538,0.00042019764],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99089444,0.0012232228,0.002484088,0.002488583,0.0015025075,0.001407179],"domain_scores_gemma":[0.9953672,0.00080691057,0.00069956464,0.0020023682,0.00031936736,0.0008045305],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028620404,0.0016859496,0.012198518,0.0027804726,0.00042975115,0.00018480884,0.00047977685,0.0014819072,0.00030088733],"category_scores_gemma":[0.0012414636,0.0012453363,0.011684649,0.004167502,0.0006335042,0.000306327,0.000582375,0.001993411,0.00024475684],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009137804,0.00050412805,0.0007229226,0.003047554,0.33714524,0.000012004492,0.0003347928,0.00090950786,0.0000058653386,0.0000015728482,0.00048350383,0.6567415],"study_design_scores_gemma":[0.006978125,0.00021315287,0.0055123786,0.002417688,0.5010164,0.00001271182,0.00036455152,0.0031478717,0.0000014232613,0.000013511686,0.47891262,0.0014095964],"about_ca_topic_score_codex":0.003017935,"about_ca_topic_score_gemma":0.0014727442,"teacher_disagreement_score":0.6553319,"about_ca_system_score_codex":0.00083156565,"about_ca_system_score_gemma":0.00048279404,"threshold_uncertainty_score":0.9998144},"labels":[],"label_agreement":null},{"id":"W1971770137","doi":"10.1016/j.msard.2015.02.005","title":"Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre Hospitalier de l’Université de Montréal","funders":"EMD Serono; Multiple Sclerosis Society; Teva Pharmaceutical Industries; Sanofi","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology; Artificial intelligence","score_opus":0.2841576429537343,"score_gpt":0.3570499051392593,"score_spread":0.07289226218552503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971770137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016145889,0.96794504,0.0000046844384,0.001466255,0.0014955597,0.011416351,0.0006738389,0.0001977482,0.00065464433],"genre_scores_gemma":[0.33387607,0.6606828,0.00020360347,0.00036441712,0.00008070176,0.004155063,0.00046852298,0.00016137502,0.000007456237],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9811895,0.011187772,0.003276348,0.0016595016,0.0010692374,0.0016176772],"domain_scores_gemma":[0.9850599,0.010043049,0.001798049,0.0024470976,0.0003018754,0.0003499959],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0026499436,0.0012608021,0.0022176888,0.000571446,0.0028169528,0.00015580619,0.0019489835,0.0013683144,0.00006750604],"category_scores_gemma":[0.0031766954,0.00083113776,0.00061130966,0.0018871241,0.00043986854,0.00042418385,0.0017267814,0.0064360457,0.00010510268],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017042947,0.0011179562,0.05063687,0.0031214852,0.00044831407,0.0000029241564,0.20008561,0.00021120417,0.000012711257,0.0002877671,0.0006360602,0.74326867],"study_design_scores_gemma":[0.008194093,0.0002467559,0.0794413,0.071509875,0.00053271634,0.000001330285,0.47924918,0.0013562333,2.3047149e-7,0.00012247091,0.3577853,0.0015605023],"about_ca_topic_score_codex":0.03331306,"about_ca_topic_score_gemma":0.02708423,"teacher_disagreement_score":0.74170816,"about_ca_system_score_codex":0.0020595505,"about_ca_system_score_gemma":0.0005386194,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W1976230349","doi":"10.1016/j.msard.2013.12.007","title":"Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Multiple sclerosis; Interferon beta; Microangiopathy; Adverse effect; Disease; Interferon beta-1a; Intensive care medicine; BETA (programming language); Internal medicine; Dermatology; Immunology; Diabetes mellitus","score_opus":0.03895654620137163,"score_gpt":0.27182653165383974,"score_spread":0.23286998545246812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976230349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022813106,0.97393745,0.0000036908273,0.000031294367,0.0003684057,0.0022092555,0.00054796645,0.00004269254,0.000046153942],"genre_scores_gemma":[0.13451608,0.86263293,0.00003605287,0.00001833149,0.000009381082,0.00008158137,0.002536076,0.00006637853,0.00010317146],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952738,0.00080957025,0.0024616604,0.00090645277,0.00010372407,0.00044473814],"domain_scores_gemma":[0.99658525,0.0007535251,0.0016864995,0.0007409464,0.00014827188,0.00008551368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044583186,0.000755203,0.0033375658,0.00047024494,0.000103079445,0.000023841507,0.00031957074,0.0006091016,0.00011967788],"category_scores_gemma":[0.00061740604,0.0005893947,0.00065647013,0.00064672885,0.00036540694,0.00011799639,0.00029388687,0.00047957007,0.000011906151],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016978417,0.0013743724,0.049781546,0.14274585,0.0021659548,0.000016274123,0.0009873587,0.0000045013758,0.0003858442,0.000020190737,0.004399263,0.7979491],"study_design_scores_gemma":[0.01103056,0.0009339087,0.015029181,0.8471374,0.0044074603,0.00017474733,0.00014991278,0.000011837894,0.00008462044,0.000025287016,0.11958263,0.0014324922],"about_ca_topic_score_codex":0.0013666186,"about_ca_topic_score_gemma":0.00035227777,"teacher_disagreement_score":0.79651654,"about_ca_system_score_codex":0.00006460384,"about_ca_system_score_gemma":0.000096128795,"threshold_uncertainty_score":0.9996557},"labels":[],"label_agreement":null},{"id":"W2001146581","doi":"10.1016/j.msard.2013.11.005","title":"Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Tolerability; Adverse effect; Clinical trial; Disease; Interferon; Intensive care medicine; Depression (economics); Internal medicine; Immunology","score_opus":0.09804602375119577,"score_gpt":0.31789769229828535,"score_spread":0.2198516685470896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001146581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24629667,0.74893576,0.000010398526,0.00013738351,0.00016657611,0.0040616393,0.00017810814,0.00007770999,0.00013573545],"genre_scores_gemma":[0.3551506,0.64409804,0.00009617078,0.000010472771,0.000027366754,0.00027111487,0.00016413565,0.00010585828,0.00007624099],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99357545,0.0005386274,0.0024547614,0.0017497351,0.00063801795,0.0010434062],"domain_scores_gemma":[0.99634093,0.0013705721,0.0005401791,0.0009437022,0.00019288923,0.0006117279],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094644044,0.0012353029,0.0045255376,0.00079625205,0.0003427063,0.00012089404,0.00031723778,0.0011372329,0.00010977913],"category_scores_gemma":[0.0009865075,0.00095368107,0.0005837966,0.0007288171,0.0017290991,0.00031407957,0.0009796537,0.0015674039,0.000012083596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027935635,0.00062888983,0.19972543,0.015161494,0.00064940733,0.0000037729071,0.00055382843,0.0000016668062,0.0003040972,0.0000030239576,0.0000385837,0.7826505],"study_design_scores_gemma":[0.008305886,0.00069426454,0.9365869,0.046287563,0.0010498211,0.000026563677,0.00031945485,0.00050474063,0.000019075042,0.0000069780554,0.0050447294,0.0011540104],"about_ca_topic_score_codex":0.0005982051,"about_ca_topic_score_gemma":0.0010150542,"teacher_disagreement_score":0.78149647,"about_ca_system_score_codex":0.00025523303,"about_ca_system_score_gemma":0.000117890755,"threshold_uncertainty_score":0.99929136},"labels":[],"label_agreement":null},{"id":"W2002339381","doi":"10.1016/j.msard.2012.07.004","title":"Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Medicine; Multiple sclerosis; Primary biliary cirrhosis; Autoimmune hepatitis; Interferon; Cirrhosis; Interferon beta; Autoimmune disease; Immunology; Liver disease; Hepatitis; Disease; Gastroenterology; Internal medicine","score_opus":0.018338449541394183,"score_gpt":0.2002302896517374,"score_spread":0.1818918401103432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002339381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758155,0.02148262,0.000009595446,0.0007299624,0.00029244288,0.0009985489,0.00012585257,0.0001464989,0.00039898074],"genre_scores_gemma":[0.9756635,0.023180012,0.00016946836,0.00030945506,0.000017830384,0.00009771506,0.00036903523,0.00007121078,0.00012180333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754035,0.00020892713,0.0006943412,0.000536034,0.00029453496,0.0007258201],"domain_scores_gemma":[0.9986024,0.0002530419,0.0001818944,0.0004644376,0.00006719905,0.00043105247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023906615,0.00043733005,0.0006505162,0.00026200147,0.00030852205,0.00005798015,0.00011976772,0.0003211906,0.0001614012],"category_scores_gemma":[0.00014858274,0.00038315827,0.00017914988,0.00052103645,0.00036962656,0.00043386614,0.00027661593,0.00053960114,0.000015650061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051085086,0.001621826,0.9170389,0.00015375577,0.00025744468,0.0000014721244,0.002709452,0.0000045482866,0.030544631,0.000009133708,0.00088023045,0.046267755],"study_design_scores_gemma":[0.007821877,0.0004972712,0.98576325,0.0006916747,0.00022628315,0.000005279617,0.0011911318,0.0018291577,0.00085179467,0.000013954246,0.0006428772,0.00046543244],"about_ca_topic_score_codex":0.006114961,"about_ca_topic_score_gemma":0.0001755226,"teacher_disagreement_score":0.068724364,"about_ca_system_score_codex":0.00017445518,"about_ca_system_score_gemma":0.00004712811,"threshold_uncertainty_score":0.999862},"labels":[],"label_agreement":null},{"id":"W2005104380","doi":"10.1016/j.msard.2014.05.005","title":"First-dose effects of fingolimod: Pooled safety data from three phase 3 studies","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; National Research Foundation; Novartis","keywords":"Fingolimod; Medicine; Bradycardia; Cardiology; Heart rate; Internal medicine; Electrocardiography; Atrioventricular block; Anesthesia; Disopyramide; Multiple sclerosis; Blood pressure","score_opus":0.02777977866621691,"score_gpt":0.257610424226585,"score_spread":0.22983064556036806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005104380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97573113,0.021118661,0.0021353066,0.0001441681,0.0004066987,0.0002582539,0.000100320154,0.000021864733,0.000083577],"genre_scores_gemma":[0.9872413,0.011576521,0.00053176016,0.000087387794,0.00010514585,0.000011746135,0.00039266943,0.000028471199,0.00002496842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867654,0.00007821855,0.00034889375,0.00053245755,0.00012648123,0.00023740169],"domain_scores_gemma":[0.9988192,0.00020784624,0.00015226942,0.0006868124,0.000047569003,0.00008635361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026277665,0.00021712096,0.0003534759,0.000044501005,0.0001881709,0.000017373002,0.00030318057,0.00019040378,0.000010871683],"category_scores_gemma":[0.0008363446,0.00018208807,0.000087493914,0.00010070186,0.00017766979,0.000012528361,0.00036252305,0.00011004713,0.0000037282323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007577501,0.0006084528,0.018466637,0.0002613731,0.0015555057,9.1531297e-7,0.000858817,0.0011574788,0.90151614,0.000101197926,0.0011683239,0.0735474],"study_design_scores_gemma":[0.1066486,0.0022917571,0.3567339,0.0020777243,0.0028101448,0.0000054637458,0.0017455389,0.17772433,0.27821252,0.003726107,0.06477677,0.0032471593],"about_ca_topic_score_codex":0.00024009417,"about_ca_topic_score_gemma":0.0004908621,"teacher_disagreement_score":0.62330365,"about_ca_system_score_codex":0.000003951828,"about_ca_system_score_gemma":0.000014882975,"threshold_uncertainty_score":0.7425336},"labels":[],"label_agreement":null},{"id":"W2006831887","doi":"10.1016/j.msard.2014.09.211","title":"Health-related quality of life in patients with longstanding ‘benign multiple sclerosis’","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Multiple sclerosis; Quality of life (healthcare); Dermatology; Intensive care medicine; Immunology","score_opus":0.057166858253274076,"score_gpt":0.2762775956961433,"score_spread":0.2191107374428692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006831887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940028,0.0015306976,0.00011844473,0.0015384128,0.00014725333,0.0018415934,0.00006370701,0.00013649154,0.00062057184],"genre_scores_gemma":[0.9966119,0.0022424173,0.00062625075,0.0001439638,0.000017297229,0.00007846805,0.00012928343,0.000090893656,0.00005953606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946317,0.0005946594,0.0018110888,0.000935101,0.0010316334,0.0009958147],"domain_scores_gemma":[0.99684596,0.0009145381,0.0006968076,0.00064927246,0.00028025583,0.0006131381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016549142,0.0005311138,0.0016498538,0.00053140393,0.00039887015,0.00004424533,0.000210505,0.00034460847,0.000074494346],"category_scores_gemma":[0.0029907774,0.00041682913,0.00022764046,0.0010713493,0.0007006405,0.00025042368,0.00020147492,0.0007530677,0.000013431702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018250394,0.0011737897,0.9654643,0.000396285,0.0003341877,3.141436e-7,0.001450051,0.00042292464,0.0011227662,0.00006902129,0.00016621937,0.027575128],"study_design_scores_gemma":[0.03201466,0.00096220255,0.95995516,0.0013649962,0.000041179075,3.9570298e-7,0.0007499959,0.0042825514,0.00007405158,0.00004145132,0.00007967032,0.00043367257],"about_ca_topic_score_codex":0.00452921,"about_ca_topic_score_gemma":0.0026045784,"teacher_disagreement_score":0.03018962,"about_ca_system_score_codex":0.00019934164,"about_ca_system_score_gemma":0.00013183884,"threshold_uncertainty_score":0.99982834},"labels":[],"label_agreement":null},{"id":"W2007702618","doi":"10.1016/j.msard.2014.08.002","title":"Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre","funders":"Celgene","keywords":"Multiple sclerosis; Medicine; Randomized controlled trial; Placebo; Placenta; Human placenta; Internal medicine; Pregnancy; Immunology; Pathology; Alternative medicine; Fetus","score_opus":0.028786300396516366,"score_gpt":0.2540695841590502,"score_spread":0.22528328376253381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007702618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97254467,0.0025242867,0.0002693049,0.00042726577,0.00021868256,0.023512254,0.000058966627,0.00012392858,0.0003206306],"genre_scores_gemma":[0.9910708,0.003329944,0.00039468883,0.000043108783,0.000071276256,0.003997152,0.00007968171,0.00013543943,0.0008778953],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951856,0.0007614527,0.0012827711,0.0010320293,0.0008333767,0.00090475404],"domain_scores_gemma":[0.99234134,0.0054441146,0.00056171557,0.0009176184,0.0003083303,0.00042690543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015578846,0.0007474507,0.0022240337,0.0002859652,0.0008402935,0.000092182556,0.0002969387,0.00030805747,0.00012350397],"category_scores_gemma":[0.0008373514,0.00040497453,0.0006743746,0.0003827405,0.0007974874,0.000114366674,0.00008671425,0.00035970812,0.000018844174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8202553,0.014957661,0.05385875,0.00045783896,0.0060198028,0.000006727212,0.013741724,0.0023408562,0.047261067,0.000023021576,0.00029752776,0.040779717],"study_design_scores_gemma":[0.8636104,0.0067802053,0.025371995,0.0005737958,0.0016206023,0.000003533146,0.0074793138,0.090725824,0.0029445845,0.000009200333,0.0003967341,0.00048380432],"about_ca_topic_score_codex":0.0030694145,"about_ca_topic_score_gemma":0.0030782185,"teacher_disagreement_score":0.08838496,"about_ca_system_score_codex":0.00012902635,"about_ca_system_score_gemma":0.00007405687,"threshold_uncertainty_score":0.9998402},"labels":[],"label_agreement":null},{"id":"W2013199340","doi":"10.1016/j.msard.2012.11.003","title":"The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Multiple sclerosis; Drug; Drug reaction; Adverse effect; Intensive care medicine; Pharmacology; Immunology","score_opus":0.0915563427425296,"score_gpt":0.3518274075304867,"score_spread":0.2602710647879571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013199340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122495145,0.8733454,0.0000023460666,0.00011498199,0.0009045278,0.002606847,0.000205197,0.000019531319,0.0003060685],"genre_scores_gemma":[0.27620623,0.7231227,0.000030100584,0.000027519745,0.000039446608,0.00035178429,0.00007138825,0.000047775433,0.00010305249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504673,0.0018255076,0.0017546966,0.00052025233,0.0002667106,0.00058607454],"domain_scores_gemma":[0.99717796,0.001127867,0.0010776095,0.00039961416,0.00008128976,0.00013565089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017104872,0.00054196507,0.0011569703,0.0003633092,0.0003971875,0.000028425804,0.00070353586,0.00065978605,0.000116426614],"category_scores_gemma":[0.00012923173,0.00036279875,0.00063286425,0.0007936587,0.0005541165,0.00013086939,0.00020276864,0.0016115456,0.000020180021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013002308,0.0009078467,0.00054085656,0.00095462566,0.0005233834,0.0000015642987,0.0012733454,0.0020140873,0.0069219926,0.000053885484,0.00016890597,0.9865095],"study_design_scores_gemma":[0.008187059,0.000080651465,0.003458437,0.0021283175,0.00249693,0.0000137885945,0.0024979794,0.011117265,0.0008306225,0.00060434523,0.96777236,0.0008122111],"about_ca_topic_score_codex":0.00066960126,"about_ca_topic_score_gemma":0.00042889,"teacher_disagreement_score":0.98569727,"about_ca_system_score_codex":0.00006160136,"about_ca_system_score_gemma":0.00015319436,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W2013347874","doi":"10.1016/j.msard.2013.08.002","title":"Bilateral trochlear nerve palsy in a patient with neuromyelitis optica","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Ophthalmology and Eye Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Neuromyelitis optica; Medicine; Multiple sclerosis; Cranial nerve palsy; Palsy; Trochlear nerve; Surgery; Pathology; Immunology","score_opus":0.012470846217821607,"score_gpt":0.20406477836707482,"score_spread":0.19159393214925322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013347874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992386,0.0007254232,0.000004690527,0.0027341882,0.00009230223,0.00075771485,0.0000037907696,0.00006058437,0.0032353015],"genre_scores_gemma":[0.9985013,0.0005900417,0.00025726706,0.0002546824,0.0000073396372,0.00010919526,0.00003075771,0.00003665899,0.00021277073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861664,0.00006659577,0.00032966267,0.00041245262,0.00014771399,0.00042695343],"domain_scores_gemma":[0.99942493,0.00007096978,0.0000674091,0.00021725855,0.000043300763,0.00017614075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006117985,0.00024087055,0.00034264245,0.00016107649,0.00011360283,0.000029564071,0.000055790555,0.00021409796,0.0004085204],"category_scores_gemma":[0.000057738045,0.00016878775,0.000083496736,0.0002996342,0.00022645517,0.00014961905,0.000039451843,0.0003650582,0.00008079266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080930814,0.001083356,0.93416023,0.00012381791,0.00025000775,0.00024833993,0.0036438084,0.0006931841,0.003906299,0.00007744439,0.00034190045,0.054662306],"study_design_scores_gemma":[0.0064124535,0.0012580375,0.9861837,0.00025370793,0.000056196684,0.00020871928,0.0014914097,0.0032509195,0.00007622032,0.00024822715,0.00026403632,0.00029638343],"about_ca_topic_score_codex":0.0010368137,"about_ca_topic_score_gemma":0.00007672183,"teacher_disagreement_score":0.05436592,"about_ca_system_score_codex":0.000018685636,"about_ca_system_score_gemma":0.000024113744,"threshold_uncertainty_score":0.6882965},"labels":[],"label_agreement":null},{"id":"W2031617600","doi":"10.1016/j.msard.2013.07.001","title":"Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Glatiramer acetate; Clinically isolated syndrome; Placebo; Clinical trial; McDonald criteria; Natalizumab; Pediatrics; Fingolimod; Disease; Physical therapy; Internal medicine; Alternative medicine; Pathology; Psychiatry","score_opus":0.45045643630905796,"score_gpt":0.49496657379006515,"score_spread":0.044510137481007184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031617600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018693728,0.968563,0.00013908895,0.0010922642,0.00041398584,0.0093307905,0.0016055426,0.00007348755,0.00008810639],"genre_scores_gemma":[0.019873785,0.96838254,0.009039971,0.00004066494,0.00020625537,0.0017640904,0.00044921756,0.00015539775,0.000088063585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98838556,0.0019871679,0.006764982,0.0016152398,0.0005238414,0.00072321587],"domain_scores_gemma":[0.95496935,0.03957509,0.00312923,0.0010053662,0.00064351514,0.0006774373],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0050650407,0.0009374161,0.008436697,0.0004317259,0.00030948417,0.0000795536,0.00031366688,0.0016461265,0.000054944187],"category_scores_gemma":[0.04816678,0.0006483716,0.002760424,0.00051007123,0.001191082,0.00025311383,0.0003270711,0.0008621826,0.000011893234],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005676825,0.00207098,0.02522432,0.0032798261,0.0060014357,4.4526638e-7,0.0005668999,0.0000010979131,0.00012929918,0.000014338237,0.00096588343,0.96117777],"study_design_scores_gemma":[0.03621255,0.0036494206,0.35137218,0.026500924,0.017593255,0.000009149298,0.0015935849,0.000974837,0.00003485742,0.00007528348,0.56072384,0.0012601005],"about_ca_topic_score_codex":0.0011783539,"about_ca_topic_score_gemma":0.0000714522,"teacher_disagreement_score":0.95991766,"about_ca_system_score_codex":0.000115999566,"about_ca_system_score_gemma":0.00045312822,"threshold_uncertainty_score":0.99964994},"labels":[],"label_agreement":null},{"id":"W2033461650","doi":"10.1016/j.msard.2014.08.003","title":"Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Biogen Idec; Biogen","keywords":"Medicine; Placebo; Multiple sclerosis; Interferon beta-1a; Clinically isolated syndrome; Internal medicine; Magnetic resonance imaging; Gastroenterology; Randomized controlled trial; Radiology; Pathology; Interferon beta; Immunology","score_opus":0.028910441075158843,"score_gpt":0.27207735077641765,"score_spread":0.24316690970125882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033461650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946004,0.0004068133,0.00037388186,0.0020878157,0.00011145334,0.0017120228,0.000022426937,0.0001769183,0.00050825457],"genre_scores_gemma":[0.99357706,0.0053873067,0.0003972395,0.000069771464,0.000022751548,0.00021341175,0.000032736985,0.00008109162,0.00021860875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963887,0.0005583224,0.0007241095,0.00097238977,0.00052899687,0.0008274782],"domain_scores_gemma":[0.99775064,0.00083257916,0.00019312784,0.00064661185,0.00011403651,0.00046298836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088053197,0.00054215424,0.0010236694,0.0003927774,0.00024703547,0.00007651059,0.00016675483,0.00040792595,0.00007023058],"category_scores_gemma":[0.00046303048,0.00037821548,0.00023153197,0.00060058857,0.00057102874,0.0002248904,0.00015343704,0.00072564435,0.000039877195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03872458,0.004849104,0.6909482,0.00026126424,0.0025010146,0.00010109007,0.0051707355,0.0011150219,0.014775755,0.000017474924,0.00012126797,0.2414145],"study_design_scores_gemma":[0.019172806,0.015642725,0.93598753,0.0007819301,0.00020155181,0.00002515577,0.00026165816,0.026814315,0.00016079887,0.000013866047,0.0005108628,0.0004268009],"about_ca_topic_score_codex":0.001145162,"about_ca_topic_score_gemma":0.0009427731,"teacher_disagreement_score":0.24503934,"about_ca_system_score_codex":0.00021130717,"about_ca_system_score_gemma":0.000091589725,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W2042115859","doi":"10.1016/j.msard.2012.11.002","title":"CNS vasculitis in children","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Vasculitis; Multiple sclerosis; Differential diagnosis; Disease; Pathogenesis; Epidemiology; Pathology; Immunology","score_opus":0.027282652981673497,"score_gpt":0.25330668239568593,"score_spread":0.22602402941401245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042115859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015897318,0.9930226,0.000002558205,0.00019919068,0.00022394647,0.0024871011,0.00008583524,0.00012389812,0.0022651053],"genre_scores_gemma":[0.0022360685,0.995059,0.00009255278,0.000036329573,0.000049773695,0.0003740754,0.001024224,0.00011680299,0.0010111507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738145,0.00014388667,0.00093208393,0.0007565578,0.00024307198,0.0005429496],"domain_scores_gemma":[0.9988512,0.000103661725,0.00022559302,0.0004872659,0.0000373377,0.0002949646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014840541,0.0005939594,0.001842382,0.0005154372,0.0001840222,0.000060809914,0.00014445452,0.0012282515,0.00068305933],"category_scores_gemma":[0.00008174797,0.0004323881,0.0009403849,0.00069006643,0.00021744806,0.000109379755,0.00009592548,0.001268906,0.00039588587],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002269636,0.00022928487,0.0020357545,0.0013793007,0.0011220877,0.0000056863364,0.000092555245,0.0000031241673,5.9798697e-7,0.0000731131,0.0007732673,0.99428296],"study_design_scores_gemma":[0.009313514,0.00022177635,0.05121386,0.040544417,0.004627093,0.00053333107,0.0001384865,0.00012693198,2.9755404e-7,0.00023441264,0.89167064,0.0013752317],"about_ca_topic_score_codex":0.00063813385,"about_ca_topic_score_gemma":0.000046892554,"teacher_disagreement_score":0.9929077,"about_ca_system_score_codex":0.00009928589,"about_ca_system_score_gemma":0.00012771811,"threshold_uncertainty_score":0.9998128},"labels":[],"label_agreement":null},{"id":"W2042737626","doi":"10.1016/j.msard.2013.10.006","title":"Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; London Health Sciences Centre; Western University","funders":"Novartis Pharma; EMD Serono; Genentech; Daiichi Sankyo Europe; Sanofi; European Commission; Glenmark Pharmaceuticals; Eli Lilly and Company; CSL Behring; Novartis Pharmaceuticals Corporation; Biogen; Novo Nordisk; Teva Pharmaceutical Industries; National Research Foundation; Universitätsspital Basel","keywords":"Fingolimod; Medicine; Glatiramer acetate; Discontinuation; Placebo; Adverse effect; Multiple sclerosis; Internal medicine; Disease; Immunology; Pathology; Alternative medicine","score_opus":0.0934681497190447,"score_gpt":0.349094815101173,"score_spread":0.2556266653821283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042737626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946352,0.002800857,0.000016939248,0.000042218682,0.000029815712,0.0024255957,0.000040892337,0.0000026124346,0.000005850099],"genre_scores_gemma":[0.99591035,0.003799195,0.00010898061,0.000003440635,0.000009484745,0.00012614919,0.000016718428,0.000019873052,0.0000057893085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99823904,0.00048281648,0.00047343943,0.00032312592,0.00022242365,0.00025918274],"domain_scores_gemma":[0.9982378,0.0009157163,0.00030470346,0.00033059745,0.000160625,0.00005056426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008187333,0.00019042504,0.0004018341,0.00011684654,0.00016579461,0.00001902555,0.00012466114,0.0001177322,0.0000028334737],"category_scores_gemma":[0.0012117865,0.00010445584,0.00014718721,0.00028188573,0.00034847794,0.000014680195,0.000090882764,0.000103830775,3.9555992e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007441539,0.0007706487,0.29337394,0.000031467913,0.00025716046,1.1660666e-8,0.0028071739,0.0010603255,0.6735262,0.0000075273974,0.0000037928166,0.027417567],"study_design_scores_gemma":[0.010824591,0.0028945317,0.908747,0.00021128959,0.00008688853,8.367264e-8,0.0013082683,0.0038421452,0.07196199,0.000023348879,0.0000013287665,0.00009853895],"about_ca_topic_score_codex":0.0070599634,"about_ca_topic_score_gemma":0.00049122097,"teacher_disagreement_score":0.6153731,"about_ca_system_score_codex":0.000015920126,"about_ca_system_score_gemma":0.0000536265,"threshold_uncertainty_score":0.99955213},"labels":[],"label_agreement":null},{"id":"W2043370356","doi":"10.1016/j.msard.2013.03.001","title":"Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health; Health Sciences Centre","funders":"","keywords":"Medicine; Incidence (geometry); Population; Medical record; Disease; Multiple sclerosis; Internal medicine; Medical prescription; Epidemiology; Demography; Environmental health; Immunology","score_opus":0.03971804447623006,"score_gpt":0.27330132800020895,"score_spread":0.2335832835239789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043370356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329877,0.0021027343,0.000014910663,0.0011111719,0.00005583534,0.0032763756,0.00002895306,0.000074869,0.000036361515],"genre_scores_gemma":[0.9970285,0.0018387215,0.0003833259,0.00007513335,0.000012710162,0.0005340262,0.00004079048,0.00004179306,0.000044940043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971734,0.00023080771,0.00078230974,0.00073539355,0.0006107967,0.00046727044],"domain_scores_gemma":[0.99820566,0.0005930582,0.00020094798,0.00045724612,0.00019244643,0.0003506498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048014286,0.00033997872,0.00056618435,0.0003814101,0.00023808442,0.00005967399,0.0001292865,0.00014821005,0.0000940029],"category_scores_gemma":[0.001887538,0.0002943263,0.00010490879,0.0005796497,0.0003159309,0.0003874423,0.00016649267,0.00035283834,0.000012312096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026694976,0.000990616,0.97142905,0.00041112443,0.00006151572,7.836347e-7,0.0007511977,0.0006042964,0.02164438,0.0000011357374,0.000109108645,0.003729866],"study_design_scores_gemma":[0.0072784717,0.00029080058,0.95788497,0.0012139672,0.000095772455,5.038931e-7,0.00068903546,0.03173352,0.0005089734,0.000023355024,0.0000068880377,0.00027372147],"about_ca_topic_score_codex":0.0062673497,"about_ca_topic_score_gemma":0.00036986443,"teacher_disagreement_score":0.031129222,"about_ca_system_score_codex":0.00007959618,"about_ca_system_score_gemma":0.00007104889,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W2046066091","doi":"10.1016/j.msard.2012.03.006","title":"B cells in MS: Why, where and how?","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Inflammation; Disease; Mechanism (biology); Myelin; Immunology; Central nervous system; Neuroscience; Pathology; Biology; Internal medicine","score_opus":0.02934495998023967,"score_gpt":0.2244944407992191,"score_spread":0.19514948081897943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046066091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019225405,0.9950984,0.0000023296168,0.00020497681,0.0012860959,0.0007631734,0.00007443306,0.00008057369,0.0005674382],"genre_scores_gemma":[0.017860629,0.97868174,0.000017122056,0.000030420617,0.00001863431,0.00008665007,0.00022257605,0.00007726944,0.0030049686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735564,0.0005294781,0.0005656223,0.0007250112,0.00003801886,0.0007862419],"domain_scores_gemma":[0.99886,0.000343747,0.00033130974,0.00038297134,0.000020724825,0.00006127298],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00028078468,0.00067402475,0.0016105995,0.00033009422,0.00025820863,0.00004712272,0.0002624658,0.0020814575,0.00035816405],"category_scores_gemma":[0.000028464308,0.0005171837,0.0002911426,0.00029538182,0.0006395503,0.0001371814,0.00027056714,0.0012883041,0.00028368313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025899677,0.0003029563,0.00039698003,0.0023402174,0.0006105246,0.0000026659025,0.00041412583,4.3619286e-7,0.012294298,0.000047745765,0.0025552544,0.9810089],"study_design_scores_gemma":[0.0021834709,0.00009059179,0.00010636295,0.0028779998,0.00057270384,0.000040074443,0.0002290335,0.0000016155634,0.00008866558,0.000021792945,0.9931491,0.0006385726],"about_ca_topic_score_codex":0.00047693404,"about_ca_topic_score_gemma":0.0005844593,"teacher_disagreement_score":0.99059385,"about_ca_system_score_codex":0.000042009666,"about_ca_system_score_gemma":0.00004609629,"threshold_uncertainty_score":0.99972796},"labels":[],"label_agreement":null},{"id":"W2056201587","doi":"10.1016/j.msard.2013.06.017","title":"Increased deep gray matter iron is present in clinically isolated syndromes","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society; Canada Research Chairs; Multiple Sclerosis Society of Canada; Health Research Board","keywords":"Medicine; Gray (unit); Multiple sclerosis; Dermatology; Psychiatry; Nuclear medicine","score_opus":0.028814022370232915,"score_gpt":0.2759955838907996,"score_spread":0.24718156152056667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056201587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520565,0.0017881091,0.00003079717,0.0076557505,0.00012915871,0.0020167914,0.000014248115,0.00012347332,0.0030360003],"genre_scores_gemma":[0.9892331,0.008453254,0.00037096711,0.0007570808,0.000029017032,0.00030861716,0.000050084655,0.000072742565,0.0007251865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655646,0.00021865263,0.0010130306,0.00082847045,0.0005276893,0.00085570506],"domain_scores_gemma":[0.9981832,0.00049205124,0.00017047177,0.0005506744,0.00014834493,0.00045526362],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040564506,0.00043393942,0.0007588418,0.00037026813,0.00022863346,0.000097714714,0.00019788911,0.0004109977,0.0025767758],"category_scores_gemma":[0.00043641045,0.00033568227,0.00023928199,0.00057520904,0.00046127313,0.00026802786,0.0002679222,0.0007454259,0.00076224084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036500974,0.0008214684,0.9549232,0.0001698114,0.00027884435,0.0000072438684,0.0013337223,0.000045004268,0.005601995,0.0000026873342,0.007428851,0.029022153],"study_design_scores_gemma":[0.00829794,0.00040400182,0.9635757,0.00034623453,0.000069130314,0.000008394816,0.0007653878,0.025208438,0.00007802462,0.00010260496,0.00075992016,0.00038418887],"about_ca_topic_score_codex":0.004474883,"about_ca_topic_score_gemma":0.0002609632,"teacher_disagreement_score":0.028637966,"about_ca_system_score_codex":0.000070234804,"about_ca_system_score_gemma":0.00004185191,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W2066064324","doi":"10.1016/j.msard.2012.12.003","title":"Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Prospective cohort study; Cohort; Multiple sclerosis; Predictive value; Clinically isolated syndrome; Predictive value of tests; Internal medicine; Pediatrics; Immunology","score_opus":0.022676100496885544,"score_gpt":0.243213334480317,"score_spread":0.22053723398343147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066064324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951377,0.00082703575,0.00008880635,0.0009016986,0.000068916626,0.00262199,0.0000997017,0.00007223764,0.00018194492],"genre_scores_gemma":[0.9795087,0.018503468,0.001138863,0.000021873804,0.000021316124,0.0005362337,0.00017126874,0.00006031087,0.00003799518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970626,0.0001571039,0.00093578064,0.0006090841,0.0007137635,0.00052165694],"domain_scores_gemma":[0.9981866,0.0004068413,0.00040560833,0.00041863148,0.0003614779,0.00022087454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003690658,0.00037846665,0.0007753189,0.00059794914,0.00015641739,0.00003049407,0.00017656673,0.00029367284,0.00013177133],"category_scores_gemma":[0.0005870374,0.0002941677,0.00017874024,0.0009970564,0.00057447527,0.00041240235,0.00015120704,0.00037996948,0.000010792816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021018951,0.00077563175,0.9512191,0.00009932114,0.0009233582,3.0926907e-7,0.0010597317,0.0007920481,0.02852113,0.0000056799677,0.00024997565,0.01614356],"study_design_scores_gemma":[0.009368023,0.0005956192,0.9606665,0.0007995234,0.00026205936,0.000002827852,0.0005772288,0.0050280765,0.022382388,0.000027324917,0.000014749972,0.00027567658],"about_ca_topic_score_codex":0.0031223954,"about_ca_topic_score_gemma":0.00031417326,"teacher_disagreement_score":0.017676434,"about_ca_system_score_codex":0.000086237975,"about_ca_system_score_gemma":0.000066086715,"threshold_uncertainty_score":0.99995106},"labels":[],"label_agreement":null},{"id":"W2077138786","doi":"10.1016/j.msard.2012.08.001","title":"Cognitive and neuropsychiatric disease manifestations in MS","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Psychiatry; Disease; Cognitive impairment; Mental health; Pathology","score_opus":0.0799669021878602,"score_gpt":0.3268902966310698,"score_spread":0.24692339444320957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077138786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041793315,0.9915704,0.000003280709,0.00026727738,0.00021069498,0.0027115769,0.00019917947,0.00007731388,0.0007809173],"genre_scores_gemma":[0.042232085,0.9565241,0.000060559418,0.000038309394,0.00006378104,0.0004227709,0.00029080157,0.00010864341,0.00025899158],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970369,0.00031622368,0.0007834945,0.0008029296,0.00037001946,0.0006904697],"domain_scores_gemma":[0.99794406,0.00080282416,0.00023796679,0.00029784703,0.000071781804,0.0006455427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003030465,0.0006150917,0.0013665527,0.0007437414,0.00028321822,0.00005644682,0.00009926181,0.00033935538,0.00008117458],"category_scores_gemma":[0.0007218517,0.0004754608,0.0003274272,0.0008026114,0.000438207,0.00015129922,0.00023040669,0.0009731357,0.000051954084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076949735,0.00048338002,0.026509697,0.00857656,0.00034562347,0.000016731146,0.00036892964,7.0846255e-7,9.468296e-7,0.000016621423,0.00008282323,0.963521],"study_design_scores_gemma":[0.006974605,0.00019885768,0.79816693,0.025342511,0.0041891485,0.00004210503,0.00054585264,0.00032541642,6.0230214e-8,0.00003742868,0.16317284,0.0010042501],"about_ca_topic_score_codex":0.0002207671,"about_ca_topic_score_gemma":0.00019679467,"teacher_disagreement_score":0.9625168,"about_ca_system_score_codex":0.000069053865,"about_ca_system_score_gemma":0.00014270961,"threshold_uncertainty_score":0.9997697},"labels":[],"label_agreement":null},{"id":"W2080669720","doi":"10.1016/j.msard.2013.06.015","title":"MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hotchkiss Brain Institute; University of Manitoba; McGill University; McGill University Health Centre; Hospital for Sick Children; University of Saskatchewan; University of Calgary; Western University; University of Toronto; SickKids Foundation; University of British Columbia","funders":"","keywords":"Incidence (geometry); Medicine; Demography; Epidemiology; Ethnic group; Geography; Pathology","score_opus":0.11074921417805134,"score_gpt":0.3339412673334964,"score_spread":0.22319205315544505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080669720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054556807,0.9900943,0.0000012572779,0.0004968841,0.00007213872,0.008562339,0.000036655016,0.000061001847,0.00012982255],"genre_scores_gemma":[0.0011563846,0.9927831,0.00018459739,0.00003316805,0.000024471514,0.0010065455,0.000034118166,0.000077330835,0.00470025],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99534255,0.0005240533,0.0016292477,0.0011226689,0.0005927943,0.0007886743],"domain_scores_gemma":[0.99721235,0.0008540337,0.0005766833,0.00064610626,0.00008949193,0.00062132877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009866734,0.0008478702,0.004154053,0.00042482358,0.00016708233,0.000116949544,0.0002449684,0.00057527586,0.000164255],"category_scores_gemma":[0.0024436808,0.0005726155,0.0003129109,0.0007400538,0.0004523244,0.00022545877,0.00040322574,0.001082221,0.00007188886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001119484,0.000098108714,0.0017632332,0.86577314,0.00045048268,0.000007782533,0.00043744838,1.8629004e-7,0.0000059678036,0.0000058638943,0.0037319763,0.12771462],"study_design_scores_gemma":[0.002062432,0.00020251653,0.01023412,0.9484124,0.003093261,0.0000777907,0.00010010354,0.000089315814,2.3218551e-7,0.000024358209,0.03501304,0.0006903859],"about_ca_topic_score_codex":0.0017101016,"about_ca_topic_score_gemma":0.00027351003,"teacher_disagreement_score":0.12702423,"about_ca_system_score_codex":0.00011922277,"about_ca_system_score_gemma":0.00013791044,"threshold_uncertainty_score":0.99967253},"labels":[],"label_agreement":null},{"id":"W2082026472","doi":"10.1016/j.msard.2014.06.004","title":"Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306]","year":2014,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Vitamin D and neurology; Regret; Harm; Vitamin; Number needed to treat; Disease; Internal medicine; Relative risk; Immunology; Psychology; Confidence interval","score_opus":0.03540118076370324,"score_gpt":0.23442800424744814,"score_spread":0.1990268234837449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082026472","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20423748,0.30407307,0.005016806,0.028655123,0.3793822,0.05185238,0.012598363,0.0015350188,0.0126495585],"genre_scores_gemma":[0.89299226,0.009412337,0.00019112644,0.00027666753,0.00034377337,0.0020749718,0.0052082776,0.00026163092,0.08923898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99403363,0.0009208284,0.0015733944,0.0020117585,0.00015526827,0.0013051076],"domain_scores_gemma":[0.99708,0.00056667044,0.0007328453,0.0012675308,0.00020942709,0.00014348543],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001309445,0.0010413468,0.001271036,0.0005555264,0.0013788842,0.00013520135,0.00062074553,0.001958414,0.00039145915],"category_scores_gemma":[0.00082221365,0.00082575914,0.0004869716,0.0006479997,0.00047536244,0.00024496295,0.00031655538,0.0015908213,0.00041958515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041066326,0.00044352672,0.0082965605,0.00040308572,0.00061880087,0.000010857953,0.0037821755,0.00022017618,0.0045660175,0.000100214915,0.9368491,0.044298805],"study_design_scores_gemma":[0.01718477,0.00094884925,0.050035894,0.0029943716,0.00051670487,0.00016105016,0.004688875,0.0006993667,0.0005303916,0.00021687728,0.9198862,0.0021366775],"about_ca_topic_score_codex":0.0061528604,"about_ca_topic_score_gemma":0.026246069,"teacher_disagreement_score":0.68875474,"about_ca_system_score_codex":0.00017396943,"about_ca_system_score_gemma":0.00011685504,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W2082278718","doi":"10.1016/j.msard.2012.03.003","title":"Autoantibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in paediatric CNS demyelination: Recent developments and future directions","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"Neuromyelitis optica; Medicine; Acute disseminated encephalomyelitis; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunology; Autoantibody; Aquaporin 4; Antibody; Myelin; Demyelinating disease; Demyelinating Disorder; Oligodendrocyte; Pathogenesis; Disease; Central nervous system; Pathology; Experimental autoimmune encephalomyelitis; Internal medicine","score_opus":0.05407009413105779,"score_gpt":0.3009606424040809,"score_spread":0.2468905482730231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082278718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039129155,0.99115086,0.000002561755,0.0007965364,0.00051547756,0.0027274976,0.00007616128,0.00013075052,0.0006872593],"genre_scores_gemma":[0.0038651442,0.99395174,0.0007169001,0.00003493918,0.0002898222,0.00051707804,0.00027706425,0.00011541134,0.00023193023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593675,0.00033019081,0.0012360105,0.0010524077,0.00054570124,0.00089890935],"domain_scores_gemma":[0.99823785,0.00038082985,0.0003991057,0.00035344245,0.00014132164,0.00048742522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074485736,0.00087316363,0.002017331,0.001025911,0.0005941552,0.00009983503,0.0001393367,0.0008764986,0.00004534291],"category_scores_gemma":[0.00041868846,0.0006863721,0.00023675426,0.001252582,0.00038810377,0.00023494524,0.00044516625,0.0013026699,0.000023380395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004265899,0.00021763495,0.005957255,0.004751255,0.00050892914,0.0000051608613,0.0009287077,9.3417987e-7,0.0000074595746,0.000009988038,0.00009080577,0.9874792],"study_design_scores_gemma":[0.0033750236,0.000081472994,0.076685205,0.0060254973,0.00072154164,0.000026802643,0.0005390993,0.00014895824,0.000002149891,0.0000074338395,0.91165495,0.00073186174],"about_ca_topic_score_codex":0.0001413143,"about_ca_topic_score_gemma":0.00040121103,"teacher_disagreement_score":0.9867473,"about_ca_system_score_codex":0.0002683567,"about_ca_system_score_gemma":0.0002062159,"threshold_uncertainty_score":0.99955875},"labels":[],"label_agreement":null},{"id":"W2082490967","doi":"10.1016/j.msard.2012.05.001","title":"Computerized cognitive testing for patients with multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Canada Research Chairs","funders":"","keywords":"Neuropsychology; Cognition; Medicine; Neuropsychological testing; Multiple sclerosis; Neuropsychological assessment; Cognitive test; Neuropsychological test; Physical medicine and rehabilitation; Psychiatry","score_opus":0.11894524235970247,"score_gpt":0.30594174571457217,"score_spread":0.1869965033548697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082490967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005038293,0.9779729,0.00019019206,0.000068262925,0.00043551993,0.014486281,0.0011479054,0.00035510072,0.00030549316],"genre_scores_gemma":[0.041578565,0.94883794,0.0040894384,0.000050401435,0.00017255872,0.0028896255,0.001884754,0.0003741991,0.00012251124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99434805,0.00030563006,0.0014121226,0.0015118442,0.00083601015,0.0015863624],"domain_scores_gemma":[0.9925198,0.004506075,0.00086127996,0.0006070654,0.0007490632,0.00075674057],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005443127,0.0014154372,0.003616909,0.0005916135,0.00094584876,0.00015398445,0.0002983612,0.00088206155,0.000052013584],"category_scores_gemma":[0.0023502193,0.0009898063,0.00085834134,0.0010988436,0.0007734398,0.00028549394,0.0004378522,0.0011082789,0.00005273525],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048979453,0.0012534488,0.034473676,0.010535568,0.002241318,0.0000010202116,0.00028043712,0.0000017126298,0.000011370081,0.0000018779862,0.00016632787,0.95054346],"study_design_scores_gemma":[0.07016516,0.0041401708,0.3240572,0.1421083,0.014677832,0.000019405217,0.0005344351,0.001977046,0.0000063596426,0.00001003943,0.43819752,0.004106545],"about_ca_topic_score_codex":0.00014358203,"about_ca_topic_score_gemma":0.000063444284,"teacher_disagreement_score":0.9464369,"about_ca_system_score_codex":0.00021529311,"about_ca_system_score_gemma":0.00021724569,"threshold_uncertainty_score":0.9998596},"labels":[],"label_agreement":null},{"id":"W2094244969","doi":"10.1016/j.msard.2012.07.003","title":"A proposed methodology to estimate the cumulative life-time UVB exposure using geographic information systems: An application to multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health; Simon Fraser University","funders":"","keywords":"Multiple sclerosis; Medicine; Proxy (statistics); Sun exposure; Sunlight; Demography; Statistics; Immunology","score_opus":0.08826487081443886,"score_gpt":0.3370960559294761,"score_spread":0.24883118511503727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094244969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804993,0.0010482015,0.009388436,0.0022950417,0.00025670815,0.005982699,0.000081558646,0.00027888818,0.00016915888],"genre_scores_gemma":[0.9882573,0.0004352403,0.0097890925,0.00048450351,0.00009494231,0.0007138018,0.00011921556,0.00007306687,0.000032872635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958184,0.0007847553,0.00096770556,0.00060553534,0.00073704246,0.001086587],"domain_scores_gemma":[0.99632996,0.0011141452,0.00032322295,0.00076791947,0.00044614187,0.001018601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022545338,0.00052819913,0.0007878585,0.00063346175,0.0009960853,0.00016937352,0.00028886946,0.0003688308,0.00003763644],"category_scores_gemma":[0.004208225,0.00037291838,0.00019130403,0.0013434518,0.00032054118,0.0009164798,0.0003252462,0.00050613616,0.0001550708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021689094,0.0013855565,0.4843652,0.0005406418,0.001582037,6.649732e-7,0.032763742,0.04192667,0.34679484,0.00045299716,0.000725858,0.08729289],"study_design_scores_gemma":[0.0043103984,0.00064775546,0.7707512,0.0005518656,0.0002852853,0.000007575225,0.0053242254,0.21469064,0.001003471,0.000021612714,0.0017430552,0.000662969],"about_ca_topic_score_codex":0.0020283542,"about_ca_topic_score_gemma":0.00014389855,"teacher_disagreement_score":0.34579137,"about_ca_system_score_codex":0.00015359928,"about_ca_system_score_gemma":0.00007675538,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W2096243634","doi":"10.1016/j.msard.2014.06.001","title":"CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; University of Alberta","keywords":"CD20; Medicine; Flow cytometry; Immunology; Multiple sclerosis; Inflammation; Fas ligand; Apoptosis; Antigen; Programmed cell death; Biology","score_opus":0.02386338981250617,"score_gpt":0.23574816432708853,"score_spread":0.21188477451458237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096243634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939034,0.0009647431,0.000046892863,0.0023127396,0.00008554225,0.0024337117,0.0001455606,0.000055600303,0.00005179216],"genre_scores_gemma":[0.9943776,0.0044440413,0.00058329914,0.000104258936,0.000024070498,0.00025073637,0.00008770733,0.00006465338,0.00006364746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972644,0.00022207946,0.0007025383,0.00075454905,0.00045477238,0.00060167565],"domain_scores_gemma":[0.9976193,0.0012021384,0.0003207833,0.0002505764,0.00031907222,0.0002881465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060457236,0.00039655677,0.00072963804,0.00043639157,0.0002984786,0.000042611864,0.000101534715,0.00029410506,0.000007954459],"category_scores_gemma":[0.002437371,0.0003542115,0.000117068965,0.00038305548,0.0004885832,0.00015816689,0.00017127626,0.00032909046,5.8175146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063425105,0.0010693726,0.781093,0.00084749534,0.0003821591,4.2410306e-7,0.002964644,0.00017043093,0.1835432,0.000020596677,0.00046631068,0.028808126],"study_design_scores_gemma":[0.020582048,0.0007360766,0.9401092,0.00064175006,0.00015134149,6.621761e-7,0.00097518467,0.020563634,0.015698776,0.00004062029,0.00015528017,0.00034543846],"about_ca_topic_score_codex":0.00067485485,"about_ca_topic_score_gemma":0.0013228055,"teacher_disagreement_score":0.16784443,"about_ca_system_score_codex":0.000065737055,"about_ca_system_score_gemma":0.000039513976,"threshold_uncertainty_score":0.999891},"labels":[],"label_agreement":null},{"id":"W2103526247","doi":"10.1016/j.msard.2015.05.010","title":"Health care utilization before and after intensive care unit admission in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Manitoba Health; University of Winnipeg; University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Intensive care unit; Population; Incidence (geometry); Comorbidity; Emergency medicine; Quartile; Cohort; Pediatrics; Intensive care medicine; Internal medicine; Environmental health; Confidence interval","score_opus":0.09086773463233234,"score_gpt":0.313579904261413,"score_spread":0.2227121696290807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103526247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96466976,0.029203475,0.000023238174,0.003612999,0.00020545849,0.001792498,0.00009953238,0.0001380284,0.00025503204],"genre_scores_gemma":[0.98339117,0.015002738,0.00039221844,0.0005247011,0.000036371464,0.00018110646,0.00031055484,0.00008164487,0.0000794908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684054,0.00023625752,0.0006861093,0.0008646787,0.0005968369,0.00077555404],"domain_scores_gemma":[0.99749166,0.00014751824,0.00017275948,0.0004165613,0.00091709493,0.0008543906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030581118,0.00047511453,0.00078526407,0.00049624837,0.0003720569,0.00007322456,0.00011463553,0.00035571767,0.00002992196],"category_scores_gemma":[0.0018154528,0.00039206116,0.0001279691,0.0007213018,0.00045105367,0.00026065813,0.00032814877,0.0006081422,0.000013592346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008308041,0.00012022143,0.79240125,0.0004035349,0.000088147215,0.0000053058307,0.04548538,0.00006617338,0.0003672731,0.000004282574,0.00038394055,0.15984371],"study_design_scores_gemma":[0.012275591,0.0007602009,0.8816394,0.0016998585,0.00005392796,0.0000052365126,0.098115355,0.0033506155,0.00013465672,0.000016669455,0.0016046636,0.00034381004],"about_ca_topic_score_codex":0.0021082277,"about_ca_topic_score_gemma":0.011831177,"teacher_disagreement_score":0.1594999,"about_ca_system_score_codex":0.0003180561,"about_ca_system_score_gemma":0.00024173544,"threshold_uncertainty_score":0.99985313},"labels":[],"label_agreement":null},{"id":"W2115266762","doi":"10.1016/j.msard.2012.06.001","title":"The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; McGill University; McGill University Health Centre; University of Alberta; University of Manitoba","funders":"","keywords":"Fibromyalgia; Medicine; Incidence (geometry); Population; Epidemiology; Cohort; Medical record; Cohort study; Physical therapy; Rochester Epidemiology Project; Internal medicine; Demography; Population based study; Environmental health","score_opus":0.03990284989607915,"score_gpt":0.27237564528386604,"score_spread":0.2324727953877869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115266762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902019,0.0072662085,0.000003767528,0.001098641,0.00013618721,0.0012327037,0.000013163575,0.000030918807,0.000016524244],"genre_scores_gemma":[0.9984687,0.0010382885,0.00009346056,0.000006394327,0.0000125333445,0.00010388914,0.000021014046,0.000030895404,0.00022483616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978363,0.0002933433,0.0005220804,0.0003520699,0.000508271,0.0004879664],"domain_scores_gemma":[0.9985392,0.000585062,0.00020255837,0.00045023914,0.00006426704,0.0001586597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068918517,0.000237058,0.00032615958,0.00011690844,0.0004987759,0.000046955585,0.00016776561,0.00016328067,0.000060457307],"category_scores_gemma":[0.00028073296,0.00014114758,0.00009427328,0.00048229937,0.00024260522,0.00018310732,0.00010991872,0.00036719852,0.0000033528524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015519586,0.00033120002,0.99583715,0.0006690421,0.00006772465,5.9121635e-7,0.0007619783,0.0002233999,0.0006133282,0.000029883227,0.00003167194,0.0012788157],"study_design_scores_gemma":[0.0035439592,0.00023434362,0.9875507,0.0011206999,0.00008124908,0.0000026143152,0.0008492196,0.0063612643,0.00004539513,0.00003521471,0.0000064579617,0.00016890494],"about_ca_topic_score_codex":0.003948018,"about_ca_topic_score_gemma":0.00027947736,"teacher_disagreement_score":0.008286492,"about_ca_system_score_codex":0.00008088564,"about_ca_system_score_gemma":0.00004016968,"threshold_uncertainty_score":0.5968249},"labels":[],"label_agreement":null},{"id":"W2122096478","doi":"10.1016/j.msard.2015.10.005","title":"Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; University of British Columbia; Hotchkiss Brain Institute; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Cholesterol; Multiple sclerosis; Medicine; Apolipoprotein B; Pathogenesis; Myelin; Internal medicine; Apolipoprotein E; Cerebrospinal fluid; Disease; Lipoprotein; Endocrinology; Central nervous system; Immunology","score_opus":0.10506030241656844,"score_gpt":0.31284291299262385,"score_spread":0.2077826105760554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122096478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11381976,0.8802319,0.000006070111,0.00033998414,0.00014777792,0.004755389,0.00033651714,0.0001172599,0.0002453294],"genre_scores_gemma":[0.29819816,0.70055866,0.00015100244,0.00003455172,0.000020360016,0.0004843067,0.00019456838,0.0001580633,0.00020032209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943171,0.0005367097,0.001731615,0.0014128855,0.0010704364,0.0009312196],"domain_scores_gemma":[0.99580216,0.0012672935,0.0007668548,0.0009863152,0.00023224123,0.00094512646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096132664,0.0011998533,0.0035103352,0.0010780604,0.00026890985,0.00010878528,0.00030817464,0.00075654493,0.000024469698],"category_scores_gemma":[0.0014925777,0.00083639997,0.00053253403,0.0011081593,0.0012079685,0.0003708037,0.00033500782,0.0015061027,0.000016956503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172702,0.0006967026,0.6020883,0.010865024,0.00105249,0.000006517953,0.0007035557,0.00003326963,0.000007251793,0.000006275562,0.00017613989,0.38374725],"study_design_scores_gemma":[0.01446221,0.00042061636,0.9165679,0.038109835,0.0016124321,0.0000110984365,0.0004663456,0.00038240146,7.9317726e-7,0.000012486599,0.027070543,0.0008833328],"about_ca_topic_score_codex":0.00055513595,"about_ca_topic_score_gemma":0.0010096028,"teacher_disagreement_score":0.3828639,"about_ca_system_score_codex":0.0002563303,"about_ca_system_score_gemma":0.00033377425,"threshold_uncertainty_score":0.99940866},"labels":[],"label_agreement":null},{"id":"W2123705151","doi":"10.1016/j.msard.2015.06.004","title":"Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"Fogarty International Center; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Placebo; Quality of life (healthcare); Internal medicine; Expanded Disability Status Scale; Post-hoc analysis; Clinical endpoint; Physical therapy; Clinical trial; Pathology; Psychiatry","score_opus":0.14454473885104863,"score_gpt":0.331492370615714,"score_spread":0.1869476317646654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123705151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483764,0.002672842,0.000011089217,0.0008071321,0.00009843415,0.001043487,0.00024423498,0.000052367377,0.00023276897],"genre_scores_gemma":[0.99524003,0.004413247,0.000088927285,0.000035563327,0.000016255548,0.000044017896,0.000067377296,0.000054386554,0.000040218223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658954,0.0003026078,0.0011057795,0.0006871098,0.00073037663,0.00058459037],"domain_scores_gemma":[0.99684536,0.00082658796,0.00038267477,0.0005436111,0.00023608544,0.0011656772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073929736,0.00047360707,0.0012378184,0.00050689303,0.00011810948,0.00002669437,0.00016141086,0.00023997531,0.00004731224],"category_scores_gemma":[0.0048457272,0.00034979783,0.00038232162,0.0005334982,0.0008193379,0.00019434969,0.0002334337,0.00046655847,0.000004426585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037939209,0.0012603619,0.9759394,0.00026004214,0.0004522466,8.1091764e-7,0.002878979,0.00055253494,0.009862361,0.00001648342,0.0002853858,0.004697462],"study_design_scores_gemma":[0.0138522,0.0012627674,0.9783925,0.00072934,0.00008429967,2.3535826e-7,0.0017970752,0.0032271831,0.00028238344,0.000034912933,0.000020608402,0.00031653667],"about_ca_topic_score_codex":0.0062779617,"about_ca_topic_score_gemma":0.0006391773,"teacher_disagreement_score":0.010058279,"about_ca_system_score_codex":0.00015853131,"about_ca_system_score_gemma":0.00021908754,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2126814542","doi":"10.1016/j.msard.2013.06.013","title":"A review of the anterior visual pathway model and the study of vitamin D in demyelinating disease","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Multiple sclerosis; Demyelinating disease; Neuroprotection; Neurodegeneration; Neuroscience; Disease; Vitamin D and neurology; Lesion; Demyelinating Disorder; Pathology; Internal medicine; Immunology; Psychology","score_opus":0.05033969121749002,"score_gpt":0.32295917023734727,"score_spread":0.2726194790198573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126814542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030015884,0.9636055,8.1713756e-7,0.00026996396,0.000038931397,0.005995935,0.000028314214,0.000009050756,0.000035604],"genre_scores_gemma":[0.11841841,0.8809093,0.000014195574,0.000033872362,0.0000060999387,0.0005083966,0.0000061861715,0.000035203466,0.00006828863],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971509,0.0006417131,0.0011433489,0.00040734865,0.000392761,0.00026393283],"domain_scores_gemma":[0.9982376,0.00057145796,0.0005599542,0.00042142064,0.00010791399,0.00010166127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009826515,0.00036107123,0.0020458952,0.00015222581,0.00015078654,0.000012582905,0.00020636499,0.0001430735,0.0000071397735],"category_scores_gemma":[0.0018136005,0.00015740856,0.0003792934,0.000539564,0.0006943954,0.00004755328,0.0005155215,0.000590501,8.273278e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000405403,0.0007211864,0.0020224357,0.10326714,0.0004453684,0.0000012780287,0.0009927013,0.0000075641115,0.0000068739623,0.0000038137337,0.00005395484,0.89243716],"study_design_scores_gemma":[0.017775899,0.0005770226,0.040167656,0.9120509,0.004469545,0.0000074529858,0.0030283392,0.015388845,8.1564195e-7,0.000037014415,0.0058822734,0.00061423145],"about_ca_topic_score_codex":0.00017769072,"about_ca_topic_score_gemma":0.000069199305,"teacher_disagreement_score":0.89182293,"about_ca_system_score_codex":0.00002969921,"about_ca_system_score_gemma":0.00013381973,"threshold_uncertainty_score":0.64189345},"labels":[],"label_agreement":null},{"id":"W2131152693","doi":"10.1016/j.msard.2015.03.006","title":"Systematic review of efficacy of TENS for management of central pain in people with multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Central pain; Pain management; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.08999826284677248,"score_gpt":0.30954718935544195,"score_spread":0.21954892650866947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131152693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092270103,0.9879037,0.00013323917,0.000041793162,0.0000701018,0.010521877,0.0002741983,0.00002818125,0.00010418788],"genre_scores_gemma":[0.031162672,0.9677053,0.00034677167,0.00001277464,0.0000034742275,0.00055119616,0.000071030365,0.00007964643,0.00006712385],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99471235,0.0010434649,0.002206556,0.0007292123,0.00077240693,0.0005359983],"domain_scores_gemma":[0.9951034,0.0023381668,0.0015061271,0.00069956057,0.00019167474,0.00016108014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001980288,0.0004921061,0.0032479991,0.0004389039,0.000075442564,0.000018026672,0.00052651047,0.00026586643,0.000019500067],"category_scores_gemma":[0.0027373673,0.00034590423,0.0005805908,0.001651163,0.00029211643,0.00009512153,0.00017579366,0.00029827032,0.0000027078652],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006577381,0.0005397601,0.00030999997,0.935476,0.0002537308,8.221539e-7,0.0001772626,0.00031739238,0.000038076323,0.00005041439,0.00006125686,0.0627095],"study_design_scores_gemma":[0.004746093,0.00043316022,0.0011206215,0.98648185,0.0015091368,0.0000019997708,0.00018116925,0.0036881962,0.00003360928,0.000010251204,0.0013189787,0.0004749324],"about_ca_topic_score_codex":0.0001369788,"about_ca_topic_score_gemma":0.000071793795,"teacher_disagreement_score":0.06223457,"about_ca_system_score_codex":0.00010697355,"about_ca_system_score_gemma":0.00014275261,"threshold_uncertainty_score":0.99989927},"labels":[],"label_agreement":null},{"id":"W2133260093","doi":"10.1016/j.msard.2014.06.006","title":"First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Discontinuation; Palpitations; Internal medicine; Concomitant; Population; Asymptomatic; Bradycardia; Multiple sclerosis; Hazard ratio; Randomized controlled trial; Anesthesia; Heart rate; Blood pressure; Confidence interval","score_opus":0.03996981292271586,"score_gpt":0.28837461309460405,"score_spread":0.24840480017188818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133260093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841633,0.0050350386,0.000055437067,0.0011086359,0.0003360381,0.009066528,0.0000205414,0.000058754253,0.00015573784],"genre_scores_gemma":[0.9912281,0.0054313703,0.0008749031,0.00033012746,0.000018335304,0.0019829788,0.000021030972,0.00009429698,0.000018868946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99297607,0.002280797,0.001681906,0.0010895235,0.0010469244,0.0009247878],"domain_scores_gemma":[0.99008054,0.008130696,0.0004958418,0.0009546501,0.00015303043,0.00018524498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030914533,0.0007164705,0.0021012493,0.00056090916,0.00045505277,0.000216914,0.0005817083,0.0002781141,0.0000401787],"category_scores_gemma":[0.006584736,0.0004589583,0.0002766264,0.00084359566,0.00042315945,0.00045130518,0.00075263495,0.00096936605,0.000008846661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025031034,0.00690707,0.86933696,0.00025691744,0.0009442428,0.000010372771,0.056236498,0.0005973483,0.005838713,0.0000058132205,0.000041783824,0.034793224],"study_design_scores_gemma":[0.26628557,0.00068838475,0.68000066,0.002336841,0.00024156635,5.66843e-7,0.0058394605,0.043922257,0.00017091514,0.00010293642,0.000032266154,0.00037856353],"about_ca_topic_score_codex":0.020048724,"about_ca_topic_score_gemma":0.0146923475,"teacher_disagreement_score":0.24125454,"about_ca_system_score_codex":0.00014975405,"about_ca_system_score_gemma":0.00005069026,"threshold_uncertainty_score":0.9997862},"labels":[],"label_agreement":null},{"id":"W2134894009","doi":"10.1016/j.msard.2015.10.004","title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba","funders":"Canadian Institutes of Health Research; Dalhousie University; Multiple Sclerosis Society of Canada; Research Manitoba","keywords":"Medicine; Anxiety; Meta-analysis; Depression (economics); PsycINFO; CINAHL; MEDLINE; Population; Psychological intervention; Randomized controlled trial; Clinical trial; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.18421839617710947,"score_gpt":0.36616257904167976,"score_spread":0.1819441828645703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134894009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024843626,0.98858535,0.00004769651,0.00023344226,0.00002085924,0.009878826,0.0009010345,0.000044346325,0.000040033523],"genre_scores_gemma":[0.007844049,0.9874913,0.0006867195,0.000037106678,0.0000050198414,0.00332341,0.00033172217,0.000097065385,0.00018361308],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951055,0.0005950252,0.0020241796,0.0011708767,0.0005584669,0.00054595835],"domain_scores_gemma":[0.9962374,0.0012561947,0.0010586093,0.00075077714,0.0003105792,0.00038643938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017627482,0.00085086765,0.010721535,0.0011526969,0.00023814956,0.00006110666,0.00020035433,0.00047214524,0.000038954196],"category_scores_gemma":[0.0018301603,0.0005068624,0.0026264002,0.0017398106,0.0005272219,0.00016131892,0.0003060605,0.00059438153,0.0000012159553],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064002335,0.00040039752,0.0015499076,0.8299914,0.14146979,8.432021e-7,0.00045541977,0.000008562851,0.0000050860917,0.0000031796285,0.00017793145,0.025873497],"study_design_scores_gemma":[0.00315251,0.0002706848,0.0026396841,0.23568845,0.7543109,0.0000088317265,0.0005280096,0.0008947652,6.283569e-7,0.0000025478253,0.0019482389,0.00055473513],"about_ca_topic_score_codex":0.0003647253,"about_ca_topic_score_gemma":0.001193619,"teacher_disagreement_score":0.6128411,"about_ca_system_score_codex":0.000101748985,"about_ca_system_score_gemma":0.00009611301,"threshold_uncertainty_score":0.9997383},"labels":[],"label_agreement":null},{"id":"W2143842592","doi":"10.1016/j.msard.2015.06.011","title":"Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; McGill University","keywords":"Telerehabilitation; Psychological intervention; Medicine; Observational study; Physical therapy; Quality of life (healthcare); Physical medicine and rehabilitation; Intervention (counseling); MEDLINE; Randomized controlled trial; Telemedicine; Systematic review; Evidence-based medicine; Health care; Alternative medicine; Nursing","score_opus":0.09180659834877229,"score_gpt":0.3407987065212382,"score_spread":0.24899210817246592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143842592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011989479,0.9833682,0.000022748654,0.0000794945,0.000100483136,0.014787855,0.0001936207,0.00009551159,0.00015314977],"genre_scores_gemma":[0.030123966,0.96519923,0.00026337232,0.00000897367,0.000009980711,0.0039644446,0.00022664938,0.00014534075,0.00005805418],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928344,0.0021595305,0.0023502144,0.0010863019,0.00090257725,0.000666988],"domain_scores_gemma":[0.9944733,0.0027387557,0.0010498937,0.0009311523,0.00045444403,0.000352485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033358359,0.00092251616,0.006462634,0.00093558483,0.0001707603,0.000041813917,0.0003152419,0.0005426386,0.000027292559],"category_scores_gemma":[0.005216004,0.00061505655,0.0013913421,0.0018801547,0.0006609527,0.00020457029,0.00023613975,0.0010290502,0.00002341244],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013836488,0.0008604354,0.0011771431,0.92492634,0.0014903244,0.0000030639962,0.00041174298,0.000008785236,0.000016431357,0.0000057261873,0.00007938823,0.070882276],"study_design_scores_gemma":[0.0054888744,0.00078842096,0.0105508,0.9750605,0.0055825906,0.00001879603,0.00072494836,0.00013160786,0.0000014748127,0.0000067467963,0.0010582415,0.00058698806],"about_ca_topic_score_codex":0.00039317933,"about_ca_topic_score_gemma":0.00035343852,"teacher_disagreement_score":0.07029529,"about_ca_system_score_codex":0.0004590105,"about_ca_system_score_gemma":0.000349791,"threshold_uncertainty_score":0.9996301},"labels":[],"label_agreement":null},{"id":"W2144456095","doi":"10.1016/j.msard.2014.10.001","title":"The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"IC Design Education Center; Teva Pharmaceutical Industries; Canadian Institutes of Health Research; Biogen","keywords":"Medicine; Pregnancy; Multiple sclerosis; Epidemiology; Gestation; Disease; Obstetrics; Disease registry; Pediatrics; Internal medicine; Immunology","score_opus":0.05401995808955339,"score_gpt":0.2536066723674934,"score_spread":0.19958671427794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144456095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042449952,0.9834316,0.0006377438,0.0002105385,0.0027944117,0.01130751,0.0010866432,0.00019678033,0.00029231678],"genre_scores_gemma":[0.010062539,0.9755598,0.00009319805,0.000011206095,0.00013728606,0.008058075,0.001041222,0.00021778666,0.0048189047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499816,0.0005887296,0.001396889,0.0018511759,0.00010390668,0.0010611359],"domain_scores_gemma":[0.99446386,0.0026272542,0.0011278702,0.0014115255,0.00024071675,0.00012878801],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006982418,0.0010478201,0.0021395925,0.0001831145,0.0021101125,0.00017460936,0.0007184314,0.0012117184,0.000029048293],"category_scores_gemma":[0.0009445273,0.00068430835,0.001576789,0.00037043216,0.0008467701,0.00014027412,0.00018696632,0.0006874305,0.00008284907],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034883808,0.00026594193,0.0007437689,0.008168225,0.0017942006,3.6523463e-7,0.00035146408,0.000004796762,0.00012150262,0.00083053357,0.0072951885,0.9800752],"study_design_scores_gemma":[0.005325646,0.00025561737,0.0012602546,0.026394285,0.0011255614,0.000008119595,0.00019641173,0.000017277534,0.000020286636,0.00063126045,0.9637804,0.0009848485],"about_ca_topic_score_codex":0.000050876457,"about_ca_topic_score_gemma":0.000061874685,"teacher_disagreement_score":0.97909033,"about_ca_system_score_codex":0.00011673567,"about_ca_system_score_gemma":0.00016162242,"threshold_uncertainty_score":0.99956083},"labels":[],"label_agreement":null},{"id":"W2148777218","doi":"10.1016/j.msard.2015.07.008","title":"Causes of death among persons with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Pharmaceuticals Bayer","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.071921140258111,"score_gpt":0.27006203358034037,"score_spread":0.19814089332222937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148777218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917882,0.002897624,0.00008048254,0.0009994158,0.00013439027,0.0012596552,0.000087337095,0.00019797719,0.0025549028],"genre_scores_gemma":[0.99310786,0.004525126,0.0014078615,0.00006169213,0.00003895411,0.00014065459,0.00005417725,0.00009962276,0.00056402973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966923,0.00014974471,0.0006452466,0.00077805447,0.00093305146,0.0008016007],"domain_scores_gemma":[0.9976299,0.0003422167,0.00026435987,0.00060294813,0.00039745212,0.00076312665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000482835,0.0005106773,0.000903407,0.00038085348,0.00034013749,0.00005632823,0.00020229584,0.0003042154,0.000066692475],"category_scores_gemma":[0.0011885032,0.00037305616,0.00023389519,0.0007268525,0.0011076176,0.0002961094,0.00022396332,0.00053809816,0.00001974449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008619094,0.00066829065,0.97380704,0.00015714485,0.00075572234,0.0000064661244,0.0034061216,0.0003255822,0.010343088,0.00002165791,0.0016548396,0.007992149],"study_design_scores_gemma":[0.014437767,0.0010085525,0.96818864,0.0009823261,0.00029843266,0.000010253965,0.0060123946,0.0052092317,0.0025790224,0.000020533962,0.00076840504,0.00048441484],"about_ca_topic_score_codex":0.0031815455,"about_ca_topic_score_gemma":0.0016957712,"teacher_disagreement_score":0.0135758575,"about_ca_system_score_codex":0.000119983444,"about_ca_system_score_gemma":0.0001644913,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W2150598981","doi":"10.1016/j.msard.2012.06.002","title":"Treatment of neuromyelitis optica: Review and recommendations","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Neuromyelitis optica; Medicine; Azathioprine; Rituximab; Multiple sclerosis; Mitoxantrone; Natalizumab; Prednisone; Optic neuritis; Methotrexate; Disease; Demyelinating disease; Immunology; Intensive care medicine; Dermatology; Internal medicine; Lymphoma; Chemotherapy","score_opus":0.05910238043995268,"score_gpt":0.30503082558224137,"score_spread":0.24592844514228868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150598981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6125699,0.3434561,0.000029060824,0.035612695,0.0002658485,0.0028024777,0.00012963476,0.00012858969,0.0050056865],"genre_scores_gemma":[0.57684726,0.42219022,0.0006078083,0.000079986436,0.000014065434,0.000060434708,0.000026378819,0.000014198895,0.00015965052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99882114,0.000070250084,0.00036295064,0.00024525018,0.00015573653,0.00034465478],"domain_scores_gemma":[0.999122,0.00023226887,0.0000891758,0.00023028268,0.00006456468,0.0002617033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014289655,0.00019732614,0.0004990194,0.00008037558,0.00016512138,0.00000938811,0.00003371458,0.00008014945,0.00014578729],"category_scores_gemma":[0.0002645431,0.00014006057,0.00013211704,0.00022246648,0.0002624364,0.00012112287,0.00006233574,0.000108856315,0.000008196207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010809941,0.0018876984,0.32328117,0.0018055063,0.0011911255,9.721487e-7,0.003019867,0.0000023970742,0.0084317755,0.00021291763,0.0033564332,0.65670204],"study_design_scores_gemma":[0.005691293,0.0007601629,0.95607156,0.0011836125,0.0007065177,0.000022814922,0.00068929663,0.00046642445,0.0003211792,0.000014878998,0.03381795,0.00025428407],"about_ca_topic_score_codex":0.00014418055,"about_ca_topic_score_gemma":0.000016386452,"teacher_disagreement_score":0.65644777,"about_ca_system_score_codex":0.00003278852,"about_ca_system_score_gemma":0.00001518273,"threshold_uncertainty_score":0.5711504},"labels":[],"label_agreement":null},{"id":"W2150843744","doi":"10.1016/j.msard.2015.03.005","title":"Impact of multiple sclerosis relapse: The NARCOMS participant perspective","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; University of Alabama at Birmingham; Cleveland Clinic","keywords":"Medicine; Weakness; Adverse effect; Socioeconomic status; Multiple sclerosis; Physical therapy; Pediatrics; Internal medicine; Psychiatry; Population; Surgery; Environmental health","score_opus":0.11985218648706887,"score_gpt":0.32715469634648775,"score_spread":0.2073025098594189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150843744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438674,0.008099242,0.00003985392,0.0035809884,0.00023264429,0.0015870136,0.00008998924,0.00015033652,0.0018331935],"genre_scores_gemma":[0.9915591,0.0074970103,0.00027721009,0.00006536196,0.00006215546,0.00017066734,0.000027650565,0.00008243523,0.00025843835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614906,0.00034139727,0.0008407489,0.0007642246,0.0009494343,0.00095510716],"domain_scores_gemma":[0.9967791,0.00068619446,0.00031489352,0.0008366967,0.0006872309,0.00069589744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010406126,0.00052377145,0.0009284568,0.00027760727,0.0004850754,0.00006806933,0.00031268547,0.0002967562,0.00010747684],"category_scores_gemma":[0.0040555154,0.00031639138,0.0006128952,0.0009508752,0.0014331985,0.00023710578,0.0003755413,0.00077870535,0.000048641996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027055002,0.0022530092,0.88547105,0.00011528474,0.0035434738,0.0000074672334,0.027265185,0.0020227386,0.04298149,0.0002479292,0.007933807,0.025453053],"study_design_scores_gemma":[0.012709641,0.001430852,0.9550571,0.00044904003,0.00035900934,0.000012218289,0.015778694,0.012539035,0.00061043765,0.00023295445,0.0003958218,0.00042523985],"about_ca_topic_score_codex":0.005828563,"about_ca_topic_score_gemma":0.00055748585,"teacher_disagreement_score":0.069585994,"about_ca_system_score_codex":0.0003250872,"about_ca_system_score_gemma":0.000274542,"threshold_uncertainty_score":0.99992883},"labels":[],"label_agreement":null},{"id":"W2153660935","doi":"10.1016/j.msard.2013.05.001","title":"Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Ottawa; Ottawa Hospital","funders":"Multiple Sclerosis Society of Canada; Ottawa Hospital Research Institute","keywords":"Medicine; Brain size; Multiple sclerosis; Hematopoietic stem cell transplantation; Cognitive decline; Neuropsychology; Cognition; Neuroimaging; Transplantation; White matter; Internal medicine; Immunosuppression; Stem cell; Stem-cell therapy; Magnetic resonance imaging; Psychiatry; Dementia; Radiology; Disease","score_opus":0.10941312305433593,"score_gpt":0.27682485745710045,"score_spread":0.16741173440276452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153660935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247623,0.011332071,0.000016869513,0.0006213033,0.00009436741,0.0051802634,0.00002235714,0.00010459841,0.00015195324],"genre_scores_gemma":[0.9588129,0.03981513,0.000077708086,0.00013694816,0.000016666077,0.00100603,0.00002324961,0.00007579933,0.000035586523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970624,0.00034055655,0.00060981425,0.00088787294,0.00044059666,0.00065877114],"domain_scores_gemma":[0.998464,0.00079363567,0.00015183937,0.0002239479,0.00010721036,0.0002593861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044535153,0.0004952661,0.0007232437,0.00040809796,0.000512834,0.00015826515,0.00008885434,0.000117538395,0.000024178566],"category_scores_gemma":[0.00010579631,0.00041528887,0.00009392284,0.00050512294,0.0003529714,0.0005993434,0.00013041892,0.0005628364,0.000010083972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081319665,0.0016957056,0.81533766,0.00023419654,0.00034811534,0.000014318346,0.042517606,0.00000567258,0.04229673,0.0000014838034,0.0000095033265,0.09672584],"study_design_scores_gemma":[0.024849499,0.001802616,0.9383323,0.0010946174,0.00013643217,0.000006428019,0.028581455,0.00425082,0.0005191963,0.000017709277,0.0000040737573,0.00040482357],"about_ca_topic_score_codex":0.003563561,"about_ca_topic_score_gemma":0.000562594,"teacher_disagreement_score":0.1229947,"about_ca_system_score_codex":0.000045703044,"about_ca_system_score_gemma":0.00002302012,"threshold_uncertainty_score":0.9998299},"labels":[],"label_agreement":null},{"id":"W2155985098","doi":"10.1016/j.msard.2012.12.008","title":"The case for vitamin D supplementation in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Northeast Agricultural University","keywords":"Multiple sclerosis; Medicine; Vitamin D and neurology; Vitamin; Dermatology; Immunology; Internal medicine","score_opus":0.09870726692141728,"score_gpt":0.32930019459119186,"score_spread":0.23059292766977457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155985098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030915078,0.9876995,0.000018803743,0.00075607834,0.00031326234,0.0076702023,0.0002578702,0.00006699194,0.00012577054],"genre_scores_gemma":[0.018368196,0.97563016,0.00037467616,0.000023345032,0.000053694836,0.004087557,0.00045319347,0.00012549212,0.00088367535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660486,0.0002789852,0.0011469388,0.00079088483,0.0003203251,0.0008580137],"domain_scores_gemma":[0.9962094,0.0025601168,0.0003500601,0.0005158022,0.00013842204,0.00022620849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007842776,0.0006324328,0.0014897741,0.00038437103,0.0009443547,0.00014829882,0.0002053195,0.0005226307,0.000052826257],"category_scores_gemma":[0.0013208352,0.00038539182,0.0005782297,0.0006277027,0.00048041786,0.00014214759,0.00022893168,0.00074463926,0.000039964092],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003817666,0.00021864634,0.00062835857,0.0053856336,0.0005665234,0.000021126547,0.0003449429,0.000002876602,0.000017351816,0.000015002922,0.00500613,0.98775524],"study_design_scores_gemma":[0.018297479,0.0007544174,0.0050882567,0.023738004,0.0021035103,0.00021142591,0.005824406,0.0027414076,0.000012316184,0.000084409534,0.93991244,0.0012319194],"about_ca_topic_score_codex":0.0010332939,"about_ca_topic_score_gemma":0.0027839465,"teacher_disagreement_score":0.98652333,"about_ca_system_score_codex":0.00023285107,"about_ca_system_score_gemma":0.0001237748,"threshold_uncertainty_score":0.9998598},"labels":[],"label_agreement":null},{"id":"W2157274485","doi":"10.1016/j.msard.2012.05.002","title":"Cognitive impact of anticholinergic medication in MS: Adding insult to injury?","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anticholinergic; Cognition; Multiple sclerosis; Context (archaeology); Beck Depression Inventory; Depression (economics); Population; Effects of sleep deprivation on cognitive performance; Clinical psychology; Psychiatry; Internal medicine; Anxiety","score_opus":0.041557110188370765,"score_gpt":0.3309136278458142,"score_spread":0.2893565176574434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157274485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953243,0.0018249509,0.000031681127,0.00047345087,0.00009949802,0.0009055631,0.00006421629,0.00004192636,0.0012344127],"genre_scores_gemma":[0.9932317,0.006217938,0.00024219164,0.000058187055,0.00004114727,0.00008011844,0.000057081772,0.000032652297,0.000038986043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980574,0.00010832216,0.0005354335,0.00032024566,0.0003984777,0.0005800983],"domain_scores_gemma":[0.9987743,0.0003400123,0.00013297694,0.00019807293,0.00015182368,0.00040283875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005697337,0.00023678428,0.0004878171,0.00051329186,0.000104449486,0.000012387267,0.00008054902,0.00018142702,0.00011247503],"category_scores_gemma":[0.0022844002,0.00018111261,0.00014962553,0.00086355425,0.0002301378,0.00020752674,0.00012862042,0.00034929463,0.000024718793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005859099,0.00072441006,0.8920259,0.00007306778,0.0002750493,4.6010206e-7,0.0043907324,0.00006407961,0.039737098,0.000012011444,0.00030430377,0.06180698],"study_design_scores_gemma":[0.004741617,0.0004063967,0.9897899,0.0008167322,0.000063912594,0.0000017363553,0.0012416438,0.0015191556,0.001113696,0.0000069631897,0.000107391024,0.00019082415],"about_ca_topic_score_codex":0.0012504404,"about_ca_topic_score_gemma":0.000109314395,"teacher_disagreement_score":0.09776404,"about_ca_system_score_codex":0.000110429486,"about_ca_system_score_gemma":0.000057116915,"threshold_uncertainty_score":0.7385558},"labels":[],"label_agreement":null},{"id":"W2157932760","doi":"10.1016/j.msard.2015.06.012","title":"Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neurosarcoidosis; Medicine; Multiple sclerosis; Sarcoidosis; Differential diagnosis; Brain biopsy; Presentation (obstetrics); Intensive care medicine; Pathology; Biopsy; Radiology; Immunology","score_opus":0.242094896031619,"score_gpt":0.4067767959533758,"score_spread":0.1646818999217568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012662888,0.98292786,0.0000024781427,0.00082342,0.00016665972,0.0027807842,0.00019624416,0.00005390879,0.00038574653],"genre_scores_gemma":[0.057743948,0.9412735,0.00007374276,0.00006748311,0.00007306388,0.00039279365,0.00016136988,0.00009477072,0.00011933877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539596,0.001241366,0.0015183723,0.00074922945,0.0006214234,0.0004736339],"domain_scores_gemma":[0.9959614,0.002145981,0.00071514887,0.000669377,0.0001746271,0.0003334391],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025361096,0.0005566248,0.0030442078,0.00043574732,0.0003657824,0.00012781494,0.00025864068,0.00058139814,0.0001216227],"category_scores_gemma":[0.0024371946,0.00032123766,0.00074875396,0.0008838861,0.0005583351,0.00013365998,0.00021994216,0.0008446231,0.000012575529],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009910335,0.0004949921,0.002032857,0.0025554288,0.00067867216,0.0000033328868,0.00039654542,0.000004288891,0.000029154577,0.000059253176,0.00042820175,0.9932182],"study_design_scores_gemma":[0.006767655,0.0014190204,0.0059658503,0.020355025,0.008878818,0.00015868939,0.0007322336,0.0010926554,0.000021620737,0.0003138213,0.9533172,0.0009773766],"about_ca_topic_score_codex":0.0004598087,"about_ca_topic_score_gemma":0.000096234784,"teacher_disagreement_score":0.9922408,"about_ca_system_score_codex":0.00005611597,"about_ca_system_score_gemma":0.0002680738,"threshold_uncertainty_score":0.99992394},"labels":[],"label_agreement":null},{"id":"W2171984869","doi":"10.1016/j.msard.2014.09.213","title":"CD20+ T cells in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; CD8; Medicine; Cytotoxic T cell; Immunology; Rituximab; Web of science; T cell; Antibody; Pathology; Biology; Antigen; Immune system; Meta-analysis; In vitro; Biochemistry","score_opus":0.044285024032432965,"score_gpt":0.25267670031417616,"score_spread":0.2083916762817432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171984869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886574,0.0016462457,0.00013180322,0.002487025,0.00040469022,0.0014418111,0.00004011707,0.00026369732,0.004927199],"genre_scores_gemma":[0.9843466,0.013399095,0.001041888,0.00030788587,0.00007426453,0.00017974978,0.00004849842,0.00010492048,0.00049709633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594045,0.0002837209,0.00087924494,0.0010632784,0.0007055167,0.001127791],"domain_scores_gemma":[0.99758404,0.0008861091,0.00017758738,0.00069262175,0.00013689592,0.0005227452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008927325,0.0005624676,0.00092418474,0.00056307483,0.00046577762,0.00009318623,0.00025089775,0.0004435054,0.00019830951],"category_scores_gemma":[0.001492183,0.0004811701,0.0002996157,0.0009052897,0.000653687,0.0002429859,0.00030856812,0.0008736222,0.00017425745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071468146,0.001452174,0.56074816,0.0003401378,0.0003722663,0.0000064100273,0.002210639,0.0007793346,0.20976764,0.000096323114,0.002820722,0.22069149],"study_design_scores_gemma":[0.016503867,0.00042617964,0.9301559,0.00087779306,0.00009029355,0.0000042811303,0.0009128053,0.03824045,0.0048608137,0.00012024734,0.0071341326,0.00067326316],"about_ca_topic_score_codex":0.0012866132,"about_ca_topic_score_gemma":0.001365075,"teacher_disagreement_score":0.36940768,"about_ca_system_score_codex":0.00013698138,"about_ca_system_score_gemma":0.00005495111,"threshold_uncertainty_score":0.999764},"labels":[],"label_agreement":null},{"id":"W2175178720","doi":"10.1016/j.msard.2015.10.007","title":"Spasticity in multiple sclerosis: Associations with impairments and overall quality of life","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux; Biogen","keywords":"Spasticity; Medicine; Depression (economics); Anxiety; Quality of life (healthcare); Multiple sclerosis; Physical therapy; Hospital Anxiety and Depression Scale; Mood; Physical medicine and rehabilitation; Visual analogue scale; Psychiatry","score_opus":0.10090376673045053,"score_gpt":0.2992243905898357,"score_spread":0.19832062385938515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175178720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515355,0.0017281871,0.000046323858,0.0012104497,0.00007264536,0.001101551,0.00011626852,0.00007412213,0.00049691],"genre_scores_gemma":[0.99592745,0.002888458,0.0008080035,0.00010807975,0.000019577705,0.00008922354,0.000053404758,0.000042255746,0.00006355836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969582,0.00027203184,0.00084329734,0.0005912127,0.0007533958,0.00058186473],"domain_scores_gemma":[0.99789107,0.00060373696,0.00032174386,0.00032989454,0.00027817872,0.0005753578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010061935,0.00034531884,0.0008867348,0.000286151,0.00017973334,0.000042959833,0.000109404624,0.00024734458,0.000019419078],"category_scores_gemma":[0.00358505,0.00027195938,0.000110357454,0.00051264506,0.0005560551,0.00024029196,0.0002051805,0.00045914663,0.0000052598757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096346193,0.0009249065,0.9852791,0.00013625984,0.0003568367,0.0000013322212,0.0022939914,0.00040288988,0.005508172,0.000020659068,0.00026522993,0.0038471718],"study_design_scores_gemma":[0.021999702,0.0005120072,0.9688355,0.0004590817,0.000071991606,0.0000013066241,0.0021635394,0.0054085846,0.00014671059,0.00006886438,0.000043625154,0.0002891025],"about_ca_topic_score_codex":0.0049523637,"about_ca_topic_score_gemma":0.0029725302,"teacher_disagreement_score":0.02103624,"about_ca_system_score_codex":0.00015469738,"about_ca_system_score_gemma":0.00016992078,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2188134163","doi":"10.1016/j.msard.2015.11.007","title":"Reducing clinical trial risk in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Clinical trial; Multiple sclerosis; Drug; Population; Phases of clinical research; Pharmaceutical industry; Clinical research; Internal medicine; Intensive care medicine; Pharmacology; Immunology; Environmental health","score_opus":0.172068959375452,"score_gpt":0.3449676101354311,"score_spread":0.1728986507599791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188134163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890226,0.0033668852,0.000039868522,0.0016248537,0.001072892,0.0025443835,0.000047737463,0.00023515511,0.0020455834],"genre_scores_gemma":[0.9709531,0.026698083,0.0013234296,0.00011603496,0.0002288069,0.00023440183,0.00005573929,0.00009923546,0.00029116182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99423176,0.0007686404,0.0017189676,0.0012794541,0.0009159914,0.0010851619],"domain_scores_gemma":[0.9962378,0.0013426784,0.0003958959,0.00079139945,0.00024251424,0.0009897272],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032562152,0.0005552163,0.001245695,0.00052103726,0.00041688688,0.00010458971,0.0002676608,0.0006318293,0.00007716331],"category_scores_gemma":[0.012048329,0.0004639673,0.00046385228,0.0010059946,0.0008592556,0.0003026357,0.00039513264,0.0015765054,0.00011266287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025290117,0.0022919052,0.75947577,0.000070008944,0.00049015245,0.000011112013,0.002265317,0.00053655147,0.0013788741,0.00001049746,0.00393231,0.20424739],"study_design_scores_gemma":[0.21321405,0.0015993329,0.75800174,0.0006589044,0.00017527441,0.000004590869,0.0023116448,0.020854138,0.00013236915,0.000098752724,0.0023768945,0.00057228276],"about_ca_topic_score_codex":0.0034355046,"about_ca_topic_score_gemma":0.0013128724,"teacher_disagreement_score":0.2036751,"about_ca_system_score_codex":0.00021731447,"about_ca_system_score_gemma":0.00023483795,"threshold_uncertainty_score":0.9997812},"labels":[],"label_agreement":null},{"id":"W2195362151","doi":"10.1016/j.msard.2015.11.006","title":"Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Tolerability; Discontinuation; Adverse effect; Placebo; Internal medicine; Clinical trial; Nausea; Multiple sclerosis; Fingolimod; Immunology; Pathology; Alternative medicine","score_opus":0.12482319335835053,"score_gpt":0.3203329941100626,"score_spread":0.1955098007517121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195362151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544169,0.03517253,0.000046828543,0.007443102,0.00022046083,0.0018949975,0.00021484734,0.00013404244,0.00045633392],"genre_scores_gemma":[0.95033747,0.047672816,0.0012794305,0.00019007038,0.00005594286,0.000075445976,0.000118087395,0.00004190363,0.0002288522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682826,0.00031296004,0.00077602477,0.0011078685,0.00044999341,0.0005248757],"domain_scores_gemma":[0.996647,0.0014381894,0.0001750271,0.0008881445,0.00025150782,0.0006001161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012497881,0.0004337941,0.0013606455,0.00014830627,0.00050486194,0.00008648893,0.00017717647,0.00022553008,0.000029618483],"category_scores_gemma":[0.0064681876,0.00030916103,0.00009183264,0.00020667337,0.0009491339,0.00030491006,0.001104128,0.00045834435,0.000010937445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053408183,0.0012074809,0.68093294,0.0005526623,0.0090434365,0.00004326562,0.012885527,0.00017486347,0.028276438,0.000051934418,0.010747935,0.20267536],"study_design_scores_gemma":[0.07933719,0.0003774309,0.8757399,0.0006023434,0.0008145574,0.000012534662,0.008093211,0.032019414,0.000041548217,0.0003912351,0.0020689785,0.0005016809],"about_ca_topic_score_codex":0.0009947382,"about_ca_topic_score_gemma":0.0010193236,"teacher_disagreement_score":0.20217368,"about_ca_system_score_codex":0.00007514754,"about_ca_system_score_gemma":0.000083700215,"threshold_uncertainty_score":0.99993604},"labels":[],"label_agreement":null},{"id":"W2219352761","doi":"10.1016/j.msard.2015.05.002","title":"Corrigendum to “Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis” [Mult. Scler. Relat. Disord. 4 (2015) 104–111]","year":2015,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Dysautonomia; Regret; Spelling; Internal medicine; Cardiology; Psychiatry; Disease","score_opus":0.08134465008097701,"score_gpt":0.24602184000507774,"score_spread":0.16467718992410074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219352761","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22639728,0.5644542,0.0037415891,0.04078235,0.0868499,0.043689363,0.006039293,0.0042678993,0.023778148],"genre_scores_gemma":[0.9252743,0.013796428,0.0008262689,0.0010069936,0.0005463139,0.0016029755,0.0034206675,0.0004997114,0.053026307],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907217,0.0008831389,0.0026142776,0.003035785,0.0011538918,0.0015911845],"domain_scores_gemma":[0.9949133,0.00031483854,0.0006084984,0.0025392391,0.00037035794,0.0012537786],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0033176963,0.0016463177,0.0061570187,0.0019628985,0.0005118674,0.00025329937,0.000501935,0.0027186929,0.00085839955],"category_scores_gemma":[0.0012320725,0.0014321151,0.005548917,0.0026594226,0.0004135772,0.00040607256,0.0004044755,0.003200885,0.0005520193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017258142,0.003742064,0.010869482,0.00075998704,0.44254577,0.00005696209,0.005159332,0.039659057,0.0020770633,0.000026020854,0.41050845,0.08286999],"study_design_scores_gemma":[0.016101023,0.0007540397,0.08965054,0.0005438993,0.19866586,0.000011260727,0.0010220552,0.08073201,0.000026396981,0.00013096881,0.6098066,0.0025553228],"about_ca_topic_score_codex":0.007321242,"about_ca_topic_score_gemma":0.0049093408,"teacher_disagreement_score":0.69887704,"about_ca_system_score_codex":0.00095284934,"about_ca_system_score_gemma":0.0009178202,"threshold_uncertainty_score":0.9996284},"labels":[],"label_agreement":null},{"id":"W2269092789","doi":"10.1016/j.msard.2016.02.001","title":"Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"Biogen","keywords":"Medicine; Daclizumab; Multiple sclerosis; Disease; Ocrelizumab; Relapsing remitting; Physical therapy; Clinical trial; Internal medicine; Natalizumab; Dimethyl fumarate; Alemtuzumab; Intensive care medicine; Immunology; Rituximab; Transplantation","score_opus":0.08869802365204665,"score_gpt":0.32983019147040266,"score_spread":0.241132167818356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269092789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990917,0.00089785614,0.000014413929,0.004517327,0.00018368792,0.0026077335,0.00059209537,0.00008952558,0.00018031317],"genre_scores_gemma":[0.9905827,0.008859777,0.000044254033,0.000052369523,0.00005612364,0.00021784345,0.00006007723,0.000061909064,0.00006495748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962096,0.0005733517,0.00088287983,0.0009222144,0.0007467983,0.0006651383],"domain_scores_gemma":[0.99165386,0.0061731124,0.0005790387,0.0010292281,0.00015919999,0.0004055885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054660003,0.0005851128,0.0008357338,0.00014117332,0.00084241683,0.00013970451,0.00018773532,0.00020843267,0.000044922977],"category_scores_gemma":[0.00580275,0.00023487791,0.00057549647,0.0004062,0.0008676794,0.0002939044,0.00020255611,0.000355786,0.000006126376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055787474,0.002426033,0.518156,0.000021331123,0.0030811946,0.000006146576,0.0022184309,0.000117814285,0.041182604,0.000002069403,0.00054491655,0.37645602],"study_design_scores_gemma":[0.098578915,0.0019079827,0.8941423,0.00060831377,0.00036700614,0.00000106532,0.0006579954,0.0021034523,0.0012544926,0.000022418484,0.00007666015,0.00027935504],"about_ca_topic_score_codex":0.007465598,"about_ca_topic_score_gemma":0.00043617806,"teacher_disagreement_score":0.37617666,"about_ca_system_score_codex":0.00026897638,"about_ca_system_score_gemma":0.0002087513,"threshold_uncertainty_score":0.9991438},"labels":[],"label_agreement":null},{"id":"W2284283107","doi":"10.1016/j.msard.2016.02.012","title":"Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life – A post hoc analysis of the TEMSO and TOWER studies","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare; Sanofi Genzyme; Sanofi; Genzyme","keywords":"Post-hoc analysis; Medicine; Multiple sclerosis; Post hoc; Quality of life (healthcare); Health related quality of life; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Disease; Immunology","score_opus":0.09871362279575006,"score_gpt":0.3100903200121196,"score_spread":0.21137669721636954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284283107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761211,0.015755974,0.000007272702,0.0060600527,0.000077593286,0.0014141105,0.00043419324,0.00008340201,0.000046273122],"genre_scores_gemma":[0.969232,0.030240634,0.00010209906,0.0001352791,0.000007715369,0.00008527386,0.000043577875,0.000054236636,0.00009916656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995095,0.0008424823,0.0016292646,0.0009037572,0.0008736288,0.0006558258],"domain_scores_gemma":[0.99363625,0.0029778518,0.0014731784,0.00069281604,0.0007740026,0.000445912],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015319918,0.00054184406,0.0022214,0.0005652945,0.00061446574,0.00003090768,0.00018970203,0.00033484792,0.000034729383],"category_scores_gemma":[0.011654696,0.00029247164,0.00035965824,0.0019322897,0.0023697868,0.00020474438,0.00037761984,0.0003993959,5.2277915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018422768,0.0006626807,0.9140036,0.00031824192,0.011374741,6.683838e-7,0.003938214,0.00005040469,0.05919736,0.000015161622,0.00025074603,0.008345896],"study_design_scores_gemma":[0.014173729,0.00075376744,0.9729159,0.0029926037,0.0011516509,0.0000010581109,0.0062215873,0.0007552643,0.00064245425,0.000016691714,0.000012268184,0.00036303708],"about_ca_topic_score_codex":0.0041487995,"about_ca_topic_score_gemma":0.006857557,"teacher_disagreement_score":0.05891228,"about_ca_system_score_codex":0.0001387504,"about_ca_system_score_gemma":0.00016966561,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W2346221108","doi":"10.1016/j.msard.2016.05.006","title":"Adherence and persistence to drug therapies for multiple sclerosis: A population-based study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Quality Council; University of British Columbia Hospital; Health Sciences Centre; Manitoba Health; University of Manitoba; University of Saskatchewan","funders":"Ministry of Health, British Columbia; National Multiple Sclerosis Society","keywords":"Medicine; Discontinuation; Persistence (discontinuity); Glatiramer acetate; Population; Multiple sclerosis; Demography; Internal medicine; Socioeconomic status; Pediatrics; Disease; Immunology; Environmental health","score_opus":0.06897687515609541,"score_gpt":0.2839010022949514,"score_spread":0.214924127138856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346221108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987308,0.0018594625,0.0003148351,0.0057384907,0.0001631014,0.0042615808,0.00011382113,0.00018800754,0.000052697596],"genre_scores_gemma":[0.994914,0.0016438841,0.001636989,0.00023558202,0.00003965788,0.001054637,0.00001977803,0.0000750655,0.00038039568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693465,0.00015762863,0.00060098193,0.0010402094,0.0005442088,0.0007222953],"domain_scores_gemma":[0.9972843,0.0013309463,0.00015174189,0.0005073008,0.00025410551,0.00047158895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005800233,0.00046423334,0.00067306584,0.00032382997,0.0007365945,0.00009734989,0.00018904994,0.00015675208,0.00006170863],"category_scores_gemma":[0.0017890394,0.0003064288,0.00020516737,0.00043465092,0.0002686564,0.00021379306,0.0001658317,0.00020063338,0.00001693063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009225792,0.0007240137,0.8585194,0.00011315553,0.0003477309,7.8334415e-7,0.0034304333,0.000039361836,0.02422707,0.000008185705,0.0003624073,0.1113049],"study_design_scores_gemma":[0.015634509,0.0012080818,0.97297937,0.0009685645,0.00014599456,8.6180364e-7,0.0054482436,0.0022915916,0.00040712088,0.000039603263,0.00041265023,0.00046343636],"about_ca_topic_score_codex":0.0009202519,"about_ca_topic_score_gemma":0.0019408622,"teacher_disagreement_score":0.11445996,"about_ca_system_score_codex":0.000108261505,"about_ca_system_score_gemma":0.000059048176,"threshold_uncertainty_score":0.9999388},"labels":[],"label_agreement":null},{"id":"W2359083594","doi":"10.1016/j.msard.2016.05.009","title":"Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Manitoba Health; University of British Columbia; University of Alberta; University of Manitoba; Ministry of Health; McGill University; University of Calgary","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Department of Health and Wellness; Multiple Sclerosis Society; University of Alberta; Department of Health, Western Cape Government; Research Manitoba; Multiple Sclerosis Society of Canada; McGill University","keywords":"Medicine; Incidence (geometry); Population; Poisson regression; Epidemiology; Cohort; Asthma; Multiple sclerosis; Demography; Internal medicine; Pediatrics; Immunology; Environmental health","score_opus":0.03066636304140985,"score_gpt":0.2657576412911219,"score_spread":0.23509127824971204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2359083594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513245,0.040001307,0.000063077285,0.006407783,0.00017240219,0.001141763,0.00017856433,0.00025159577,0.00045901473],"genre_scores_gemma":[0.8942759,0.10352149,0.00015855752,0.000076352735,0.00010243395,0.00015683846,0.000027985783,0.000077341676,0.0016031091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628776,0.00018150551,0.0006857887,0.0012352613,0.00065904186,0.00095065346],"domain_scores_gemma":[0.9974807,0.00057780585,0.0002015652,0.0005732714,0.00013606343,0.0010306117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004878502,0.0005972301,0.00071711617,0.0005017094,0.0006926946,0.000116856696,0.00017502208,0.00028691487,0.00021167038],"category_scores_gemma":[0.0010576601,0.00039950336,0.00018726644,0.0005614577,0.0014754435,0.0005235929,0.00048575658,0.00040752575,0.000017139138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043871978,0.000180139,0.79032415,0.0004901744,0.00032018978,0.0000066259067,0.00036538116,0.0000049330147,0.015618631,0.000027082879,0.0009895694,0.19123441],"study_design_scores_gemma":[0.012331028,0.0003056928,0.97254276,0.0026469354,0.00031799695,0.000008807554,0.00017179246,0.009386117,0.000191565,0.00006289699,0.0014667477,0.00056763046],"about_ca_topic_score_codex":0.00028194737,"about_ca_topic_score_gemma":0.00034446383,"teacher_disagreement_score":0.19066676,"about_ca_system_score_codex":0.00016189895,"about_ca_system_score_gemma":0.00011120232,"threshold_uncertainty_score":0.9998457},"labels":[],"label_agreement":null},{"id":"W2463810424","doi":"10.1016/j.msard.2016.07.003","title":"Brain health: time matters in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":451,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Actelion Pharmaceuticals; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Università degli Studi di Firenze; Karolinska Institutet; Multiple Sclerosis Society; Multiple Sclerosis Trust; Universität Basel; Univerzita Karlova v Praze; Sanofi Genzyme; F. Hoffmann-La Roche; Sanofi; AbbVie; Biogen; Royal Holloway, University of London; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Cognition; Action (physics); Health care; Intensive care medicine; Psychiatry; Pathology","score_opus":0.08942027039325148,"score_gpt":0.320134813110155,"score_spread":0.23071454271690353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463810424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004198444,0.9788709,0.000012254173,0.013932387,0.0003774955,0.0050841975,0.00047566605,0.00031857306,0.00050865865],"genre_scores_gemma":[0.0011863271,0.99403125,0.0002764973,0.0009489927,0.00011793417,0.0008107718,0.00042705308,0.00036297913,0.0018382164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914975,0.000945189,0.0024742866,0.0020472049,0.0010040099,0.00203181],"domain_scores_gemma":[0.9942346,0.0026463561,0.00085256784,0.001200672,0.000120756056,0.0009450345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014918243,0.0015224478,0.0049390765,0.0015162429,0.00060640485,0.00013422148,0.00052712235,0.0011751043,0.00057280663],"category_scores_gemma":[0.0017852444,0.0010874383,0.0012750175,0.0014709021,0.0009431464,0.00026977135,0.00064298575,0.0016996057,0.0010621053],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011255444,0.0004972977,0.0013881346,0.008158703,0.00080974674,0.000009158035,0.00039254298,0.0000025598706,0.00010212505,0.00000474908,0.021276968,0.96724546],"study_design_scores_gemma":[0.010216838,0.0003965323,0.010498375,0.09503075,0.00030857927,0.000034269193,0.00016036133,0.0003347499,0.0000023956488,0.00001863027,0.8816637,0.0013348549],"about_ca_topic_score_codex":0.0008660677,"about_ca_topic_score_gemma":0.0004391669,"teacher_disagreement_score":0.9659106,"about_ca_system_score_codex":0.00081299583,"about_ca_system_score_gemma":0.0005009532,"threshold_uncertainty_score":0.9997524},"labels":[],"label_agreement":null},{"id":"W2468098431","doi":"10.1016/j.msard.2016.07.001","title":"Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Multiple sclerosis; Quality of life (healthcare); Internal medicine; Body mass index; Physical therapy; Expanded Disability Status Scale; Psychological intervention; Hyperlipidemia; Disease; Diabetes mellitus; Endocrinology; Psychiatry","score_opus":0.037044732526616615,"score_gpt":0.2556401940503584,"score_spread":0.21859546152374182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468098431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974536,0.003073111,0.0005673635,0.0055231345,0.0007209496,0.0140874,0.00015247296,0.0003471295,0.0009924658],"genre_scores_gemma":[0.9794608,0.01588169,0.0002717147,0.00023753029,0.00010890997,0.0034796053,0.00006603358,0.000114756855,0.00037897943],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934749,0.001017831,0.0019548216,0.0012191944,0.001022057,0.00131117],"domain_scores_gemma":[0.99209523,0.005941684,0.00048596997,0.00071763375,0.00019962319,0.0005598487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022182786,0.0008169835,0.0034865425,0.00080656365,0.0004341765,0.000087686094,0.00028652584,0.00057220226,0.0003035176],"category_scores_gemma":[0.00767614,0.00047462992,0.0011501624,0.00067304657,0.0016240922,0.00026182877,0.00019854469,0.0006397514,0.00007955233],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9459551,0.0017957641,0.009938458,0.00012568908,0.0009543903,0.000010544112,0.000454635,0.00011211651,0.018078962,0.000033451015,0.0006032985,0.021937566],"study_design_scores_gemma":[0.9516163,0.0009800678,0.025622087,0.0025745109,0.00031319814,0.0000015376919,0.00040692004,0.016436778,0.0011259562,0.00007511611,0.00021904349,0.0006284932],"about_ca_topic_score_codex":0.00065661594,"about_ca_topic_score_gemma":0.0010558926,"teacher_disagreement_score":0.021309072,"about_ca_system_score_codex":0.00022751957,"about_ca_system_score_gemma":0.00017346459,"threshold_uncertainty_score":0.9997705},"labels":[],"label_agreement":null},{"id":"W2511874025","doi":"10.1016/j.msard.2016.08.010","title":"Physical activity in pediatric onset multiple sclerosis: Validating a questionnaire for clinical practice and research","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Physical activity; Physical therapy; Multiple sclerosis; Clinical Practice; Psychiatry","score_opus":0.14804708776579145,"score_gpt":0.40799472083657845,"score_spread":0.259947633070787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511874025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848135,0.0022989654,0.00018141298,0.009795182,0.0001792011,0.00235771,0.000068390014,0.00012604472,0.00017957637],"genre_scores_gemma":[0.9481465,0.049520917,0.0013182687,0.00006522591,0.00021312862,0.00054108305,0.000010696581,0.00007491324,0.00010923938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99510086,0.0010346822,0.0007235595,0.001231886,0.0008528709,0.0010561295],"domain_scores_gemma":[0.988314,0.009949274,0.00023900322,0.00049668126,0.0005139886,0.00048710106],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004056098,0.00039977737,0.0007969893,0.00049494114,0.00068252545,0.00010297142,0.00017616259,0.00040853012,0.000008472073],"category_scores_gemma":[0.032304488,0.00028088785,0.00023687811,0.0008453468,0.00094738,0.00057544676,0.00040465582,0.001014799,0.00001988538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017760332,0.002058615,0.6989468,0.00027300697,0.00017693399,0.000004146082,0.0010538393,0.0000055512683,0.009104866,0.00003228619,0.0010480698,0.28551987],"study_design_scores_gemma":[0.016048294,0.0008562588,0.9733458,0.0011536557,0.00014231792,0.000006738415,0.0008869341,0.005906784,0.00047753475,0.00014686698,0.00065008434,0.00037873682],"about_ca_topic_score_codex":0.00053179235,"about_ca_topic_score_gemma":0.0003858543,"teacher_disagreement_score":0.2851411,"about_ca_system_score_codex":0.00016159899,"about_ca_system_score_gemma":0.00017080535,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W2523998887","doi":"10.1016/j.msard.2016.09.008","title":"Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Cannabis; Psychiatry","score_opus":0.03496767093008995,"score_gpt":0.24539567766059045,"score_spread":0.2104280067305005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523998887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933544,0.00045487442,0.00013979324,0.0040801815,0.000073580035,0.0013464543,0.00033919123,0.00009113542,0.00012041197],"genre_scores_gemma":[0.9917213,0.0064488836,0.00055488036,0.00015338422,0.000022497003,0.00017772667,0.000018998893,0.000084065294,0.00081829244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721557,0.0000983445,0.0005420153,0.000811868,0.00053438684,0.0007978028],"domain_scores_gemma":[0.99778605,0.00044246097,0.00015741508,0.0005236189,0.0002531592,0.0008373061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025283685,0.0004425286,0.0007170271,0.00040874787,0.00032475241,0.0000656891,0.0001497922,0.000220732,0.000096437754],"category_scores_gemma":[0.0009536743,0.00027775744,0.00012426592,0.0004346573,0.00069392176,0.00032793012,0.00021051666,0.00024963703,0.0000075022076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037099526,0.00020425304,0.94175196,0.0001456504,0.00043936132,0.000004410952,0.0012348697,0.00002920715,0.022060506,0.000009894793,0.00075142196,0.03299747],"study_design_scores_gemma":[0.0071979724,0.0005937821,0.9865171,0.0020707173,0.00012188529,0.0000045158404,0.00079446065,0.00023114559,0.0012113049,0.0000036145086,0.000844483,0.00040907212],"about_ca_topic_score_codex":0.057681564,"about_ca_topic_score_gemma":0.1716014,"teacher_disagreement_score":0.11391984,"about_ca_system_score_codex":0.000119449396,"about_ca_system_score_gemma":0.00008744571,"threshold_uncertainty_score":0.99996746},"labels":[],"label_agreement":null},{"id":"W2524490682","doi":"10.1016/j.msard.2016.09.006","title":"The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Effective diffusion coefficient; Diffusion MRI; Gadolinium; Nuclear medicine; Magnetic resonance imaging; Asymptomatic; White matter; Lesion; Hyperintensity; Radiology; Pathology","score_opus":0.08899565199143981,"score_gpt":0.31462113734651614,"score_spread":0.22562548535507632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524490682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242526,0.002848039,0.000076738106,0.0024119248,0.00013389796,0.0015261667,0.000050859224,0.000037407124,0.0004897145],"genre_scores_gemma":[0.9682906,0.031099988,0.00030284154,0.000011024818,0.000018729523,0.00015298133,0.000011240473,0.000037516118,0.000075076015],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964225,0.00050907885,0.000923171,0.00050611416,0.0011347851,0.0005042972],"domain_scores_gemma":[0.99585253,0.0025423327,0.0004102664,0.00045314152,0.00059544836,0.00014629301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020211705,0.00028417917,0.0005711294,0.0003169475,0.00047283873,0.000015965388,0.00019051168,0.000227765,0.00005384879],"category_scores_gemma":[0.0065261554,0.00015847517,0.00021807497,0.00062422693,0.00090477755,0.00018512907,0.0002628364,0.00029083402,0.000004902376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042179824,0.00040112063,0.1658019,0.00005776842,0.00018452556,1.6102372e-7,0.001647514,0.00015508356,0.230215,0.000024851177,0.000076908975,0.60101336],"study_design_scores_gemma":[0.012098846,0.00023539194,0.94055635,0.0019331911,0.00015113843,6.519647e-7,0.0035465495,0.025540395,0.015368404,0.00032382508,0.00005561689,0.00018963117],"about_ca_topic_score_codex":0.00072270917,"about_ca_topic_score_gemma":0.0010562796,"teacher_disagreement_score":0.77475446,"about_ca_system_score_codex":0.00015732653,"about_ca_system_score_gemma":0.00011334286,"threshold_uncertainty_score":0.7812889},"labels":[],"label_agreement":null},{"id":"W2526902842","doi":"10.1016/j.msard.2016.09.005","title":"Language disorders in multiple sclerosis: A systematic review","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université Laval","funders":"","keywords":"PsycINFO; Multiple sclerosis; Medicine; Cognition; MEDLINE; English language; Psychology; Psychiatry","score_opus":0.062424120586532385,"score_gpt":0.31179313993916813,"score_spread":0.24936901935263575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526902842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011988303,0.9833585,0.0000093775925,0.00077381055,0.00031509547,0.013807658,0.00027355435,0.00031226824,0.0010298344],"genre_scores_gemma":[0.0041504796,0.9901021,0.000096925825,0.00016346986,0.00006757362,0.004000038,0.0002733178,0.00034291326,0.00080315676],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908428,0.0011880228,0.0032114903,0.0019308245,0.0011817237,0.0016451117],"domain_scores_gemma":[0.99419314,0.0021786648,0.0011028243,0.0017173502,0.0001402767,0.00066776946],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016664951,0.0017069199,0.007796494,0.0011534751,0.00042305936,0.000112075526,0.00068655005,0.001098731,0.00024613118],"category_scores_gemma":[0.0057832445,0.0010979088,0.001848514,0.0017766677,0.00074043614,0.00028201603,0.00062558416,0.0016750342,0.00045280711],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036106496,0.00041641993,0.0003331606,0.5920595,0.0010735521,0.000008493028,0.00034809555,4.801613e-7,0.000016891929,0.0000056822732,0.00056854245,0.40513307],"study_design_scores_gemma":[0.00559741,0.00019290118,0.0012879694,0.9409272,0.0030932566,0.000024708059,0.00043859563,0.00010646463,0.0000010435273,0.000011131162,0.047027778,0.0012915407],"about_ca_topic_score_codex":0.0004546083,"about_ca_topic_score_gemma":0.0012145924,"teacher_disagreement_score":0.40384153,"about_ca_system_score_codex":0.0005000318,"about_ca_system_score_gemma":0.00028413147,"threshold_uncertainty_score":0.99956775},"labels":[],"label_agreement":null},{"id":"W2548126365","doi":"10.1016/j.msard.2016.10.010","title":"Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi Genzyme; Sanofi","keywords":"Fingolimod; Teriflunomide; Medicine; Dimethyl fumarate; Number needed to harm; Multiple sclerosis; Number needed to treat; Placebo; Absolute risk reduction; Relative risk; Internal medicine; Confidence interval; Immunology; Alternative medicine","score_opus":0.22080275257219195,"score_gpt":0.40229793219424764,"score_spread":0.1814951796220557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548126365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273515,0.004643776,0.00025458704,0.0014872917,0.00012517121,0.00059626036,0.000037667185,0.000060641178,0.00005943169],"genre_scores_gemma":[0.98567915,0.011507805,0.0025837696,0.0000772096,0.00001988291,0.0000372506,0.000009419051,0.000041750114,0.000043783373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965028,0.00042421703,0.0012093994,0.0008620403,0.0004178398,0.00058371644],"domain_scores_gemma":[0.99671674,0.0020853372,0.0003175137,0.00038985518,0.00014794528,0.00034260305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079209724,0.0004536119,0.001851061,0.0005527584,0.0003461206,0.00010757197,0.00013686962,0.00018602911,0.000037031794],"category_scores_gemma":[0.0016456208,0.00028416023,0.0003428433,0.0008355948,0.00078661577,0.000376831,0.00036091043,0.00029755288,0.0000026910823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056640705,0.00024655304,0.9506599,0.00008918929,0.002286082,0.000003837398,0.0029135062,0.00013314109,0.01787135,0.000002762588,0.000015530635,0.025211746],"study_design_scores_gemma":[0.0071317917,0.00007899845,0.97185755,0.0017241783,0.0009929888,4.6397255e-7,0.005260564,0.012423366,0.00009462495,0.00007970353,0.0000074258587,0.00034835254],"about_ca_topic_score_codex":0.005804185,"about_ca_topic_score_gemma":0.0013197622,"teacher_disagreement_score":0.024863394,"about_ca_system_score_codex":0.00012079019,"about_ca_system_score_gemma":0.00005123742,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2548283306","doi":"10.1016/j.msard.2016.10.011","title":"The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Placebo; Crossover study; Randomized controlled trial; Physical therapy; Multiple sclerosis; Paced Auditory Serial Addition Test; Cognition; Physical medicine and rehabilitation; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.034565119169412295,"score_gpt":0.2910974223698583,"score_spread":0.256532303200446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548283306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112856,0.00043811023,0.000009460109,0.00055585575,0.000119849276,0.007057131,0.000025460604,0.000022065446,0.00064348354],"genre_scores_gemma":[0.9956198,0.0035240394,0.0000074940376,0.000014855486,0.000014952713,0.0006802019,0.000017786238,0.000034763758,0.000086130596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972232,0.00048228944,0.0007105989,0.00047630002,0.00060696696,0.00050066394],"domain_scores_gemma":[0.99402606,0.005234155,0.00023784755,0.0002580413,0.00012409136,0.00011977195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012670317,0.0003286265,0.0010614906,0.0002946079,0.00017065628,0.000030199768,0.0001094282,0.000190764,0.000028860883],"category_scores_gemma":[0.0030451568,0.00013861035,0.000204835,0.0004720575,0.0010038922,0.000111243746,0.00008675645,0.0003598247,0.0000060852135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76598483,0.00040635065,0.2120896,0.000042668922,0.00030444682,7.6844304e-7,0.00038352914,0.000017780805,0.00020153339,0.000008767639,0.000017519837,0.020542203],"study_design_scores_gemma":[0.7003028,0.001999389,0.2951883,0.0014369438,0.0000671098,7.949955e-8,0.00006222176,0.00012361175,0.0006585586,0.000008027783,0.000013527801,0.00013942401],"about_ca_topic_score_codex":0.00045334426,"about_ca_topic_score_gemma":0.00066998997,"teacher_disagreement_score":0.0830987,"about_ca_system_score_codex":0.00007684229,"about_ca_system_score_gemma":0.000041149782,"threshold_uncertainty_score":0.5652366},"labels":[],"label_agreement":null},{"id":"W2559196805","doi":"10.1016/j.msard.2016.11.012","title":"Processing speed and distractibility in multiple sclerosis: the role of sleep","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Carleton University; Sunnybrook Health Science Centre; Ottawa Hospital; Health Sciences Centre","funders":"Multiple Sclerosis Society","keywords":"Epworth Sleepiness Scale; Excessive daytime sleepiness; Somnolence; Psychology; Cognition; Audiology; Multiple sclerosis; Mood; Alertness; Distraction; Anxiety; Effects of sleep deprivation on cognitive performance; Medicine; Clinical psychology; Polysomnography; Psychiatry; Sleep disorder; Electroencephalography; Cognitive psychology","score_opus":0.04020565677912618,"score_gpt":0.2619082070018374,"score_spread":0.22170255022271124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559196805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782945,0.0073985206,0.000021998056,0.0027911225,0.000060618877,0.0011158318,0.000043988377,0.0000670749,0.0006713725],"genre_scores_gemma":[0.988782,0.010825115,0.00016540186,0.00003636895,0.000024201658,0.000056417437,0.000007433934,0.000041909032,0.00006118569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973424,0.00017380556,0.0007196595,0.00068783155,0.00048163204,0.00059467787],"domain_scores_gemma":[0.9981091,0.0008389106,0.00022808285,0.00046135174,0.00014116913,0.00022135446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076331635,0.00033932057,0.00059757597,0.00019146531,0.00034310034,0.00004504031,0.00016805847,0.00022729379,0.00004764219],"category_scores_gemma":[0.0017430016,0.00018593941,0.0001397176,0.00048063867,0.0012532797,0.00027774263,0.00023932681,0.0003995086,0.0000065877666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003605719,0.00032842945,0.5494576,0.0000992717,0.000086777814,6.2324335e-7,0.0010034075,0.000011932269,0.14431149,0.000011951504,0.000017464152,0.30431047],"study_design_scores_gemma":[0.0074195988,0.00016802056,0.9756665,0.0010801756,0.00006884069,0.0000039205893,0.002811743,0.006583249,0.005388432,0.0002254113,0.00033554298,0.00024851612],"about_ca_topic_score_codex":0.00091702316,"about_ca_topic_score_gemma":0.0009544676,"teacher_disagreement_score":0.42620894,"about_ca_system_score_codex":0.00007854379,"about_ca_system_score_gemma":0.000054339394,"threshold_uncertainty_score":0.7582389},"labels":[],"label_agreement":null},{"id":"W2566431041","doi":"10.1016/j.msard.2016.12.007","title":"From bugs to brains: The microbiome in neurological health","year":2016,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia","funders":"Health Canada; University of British Columbia; Canada Research Chairs","keywords":"Microbiome; Gut microbiome; Multiple sclerosis; Medicine; Discipline; Engineering ethics; Neuroscience; Data science; Bioinformatics; Biology; Sociology; Immunology; Computer science; Social science; Engineering","score_opus":0.009993076417919413,"score_gpt":0.24453742194585226,"score_spread":0.23454434552793285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566431041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49493098,0.01629728,0.0000625776,0.02765494,0.456091,0.0021387774,0.0025533442,0.00007049483,0.00020060768],"genre_scores_gemma":[0.5652034,0.0948383,0.00042855705,0.008329291,0.32075086,0.00028720137,0.0067705014,0.00038336922,0.0030084827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975337,0.00026860775,0.00051525416,0.00092672283,0.00015953535,0.00059620873],"domain_scores_gemma":[0.9988857,0.00019736335,0.00019103407,0.00048752327,0.000043242788,0.00019515515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003736052,0.00038233498,0.00043484682,0.000100187885,0.00022645811,0.000052766987,0.00038758185,0.0012124534,0.000028715094],"category_scores_gemma":[0.00033729497,0.00024166635,0.00014279691,0.00016375027,0.00018211732,0.0000036259055,0.00029910562,0.0006234521,0.00003775977],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017557942,0.00010559557,0.0007343465,0.000027837168,0.0000628212,8.860727e-7,0.0003317893,0.000008378683,0.071185865,0.0000017929916,0.917712,0.009653155],"study_design_scores_gemma":[0.002254578,0.00044318254,0.0141097605,0.00020191722,0.000014015888,8.112695e-7,0.00007343167,0.000007678075,0.000104873485,0.000055564553,0.98235685,0.00037732947],"about_ca_topic_score_codex":0.0016118581,"about_ca_topic_score_gemma":0.002500136,"teacher_disagreement_score":0.13534012,"about_ca_system_score_codex":0.000027643926,"about_ca_system_score_gemma":0.00021659845,"threshold_uncertainty_score":0.98548675},"labels":[],"label_agreement":null},{"id":"W2590528884","doi":"10.1016/j.msard.2017.02.013","title":"Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Alabama at Birmingham","keywords":"Upper limb; Physical medicine and rehabilitation; Medicine; Multiple sclerosis; Logistic regression; Physical therapy; Rehabilitation; Ambulatory; Association (psychology); Psychology; Psychiatry; Surgery","score_opus":0.07439613338366442,"score_gpt":0.28050667862031614,"score_spread":0.20611054523665173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590528884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941518,0.0014065959,0.000008599452,0.0024154403,0.00007865611,0.0015018161,0.00015513021,0.00006368422,0.00021833084],"genre_scores_gemma":[0.9873185,0.011533828,0.0005004476,0.00014067521,0.000012956645,0.0001503782,0.000041577456,0.00006830071,0.00023331573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968281,0.00015516726,0.0007190325,0.00085758325,0.0006968728,0.00074329076],"domain_scores_gemma":[0.99742925,0.0007473764,0.00052093825,0.00070093677,0.00025315146,0.00034834843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004981227,0.0005011663,0.00097442366,0.00036019617,0.0007937109,0.00019260905,0.00018946719,0.00031355352,0.00005728046],"category_scores_gemma":[0.001691336,0.00037518982,0.00018263035,0.00029093158,0.0011739793,0.0004667529,0.0004133695,0.00049352064,0.0000047446933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008958666,0.0010752793,0.97524565,0.00012541247,0.0008344193,0.000006118799,0.0014130163,0.000054392513,0.0042490917,0.0000052302844,0.00028067664,0.015814833],"study_design_scores_gemma":[0.013569662,0.0009813549,0.9721713,0.0024465239,0.00020110547,0.0000023350804,0.0009617924,0.008060196,0.000934532,0.0000082540255,0.00024921965,0.0004137277],"about_ca_topic_score_codex":0.0036857384,"about_ca_topic_score_gemma":0.0047780224,"teacher_disagreement_score":0.015401104,"about_ca_system_score_codex":0.0001591737,"about_ca_system_score_gemma":0.00007744445,"threshold_uncertainty_score":0.99987},"labels":[],"label_agreement":null},{"id":"W2591549758","doi":"10.1016/j.msard.2017.02.012","title":"Increased incidence and prevalence of psoriasis in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McGill University; University of British Columbia; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Dalhousie University; Multiple Sclerosis Society of Canada; Public Health Agency of Canada; Multiple Sclerosis Trust; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Crohn's and Colitis Canada; Dalhousie Medical Research Foundation; Multiple Sclerosis Scientific Research Foundation; U.S. Department of Veterans Affairs; Teva Pharmaceutical Industries; Sanofi; Public Health Agency; National Multiple Sclerosis Society; Michael Smith Health Research BC; Biogen","keywords":"Psoriasis; Medicine; Incidence (geometry); Population; Multiple sclerosis; Cohort; Demography; Medical prescription; Internal medicine; Dermatology; Immunology; Environmental health","score_opus":0.030879322888268362,"score_gpt":0.22577340154250602,"score_spread":0.19489407865423766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591549758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688555,0.011673461,0.0000060062234,0.00016804055,0.00036696,0.00042615298,0.00011514903,0.000042221844,0.00031645072],"genre_scores_gemma":[0.9793849,0.020104421,0.00013143937,0.000017030534,0.000007724965,0.000058656064,0.000028742481,0.000023908866,0.00024315907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983029,0.00019900741,0.0004745799,0.0005606164,0.00006683441,0.000396063],"domain_scores_gemma":[0.9986092,0.0003843182,0.00034948118,0.0005500519,0.000046710862,0.000060234655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003719963,0.000300177,0.000464351,0.00017879013,0.0006363897,0.00004378396,0.00031530487,0.0004292212,0.00010905543],"category_scores_gemma":[0.000582239,0.0002633656,0.00011163683,0.00012305626,0.0007519879,0.00029321818,0.00021940506,0.00021995784,0.000023944815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031866677,0.00024606206,0.8170633,0.000090307374,0.00017277009,0.0000013434069,0.0007893381,0.000008840253,0.0899011,0.000037701077,0.00004098594,0.09132961],"study_design_scores_gemma":[0.008133809,0.00013801492,0.9765164,0.00043647093,0.00015937052,0.000004664226,0.00027028998,0.00015088244,0.013663159,0.00012578635,0.00010744268,0.00029365835],"about_ca_topic_score_codex":0.0036230483,"about_ca_topic_score_gemma":0.0013520848,"teacher_disagreement_score":0.15945317,"about_ca_system_score_codex":0.00002409302,"about_ca_system_score_gemma":0.000030405077,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W2603876309","doi":"10.1016/j.msard.2017.03.009","title":"Hospitalization is associated with subsequent disability in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Manitoba; Hotchkiss Brain Institute; Manitoba Health","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; AbbVie Canada; Crohn's and Colitis Canada; Research Manitoba; Multiple Sclerosis Society; Takeda Canada; Mylan; Multiple Sclerosis Scientific Research Foundation; Pfizer Canada; Janssen Canada; Sanofi; Pfizer","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Disease; Cohort; Pediatrics; Cohort study; Population; Young adult; Proportional hazards model; Physical therapy; Internal medicine; Psychiatry","score_opus":0.05859635771339704,"score_gpt":0.2757565066892163,"score_spread":0.21716014897581926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603876309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141973,0.00076710223,0.000028819131,0.0044952105,0.00016068477,0.001747977,0.00009630131,0.00015473584,0.0011294425],"genre_scores_gemma":[0.9925308,0.0065153567,0.00017325184,0.0001218995,0.000027492588,0.00022015753,0.00011766742,0.000084551284,0.00020881898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964288,0.00016691448,0.000705265,0.0010405487,0.0007754151,0.00088304275],"domain_scores_gemma":[0.9975468,0.00036147103,0.00039465466,0.0011002913,0.00022296523,0.0003738123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068841124,0.0005128123,0.00083650986,0.00017923006,0.0012757016,0.00024120836,0.0003233972,0.00039234073,0.00013425823],"category_scores_gemma":[0.0032403923,0.00040246872,0.00021118493,0.00040987052,0.0016839788,0.0005114746,0.00030916353,0.0005986793,0.000019573434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000415284,0.0011105265,0.97167355,0.00008471268,0.00034751795,0.0000057627362,0.0013635976,0.00008631872,0.0034328417,0.000014859844,0.00024456435,0.021220464],"study_design_scores_gemma":[0.013888757,0.00038083832,0.9710906,0.0012169745,0.000111079935,0.0000018827484,0.00070634414,0.011178958,0.00072965736,0.000064072876,0.00014570396,0.0004850904],"about_ca_topic_score_codex":0.0030632073,"about_ca_topic_score_gemma":0.0069587096,"teacher_disagreement_score":0.020735374,"about_ca_system_score_codex":0.00035042755,"about_ca_system_score_gemma":0.00007154346,"threshold_uncertainty_score":0.9998427},"labels":[],"label_agreement":null},{"id":"W2610278979","doi":"10.1016/j.msard.2017.05.001","title":"Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: “Second International Workshop on Human Endogenous Retroviruses and Disease”, Washington DC, March 13th and 14th 2017","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Servier; Advanced Foods and Materials Canada","keywords":"Endogenous retrovirus; Multiple sclerosis; Endogeny; Disease; Human disease; Medicine; Virology; Immunology; Biology; Genetics; Pathology","score_opus":0.06138738554699816,"score_gpt":0.25136995078566166,"score_spread":0.1899825652386635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610278979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950057,0.0013524463,7.919798e-7,0.0022062454,0.00023462695,0.0004671649,0.00017314948,0.000039594943,0.00052027946],"genre_scores_gemma":[0.9988167,0.0007126986,0.000010795535,0.00011086382,0.00010327274,0.000038355665,0.00010361739,0.0000038033215,0.000099861645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842596,0.00011763596,0.00040249684,0.00052905816,0.0002700752,0.00025475075],"domain_scores_gemma":[0.9987417,0.00033727897,0.0004087932,0.00020137684,0.00007874024,0.00023213233],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00026436598,0.00021687684,0.00025649928,0.000030955576,0.0022277853,0.00024058901,0.0003095175,0.0001291499,0.00005116213],"category_scores_gemma":[0.0010540328,0.00009744527,0.00008930997,0.00008374171,0.00037577766,0.00012804888,0.00028488075,0.00020318158,0.0000012533342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023731406,0.00030403904,0.73312265,0.00001674071,0.00010499859,0.000019776942,0.0006559701,0.00006116395,0.25726512,0.0006053632,0.00013493626,0.0074718953],"study_design_scores_gemma":[0.00065349054,0.00039963747,0.9958409,0.00009446136,0.00007771866,0.000014138051,0.00018631638,0.00008991054,0.00050334097,0.0009099468,0.0010139706,0.00021617346],"about_ca_topic_score_codex":0.0006933226,"about_ca_topic_score_gemma":0.0017314168,"teacher_disagreement_score":0.26271823,"about_ca_system_score_codex":0.00002487627,"about_ca_system_score_gemma":0.000012251881,"threshold_uncertainty_score":0.9990712},"labels":[],"label_agreement":null},{"id":"W2615643304","doi":"10.1016/j.msard.2017.05.006","title":"Cognitive impairment in Chinese IIDDs revealed by MoCA and P300","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Audiology; Multiple sclerosis; Cognition; Depression (economics); Internal medicine; Psychiatry","score_opus":0.026365294199694158,"score_gpt":0.29376505214153686,"score_spread":0.26739975794184273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615643304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869696,0.004260654,0.0000062042463,0.0047216234,0.00009968263,0.0012909427,0.00006946503,0.000056971494,0.0025248616],"genre_scores_gemma":[0.9704545,0.028481076,0.00008211639,0.0001259112,0.000022391978,0.00014073578,0.000043933924,0.000040523857,0.0006088131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791205,0.00009554298,0.00043124394,0.0006394588,0.00035910352,0.0005626091],"domain_scores_gemma":[0.99875116,0.00026648105,0.00017292642,0.0004070737,0.00008572225,0.00031664575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044433385,0.00034593532,0.0005928136,0.00018791293,0.0007433793,0.00012408037,0.00013987551,0.00022217126,0.000072163726],"category_scores_gemma":[0.0014012847,0.00026121104,0.00010600041,0.0001672432,0.00074629893,0.00023440296,0.0003268349,0.00048342664,0.000014494752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055712817,0.00048515646,0.9439753,0.00012654018,0.00022944095,0.000007858599,0.00134167,0.0000023812852,0.0054309606,0.000003861845,0.00096750754,0.046872176],"study_design_scores_gemma":[0.015835658,0.000350764,0.9789096,0.00065028586,0.000058466416,0.000005140444,0.000792394,0.0027409445,0.00009016665,0.00006976996,0.000210058,0.0002867137],"about_ca_topic_score_codex":0.0012191992,"about_ca_topic_score_gemma":0.0007063456,"teacher_disagreement_score":0.046585463,"about_ca_system_score_codex":0.000058114736,"about_ca_system_score_gemma":0.000032768898,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W2625299651","doi":"10.1016/j.msard.2017.06.003","title":"The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Expanded Disability Status Scale; Medicine; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Physical disability; MEDLINE; Inclusion (mineral); Psychology; Psychiatry","score_opus":0.08286083481255867,"score_gpt":0.3428479991164018,"score_spread":0.2599871643038431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625299651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031875568,0.9748787,3.1576846e-7,0.0005269682,0.00008329503,0.020892134,0.00015178628,0.000075276985,0.00020392305],"genre_scores_gemma":[0.03605452,0.9572798,0.000047383095,0.0000043366404,0.000036747086,0.0062613552,0.00007183918,0.00014043092,0.00010358787],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99209,0.0022422357,0.0017523979,0.0015275483,0.0012538038,0.0011340427],"domain_scores_gemma":[0.9904892,0.00574247,0.0008993088,0.0020611647,0.00037358873,0.00043428267],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0053583533,0.0010718934,0.006206577,0.0003607616,0.0016454193,0.00016724074,0.00054448046,0.0006285322,0.000013060651],"category_scores_gemma":[0.004491387,0.0005138041,0.00056521257,0.0014081617,0.0033655418,0.00022997116,0.00042021874,0.0022710422,0.0000042733673],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049307116,0.00018482257,0.0047852127,0.5495877,0.0008521955,0.0000030855065,0.00090590114,6.808823e-7,5.69306e-7,0.0000012519693,0.000024538977,0.44316092],"study_design_scores_gemma":[0.0068095764,0.0015050292,0.014995581,0.9592826,0.0052171815,0.000054073378,0.0025092592,0.00009968204,9.3609276e-7,0.0000028374475,0.00884362,0.00067963905],"about_ca_topic_score_codex":0.0009097827,"about_ca_topic_score_gemma":0.0036173365,"teacher_disagreement_score":0.44248128,"about_ca_system_score_codex":0.00029121825,"about_ca_system_score_gemma":0.0002852542,"threshold_uncertainty_score":0.99973136},"labels":[],"label_agreement":null},{"id":"W2724713160","doi":"10.1016/j.msard.2017.06.016","title":"Human glutathione s-transferase enzyme gene variations and risk of multiple sclerosis in Iranian population cohort","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Genotype; Multiple sclerosis; Oxidative stress; Glutathione S-transferase; Glutathione; Medicine; Population; GSTP1; Expanded Disability Status Scale; Etiology; Internal medicine; Immunology; Physiology; Biology; Gene; Enzyme; Genetics; Biochemistry","score_opus":0.01666816719396034,"score_gpt":0.2230700579039939,"score_spread":0.20640189071003356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724713160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969516,0.0014147691,0.0005436259,0.00019403418,0.00011398275,0.00046264712,0.00022531282,0.000016602582,0.00007745701],"genre_scores_gemma":[0.9893812,0.009883318,0.00032573388,0.00002172817,0.000024832852,0.000034336583,0.00025294878,0.00003611695,0.00003979857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850947,0.00011128628,0.0004660694,0.00049423246,0.00014136889,0.00027758855],"domain_scores_gemma":[0.99917233,0.00003212284,0.0001811455,0.00044693175,0.00004248606,0.00012499162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003001509,0.00024660068,0.00029999882,0.000105764346,0.00070177217,0.00006418074,0.00015478993,0.00031755326,0.000017164059],"category_scores_gemma":[0.00012056816,0.00024154648,0.00012010788,0.00008027651,0.00022212528,0.000028655766,0.0000628288,0.00019008547,0.0000013506076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008467309,0.00016474877,0.69178843,0.000020274534,0.00013289343,5.914727e-7,0.0002624857,0.00053183077,0.30271938,0.00006723926,0.000009689179,0.004217743],"study_design_scores_gemma":[0.004626709,0.00017254996,0.98230183,0.000081478094,0.00013161145,0.0000023766706,0.00006923736,0.0023979498,0.009752778,0.00012617433,0.000041751446,0.00029555196],"about_ca_topic_score_codex":0.008218468,"about_ca_topic_score_gemma":0.0068847416,"teacher_disagreement_score":0.2929666,"about_ca_system_score_codex":0.000010821382,"about_ca_system_score_gemma":0.00001579124,"threshold_uncertainty_score":0.9983859},"labels":[],"label_agreement":null},{"id":"W2737064420","doi":"10.1016/j.msard.2017.07.020","title":"Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Meta-analysis; Multiple sclerosis; Cochrane Library; Internal medicine; MEDLINE; Relative risk; Causality (physics); Clinically isolated syndrome; CINAHL; Physical therapy; Psychiatry; Confidence interval","score_opus":0.344363908382509,"score_gpt":0.4033033450547217,"score_spread":0.058939436672212686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737064420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011957255,0.9849604,0.00013206054,0.00094788516,0.00009980048,0.0130896475,0.0005380932,0.00008188815,0.0000306456],"genre_scores_gemma":[0.010185954,0.986591,0.0004277937,0.00020536954,0.000040302457,0.0019396694,0.00024686242,0.00015448677,0.000208586],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99374235,0.0011113756,0.00219659,0.0014559773,0.0006731785,0.00082053564],"domain_scores_gemma":[0.99361944,0.0023946129,0.0017959719,0.0014796319,0.00032823597,0.00038212087],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0034969077,0.0011898677,0.009699583,0.0006275158,0.001893759,0.0004948702,0.00039527466,0.0006657183,0.000048305155],"category_scores_gemma":[0.005250074,0.00067348103,0.0028108817,0.0007432076,0.00078285136,0.00030897403,0.000509752,0.00083636766,0.000002245246],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033525426,0.00013558305,0.00021296996,0.74813986,0.21174568,0.0000016938833,0.00059976,0.0000059180556,0.000015483729,0.000010803885,0.00022133086,0.03887741],"study_design_scores_gemma":[0.002016869,0.00011542101,0.0006340639,0.09799277,0.8828756,0.00003195368,0.00032240342,0.005567731,7.9447915e-7,0.000013690869,0.009589615,0.0008390639],"about_ca_topic_score_codex":0.0005621896,"about_ca_topic_score_gemma":0.00032612242,"teacher_disagreement_score":0.67112994,"about_ca_system_score_codex":0.00014488742,"about_ca_system_score_gemma":0.00010802128,"threshold_uncertainty_score":0.9995716},"labels":[],"label_agreement":null},{"id":"W2745955927","doi":"10.1016/j.msard.2017.08.006","title":"Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Carleton University; Ottawa Hospital; University of Ottawa; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Numerical digit; Medicine; Multiple sclerosis; Symbol (formal); Modalities; Test (biology); Arithmetic; Psychiatry; Computer science; Biology","score_opus":0.044818295759184515,"score_gpt":0.25957459600032845,"score_spread":0.21475630024114395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745955927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845451,0.0048937663,0.0000029689822,0.0037782355,0.00018761853,0.0014397926,0.000066486646,0.0000687813,0.0050172103],"genre_scores_gemma":[0.99019843,0.009103481,0.00009861076,0.000070134374,0.00006105235,0.00021038209,0.000010151468,0.00005764553,0.00019012399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970578,0.00016567092,0.00082665845,0.0005913637,0.00060990074,0.0007486321],"domain_scores_gemma":[0.99593556,0.0019851588,0.00046684916,0.0012660372,0.00017127887,0.00017509043],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00083448744,0.00040855806,0.000685622,0.00018132108,0.0019177962,0.00022877115,0.0006674354,0.00023671116,0.00005066735],"category_scores_gemma":[0.0054051927,0.00023788956,0.00027702854,0.00026449093,0.0025186066,0.00034612088,0.0006070152,0.00079137215,0.000012431147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018209314,0.00029711693,0.8176593,0.00009419537,0.00026564582,0.0000013149345,0.004623657,0.00014132826,0.021718327,0.000058550915,0.000087918954,0.15487054],"study_design_scores_gemma":[0.0057504987,0.00014607304,0.94864035,0.000976045,0.00010046108,0.000007532034,0.02629896,0.01151249,0.0055661174,0.0003648052,0.0003387218,0.00029797683],"about_ca_topic_score_codex":0.003727079,"about_ca_topic_score_gemma":0.002374694,"teacher_disagreement_score":0.15457258,"about_ca_system_score_codex":0.00006838155,"about_ca_system_score_gemma":0.00009101352,"threshold_uncertainty_score":0.99938154},"labels":[],"label_agreement":null},{"id":"W2761661211","doi":"10.1016/j.msard.2017.10.004","title":"Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Depression (economics); Multiple sclerosis; Medicine; Antidepressant; Clinical trial; Disease; Comorbidity; Quality of life (healthcare); Randomized controlled trial; Psychiatry; Internal medicine; Anxiety","score_opus":0.5195576048701573,"score_gpt":0.510673184639342,"score_spread":0.00888442023081537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761661211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010964029,0.97955096,0.000078428595,0.00024877113,0.00022147273,0.008157478,0.0003406579,0.000049699185,0.00038852272],"genre_scores_gemma":[0.02308174,0.9735214,0.00196461,0.0000415047,0.000091838636,0.0008380843,0.0002275803,0.0001292279,0.000104007784],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98444235,0.003271032,0.008886602,0.001769891,0.00096058525,0.0006695107],"domain_scores_gemma":[0.978912,0.013794875,0.0044793845,0.0016366611,0.00046362024,0.0007134585],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010005805,0.0010096404,0.011943246,0.0006843779,0.0003636062,0.0000651765,0.00039415396,0.0009982868,0.00003349855],"category_scores_gemma":[0.06473351,0.0006115919,0.0017096909,0.0007220812,0.000930713,0.00036329858,0.0005102073,0.0009230705,0.0000056238014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006823979,0.0012050451,0.093916945,0.01234644,0.0015091995,0.0000055658807,0.00020367837,0.000007925015,0.000017524351,0.0000013846516,0.00027396675,0.88982993],"study_design_scores_gemma":[0.023619702,0.0024272222,0.21283372,0.65607435,0.004633339,0.000010404971,0.00027155777,0.0006354456,0.000014529251,0.00000549453,0.09863536,0.0008388781],"about_ca_topic_score_codex":0.001350435,"about_ca_topic_score_gemma":0.00080810656,"teacher_disagreement_score":0.88899106,"about_ca_system_score_codex":0.00010692906,"about_ca_system_score_gemma":0.00055809395,"threshold_uncertainty_score":0.99963355},"labels":[],"label_agreement":null},{"id":"W2763071712","doi":"10.1016/j.msard.2017.10.001","title":"The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Alberta Health Services; Université de Montréal; Hôpital Notre-Dame; University of Calgary","funders":"EMD Serono; Novartis Pharmaceuticals Canada; Multiple Sclerosis Society of Canada; Government of Alberta; Alberta Health Services; Genzyme; F. Hoffmann-La Roche; Teva Canada Innovation; Biogen Idec; Canadian Institutes of Health Research; Novartis","keywords":"Multiple sclerosis; Medicine; Real world evidence; Intensive care medicine; Psychiatry; Internal medicine","score_opus":0.12576575454439287,"score_gpt":0.356829119700862,"score_spread":0.23106336515646914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763071712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947312,0.0013442569,3.083219e-7,0.0019507218,0.00026535455,0.0010595215,0.00012978962,0.00001723763,0.00050159503],"genre_scores_gemma":[0.9325365,0.06679277,0.000044947345,0.00002114599,0.000032737356,0.0001113718,0.000012222194,0.000033550266,0.00041474873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719626,0.00021976455,0.0009533925,0.00074743707,0.0002932448,0.00058991724],"domain_scores_gemma":[0.9932629,0.004882756,0.00044548305,0.0009978703,0.00006043337,0.0003505716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004999678,0.00043286357,0.0009831433,0.00011842833,0.0008266975,0.00012662943,0.000331343,0.00017173366,0.00004797783],"category_scores_gemma":[0.0025485388,0.00025615783,0.00029539646,0.000089417576,0.0011222954,0.00019721697,0.00024160431,0.0004232291,0.000009413414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009306094,0.0002411104,0.9509107,0.000012623348,0.00065507274,0.0000019036198,0.00039554833,0.00019619837,0.00048656185,0.0000049658865,0.00037168345,0.045793053],"study_design_scores_gemma":[0.008729975,0.0009686293,0.9798724,0.0008903284,0.00007864353,3.3159725e-7,0.0003804649,0.008618268,0.00011147879,0.000022556182,0.00007948958,0.00024745276],"about_ca_topic_score_codex":0.97246796,"about_ca_topic_score_gemma":0.9838419,"teacher_disagreement_score":0.065448515,"about_ca_system_score_codex":0.0005214721,"about_ca_system_score_gemma":0.0005588281,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2765282886","doi":"10.1016/j.msard.2017.11.003","title":"The prevalence of anxiety and associated factors in persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Canada Research Chairs; Alberta Health; Cumming School of Medicine, University of Calgary; University of Calgary; Alberta Health Services","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Medicine; Depression (economics); Quality of life (healthcare); Confounding; Odds ratio; Cross-sectional study; Psychiatry; Population; Multiple sclerosis; Logistic regression; Clinical psychology; Odds; Internal medicine; Environmental health; Pathology","score_opus":0.036971088562393006,"score_gpt":0.2572941627361175,"score_spread":0.2203230741737245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765282886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462694,0.0026220335,0.000007844909,0.0008793976,0.000083304134,0.0010647572,0.00009307081,0.00007069208,0.0005519858],"genre_scores_gemma":[0.96767366,0.031650774,0.00014054956,0.000030600848,0.000016772352,0.00006755268,0.000013091723,0.000046992507,0.00036001584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973939,0.00018845712,0.00053094333,0.00063556933,0.0005586299,0.00069249363],"domain_scores_gemma":[0.998017,0.00088388874,0.0002237256,0.0004099254,0.00022417674,0.0002412855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062825135,0.00036682878,0.0005357384,0.00019471612,0.00071516837,0.000056924375,0.0001795863,0.00024307391,0.000041321673],"category_scores_gemma":[0.0016420722,0.00022335793,0.00011857232,0.0007310571,0.002047526,0.00017112157,0.00020022751,0.00048556825,0.0000030762478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043710961,0.00029579288,0.9686085,0.00016398558,0.0002883114,4.907774e-7,0.0037227795,0.000008713363,0.014286696,0.000008716826,0.00018559465,0.011993321],"study_design_scores_gemma":[0.0065424214,0.0006092688,0.9821357,0.0008839459,0.00012134847,0.000002141918,0.0032044386,0.0043680603,0.0015357828,0.0000111580575,0.0003203488,0.00026537347],"about_ca_topic_score_codex":0.0012474256,"about_ca_topic_score_gemma":0.0042347955,"teacher_disagreement_score":0.029028742,"about_ca_system_score_codex":0.00008333017,"about_ca_system_score_gemma":0.00006704247,"threshold_uncertainty_score":0.9108272},"labels":[],"label_agreement":null},{"id":"W2765634741","doi":"10.1016/j.msard.2017.11.001","title":"Can falling infection rates in one country explain rising incidence of autoimmune and allergic diseases in other countries? Caution when (over) interpreting ecological data from disparate areas","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"","keywords":"Scopus; Mythology; Falling (accident); Web of science; Medicine; Incidence (geometry); MEDLINE; Environmental ethics; Data science; History; Environmental health; Political science; Classics; Law; Computer science; Philosophy","score_opus":0.060061046519949715,"score_gpt":0.27902149463649284,"score_spread":0.21896044811654314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765634741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787801,0.0023887523,0.00000829563,0.017409516,0.0001738878,0.0005034915,0.000638465,0.000026028742,0.00007145249],"genre_scores_gemma":[0.97785616,0.015729096,0.000032711647,0.0052367896,0.000045784003,0.000028784169,0.0010198731,0.00003284443,0.000017944172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977416,0.00020854274,0.00061216526,0.0007043152,0.00026725171,0.00046613198],"domain_scores_gemma":[0.99844545,0.00046132074,0.0005555208,0.00044357276,0.000008336374,0.000085801534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004575772,0.00031674217,0.00054033444,0.000119888144,0.0002760835,0.00012837074,0.00027919325,0.0006195568,0.00034549012],"category_scores_gemma":[0.00037512582,0.00028976175,0.000033073393,0.00011508078,0.00042596977,0.00047427992,0.000508436,0.0008117043,0.0000063067523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009699979,0.00011828347,0.9912412,0.00012902588,0.000029655424,0.000013313007,0.0018664039,0.0005291116,0.0003341811,4.967298e-7,0.004172515,0.0014687805],"study_design_scores_gemma":[0.001357721,0.000055294982,0.9671958,0.002485466,0.00005051298,0.0000010647226,0.00016131198,0.026156044,0.0000066535536,0.00044891165,0.001736177,0.00034501887],"about_ca_topic_score_codex":0.09259935,"about_ca_topic_score_gemma":0.08744049,"teacher_disagreement_score":0.025626933,"about_ca_system_score_codex":0.0002516947,"about_ca_system_score_gemma":0.000027006856,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W2770280018","doi":"10.1016/j.msard.2017.11.013","title":"Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Deutsche Stiftung Neurologie; Biogen Idec; Merck KGaA; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Novartis; Bayer","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical therapy; Physical medicine and rehabilitation; Psychiatry","score_opus":0.05478649989018387,"score_gpt":0.26781902990872924,"score_spread":0.21303253001854539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770280018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288035,0.009332773,0.0000018015008,0.0041850233,0.000159978,0.0023863025,0.00009884019,0.00003005244,0.00092490274],"genre_scores_gemma":[0.9394783,0.05993678,0.000091333466,0.00007436741,0.000035214314,0.00030356678,0.00003192369,0.00003766528,0.000010899528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973871,0.00043899738,0.00061383453,0.0005870292,0.0004163319,0.00055670494],"domain_scores_gemma":[0.9975247,0.00112044,0.0002967581,0.000844297,0.000083516155,0.00013033264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006259103,0.00040771885,0.00065088656,0.00023466797,0.00085535285,0.0001488303,0.00035209281,0.00017473836,0.000022298414],"category_scores_gemma":[0.0011627994,0.00023917874,0.00016678152,0.00033369442,0.0008012803,0.00020062191,0.00040364152,0.00057578954,0.0000027597418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001243883,0.0016171946,0.73302627,0.00007622248,0.0009125168,0.000006185659,0.13815786,0.00027216834,0.020535551,0.00029873912,0.00011900524,0.10373438],"study_design_scores_gemma":[0.014236993,0.0007538055,0.84731495,0.00079037936,0.00010812621,8.679145e-7,0.13222417,0.0033649465,0.00014899632,0.000066362045,0.00075523736,0.00023513853],"about_ca_topic_score_codex":0.047397956,"about_ca_topic_score_gemma":0.007528378,"teacher_disagreement_score":0.11428867,"about_ca_system_score_codex":0.00025013988,"about_ca_system_score_gemma":0.000040862677,"threshold_uncertainty_score":0.97534263},"labels":[],"label_agreement":null},{"id":"W2771416990","doi":"10.1016/j.msard.2017.12.006","title":"Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Logistic regression; Patient satisfaction; Internal medicine; Disease; Physical therapy; Psychiatry; Surgery","score_opus":0.054119972625521116,"score_gpt":0.28039351043484706,"score_spread":0.22627353780932594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771416990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133825,0.0032548832,0.000010735898,0.0026173494,0.00024023931,0.0015158198,0.00006606553,0.00013648029,0.0008201994],"genre_scores_gemma":[0.96674436,0.032046393,0.00025170605,0.000058237492,0.000059578597,0.00023479275,0.000031719035,0.00008266837,0.0004905355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969693,0.00012846266,0.0005996093,0.0010056819,0.0004687274,0.0008282081],"domain_scores_gemma":[0.9980851,0.0003332688,0.00026445725,0.0008201462,0.00007671423,0.00042031865],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00029236524,0.000554915,0.0007713572,0.0003457968,0.0013258394,0.00025728767,0.00015062437,0.00038366622,0.00009151257],"category_scores_gemma":[0.0007088141,0.00045023332,0.00014982361,0.00018122866,0.0009565494,0.00045856938,0.00024780325,0.00044753565,0.0000312985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039072416,0.0003673378,0.7253775,0.00006292971,0.0004260411,0.0000066029984,0.0013807993,0.000035168003,0.02065253,0.000010081708,0.00010814824,0.25118217],"study_design_scores_gemma":[0.019697497,0.0008195777,0.9659762,0.00033358592,0.00013943834,0.000010188057,0.0015927925,0.010069892,0.00038894758,0.000030749765,0.00049207103,0.0004490783],"about_ca_topic_score_codex":0.010090591,"about_ca_topic_score_gemma":0.008415951,"teacher_disagreement_score":0.25073308,"about_ca_system_score_codex":0.00023835344,"about_ca_system_score_gemma":0.0000606098,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2771966364","doi":"10.1016/j.msard.2017.12.007","title":"The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Nova Scotia Health Authority; Dalhousie University; University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Heart and Stroke Foundation of Canada","keywords":"Multiple sclerosis; Medicine; Anxiety; Depression (economics); Reliability (semiconductor); Clinical psychology; Psychiatry; Validity; Psychometrics","score_opus":0.0754390113063081,"score_gpt":0.2944983733866809,"score_spread":0.2190593620803728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771966364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072427,0.003702556,0.0002858319,0.0026889269,0.0001303625,0.0021302577,0.00006973853,0.00004878184,0.00021929042],"genre_scores_gemma":[0.90836906,0.09000667,0.0012617693,0.000017704215,0.000021326825,0.00022710333,0.000013208236,0.00004348542,0.000039668124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718493,0.00020210986,0.0006690279,0.0008318979,0.00047307313,0.00063895626],"domain_scores_gemma":[0.99685735,0.0015420691,0.0003484082,0.00080436957,0.00018568875,0.00026211396],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0017688847,0.00037624614,0.0006657855,0.000137984,0.002246203,0.00016232028,0.0002531539,0.00029904803,0.000004217449],"category_scores_gemma":[0.007111622,0.00025820758,0.00018819653,0.00015064291,0.0018498013,0.0003169021,0.0005103072,0.0004712673,4.098599e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007242715,0.00016640294,0.7633522,0.00017300271,0.000073442054,1.0636695e-7,0.00057607045,0.000055978882,0.0066965343,0.0000060128928,0.00008503265,0.22809093],"study_design_scores_gemma":[0.0099471565,0.0002161125,0.96601963,0.00065423065,0.000092335504,0.0000012230688,0.0010334606,0.01930234,0.000921194,0.0002559584,0.0012784302,0.0002779361],"about_ca_topic_score_codex":0.0021862173,"about_ca_topic_score_gemma":0.004767989,"teacher_disagreement_score":0.22781299,"about_ca_system_score_codex":0.000039180453,"about_ca_system_score_gemma":0.000036676425,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2775283417","doi":"10.1016/j.msard.2017.11.022","title":"Validation of an algorithm to detect severe MS relapses in administrative health databases","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Dalhousie University","keywords":"Medicine; Prednisone; Medical prescription; Diagnosis code; Database; Methylprednisolone; Population; Record linkage; Pediatrics; Algorithm; Outpatient clinic; Pharmacoepidemiology; Internal medicine","score_opus":0.09317554801030638,"score_gpt":0.35737687175260124,"score_spread":0.2642013237422949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775283417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356914,0.000847629,0.00019190398,0.0027610103,0.00012554749,0.0013706239,0.00023534407,0.00005061218,0.0008481857],"genre_scores_gemma":[0.9860997,0.0050741904,0.008383981,0.00007310606,0.000022643448,0.000075554046,0.00011561761,0.00003105288,0.00012414137],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978996,0.00016405448,0.0005494616,0.00055162574,0.00040119133,0.000434052],"domain_scores_gemma":[0.99836725,0.00019697567,0.0002835475,0.00069010915,0.00011338145,0.00034875152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059634016,0.00024292181,0.00056068366,0.00024930766,0.0004499963,0.00005627058,0.00019079288,0.000106123574,0.000048556274],"category_scores_gemma":[0.0015804998,0.0002049368,0.00008395049,0.00021473478,0.0003339408,0.00037367345,0.00020261106,0.0003078664,0.000007373203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056646974,0.00064807304,0.112074606,0.00021907371,0.00020071454,0.000006434838,0.003295744,0.00015939072,0.011310565,0.00001876909,0.00035757173,0.87114257],"study_design_scores_gemma":[0.0056542796,0.0011848288,0.9805073,0.00089051115,0.000029782528,0.00000542826,0.0016806204,0.0028494922,0.0062221545,0.000038697963,0.0006765604,0.0002603404],"about_ca_topic_score_codex":0.003695799,"about_ca_topic_score_gemma":0.0030701628,"teacher_disagreement_score":0.8708823,"about_ca_system_score_codex":0.00007663546,"about_ca_system_score_gemma":0.00013351075,"threshold_uncertainty_score":0.8357081},"labels":[],"label_agreement":null},{"id":"W2776489476","doi":"10.1016/j.msard.2017.12.012","title":"Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Neuromyelitis optica; Cancer; Serous fluid; Pathology; Serous carcinoma; Ovarian cancer; Serology; Oncology; Multiple sclerosis; Internal medicine; Antibody; Immunology","score_opus":0.03205792600054316,"score_gpt":0.2312441609377451,"score_spread":0.19918623493720194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776489476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531007,0.0006117471,0.0002608904,0.0012164804,0.00013563248,0.00066062825,0.000022808512,0.00006982095,0.001711944],"genre_scores_gemma":[0.99804276,0.0014359723,0.0001713305,0.00004699802,0.000008255211,0.000038519174,0.000093084425,0.000028487317,0.00013461676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856216,0.000063333675,0.00036241137,0.00047194827,0.00022708124,0.00031304438],"domain_scores_gemma":[0.9990216,0.00012313253,0.00028872106,0.0004045353,0.00004234764,0.000119658725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006372645,0.0002688016,0.0004775679,0.00007537263,0.00044971728,0.000062032304,0.00010096984,0.00014341353,0.00010463523],"category_scores_gemma":[0.00028562656,0.0001787205,0.00012706437,0.00007926171,0.00054761366,0.00016195598,0.00006985375,0.00019911453,0.000009474014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008797278,0.0015058283,0.9857319,0.000041572257,0.00020385592,0.000063312495,0.00008322146,0.00016841273,0.0021543493,0.00008259458,0.000016681988,0.009068562],"study_design_scores_gemma":[0.008999025,0.0024317158,0.98550636,0.00015810817,0.00033199743,0.00016367652,0.00006423869,0.0015248082,0.0001693587,0.00022827594,0.00021881926,0.00020360372],"about_ca_topic_score_codex":0.0006417508,"about_ca_topic_score_gemma":0.0001783655,"teacher_disagreement_score":0.008864958,"about_ca_system_score_codex":0.000026277723,"about_ca_system_score_gemma":0.000017860059,"threshold_uncertainty_score":0.728801},"labels":[],"label_agreement":null},{"id":"W2787300357","doi":"10.1016/j.msard.2018.02.005","title":"The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Age of onset; Multiple sclerosis; Young adult; Penetrance; Disease; Demography; Internal medicine; Immunology; Phenotype; Biology","score_opus":0.10358821818861248,"score_gpt":0.2749136728281766,"score_spread":0.1713254546395641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787300357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921499,0.0036759453,0.00009981995,0.0019292285,0.00013078231,0.0014396308,0.00046758668,0.00004694889,0.000060188126],"genre_scores_gemma":[0.9665905,0.031887084,0.0010120415,0.00009179992,0.000037037476,0.000037932576,0.00013029524,0.00004861613,0.00016467558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692005,0.00022539195,0.00066561595,0.00069953385,0.0009107323,0.0005786796],"domain_scores_gemma":[0.99696326,0.0009106913,0.00034778164,0.0007786428,0.0007293045,0.00027031222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008580745,0.000330647,0.0006097013,0.00016836864,0.0005353812,0.00008525558,0.00030810712,0.0002388093,0.000014943731],"category_scores_gemma":[0.0033576463,0.00022020524,0.0000925961,0.0006106156,0.0006965171,0.00029002628,0.0003110586,0.0003605418,0.00000656988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031318404,0.00049289304,0.47775194,0.00021614291,0.0012545203,0.0000022995716,0.002217388,0.00012123977,0.434711,0.000008276051,0.0011802418,0.0789122],"study_design_scores_gemma":[0.0058032875,0.00059285143,0.9785757,0.0009358195,0.00023324795,0.000002955874,0.00058005063,0.0046524475,0.006036103,0.0000037674472,0.0023173413,0.00026641178],"about_ca_topic_score_codex":0.00079306436,"about_ca_topic_score_gemma":0.002570365,"teacher_disagreement_score":0.5008238,"about_ca_system_score_codex":0.000058394282,"about_ca_system_score_gemma":0.00006571142,"threshold_uncertainty_score":0.8979709},"labels":[],"label_agreement":null},{"id":"W2787385618","doi":"10.1016/j.msard.2018.02.009","title":"Factors associated with excessive sitting time in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Alabama at Birmingham; National Multiple Sclerosis Society","keywords":"Medicine; Sitting; Ambulatory; Multiple sclerosis; Logistic regression; Population; Percentile; Psychological intervention; Odds ratio; Physical therapy; Odds; Demography; Gerontology; Environmental health; Psychiatry; Internal medicine","score_opus":0.07177685466909786,"score_gpt":0.26636156601682015,"score_spread":0.1945847113477223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787385618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947808,0.000687564,0.000022280856,0.00085755263,0.00013423695,0.0012974651,0.00006296341,0.00027661942,0.0018805198],"genre_scores_gemma":[0.9976644,0.0011238295,0.00017330266,0.00011315102,0.00006169591,0.000102455146,0.000138535,0.000117639334,0.00050498976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996002,0.00024953252,0.0007639109,0.0010349661,0.00078144355,0.0011680997],"domain_scores_gemma":[0.99732906,0.0011018253,0.00031256763,0.0004800352,0.00033876463,0.00043778008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006049927,0.0006316931,0.0009769321,0.00053144473,0.0007746073,0.00010471949,0.00022478105,0.00043768936,0.00030682454],"category_scores_gemma":[0.0031004678,0.00045981794,0.00020412375,0.0013611731,0.0012485526,0.0003379511,0.00026110746,0.0007569662,0.000067691115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045573412,0.0007922601,0.93719345,0.000058666228,0.000652802,0.000005430349,0.0046982453,0.00006968323,0.03880283,0.000003864788,0.00052581535,0.016741203],"study_design_scores_gemma":[0.012201325,0.0007606111,0.9660803,0.0016968545,0.0001269136,0.0000012416567,0.0026407032,0.0132480385,0.0024750943,0.00001934028,0.00017253215,0.0005770416],"about_ca_topic_score_codex":0.0006466982,"about_ca_topic_score_gemma":0.0018853713,"teacher_disagreement_score":0.036327735,"about_ca_system_score_codex":0.00023952391,"about_ca_system_score_gemma":0.000098166165,"threshold_uncertainty_score":0.99978536},"labels":[],"label_agreement":null},{"id":"W2787599611","doi":"10.1016/j.msard.2018.01.021","title":"Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011–2016)","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Physical therapy; Physical medicine and rehabilitation; Adverse effect; Rehabilitation; MEDLINE; Balance (ability); Multiple sclerosis","score_opus":0.09789177387970635,"score_gpt":0.3365683771397416,"score_spread":0.23867660326003523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787599611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015025554,0.971683,0.0000029863202,0.0006311788,0.0002120932,0.011893679,0.00023670871,0.00019691231,0.00011784332],"genre_scores_gemma":[0.04540299,0.95142174,0.0000737948,0.00007061087,0.00006619294,0.0024591133,0.00009151807,0.00018498802,0.00022907941],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99240625,0.0013555796,0.0019033699,0.0020795644,0.0010047315,0.0012504879],"domain_scores_gemma":[0.99376,0.0028679534,0.0009155047,0.0016319039,0.00017743648,0.0006472207],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016529446,0.0015703319,0.008857496,0.00039234725,0.0004893018,0.00012287917,0.00044214886,0.0008389475,0.00006471436],"category_scores_gemma":[0.0053060874,0.0010353314,0.0014442321,0.0008333401,0.0019320168,0.0003196564,0.0008177589,0.0016781661,0.00016561161],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000729462,0.0020836138,0.006018157,0.7671279,0.0016043363,0.0000042165816,0.0003331556,2.4761934e-7,0.000017342194,0.0000031003092,0.00039183898,0.22234315],"study_design_scores_gemma":[0.0057275253,0.00043771876,0.06408009,0.9153351,0.0061460626,0.000021073296,0.00020819042,0.0008009458,0.0000028768711,0.000018604875,0.0056603393,0.0015614476],"about_ca_topic_score_codex":0.0008680621,"about_ca_topic_score_gemma":0.00065400614,"teacher_disagreement_score":0.2207817,"about_ca_system_score_codex":0.0004299113,"about_ca_system_score_gemma":0.00019212779,"threshold_uncertainty_score":0.9997045},"labels":[],"label_agreement":null},{"id":"W2788304256","doi":"10.1016/j.msard.2018.02.019","title":"A survey of dietary characteristics in a large population of people with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Population; Environmental health; Gerontology; Immunology","score_opus":0.048489580740819535,"score_gpt":0.2718305457115136,"score_spread":0.22334096497069406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788304256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750054,0.00063405966,0.000042456177,0.00018876782,0.00009920506,0.0010188549,0.00032520902,0.000044438097,0.00014644164],"genre_scores_gemma":[0.99534863,0.0037318396,0.00040024766,0.000025872327,0.000021081234,0.00005572621,0.0003281547,0.000056409852,0.00003206246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713755,0.0002344996,0.0009453406,0.0005471911,0.0005600156,0.0005754075],"domain_scores_gemma":[0.99798334,0.0005278578,0.0003950925,0.00045305621,0.00045583164,0.00018479748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085736695,0.00033351747,0.0010176589,0.0004215292,0.00018043087,0.000016368629,0.00013846136,0.00023946611,0.00007953681],"category_scores_gemma":[0.0016357386,0.00026327433,0.000121683144,0.0011911078,0.0004969603,0.00016221641,0.00017307824,0.00033475689,0.0000057137618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015125722,0.0009648718,0.9686723,0.0002600036,0.00023719443,7.5562286e-7,0.0021018889,0.000012048822,0.0132248765,0.0000037383456,0.000046360314,0.012963398],"study_design_scores_gemma":[0.008803289,0.0009165056,0.97441626,0.0010685853,0.00007940905,0.0000013162188,0.0005504725,0.013378346,0.0005029495,0.000005145482,0.00001594393,0.000261756],"about_ca_topic_score_codex":0.014026508,"about_ca_topic_score_gemma":0.033176493,"teacher_disagreement_score":0.019149983,"about_ca_system_score_codex":0.00005828135,"about_ca_system_score_gemma":0.000063519685,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W2797993398","doi":"10.1016/j.msard.2018.04.006","title":"Frequent retinal ganglion cell damage after acute optic neuritis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Ophthalmology; Ganglion; Retinal ganglion cell; Visual acuity; Optic nerve; Anatomy","score_opus":0.019517482726725325,"score_gpt":0.2536248396638929,"score_spread":0.23410735693716755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797993398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98791635,0.0018660835,0.000039353916,0.002227702,0.00037020448,0.0008760231,0.000050821393,0.00017552741,0.00647794],"genre_scores_gemma":[0.9888482,0.008308964,0.0011538067,0.00024250342,0.00015142676,0.00013255232,0.000046218265,0.00007314209,0.0010431941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973773,0.00011921837,0.00048145105,0.00073256996,0.00053541077,0.0007540727],"domain_scores_gemma":[0.99865186,0.0001294315,0.000108456916,0.00049778103,0.00020805676,0.0004044246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027780642,0.00037684492,0.000469337,0.00025298473,0.0004409044,0.00008568066,0.00014719754,0.00025763598,0.00065867446],"category_scores_gemma":[0.00022916202,0.0003108265,0.00020827613,0.00046437947,0.00088906393,0.00018530908,0.00024719164,0.0005195033,0.00020996103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050447513,0.0031583563,0.53588784,0.0008721985,0.0020482682,0.00045831242,0.010744237,0.00003411731,0.32680258,0.00009289218,0.018457826,0.09639863],"study_design_scores_gemma":[0.009444176,0.001481132,0.97170764,0.0005803231,0.00034211966,0.000035451158,0.0007623159,0.006341029,0.005162929,0.00007443399,0.003491812,0.0005766438],"about_ca_topic_score_codex":0.00024111429,"about_ca_topic_score_gemma":0.00013153549,"teacher_disagreement_score":0.4358198,"about_ca_system_score_codex":0.0000741729,"about_ca_system_score_gemma":0.000044073935,"threshold_uncertainty_score":0.9999344},"labels":[],"label_agreement":null},{"id":"W2799999954","doi":"10.1016/j.msard.2018.04.008","title":"Severe aseptic temporal lobe encephalitis on fingolimod","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Fingolimod; Medicine; Etiology; Multiple sclerosis; Aseptic meningitis; Encephalitis; Viral encephalitis; Temporal lobe; Immunology; Pediatrics; Pathology; Virus; Cerebrospinal fluid; Psychiatry","score_opus":0.014247635459749435,"score_gpt":0.21929233576179605,"score_spread":0.2050447003020466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799999954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947639,0.0010995795,0.00013173356,0.00022189236,0.00040395092,0.00017043293,0.000024314306,0.000034966473,0.0031492242],"genre_scores_gemma":[0.9972583,0.0010274841,0.00024166929,0.00047222275,0.00021842736,0.000014525178,0.000084955806,0.000032152395,0.00065027364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988141,0.000057863177,0.000223001,0.0004548527,0.00013268641,0.0003174706],"domain_scores_gemma":[0.9994603,0.000021180975,0.0000751525,0.00027230804,0.00004625826,0.00012480468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014984187,0.0002040037,0.00016731593,0.00005680768,0.00026307558,0.000041861495,0.00013009938,0.00023057987,0.00010496606],"category_scores_gemma":[0.00011957026,0.00017974342,0.00010123432,0.00012677432,0.00022108848,0.000007648577,0.00007603982,0.000121967634,0.00004194666],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068019604,0.00054150226,0.06320245,0.00006229739,0.00042376126,0.0000041828785,0.0015363527,0.0005108689,0.825668,0.0005982186,0.009269156,0.097503066],"study_design_scores_gemma":[0.029507156,0.0049457066,0.34850943,0.00084961957,0.00040183,0.00008596126,0.0032191474,0.008842798,0.27427956,0.0020464195,0.32268763,0.004624711],"about_ca_topic_score_codex":0.00016181785,"about_ca_topic_score_gemma":0.00009452846,"teacher_disagreement_score":0.5513884,"about_ca_system_score_codex":0.000006354055,"about_ca_system_score_gemma":0.00002534346,"threshold_uncertainty_score":0.73297244},"labels":[],"label_agreement":null},{"id":"W2801839118","doi":"10.1016/j.msard.2018.04.007","title":"Autonomic dysreflexia following acute myelitis due to neuromyelitis optica","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Autonomic dysreflexia; Tetraplegia; Medicine; Spinal cord injury; Blood pressure; Neuromyelitis optica; Anesthesia; Myelitis; Spinal cord; Surgery; Internal medicine; Multiple sclerosis","score_opus":0.03398605089543806,"score_gpt":0.30694777614924745,"score_spread":0.2729617252538094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801839118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98320174,0.00037379857,0.00020575614,0.0059513445,0.00058114826,0.0008208403,0.000023785462,0.00020519432,0.00863642],"genre_scores_gemma":[0.9952779,0.0004371239,0.0019597437,0.0006712495,0.00011808619,0.000061988685,0.000027684086,0.000076552766,0.0013696626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977978,0.00007001096,0.00042150015,0.0006747687,0.00034994952,0.0006859619],"domain_scores_gemma":[0.9987399,0.0001054846,0.000055835484,0.00046668568,0.000099569144,0.0005325296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024806822,0.000291569,0.0004634909,0.00028391927,0.00038167706,0.00008751961,0.0001768969,0.00021013373,0.0003912177],"category_scores_gemma":[0.00031590596,0.00025459134,0.00022425978,0.0005583675,0.00026050402,0.00015479239,0.00020515459,0.00039487332,0.00056034623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063328305,0.00065969105,0.061584458,0.00014331582,0.0024623598,0.00042470588,0.0026725652,0.000048316073,0.3219343,0.0006172787,0.00873034,0.59438986],"study_design_scores_gemma":[0.008328341,0.007874488,0.94864,0.00064733427,0.00045233694,0.0001608268,0.00057286036,0.0067039253,0.0039477837,0.00038314387,0.021467028,0.000821942],"about_ca_topic_score_codex":0.00036378784,"about_ca_topic_score_gemma":0.00007836254,"teacher_disagreement_score":0.8870555,"about_ca_system_score_codex":0.00009329109,"about_ca_system_score_gemma":0.00008733742,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2808932716","doi":"10.1016/j.msard.2018.06.010","title":"Radiologically isolated syndrome in children: Current knowledge and future directions","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Mental Health Research Canada; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Ontario Institute for Regenerative Medicine; Stem Cell Network; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Magnetic resonance imaging; Observational study; Clinical significance; Psychological intervention; McDonald criteria; Demyelinating disease; Disease; Clinical Practice; Pediatrics; Intensive care medicine; Pathology; Physical therapy; Radiology; Psychiatry","score_opus":0.04744703907342532,"score_gpt":0.3147260977311121,"score_spread":0.26727905865768675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808932716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005244993,0.9902803,0.0000017754223,0.00022131803,0.0005497496,0.0029881631,0.00011007203,0.00018022899,0.00042343923],"genre_scores_gemma":[0.0032066265,0.9955727,0.000062877094,0.000010363928,0.00020860355,0.00038421067,0.00031042125,0.00010484157,0.00013937305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996062,0.00044191006,0.0010988964,0.0013001378,0.00028768182,0.00080936716],"domain_scores_gemma":[0.9983088,0.00036305032,0.00028803037,0.0005054526,0.00011066548,0.00042403987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048962113,0.0008748075,0.0025443798,0.00079392956,0.00044698513,0.00007120033,0.00020965937,0.0009859863,0.000095677016],"category_scores_gemma":[0.00033467883,0.00060860976,0.00052161247,0.0012747697,0.0007785836,0.00010751822,0.00037988735,0.0017189707,0.00006810061],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004600919,0.00053000223,0.0061903275,0.002998996,0.00079500995,0.000004054825,0.00026543604,1.1824031e-7,0.000001152792,0.0000073721917,0.0007525001,0.98840904],"study_design_scores_gemma":[0.0031132007,0.00051771675,0.15382642,0.013653881,0.0007274488,0.0002161489,0.000056598445,0.00014914239,4.5384272e-8,0.000011075521,0.8270779,0.00065041863],"about_ca_topic_score_codex":0.00007308749,"about_ca_topic_score_gemma":0.00010533152,"teacher_disagreement_score":0.9877586,"about_ca_system_score_codex":0.00016666934,"about_ca_system_score_gemma":0.00014322433,"threshold_uncertainty_score":0.99963653},"labels":[],"label_agreement":null},{"id":"W2856119501","doi":"10.1016/j.msard.2018.07.012","title":"Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Teriflunomide; Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Natalizumab; Medical prescription; Poisson regression; Internal medicine; Pediatrics; Pharmacology; Environmental health; Population; Immunology","score_opus":0.056556920343223197,"score_gpt":0.24977946225881328,"score_spread":0.19322254191559007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2856119501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877293,0.0028811765,0.000018196331,0.0061926525,0.00035676733,0.002481297,0.00027071347,0.0000444456,0.000025439454],"genre_scores_gemma":[0.9931025,0.004997354,0.00028815796,0.0005040646,0.00007141869,0.00020049886,0.000023956687,0.00006724345,0.00074478926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972335,0.00013960773,0.00064504525,0.0006139175,0.00063017703,0.0007377546],"domain_scores_gemma":[0.99763316,0.0010257313,0.00021674698,0.0006174465,0.00022745373,0.00027946054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037812744,0.00026663704,0.00056201813,0.000078187055,0.00095223344,0.00023103884,0.00035859158,0.00016615573,0.00006994607],"category_scores_gemma":[0.0022368995,0.0002337718,0.00027466498,0.00067986967,0.0011130334,0.00019817834,0.00030853078,0.0003993867,0.0000016797245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031151032,0.00023776712,0.92101866,0.000116899246,0.00035654297,0.0000016801246,0.0016762437,0.00016781257,0.0010196448,0.0000034494587,0.021999337,0.05309047],"study_design_scores_gemma":[0.006457323,0.00013489458,0.970481,0.0010199259,0.00011546105,0.0000016145921,0.0012942392,0.007631299,0.00005879114,0.000043088472,0.012491415,0.0002709695],"about_ca_topic_score_codex":0.8682597,"about_ca_topic_score_gemma":0.9907657,"teacher_disagreement_score":0.12250597,"about_ca_system_score_codex":0.00017905732,"about_ca_system_score_gemma":0.0004758602,"threshold_uncertainty_score":0.95329374},"labels":[],"label_agreement":null},{"id":"W2884191823","doi":"10.1016/j.msard.2018.07.019","title":"Perceived cognitive deficits and depressive symptoms in patients with multiple sclerosis: Perceived stress and sleep quality as mediators","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Perceived Stress Scale; Medicine; Mediation; Pittsburgh Sleep Quality Index; Center for Epidemiologic Studies Depression Scale; Clinical psychology; Cognition; Depression (economics); Multiple sclerosis; Psychiatry; Depressive symptoms; Sleep quality; Stress (linguistics)","score_opus":0.023452416125247358,"score_gpt":0.2642543371818235,"score_spread":0.24080192105657616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884191823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442023,0.0021817754,0.0000095929245,0.00030750775,0.00011168074,0.002277394,0.00021277223,0.0001239285,0.00035511324],"genre_scores_gemma":[0.99271977,0.0064960015,0.00011173027,0.00015561398,0.000044213943,0.00020924077,0.00013398926,0.00009567921,0.000033754157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957502,0.00037113612,0.00076469127,0.0013305418,0.00083073415,0.00095271156],"domain_scores_gemma":[0.99716884,0.000998784,0.00027564383,0.00038145098,0.0005370898,0.00063817046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033265026,0.000677116,0.0009894988,0.0004242446,0.0007141425,0.00012433428,0.00014680818,0.0004266115,0.00007533327],"category_scores_gemma":[0.0020577805,0.0005222824,0.000106281084,0.0005345314,0.0021500755,0.00038733406,0.00034885248,0.00069063064,0.0000167407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002099884,0.00073982443,0.95376456,0.00017248037,0.0006225011,0.0000030386366,0.0074033053,0.000009502738,0.0018868282,0.000005228291,0.000015526173,0.033277344],"study_design_scores_gemma":[0.033203494,0.0013252505,0.95567775,0.0021299836,0.00027038335,0.0000022018453,0.004737878,0.0017648037,0.00022717961,0.000015738255,0.000010469566,0.0006348887],"about_ca_topic_score_codex":0.002080141,"about_ca_topic_score_gemma":0.0026748867,"teacher_disagreement_score":0.032642454,"about_ca_system_score_codex":0.00010117919,"about_ca_system_score_gemma":0.00006737784,"threshold_uncertainty_score":0.9997229},"labels":[],"label_agreement":null},{"id":"W2887080097","doi":"10.1016/j.msard.2018.08.007","title":"Mining healthcare data for markers of the multiple sclerosis prodrome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of Manitoba; Health Sciences Centre; Dalhousie University; University of Saskatchewan; Manitoba Health; University of British Columbia Hospital; Saskatchewan Health Quality Council; University of British Columbia","funders":"","keywords":"Medicine; Logistic regression; Medical prescription; Multiple sclerosis; Prodrome; Cohort; Odds ratio; Diagnosis code; Internal medicine; Population; Predictive analytics; Psychiatry; Statistics; Environmental health","score_opus":0.11055498326435126,"score_gpt":0.31147776379333775,"score_spread":0.2009227805289865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887080097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781032,0.0028541584,0.000100971454,0.013145126,0.0006569752,0.0038598368,0.00067682954,0.00013650821,0.0004663539],"genre_scores_gemma":[0.9922673,0.0037855445,0.002788452,0.00029204454,0.0001151343,0.0001916703,0.00015886743,0.00008800593,0.0003129866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964898,0.00018530908,0.0008238442,0.0010177736,0.00065533613,0.0008279336],"domain_scores_gemma":[0.99650115,0.00078099116,0.00034105024,0.0016525927,0.00042576296,0.00029845204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094961707,0.00040385444,0.0007139599,0.00020204893,0.0009175823,0.00004801909,0.0006635197,0.00029459945,0.00006899653],"category_scores_gemma":[0.0032631096,0.00027756044,0.0002632074,0.00075521955,0.0014313207,0.00022862294,0.00092290767,0.00037666634,0.000008044272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035156107,0.0011097322,0.62190133,0.0016357667,0.0017875975,8.991055e-7,0.004153764,0.000031493473,0.0939159,0.00006176892,0.025156083,0.24673001],"study_design_scores_gemma":[0.0113248555,0.0010863967,0.94287974,0.0018990361,0.00026915412,0.0000045266647,0.0030468109,0.027269745,0.003269391,0.00005085216,0.008437332,0.0004621603],"about_ca_topic_score_codex":0.0008809045,"about_ca_topic_score_gemma":0.0015381264,"teacher_disagreement_score":0.32097837,"about_ca_system_score_codex":0.00007809752,"about_ca_system_score_gemma":0.00015930666,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W2887090343","doi":"10.1016/j.msard.2018.08.004","title":"Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Nationale de la Recherche; Ministère de la Santé et des Services sociaux","keywords":"Medicine; Multiple sclerosis; Retrospective cohort study; Natural history; Disease; Pediatrics; Epidemiology; Cohort study; Age of onset; Cohort; Internal medicine; Psychiatry","score_opus":0.06813667192759514,"score_gpt":0.3001277340746917,"score_spread":0.23199106214709653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887090343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928345,0.0017010975,0.00004678887,0.00054080226,0.00017323579,0.0036637099,0.00010242375,0.00014568886,0.00079176243],"genre_scores_gemma":[0.98292416,0.0148667395,0.0014543063,0.000045674577,0.0000449959,0.00039290186,0.000037673177,0.000051494328,0.0001820467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636275,0.00027220877,0.0009090284,0.0011997548,0.0005723096,0.0006839471],"domain_scores_gemma":[0.9978832,0.000696276,0.00025621656,0.0006401205,0.00017922073,0.00034496174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006321041,0.0005946793,0.0014819623,0.00022747238,0.00045229335,0.000043563006,0.00015987348,0.00024863577,0.00012724932],"category_scores_gemma":[0.0006471045,0.00040591,0.0002641582,0.00042370486,0.000995864,0.00012492594,0.000426382,0.0003238558,0.000017422226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039945354,0.0018219806,0.961497,0.00004692554,0.0034032126,0.000006775136,0.0028207698,0.000007368642,0.0024493998,0.00001380539,0.000081013364,0.027452301],"study_design_scores_gemma":[0.015377489,0.0024689902,0.9729576,0.00048540585,0.00058923016,0.0000012991952,0.0048707365,0.0024984512,0.00023812699,0.000079586636,0.00007218556,0.00036091733],"about_ca_topic_score_codex":0.0056829685,"about_ca_topic_score_gemma":0.00158863,"teacher_disagreement_score":0.027091384,"about_ca_system_score_codex":0.00019937132,"about_ca_system_score_gemma":0.000021768661,"threshold_uncertainty_score":0.99983925},"labels":[],"label_agreement":null},{"id":"W2887342729","doi":"10.1016/j.msard.2018.07.043","title":"Factors associated with perceived need for mental health care in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; Nova Scotia Health Authority; Dalhousie University; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada","keywords":"Multiple sclerosis; Medicine; Mental health; Psychiatry","score_opus":0.07561283902120947,"score_gpt":0.29159784607455835,"score_spread":0.2159850070533489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887342729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063,0.0018868691,0.000029513987,0.0028288518,0.0002329179,0.0034908035,0.00037405486,0.00021344362,0.00031355888],"genre_scores_gemma":[0.99545366,0.0026264498,0.00039190223,0.00026884247,0.000050563456,0.00026167234,0.00068112573,0.0001231435,0.00014264263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625784,0.00019657053,0.0007411419,0.0009705433,0.0006196357,0.0012142475],"domain_scores_gemma":[0.9979535,0.0005477727,0.0002603221,0.00041048363,0.00033881867,0.00048913585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000424486,0.00059759605,0.0010118627,0.00046557747,0.001119228,0.00007941983,0.00018859243,0.0003371515,0.000074833806],"category_scores_gemma":[0.0011550216,0.00044467582,0.00025574627,0.00082428614,0.0009098946,0.00021787104,0.00014920555,0.0004934576,0.000007717907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020188212,0.0010536306,0.91255224,0.00023575318,0.000869713,8.0665075e-7,0.03333624,0.000044470205,0.015196243,0.000007894003,0.0022396592,0.032444537],"study_design_scores_gemma":[0.02414165,0.0023287984,0.94575316,0.0013486965,0.000072401526,6.0136773e-7,0.019887706,0.0045500845,0.0005225636,0.000005683018,0.0008832805,0.0005054074],"about_ca_topic_score_codex":0.0012451274,"about_ca_topic_score_gemma":0.0142055405,"teacher_disagreement_score":0.033200897,"about_ca_system_score_codex":0.000548836,"about_ca_system_score_gemma":0.00019314801,"threshold_uncertainty_score":0.9998005},"labels":[],"label_agreement":null},{"id":"W2887465886","doi":"10.1016/j.msard.2018.08.013","title":"Identifying optic neuritis and transverse myelitis using administrative data","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dalhousie University; University of British Columbia Hospital; Vancouver Coastal Health; University of Manitoba; University of British Columbia; Manitoba Health","funders":"National Multiple Sclerosis Society","keywords":"Transverse myelitis; Optic neuritis; Medicine; Multiple sclerosis; Myelitis; Acute Transverse Myelitis; Dermatology; Spinal cord; Immunology; Psychiatry","score_opus":0.18617264876897346,"score_gpt":0.3586782497665155,"score_spread":0.17250560099754206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887465886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930804,0.003290495,0.00023127894,0.0011292924,0.00022544118,0.0007974097,0.00017222717,0.00010429534,0.0009692089],"genre_scores_gemma":[0.98365724,0.012489384,0.0034286228,0.000065120024,0.00009174211,0.000017824756,0.00008155394,0.000047599555,0.00012091368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976683,0.00011262179,0.0004359171,0.0008473368,0.0003888802,0.00054690806],"domain_scores_gemma":[0.99864006,0.00021654561,0.00009670201,0.0005795837,0.00012746833,0.00033966845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033941283,0.0003016387,0.00045091345,0.00018268535,0.0006875043,0.0001229623,0.00018367832,0.00018309802,0.00015818117],"category_scores_gemma":[0.00054478634,0.00026855274,0.000075858516,0.00035932582,0.0012472959,0.00041165046,0.00036067312,0.0003653095,0.000015792177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017641832,0.0013395543,0.20860937,0.0012887575,0.003154254,0.00014981483,0.02160268,0.000025870777,0.27628443,0.00034430015,0.0028899226,0.48254687],"study_design_scores_gemma":[0.01110734,0.0008516992,0.9016678,0.0012771545,0.0004825914,0.00012849714,0.0070992527,0.07348492,0.0011919017,0.000110965935,0.0019203397,0.00067754625],"about_ca_topic_score_codex":0.000885123,"about_ca_topic_score_gemma":0.00063599116,"teacher_disagreement_score":0.69305843,"about_ca_system_score_codex":0.000039329705,"about_ca_system_score_gemma":0.00006635914,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W2888242617","doi":"10.1016/j.msard.2018.08.019","title":"No association between socioeconomic status and risk of multiple sclerosis: A population-based incident case-control study in a developing country","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Association (psychology); Environmental health; Population; Developing country; Case-control study; Demography; Immunology; Internal medicine; Economic growth","score_opus":0.02864059619302026,"score_gpt":0.2720505355833588,"score_spread":0.24340993939033853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888242617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961121,0.0007379349,0.00004959703,0.0002518947,0.00013931985,0.002284025,0.00029926593,0.00007467225,0.00005117206],"genre_scores_gemma":[0.99575925,0.0033667684,0.0004480805,0.00006590782,0.00006996197,0.0001583425,0.00005305341,0.000056282428,0.000022336673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965175,0.00047360777,0.0010816667,0.00070924417,0.0004943791,0.0007236202],"domain_scores_gemma":[0.9967482,0.0017414257,0.0006188205,0.0003190686,0.00033187817,0.0002406223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015126395,0.00038759466,0.00093130604,0.00045513,0.00053433987,0.000069219954,0.00009497007,0.00033404355,0.000049829217],"category_scores_gemma":[0.0027505078,0.00035492098,0.00012327763,0.0004063112,0.0002592607,0.00021946679,0.00012548262,0.00051246386,0.000015681017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041408942,0.00034574338,0.9874187,0.00010455308,0.0009758966,0.0000036272618,0.0020201057,0.0001377588,0.00039346196,0.0000017308639,0.000031482614,0.008152823],"study_design_scores_gemma":[0.024575483,0.0005745163,0.9552293,0.00039887946,0.00041760178,0.000001424121,0.002025924,0.016333686,0.00004941457,0.000015237024,0.00003927271,0.0003392792],"about_ca_topic_score_codex":0.022312861,"about_ca_topic_score_gemma":0.025840806,"teacher_disagreement_score":0.032189444,"about_ca_system_score_codex":0.0006796476,"about_ca_system_score_gemma":0.00015934827,"threshold_uncertainty_score":0.99989027},"labels":[],"label_agreement":null},{"id":"W2888696829","doi":"10.1016/j.msard.2018.08.022","title":"Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université de Sherbrooke; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Comorbidity; PsycINFO; Observational study; Physical therapy; CINAHL; MEDLINE; Type 2 diabetes; Population; Diabetes mellitus; Intensive care medicine; Internal medicine; Psychiatry; Environmental health; Psychological intervention","score_opus":0.11759941515899497,"score_gpt":0.31535378527287294,"score_spread":0.19775437011387798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888696829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025977008,0.9644905,0.000014788319,0.0001466245,0.00007224319,0.009095551,0.00007280856,0.000066855355,0.0000636529],"genre_scores_gemma":[0.06025909,0.9352138,0.00016221874,0.000012870285,0.00005684524,0.004096333,0.000050272225,0.0001361006,0.000012461611],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964486,0.00030684608,0.0008265991,0.001037219,0.0006102193,0.0007705557],"domain_scores_gemma":[0.9967493,0.0015920381,0.0005227897,0.0007514515,0.00017563549,0.00020881805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008956934,0.0008058696,0.0034952902,0.00038369242,0.0004799764,0.000069238165,0.00027925547,0.0002049463,0.0000064369174],"category_scores_gemma":[0.00069541053,0.00049931754,0.00068063656,0.0008982573,0.0008178931,0.00032350878,0.0004111069,0.00074458437,0.0000029768132],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001567675,0.000385153,0.0011890234,0.12534304,0.00069476955,6.960274e-7,0.001447135,0.000007962147,0.000041905736,0.0000064226283,0.00002410213,0.87070304],"study_design_scores_gemma":[0.0049747713,0.0005133331,0.01788046,0.9617549,0.002993917,0.0000061380074,0.0016015831,0.0028797109,0.00005192823,0.000017707862,0.0064753136,0.00085020205],"about_ca_topic_score_codex":0.00084233395,"about_ca_topic_score_gemma":0.0010569282,"teacher_disagreement_score":0.86985284,"about_ca_system_score_codex":0.00010346454,"about_ca_system_score_gemma":0.00017188814,"threshold_uncertainty_score":0.99974585},"labels":[],"label_agreement":null},{"id":"W2889718825","doi":"10.1016/j.msard.2018.08.020","title":"Pilot randomized controlled trial of functional electrical stimulation cycling exercise in people with multiple sclerosis with mobility disability","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Cycling; Physical medicine and rehabilitation; Functional electrical stimulation; Randomized controlled trial; Physical therapy; Stimulation; Internal medicine; Psychiatry","score_opus":0.03322548054890444,"score_gpt":0.26492313228075803,"score_spread":0.23169765173185358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889718825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986148,0.00055862,0.0005316084,0.00036713007,0.00016944518,0.011821225,0.000018326491,0.00011491057,0.0002707263],"genre_scores_gemma":[0.9950255,0.0022980105,0.0007329898,0.000018095618,0.000066830755,0.0016783427,0.000056013254,0.000061504856,0.0000627017],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950624,0.00063432433,0.0014988766,0.001007221,0.0010750502,0.0007221088],"domain_scores_gemma":[0.99448246,0.0036609645,0.00047388638,0.0005739257,0.00050855894,0.00030017758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021789866,0.0005488671,0.002714859,0.00032581747,0.0003915621,0.000048582915,0.00013414884,0.00022376364,0.0001392068],"category_scores_gemma":[0.003867577,0.00034220231,0.0004125208,0.0011732675,0.0022832768,0.00025405706,0.00010750822,0.0006117825,0.0000058693263],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7087094,0.003427719,0.27690482,0.00010524699,0.0004959925,4.834433e-7,0.0005839157,0.001148966,0.004857845,0.000007344109,0.000014630069,0.0037436278],"study_design_scores_gemma":[0.5188076,0.0018362424,0.42921755,0.0005560858,0.00029684114,0.0000010501918,0.00020524386,0.048604216,0.00023033716,0.000023439716,0.0000012953817,0.00022010088],"about_ca_topic_score_codex":0.0019140282,"about_ca_topic_score_gemma":0.0032204806,"teacher_disagreement_score":0.18990183,"about_ca_system_score_codex":0.00019952512,"about_ca_system_score_gemma":0.00017068036,"threshold_uncertainty_score":0.999903},"labels":[],"label_agreement":null},{"id":"W2889883532","doi":"10.1016/j.msard.2018.09.004","title":"Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple sclerosis; Medicine; Mitochondrial DNA; DNA; Genetics; Immunology; Gene; Biology","score_opus":0.011477791379696616,"score_gpt":0.19424484342829393,"score_spread":0.1827670520485973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889883532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705786,0.00023306855,0.0007141061,0.00019847244,0.00068316463,0.00051292934,0.000051953735,0.000027811548,0.0005206586],"genre_scores_gemma":[0.9975201,0.00047381318,0.0012129999,0.00016685278,0.00012535302,0.00004583773,0.00020838973,0.000035591853,0.00021106601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985191,0.0001113499,0.00030547005,0.000604475,0.00013089157,0.00032867317],"domain_scores_gemma":[0.99934095,0.000045799152,0.00010586967,0.00027895308,0.0000926673,0.00013577694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093292845,0.00024392261,0.00021886823,0.000119065095,0.00027116598,0.00004529736,0.00009622061,0.00034827107,0.00006743515],"category_scores_gemma":[0.00020197059,0.00020800845,0.000054638876,0.00022184763,0.0003216346,0.000017461405,0.00009730144,0.00015751894,0.000015121505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015325699,0.0004848746,0.8069285,0.000016368345,0.00014043458,4.97323e-7,0.00065569277,0.000054706772,0.17772202,0.00008284773,0.0013155135,0.011065966],"study_design_scores_gemma":[0.014942791,0.0012915467,0.9726809,0.00007583081,0.000056316247,0.0000021601934,0.0001668075,0.0006809971,0.0038983223,0.0000734783,0.0056167953,0.0005140531],"about_ca_topic_score_codex":0.00016623655,"about_ca_topic_score_gemma":0.0015120173,"teacher_disagreement_score":0.1738237,"about_ca_system_score_codex":0.0000121127805,"about_ca_system_score_gemma":0.000028748718,"threshold_uncertainty_score":0.8482338},"labels":[],"label_agreement":null},{"id":"W2890102036","doi":"10.1016/j.msard.2018.09.008","title":"Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; Dalhousie University; University of Calgary; University of Manitoba; University of Toronto","funders":"Crohn's and Colitis Canada; Canadian Institutes of Health Research; Dalhousie University; Research Manitoba","keywords":"Medicine; Fingolimod; Adverse effect; Natalizumab; Psychiatry; Depression (economics); Anxiety; Meta-analysis; Relative risk; Incidence (geometry); Systematic review; Observational study; MEDLINE; Internal medicine; Multiple sclerosis; Confidence interval","score_opus":0.06242617778613777,"score_gpt":0.3091988898515426,"score_spread":0.24677271206540483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890102036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073230057,0.9830818,0.00001074338,0.00021058148,0.00043347903,0.015159197,0.000109765024,0.00015896298,0.00010315162],"genre_scores_gemma":[0.011796157,0.98436606,0.0002649374,0.00009942828,0.00006846209,0.002902485,0.00015302077,0.00023555054,0.00011392836],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9918116,0.0012503783,0.0031437066,0.001544715,0.0011277458,0.0011218913],"domain_scores_gemma":[0.99378204,0.0023117836,0.0015119157,0.0015262393,0.00025751107,0.00061050296],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013496917,0.0013984973,0.0070990287,0.0012760229,0.00037569972,0.000046221612,0.0005725734,0.00070935074,0.000044283606],"category_scores_gemma":[0.004894797,0.0009873849,0.0019422695,0.002293347,0.0008322675,0.0002166438,0.0004282672,0.0011885435,0.00008145339],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012089777,0.0007882289,0.0014110652,0.9427503,0.0018712066,0.000007990948,0.00041522027,0.000002112455,0.000010672376,0.000004863686,0.0004631903,0.052154277],"study_design_scores_gemma":[0.006040044,0.00036928253,0.0066284123,0.97106665,0.008199449,0.0000066579582,0.00021943629,0.0003174001,0.0000014878752,0.000014203054,0.006171908,0.00096504804],"about_ca_topic_score_codex":0.0002060925,"about_ca_topic_score_gemma":0.00012989622,"teacher_disagreement_score":0.05118923,"about_ca_system_score_codex":0.00026855382,"about_ca_system_score_gemma":0.00033007519,"threshold_uncertainty_score":0.99987656},"labels":[],"label_agreement":null},{"id":"W2890349017","doi":"10.1016/j.msard.2018.09.002","title":"Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Family medicine; MEDLINE; Health care; Psychiatry","score_opus":0.06507269190061979,"score_gpt":0.28866250422135786,"score_spread":0.22358981232073807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890349017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585162,0.035313193,0.000015798983,0.0025837997,0.000330629,0.0023188982,0.0003340252,0.000117242584,0.0004702552],"genre_scores_gemma":[0.92109656,0.077275135,0.00031081153,0.0007016363,0.00006505364,0.00019175523,0.0002396073,0.000066909604,0.000052558422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953675,0.00098688,0.0009018198,0.0011554551,0.0007227361,0.000865561],"domain_scores_gemma":[0.99684674,0.0013016451,0.00032848094,0.0008206003,0.0002668936,0.00043565116],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00066310033,0.0005414129,0.0007977016,0.00027340042,0.0013180935,0.00012301687,0.00028454207,0.00026375777,0.000076771175],"category_scores_gemma":[0.0014669806,0.0003765066,0.00014274243,0.00081948534,0.0013799578,0.00023101381,0.0005615342,0.0008918907,0.000040277737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005060546,0.00043210792,0.83081466,0.00015919005,0.00035388075,0.0000023945033,0.029031454,0.000023762499,0.0012019004,0.0000060566153,0.004851966,0.13261655],"study_design_scores_gemma":[0.0069729392,0.0009107159,0.9775589,0.0012451852,0.00006685604,0.000001124347,0.0060843294,0.002464477,0.00010524961,0.000015453614,0.004170665,0.00040407726],"about_ca_topic_score_codex":0.017674012,"about_ca_topic_score_gemma":0.017113237,"teacher_disagreement_score":0.14674425,"about_ca_system_score_codex":0.00021577964,"about_ca_system_score_gemma":0.00014065737,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W2894796500","doi":"10.1016/j.msard.2018.09.036","title":"Use of eHealth and mHealth technology by persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Canon Foundation for Scientific Research; National Multiple Sclerosis Society; Research Manitoba; Biogen; Canadian Institutes of Health Research; Novartis","keywords":"eHealth; mHealth; Telehealth; Telemedicine; Health Information National Trends Survey; Medicine; The Internet; Health informatics; Health care; Health information technology; Patient portal; Descriptive statistics; Internet privacy; Family medicine; Medical education; Nursing; World Wide Web; Health information; Computer science; Public health; Psychological intervention","score_opus":0.05599073180113199,"score_gpt":0.2815563722829021,"score_spread":0.2255656404817701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894796500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881715,0.003970756,0.00012110196,0.005673705,0.00009105141,0.0013299714,0.00018943801,0.00020046104,0.00025197514],"genre_scores_gemma":[0.9726562,0.02371493,0.0029301904,0.0001976708,0.000030233996,0.00009459855,0.0000441744,0.000082424376,0.00024958252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969031,0.00012631244,0.00064317987,0.00089816086,0.0005270298,0.0009021937],"domain_scores_gemma":[0.9978765,0.00045978196,0.00028495767,0.00056626066,0.00031239798,0.0005000937],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0003548296,0.00045683983,0.00086442125,0.0005318563,0.0007028813,0.00005148229,0.00014585396,0.0004120772,0.0000600858],"category_scores_gemma":[0.00082204014,0.00034526025,0.00010367703,0.0010323547,0.0027891786,0.00024548997,0.00023152617,0.0005951489,0.000010214206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001217715,0.0007836177,0.8206971,0.00038764288,0.0006123387,0.0000018624394,0.0021327191,0.000008428518,0.07362209,0.000050021332,0.0048569744,0.09562943],"study_design_scores_gemma":[0.013802296,0.003696231,0.9576499,0.0014657929,0.0002724351,0.00002438145,0.0035846347,0.007041215,0.0054018595,0.000031197054,0.006395331,0.00063471333],"about_ca_topic_score_codex":0.0020645075,"about_ca_topic_score_gemma":0.0013109032,"teacher_disagreement_score":0.13695276,"about_ca_system_score_codex":0.00008366739,"about_ca_system_score_gemma":0.000119254335,"threshold_uncertainty_score":0.99992466},"labels":[],"label_agreement":null},{"id":"W2894945114","doi":"10.1016/j.msard.2018.09.033","title":"Cardiorespiratory fitness and cognitive processing speed in multiple sclerosis: The possible roles of psychological symptoms","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Cardiorespiratory fitness; Aerobic exercise; Cognition; Medicine; Anxiety; Depression (economics); Physical therapy; Confounding; Physical fitness; Physical medicine and rehabilitation; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.0617102155698691,"score_gpt":0.3063507402815769,"score_spread":0.24464052471170777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894945114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882702,0.008694143,0.000025011335,0.000635835,0.000107091844,0.0012992728,0.000041463056,0.00007889489,0.00084804546],"genre_scores_gemma":[0.9958559,0.0036107185,0.00009405296,0.00016486745,0.00007281655,0.00009335261,0.000014179517,0.000049501,0.000044562225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970443,0.00026620668,0.00070121523,0.00078944454,0.00053613225,0.00066268747],"domain_scores_gemma":[0.99838704,0.0004992378,0.00021881242,0.00034559163,0.00031940648,0.0002299396],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0007663626,0.0003986745,0.000745548,0.00030016436,0.00055667904,0.00007369148,0.00018728351,0.00032828166,0.000039603376],"category_scores_gemma":[0.0012602272,0.00026072157,0.00015952987,0.0008071472,0.0028669802,0.00020012722,0.00026662558,0.00058119633,0.0000092107075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087990577,0.00053151493,0.7477124,0.00015828467,0.0002437115,0.0000028452241,0.004629203,0.000017498647,0.021932626,0.0000100130355,0.000067134235,0.2238149],"study_design_scores_gemma":[0.009964329,0.0008219408,0.9748155,0.0017355484,0.00014705602,0.000007733503,0.0045474037,0.0059757335,0.0015726715,0.000055343866,0.00006979661,0.00028693597],"about_ca_topic_score_codex":0.00029825786,"about_ca_topic_score_gemma":0.0007891364,"teacher_disagreement_score":0.22710314,"about_ca_system_score_codex":0.000040757383,"about_ca_system_score_gemma":0.00005603267,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W2897403748","doi":"10.1016/j.msard.2018.10.013","title":"Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Isfahan University of Medical Sciences","keywords":"Myelin oligodendrocyte glycoprotein; Medicine; Optic neuritis; Multiple sclerosis; Immunology; Oligodendrocyte; Antibody; Myelin; Pathology; Internal medicine; Central nervous system; Experimental autoimmune encephalomyelitis","score_opus":0.07496108249906837,"score_gpt":0.35103774748402017,"score_spread":0.2760766649849518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897403748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914912,0.0043718503,0.000030148642,0.001283369,0.0003014657,0.001745144,0.000050095176,0.00018598334,0.00054072845],"genre_scores_gemma":[0.961078,0.03761013,0.00050070067,0.00011324048,0.00012633333,0.00009556069,0.00008584571,0.000084349354,0.000305878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960335,0.00027177198,0.0011436066,0.0011082565,0.0005212975,0.0009215519],"domain_scores_gemma":[0.9978756,0.000497247,0.00028936588,0.00047817707,0.00020504929,0.0006545642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079643884,0.00060079497,0.0013546842,0.0002182098,0.00079162477,0.00015249742,0.00013825174,0.00047485981,0.000046860026],"category_scores_gemma":[0.00089138036,0.0004849001,0.00023227383,0.00036758435,0.0014825392,0.00020650786,0.00033419966,0.00064716977,0.000035594494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062573276,0.0010782048,0.961279,0.00009651838,0.0010307293,0.000024092684,0.00081221637,0.000013790616,0.005704424,0.000008163281,0.00021458989,0.029112548],"study_design_scores_gemma":[0.019430436,0.0019138029,0.93444103,0.0005836344,0.0004360879,0.000019011834,0.0007577914,0.04131356,0.00028447842,0.000009866676,0.00033364448,0.0004766803],"about_ca_topic_score_codex":0.00153454,"about_ca_topic_score_gemma":0.0011235835,"teacher_disagreement_score":0.041299768,"about_ca_system_score_codex":0.00012588847,"about_ca_system_score_gemma":0.000070821174,"threshold_uncertainty_score":0.99976027},"labels":[],"label_agreement":null},{"id":"W2897720855","doi":"10.1016/j.msard.2018.10.018","title":"Diabetes and anxiety adversely affect cognition in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; Health Sciences Centre; University of Manitoba","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Nova Scotia Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Health Sciences Centre Foundation; Brain and Behavior Research Foundation","keywords":"Medicine; Multiple sclerosis; Affect (linguistics); Cognition; Anxiety; Diabetes mellitus; Clinical psychology; Psychiatry; Endocrinology; Psychology","score_opus":0.04239819271777926,"score_gpt":0.25914880637747495,"score_spread":0.2167506136596957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897720855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263495,0.002616123,0.000015817244,0.0011089809,0.00021126254,0.0014831637,0.000060151102,0.00018775596,0.0016818232],"genre_scores_gemma":[0.97706074,0.021686627,0.0005027965,0.00022879447,0.00008435928,0.00018654835,0.000073243806,0.00007370836,0.000103183986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968324,0.0002025386,0.0005859426,0.00096038176,0.000492164,0.0009265926],"domain_scores_gemma":[0.9984067,0.0004902294,0.00014440302,0.00037702458,0.00017807569,0.00040357042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064522395,0.000480794,0.00069837715,0.00044911844,0.00058862334,0.0000864094,0.00012227717,0.00037663238,0.00014088851],"category_scores_gemma":[0.0012376693,0.000414708,0.00017277409,0.0007226527,0.0013079841,0.00032655083,0.00026729432,0.0005678425,0.00005980603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039141826,0.00044738982,0.8020644,0.00018017659,0.0002691622,0.0000014025353,0.001348585,0.000009100924,0.09118514,0.000008894329,0.0006831214,0.1034112],"study_design_scores_gemma":[0.012854529,0.00061363954,0.9657342,0.001032356,0.00013853984,0.0000036105762,0.0011510823,0.012695368,0.0043223314,0.00006140245,0.0009178701,0.00047509102],"about_ca_topic_score_codex":0.0004287895,"about_ca_topic_score_gemma":0.0014195697,"teacher_disagreement_score":0.16366976,"about_ca_system_score_codex":0.00008900841,"about_ca_system_score_gemma":0.00004405828,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W2898257974","doi":"10.1016/j.msard.2018.10.109","title":"Coexistence of Multiple Sclerosis and Alzheimer's disease: A review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; International Collaboration On Repair Discoveries; Vancouver Coastal Health; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech; Multiple Sclerosis Society; Michael Smith Health Research BC; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Novartis; Multiple Sclerosis Society of Canada; American Academy of Neurology; National Multiple Sclerosis Society Michigan Chapter; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Alzheimer's disease; Neuroscience; Dermatology; Pathology; Immunology","score_opus":0.12690580694838247,"score_gpt":0.3355699256097763,"score_spread":0.2086641186613938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898257974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031699956,0.9923598,0.0000044379194,0.0005547323,0.00026604082,0.0052840943,0.0005608417,0.00015972002,0.00049330614],"genre_scores_gemma":[0.0051702214,0.992672,0.0004386601,0.00014546048,0.00009528412,0.0006954014,0.0003790513,0.00021420345,0.00018966185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99350816,0.0005267355,0.0021161227,0.0017564922,0.001048868,0.0010436084],"domain_scores_gemma":[0.9949151,0.001242094,0.001048723,0.0013384561,0.00040984323,0.0010457424],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009827164,0.0012922371,0.00460629,0.00052654574,0.000521034,0.000073354335,0.00045534602,0.00068962935,0.0001831734],"category_scores_gemma":[0.0028552948,0.00096740574,0.0012343872,0.0012060367,0.0022297043,0.0002080126,0.00080781203,0.0010418999,0.00006836342],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015248547,0.0005047436,0.002123172,0.0773656,0.0025619562,0.0000069883895,0.00019932174,4.8156863e-7,0.000020850619,0.00001047351,0.0050115045,0.91204244],"study_design_scores_gemma":[0.0045161746,0.00047897812,0.01914644,0.34004575,0.0099189365,0.00002489404,0.00012849367,0.00033956787,0.000005067327,0.000015066724,0.6240746,0.0013060943],"about_ca_topic_score_codex":0.00025371372,"about_ca_topic_score_gemma":0.000079568126,"teacher_disagreement_score":0.9107363,"about_ca_system_score_codex":0.000100887046,"about_ca_system_score_gemma":0.00032444848,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W2898436682","doi":"10.1016/j.msard.2018.10.112","title":"Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Cognition; Multiple sclerosis; Audiology; Medicine; Association (psychology); Depression (economics); Montreal Cognitive Assessment; Analysis of variance; Physical medicine and rehabilitation; Physical therapy; Psychology; Psychiatry; Cognitive impairment; Internal medicine","score_opus":0.08145335485976651,"score_gpt":0.29633660455167227,"score_spread":0.21488324969190575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898436682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474955,0.0010306811,0.00033101006,0.0014307977,0.00013953286,0.0017839823,0.00011355914,0.000081597056,0.00033930884],"genre_scores_gemma":[0.9969399,0.0023942254,0.00021438445,0.0001444926,0.00010583562,0.00009478643,0.000026716636,0.000047564172,0.000032124146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685246,0.00039961893,0.0006894948,0.0007229215,0.0005931331,0.0007423651],"domain_scores_gemma":[0.9964101,0.002483924,0.0002733611,0.00029313914,0.00030351226,0.00023599963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013542889,0.00037839633,0.0006920705,0.00022298234,0.0008519018,0.00011259483,0.00012146487,0.0003385182,0.000031678395],"category_scores_gemma":[0.0047263275,0.00027827462,0.00014495726,0.00066020334,0.0009133382,0.00026868397,0.00020597303,0.0006573632,0.000010312115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027688852,0.00014455042,0.9592888,0.00006450984,0.0004697438,5.401366e-7,0.0022309846,0.00008766693,0.008561596,0.000002401917,0.000031852076,0.028840486],"study_design_scores_gemma":[0.012264006,0.00024298418,0.96337444,0.0007549272,0.00024580798,9.969364e-7,0.0020530077,0.019816509,0.0007869925,0.000075167794,0.00008479922,0.00030036474],"about_ca_topic_score_codex":0.002558195,"about_ca_topic_score_gemma":0.0021085744,"teacher_disagreement_score":0.028540121,"about_ca_system_score_codex":0.00030515276,"about_ca_system_score_gemma":0.00006677184,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W2900371473","doi":"10.1016/j.msard.2018.11.004","title":"Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Manitoba; University of British Columbia Hospital; Manitoba Health; University of British Columbia","funders":"Crohn's and Colitis Canada; University of British Columbia; MedImmune; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Ministry of Health, British Columbia; Saskatchewan Health Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Guthy-Jackson Charitable Foundation","keywords":"Medicine; Fingolimod; Odds ratio; Discontinuation; Population; Internal medicine; Medical prescription; Teriflunomide; Persistence (discontinuity); Logistic regression; Confidence interval; Comorbidity; Multiple sclerosis; Pediatrics; Demography; Psychiatry; Environmental health","score_opus":0.11230498106763695,"score_gpt":0.3148480857448274,"score_spread":0.20254310467719047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900371473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98351306,0.0031128877,0.0006598078,0.0073711304,0.00023803033,0.004834056,0.00007231389,0.00016086789,0.000037869126],"genre_scores_gemma":[0.99588025,0.0007786899,0.0017679125,0.00050132605,0.00012309165,0.0006104787,0.000034962683,0.00006826624,0.00023504435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707764,0.00017165142,0.00052604725,0.0009402956,0.0005762864,0.0007081021],"domain_scores_gemma":[0.99762625,0.000746835,0.000143172,0.0005919619,0.00026227994,0.000629482],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0005803816,0.0004429746,0.0005441896,0.00022093966,0.0014706095,0.00019447085,0.00025328496,0.00012943045,0.000053376203],"category_scores_gemma":[0.0018763249,0.00030025968,0.00020150252,0.0005738749,0.0003740425,0.00018266922,0.00020157742,0.00028376078,0.000017377712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018445282,0.00061576115,0.88180435,0.000114454124,0.0004503848,8.144881e-7,0.007740312,0.00023420579,0.0032505898,0.000010955034,0.0011539147,0.10277973],"study_design_scores_gemma":[0.009820996,0.0016834503,0.9531166,0.0005207568,0.00024576206,5.908643e-7,0.006380214,0.026788404,0.000063757725,0.000045694545,0.00094933435,0.00038443375],"about_ca_topic_score_codex":0.002083767,"about_ca_topic_score_gemma":0.0045884536,"teacher_disagreement_score":0.102395296,"about_ca_system_score_codex":0.00007901285,"about_ca_system_score_gemma":0.00011757063,"threshold_uncertainty_score":0.9999449},"labels":[],"label_agreement":null},{"id":"W2900596677","doi":"10.1016/j.msard.2018.11.021","title":"Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Tolerability; Adverse effect; Placebo; Internal medicine; Multiple sclerosis; Clinical trial; Cohort; Gastroenterology; Immunology; Pathology","score_opus":0.03259422897934258,"score_gpt":0.2599261944930275,"score_spread":0.22733196551368492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900596677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966251,0.00075705803,0.000097248194,0.0003028336,0.000052093354,0.0016349013,0.0002492691,0.000039560295,0.0002419318],"genre_scores_gemma":[0.99212646,0.0065620276,0.00068290293,0.000037298618,0.000019291258,0.00010390131,0.00039348647,0.000039310788,0.00003529151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968971,0.00031388868,0.00090482767,0.00063953735,0.00069876504,0.00054585637],"domain_scores_gemma":[0.9978114,0.00041673958,0.00033307308,0.0007489934,0.0005047213,0.00018508217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044156314,0.00041846043,0.0010492117,0.00063888676,0.00025740336,0.000025703635,0.00022293498,0.00021130785,0.00012253011],"category_scores_gemma":[0.0003058867,0.00023394043,0.00025888768,0.0025463381,0.0010983528,0.00018130701,0.00005482274,0.00023789436,0.0000034480754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029918372,0.004634396,0.9394008,0.00005147583,0.0018997098,8.4527375e-7,0.0059436243,0.00035200987,0.002970007,0.0000067186497,0.00003671619,0.04171185],"study_design_scores_gemma":[0.017339632,0.0042726463,0.9637292,0.00030255382,0.0008350618,3.0938918e-7,0.0029575187,0.00891526,0.0008785634,0.000004480071,0.0005261549,0.0002386263],"about_ca_topic_score_codex":0.0032992184,"about_ca_topic_score_gemma":0.0086220745,"teacher_disagreement_score":0.04147322,"about_ca_system_score_codex":0.000114784074,"about_ca_system_score_gemma":0.00006561981,"threshold_uncertainty_score":0.9539814},"labels":[],"label_agreement":null},{"id":"W2901626095","doi":"10.1016/j.msard.2018.11.015","title":"Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"University of British Columbia; Michael Smith Health Research BC; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Institutes of Health; Bayer HealthCare; European Committee for Treatment and Research in Multiple Sclerosis; Michael J. Fox Foundation for Parkinson's Research; American Academy of Neurology; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Life course approach; Course (navigation); Case-control study; Gerontology; Environmental health; Demography; Internal medicine; Psychiatry; Developmental psychology; Psychology","score_opus":0.024671919138558557,"score_gpt":0.2652599387456144,"score_spread":0.2405880196070558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901626095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138683,0.004659975,0.000011887918,0.00023955935,0.00017906248,0.003059739,0.0002845386,0.000077990415,0.00010041926],"genre_scores_gemma":[0.9953099,0.0039946227,0.00014616965,0.00007376728,0.00008517691,0.0002688581,0.0000051454267,0.000079223944,0.00003714466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957983,0.00062291,0.001169786,0.0008323067,0.0008018185,0.00077490596],"domain_scores_gemma":[0.99656194,0.0010812128,0.0006639004,0.00080696825,0.00042302196,0.00046294281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019040466,0.0005331218,0.0012034966,0.0002454222,0.00074033096,0.00005769285,0.0002198067,0.00024717115,0.00013557503],"category_scores_gemma":[0.0022130255,0.0003523777,0.00021774576,0.00065197103,0.0020323717,0.00019920238,0.00030778156,0.00068112655,0.0000047270246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022960498,0.0015687213,0.9507661,0.000112984206,0.003575005,0.0000149811995,0.018738415,0.00011266321,0.011957294,0.0000049120536,0.00014178202,0.010711088],"study_design_scores_gemma":[0.02656281,0.0033683141,0.93628573,0.00033742035,0.0012122253,0.000027988443,0.019197404,0.012288993,0.00034260174,0.000014323402,0.000028480452,0.00033368854],"about_ca_topic_score_codex":0.005030853,"about_ca_topic_score_gemma":0.0043253363,"teacher_disagreement_score":0.024266759,"about_ca_system_score_codex":0.000049023845,"about_ca_system_score_gemma":0.00011754805,"threshold_uncertainty_score":0.99989283},"labels":[],"label_agreement":null},{"id":"W2903804915","doi":"10.1016/j.msard.2018.10.103","title":"Sustained Reduction in Confirmed Disability Progression in Patients with Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-label Extension Period of the Phase III ORATORIO trial","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Placebo; Myelofibrosis; Oratorio; Open label; Internal medicine; Clinical trial; Immunology; Pathology; Alternative medicine","score_opus":0.04062952160412597,"score_gpt":0.3035690542692676,"score_spread":0.26293953266514164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903804915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601794,0.00039627985,0.00000263759,0.0010601088,0.00010064503,0.012207995,0.000032732318,0.000036672693,0.0001450033],"genre_scores_gemma":[0.9982862,0.00030294902,0.00018585891,0.000033010725,0.000029725314,0.0009763705,0.00011350244,0.00005397595,0.000018442424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955586,0.0007781229,0.0010132836,0.00096126384,0.0009733735,0.0007153503],"domain_scores_gemma":[0.99779487,0.00028628355,0.00048631962,0.0008193028,0.00047041647,0.0001428365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010342441,0.00048648036,0.0009307521,0.00024724266,0.00047676166,0.000098211705,0.0004163516,0.00028564426,0.00002301036],"category_scores_gemma":[0.00091414875,0.00024197747,0.000078133875,0.0021041618,0.0022778031,0.00038483134,0.00040015168,0.00073880085,8.4898153e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21198358,0.015561274,0.70925623,0.00015766786,0.00015151063,0.0000053923636,0.0060320655,0.0000239754,0.0048348084,0.000005251467,0.000071303286,0.051916916],"study_design_scores_gemma":[0.30074763,0.0050961506,0.6862662,0.0018952485,0.00006600161,0.000001939039,0.0039524124,0.0011975715,0.0005063384,0.000005752491,0.000018745264,0.00024599003],"about_ca_topic_score_codex":0.0013746419,"about_ca_topic_score_gemma":0.001915732,"teacher_disagreement_score":0.088764064,"about_ca_system_score_codex":0.0003806057,"about_ca_system_score_gemma":0.0002437159,"threshold_uncertainty_score":0.9867555},"labels":[],"label_agreement":null},{"id":"W2903866675","doi":"10.1016/j.msard.2018.10.105","title":"Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Opera; Multiple sclerosis; Clinical trial; Internal medicine; Surgery; Oncology; Immunology","score_opus":0.01277753586088721,"score_gpt":0.2321336456996975,"score_spread":0.2193561098388103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903866675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974255,0.0010763411,0.000008544832,0.00009553528,0.00015194608,0.0011117806,0.00006103369,0.000026770811,0.000042526513],"genre_scores_gemma":[0.9983547,0.0012523648,0.00016640897,0.0000074977866,0.00001953762,0.000056076038,0.00008140861,0.000033742854,0.000028270944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840814,0.00011168277,0.00052651827,0.00047016784,0.00021866696,0.00026485432],"domain_scores_gemma":[0.9991471,0.000068210065,0.00022919083,0.0002859411,0.00011993664,0.0001496166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014250536,0.00023914952,0.00046362085,0.000120143835,0.000091128335,0.000014317629,0.000043813798,0.00019568545,0.000039505976],"category_scores_gemma":[0.0000768919,0.00018381949,0.00010972032,0.0002509295,0.0010022089,0.00016407444,0.00005006207,0.00014035091,0.0000013716694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021043146,0.0016819572,0.92461985,0.00020376248,0.00011848735,0.0000022250927,0.0011014595,0.00000565033,0.0045720097,0.000002919786,0.0000044822273,0.046644058],"study_design_scores_gemma":[0.011579961,0.0061169257,0.9773918,0.0028882376,0.00021274421,0.0000024107019,0.00023399599,0.00044131756,0.0009207049,0.000010034982,0.000008739882,0.00019315878],"about_ca_topic_score_codex":0.00043269346,"about_ca_topic_score_gemma":0.0001256753,"teacher_disagreement_score":0.052771926,"about_ca_system_score_codex":0.00010367639,"about_ca_system_score_gemma":0.000040095285,"threshold_uncertainty_score":0.7495941},"labels":[],"label_agreement":null},{"id":"W2903995358","doi":"10.1016/j.msard.2018.10.035","title":"Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (SC IFNβ-1a)-treated Patients","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Gadolinium; Interferon beta-1a; Internal medicine; Interferon; BETA (programming language); Gastroenterology; Interferon beta; Pathology; Immunology","score_opus":0.040974278351388844,"score_gpt":0.31022498245071906,"score_spread":0.2692507040993302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903995358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975686,0.00060101907,0.000012439277,0.00007528557,0.00017142338,0.0011832728,0.00006904681,0.00004304046,0.00027586875],"genre_scores_gemma":[0.99756986,0.002146864,0.000028203209,0.000009316309,0.0000211119,0.000026583499,0.000027234068,0.00005235867,0.00011848955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723554,0.0002711023,0.00074403535,0.0005578424,0.0005975623,0.0005939093],"domain_scores_gemma":[0.99754053,0.00076072256,0.0003225732,0.0005680718,0.00039242618,0.00041567802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035251895,0.00032616104,0.00072146306,0.00042847413,0.000110158675,0.000016311189,0.00015008585,0.00023823668,0.00015722196],"category_scores_gemma":[0.0010832496,0.00024189366,0.00025787603,0.0006012387,0.00043205693,0.00016368306,0.00012855795,0.0004017267,0.00003722484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033188734,0.0015734647,0.9080551,0.00057027314,0.00022916932,0.0000072023545,0.002016628,0.00007955533,0.04887329,0.0000014865175,0.000098598495,0.005306444],"study_design_scores_gemma":[0.009696521,0.024250815,0.94109607,0.013319953,0.00018306797,0.000014853017,0.00052895735,0.00593052,0.0045582647,0.00001455332,0.0000061546866,0.00040024653],"about_ca_topic_score_codex":0.0023338844,"about_ca_topic_score_gemma":0.0004530923,"teacher_disagreement_score":0.04431503,"about_ca_system_score_codex":0.00028284095,"about_ca_system_score_gemma":0.00021390145,"threshold_uncertainty_score":0.9864137},"labels":[],"label_agreement":null},{"id":"W2904219708","doi":"10.1016/j.msard.2018.10.087","title":"Alemtuzumab Improves Clinical and Radiological Outcomes in Patients with Relapsing-remitting Multiple Sclerosis Over 8 Years: Care-MS I Follow-up (topaz Study)","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Radiological weapon; Clinical trial; Internal medicine; Physical therapy; Surgery; Psychiatry","score_opus":0.03784702482552056,"score_gpt":0.28934184226628107,"score_spread":0.2514948174407605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904219708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683964,0.00096194254,0.0000034179202,0.0002381941,0.00034784595,0.0012667481,0.0000283914,0.000067253524,0.00024657493],"genre_scores_gemma":[0.99798787,0.0010208602,0.0003474794,0.00015792255,0.00007201726,0.000037362926,0.000049083388,0.000048877806,0.00027852287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970512,0.00022615468,0.0007637809,0.0008457617,0.00049821776,0.0006148961],"domain_scores_gemma":[0.9985422,0.00051452324,0.00015745436,0.00032458847,0.00013747977,0.00032375957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046550587,0.00037418742,0.0008054219,0.00019984083,0.00031687727,0.00006701685,0.0001423463,0.00034056834,0.00005537827],"category_scores_gemma":[0.00060496497,0.00024960996,0.00017370786,0.0003286167,0.00093996566,0.00015267637,0.00024396517,0.000700127,0.000014450236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022799915,0.0008981067,0.9494949,0.00003707584,0.00027744737,0.0000056345502,0.002283544,0.0000021654512,0.00024547562,0.000004534038,0.00009472063,0.0443764],"study_design_scores_gemma":[0.026769247,0.003406459,0.96657246,0.00032388745,0.000110857945,0.0000018648176,0.0015119134,0.0006204931,0.000016004074,0.000014776645,0.00031486287,0.0003371677],"about_ca_topic_score_codex":0.0012517206,"about_ca_topic_score_gemma":0.0008904207,"teacher_disagreement_score":0.04403923,"about_ca_system_score_codex":0.000050681574,"about_ca_system_score_gemma":0.000049216884,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2904422419","doi":"10.1016/j.msard.2018.10.037","title":"Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) Score Predicts Long-term Clinical Disease Activity (CDA)-free Status and Disability Progression in Subcutaneous Interferon Beta-1a (scifnβ-1a)-treated Patients","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Internal medicine; Disease; Post-hoc analysis; Interferon beta-1a; Interferon beta; BETA (programming language); Oncology; Pathology; Immunology; Radiology","score_opus":0.041922100974179345,"score_gpt":0.2947016932364096,"score_spread":0.25277959226223023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904422419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887951,0.0067642205,0.000006091966,0.00044963593,0.000317861,0.0033337888,0.0001294173,0.00014345151,0.000060443133],"genre_scores_gemma":[0.9941159,0.0052587315,0.00007672749,0.00003244454,0.000052133844,0.00020077876,0.00010508041,0.000098892284,0.00005930091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945414,0.0007083817,0.0012548012,0.0015491679,0.00078544364,0.0011607957],"domain_scores_gemma":[0.9969055,0.00073154765,0.00027274078,0.0010551802,0.00019902714,0.00083602243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090343325,0.00057794555,0.00092641707,0.00032540684,0.00028200253,0.00010954205,0.00030271747,0.00038905832,0.000064517386],"category_scores_gemma":[0.0016459522,0.00047251175,0.00017766765,0.00074756576,0.0021486345,0.00037046443,0.0006268002,0.00086549844,0.000012912896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010630969,0.0021446089,0.79920554,0.00041140438,0.000025751477,0.000033227392,0.0008851797,0.0000021313106,0.00051973294,5.6136753e-7,0.000038605154,0.18610226],"study_design_scores_gemma":[0.021573838,0.0023940103,0.96104264,0.0054127164,0.00009134791,0.000025070993,0.0002421708,0.008655459,0.0000854911,0.000024021023,0.000013565026,0.0004396565],"about_ca_topic_score_codex":0.0010586325,"about_ca_topic_score_gemma":0.004117038,"teacher_disagreement_score":0.1856626,"about_ca_system_score_codex":0.00037242065,"about_ca_system_score_gemma":0.00011870086,"threshold_uncertainty_score":0.99977267},"labels":[],"label_agreement":null},{"id":"W2904733418","doi":"10.1016/j.msard.2018.10.093","title":"Pregnancy Outcomes During the Clinical Development of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Pregnancy; Clinical trial; Pediatrics; Internal medicine; Immunology","score_opus":0.05563929869226659,"score_gpt":0.2898989886019169,"score_spread":0.2342596899096503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904733418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997939,0.00077855197,0.000052059087,0.00015496273,0.00012348632,0.00076493947,0.00004111276,0.00004726644,0.00009860943],"genre_scores_gemma":[0.9963889,0.001592951,0.0016723945,0.000025276513,0.000008029621,0.000028744511,0.00012865916,0.00003367677,0.0001213686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969257,0.000200585,0.0016076143,0.000556297,0.0003370557,0.00037273052],"domain_scores_gemma":[0.9983076,0.00032843978,0.00043237075,0.00061803573,0.00015672694,0.00015683637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051778974,0.000313478,0.001031956,0.0004221644,0.00020352691,0.000011060185,0.00019062149,0.00029365087,0.00013899597],"category_scores_gemma":[0.0004368797,0.00019965522,0.00031588273,0.0014227469,0.00059741,0.00011330404,0.000120657845,0.00034926095,0.00000521508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048695222,0.0011120847,0.9393899,0.000060425104,0.0025438939,0.0000011395155,0.0032852963,0.00019515467,0.0036673723,0.000004386408,0.0000039470624,0.049249448],"study_design_scores_gemma":[0.013397769,0.000266921,0.9726499,0.0009972219,0.0008918554,6.097021e-7,0.0014220806,0.008524906,0.0015946794,0.000003511083,0.00005720441,0.00019334503],"about_ca_topic_score_codex":0.0009933807,"about_ca_topic_score_gemma":0.0065758955,"teacher_disagreement_score":0.0490561,"about_ca_system_score_codex":0.00022235529,"about_ca_system_score_gemma":0.00020849591,"threshold_uncertainty_score":0.81417036},"labels":[],"label_agreement":null},{"id":"W2905125234","doi":"10.1016/j.msard.2018.10.026","title":"Long-term Disease Control with Fingolimod in RRMS Patients with Active Disease","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Relapsing remitting; Disease; Term (time); Pediatrics; Internal medicine; Physical therapy; Immunology","score_opus":0.015689631620237655,"score_gpt":0.24222356630056663,"score_spread":0.22653393468032898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905125234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952981,0.0007167706,0.00005820368,0.0012839651,0.00006306066,0.0020729045,0.00013254529,0.00009424,0.00028024567],"genre_scores_gemma":[0.99782336,0.0013354585,0.00006882351,0.0001897605,0.000042975833,0.00023727155,0.00012184836,0.00007117096,0.00010934103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974295,0.00010485749,0.00034672458,0.0007653815,0.0006383947,0.00071514584],"domain_scores_gemma":[0.99816287,0.00017938504,0.00013172599,0.0004554391,0.0002667123,0.0008038932],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012183135,0.00041393467,0.0005054914,0.00027288013,0.00034114582,0.00005406824,0.00012725813,0.000107005326,0.000108128435],"category_scores_gemma":[0.00038819338,0.00026719872,0.00009564417,0.0005084876,0.0010079149,0.0002587195,0.00009562551,0.00038637393,0.000024102821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011936019,0.0012384959,0.9545706,0.00011609649,0.00034593468,0.000017707493,0.00057031936,0.000057887275,0.000103296145,0.0000049656933,0.000055891258,0.030982818],"study_design_scores_gemma":[0.030565703,0.00086761295,0.964736,0.0010220587,0.00021615921,4.4944716e-7,0.00012899448,0.0019890838,0.000023416207,0.0000117610225,0.00006406347,0.00037468347],"about_ca_topic_score_codex":0.00016988804,"about_ca_topic_score_gemma":0.00077601505,"teacher_disagreement_score":0.030608136,"about_ca_system_score_codex":0.00010182093,"about_ca_system_score_gemma":0.00012575054,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W2905179560","doi":"10.1016/j.msard.2018.10.084","title":"Long-term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Clinical trial; Pooled analysis; Multiple sclerosis; Safety profile; Internal medicine; Adverse effect; Immunology; Fingolimod; Meta-analysis","score_opus":0.0638662203504422,"score_gpt":0.35010310544773837,"score_spread":0.28623688509729617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905179560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961643,0.0025758254,0.000085800355,0.00018186151,0.000112455054,0.0006232601,0.000053339274,0.00004308354,0.0001600316],"genre_scores_gemma":[0.9956628,0.0038827672,0.00017081015,0.00005070383,0.000028289964,0.0000064481337,0.00011615513,0.000026535985,0.00005548049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970837,0.00046326616,0.0015939341,0.00044015885,0.00020270201,0.00021621319],"domain_scores_gemma":[0.9977174,0.00082402246,0.0006220972,0.00048588915,0.00013361413,0.0002170043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00153963,0.00020903847,0.001462132,0.00030824388,0.00010490706,0.000013543188,0.000100206475,0.00026948802,0.0002923698],"category_scores_gemma":[0.0020093678,0.00016044344,0.000418523,0.00051474286,0.00095184153,0.00007616431,0.00008260536,0.00015499661,0.0000027410883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002901522,0.0010255624,0.91336465,0.00006032461,0.00307523,0.0000012430719,0.0004622382,0.000020010926,0.0062930565,0.0000135053715,0.000025289273,0.07275739],"study_design_scores_gemma":[0.011511696,0.0008832442,0.9767365,0.00024381337,0.0068918164,0.0000014831718,0.00016707624,0.0030307404,0.00033475357,0.000010525629,0.000029290824,0.00015908387],"about_ca_topic_score_codex":0.0001900285,"about_ca_topic_score_gemma":0.00008313535,"teacher_disagreement_score":0.07259831,"about_ca_system_score_codex":0.000012780918,"about_ca_system_score_gemma":0.000056307006,"threshold_uncertainty_score":0.65426934},"labels":[],"label_agreement":null},{"id":"W29055455","doi":"10.1016/j.msard.2017.08.006","title":"¿Es la aplicación de las técnicas administrativas, un elemento determinante que garantiza el éxito en los microempresarios de la ciudad de Quito?","year":2012,"lang":"es","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Business, Innovation, and Economy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society of Canada","keywords":"Humanities; Art","score_opus":0.017069567541204336,"score_gpt":0.23634664728017613,"score_spread":0.2192770797389718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29055455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809493,0.011360178,0.0010315314,0.0005623312,0.00040219008,0.0005149387,0.00028919883,0.00007940208,0.00481093],"genre_scores_gemma":[0.97544235,0.022354955,0.0010791243,0.0002641735,0.000204089,0.00010386964,0.00007206073,0.0001090303,0.0003703668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966028,0.00022536883,0.0012126213,0.00071222056,0.00006791465,0.0011791219],"domain_scores_gemma":[0.997974,0.0005152444,0.000655743,0.0004936,0.000049720336,0.00031169824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016889997,0.0005490404,0.00073079974,0.00034755404,0.0005332201,0.00040392907,0.00039339383,0.00094457006,0.00030352134],"category_scores_gemma":[0.00029906223,0.00063459185,0.00027048012,0.00048356206,0.00042203543,0.00062226906,0.00015207888,0.00062122475,0.00009910491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000938939,0.00079760404,0.9750799,0.00023763433,0.00038723313,0.000003895926,0.0030033092,0.00008374821,0.0019254055,0.008622737,0.00073245633,0.009032201],"study_design_scores_gemma":[0.003348975,0.00008909722,0.9264612,0.00027257425,0.0001168827,0.000042287054,0.0009200493,0.0037218626,0.0012132414,0.0016999535,0.06121203,0.00090183574],"about_ca_topic_score_codex":0.0011382297,"about_ca_topic_score_gemma":0.00020003927,"teacher_disagreement_score":0.060479574,"about_ca_system_score_codex":0.00020896399,"about_ca_system_score_gemma":0.00015712596,"threshold_uncertainty_score":0.99961054},"labels":[],"label_agreement":null},{"id":"W2905645019","doi":"10.1016/j.msard.2018.12.028","title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Neuromyelitis optica; Myasthenia gravis; Spectrum disorder; Immunology; Sarcoidosis; Autoimmunity; Autoimmune disease; Multiple sclerosis; Optic neuritis; Antibody; Dermatology","score_opus":0.013989571030606461,"score_gpt":0.22072613800697308,"score_spread":0.2067365669763666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905645019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875692,0.0034526861,0.00016358272,0.0031119331,0.00049367105,0.00068260875,0.000028961415,0.0002833124,0.004214018],"genre_scores_gemma":[0.9958437,0.0028139981,0.00011416674,0.00028093066,0.00007766698,0.000039483046,0.00004732533,0.00007438571,0.00070833584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979965,0.00006820196,0.0003878273,0.0006362748,0.00031633908,0.0005948303],"domain_scores_gemma":[0.99904734,0.000086766224,0.00012506264,0.00037091324,0.000070867114,0.00029902338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006308632,0.00037078134,0.0004364032,0.00011351791,0.00048839225,0.000084635314,0.00011392879,0.00012161094,0.00037856447],"category_scores_gemma":[0.0001415832,0.00026829695,0.00015220838,0.00039920668,0.00081218896,0.00017256776,0.00012319574,0.00029664824,0.000031041593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012263901,0.0019393614,0.88745886,0.00033760603,0.00061029167,0.00007045803,0.0019449197,0.0002332114,0.004602707,0.00067199377,0.002496476,0.098407716],"study_design_scores_gemma":[0.009157434,0.0014471926,0.9578484,0.00028002934,0.00027864645,0.000041378313,0.0008947098,0.012265907,0.000098164,0.0001766435,0.016956752,0.00055471505],"about_ca_topic_score_codex":0.0003486222,"about_ca_topic_score_gemma":0.00031981696,"teacher_disagreement_score":0.097853,"about_ca_system_score_codex":0.000019499113,"about_ca_system_score_gemma":0.000050095856,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W2906242579","doi":"10.1016/j.msard.2018.12.030","title":"MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Saskatchewan; Memorial University of Newfoundland; University of Manitoba; Manitoba Health; University of British Columbia; Dalhousie University; University of British Columbia Hospital","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Dalhousie Medical Research Foundation","keywords":"Medicine; Multiple sclerosis; Diagnostic test; Magnetic resonance imaging; Radiology; Pathology; Pediatrics; Psychiatry","score_opus":0.052010026890492715,"score_gpt":0.27606046027123377,"score_spread":0.22405043338074104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906242579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98399734,0.010108544,0.000045442564,0.0031404935,0.00023590501,0.001918765,0.000055319397,0.00020140168,0.00029678506],"genre_scores_gemma":[0.9164871,0.082597256,0.00012750362,0.00020957009,0.00009806251,0.00024917282,0.00003495584,0.00008418836,0.000112160495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996904,0.00021812465,0.0006801161,0.0008434077,0.00052499794,0.0008293427],"domain_scores_gemma":[0.9946747,0.0040963134,0.00016152638,0.00050126755,0.00025360365,0.0003126312],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004797454,0.000462131,0.0005628032,0.00038037912,0.001038667,0.00012478733,0.0001861955,0.0002654364,0.00015808106],"category_scores_gemma":[0.011739086,0.00033223483,0.000134778,0.0008368174,0.0014275657,0.0003285763,0.00032535574,0.00052882655,0.00004400795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048958615,0.0006610839,0.9118491,0.00020668485,0.00021350027,0.000008310098,0.0032757034,0.00011380491,0.028115101,0.000022537899,0.00040101653,0.054643616],"study_design_scores_gemma":[0.009852914,0.00044953896,0.97610533,0.0011514232,0.000115238,0.000013060017,0.0019246939,0.007890844,0.0014689867,0.000038398062,0.0006102832,0.0003793018],"about_ca_topic_score_codex":0.0014662552,"about_ca_topic_score_gemma":0.0043464857,"teacher_disagreement_score":0.07248872,"about_ca_system_score_codex":0.00010380182,"about_ca_system_score_gemma":0.00005365982,"threshold_uncertainty_score":0.999913},"labels":[],"label_agreement":null},{"id":"W2906840863","doi":"10.1016/j.msard.2019.01.003","title":"Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Medicine; Multiple sclerosis; Incidence (geometry); Cohort; Pregnancy; Disease; Cohort study; Pediatrics; Environmental health; Demography; Internal medicine; Immunology","score_opus":0.04406432906042038,"score_gpt":0.270324932803981,"score_spread":0.22626060374356063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906840863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979863,0.015760766,0.0000043801756,0.0003721038,0.00006633271,0.0034332043,0.00003981591,0.000089997215,0.00037043216],"genre_scores_gemma":[0.98284686,0.01602006,0.000089081055,0.00005906346,0.000010324529,0.00071713544,0.000023556779,0.00007608351,0.00015781267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964408,0.00025821966,0.0007870957,0.0010390116,0.0007867428,0.00068809406],"domain_scores_gemma":[0.9980446,0.0003655428,0.0002757153,0.0006570208,0.00015011196,0.0005069854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006075947,0.0005061951,0.0010794776,0.00058690464,0.0002024781,0.000055214423,0.00018541909,0.000181228,0.00007745746],"category_scores_gemma":[0.00032689815,0.00037378087,0.0001027163,0.0009331868,0.00048261238,0.0003688465,0.00021815655,0.00051626714,0.0000041669537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036975099,0.0015407332,0.9224657,0.00020153826,0.0005546194,0.000010050203,0.0071394434,0.0001006876,0.00566203,0.000001867904,0.000032827676,0.058593024],"study_design_scores_gemma":[0.027538313,0.0021054717,0.956995,0.0029592759,0.000053255546,0.0000017177986,0.007840134,0.0019914035,0.000068952824,0.000011579423,0.000028267052,0.0004066423],"about_ca_topic_score_codex":0.0010441347,"about_ca_topic_score_gemma":0.0003638221,"teacher_disagreement_score":0.058186382,"about_ca_system_score_codex":0.0001036371,"about_ca_system_score_gemma":0.00012567015,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W2907887556","doi":"10.1016/j.msard.2019.01.009","title":"Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Hologic; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Lean body mass; Bone mineral; Physical therapy; Internal medicine; Dual-energy X-ray absorptiometry; Fat mass; Body mass index; Osteoporosis; Body weight","score_opus":0.021643538902952206,"score_gpt":0.2502054367341004,"score_spread":0.2285618978311482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907887556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424535,0.0013946745,0.000029648068,0.0009430945,0.00013255396,0.0026714832,0.00004380776,0.00016186567,0.00037755014],"genre_scores_gemma":[0.9951509,0.0038474726,0.0002344918,0.00008615387,0.00002910928,0.0003498203,0.00008724532,0.000086552645,0.00012824066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599653,0.00032593278,0.00077752315,0.0012784959,0.00079973356,0.00082176254],"domain_scores_gemma":[0.9979395,0.000640257,0.00019017042,0.0006932699,0.00014454169,0.00039221332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000665605,0.00057562493,0.0010472685,0.00045823396,0.0003637734,0.00012198235,0.00013733974,0.00028065397,0.000112556554],"category_scores_gemma":[0.0002467572,0.00044746665,0.00013811585,0.001346024,0.0006014139,0.0003734311,0.00030978734,0.0006402957,0.00002334534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001346857,0.0037396653,0.95401055,0.00019699743,0.00040436143,0.0000046689097,0.0024670763,0.0003184369,0.029001359,0.000012847943,0.00005116798,0.008446014],"study_design_scores_gemma":[0.021658503,0.0015374093,0.95521116,0.00064301654,0.00013472317,0.0000075857,0.0065593235,0.01346299,0.00017386605,0.0000121075145,0.00007927835,0.00052005216],"about_ca_topic_score_codex":0.0045086904,"about_ca_topic_score_gemma":0.0056436826,"teacher_disagreement_score":0.028827494,"about_ca_system_score_codex":0.00020147675,"about_ca_system_score_gemma":0.000050669027,"threshold_uncertainty_score":0.9997977},"labels":[],"label_agreement":null},{"id":"W2909559055","doi":"10.1016/j.msard.2019.01.022","title":"Factors associated with receiving bone mineral density screening among people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Manitoba Health; Queen's University","funders":"Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Health Sciences Centre Foundation; Health Sciences Centre Research Foundation","keywords":"Medicine; Multiple sclerosis; Bone mineral; Environmental health; Internal medicine; Osteoporosis; Immunology","score_opus":0.04228576874004348,"score_gpt":0.23608740750738025,"score_spread":0.19380163876733678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909559055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954268,0.00055998296,0.00014011154,0.00050986675,0.00014483609,0.0021604632,0.000058094127,0.00041359075,0.00058626704],"genre_scores_gemma":[0.9969691,0.0010701672,0.0005933059,0.00007317633,0.00003239207,0.00010860302,0.00026029392,0.00018180469,0.00071114727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951933,0.00023785271,0.00071915396,0.0013084767,0.0012027695,0.0013384466],"domain_scores_gemma":[0.99679756,0.0010431551,0.00042360928,0.0007122616,0.00039660305,0.00062683376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005949603,0.0008505155,0.0013855923,0.00044207263,0.0008307275,0.00017386058,0.00021663017,0.0004592223,0.00018650224],"category_scores_gemma":[0.0012542899,0.0005817704,0.00028966516,0.0013016419,0.00064868364,0.00053875573,0.00028351805,0.0010655087,0.000019485118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007312399,0.00047879026,0.9738319,0.000098028206,0.0011501416,0.000005108201,0.0022493612,0.00076279277,0.015598301,0.000002323567,0.00020322445,0.004888795],"study_design_scores_gemma":[0.0152368825,0.0008502885,0.9628224,0.0020831786,0.00030748424,0.00000474656,0.0030968934,0.01393598,0.0007983986,0.0000026853215,0.000049552556,0.00081153895],"about_ca_topic_score_codex":0.002030201,"about_ca_topic_score_gemma":0.009940282,"teacher_disagreement_score":0.014799902,"about_ca_system_score_codex":0.00018906912,"about_ca_system_score_gemma":0.00008663974,"threshold_uncertainty_score":0.99966335},"labels":[],"label_agreement":null},{"id":"W2912026765","doi":"10.1016/j.msard.2019.01.044","title":"Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; European Commission; Universitätsspital Basel; Bayer HealthCare; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Oratorio; Multiple sclerosis; Opera; Internal medicine; Literature; Psychiatry; Musical; Art","score_opus":0.0340385116582444,"score_gpt":0.2778177616240176,"score_spread":0.24377924996577321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912026765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705535,0.022330426,0.0000033143788,0.0015106137,0.0002082697,0.005060262,0.000119377335,0.00008645965,0.00012776848],"genre_scores_gemma":[0.9599916,0.03845803,0.0005988757,0.00023358727,0.00002958627,0.00039798665,0.00015562763,0.0000656798,0.000069025205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957859,0.00045171037,0.0010326591,0.0012426428,0.00078963366,0.0006974453],"domain_scores_gemma":[0.99643475,0.001977239,0.00035382755,0.0006083291,0.00034877198,0.00027710962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087336515,0.00062034035,0.0014462646,0.00021219143,0.00096670276,0.00016404952,0.00019285796,0.00026488575,0.00002671047],"category_scores_gemma":[0.0029098145,0.00035600452,0.00011423902,0.0005821034,0.0016048085,0.0005408705,0.00076636096,0.0007491551,0.000004505277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14920178,0.0017689862,0.71326125,0.00020436969,0.001345878,0.000009248649,0.065006025,0.00010455929,0.008751341,0.000008824056,0.00035151865,0.059986208],"study_design_scores_gemma":[0.415179,0.0010287096,0.5661527,0.0037905849,0.00016103662,0.0000017767127,0.008621794,0.004167132,0.00018096465,0.0000126861805,0.0002162362,0.00048734696],"about_ca_topic_score_codex":0.00084487366,"about_ca_topic_score_gemma":0.00021025672,"teacher_disagreement_score":0.26597726,"about_ca_system_score_codex":0.0001383471,"about_ca_system_score_gemma":0.00008484554,"threshold_uncertainty_score":0.9998892},"labels":[],"label_agreement":null},{"id":"W2913554609","doi":"10.1016/j.msard.2019.01.031","title":"Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Medicine; Multiple sclerosis; Medical physics; Intensive care medicine; Psychiatry","score_opus":0.03788694581344837,"score_gpt":0.27768644878981397,"score_spread":0.2397995029763656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913554609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949109,0.0001180089,0.000016687914,0.0020945752,0.00013237141,0.0013701344,0.000016458118,0.00005709653,0.0012837457],"genre_scores_gemma":[0.99773157,0.0009773012,0.00026591122,0.00018628789,0.0000088952465,0.000048995164,0.000020779418,0.000036914214,0.00072336267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817425,0.0000982286,0.0004553352,0.00036561958,0.0005695879,0.00033697565],"domain_scores_gemma":[0.99853796,0.00046881023,0.00022519303,0.00051008724,0.00015521633,0.00010273651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032276532,0.00024227207,0.0005105595,0.0001314465,0.00019893836,0.000023218783,0.00015918295,0.00015318721,0.00018661517],"category_scores_gemma":[0.00031343658,0.0001174536,0.00016303285,0.0005034059,0.0003299267,0.0001240838,0.00009363062,0.00030953984,0.00001803024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078806304,0.00028742183,0.9823399,0.00020634067,0.00028342023,2.3082879e-7,0.0002182405,0.00068994483,0.0055223033,0.0000051777906,0.000076781675,0.009582155],"study_design_scores_gemma":[0.010391154,0.0006795023,0.9726437,0.0005545097,0.00012510672,9.561892e-7,0.0004738442,0.009498421,0.005202957,0.0000024970557,0.00025152645,0.00017582338],"about_ca_topic_score_codex":0.00015770516,"about_ca_topic_score_gemma":0.000082038205,"teacher_disagreement_score":0.009696218,"about_ca_system_score_codex":0.00003940804,"about_ca_system_score_gemma":0.00013651542,"threshold_uncertainty_score":0.47896188},"labels":[],"label_agreement":null},{"id":"W2913597401","doi":"10.1016/j.msard.2019.02.007","title":"Time between expanded disability status scale (EDSS) scores","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Pharmaceuticals Bayer; National Institutes of Health; Multiple Sclerosis Society of Canada; Bayer; Celgene; Biogen; Nancy Davis Foundation for Multiple Sclerosis; EMD Serono; Novartis; Genentech; Multiple Sclerosis Society; Roche; University of Toronto; Genzyme; Sanofi; Merck","keywords":"Expanded Disability Status Scale; Medicine; Multiple sclerosis; Scale (ratio); Physical therapy; Physical medicine and rehabilitation; Gerontology; Psychiatry","score_opus":0.027496509609381728,"score_gpt":0.2690450577015438,"score_spread":0.24154854809216209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913597401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916899,0.0012343698,0.0000058710075,0.0013565854,0.00014864742,0.0016405772,0.00009726853,0.00023389491,0.0035928406],"genre_scores_gemma":[0.99400324,0.004130106,0.00027838972,0.00006135748,0.000057642497,0.000068976384,0.00015171262,0.00006535138,0.0011832237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681026,0.00015920529,0.0005906739,0.0008574001,0.00064783596,0.0009346383],"domain_scores_gemma":[0.9980215,0.0005424384,0.00012664321,0.00066708104,0.00011043827,0.0005319131],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042616876,0.00040277586,0.0008098529,0.00013930861,0.00031570438,0.00006438011,0.00015643818,0.0002937965,0.0009437166],"category_scores_gemma":[0.00045032156,0.00031548992,0.00026684257,0.000460556,0.0009909485,0.00022091568,0.00028674855,0.0005501825,0.00054736994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002489775,0.0003360295,0.92910135,0.00014507641,0.00029593697,5.616493e-7,0.0008282701,0.000028695256,0.016055617,0.0000035975775,0.0004920163,0.052463878],"study_design_scores_gemma":[0.007495625,0.0003661316,0.98594433,0.00029658974,0.000112456284,0.0000014624464,0.00076971255,0.0022870235,0.00073870225,0.00006676855,0.0015452674,0.0003759323],"about_ca_topic_score_codex":0.0005625062,"about_ca_topic_score_gemma":0.00013033117,"teacher_disagreement_score":0.056842983,"about_ca_system_score_codex":0.00013568794,"about_ca_system_score_gemma":0.000058309488,"threshold_uncertainty_score":0.99996954},"labels":[],"label_agreement":null},{"id":"W2922410885","doi":"10.1016/j.msard.2019.03.009","title":"A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditions","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Novartis Pharmaceuticals Canada; Novartis Pharma; Mitsubishi Tanabe Pharma Corporation; European Commission; Biogen; Merck; Sanofi; Bayer Schering; Novartis","keywords":"Secukinumab; Medicine; Multiple sclerosis; Rituximab; Psoriasis; Concomitant; Immunology; Ixekizumab; Dermatology; Internal medicine; Antibody; Psoriatic arthritis","score_opus":0.01381924356041253,"score_gpt":0.22112681122446656,"score_spread":0.20730756766405403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922410885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97669023,0.021143513,0.0000050887998,0.00008000089,0.00052230275,0.0011005868,0.00020508024,0.000075306896,0.0001778961],"genre_scores_gemma":[0.99352586,0.005957657,0.00007833395,0.000031144304,0.0000055924324,0.0000976485,0.00013077038,0.000039987426,0.00013301372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979892,0.00030392394,0.0005628162,0.00062566507,0.00005281463,0.00046560468],"domain_scores_gemma":[0.99854285,0.0008066628,0.00021560861,0.00032347275,0.00004225183,0.000069131675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002526821,0.00039958212,0.00078108266,0.00028441296,0.00030048232,0.00003127677,0.00009967557,0.00038291258,0.000086486754],"category_scores_gemma":[0.00011154451,0.00035086088,0.00012637733,0.0002893095,0.00045403058,0.00017968708,0.00012594955,0.00030257716,0.00003465296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013084426,0.0021738182,0.4748456,0.00035392257,0.0015147642,0.00010798336,0.0071452036,0.0000773912,0.42473888,0.00040992541,0.0000990841,0.087224975],"study_design_scores_gemma":[0.12325868,0.00087543024,0.84994274,0.0011813535,0.0008055561,0.000666601,0.0035622094,0.0018703516,0.015979262,0.00048134636,0.00027895803,0.0010975226],"about_ca_topic_score_codex":0.0024284162,"about_ca_topic_score_gemma":0.001184283,"teacher_disagreement_score":0.40875962,"about_ca_system_score_codex":0.00003637735,"about_ca_system_score_gemma":0.000029093608,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W2935354372","doi":"10.1016/j.msard.2019.04.003","title":"Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi; Genzyme","keywords":"Multiple sclerosis; Medicine; Pregnancy; Disease; Postpartum period; Intensive care medicine; Immunology; Pathology","score_opus":0.0732434747957501,"score_gpt":0.2737825918765738,"score_spread":0.20053911708082367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935354372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007814161,0.98900384,0.00012013347,0.000043787215,0.00092566747,0.008564511,0.0003243947,0.00007820282,0.00015804432],"genre_scores_gemma":[0.044672284,0.9524834,0.00022000604,0.000019105153,0.000024348881,0.0010380215,0.0010711991,0.00010712566,0.00036451494],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954076,0.0008029268,0.0012856119,0.0018021378,0.00014912365,0.00055260555],"domain_scores_gemma":[0.99663967,0.00031247045,0.0013131873,0.0013456022,0.00033399815,0.000055052722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007335737,0.00080020097,0.0024257218,0.00026645692,0.00030182477,0.000046686466,0.00045915786,0.0006312187,0.000064818254],"category_scores_gemma":[0.00018504106,0.0005590928,0.00065054855,0.00044010463,0.00044901684,0.00045511435,0.0001247532,0.0004149211,0.000044771452],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000366489,0.0008749074,0.0012068491,0.11438538,0.0025660798,8.977722e-7,0.00030444245,0.00009742671,0.00009937141,0.00008452515,0.0004338216,0.8795798],"study_design_scores_gemma":[0.01351571,0.003774482,0.010805021,0.7623891,0.012191103,0.000014467001,0.0019199849,0.000014442927,0.00011911752,0.00007554936,0.19248544,0.002695557],"about_ca_topic_score_codex":0.0001262199,"about_ca_topic_score_gemma":0.000020781734,"teacher_disagreement_score":0.8768842,"about_ca_system_score_codex":0.000056871435,"about_ca_system_score_gemma":0.00018214482,"threshold_uncertainty_score":0.99968606},"labels":[],"label_agreement":null},{"id":"W2937440369","doi":"10.1016/j.msard.2019.04.014","title":"The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institutes of Health; Crohn's and Colitis Canada; Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Centers for Disease Control and Prevention; University of Alabama at Birmingham; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Association (psychology); Physical medicine and rehabilitation; Physical therapy; Immunology; Psychology; Psychotherapist","score_opus":0.07673923869246745,"score_gpt":0.3188534154269969,"score_spread":0.24211417673452945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937440369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996755,0.0003903366,0.000010814057,0.0010817451,0.0001850686,0.0012465133,0.000019436517,0.00003455119,0.00027653502],"genre_scores_gemma":[0.9959761,0.0036431053,0.00007867088,0.000040193598,0.000019991969,0.000076171105,0.00003243297,0.00003513187,0.000098239376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974083,0.0002743034,0.0006755251,0.0004453549,0.00064509513,0.000551454],"domain_scores_gemma":[0.99840075,0.00075682934,0.00036393525,0.00021769662,0.00014704755,0.00011371719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062680186,0.0002767047,0.00055844855,0.00019162426,0.00048164706,0.00007917914,0.00009947251,0.00022304105,0.000027523609],"category_scores_gemma":[0.0008192443,0.00020155993,0.00012641885,0.0003707118,0.00023764343,0.00020000288,0.00017577434,0.000390894,0.0000058727464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002988592,0.00036361205,0.89289194,0.00009685971,0.00025173562,1.6997573e-7,0.00163058,0.0001379092,0.07653773,0.00004382114,0.000019148823,0.02772765],"study_design_scores_gemma":[0.011923715,0.0001669824,0.94296265,0.000337623,0.00008999151,3.6722673e-7,0.0015629621,0.04055959,0.0020780633,0.000057833964,0.000062761865,0.00019746156],"about_ca_topic_score_codex":0.0013103436,"about_ca_topic_score_gemma":0.0013269476,"teacher_disagreement_score":0.074459665,"about_ca_system_score_codex":0.00024534215,"about_ca_system_score_gemma":0.000049611957,"threshold_uncertainty_score":0.82193756},"labels":[],"label_agreement":null},{"id":"W2945447515","doi":"10.1016/j.msard.2019.05.014","title":"Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Medicine; Teriflunomide; Multiple sclerosis; Term (time); Extension (predicate logic); Pediatrics; Dermatology; Internal medicine; Intensive care medicine; Immunology; Fingolimod","score_opus":0.024814999333749276,"score_gpt":0.2686279693662391,"score_spread":0.24381297003248983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945447515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958414,0.00008360033,0.000001911248,0.00055226305,0.00011053847,0.0031830638,0.000018815517,0.000037392678,0.00017101469],"genre_scores_gemma":[0.9991754,0.0002690599,0.00006951651,0.000058089496,0.0000030254416,0.00004002744,0.000021919785,0.00004006229,0.00032289233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973325,0.00017385729,0.00082630274,0.0006350189,0.0006224215,0.00040986092],"domain_scores_gemma":[0.9983387,0.00031134754,0.00029796676,0.000743135,0.00018776815,0.00012108285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038383092,0.00031207336,0.00075607264,0.00017304214,0.00012607279,0.00002353985,0.00018851897,0.00015902196,0.000027779437],"category_scores_gemma":[0.0003216458,0.00015738008,0.000112225025,0.00053830515,0.00031148063,0.00012130529,0.0002157592,0.0004943704,0.000008213642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068697687,0.0017568684,0.98560524,0.00007752716,0.00032879564,0.0000047536478,0.00082684983,0.00009033031,0.00021925867,4.8045234e-7,0.000011679791,0.0042084316],"study_design_scores_gemma":[0.03957236,0.0052700494,0.95326513,0.0009386406,0.00009889803,0.0000015718664,0.00039426397,0.00023671037,0.000010945279,0.0000013935568,0.000004363316,0.00020569307],"about_ca_topic_score_codex":0.00033867444,"about_ca_topic_score_gemma":0.00055800786,"teacher_disagreement_score":0.03270259,"about_ca_system_score_codex":0.000051293537,"about_ca_system_score_gemma":0.000054457614,"threshold_uncertainty_score":0.64177734},"labels":[],"label_agreement":null},{"id":"W2947604924","doi":"10.1016/j.msard.2019.05.027","title":"Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Exon; Multiple sclerosis; Missense mutation; Immunology; TLR3; Gene; Sanger sequencing; Medicine; Allele; TLR7; Mutation; Biology; Toll-like receptor; Genetics; Innate immune system; Immune system","score_opus":0.021063925953333475,"score_gpt":0.21247428652853748,"score_spread":0.191410360575204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947604924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950091,0.0008972849,0.000005987205,0.00002833886,0.0034152532,0.00039094055,0.000050741088,0.000026467545,0.00017588586],"genre_scores_gemma":[0.99644816,0.00081164885,0.0000396222,0.00004383309,0.0000023686227,0.000011842265,0.0009610224,0.000019814652,0.001661708],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829066,0.00019208678,0.00073624327,0.00040962364,0.0000779983,0.00029337904],"domain_scores_gemma":[0.9989913,0.00016970182,0.00039012625,0.00030142601,0.00012315845,0.00002430322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001618872,0.00023198804,0.0005993457,0.00052160665,0.00012267698,0.00001002331,0.00016088183,0.00030134997,0.0011647068],"category_scores_gemma":[0.000046552625,0.00020635861,0.0002716193,0.0006618387,0.00022082638,0.00016021651,0.000083448394,0.00034033743,0.00008946576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021004849,0.00031547633,0.23829843,0.000019864014,0.0006506743,3.5234777e-8,0.0006404671,0.0004835635,0.75764793,0.0000061462856,0.00039148907,0.0013358901],"study_design_scores_gemma":[0.0088579515,0.00041750298,0.8933817,0.00021019894,0.0003387139,3.7805194e-7,0.0010067046,0.002691224,0.09007205,0.000004471651,0.0025850178,0.00043405272],"about_ca_topic_score_codex":0.0015683423,"about_ca_topic_score_gemma":0.00033411983,"teacher_disagreement_score":0.66757584,"about_ca_system_score_codex":0.00004973941,"about_ca_system_score_gemma":0.000012094016,"threshold_uncertainty_score":0.99974835},"labels":[],"label_agreement":null},{"id":"W2947723815","doi":"10.1016/j.msard.2019.05.028","title":"Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Globus pallidus; Putamen; Medicine; Caudate nucleus; Atrophy; Thalamus; Grey matter; Internal medicine; Gastroenterology; Basal ganglia; White matter; Nuclear medicine; Magnetic resonance imaging; Central nervous system; Radiology","score_opus":0.031792684736056655,"score_gpt":0.2664433048164932,"score_spread":0.23465062008043655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947723815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98278475,0.001948096,0.00003429117,0.009282736,0.0004746661,0.0035978756,0.00006110815,0.00017624168,0.0016402225],"genre_scores_gemma":[0.9918623,0.004348648,0.0010739991,0.0014771338,0.000070105656,0.0003121943,0.00008866233,0.0001322301,0.0006347034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953892,0.00028894068,0.00092208997,0.001260344,0.00075176486,0.0013876094],"domain_scores_gemma":[0.99736327,0.0008647571,0.00025630867,0.0007133542,0.00017841639,0.0006238985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007894176,0.0006232566,0.0012532034,0.00069344224,0.0003865607,0.00011368592,0.00027534453,0.0004141778,0.00049615826],"category_scores_gemma":[0.00085954217,0.00054594676,0.00023786657,0.00092944567,0.00027466533,0.00021041794,0.00036474344,0.0009155073,0.000692737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017484234,0.00053824566,0.9290951,0.0003078279,0.00020296336,0.0000029898729,0.0042099943,0.0010868089,0.049020115,0.000008125954,0.0014189689,0.012360471],"study_design_scores_gemma":[0.020906573,0.0006023452,0.9566528,0.0016955326,0.00007246382,0.0000033410784,0.0044490146,0.0134042995,0.00040837642,0.000014613772,0.0011567503,0.0006338694],"about_ca_topic_score_codex":0.002019441,"about_ca_topic_score_gemma":0.004744636,"teacher_disagreement_score":0.04861174,"about_ca_system_score_codex":0.00024482238,"about_ca_system_score_gemma":0.000057987534,"threshold_uncertainty_score":0.9996992},"labels":[],"label_agreement":null},{"id":"W2948027444","doi":"10.1016/j.msard.2019.06.001","title":"Multiple Sclerosis and psychosis: A case report","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; University of Toronto","funders":"","keywords":"Multiple sclerosis; Paranoia; Psychosis; Medicine; Psychiatry; Context (archaeology); Acute Psychosis","score_opus":0.042994523681006494,"score_gpt":0.2781926257522483,"score_spread":0.2351981020712418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948027444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856773,0.0056357244,0.000028836048,0.0026684592,0.00045622615,0.0022241017,0.000058154455,0.00029536017,0.0029558525],"genre_scores_gemma":[0.980867,0.01620104,0.0009437575,0.00024749502,0.000060751987,0.00023671145,0.000063852574,0.000118133205,0.0012611998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958218,0.00015323116,0.0009468763,0.0014099288,0.00068517384,0.0009830402],"domain_scores_gemma":[0.9973336,0.00055387843,0.00027806286,0.00094034616,0.00021660051,0.0006775145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071420125,0.0006247336,0.0009686743,0.0004098695,0.0006219197,0.00014360412,0.00014917867,0.00045472986,0.00029517268],"category_scores_gemma":[0.0010475665,0.00052025524,0.00030380487,0.00067134417,0.0006001083,0.0003289985,0.00035550306,0.00077994046,0.00012611334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075067265,0.00089605415,0.8663504,0.0004926327,0.0011108037,0.0009873672,0.002239875,0.000056562905,0.032863203,0.00003236564,0.0032296109,0.090990424],"study_design_scores_gemma":[0.021366436,0.0007597724,0.94517803,0.0013560194,0.0003571552,0.0048374003,0.004278418,0.013006976,0.00075212494,0.00006512136,0.0069700526,0.00107248],"about_ca_topic_score_codex":0.0017915267,"about_ca_topic_score_gemma":0.00070694287,"teacher_disagreement_score":0.08991794,"about_ca_system_score_codex":0.00009319594,"about_ca_system_score_gemma":0.00005779277,"threshold_uncertainty_score":0.9997249},"labels":[],"label_agreement":null},{"id":"W2948265715","doi":"10.1016/j.msard.2019.05.029","title":"Emotional expressions associated with therapeutic inertia in multiple sclerosis care","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Roche (Canada); St. Michael's Hospital","funders":"National Science Foundation of Sri Lanka; F. Hoffmann-La Roche","keywords":"Multiple sclerosis; Medicine; Inertia; Physical medicine and rehabilitation; Psychiatry","score_opus":0.044756782169413215,"score_gpt":0.25680202929845997,"score_spread":0.21204524712904677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948265715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911285,0.003614354,0.000018433535,0.0010752898,0.00017521321,0.0018376412,0.00007810321,0.00018833081,0.0018841085],"genre_scores_gemma":[0.9948042,0.0037610692,0.00022042889,0.0001770571,0.000022936185,0.00019528372,0.00023450694,0.00009897588,0.0004855632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657506,0.00022550496,0.00061703875,0.0009110057,0.00079285644,0.00087852444],"domain_scores_gemma":[0.99805427,0.00067192246,0.00018295867,0.0005214598,0.0002465039,0.00032287618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029938598,0.0005053951,0.000769657,0.00044286152,0.0003949827,0.00006949297,0.00019623025,0.00039125915,0.00035509936],"category_scores_gemma":[0.0006226361,0.00037412174,0.00020749409,0.00092752796,0.00041558567,0.00025618917,0.00019931165,0.0008236468,0.000069318456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005493272,0.0007279461,0.92581147,0.0001244789,0.00044058508,0.000003803168,0.0030520698,0.0009038907,0.049552005,0.000015733793,0.00014524262,0.018673468],"study_design_scores_gemma":[0.017054996,0.00047768993,0.96706223,0.002333436,0.00009161577,0.000002707497,0.004216035,0.007364625,0.0005655642,0.000018520208,0.0003373197,0.00047525406],"about_ca_topic_score_codex":0.00052874937,"about_ca_topic_score_gemma":0.0014203374,"teacher_disagreement_score":0.048986442,"about_ca_system_score_codex":0.00023583575,"about_ca_system_score_gemma":0.00012121116,"threshold_uncertainty_score":0.9998711},"labels":[],"label_agreement":null},{"id":"W2953858782","doi":"10.1016/j.msard.2019.07.002","title":"Higher health care use before a clinically isolated syndrome with or without subsequent MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan; Saskatchewan Health Quality Council; University of British Columbia Hospital; Manitoba Health; University of British Columbia; Vancouver Coastal Health; University of Manitoba","funders":"Nova Scotia Department of Health and Wellness; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Dalhousie University; Michael Smith Health Research BC; Saskatchewan Health Research Foundation; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Dalhousie Medical Research Foundation; Health Research","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Internal medicine; Intensive care medicine; Pediatrics; Psychiatry","score_opus":0.04474073713536785,"score_gpt":0.30133620566208963,"score_spread":0.25659546852672177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953858782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112445,0.0016414094,0.000020110423,0.003056288,0.00026136596,0.0030286813,0.00006363692,0.0002913742,0.00051267416],"genre_scores_gemma":[0.9901394,0.0048095235,0.0010656131,0.0007579101,0.000024932526,0.00012249031,0.00015189093,0.00013005291,0.002798143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961521,0.00018996323,0.0009026093,0.0010245375,0.00074310345,0.0009876874],"domain_scores_gemma":[0.99777573,0.00027202294,0.00030352417,0.0007455856,0.00026956463,0.0006335836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034780556,0.0005410911,0.0011861415,0.00024519642,0.00038289293,0.00011296782,0.0001830367,0.00035419577,0.0004984381],"category_scores_gemma":[0.00019110467,0.000333983,0.00021816892,0.00066025753,0.00045420224,0.00029144596,0.00019327011,0.0008355846,0.000114598035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051327506,0.0005177435,0.97330594,0.00053260825,0.00097585324,0.000031972846,0.0038023216,0.00007403946,0.00037293838,0.000017263297,0.0006182239,0.0146183325],"study_design_scores_gemma":[0.018563969,0.009634166,0.96077394,0.0016961477,0.00014808014,0.000067891655,0.002227252,0.0023540102,0.000009445456,0.000006183266,0.003974192,0.0005447151],"about_ca_topic_score_codex":0.0019181814,"about_ca_topic_score_gemma":0.001918298,"teacher_disagreement_score":0.014073617,"about_ca_system_score_codex":0.00022044375,"about_ca_system_score_gemma":0.00028386014,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2971720933","doi":"10.1016/j.msard.2019.101387","title":"Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; University of Calgary; McGill University; Mental Health Research Canada; Hospital for Sick Children","funders":"Sickkids Research Institute; Ontario Institute for Regenerative Medicine; Stem Cell Network; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Optic neuritis; Multiple sclerosis; Physical medicine and rehabilitation; Dermatology; Immunology","score_opus":0.03143187486149151,"score_gpt":0.2884065385178837,"score_spread":0.2569746636563922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971720933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376774,0.0014263248,0.0000023216446,0.0023310615,0.0001461805,0.0013031737,0.000097115684,0.000035505185,0.0008905597],"genre_scores_gemma":[0.98569584,0.0136260595,0.00009054628,0.00023901847,0.00003838994,0.000063310756,0.000021945187,0.00003578126,0.00018911393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770105,0.00015712643,0.0005515488,0.0004897137,0.0006093043,0.0004912427],"domain_scores_gemma":[0.9988415,0.00035612972,0.00014100895,0.00043946118,0.000086908854,0.00013493917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003803219,0.00026630488,0.0005004583,0.00032451798,0.0001253533,0.000037570007,0.00022738278,0.00017184006,0.0001742354],"category_scores_gemma":[0.00019988336,0.00018601619,0.00019514412,0.00083566277,0.00023062917,0.00015832002,0.00015006657,0.00060245016,0.00004761431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010250601,0.0016654351,0.93003917,0.00027437613,0.00042718067,0.00001934492,0.0051003345,0.000029211145,0.02479454,0.000038000526,0.002032955,0.034554426],"study_design_scores_gemma":[0.0113588795,0.0011822304,0.9826921,0.00011198132,0.00018108645,0.000007702414,0.0005269236,0.0030917327,0.0002218149,0.000029954801,0.00037878388,0.0002168166],"about_ca_topic_score_codex":0.00035960114,"about_ca_topic_score_gemma":0.00001898103,"teacher_disagreement_score":0.052652955,"about_ca_system_score_codex":0.000022982069,"about_ca_system_score_gemma":0.000049834925,"threshold_uncertainty_score":0.758552},"labels":[],"label_agreement":null},{"id":"W2971886490","doi":"10.1016/j.msard.2019.101383","title":"Predictors of people's perceptions of second hand smoke exposure as a risk factor for multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan; University of Toronto","funders":"","keywords":"Medicine; Residence; Environmental health; Logistic regression; Risk factor; Risk perception; Demography; Odds; Odds ratio; Smoke; Passive smoking; Perception; Psychology; Geography","score_opus":0.03035046052589006,"score_gpt":0.25872396651358864,"score_spread":0.2283735059876986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971886490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177754,0.0017487817,0.000062595354,0.00024402566,0.000366882,0.0032167626,0.002094756,0.00008488574,0.00040374944],"genre_scores_gemma":[0.98918825,0.009219339,0.00051609223,0.000027690025,0.00004261401,0.0002207256,0.00010974325,0.00009765836,0.0005778566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655485,0.00016007616,0.0010704924,0.00082214095,0.0006839167,0.0007084991],"domain_scores_gemma":[0.99673104,0.0011965805,0.0005282665,0.00070460123,0.00047425792,0.00036523244],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043180553,0.00050004176,0.0012215959,0.00044484177,0.00040817147,0.000043555203,0.00023535255,0.0004643623,0.0013282382],"category_scores_gemma":[0.0016523043,0.00041425784,0.0006262131,0.00058090285,0.00069211813,0.00023073565,0.00020642018,0.00051639904,0.000023866616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077595125,0.0005710023,0.78737485,0.0006221171,0.00092138804,1.516196e-7,0.0062456676,0.000121354475,0.19103196,0.000006649522,0.0002083075,0.012120578],"study_design_scores_gemma":[0.015466271,0.0016595043,0.966329,0.00068009837,0.00031014896,0.0000020150364,0.0054419227,0.0029603234,0.006345225,0.00002354011,0.0003988607,0.0003830941],"about_ca_topic_score_codex":0.0010523397,"about_ca_topic_score_gemma":0.0014941368,"teacher_disagreement_score":0.18468674,"about_ca_system_score_codex":0.00007317218,"about_ca_system_score_gemma":0.00012464084,"threshold_uncertainty_score":0.9998309},"labels":[],"label_agreement":null},{"id":"W2973460607","doi":"10.1016/j.msard.2019.101407","title":"Long noncoding RNAs associated with phenotypic severity in multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hotchkiss Brain Institute; University of Calgary","funders":"Canada Foundation for Innovation; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Hotchkiss Brain Institute; Cumming School of Medicine, University of Calgary; School of Medicine; University of Calgary","keywords":"Multiple sclerosis; Phenotype; Medicine; Genetics; Gene; Immunology; Biology","score_opus":0.019158470407961432,"score_gpt":0.2202551167887921,"score_spread":0.20109664638083066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973460607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952748,0.0015966123,0.00096898584,0.0001638771,0.00019933237,0.00085180934,0.000031329786,0.000049779952,0.0008634864],"genre_scores_gemma":[0.99680245,0.002091626,0.0001644193,0.00009991068,0.000021081723,0.00006343447,0.0002080051,0.00008634563,0.0004627464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975655,0.00017806093,0.0003781913,0.0008452982,0.00034911605,0.00068379706],"domain_scores_gemma":[0.99904877,0.00007548314,0.00014897072,0.00045392776,0.00009381775,0.00017900176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039066022,0.00035391937,0.00035480186,0.00017807368,0.00020170434,0.00007429696,0.0002455413,0.0005352398,0.00008807718],"category_scores_gemma":[0.00026099963,0.00033096896,0.00013203787,0.0005308017,0.00016734033,0.000023455163,0.0002203373,0.000501923,0.000028965924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088944496,0.00056114676,0.18632254,0.0000705807,0.0005091437,0.000007666849,0.00043699177,0.008624456,0.77699345,0.000026855458,0.00018174942,0.02537599],"study_design_scores_gemma":[0.0259552,0.0012888032,0.82982576,0.0012250236,0.00012010382,0.000012924344,0.00093399273,0.03203646,0.105302915,0.000107693384,0.0013704337,0.0018207086],"about_ca_topic_score_codex":0.00047896532,"about_ca_topic_score_gemma":0.0035856457,"teacher_disagreement_score":0.6716905,"about_ca_system_score_codex":0.000101215715,"about_ca_system_score_gemma":0.000095543954,"threshold_uncertainty_score":0.9999142},"labels":[],"label_agreement":null},{"id":"W2974551108","doi":"10.1016/j.msard.2019.101402","title":"Rituximab-induced serum sickness in multiple sclerosis patients","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada; Genentech; National Institutes of Health; Patient-Centered Outcomes Research Institute; Biogen; University of Rochester; Novartis; Joint Research Centre; Genzyme; EMD Serono; National Multiple Sclerosis Society","keywords":"Rituximab; Medicine; Serum sickness; Multiple sclerosis; Immunology; CD20; Rash; Rheumatoid arthritis; Monoclonal antibody; Monoclonal; Population; Antibody; Internal medicine","score_opus":0.023964275356999545,"score_gpt":0.21103659235023065,"score_spread":0.1870723169932311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974551108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466395,0.00063200126,0.0000033911026,0.00066196336,0.00080087356,0.0012338591,0.00003133901,0.00014979037,0.0018228265],"genre_scores_gemma":[0.9972116,0.0015586647,0.00007919773,0.0005643242,0.000019657497,0.000050006678,0.00006508575,0.00008640354,0.00036508968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974241,0.000103473554,0.00061083416,0.0007862951,0.00038728773,0.00068796787],"domain_scores_gemma":[0.9988956,0.00013509244,0.00015191354,0.00045935123,0.000085617874,0.00027246372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017520945,0.00042987862,0.00068822067,0.00025546967,0.00019478958,0.00005557131,0.0001525811,0.00035749772,0.0003168447],"category_scores_gemma":[0.00021410797,0.00037731996,0.00021360483,0.0006210946,0.00013702325,0.00027425768,0.00013817324,0.0005396463,0.00016818338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049412716,0.0014316486,0.9443841,0.0001207807,0.00006029068,0.0000034211112,0.00068570336,0.00012862172,0.0109828925,0.000012781065,0.00023135674,0.041464258],"study_design_scores_gemma":[0.029881408,0.0005224466,0.95999056,0.00044511782,0.000051433817,0.000001900033,0.001011498,0.0063175964,0.00036260823,0.000053597392,0.0008679505,0.00049389084],"about_ca_topic_score_codex":0.0009908032,"about_ca_topic_score_gemma":0.0010327874,"teacher_disagreement_score":0.040970366,"about_ca_system_score_codex":0.00006978242,"about_ca_system_score_gemma":0.00004322713,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W2975742859","doi":"10.1016/j.msard.2019.101411","title":"Predictors of vocational status among persons with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parkwood Institute; Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"EMD Serono; AbbVie; Biogen Idec; Genzyme; Roche; Novartis","keywords":"Multiple sclerosis; Medicine; Vocational education; Physical therapy; Gerontology; Physical medicine and rehabilitation; Psychiatry; Psychology","score_opus":0.025891768759914176,"score_gpt":0.2385197626102714,"score_spread":0.21262799385035724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975742859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992487,0.0013768342,0.000036373865,0.00053861004,0.00021060172,0.0017592188,0.00017304502,0.00014812095,0.0032701865],"genre_scores_gemma":[0.99298173,0.0050986214,0.0007211237,0.000046670255,0.00003564852,0.00013193594,0.00014866517,0.00008784991,0.00074773317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665916,0.00011479326,0.0006403828,0.0008006084,0.0009441317,0.000840939],"domain_scores_gemma":[0.99784243,0.00054211257,0.0002800201,0.000573847,0.0002851012,0.00047650014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032137503,0.00045172518,0.00076667994,0.00038170093,0.00029559198,0.000044409713,0.00017117278,0.0002835674,0.00035384163],"category_scores_gemma":[0.00051475124,0.00034140865,0.00024096026,0.00072273484,0.00096189906,0.0002931167,0.0001734872,0.00054361735,0.000041367242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006435455,0.0005156343,0.96828586,0.00021807692,0.0008500332,9.3333335e-7,0.0019633872,0.0002456878,0.01872628,0.000018745444,0.00055531657,0.007976486],"study_design_scores_gemma":[0.01135894,0.0007489571,0.9753884,0.0008332913,0.0001860258,0.0000029250564,0.003106493,0.0063443994,0.00096765795,0.000006268545,0.0006775377,0.00037906683],"about_ca_topic_score_codex":0.0015434942,"about_ca_topic_score_gemma":0.0005677839,"teacher_disagreement_score":0.017758623,"about_ca_system_score_codex":0.00011096086,"about_ca_system_score_gemma":0.00015638839,"threshold_uncertainty_score":0.9999038},"labels":[],"label_agreement":null},{"id":"W2978655339","doi":"10.1016/j.msard.2019.101427","title":"The multiple sclerosis gut microbiota: A systematic review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Toronto; University of Manitoba; Public Health Agency of Canada; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Gut flora; Neuroscience; Immunology; Biology","score_opus":0.04001760140771747,"score_gpt":0.26519320139091923,"score_spread":0.22517559998320175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978655339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008933881,0.9934259,0.0000066414086,0.00021478155,0.0006227722,0.005240624,0.00019961808,0.00004288787,0.00015741838],"genre_scores_gemma":[0.0005872309,0.9959742,0.000042827287,0.00031781162,0.00005576869,0.0004222845,0.0007447986,0.00015996365,0.0016951237],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569297,0.0006276806,0.0015703576,0.0011032487,0.0002034871,0.00080223323],"domain_scores_gemma":[0.9970776,0.00028974557,0.0009573331,0.0013657645,0.00010021662,0.00020937066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007952266,0.00089276297,0.0024513756,0.00010421348,0.00070737296,0.00015147077,0.00071317016,0.0010238494,0.000017859498],"category_scores_gemma":[0.0004935784,0.00055777887,0.0011562482,0.00038388598,0.00028474827,0.000008852093,0.0003923894,0.0006501808,0.0002178799],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020332634,0.00015486755,0.00002743526,0.8878259,0.0013318649,7.514537e-7,0.000051109866,0.0000017213276,0.0026492155,0.000012939199,0.011319825,0.096604005],"study_design_scores_gemma":[0.0009436694,0.00012278905,0.000073538846,0.36289787,0.0024681028,0.00003198725,0.000055670618,0.000011856832,0.000005991615,0.0000023634075,0.6325855,0.0008006291],"about_ca_topic_score_codex":0.00007513166,"about_ca_topic_score_gemma":0.0001846536,"teacher_disagreement_score":0.6212657,"about_ca_system_score_codex":0.00006543617,"about_ca_system_score_gemma":0.00024646628,"threshold_uncertainty_score":0.9996874},"labels":[],"label_agreement":null},{"id":"W2980183442","doi":"10.1016/j.msard.2019.101440","title":"Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sexual orientation; Medicine; Transgender; Logistic regression; Confounding; Affect (linguistics); Sexual identity; Health care; Clinical psychology; Gender identity; Demography; Human sexuality; Psychology; Social psychology; Internal medicine","score_opus":0.06639426740800924,"score_gpt":0.3086385789962187,"score_spread":0.24224431158820947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980183442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928691,0.0031616169,0.00019764528,0.00089677103,0.00017641693,0.0022985616,0.00010507097,0.0001286522,0.00016621298],"genre_scores_gemma":[0.99167347,0.0070317546,0.0005715155,0.0002127522,0.00002469995,0.00013081564,0.00017096466,0.00006944313,0.00011461179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688476,0.00023270314,0.00054597715,0.0009711672,0.00070305757,0.00066230225],"domain_scores_gemma":[0.99857944,0.00029045515,0.00020749292,0.0003865208,0.00020329776,0.0003327719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042752086,0.0004108096,0.0006410987,0.0004235871,0.0005289249,0.00011265442,0.00008504992,0.00022954789,0.00008722861],"category_scores_gemma":[0.0003490072,0.0003438272,0.000079307996,0.0007703159,0.00033043962,0.00059190555,0.00012884197,0.00049416965,0.000020718211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051322195,0.00016606589,0.951655,0.0004979574,0.00019973367,0.0000012344226,0.009924246,0.00026197924,0.008000761,0.00002491676,0.00017470366,0.028580217],"study_design_scores_gemma":[0.011756438,0.00060632615,0.95699006,0.00039620622,0.00006579938,0.00000630702,0.02534757,0.0041021523,0.0002767961,0.0000053752697,0.00009335249,0.00035361524],"about_ca_topic_score_codex":0.0061052204,"about_ca_topic_score_gemma":0.015164261,"teacher_disagreement_score":0.028226603,"about_ca_system_score_codex":0.00027507008,"about_ca_system_score_gemma":0.00016204806,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W2981054419","doi":"10.1016/j.msard.2019.101448","title":"Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Berlin Institute of Health; NeuroCure Exzellenzcluster; Tohoku University; Stanford University","keywords":"Medicine; Serostatus; Neuromyelitis optica; Rituximab; Cohort; Pediatrics; Transverse myelitis; Optic neuritis; Azathioprine; Myelitis; Internal medicine; Multiple sclerosis; Surgery; Disease; Immunology","score_opus":0.0147594950965529,"score_gpt":0.23692000474149674,"score_spread":0.22216050964494385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981054419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926314,0.00039913887,0.000015867818,0.0034302683,0.00019359302,0.0015033634,0.000056218407,0.000044126762,0.0017260405],"genre_scores_gemma":[0.9863433,0.013165935,0.00010597704,0.00006166419,0.000017499426,0.00006925444,0.00010553645,0.000041306812,0.00008948783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771595,0.00011449836,0.00064149016,0.00061084545,0.00042471566,0.00049250707],"domain_scores_gemma":[0.9990144,0.00016624767,0.0002063107,0.00036526952,0.00004661733,0.00020119871],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019772013,0.00030137604,0.0005714957,0.00033084396,0.000109028726,0.000046983405,0.000091647074,0.00019382435,0.00011426222],"category_scores_gemma":[0.00029777395,0.00026216847,0.00010492753,0.00044871558,0.00035164514,0.00021826496,0.00019044618,0.00039816397,0.000007812399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080215355,0.00087583764,0.82223785,0.0005191365,0.00020860016,0.000005160314,0.0034874214,0.00013433004,0.07463901,0.00012569086,0.00003137012,0.096933454],"study_design_scores_gemma":[0.006470161,0.0007443098,0.9848667,0.0006401403,0.000038545262,0.0000050400827,0.0010051968,0.003958194,0.0010067465,0.00009882212,0.0008848555,0.00028133695],"about_ca_topic_score_codex":0.0006116648,"about_ca_topic_score_gemma":0.00040426457,"teacher_disagreement_score":0.16262881,"about_ca_system_score_codex":0.000059603695,"about_ca_system_score_gemma":0.000049825663,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2981920413","doi":"10.1016/j.msard.2019.101441","title":"Physician referral improves adherence to the physical activity guidelines for adults with MS: A randomized controlled trial","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Physical Activity and Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Referral; Randomized controlled trial; Physical therapy; Multiple sclerosis; Physical activity; Clinical trial; Internal medicine; Family medicine; Psychiatry","score_opus":0.056240014693024795,"score_gpt":0.31583561787921305,"score_spread":0.25959560318618824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981920413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765161,0.00010529211,0.00013828355,0.008952938,0.00023862964,0.013468505,0.000016572723,0.00006692157,0.00049673696],"genre_scores_gemma":[0.996838,0.00018794251,0.00015673239,0.00070977217,0.00023020172,0.0014501819,0.000013152502,0.000030712625,0.00038335263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983711,0.00015634399,0.00034456764,0.0004728749,0.0002825256,0.00037256698],"domain_scores_gemma":[0.99806595,0.0010403987,0.00022743834,0.00029549,0.0001956597,0.00017503867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042195097,0.00028214176,0.0016030432,0.000050239636,0.00021985141,0.000036947775,0.00009870929,0.000115758005,0.000007506699],"category_scores_gemma":[0.0006542246,0.00013581118,0.0004681968,0.0002032335,0.00016393008,0.00013819971,0.000038848364,0.0003148648,0.00001847132],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.953263,0.0014658882,0.00002743904,0.000086269814,0.0003772319,1.17904705e-7,0.0011661184,0.000060105103,0.006298861,0.000116620235,0.00023961377,0.036898725],"study_design_scores_gemma":[0.9381494,0.004509108,0.0012522857,0.0003743101,0.00035836338,4.7305159e-7,0.0003969371,0.053994462,0.00025031323,0.00022549056,0.00026631044,0.00022256705],"about_ca_topic_score_codex":0.0005348656,"about_ca_topic_score_gemma":0.00019712209,"teacher_disagreement_score":0.053934358,"about_ca_system_score_codex":0.000026222897,"about_ca_system_score_gemma":0.000093371,"threshold_uncertainty_score":0.55382186},"labels":[],"label_agreement":null},{"id":"W2987685056","doi":"10.1016/j.msard.2019.101516","title":"Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Legalization; Medicine; Recreation; Family medicine; Demographics; Principle of legality; Psychiatry; Cross-sectional study; Demography; Environmental health; Law; Pathology; Political science","score_opus":0.03910574055481355,"score_gpt":0.25931294236243807,"score_spread":0.22020720180762451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987685056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465847,0.0012492352,0.0000017945091,0.0020419771,0.00017952235,0.0015211429,0.00028040627,0.000012323642,0.000055124907],"genre_scores_gemma":[0.99726814,0.0013567627,0.000023747416,0.00022558535,0.00001115489,0.00017900228,0.00012322528,0.000036641046,0.00077575655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772197,0.00017552444,0.00059823657,0.00053915347,0.00046077155,0.00050431426],"domain_scores_gemma":[0.99891865,0.00027720068,0.00012727019,0.0003290825,0.0002073892,0.00014042786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009903606,0.00024277909,0.00044632913,0.0002294892,0.00015931617,0.000080570746,0.0001492933,0.00023881614,0.000032701373],"category_scores_gemma":[0.00074691937,0.00018016392,0.00009450141,0.0004995263,0.00028531894,0.0001496686,0.00007548849,0.00042136203,0.0000010424739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007271193,0.00026591454,0.99188215,0.00015102296,0.00005808118,0.0000018582381,0.0003712933,0.00052915065,0.001995222,0.000016391205,0.0032587836,0.0007430419],"study_design_scores_gemma":[0.008599983,0.0003016554,0.9833491,0.00017282329,0.000014308354,0.000006845218,0.00047190383,0.0045712446,0.00006622743,0.0000103812545,0.0022255948,0.0002099501],"about_ca_topic_score_codex":0.792268,"about_ca_topic_score_gemma":0.87680566,"teacher_disagreement_score":0.08453765,"about_ca_system_score_codex":0.00015672366,"about_ca_system_score_gemma":0.00041915243,"threshold_uncertainty_score":0.7346871},"labels":[],"label_agreement":null},{"id":"W2988939654","doi":"10.1016/j.msard.2019.101511","title":"Factors associated with health care utilization in pediatric multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; Institute for Clinical Evaluative Sciences; University of Waterloo; York University; Hospital for Sick Children; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; University of Manitoba; Manitoba Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Crohn's and Colitis Canada; University of Waterloo; Multiple Sclerosis Society of Canada; Physicians' Services Incorporated Foundation; Institute for Clinical Evaluative Sciences; Multiple Sclerosis Scientific Research Foundation; McMaster University; Dalhousie University; Hamilton Health Sciences; Ontario Ministry of Health and Long-Term Care; National Multiple Sclerosis Society; Research Manitoba; Royal Bank of Canada; University of Windsor","keywords":"Medicine; Odds ratio; Multiple sclerosis; Generalized estimating equation; Ambulatory; Neurocognitive; Quality of life (healthcare); Odds; Population; Cognition; Cohort; Pediatrics; Socioeconomic status; Physical therapy; Internal medicine; Logistic regression; Psychiatry","score_opus":0.08005793607646335,"score_gpt":0.2844188698074197,"score_spread":0.20436093373095637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988939654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898166,0.005801067,0.00001650164,0.0008191817,0.00019670877,0.002359257,0.00008338382,0.00022028686,0.000687],"genre_scores_gemma":[0.98786664,0.011084557,0.00007919509,0.00012791439,0.00002428132,0.000093384195,0.00046187322,0.000104722916,0.00015740837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625516,0.00025080377,0.00075110386,0.00095426047,0.00078936043,0.0009993099],"domain_scores_gemma":[0.99802685,0.00056831684,0.00031293588,0.00046548233,0.00022359955,0.0004028119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040496292,0.0005428026,0.0009455045,0.00063491124,0.0003766039,0.000070209855,0.00016586726,0.0003548065,0.00011352246],"category_scores_gemma":[0.00089672673,0.00040913085,0.00018474352,0.0015269979,0.00021036137,0.00027067334,0.00015252549,0.0006896987,0.00002531529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021344938,0.00048524953,0.98117125,0.0002648961,0.00017640919,8.773185e-7,0.005067188,0.00035537596,0.0005361303,0.00000566558,0.00021368831,0.011509792],"study_design_scores_gemma":[0.0131710395,0.0007295629,0.97406065,0.00075485965,0.000076316166,4.0876284e-7,0.006830632,0.0036484879,0.00013485017,0.0000032556097,0.00014747822,0.00044242697],"about_ca_topic_score_codex":0.0008167651,"about_ca_topic_score_gemma":0.004080418,"teacher_disagreement_score":0.01295759,"about_ca_system_score_codex":0.00042181456,"about_ca_system_score_gemma":0.00020961286,"threshold_uncertainty_score":0.999836},"labels":[],"label_agreement":null},{"id":"W2989533252","doi":"10.1016/j.msard.2019.101493","title":"Effects of Mindfulness-based interventions on physical symptoms in people with multiple sclerosis – a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Meta-analysis; Mindfulness; Medicine; Psychological intervention; Psychotherapist; Systematic review; Physical therapy; MEDLINE; Clinical psychology; Physical medicine and rehabilitation; Psychology; Psychiatry; Internal medicine","score_opus":0.07933472634197179,"score_gpt":0.33076535588822503,"score_spread":0.2514306295462532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989533252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013166441,0.98471624,0.00006741918,0.00022178314,0.000037334863,0.013277663,0.00026227557,0.000064126805,0.000036533882],"genre_scores_gemma":[0.122127965,0.87243366,0.000057421385,0.00007229646,0.000007330265,0.0048013297,0.0002017536,0.00013205872,0.00016620642],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99370545,0.0011574595,0.0020276755,0.0014435649,0.0009482771,0.0007175988],"domain_scores_gemma":[0.9927435,0.0042975447,0.0012751127,0.0011441036,0.00021349791,0.00032625537],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0008358011,0.0012392228,0.014704537,0.0015657195,0.00018457836,0.000064710424,0.00033378875,0.00047102827,0.000061987244],"category_scores_gemma":[0.0016945036,0.0007401261,0.005039004,0.003121551,0.00046244843,0.0001230276,0.00023469068,0.0010324877,0.000023137538],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077577555,0.0015305893,0.00036496768,0.8678199,0.11952961,0.0000033695303,0.00015054877,0.000054465494,0.0000034261627,0.000009152691,0.00002547231,0.0104309125],"study_design_scores_gemma":[0.0040392303,0.0007408743,0.0031528326,0.32831907,0.6618653,0.0000029357013,0.00006517932,0.0010197213,0.000013169092,0.0000021786077,0.000114061884,0.0006654404],"about_ca_topic_score_codex":0.00035690036,"about_ca_topic_score_gemma":0.000616217,"teacher_disagreement_score":0.5423357,"about_ca_system_score_codex":0.00016373386,"about_ca_system_score_gemma":0.0001390549,"threshold_uncertainty_score":0.9999232},"labels":[],"label_agreement":null},{"id":"W2994623253","doi":"10.1016/j.msard.2019.101891","title":"No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Actelion Pharmaceuticals; Schweizerische Multiple Sklerose Gesellschaft; Sanofi; European Commission; Bayer HealthCare; Universitätsspital Basel; Acorda Therapeutics; Merck KGaA; Merck; AbbVie; Bayer Schering; Teva Pharmaceutical Industries; EMD Serono; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Interferon; Internal medicine; Immunology; Dermatology; Gastroenterology","score_opus":0.021164755843350862,"score_gpt":0.25052083811436027,"score_spread":0.2293560822710094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994623253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968936,0.00064275623,0.0000034896518,0.00016143311,0.00007466334,0.0017591885,0.000051370003,0.00006021001,0.00035330513],"genre_scores_gemma":[0.9947216,0.004758065,0.00005723449,0.000022657545,0.0000061747496,0.00005536363,0.000033614433,0.000050570772,0.00029472733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751955,0.00015880373,0.0004486499,0.0006451741,0.0005910436,0.0006368019],"domain_scores_gemma":[0.9983478,0.00036015472,0.00018966934,0.00046624534,0.00026085388,0.0003752471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017753942,0.00034788705,0.0006431619,0.00027748215,0.0000890015,0.000028860451,0.00012314582,0.00015565153,0.000110859655],"category_scores_gemma":[0.0003486381,0.0002564717,0.00012096417,0.00050911854,0.00031298332,0.00028535043,0.00014563325,0.00043250382,0.000043747616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06952595,0.00092023256,0.9108249,0.0002841346,0.00024642446,0.000005162797,0.00051475473,0.00010379957,0.007848301,0.0000011379447,0.000030783824,0.009694424],"study_design_scores_gemma":[0.010967332,0.012113207,0.97108513,0.0018368653,0.000097088116,5.012085e-7,0.00009273078,0.0032735027,0.00021656556,0.0000020027917,0.000032241434,0.00028282023],"about_ca_topic_score_codex":0.0031541626,"about_ca_topic_score_gemma":0.00046293254,"teacher_disagreement_score":0.060260247,"about_ca_system_score_codex":0.00015106311,"about_ca_system_score_gemma":0.00008349984,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W2995378675","doi":"10.1016/j.msard.2019.101887","title":"Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Roche (Canada); St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Multiple sclerosis; Inertia; Physical medicine and rehabilitation; Psychiatry","score_opus":0.06129911747051195,"score_gpt":0.26937376181334854,"score_spread":0.2080746443428366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995378675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376637,0.0009749079,0.00014968787,0.0003546688,0.00017952264,0.0037326259,0.00011236508,0.0003205301,0.00040934444],"genre_scores_gemma":[0.9969844,0.0013163036,0.00014891941,0.0000921772,0.000027571132,0.0004239946,0.00026720372,0.00019145837,0.000547974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625194,0.00012915551,0.00059382163,0.001084729,0.0007903404,0.001150028],"domain_scores_gemma":[0.99724245,0.0010981397,0.00031475685,0.00054656283,0.0003522741,0.0004458053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038455595,0.0007363068,0.0011407018,0.00033610332,0.0006217684,0.00013352101,0.00023000786,0.00033383918,0.00011990892],"category_scores_gemma":[0.00047966535,0.00048059272,0.00028193774,0.0008778586,0.00046729838,0.0003714136,0.00014544567,0.00064584194,0.000011027021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009869767,0.00052411464,0.9640352,0.00020484952,0.001804354,9.955796e-7,0.002340822,0.0007104892,0.022716662,0.000004972244,0.000118948905,0.0065516178],"study_design_scores_gemma":[0.022820566,0.0010539402,0.9471469,0.0010637534,0.00045640345,0.0000016652517,0.0017935337,0.022488352,0.0023557974,0.000007395921,0.000119854434,0.00069183507],"about_ca_topic_score_codex":0.00051376305,"about_ca_topic_score_gemma":0.0019445858,"teacher_disagreement_score":0.02183359,"about_ca_system_score_codex":0.00019227437,"about_ca_system_score_gemma":0.000096402844,"threshold_uncertainty_score":0.99976456},"labels":[],"label_agreement":null},{"id":"W2997666549","doi":"10.1016/j.msard.2020.101928","title":"Predictive medicine in multiple sclerosis: A systematic review","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Sanofi Genzyme; Merck; MedDay Pharmaceuticals; Roche; Agence Nationale de la Recherche; National Security Agency; Biogen; Sanofi; Genzyme; Teva Pharmaceutical Industries; Novartis","keywords":"Multiple sclerosis; Medicine; MEDLINE; Intensive care medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.09322648895263447,"score_gpt":0.3149819086856666,"score_spread":0.22175541973303214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997666549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015361307,0.97979,0.000014257086,0.0020547465,0.0003169711,0.016314868,0.00020996414,0.00032868632,0.0009551908],"genre_scores_gemma":[0.0019025129,0.99256325,0.00009839655,0.00042215918,0.00012592941,0.0039344733,0.0004351274,0.00029923004,0.00021891935],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9899311,0.0013148224,0.0038707473,0.0020945827,0.0014696441,0.0013190832],"domain_scores_gemma":[0.99386775,0.0023337705,0.0012954723,0.0013053279,0.0002560698,0.0009416252],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015937411,0.0017608039,0.011062499,0.0010018842,0.00040171467,0.00006683971,0.0006536604,0.0010582957,0.00018281181],"category_scores_gemma":[0.01168288,0.0011943729,0.0013697871,0.0027856634,0.0010694178,0.00023094658,0.0006421942,0.0025756583,0.00020619878],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090967005,0.00036574047,0.00023014146,0.8046189,0.002066909,0.000034735265,0.0006612111,0.0000020034256,0.0000100834095,0.0000065682952,0.0022548977,0.18965785],"study_design_scores_gemma":[0.006063647,0.00060409674,0.0010500302,0.9165888,0.007770644,0.000046930898,0.0005527285,0.0009001455,4.944728e-7,0.000010098307,0.065422624,0.000989802],"about_ca_topic_score_codex":0.00044920127,"about_ca_topic_score_gemma":0.00022074254,"teacher_disagreement_score":0.18866806,"about_ca_system_score_codex":0.00056316494,"about_ca_system_score_gemma":0.00036464006,"threshold_uncertainty_score":0.99972546},"labels":[],"label_agreement":null},{"id":"W2998846246","doi":"10.1016/j.msard.2020.101940","title":"Reliability and validity of a novel device for quantifying ankle dorsiflexion force in persons with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Mount Royal University","funders":"EMD Serono","keywords":"Medicine; Ankle dorsiflexion; Physical medicine and rehabilitation; Reliability (semiconductor); Physical therapy; Ankle; Limits of agreement; Modalities; Range of motion; Nuclear medicine; Surgery","score_opus":0.14934964528465736,"score_gpt":0.3106397778474063,"score_spread":0.16129013256274896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998846246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136126,0.0010358762,0.0010822852,0.003498545,0.000050434926,0.0025789014,0.00019191053,0.000095593576,0.00010516348],"genre_scores_gemma":[0.9894125,0.0031596017,0.0068859137,0.00016454028,0.000024793972,0.00021156413,0.000053128217,0.00006519181,0.0000228069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712515,0.00011710721,0.00070471107,0.00095723756,0.0004626936,0.0006331308],"domain_scores_gemma":[0.99764717,0.0011524195,0.00023806027,0.00034214996,0.00022946797,0.00039075207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068899826,0.00041066585,0.00088510517,0.00020033651,0.00034169195,0.000043779266,0.00014122023,0.0002676108,0.000014348594],"category_scores_gemma":[0.002599606,0.0003251942,0.00018845212,0.0007290514,0.0006062706,0.00026156422,0.0001976133,0.0004698636,0.0000012392841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037995346,0.0010347537,0.77540183,0.0017054887,0.00027546103,0.0000012483438,0.0066209165,0.0010770361,0.19882311,0.000026609343,0.00015779982,0.0110762315],"study_design_scores_gemma":[0.023236755,0.0013441563,0.81824213,0.0011792532,0.00018005443,0.000002731598,0.0045476356,0.14697038,0.0035992125,0.000014723726,0.00024702813,0.00043591255],"about_ca_topic_score_codex":0.0010270113,"about_ca_topic_score_gemma":0.0012123279,"teacher_disagreement_score":0.1952239,"about_ca_system_score_codex":0.00007513344,"about_ca_system_score_gemma":0.000081694714,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W2999802292","doi":"10.1016/j.msard.2020.101950","title":"Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Biogen; Roche; Novartis","keywords":"Medicine; Neuromyelitis optica; Spectrum disorder; Ethnic group; Phenotype; Multiple sclerosis; Pediatrics; Immunology; Psychiatry; Genetics; Gene","score_opus":0.0373750766326049,"score_gpt":0.2759022954175594,"score_spread":0.2385272187849545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999802292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849832,0.008866097,0.0000039096712,0.0038434772,0.00005241877,0.0015835058,0.000051449362,0.000015748705,0.0006001646],"genre_scores_gemma":[0.983293,0.016401807,0.000077654244,0.00005330733,0.000012187217,0.00011489144,0.000018260895,0.000024986131,0.0000039353413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974066,0.00028152394,0.00064063363,0.00045192696,0.0008727826,0.00034652252],"domain_scores_gemma":[0.99852633,0.00079904986,0.00014663381,0.00015688657,0.00016566312,0.00020540884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005897571,0.0002220148,0.0005728532,0.00008781173,0.000050228777,0.000008589649,0.000085648535,0.00012743917,0.00015605234],"category_scores_gemma":[0.008243291,0.00019215725,0.00005718148,0.00042651827,0.000257927,0.000112523085,0.00013264376,0.00027379108,5.260868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003176957,0.00041327858,0.9446513,0.00036061465,0.0001564961,0.0000038374374,0.0028361625,0.00067482033,0.003762983,0.000023377763,0.000042376218,0.046757046],"study_design_scores_gemma":[0.0076579726,0.00051734847,0.9543247,0.00047112632,0.0001394726,8.274735e-7,0.002107562,0.03421792,0.00032054892,0.000058415488,0.000030236526,0.0001538613],"about_ca_topic_score_codex":0.51957464,"about_ca_topic_score_gemma":0.7391984,"teacher_disagreement_score":0.21962374,"about_ca_system_score_codex":0.00020936421,"about_ca_system_score_gemma":0.00035442732,"threshold_uncertainty_score":0.9868584},"labels":[],"label_agreement":null},{"id":"W2999863154","doi":"10.1016/j.msard.2019.101919","title":"Under-treated depression negatively impacts lifestyle behaviors, participation and health-related quality of life among older people with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Physiotherapy Foundation of Canada","keywords":"Medicine; Depression (economics); Psychosocial; Quality of life (healthcare); Multiple sclerosis; Depressive symptoms; Anxiety; Internal medicine; Psychiatry","score_opus":0.08415249453143177,"score_gpt":0.3146048150547855,"score_spread":0.23045232052335374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999863154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883558,0.0039048754,0.00013244858,0.004933481,0.00004999544,0.0022097514,0.00010227722,0.00023898233,0.000072364506],"genre_scores_gemma":[0.9910901,0.00777514,0.00036558864,0.0002706555,0.0000215221,0.00016984368,0.0001780214,0.000101396494,0.000027686388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534285,0.00049366686,0.0014485166,0.0010329442,0.0008270776,0.00085493264],"domain_scores_gemma":[0.9965367,0.00060535315,0.00080566324,0.0004237134,0.00030150637,0.001327086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006654223,0.00059035677,0.0014001599,0.0002358865,0.00059280434,0.00006831165,0.00014475053,0.00038674462,0.000085987354],"category_scores_gemma":[0.0014709847,0.00045424077,0.00019613931,0.0010902488,0.0007712922,0.00040710397,0.00024413076,0.00067726354,0.0000071850227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010215385,0.0007135078,0.9574785,0.00045367813,0.0005055995,0.0000011052905,0.0065782582,0.00039959623,0.022591855,0.0000059691993,0.00020861442,0.010041743],"study_design_scores_gemma":[0.016298609,0.00092837424,0.9680879,0.0011742002,0.00020130306,0.0000013385118,0.002664743,0.008405083,0.0017618313,0.000007646768,0.000006447383,0.00046252253],"about_ca_topic_score_codex":0.011077592,"about_ca_topic_score_gemma":0.0054702577,"teacher_disagreement_score":0.020830024,"about_ca_system_score_codex":0.000099798344,"about_ca_system_score_gemma":0.00016126747,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W3002536563","doi":"10.1016/j.msard.2020.101964","title":"Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Plasmapheresis; Cyclophosphamide; Autoantibody; Malignancy; Antibody; Acute disseminated encephalomyelitis; Encephalomyelitis; Immunoglobulin G; Multiple sclerosis; Immunology; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.013408963881945504,"score_gpt":0.20622574861666548,"score_spread":0.19281678473471997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002536563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839569,0.011580372,0.000033017855,0.0024385357,0.000064592794,0.00088812923,0.00006029637,0.00028839326,0.00068979],"genre_scores_gemma":[0.9819262,0.016583912,0.00014740805,0.0008051854,0.0000112902035,0.000029580133,0.00029562003,0.00007356873,0.00012720715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760383,0.00010218257,0.00053169765,0.0008469239,0.00030564386,0.00060970045],"domain_scores_gemma":[0.9989597,0.00012190431,0.00021744677,0.00025254377,0.000072702176,0.00037570496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000709258,0.0005348195,0.00087858405,0.0000753321,0.0004002473,0.00008041111,0.0001136102,0.00035152756,0.000105226674],"category_scores_gemma":[0.00014192666,0.0003879172,0.00013570747,0.0005440512,0.00044028554,0.0001462622,0.00010275365,0.0004760637,0.000024044382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014026122,0.0010888588,0.9395668,0.00011240626,0.0010093636,0.00023608127,0.00080608187,0.00012982242,0.010605158,0.00002032301,0.00012466754,0.044897813],"study_design_scores_gemma":[0.01620477,0.0026492602,0.9759922,0.00024185418,0.00044859434,0.000057001245,0.0005717263,0.0026284917,0.00032928967,0.000058281068,0.0003459172,0.00047261035],"about_ca_topic_score_codex":0.00078133383,"about_ca_topic_score_gemma":0.000058255668,"teacher_disagreement_score":0.044425204,"about_ca_system_score_codex":0.0000357532,"about_ca_system_score_gemma":0.000045057852,"threshold_uncertainty_score":0.99985725},"labels":[],"label_agreement":null},{"id":"W3002578671","doi":"10.1016/j.msard.2020.101955","title":"Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan; Health Sciences Centre; Manitoba Health","funders":"Saskatchewan Health Research Foundation","keywords":"Comorbidity; Medicine; Population; Odds ratio; Odds; Internal medicine; Logistic regression; Pediatrics","score_opus":0.06059881887132283,"score_gpt":0.29942472329734876,"score_spread":0.23882590442602591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002578671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514085,0.00033106803,0.00006759216,0.0009743547,0.000043880984,0.0030526486,0.00018968125,0.00012475821,0.00007517862],"genre_scores_gemma":[0.9984346,0.0006118965,0.00028804707,0.00009075859,0.000024862158,0.00026187656,0.00020570209,0.00007680945,0.0000054513152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657226,0.0002671388,0.0008371152,0.00086081034,0.0008642635,0.0005984356],"domain_scores_gemma":[0.99782336,0.00076152285,0.0003107804,0.0004596897,0.00020174973,0.0004428742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033025042,0.00051091483,0.00096983084,0.00044785166,0.00030527185,0.000061900864,0.0001982155,0.00020179655,0.00010254255],"category_scores_gemma":[0.001706474,0.00038202608,0.00026482323,0.0015134006,0.00024587926,0.00019334248,0.000118886455,0.0005545646,0.000009064027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008077603,0.0035792696,0.96958494,0.00009220621,0.0005935249,0.0000071401455,0.0032225354,0.018456372,0.0006835425,0.0000033367335,0.00013553155,0.0028338574],"study_design_scores_gemma":[0.025702856,0.0042889835,0.94938654,0.00068107113,0.00016454738,4.6603097e-7,0.0017843203,0.0175569,0.000046182493,0.0000039640217,0.0000054427287,0.00037870376],"about_ca_topic_score_codex":0.0067568,"about_ca_topic_score_gemma":0.002939435,"teacher_disagreement_score":0.024895096,"about_ca_system_score_codex":0.00016897105,"about_ca_system_score_gemma":0.00014882731,"threshold_uncertainty_score":0.99986315},"labels":[],"label_agreement":null},{"id":"W3003639437","doi":"10.1016/j.msard.2020.101973","title":"Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Hemophagocytosis; Alemtuzumab; Medicine; Multiple sclerosis; Clinically isolated syndrome; Jaundice; Differential diagnosis; Pathology; Gastroenterology; Immunology; Bone marrow; Antibody; Pancytopenia","score_opus":0.06086326959752518,"score_gpt":0.2738405279115333,"score_spread":0.2129772583140081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003639437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865714,0.0063570384,0.0002821122,0.0032090445,0.0002077415,0.002612021,0.000046787532,0.00028882985,0.00042506887],"genre_scores_gemma":[0.9960903,0.001596087,0.0005968285,0.0002959758,0.000034721346,0.00046316098,0.00018173098,0.000117221876,0.0006240007],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99696434,0.00007415507,0.00092703255,0.0009126457,0.00037113894,0.000750692],"domain_scores_gemma":[0.99841505,0.00025521987,0.00021373495,0.00049384515,0.0000883496,0.0005338064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028135534,0.00048412752,0.000921659,0.00016963355,0.0006637734,0.00008608588,0.000121350866,0.0003375539,0.00009784765],"category_scores_gemma":[0.00068662764,0.0004058115,0.00067260175,0.00046050822,0.00018646993,0.00024318347,0.000100850084,0.00032621916,0.000049479193],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009709914,0.0071481313,0.26086915,0.003472968,0.014401143,0.09493392,0.030306624,0.002524709,0.10462973,0.0001497662,0.0074482094,0.46440572],"study_design_scores_gemma":[0.26741216,0.024018144,0.19921261,0.0038333694,0.005642461,0.045461338,0.03623537,0.3521233,0.007835677,0.00035692487,0.0519794,0.005889236],"about_ca_topic_score_codex":0.0004851292,"about_ca_topic_score_gemma":0.000077207485,"teacher_disagreement_score":0.45851648,"about_ca_system_score_codex":0.00017083436,"about_ca_system_score_gemma":0.00022063767,"threshold_uncertainty_score":0.99983937},"labels":[],"label_agreement":null},{"id":"W3005047919","doi":"10.1016/j.msard.2020.101987","title":"Management of diabetes and hypertension in people with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Research Manitoba; International Business Machines Corporation","keywords":"Medicine; Diabetes mellitus; Odds ratio; Body mass index; Logistic regression; Internal medicine; Univariate analysis; Multiple sclerosis; Blood pressure; Depression (economics); Case-control study; Comorbidity; Physical therapy; Multivariate analysis; Endocrinology; Psychiatry","score_opus":0.035704120419214204,"score_gpt":0.22812043413442892,"score_spread":0.19241631371521473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005047919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112445,0.0033127044,0.000019597326,0.003753448,0.000036819947,0.0011949927,0.000023137143,0.00007958792,0.0004552621],"genre_scores_gemma":[0.9777989,0.020544784,0.0012588745,0.00017869008,0.000012108098,0.00009588106,0.000026211252,0.00005310966,0.00003143547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771804,0.000080003665,0.0005145876,0.0006913587,0.0004631615,0.0005328631],"domain_scores_gemma":[0.99891466,0.00025580794,0.00013018987,0.00027063285,0.0000940077,0.0003347295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021693434,0.00034331458,0.0007436764,0.00019806343,0.00017135509,0.000029610761,0.00010675053,0.00015840596,0.000033929144],"category_scores_gemma":[0.00021287742,0.000258991,0.000096763026,0.00077805703,0.0004006483,0.0001494078,0.0002729666,0.00034391074,0.000006110098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005041972,0.00039649435,0.9171042,0.000765087,0.00043126714,0.0000066807397,0.0018890536,0.0001702858,0.028899036,0.0000143532,0.00013853567,0.04968085],"study_design_scores_gemma":[0.012386842,0.00057423284,0.96090716,0.001340264,0.00014688693,0.0000014175782,0.0030236242,0.020093756,0.0010909758,0.000008566544,0.00013483778,0.00029143525],"about_ca_topic_score_codex":0.00027256442,"about_ca_topic_score_gemma":0.00027593505,"teacher_disagreement_score":0.049389414,"about_ca_system_score_codex":0.000034381428,"about_ca_system_score_gemma":0.000020324418,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W3008711629","doi":"10.1016/j.msard.2020.102016","title":"Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Disease; Cohort; Compliance (psychology); Adverse effect; Medical advice; Physical therapy; Internal medicine; Pediatrics; Psychiatry","score_opus":0.07107569053112676,"score_gpt":0.29799759777328194,"score_spread":0.22692190724215516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008711629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222493,0.0014931778,0.00049716735,0.003405909,0.000025282834,0.001942837,0.0001288637,0.00013859093,0.00014323641],"genre_scores_gemma":[0.9958335,0.0018994636,0.0013011801,0.0003544978,0.000018775543,0.0003083668,0.00016468021,0.000086841595,0.000032686676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626756,0.00021532454,0.00063541223,0.001154767,0.0009124571,0.00081449765],"domain_scores_gemma":[0.9978787,0.00039133875,0.00024416123,0.00046927924,0.00028333173,0.00073320454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002926352,0.00058979134,0.0010790809,0.00045458617,0.00041035857,0.000099236124,0.00021063532,0.0001483022,0.000059101953],"category_scores_gemma":[0.0004680008,0.00040668747,0.00024008173,0.002509412,0.00066421437,0.00035210597,0.00015340661,0.0006150637,0.000016682176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053176414,0.00082660007,0.95798534,0.0002454059,0.0024471618,0.0000052773726,0.024082597,0.002796433,0.0004920757,0.0000043113423,0.000053232776,0.0057438957],"study_design_scores_gemma":[0.021011755,0.000746505,0.9287919,0.0009342564,0.00061544526,1.17495595e-7,0.009251115,0.03803217,0.00003422083,0.000008493186,0.00003900473,0.0005350403],"about_ca_topic_score_codex":0.00062875386,"about_ca_topic_score_gemma":0.0007289734,"teacher_disagreement_score":0.03523574,"about_ca_system_score_codex":0.000104025436,"about_ca_system_score_gemma":0.00008398704,"threshold_uncertainty_score":0.9998385},"labels":[],"label_agreement":null},{"id":"W3009008098","doi":"10.1016/j.msard.2020.102028","title":"Predictors of hospitalization in a Canadian MS population: A matched cohort study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health; University of Saskatchewan","funders":"Saskatchewan Health Research Foundation","keywords":"Medicine; Comorbidity; Odds ratio; Population; Odds; Logistic regression; Cohort; Demography; Retrospective cohort study; Cohort study; Diagnosis code; Pediatrics; Internal medicine; Environmental health","score_opus":0.02436139598120182,"score_gpt":0.2527734395428892,"score_spread":0.2284120435616874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009008098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399704,0.00042417715,0.000005665151,0.0025823812,0.00008035849,0.0021983115,0.000024768193,0.00005309479,0.0006341816],"genre_scores_gemma":[0.998369,0.0012461324,0.00005056329,0.00007441022,0.000020909292,0.00009591721,0.00008476336,0.000030832816,0.000027511293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981709,0.000097081895,0.00052848,0.00042590476,0.00039302598,0.00038458308],"domain_scores_gemma":[0.99911255,0.00006494236,0.00010206388,0.00019327896,0.00008739534,0.00043975137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029005564,0.00019485233,0.000496821,0.00025861667,0.000116939074,0.000018836425,0.000082430124,0.00014083956,0.00009067647],"category_scores_gemma":[0.0007651867,0.00017121354,0.00007727519,0.00079123396,0.00011469419,0.00010668849,0.00006283656,0.000229456,0.0000052987543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010431748,0.00027752732,0.99245644,0.000072210445,0.00023847641,0.000003033395,0.004391665,0.00029305014,0.0004623641,0.000005641584,0.00015520836,0.0015400698],"study_design_scores_gemma":[0.0045855786,0.0004226605,0.982276,0.00012032769,0.000078501915,4.4361963e-7,0.0019964261,0.01024048,0.000022224354,0.0000060189864,0.000099784025,0.00015152457],"about_ca_topic_score_codex":0.23827621,"about_ca_topic_score_gemma":0.19542783,"teacher_disagreement_score":0.04284838,"about_ca_system_score_codex":0.000110736604,"about_ca_system_score_gemma":0.00008466872,"threshold_uncertainty_score":0.8192535},"labels":[],"label_agreement":null},{"id":"W3009562967","doi":"10.1016/j.msard.2020.102039","title":"Corticospinal inhibition and alexithymia in multiple sclerosis patients–An exploratory study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Biogen; Novartis","keywords":"Alexithymia; GABAergic; Toronto Alexithymia Scale; Multiple sclerosis; Transcranial magnetic stimulation; Neuropsychology; Medicine; Psychology; Neuroscience; Clinical psychology; Psychiatry; Stimulation; Cognition; Inhibitory postsynaptic potential","score_opus":0.04563936652360001,"score_gpt":0.23778593884008226,"score_spread":0.19214657231648224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009562967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966551,0.0007241854,0.00002419755,0.0006079901,0.00010707284,0.0015263509,0.000024003797,0.000105295774,0.0002258172],"genre_scores_gemma":[0.99793595,0.0012436489,0.00012795534,0.00038703458,0.00001515326,0.0001281947,0.00010048164,0.000051800762,0.000009788429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980678,0.00011500235,0.00053713034,0.0006505053,0.00028338924,0.0003461705],"domain_scores_gemma":[0.9991385,0.0000560216,0.00013726142,0.00023219215,0.00004633721,0.00038969007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011867264,0.0003294109,0.00045644923,0.00014004082,0.00020129881,0.00005430767,0.000058259986,0.0001617339,0.000047834437],"category_scores_gemma":[0.000128912,0.0002821306,0.000074184216,0.00037559413,0.00016142511,0.00031350242,0.00007338155,0.00025664046,0.0000187719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060216134,0.0039027634,0.965659,0.00006550998,0.00014509693,0.0000066955804,0.010826838,0.000025787263,0.0009576972,0.000007149307,0.000045404115,0.017755866],"study_design_scores_gemma":[0.02550314,0.002414954,0.95594585,0.00063177076,0.00010950408,0.0000011378033,0.01006819,0.0048595276,0.00004966631,0.00007750754,0.000035553738,0.00030321412],"about_ca_topic_score_codex":0.00020087953,"about_ca_topic_score_gemma":0.0004689744,"teacher_disagreement_score":0.024900978,"about_ca_system_score_codex":0.00003721134,"about_ca_system_score_gemma":0.000023777837,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W3010847380","doi":"10.1016/j.msard.2019.11.078","title":"Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis Over 48 Weeks: A Randomized, Placebo-Controlled, Phase 2 Study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of Toronto; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Gastroenterology; Internal medicine; Randomized controlled trial; Confidence interval; Adverse effect; Dimethyl fumarate; Multiple sclerosis; Immunology; Pathology","score_opus":0.017050431650200808,"score_gpt":0.2431664878634373,"score_spread":0.2261160562132365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010847380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883627,0.0016293665,0.000017387449,0.00084833894,0.00014039241,0.008773709,0.00004080939,0.000060027865,0.00012722697],"genre_scores_gemma":[0.998642,0.00076895166,0.00008507339,0.00013938641,0.00003076501,0.00016550857,0.00003115374,0.00008072915,0.000056432506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99610317,0.00057722384,0.0011240595,0.0008023738,0.0008245057,0.0005686831],"domain_scores_gemma":[0.9973513,0.0012749563,0.00038680134,0.0004896971,0.0001418484,0.0003554136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008715885,0.00047576654,0.0015258346,0.00019775082,0.00029511462,0.00005647123,0.00018703673,0.00025719547,0.00006461778],"category_scores_gemma":[0.0026593236,0.00028934047,0.00024462683,0.0008802587,0.00078198727,0.00017987496,0.0002853878,0.00066478003,0.000004395591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8145726,0.0049652876,0.16071212,0.00021189681,0.00095092575,0.000009784542,0.0066293837,0.0005175031,0.0019503767,0.0000084818075,0.00016303363,0.009308636],"study_design_scores_gemma":[0.8359392,0.001121991,0.1255831,0.0011154417,0.0005004905,0.0000016759927,0.00091491535,0.03429853,0.00019090022,0.000003408628,0.00003874304,0.0002915554],"about_ca_topic_score_codex":0.001144704,"about_ca_topic_score_gemma":0.00020879456,"teacher_disagreement_score":0.035129026,"about_ca_system_score_codex":0.0006493245,"about_ca_system_score_gemma":0.00052536704,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W3010981054","doi":"10.1016/j.msard.2020.102053","title":"Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Ahvaz Jundishapur University of Medical Sciences","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Lower limb; Physical therapy; Surgery; Psychiatry","score_opus":0.03655006522001114,"score_gpt":0.27805290895111584,"score_spread":0.2415028437311047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010981054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945431,0.0018307184,0.00019120812,0.0016938857,0.00016274281,0.0013259844,0.000034205925,0.00007280539,0.00014539414],"genre_scores_gemma":[0.99868447,0.00069331366,0.00017412,0.00019433234,0.000034589462,0.00007836644,0.000029641558,0.000044427,0.000066734945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803907,0.00031749744,0.0005767047,0.000459888,0.00023230037,0.00037452858],"domain_scores_gemma":[0.9987748,0.00025107508,0.00052467716,0.00017977867,0.00007591662,0.00019372375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023969183,0.000264857,0.00056256336,0.00006941735,0.00073023915,0.000018282979,0.000110725974,0.00022489528,0.000007718444],"category_scores_gemma":[0.00007440322,0.00017992724,0.00005925133,0.00018833372,0.00028476695,0.0002134333,0.00014347788,0.0006077908,0.000001928943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010261111,0.00024252545,0.9757195,0.00033058907,0.00013029813,8.8957e-8,0.009335875,0.0000084349085,0.01034673,0.000012246358,0.00010246551,0.0027451024],"study_design_scores_gemma":[0.011276845,0.0007795033,0.9766435,0.0009720627,0.00013758289,6.2266554e-7,0.005621416,0.004094587,0.000022673012,0.000008142225,0.0002075539,0.00023553747],"about_ca_topic_score_codex":0.0008830074,"about_ca_topic_score_gemma":0.0033415977,"teacher_disagreement_score":0.010324057,"about_ca_system_score_codex":0.00011105445,"about_ca_system_score_gemma":0.00005409048,"threshold_uncertainty_score":0.73372203},"labels":[],"label_agreement":null},{"id":"W3011079219","doi":"10.1016/j.msard.2019.11.051","title":"Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuromyelitis optica; Placebo; Internal medicine; Serostatus; Clinical endpoint; Hazard ratio; Gastroenterology; Multiple sclerosis; Confidence interval; Clinical trial; Immunology; Pathology; Viral load","score_opus":0.029854584990562663,"score_gpt":0.2756057949033446,"score_spread":0.24575120991278193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011079219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926578,0.0030276123,0.000019514411,0.00036209644,0.0001592933,0.0036516546,0.000027194577,0.00003401537,0.000060850296],"genre_scores_gemma":[0.9975608,0.0021252264,0.00001898135,0.000041877705,0.000005118936,0.000086797096,0.000063842046,0.00004988493,0.000047487025],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965097,0.00080737745,0.0015112077,0.00061119796,0.00011398154,0.00044656126],"domain_scores_gemma":[0.9983435,0.0007389856,0.00046390435,0.00035317827,0.000050658757,0.00004972034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004088387,0.0003976388,0.0012434116,0.00026264982,0.00009910114,0.00001811021,0.0002720838,0.00034787194,0.00023759759],"category_scores_gemma":[0.00017682534,0.00030318103,0.00020986202,0.00060022983,0.00046570753,0.00014297334,0.0000661635,0.00060516375,0.000008116725],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6698646,0.008672829,0.29587984,0.000020851034,0.0008726004,0.000002451652,0.0067132153,0.00031816878,0.004042846,0.000025895506,0.000007201677,0.013579485],"study_design_scores_gemma":[0.4404287,0.0067098932,0.5510628,0.00008597677,0.00006814792,6.379306e-7,0.00073289534,0.00006834285,0.00050023006,0.000008409134,0.00009778766,0.000236138],"about_ca_topic_score_codex":0.0012962726,"about_ca_topic_score_gemma":0.000445992,"teacher_disagreement_score":0.25518298,"about_ca_system_score_codex":0.00002061469,"about_ca_system_score_gemma":0.000079725105,"threshold_uncertainty_score":0.999942},"labels":[],"label_agreement":null},{"id":"W3011509562","doi":"10.1016/j.msard.2019.11.013","title":"Motor Skill Acquisition Through Virtual Reality in People with Multiple Sclerosis: The Impact of Cognitive Function and Related Biomarkers","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Multiple sclerosis; Neurorehabilitation; Dreyfus model of skill acquisition; Physical medicine and rehabilitation; Montreal Cognitive Assessment; Virtual reality; Medicine; Motor skill; Rehabilitation; Psychology; Physical therapy; Neuroscience; Cognitive impairment; Computer science; Psychiatry; Artificial intelligence","score_opus":0.03593337758143836,"score_gpt":0.27321952247038317,"score_spread":0.2372861448889448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011509562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167037,0.0022997172,0.00015491288,0.0028474454,0.00006787902,0.0022205226,0.00021306958,0.00011409752,0.00041195602],"genre_scores_gemma":[0.99107003,0.008293224,0.0000599937,0.000134966,0.000026018977,0.00015568583,0.00017176979,0.00006552939,0.00002280106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968464,0.00036984863,0.0007727629,0.0008393218,0.0005651953,0.00060651987],"domain_scores_gemma":[0.9977949,0.0010185291,0.0003272206,0.00031140665,0.00024100754,0.00030691348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005058468,0.00048928306,0.00080356485,0.00018990165,0.00040162881,0.000056538123,0.00012609406,0.00032805625,0.00010212137],"category_scores_gemma":[0.0013258848,0.0003095759,0.00025761957,0.0012731735,0.0009791947,0.00039585514,0.00019282076,0.00065078563,0.000008279464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012623444,0.0010867704,0.8991147,0.00021398692,0.0029323157,0.000004811257,0.019326702,0.00094205944,0.042436324,0.000026370391,0.00044574164,0.020846717],"study_design_scores_gemma":[0.017686663,0.0027298485,0.94474226,0.0010730253,0.00031522036,0.000006271992,0.009863196,0.022902211,0.0002830384,0.00005289907,0.0000085509555,0.00033682122],"about_ca_topic_score_codex":0.0046492964,"about_ca_topic_score_gemma":0.00076942064,"teacher_disagreement_score":0.0456275,"about_ca_system_score_codex":0.00011197782,"about_ca_system_score_gemma":0.00010220746,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W3011573122","doi":"10.1016/j.msard.2019.11.060","title":"Efficacy of a Fourth Alemtuzumab Course in RRMS Patients from CARE-MS II Who Experienced Disease Activity After Three Prior Courses","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Relapsing remitting; Physical therapy; Surgery; Immunology","score_opus":0.019191281974147045,"score_gpt":0.24445241318072583,"score_spread":0.22526113120657879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011573122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341387,0.004441741,0.000051487747,0.0010278209,0.00021395527,0.0005091494,0.00025519746,0.000035078087,0.000051690204],"genre_scores_gemma":[0.99897313,0.0005808883,0.00015063792,0.00015841523,0.00000854529,0.000035947665,0.00005175185,0.000019685423,0.000021023377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985459,0.00016634856,0.0003542462,0.0005195436,0.00007751081,0.00033645928],"domain_scores_gemma":[0.99926853,0.00019617371,0.00014112469,0.00022385853,0.000049924645,0.00012040415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006812685,0.00025532077,0.0004535895,0.00005059366,0.00015861692,0.000013843249,0.0001644878,0.0002935789,0.00026270412],"category_scores_gemma":[0.0002206928,0.00019715649,0.00016553827,0.00022200093,0.0005080941,0.000101404956,0.00017343317,0.0003305258,0.0000065983872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007213666,0.0018559438,0.7694547,0.00006290845,0.00039947082,0.0000038160697,0.010040453,0.000059321595,0.016634887,0.000012093888,0.00014710928,0.19411564],"study_design_scores_gemma":[0.008685512,0.00042384645,0.9866186,0.00015766741,0.00015044454,7.8951985e-8,0.0006149202,0.000601208,0.0019642476,0.000027537537,0.0004675242,0.0002884535],"about_ca_topic_score_codex":0.00038588975,"about_ca_topic_score_gemma":0.0002878866,"teacher_disagreement_score":0.21716388,"about_ca_system_score_codex":0.000021500327,"about_ca_system_score_gemma":0.000044833236,"threshold_uncertainty_score":0.8039808},"labels":[],"label_agreement":null},{"id":"W3012117463","doi":"10.1016/j.msard.2019.11.072","title":"Efficacy of Subcutaneous Interferon Β-1a in Patients with a First Clinical Demyelinating Event in REFLEX is Maintained After Application of the 2017 McDonald Criteria","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; McDonald criteria; Placebo; Internal medicine; Multiple sclerosis; Hazard ratio; Population; Gastroenterology; Confidence interval; Pathology; Immunology","score_opus":0.03302231902226241,"score_gpt":0.30542888989398465,"score_spread":0.27240657087172226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012117463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943765,0.00024598438,0.000028747574,0.003742693,0.000030926494,0.0014253723,0.000074520154,0.0000142613535,0.000061035076],"genre_scores_gemma":[0.9987126,0.0006891662,0.00026247348,0.00016097087,0.000012006094,0.00009555251,0.000032742188,0.000026537873,0.000007939328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978115,0.00015551689,0.0009237101,0.00044836066,0.00037612568,0.00028476305],"domain_scores_gemma":[0.9986735,0.0005033628,0.00028798456,0.0002993766,0.00012112432,0.0001146305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031428982,0.0002045278,0.00053204317,0.000110527726,0.00006395061,0.0000086508,0.00016011832,0.00016128349,0.000075789736],"category_scores_gemma":[0.0010050437,0.00013490568,0.00013898041,0.0004755737,0.00035277664,0.00005789858,0.00022076468,0.0004218066,0.0000027209073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0095815845,0.00093797786,0.96719474,0.0002646338,0.000120411874,0.0000016396402,0.0028499507,0.00010887027,0.0007057499,0.0000019135387,0.00020115034,0.018031398],"study_design_scores_gemma":[0.010986326,0.0013153624,0.97604257,0.001130622,0.00004163575,4.5722967e-7,0.0003736051,0.009791138,0.00007347725,0.0000070720434,0.000105104395,0.00013262712],"about_ca_topic_score_codex":0.00028006206,"about_ca_topic_score_gemma":0.00085962797,"teacher_disagreement_score":0.01789877,"about_ca_system_score_codex":0.000057606892,"about_ca_system_score_gemma":0.000040430597,"threshold_uncertainty_score":0.5501294},"labels":[],"label_agreement":null},{"id":"W3021383321","doi":"10.1016/j.msard.2012.10.004","title":"Book review","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.040784689367329145,"score_gpt":0.28791073046248217,"score_spread":0.24712604109515302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021383321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019817144,0.95782924,0.00001544184,0.012143521,0.00024744053,0.0012367984,0.000012044737,0.00017619878,0.008522186],"genre_scores_gemma":[0.3758158,0.6158477,0.00014656136,0.005842136,0.00005538805,0.000094276445,0.000025992542,0.000035280053,0.0021368728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810326,0.00008940612,0.00039904908,0.00032604387,0.00039554655,0.0006866856],"domain_scores_gemma":[0.9988662,0.00016331862,0.00008623626,0.00034976433,0.00007276633,0.00046169903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042389787,0.00025769038,0.00049042644,0.00011110754,0.0002623427,0.000016813035,0.000082197774,0.00014352314,0.0015502097],"category_scores_gemma":[0.0006437506,0.00019313363,0.00019336001,0.00032373605,0.00027159086,0.00025324023,0.00013912738,0.00036966175,0.0002061661],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012775943,0.0008614369,0.1585117,0.001958125,0.00058093696,0.0000019132171,0.00074894953,0.0000024927529,0.0054772184,0.00004273844,0.68812656,0.14356014],"study_design_scores_gemma":[0.002792838,0.00010762664,0.44130892,0.0022200313,0.0001818696,0.000012567011,0.00012745318,0.00019148698,0.0001822286,0.0000048524657,0.5526012,0.00026889236],"about_ca_topic_score_codex":0.000051421895,"about_ca_topic_score_gemma":0.000005387338,"teacher_disagreement_score":0.35599867,"about_ca_system_score_codex":0.0000463693,"about_ca_system_score_gemma":0.000023747389,"threshold_uncertainty_score":0.9993625},"labels":[],"label_agreement":null},{"id":"W3021487116","doi":"10.1016/j.msard.2020.102075","title":"Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Novartis Pharmaceuticals Canada; Teva Pharmaceutical Industries; Roche; Merck; Bayer","keywords":"Multiple sclerosis; Medicine; Encephalitis; Pathophysiology; Anti-NMDA receptor encephalitis; Autoimmune encephalitis; NMDA receptor; Disease; Relapsing remitting; Immunology; Neuroscience; Pediatrics; Receptor; Pathology; Internal medicine; Psychology; Virus","score_opus":0.050210539531408645,"score_gpt":0.2862886915107945,"score_spread":0.23607815197938586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021487116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011298687,0.98520994,0.0000030668032,0.0002779223,0.000110755194,0.0023107976,0.0005276057,0.000058704507,0.00020249604],"genre_scores_gemma":[0.033575427,0.96511894,0.00030273,0.00014145554,0.0000124663175,0.00012391385,0.0005675331,0.00007470786,0.00008284272],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99617934,0.00028146687,0.001717121,0.0010999204,0.00034234897,0.00037978715],"domain_scores_gemma":[0.99736136,0.00042891683,0.0012075424,0.00054711726,0.00014268524,0.00031238204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029212708,0.0007554141,0.00353499,0.00017852409,0.00018538604,0.000035438396,0.00012509088,0.0006925029,0.00006473757],"category_scores_gemma":[0.0010285712,0.00052977353,0.0005897888,0.00072052673,0.00069164706,0.00012018515,0.00015558685,0.0007176224,0.0000035467906],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009763965,0.00066091656,0.00437385,0.108676784,0.0010993012,0.0014838983,0.00042271186,1.8781589e-7,0.0000937776,0.000015314094,0.00028037233,0.8827953],"study_design_scores_gemma":[0.0116330935,0.0023030345,0.0107933665,0.60176146,0.00723372,0.012748009,0.0004642276,0.00008951045,0.000038347258,0.000045015968,0.3511351,0.0017551173],"about_ca_topic_score_codex":0.00020683199,"about_ca_topic_score_gemma":0.000007945054,"teacher_disagreement_score":0.88104016,"about_ca_system_score_codex":0.000025955947,"about_ca_system_score_gemma":0.000105595645,"threshold_uncertainty_score":0.9997154},"labels":[],"label_agreement":null},{"id":"W3022456477","doi":"10.1016/j.msard.2020.102086","title":"Alemtuzumab and prescription medication use in the MS population","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Marshall-Smith Syndroom Research Foundation; Multiple Sclerosis International Federation; Stichting MS Research; American Academy of Neurology; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Canada Foundation for Innovation; National Multiple Sclerosis Society","keywords":"Alemtuzumab; Medicine; Medical prescription; Polypharmacy; Multiple sclerosis; Population; Drug; Adverse effect; Pediatrics; Internal medicine; Psychiatry; Pharmacology; Environmental health","score_opus":0.06380809541472414,"score_gpt":0.2727158265422622,"score_spread":0.20890773112753802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022456477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819104,0.0014064936,0.000049484286,0.015302491,0.000051341794,0.0009434761,0.000009648731,0.000057469737,0.00026917932],"genre_scores_gemma":[0.9890098,0.010049624,0.00017630839,0.0005351836,0.000032726457,0.000066550645,0.000088253226,0.000017506096,0.000024066998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985633,0.0001523745,0.0003208978,0.00036232383,0.00036291307,0.00023818793],"domain_scores_gemma":[0.9993507,0.00022951417,0.0000751301,0.00016857937,0.000036861486,0.00013916081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003024998,0.0001557016,0.0002259294,0.00009609308,0.00019596882,0.00006503793,0.00006908393,0.00013074302,0.000028601533],"category_scores_gemma":[0.001061703,0.00010484107,0.00004951868,0.00031348172,0.0001715107,0.00024516182,0.00006673951,0.0003278729,0.0000059761596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002940055,0.00016652992,0.9189225,0.0001251086,0.000085038555,0.0000019218967,0.0066489563,0.000087392546,0.0074072843,0.00009719702,0.00115526,0.065008834],"study_design_scores_gemma":[0.0033853247,0.00015029915,0.96841496,0.00011993481,0.000043570155,0.0000025621437,0.0011057528,0.02548436,0.00002424162,0.000044559976,0.0011135228,0.00011091516],"about_ca_topic_score_codex":0.001508985,"about_ca_topic_score_gemma":0.0005947544,"teacher_disagreement_score":0.064897925,"about_ca_system_score_codex":0.00003155174,"about_ca_system_score_gemma":0.000012636817,"threshold_uncertainty_score":0.42752948},"labels":[],"label_agreement":null},{"id":"W3023209915","doi":"10.1016/j.msard.2020.102146","title":"Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Medicine; Pregnancy; Multiple sclerosis; Pediatrics; Obstetrics; Internal medicine; Gynecology; Immunology","score_opus":0.032012514851661844,"score_gpt":0.3002381336431129,"score_spread":0.26822561879145107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023209915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937265,0.0022057665,0.0000041954695,0.002634571,0.000013208207,0.0012351346,0.000005590755,0.00004740094,0.00012764269],"genre_scores_gemma":[0.9948518,0.0042649936,0.00019192939,0.00046854554,0.0000036298227,0.00012888653,0.000029628816,0.00002028934,0.000040298863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869186,0.000092995666,0.00038509027,0.00036226198,0.0001793909,0.00028838025],"domain_scores_gemma":[0.99936694,0.00014582364,0.000099042256,0.00013744956,0.000016503605,0.00023422673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021869903,0.00019314906,0.00035778078,0.00007744619,0.00006564666,0.0000313787,0.000054117365,0.0001313389,0.000018417852],"category_scores_gemma":[0.00014839489,0.000104963925,0.000021020609,0.00032452453,0.000271097,0.00011348844,0.000027688739,0.00033944246,0.0000012496664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011757949,0.0007800439,0.8219223,0.00006176028,0.00013076734,0.00002271495,0.008459527,0.0000016819033,0.00002300485,0.000003240166,0.00002929537,0.16738984],"study_design_scores_gemma":[0.026572773,0.0017590577,0.9667176,0.0013972193,0.000059436028,0.000008415608,0.0025000358,0.000334859,0.0000136604085,0.0000065436757,0.00046584007,0.00016454673],"about_ca_topic_score_codex":0.000074386866,"about_ca_topic_score_gemma":0.00018655116,"teacher_disagreement_score":0.1672253,"about_ca_system_score_codex":0.000033990644,"about_ca_system_score_gemma":0.000087547676,"threshold_uncertainty_score":0.42803046},"labels":[],"label_agreement":null},{"id":"W3023765813","doi":"10.1016/j.msard.2020.102078","title":"From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Hemiparesis; Lesion; Magnetic resonance imaging; Radiology; Pediatrics; Surgery; Psychiatry","score_opus":0.04924135507317509,"score_gpt":0.24627939858889356,"score_spread":0.19703804351571846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023765813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861531,0.0025566285,0.00010510374,0.0068645184,0.00036198314,0.0024122472,0.00086487643,0.00027061446,0.0004109112],"genre_scores_gemma":[0.98672247,0.009991343,0.0016365312,0.0008414781,0.00013847722,0.00020259627,0.00026270223,0.00012678682,0.00007761228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950763,0.00021506808,0.0012554952,0.0013134275,0.0011196021,0.0010200856],"domain_scores_gemma":[0.996783,0.0005403268,0.00035783963,0.0006378913,0.00047610648,0.0012048344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000248725,0.0007036181,0.0013425277,0.00025690784,0.00044918407,0.000095914256,0.00039525688,0.0003949103,0.00037033184],"category_scores_gemma":[0.0030607178,0.0006163617,0.000426372,0.0015029261,0.0006348583,0.00038784184,0.00064204336,0.00061628345,0.00013390595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030030352,0.0012019356,0.83986413,0.00031629344,0.0010450083,0.0000031028235,0.00980247,0.0002658626,0.07839782,0.000013862308,0.0064473753,0.059639115],"study_design_scores_gemma":[0.015807893,0.0012382509,0.9642572,0.0010374732,0.00026979335,4.758812e-7,0.0029630596,0.0029723803,0.0073724748,0.000023228693,0.0033740846,0.0006837295],"about_ca_topic_score_codex":0.0014008911,"about_ca_topic_score_gemma":0.00020842091,"teacher_disagreement_score":0.12439304,"about_ca_system_score_codex":0.000120900375,"about_ca_system_score_gemma":0.00009891326,"threshold_uncertainty_score":0.9996288},"labels":[],"label_agreement":null},{"id":"W3025106536","doi":"10.1016/j.msard.2020.102158","title":"Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Actelion Pharmaceuticals; Genentech; Bayer Schering; IC Design Education Center; Alkermes; Alexion Pharmaceuticals; Genzyme; Biogen Idec; Patient-Centered Outcomes Research Institute; Celgene; Bayer; Biogen; Bayer HealthCare; Sanofi; Almirall; MedDay Pharmaceuticals; Merck; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; EMD Serono; Novartis; Roche; Pfizer","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Tolerability; Adverse effect; Disease; Fingolimod; Intensive care medicine; Natalizumab; Internal medicine; Immunology","score_opus":0.0781052675865193,"score_gpt":0.3177968576131146,"score_spread":0.2396915900265953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025106536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009966596,0.9927264,0.00013044226,0.0005809003,0.00021255048,0.0044677276,0.0004037171,0.00014227131,0.00033936006],"genre_scores_gemma":[0.01609735,0.98144513,0.00083590404,0.00004428271,0.0000773003,0.00075930095,0.0003499237,0.00020335845,0.00018742206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962792,0.00014787875,0.0013263613,0.0009889748,0.00048711745,0.0007704704],"domain_scores_gemma":[0.99732304,0.0008291957,0.0006137025,0.00056548085,0.00015255273,0.00051603117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004145792,0.0008049853,0.0030685693,0.00041545424,0.00044637476,0.00007985421,0.00027192503,0.00048506245,0.000047529946],"category_scores_gemma":[0.0013780667,0.0005725946,0.0012479734,0.00061985763,0.0004891553,0.00019405907,0.00030633892,0.0007387372,0.000010205062],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065967406,0.00024862852,0.0009307135,0.0307321,0.0016053653,0.0000031636596,0.0007350184,0.000010334529,0.00011720327,0.000055258333,0.00047337014,0.9644292],"study_design_scores_gemma":[0.008396778,0.00075279217,0.0037814127,0.05170813,0.0033763456,0.00000696793,0.00060266186,0.0033992915,0.0000119524075,0.00024784554,0.9266013,0.001114506],"about_ca_topic_score_codex":0.00010103938,"about_ca_topic_score_gemma":0.000023232125,"teacher_disagreement_score":0.96331465,"about_ca_system_score_codex":0.00014836235,"about_ca_system_score_gemma":0.00031736246,"threshold_uncertainty_score":0.99967253},"labels":[],"label_agreement":null},{"id":"W3033837102","doi":"10.1016/j.msard.2020.102260","title":"Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; MEDLINE; Meta-analysis; Systematic review; Incidence (geometry); Disease; Data extraction; Multiple sclerosis; Pediatrics; Pathology; Immunology","score_opus":0.1753109828645792,"score_gpt":0.35202856237591224,"score_spread":0.17671757951133304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033837102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013258149,0.9896334,0.000023011708,0.0012621685,0.0000775955,0.007963006,0.00082775875,0.00013625497,0.00006357789],"genre_scores_gemma":[0.001499478,0.99482787,0.00063492387,0.00034401155,0.00005904813,0.0018029644,0.00046308912,0.00016297003,0.00020565304],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895707,0.002580435,0.004146872,0.0019868102,0.00072996516,0.0009852218],"domain_scores_gemma":[0.99011165,0.004989904,0.0023646175,0.0013361174,0.00039908488,0.00079860445],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0024347533,0.0015895267,0.022581529,0.0013559024,0.00033077013,0.00003742313,0.00047399962,0.0011974219,0.00014699713],"category_scores_gemma":[0.010144998,0.0009897732,0.0064479946,0.004847447,0.0006108413,0.0001727068,0.0006464118,0.001776863,0.000030845782],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029322344,0.0002495803,0.0015906754,0.75964856,0.22282904,0.000008885308,0.00027740898,0.000004001683,0.0000011281808,0.000013064995,0.0005695876,0.014778719],"study_design_scores_gemma":[0.0016449525,0.00025677716,0.0022890794,0.081303746,0.9040122,0.000029899604,0.000086999404,0.0003104404,2.02017e-7,0.00000861132,0.009184541,0.00087255024],"about_ca_topic_score_codex":0.000097245975,"about_ca_topic_score_gemma":0.0000618381,"teacher_disagreement_score":0.68118316,"about_ca_system_score_codex":0.000097774544,"about_ca_system_score_gemma":0.00016204659,"threshold_uncertainty_score":0.9996853},"labels":[],"label_agreement":null},{"id":"W3034107318","doi":"10.1016/j.msard.2020.102276","title":"Characteristics of COVID-19 disease in multiple sclerosis patients","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Immunosuppression; Disease; Coronavirus disease 2019 (COVID-19); Pandemic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.057502380615398065,"score_gpt":0.2742256895401938,"score_spread":0.21672330892479572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034107318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82741207,0.0019342683,0.000027879903,0.16576596,0.00059744384,0.002665353,0.0012042541,0.00019247386,0.00020032868],"genre_scores_gemma":[0.60207325,0.0010294592,0.000033617765,0.39574757,0.00015942291,0.00012260416,0.00068235095,0.00012086399,0.00003086394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563336,0.00024939448,0.0011664752,0.0011445567,0.0009822977,0.0008238948],"domain_scores_gemma":[0.9976958,0.0006416771,0.00044938078,0.0006797099,0.00017752525,0.00035588615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021279303,0.00068582414,0.0012695658,0.0006455082,0.0002144433,0.00006643162,0.00036432128,0.0010283514,0.000053675427],"category_scores_gemma":[0.0028671334,0.00062185107,0.00044993524,0.0008434472,0.0006129402,0.00012127561,0.00029461578,0.0022847329,0.00005659696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012545001,0.0007525299,0.9306267,0.002302846,0.00027926062,0.0001346514,0.00082404324,0.0000037865043,0.00092542544,0.000001378877,0.054702576,0.008192327],"study_design_scores_gemma":[0.01568427,0.00043141365,0.6428849,0.0014145414,0.00039462632,0.0000013437099,0.00011222166,0.0030632569,0.00017525493,0.000085417414,0.33485785,0.000894918],"about_ca_topic_score_codex":0.0018011108,"about_ca_topic_score_gemma":0.00012149315,"teacher_disagreement_score":0.28774178,"about_ca_system_score_codex":0.00025789137,"about_ca_system_score_gemma":0.0005323145,"threshold_uncertainty_score":0.9996233},"labels":[],"label_agreement":null},{"id":"W3035682087","doi":"10.1016/j.msard.2020.102283","title":"FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Fluid-attenuated inversion recovery; Medicine; Immunotherapy; Encephalitis; Hyperintensity; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Pathology; Immunology; Magnetic resonance imaging; Radiology; Immune system","score_opus":0.02941443017098383,"score_gpt":0.23175377045992404,"score_spread":0.2023393402889402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035682087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93770295,0.0020252094,0.00004046914,0.05850651,0.000074368094,0.001021363,0.000037114143,0.00012827391,0.0004637406],"genre_scores_gemma":[0.9844593,0.004355923,0.000051441966,0.010605754,0.00000778318,0.00008525304,0.00003619265,0.00005065323,0.0003477079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819654,0.0001105313,0.00040923053,0.00055268727,0.00026532184,0.00046569022],"domain_scores_gemma":[0.9992214,0.00012890405,0.00011036617,0.00028265038,0.00005482021,0.00020188303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009392014,0.00034484267,0.0005394424,0.00006537426,0.00031599108,0.00006422204,0.00015318044,0.00022132792,0.00015082506],"category_scores_gemma":[0.00018961926,0.00020314458,0.00015963477,0.00055154494,0.00022056726,0.00009754357,0.000080925136,0.0004278912,0.00003896862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068622343,0.005622257,0.59884894,0.00012870415,0.003216983,0.00043946004,0.06865026,0.0025050982,0.044577647,0.00015534087,0.013828996,0.2551641],"study_design_scores_gemma":[0.013615716,0.0019448331,0.9708899,0.0002557668,0.00014537033,0.000013392316,0.003969241,0.004697892,0.00028910013,0.00010020822,0.003641661,0.00043690094],"about_ca_topic_score_codex":0.001210705,"about_ca_topic_score_gemma":0.00019304985,"teacher_disagreement_score":0.372041,"about_ca_system_score_codex":0.000030038667,"about_ca_system_score_gemma":0.0000376084,"threshold_uncertainty_score":0.8283996},"labels":[],"label_agreement":null},{"id":"W3039192476","doi":"10.1016/j.msard.2020.102354","title":"Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Universität Zürich","keywords":"Multiple sclerosis; Medicine; Relapsing remitting; Status quo; Perception; Expanded Disability Status Scale; Sign (mathematics); Psychiatry; Psychology; Neuroscience","score_opus":0.053129104798496175,"score_gpt":0.2769729555080532,"score_spread":0.223843850709557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039192476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522775,0.0015936887,0.000074940406,0.0006688639,0.00010364181,0.0019107908,0.000114283954,0.00012678397,0.00017923013],"genre_scores_gemma":[0.98507,0.0128445,0.0016141557,0.00018937919,0.00002860091,0.00005869829,0.00009246017,0.00009457921,0.0000076278398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953709,0.0004618522,0.001579459,0.0008798731,0.0007898909,0.00091801066],"domain_scores_gemma":[0.997148,0.00093317433,0.0006060338,0.0004193321,0.0003856262,0.00050785625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006961531,0.0004945432,0.0012473696,0.00028971044,0.00018806139,0.000028738386,0.00018197337,0.0003749869,0.000062735446],"category_scores_gemma":[0.0013264361,0.00036241586,0.00029451796,0.0009946304,0.0006724667,0.00024999172,0.00019604989,0.00086973404,0.0000068272598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027309277,0.0017081423,0.89620876,0.000321035,0.0006217606,4.9095155e-7,0.0065280027,0.00020519373,0.011471584,0.0000031118996,0.00006732223,0.08013365],"study_design_scores_gemma":[0.02578318,0.0022605252,0.9514277,0.0013213047,0.00018018008,2.211463e-7,0.0061542587,0.012063381,0.0003184226,0.000008129458,0.00012492597,0.00035777088],"about_ca_topic_score_codex":0.00065111916,"about_ca_topic_score_gemma":0.00018024357,"teacher_disagreement_score":0.07977588,"about_ca_system_score_codex":0.00011882806,"about_ca_system_score_gemma":0.00016641246,"threshold_uncertainty_score":0.99988276},"labels":[],"label_agreement":null},{"id":"W3042093824","doi":"10.1016/j.msard.2020.102382","title":"Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Life Sciences Institute; Novartis Pharmaceuticals Canada; Eisai; Asahi Kasei Pharma Corporation; Genzyme; Takeda Pharmaceutical Company; Novartis; Teva Pharmaceutical Industries; Bayer; Biogen; Astellas Pharma; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Multiple sclerosis; Intrathecal; Immunology; Pediatrics; Anesthesia","score_opus":0.04270201954177836,"score_gpt":0.25925508698195204,"score_spread":0.2165530674401737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042093824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586,0.00014002182,0.000008838318,0.002007976,0.000038728987,0.001495238,0.00015567488,0.00009860771,0.00019494005],"genre_scores_gemma":[0.9985059,0.000925214,0.00019701099,0.00013289152,0.000023278104,0.00011373539,0.00003887974,0.000060140013,0.0000029308535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965695,0.0002929794,0.0007489968,0.0009645011,0.00072031765,0.0007036747],"domain_scores_gemma":[0.997535,0.001148427,0.00019566051,0.00046573475,0.00013770856,0.0005175018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028782254,0.00050358934,0.0010126568,0.00014757426,0.0001770725,0.000032601798,0.00020736156,0.00030132805,0.0001655093],"category_scores_gemma":[0.003365541,0.0003261135,0.00034514192,0.0008039521,0.0010138836,0.0001532717,0.0001941348,0.0007662008,0.000014989382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064567067,0.002728136,0.9488418,0.000100125595,0.00031232098,0.000001917385,0.0006025597,0.0007785908,0.0017494633,0.0000037785885,0.00009320848,0.03833138],"study_design_scores_gemma":[0.011744482,0.0041072797,0.97446847,0.00033082516,0.0000864759,3.5957206e-7,0.00015129175,0.008543343,0.00022467479,0.000006305529,0.000014078642,0.00032241482],"about_ca_topic_score_codex":0.0005353504,"about_ca_topic_score_gemma":0.00015354539,"teacher_disagreement_score":0.03800896,"about_ca_system_score_codex":0.00011049057,"about_ca_system_score_gemma":0.000053156567,"threshold_uncertainty_score":0.9999191},"labels":[],"label_agreement":null},{"id":"W3042866786","doi":"10.1016/j.msard.2020.102401","title":"The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"AbbVie; Sanofi Genzyme; Biogen Idec; Roche; Novartis","keywords":"Medicine; Family history; Blood pressure; Multiple sclerosis; Corticosteroid; Internal medicine; Immunology","score_opus":0.04704076254261353,"score_gpt":0.26115315599435457,"score_spread":0.21411239345174105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042866786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815817,0.005754997,0.000041427473,0.0038346178,0.0004203844,0.007963381,0.00010514455,0.00019615381,0.00010221628],"genre_scores_gemma":[0.98807824,0.009947865,0.00021244225,0.00026907484,0.00008146975,0.001066538,0.00003127192,0.00012449411,0.00018860913],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99586135,0.00033624566,0.0010067641,0.0010554299,0.0008795186,0.0008607097],"domain_scores_gemma":[0.99452573,0.0035181877,0.0003709148,0.00077362603,0.00028145275,0.0005300605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053079025,0.00058974966,0.0010301576,0.00015627682,0.0009460603,0.0000981151,0.00037104014,0.00018393295,0.000016270851],"category_scores_gemma":[0.007826972,0.0004004491,0.00029736548,0.0006347482,0.00062015,0.00013762918,0.00034318693,0.0006718096,0.000013911578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028930249,0.019851154,0.26861614,0.0030919993,0.01275547,0.000017899902,0.009729037,0.00063649146,0.54025406,0.00019973233,0.0054461816,0.11047159],"study_design_scores_gemma":[0.06964171,0.04114412,0.86511195,0.0010477896,0.002687102,0.0000020863552,0.0018239534,0.0070585166,0.009920158,0.00006190524,0.0008468833,0.0006538258],"about_ca_topic_score_codex":0.0004711268,"about_ca_topic_score_gemma":0.0002626259,"teacher_disagreement_score":0.5964958,"about_ca_system_score_codex":0.000029147093,"about_ca_system_score_gemma":0.00006567403,"threshold_uncertainty_score":0.99984473},"labels":[],"label_agreement":null},{"id":"W3044867607","doi":"10.1016/j.msard.2020.102418","title":"Functioning Profiles of Young People with MS in Inpatient Rehabilitation: Data from the National Rehabilitation Reporting System in Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rehabilitation; Functional Independence Measure; Medicine; Latent class model; Logistic regression; Young adult; Gerontology; Barthel index; Physical therapy; Physical medicine and rehabilitation","score_opus":0.029642577909029598,"score_gpt":0.22631381648668542,"score_spread":0.1966712385776558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044867607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243724,0.00028384707,0.00002631199,0.005862071,0.00007225152,0.00083330134,0.00005370434,0.000016939546,0.00041431066],"genre_scores_gemma":[0.99895114,0.00004300397,0.00045533327,0.00012935037,0.000011478079,0.000054058644,0.0003399561,0.000012566112,0.0000031215686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818426,0.00008713249,0.0008552356,0.00036435365,0.0003714203,0.00013758984],"domain_scores_gemma":[0.9986857,0.00056146487,0.0004370941,0.00018086626,0.000084077874,0.000050762657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044613786,0.000116024974,0.00026482806,0.000052284224,0.00008097095,0.000010922321,0.000076205135,0.00005223308,0.00002506235],"category_scores_gemma":[0.0020447297,0.00008251662,0.000027865335,0.000486774,0.000064878455,0.0001457322,0.000056107354,0.00018596604,4.7018412e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002452663,0.00006864496,0.9895572,0.00016326015,0.000040326086,4.3897126e-7,0.0051524793,0.0034697207,0.00023779125,0.00003734959,0.0002464489,0.00078103854],"study_design_scores_gemma":[0.0027578042,0.00017914736,0.92710894,0.0006197648,0.000027467564,6.4447755e-7,0.030943068,0.038180493,0.000009583827,0.000020556121,0.000061831706,0.00009069667],"about_ca_topic_score_codex":0.65452576,"about_ca_topic_score_gemma":0.90821236,"teacher_disagreement_score":0.25368664,"about_ca_system_score_codex":0.00016981579,"about_ca_system_score_gemma":0.0003229434,"threshold_uncertainty_score":0.3477748},"labels":[],"label_agreement":null},{"id":"W3045561006","doi":"10.1016/j.msard.2020.102429","title":"African Americans experience disproportionate neurodegenerative changes in the medulla and upper cervical spinal cord in early multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Spinal cord; Medulla; Multiple sclerosis; White matter; Expanded Disability Status Scale; Atrophy; Cord; Anatomy; Dorsum; Internal medicine; Pathology; Magnetic resonance imaging; Surgery; Radiology","score_opus":0.07829156025219836,"score_gpt":0.2939585029981723,"score_spread":0.21566694274597392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045561006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695432,0.0016674122,0.000026573329,0.02699085,0.000072363466,0.0013706279,0.00004152719,0.0000637833,0.0002236545],"genre_scores_gemma":[0.9859557,0.012011364,0.0003022554,0.0011519756,0.0000498975,0.00043692457,0.000023309336,0.000048156748,0.000020373342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668175,0.00033965937,0.00059077906,0.0009672714,0.0006721529,0.0007483735],"domain_scores_gemma":[0.99867165,0.00040299923,0.00015259095,0.00031324127,0.000086444204,0.00037309347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033401442,0.0004338956,0.00065856974,0.00024300822,0.00034420987,0.000100947975,0.00025401168,0.00017431515,0.000050382147],"category_scores_gemma":[0.0011572851,0.00030486047,0.000112146336,0.001234601,0.0010581759,0.00018445172,0.00027027764,0.00079721474,0.000008704332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001851194,0.000457907,0.89047915,0.00009821103,0.00008503606,0.000019843945,0.02778196,0.00006697929,0.02139647,0.000035949015,0.0001194981,0.057607826],"study_design_scores_gemma":[0.0047107814,0.0012623809,0.9667456,0.0002518769,0.000035016186,0.000004733316,0.015972728,0.0097323805,0.00044393778,0.0000147349565,0.00048453236,0.00034126415],"about_ca_topic_score_codex":0.002377896,"about_ca_topic_score_gemma":0.00305236,"teacher_disagreement_score":0.076266505,"about_ca_system_score_codex":0.00006297637,"about_ca_system_score_gemma":0.000044106913,"threshold_uncertainty_score":0.99994034},"labels":[],"label_agreement":null},{"id":"W3045636730","doi":"10.1016/j.msard.2020.102432","title":"The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Health Technology Assessment Programme; MicroResearch; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Multiple Sclerosis Society","keywords":"Medicine; Urinary system; Multiple sclerosis; Pediatrics; Medical record; Emergency department; Emergency medicine; Intensive care medicine; Internal medicine; Immunology","score_opus":0.032087401716870946,"score_gpt":0.25971834472882266,"score_spread":0.22763094301195172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045636730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346715,0.0009379488,0.00008857805,0.002363428,0.00007107554,0.0029117551,0.000030985055,0.000043323427,0.000085770254],"genre_scores_gemma":[0.9779909,0.021003768,0.0005725298,0.000027404129,0.000011636496,0.00027452037,0.0000473953,0.000033514454,0.00003829391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841535,0.0000681943,0.00042387279,0.00043357702,0.00031735093,0.00034163453],"domain_scores_gemma":[0.99905145,0.00025336703,0.00015950635,0.00018208892,0.00011014433,0.00024341745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021052516,0.00022622567,0.00033137595,0.00009520903,0.0003767241,0.000031701376,0.00006945662,0.000114111164,0.000009280975],"category_scores_gemma":[0.00039894294,0.00014891224,0.000109306886,0.00036211437,0.00021893154,0.00015523485,0.00012498593,0.00022466673,0.0000010682339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014175912,0.0016868337,0.9389346,0.0004166258,0.000331182,6.0439226e-7,0.00080891344,0.00007592095,0.00032222067,0.00001531061,0.00015018387,0.055839974],"study_design_scores_gemma":[0.014665071,0.0032451486,0.9760861,0.00083213544,0.00012669647,2.548292e-7,0.0006274346,0.0037145833,0.00008638221,0.000018448076,0.000421765,0.00017600071],"about_ca_topic_score_codex":0.0000982482,"about_ca_topic_score_gemma":0.00006933624,"teacher_disagreement_score":0.055663973,"about_ca_system_score_codex":0.000038635713,"about_ca_system_score_gemma":0.000024840709,"threshold_uncertainty_score":0.60724646},"labels":[],"label_agreement":null},{"id":"W3046717098","doi":"10.1016/j.msard.2020.102438","title":"Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Term (time); Tower; Extension (predicate logic); Physical medicine and rehabilitation; Physical therapy; Immunology; Fingolimod; Structural engineering","score_opus":0.03951284863092202,"score_gpt":0.25038511289518445,"score_spread":0.21087226426426242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046717098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287915,0.0015045494,0.00001788465,0.0023111836,0.00008930572,0.0028946951,0.00015956165,0.0000727309,0.00007095276],"genre_scores_gemma":[0.99524736,0.0040817843,0.00021013232,0.00017188888,0.00003158835,0.000034706474,0.00014220602,0.000064659434,0.00001569639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964222,0.00027963243,0.0010498962,0.0010403837,0.0006810055,0.00052688085],"domain_scores_gemma":[0.99735385,0.0012498816,0.00032134613,0.0005885961,0.00017947853,0.00030682827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048628703,0.0004509415,0.0008493598,0.00013577942,0.00038426224,0.00006422174,0.0002011477,0.0001940984,0.000026562257],"category_scores_gemma":[0.0023333905,0.0002851995,0.000116342606,0.0006112974,0.0005592367,0.00021249847,0.0004006274,0.0006627862,0.000004177611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015284239,0.0013852917,0.9346077,0.00004039835,0.00034010157,0.000004183645,0.008647786,0.00017727431,0.004398946,4.1025393e-7,0.000087028995,0.035026643],"study_design_scores_gemma":[0.059302,0.0013470608,0.9336271,0.0013952816,0.00018484963,3.5766885e-7,0.001996137,0.0017280999,0.00008229424,0.0000012431003,0.00003118517,0.00030435552],"about_ca_topic_score_codex":0.0012566167,"about_ca_topic_score_gemma":0.00089567027,"teacher_disagreement_score":0.04401776,"about_ca_system_score_codex":0.000062209896,"about_ca_system_score_gemma":0.00004411978,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W3048326791","doi":"10.1016/j.msard.2020.102446","title":"Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of Newcastle Australia; Multiple Sclerosis Australia","keywords":"Multiple sclerosis; Extracellular; Medicine; Extracellular vesicle; Immunology; Myelin; Central nervous system; Neutrophil extracellular traps; Pathology; Inflammation; Microvesicles; Internal medicine; Biology; Cell biology; Biochemistry","score_opus":0.032327830128448455,"score_gpt":0.23816828763479952,"score_spread":0.20584045750635108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048326791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856735,0.008371635,0.0009973798,0.0035962132,0.00006158062,0.00075298233,0.00048417583,0.000040002767,0.000022528076],"genre_scores_gemma":[0.99714017,0.0016381536,0.00047822372,0.00030185044,0.00005709884,0.000058981906,0.0002569485,0.00004580476,0.000022763328],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99811065,0.00014609753,0.00052513304,0.0006214074,0.00020226104,0.00039443313],"domain_scores_gemma":[0.9984629,0.00013221113,0.00017078262,0.00030844833,0.000071717084,0.0008538976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012472199,0.0002814898,0.00036474416,0.000041867243,0.0002302019,0.000052027655,0.00017358856,0.00016325747,0.000025054009],"category_scores_gemma":[0.0004025286,0.00027937265,0.0001293721,0.00017230169,0.00038099696,0.000017856639,0.00014925613,0.00013726058,0.0000063439475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085207145,0.00026960808,0.3536274,0.000083286744,0.00019184616,0.0000014795854,0.0004882919,0.0010378977,0.6384995,0.000058275913,0.0005341626,0.0043561435],"study_design_scores_gemma":[0.012457572,0.0007196258,0.84593284,0.00019392748,0.00042856424,8.589665e-7,0.0011447535,0.025923055,0.10895441,0.000073972995,0.0033107777,0.00085964863],"about_ca_topic_score_codex":0.000053573058,"about_ca_topic_score_gemma":0.000054792432,"teacher_disagreement_score":0.5295451,"about_ca_system_score_codex":0.000009177345,"about_ca_system_score_gemma":0.00005484548,"threshold_uncertainty_score":0.99996585},"labels":[],"label_agreement":null},{"id":"W3055474239","doi":"10.1016/j.msard.2020.102456","title":"Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba","funders":"","keywords":"Optic neuritis; Medicine; Multiple sclerosis; Optic nerve; Blurred vision; Visual acuity; Visual field; Ophthalmology; Magnetic resonance imaging; Myelin oligodendrocyte glycoprotein; Radiology; Immunology","score_opus":0.04149403892279723,"score_gpt":0.26275226853954425,"score_spread":0.22125822961674702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3055474239","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15993221,0.028395304,0.00008972226,0.7934668,0.0010267843,0.010995748,0.0012487372,0.0007797239,0.0040649613],"genre_scores_gemma":[0.8340105,0.12300449,0.002401762,0.031864244,0.0012956524,0.0011853897,0.002245014,0.0005076528,0.0034852952],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516475,0.00032524057,0.0011641955,0.0013097761,0.0010476003,0.0009884629],"domain_scores_gemma":[0.99783874,0.0003521713,0.00048646412,0.0007751041,0.00019742934,0.00035010107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000181606,0.0009132033,0.001800343,0.00044892327,0.00037608904,0.00006509119,0.00025525026,0.0012554525,0.00017876308],"category_scores_gemma":[0.0005968688,0.0007502593,0.00058126607,0.00053750194,0.0008368757,0.00012318329,0.00025747597,0.0021230478,0.00007979912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004835994,0.002301402,0.023640405,0.0073812115,0.010359386,0.001001684,0.006074686,0.0005190351,0.047456242,0.000023750092,0.7140086,0.18239759],"study_design_scores_gemma":[0.060645144,0.010651106,0.08494813,0.010096917,0.0041242386,0.00019519184,0.0013227317,0.046310335,0.0064154575,0.00013808033,0.77122283,0.00392984],"about_ca_topic_score_codex":0.001992401,"about_ca_topic_score_gemma":0.000163108,"teacher_disagreement_score":0.7616026,"about_ca_system_score_codex":0.00029828725,"about_ca_system_score_gemma":0.0001894668,"threshold_uncertainty_score":0.99949485},"labels":[],"label_agreement":null},{"id":"W3083641055","doi":"10.1016/j.msard.2020.102488","title":"Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Multiple sclerosis; Brain biopsy; Lymphoma; Biopsy; Cyclophosphamide; Pseudotumor cerebri; Presentation (obstetrics); Pathology; Stereotactic biopsy; Radiology; Chemotherapy; Internal medicine; Immunology; Intracranial pressure","score_opus":0.027886593350609862,"score_gpt":0.21407756233865427,"score_spread":0.1861909689880444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083641055","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24463677,0.011070655,0.000022623432,0.7366778,0.0010556888,0.0033365458,0.00047602312,0.00034680875,0.0023770384],"genre_scores_gemma":[0.8719944,0.020909108,0.00027644567,0.1048463,0.0003463862,0.00033115456,0.0006133973,0.00024766184,0.00043515576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955985,0.00024325952,0.0012092721,0.0012507482,0.0008605106,0.00083773327],"domain_scores_gemma":[0.9968124,0.0010777069,0.00066430395,0.0010022683,0.00013142185,0.00031190558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021346175,0.0009809987,0.0015648385,0.00031094206,0.000550509,0.00013368827,0.00037994012,0.0011856549,0.000389121],"category_scores_gemma":[0.00038426943,0.00067638024,0.0009594043,0.0007052727,0.0005633516,0.00011851201,0.0002962842,0.0012187291,0.00010929065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082241563,0.002035355,0.13887243,0.0017060001,0.008628407,0.0007132328,0.0039176187,0.0001043614,0.003450542,0.000120146666,0.71804374,0.12158572],"study_design_scores_gemma":[0.044383187,0.0021180657,0.4411499,0.0094685955,0.009129301,0.00060524995,0.0019509034,0.010775738,0.0037334727,0.00072333176,0.47253785,0.0034244077],"about_ca_topic_score_codex":0.0029647595,"about_ca_topic_score_gemma":0.00006583522,"teacher_disagreement_score":0.6318315,"about_ca_system_score_codex":0.0002516925,"about_ca_system_score_gemma":0.00020912159,"threshold_uncertainty_score":0.99956876},"labels":[],"label_agreement":null},{"id":"W3087826157","doi":"10.1016/j.msard.2020.102526","title":"Anemia and sarcoidosis following treatment with alemtuzumab","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Autoimmune hemolytic anemia; Anemia; Adverse effect; Natalizumab; Internal medicine; Dermatology; Immunology","score_opus":0.03810727548125019,"score_gpt":0.2572866105682099,"score_spread":0.2191793350869597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087826157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198014,0.005451098,0.000033324122,0.009768668,0.00004446595,0.00095465325,0.000020128775,0.00016533528,0.001582204],"genre_scores_gemma":[0.980328,0.018230734,0.0008059252,0.0002884858,0.000033182125,0.000085697095,0.000030409157,0.000053471544,0.00014406958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981524,0.000060444465,0.000302501,0.0006523199,0.0003534779,0.00047890868],"domain_scores_gemma":[0.9989778,0.00017761589,0.00007004908,0.00021520468,0.00004277846,0.000516552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009433151,0.00035278362,0.00055176235,0.00009665381,0.00037559352,0.000060165174,0.00006252908,0.00014638089,0.00004828943],"category_scores_gemma":[0.00016651461,0.0002385312,0.00014773454,0.0003481502,0.00029101674,0.00012941146,0.00009804468,0.0002516733,0.000014843917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013168212,0.0004557477,0.65276814,0.00026203663,0.0015849123,0.000045942725,0.007686441,0.00006249119,0.03992579,0.000023286597,0.0005718844,0.2952965],"study_design_scores_gemma":[0.03744305,0.0055914996,0.9263209,0.0006515156,0.000838176,0.000026174816,0.005042151,0.012208056,0.0019091412,0.000020164596,0.009074692,0.00087446655],"about_ca_topic_score_codex":0.00037691253,"about_ca_topic_score_gemma":0.0001384669,"teacher_disagreement_score":0.29442203,"about_ca_system_score_codex":0.000074058895,"about_ca_system_score_gemma":0.000051528204,"threshold_uncertainty_score":0.97270197},"labels":[],"label_agreement":null},{"id":"W3088332612","doi":"10.1016/j.msard.2020.102492","title":"Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Teva Pharmaceutical Industries; Bayer; Celgene; Biogen; Sanofi Genzyme; F. Hoffmann-La Roche; Agence Nationale de la Recherche; Roche; PTC Therapeutics; UCB","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Randomized controlled trial; Anesthesia; Clinical endpoint; Volunteer; Surgery; Internal medicine","score_opus":0.0457979791972268,"score_gpt":0.24637228151121252,"score_spread":0.2005743023139857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088332612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897172,0.0014948453,0.000050132407,0.0030005926,0.00011192797,0.004709057,0.00015325373,0.00011833964,0.0006446541],"genre_scores_gemma":[0.995083,0.0033953183,0.00049348053,0.00024462285,0.000051520314,0.00015862189,0.00041654165,0.00010154851,0.00005534305],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99481094,0.00047399045,0.0016497872,0.001130707,0.001162497,0.0007721],"domain_scores_gemma":[0.99527526,0.002742841,0.0005850561,0.000678312,0.0003473676,0.00037118464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011179461,0.0006179063,0.00163585,0.00022685314,0.00047279685,0.0000871711,0.0003382125,0.00036282552,0.00008259455],"category_scores_gemma":[0.003035921,0.00038485046,0.00034220095,0.0010949287,0.00087185507,0.0002706978,0.00043752682,0.0009842779,0.00003243704],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.512472,0.0008962873,0.4513496,0.00008793464,0.0010532378,0.0000030431243,0.01632292,0.0014840808,0.004864148,0.0000032212915,0.00083819526,0.010625366],"study_design_scores_gemma":[0.48706976,0.00044487842,0.48815447,0.0012785611,0.00024931272,3.1601678e-7,0.0013152417,0.020631863,0.00043774827,0.0000061595397,0.000054289336,0.0003574169],"about_ca_topic_score_codex":0.00310218,"about_ca_topic_score_gemma":0.0006636749,"teacher_disagreement_score":0.03680487,"about_ca_system_score_codex":0.00012352943,"about_ca_system_score_gemma":0.000107716594,"threshold_uncertainty_score":0.99986035},"labels":[],"label_agreement":null},{"id":"W3088933202","doi":"10.1016/j.msard.2020.102525","title":"The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Feeling; Multiple sclerosis; Anxiety; Mental health; Psychopathology; Clinical psychology; Psychology; Depression (economics); Psychiatry; Medicine; Social psychology","score_opus":0.06091234496272073,"score_gpt":0.2599911727729702,"score_spread":0.19907882781024944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088933202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829925,0.0034853015,0.000009188138,0.0069078,0.000084668936,0.0009551694,0.00007012501,0.000033772816,0.0001547447],"genre_scores_gemma":[0.9937933,0.005549089,0.00018003781,0.00025076847,0.000007529613,0.000026866664,0.00013658263,0.000028397135,0.00002744463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984701,0.00010004073,0.0005662444,0.00033881702,0.00022599865,0.00029877797],"domain_scores_gemma":[0.99877584,0.00049460406,0.00019936611,0.00018918002,0.000024910018,0.00031608736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013983491,0.00020974404,0.00038511903,0.00008073647,0.00041961978,0.000021231583,0.00007126069,0.00012019348,0.0000063569746],"category_scores_gemma":[0.0004165529,0.0001331046,0.00008691919,0.0003529637,0.0002520345,0.000087946326,0.00007140388,0.00022158667,0.000005802638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018165294,0.00029460157,0.98285556,0.000060911956,0.00010932702,1.3706436e-7,0.0038854482,0.0000052358596,0.000042455766,0.000039606242,0.00028636525,0.012238691],"study_design_scores_gemma":[0.010480921,0.0004831226,0.98462796,0.0010170394,0.000032969227,3.5193145e-7,0.0017530309,0.0009549263,0.000012524976,0.0002493147,0.0002545673,0.00013329259],"about_ca_topic_score_codex":0.0002895687,"about_ca_topic_score_gemma":0.00012628874,"teacher_disagreement_score":0.012105398,"about_ca_system_score_codex":0.000032918782,"about_ca_system_score_gemma":0.00003763319,"threshold_uncertainty_score":0.5427848},"labels":[],"label_agreement":null},{"id":"W3089633237","doi":"10.1016/j.msard.2020.102555","title":"Does age at diagnosis influence the use of health services for multiple sclerosis?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.09078395452362052,"score_gpt":0.28712956418233837,"score_spread":0.19634560965871783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089633237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653293,0.0037080988,0.00007160261,0.026627874,0.0001676311,0.0035200822,0.00038812563,0.00016390099,0.000023390721],"genre_scores_gemma":[0.9594301,0.0362677,0.0010900666,0.00223357,0.000047210597,0.00062890287,0.00011153111,0.00008069615,0.00011023682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639046,0.00025208527,0.00104714,0.00085571816,0.0006361458,0.0008184696],"domain_scores_gemma":[0.99625766,0.0019819227,0.00047306909,0.0005734443,0.00025012848,0.00046379364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048850855,0.00047103968,0.00097055826,0.00013183459,0.00097576855,0.00010311319,0.00032322571,0.00022992956,0.00005364189],"category_scores_gemma":[0.0015718663,0.00025747402,0.0003854254,0.0006191223,0.0007941264,0.00032799423,0.00049343205,0.00039994647,0.000013351564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012369734,0.00060417247,0.8738961,0.002271309,0.00087301136,0.0000018263371,0.011967011,0.0019687111,0.030021818,0.000022345537,0.0033002237,0.07383647],"study_design_scores_gemma":[0.008524226,0.00070945057,0.93887514,0.0013953435,0.00016069254,9.3907863e-7,0.002111769,0.01602735,0.0022441968,0.000023017266,0.029526474,0.00040140946],"about_ca_topic_score_codex":0.0021199463,"about_ca_topic_score_gemma":0.001717882,"teacher_disagreement_score":0.07343506,"about_ca_system_score_codex":0.00009651109,"about_ca_system_score_gemma":0.00006782809,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W3092309860","doi":"10.1016/j.msard.2020.102566","title":"Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Chrest Foundation","keywords":"Medicine; Dimethyl fumarate; Internal medicine; Adverse effect; Discontinuation; Nausea; Placebo; Randomized controlled trial; Relative risk; Meta-analysis; Confidence interval; Observational study; Cochrane Library; Multiple sclerosis; Gastroenterology; Pathology; Immunology","score_opus":0.1500865941086234,"score_gpt":0.3385283172169947,"score_spread":0.18844172310837132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092309860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000059094427,0.97980094,0.00013066734,0.0010849672,0.00006169786,0.016873829,0.0018156833,0.00012805237,0.000098232376],"genre_scores_gemma":[0.0012713651,0.992329,0.0008527727,0.0002173594,0.000021503232,0.0041765138,0.000549718,0.00020366782,0.00037811795],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99151963,0.0010655038,0.0038011447,0.001815856,0.0008921238,0.00090575207],"domain_scores_gemma":[0.9922149,0.003365001,0.0019969516,0.0012914574,0.0004519476,0.00067973504],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019357051,0.0015203031,0.020543234,0.000848827,0.00046839347,0.00008974643,0.000460819,0.000776445,0.0001541485],"category_scores_gemma":[0.0051290756,0.0009837607,0.0070264814,0.0026139414,0.0006779301,0.00016965446,0.0005274185,0.00096676283,0.000020058273],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008492759,0.00022262528,0.00002821676,0.68836623,0.28496173,0.0000015358506,0.00019779937,0.00000552888,0.000010351875,0.000010485446,0.00028921606,0.025821336],"study_design_scores_gemma":[0.0029899871,0.00031689068,0.00016920887,0.09467106,0.8722025,0.000007395336,0.00014647089,0.000770451,0.0000024049514,0.000007151419,0.027834166,0.00088230567],"about_ca_topic_score_codex":0.00017585371,"about_ca_topic_score_gemma":0.0001229367,"teacher_disagreement_score":0.59369516,"about_ca_system_score_codex":0.00013097041,"about_ca_system_score_gemma":0.0001907453,"threshold_uncertainty_score":0.99975455},"labels":[],"label_agreement":null},{"id":"W3093167267","doi":"10.1016/j.msard.2020.102579","title":"Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Seventh Framework Programme; Schweizerische Multiple Sklerose Gesellschaft; Shire; Guthy-Jackson Charitable Foundation; Arthur Arnstein Stiftung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; MedImmune; Deutsche Forschungsgemeinschaft; Universität Basel; Novartis; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Bayer; Biogen; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Neuropathic pain; Spinal cord; Neuromyelitis optica; Multiple sclerosis; Lesion; Intensity (physics); Spinothalamic tract; Anesthesia; Internal medicine; Pathology; Nociception; Immunology; Psychiatry","score_opus":0.01542098351110319,"score_gpt":0.1935555819865361,"score_spread":0.17813459847543292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093167267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794113,0.00031621798,0.00016636089,0.018929698,0.000102826634,0.00069089426,0.00003594434,0.00014865318,0.00019809122],"genre_scores_gemma":[0.9964194,0.0007848313,0.0001312629,0.0024163395,0.000014404165,0.000020034506,0.000064983295,0.00006877483,0.00007996756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997991,0.00023231245,0.00036483278,0.00062221714,0.00025799478,0.00053160015],"domain_scores_gemma":[0.9991978,0.000108001164,0.00011926809,0.0002072166,0.00002751735,0.00034024174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003237123,0.00034274338,0.00052994373,0.000095877636,0.00016054738,0.00004712733,0.0000889626,0.00019685758,0.000112488386],"category_scores_gemma":[0.0004140189,0.00027828745,0.00013776228,0.00045761984,0.00015141846,0.00010543909,0.000070252245,0.00048441667,0.000025794589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014337862,0.0011410434,0.95215154,0.00010227694,0.00051769527,0.00031102225,0.004526164,0.00014350703,0.0036705558,0.000034053246,0.00023088978,0.035737466],"study_design_scores_gemma":[0.009282796,0.0021703166,0.918546,0.00037186415,0.00019107248,0.000018765615,0.00059978425,0.067819975,0.00010971209,0.00017891405,0.00031793496,0.00039283044],"about_ca_topic_score_codex":0.0004704608,"about_ca_topic_score_gemma":0.00030868457,"teacher_disagreement_score":0.06767647,"about_ca_system_score_codex":0.000057249064,"about_ca_system_score_gemma":0.000038763894,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W3104936044","doi":"10.1016/j.msard.2020.102621","title":"Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jordan University of Science and Technology","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Cognition; Internal medicine; Montreal Cognitive Assessment; Neurology; Physical therapy; Cohort; Correlation; Disease; Cognitive impairment; Immunology; Psychiatry","score_opus":0.06140002202102085,"score_gpt":0.25031624152786947,"score_spread":0.18891621950684861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104936044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304324,0.0011627781,0.00011626538,0.0015866853,0.00023745441,0.002626634,0.0006140467,0.00029004307,0.00032281975],"genre_scores_gemma":[0.9959378,0.0023939125,0.00022581304,0.0006906905,0.000056732613,0.00025735493,0.00020531523,0.0001530904,0.00007927995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522966,0.00023554004,0.00096258573,0.00140731,0.001008111,0.0011567629],"domain_scores_gemma":[0.99745935,0.00067025464,0.00033593335,0.0003520687,0.00040333407,0.00077906175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024052268,0.0008046389,0.0010999691,0.00041242945,0.0006468396,0.00014881804,0.00021217337,0.00035692312,0.00026477285],"category_scores_gemma":[0.0016505346,0.0006380751,0.00027553077,0.0013593346,0.0008495415,0.00054903404,0.00031528325,0.0010877531,0.000093114206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032897114,0.000867333,0.93174314,0.00024787104,0.0006011307,0.00000816212,0.0030513252,0.00016386103,0.0047903107,0.0000041070966,0.00021246,0.055020608],"study_design_scores_gemma":[0.028245134,0.0017145581,0.95663476,0.0017037846,0.00023954592,0.0000021429255,0.0015968087,0.008101056,0.0008733577,0.00001628975,0.00013927037,0.000733287],"about_ca_topic_score_codex":0.00093943713,"about_ca_topic_score_gemma":0.0015782521,"teacher_disagreement_score":0.054287322,"about_ca_system_score_codex":0.00019172959,"about_ca_system_score_gemma":0.00014196645,"threshold_uncertainty_score":0.999607},"labels":[],"label_agreement":null},{"id":"W3112161524","doi":"10.1016/j.msard.2020.102673","title":"Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Celgene; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Numerical digit; Test (biology); Symbol (formal); Modalities; Multiple sclerosis; Audiology; Dermatology; Arithmetic; Psychiatry; Mathematics","score_opus":0.02851786071263102,"score_gpt":0.25636851520807774,"score_spread":0.22785065449544673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112161524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150854,0.00096717244,0.000003479618,0.001937307,0.00006812876,0.00094072934,0.000025314635,0.00008886896,0.00446044],"genre_scores_gemma":[0.99196386,0.0076559135,0.000042053205,0.00009759498,0.00002796024,0.0000631071,0.000019381288,0.000045993835,0.00008414283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979291,0.00012158806,0.00053087634,0.0005011752,0.0004558276,0.0004614166],"domain_scores_gemma":[0.9983602,0.0009982575,0.00011891253,0.00024330449,0.00005483029,0.00022450149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032348235,0.00031481218,0.0006801064,0.00019762511,0.00015629861,0.000027270782,0.00011727703,0.00018304754,0.000047791706],"category_scores_gemma":[0.001856355,0.00023883935,0.00014808227,0.00052965735,0.0003389236,0.00015390845,0.0001267402,0.0005394303,0.000021238537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020472452,0.00041390723,0.86841774,0.0012169732,0.00018102495,0.000004606646,0.0035431425,0.0008822998,0.030850053,0.000016395263,0.00017688143,0.09224976],"study_design_scores_gemma":[0.014728241,0.006353605,0.9143917,0.0024232347,0.00008942112,0.000002398157,0.00090959755,0.04593159,0.01445617,0.00001009666,0.000305953,0.00039800224],"about_ca_topic_score_codex":0.0001451862,"about_ca_topic_score_gemma":0.00002492541,"teacher_disagreement_score":0.091851756,"about_ca_system_score_codex":0.0000568806,"about_ca_system_score_gemma":0.000031344633,"threshold_uncertainty_score":0.97395855},"labels":[],"label_agreement":null},{"id":"W3120661261","doi":"10.1016/j.msard.2021.102740","title":"Predicting falls and injuries in people with multiple sclerosis using machine learning algorithms","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Machine learning; Decision tree; Medicine; Artificial intelligence; Algorithm; Falling (accident); Confusion; Multiple sclerosis; Recall; Scale (ratio); Expanded Disability Status Scale; Computer science; Psychology; Psychiatry; Cognitive psychology","score_opus":0.029015828797109244,"score_gpt":0.2763994065536786,"score_spread":0.24738357775656938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120661261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942312,0.003923573,0.00021943031,0.00028123998,0.00026093,0.0006008402,0.000042367155,0.00013841555,0.00030199],"genre_scores_gemma":[0.98968136,0.007845769,0.001800266,0.00008998182,0.000038625825,0.00006743934,0.00011859396,0.00006159139,0.00029637828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736756,0.0005338338,0.00062949635,0.00061259116,0.00023130914,0.0006252284],"domain_scores_gemma":[0.9987763,0.00047416438,0.00028331575,0.00020308683,0.00009980675,0.00016332918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053623243,0.00029965254,0.0004714084,0.00016119916,0.0012718984,0.00005184894,0.00008105646,0.00037387788,0.00002503927],"category_scores_gemma":[0.00031931925,0.00026265683,0.00006758035,0.0005934302,0.00014876561,0.00032194846,0.0002032353,0.0010613804,0.00000644851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009362486,0.0002335495,0.9684925,0.00016846767,0.00007734664,0.0000018893596,0.006559449,0.00016565944,0.015496044,0.000016178403,0.0000084136345,0.008686886],"study_design_scores_gemma":[0.0059620333,0.00008381408,0.87021565,0.0013285084,0.00006189736,0.0000029673415,0.009877906,0.111899205,0.000034325712,0.000055498032,0.00016925267,0.00030893317],"about_ca_topic_score_codex":0.005228207,"about_ca_topic_score_gemma":0.021145731,"teacher_disagreement_score":0.11173354,"about_ca_system_score_codex":0.000074666044,"about_ca_system_score_gemma":0.00009743632,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W3124448270","doi":"10.1016/j.msard.2021.102770","title":"Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Parkwood Institute; Ontario Shores Centre for Mental Health Sciences; London Health Sciences Centre; Lawson Health Research Institute","funders":"Lawson Health Research Institute","keywords":"Working memory training; Training (meteorology); Cognitive training; Working memory; Medicine; Cognition; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.11161438053650526,"score_gpt":0.3095001542378981,"score_spread":0.19788577370139288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124448270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916621,0.0015075145,0.00005856743,0.0011157189,0.0002856669,0.0039114915,0.000014011846,0.00019624953,0.001248694],"genre_scores_gemma":[0.99700207,0.0008321048,0.00094466034,0.00011149828,0.00010923214,0.0006468818,0.000034982313,0.00010805343,0.00021050838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957291,0.00055308605,0.00071517593,0.0011068367,0.0008127161,0.0010830828],"domain_scores_gemma":[0.9978998,0.0009626906,0.00027054286,0.0003900626,0.00021603146,0.00026089075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011092365,0.0005374321,0.00086121395,0.00030900555,0.0011569499,0.00023265908,0.00016533886,0.00015307996,0.000055918903],"category_scores_gemma":[0.00096563157,0.0003086451,0.00018056534,0.0013179897,0.0007603194,0.00019217019,0.00024693963,0.0012667842,0.0000020755058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016341317,0.0035668225,0.36481398,0.00016270543,0.0022286084,0.00014568602,0.10981915,0.00032334134,0.030954173,0.0000030744031,0.0000095134765,0.48633882],"study_design_scores_gemma":[0.017950632,0.0015170597,0.53620404,0.00316221,0.00054532953,0.000027155085,0.42593682,0.013909342,0.00017162407,0.0000088778315,0.000040538253,0.0005263644],"about_ca_topic_score_codex":0.0008996194,"about_ca_topic_score_gemma":0.0071311886,"teacher_disagreement_score":0.48581246,"about_ca_system_score_codex":0.00015079996,"about_ca_system_score_gemma":0.00027463093,"threshold_uncertainty_score":0.9999366},"labels":[],"label_agreement":null},{"id":"W3124748247","doi":"10.1016/j.msard.2021.102790","title":"MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Merck KGaA","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Multiple sclerosis; Gastroenterology; Immunology","score_opus":0.04136060337065636,"score_gpt":0.3052844282943865,"score_spread":0.2639238249237301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124748247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474144,0.0016942703,0.000005331516,0.0010000042,0.00010687825,0.0020933615,0.0001506335,0.00011556096,0.00009250805],"genre_scores_gemma":[0.9898174,0.0094315205,0.00007483076,0.00003905267,0.000022561006,0.00014060624,0.00032076202,0.00006297186,0.00009032216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615705,0.00045852282,0.00071872835,0.0011861974,0.00066983054,0.00080964493],"domain_scores_gemma":[0.9974417,0.00051611854,0.00019221626,0.0007506943,0.00022608937,0.0008731629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031866968,0.00047771103,0.0008638781,0.00012303426,0.0002594967,0.0000909526,0.00012936359,0.0002889906,0.0000707555],"category_scores_gemma":[0.0011247421,0.00034310328,0.00015501112,0.00045126415,0.0014757033,0.00022131119,0.00045145708,0.0007891148,0.0000033100719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012702279,0.0033456616,0.85381794,0.00037033262,0.00027917352,0.000065302105,0.00029413067,0.0000048953934,0.00028213527,0.0000012289751,0.00003224056,0.12880471],"study_design_scores_gemma":[0.02367807,0.0033629022,0.96972173,0.0015538695,0.00023872241,0.0000046152145,0.00015749577,0.0007837826,0.0001093482,0.0000065336185,0.000023433284,0.000359499],"about_ca_topic_score_codex":0.00021242938,"about_ca_topic_score_gemma":0.0015709294,"teacher_disagreement_score":0.12844521,"about_ca_system_score_codex":0.00015138675,"about_ca_system_score_gemma":0.00013169233,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W3125090708","doi":"10.1016/j.msard.2021.102795","title":"Physical Activity in Youth with Multiple Sclerosis receiving the ATOMIC intervention: Social connectedness above all else","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University; Hospital for Sick Children","funders":"","keywords":"Social connectedness; Medicine; Intervention (counseling); Social cognitive theory; Multiple sclerosis; Coaching; Population; Physical activity; Conversation; Physical therapy; Psychology; Developmental psychology; Psychiatry; Psychotherapist","score_opus":0.055066123820854754,"score_gpt":0.2850375983763357,"score_spread":0.22997147455548095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125090708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926618,0.00090853934,0.0000565151,0.004405289,0.00018255769,0.0010682949,0.00010274411,0.00014113045,0.000473151],"genre_scores_gemma":[0.9962179,0.0029349304,0.000091055,0.00012625523,0.00009829168,0.0001657463,0.00010025081,0.00008473254,0.00018080864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652517,0.0005104149,0.00047590252,0.00095711014,0.00067976007,0.00085163664],"domain_scores_gemma":[0.9980538,0.0007564068,0.00022212228,0.00048897084,0.00024847433,0.00023024176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005206632,0.0005000846,0.0008342209,0.00018441203,0.0006680802,0.00014855042,0.00021341575,0.00027232425,0.00007357616],"category_scores_gemma":[0.00087197026,0.0003476232,0.00037330884,0.0010308905,0.0007358036,0.00028988384,0.00036385452,0.0011062148,0.000018034276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004243712,0.007503131,0.5467361,0.00056351465,0.0027073766,0.000052690946,0.05117538,0.00038034987,0.114513904,0.00009592927,0.0006393916,0.2713885],"study_design_scores_gemma":[0.015710384,0.00024110705,0.95305693,0.0010453621,0.00026026898,0.000008658739,0.013007428,0.011634902,0.0043484825,0.000035821027,0.0001591854,0.0004914752],"about_ca_topic_score_codex":0.0014192003,"about_ca_topic_score_gemma":0.0045364257,"teacher_disagreement_score":0.4063208,"about_ca_system_score_codex":0.00021411077,"about_ca_system_score_gemma":0.000113153124,"threshold_uncertainty_score":0.9998976},"labels":[],"label_agreement":null},{"id":"W3127226135","doi":"10.1016/j.msard.2021.102800","title":"COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Neuromyelitis optica; Multiple sclerosis; Demyelinating disease; Rituximab; Pandemic; Disease; Coronavirus disease 2019 (COVID-19); Demyelinating Disorder; Natalizumab; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Infectious disease (medical specialty); Antibody","score_opus":0.044586138807301445,"score_gpt":0.29848279129229943,"score_spread":0.253896652484998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127226135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001216056,0.990162,0.000004230089,0.0003820636,0.00007982735,0.007860877,0.00022706248,0.00005336225,0.00001450646],"genre_scores_gemma":[0.05252888,0.9463917,0.000031459695,0.00012260485,0.0000117696845,0.0006732141,0.00014008417,0.000080109174,0.000020150683],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953355,0.0010803358,0.0014332336,0.00077000447,0.000806753,0.00057415885],"domain_scores_gemma":[0.99653184,0.0009817459,0.00086383923,0.00069818983,0.00016094866,0.0007634616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047658518,0.00065654574,0.003704685,0.00023439518,0.00037107983,0.000055681154,0.00024027325,0.00021125763,0.000011896058],"category_scores_gemma":[0.0065975906,0.00034492114,0.000560479,0.00091317104,0.00048202465,0.000091150796,0.00034563852,0.0005497392,8.111665e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004003388,0.00025074297,0.052337706,0.9089077,0.0009700631,0.0000054400416,0.00033907275,0.000007904736,1.3608972e-7,0.000015161737,0.00004553978,0.0370805],"study_design_scores_gemma":[0.003118561,0.00007642435,0.09577359,0.8922987,0.0066361837,0.000005405528,0.00066109834,0.00017426099,2.052299e-8,0.0000022472375,0.0008520474,0.00040148594],"about_ca_topic_score_codex":0.00019321035,"about_ca_topic_score_gemma":0.00006702865,"teacher_disagreement_score":0.051312827,"about_ca_system_score_codex":0.00033039227,"about_ca_system_score_gemma":0.0006592584,"threshold_uncertainty_score":0.9999003},"labels":[],"label_agreement":null},{"id":"W3127586358","doi":"10.1016/j.msard.2021.102809","title":"Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hotchkiss Brain Institute; University of Alberta; University of Calgary","funders":"Government of Alberta","keywords":"Medicine; Multiple sclerosis; Peripheral; Biomarker; Clinically isolated syndrome; Biomarker discovery; Pathology; Immunology; Internal medicine; Proteomics","score_opus":0.040716207046802504,"score_gpt":0.28157708864407954,"score_spread":0.24086088159727703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127586358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013716,0.0059379204,0.0001637912,0.0017624936,0.00019566277,0.0011092762,0.00008909507,0.00019718354,0.00040742412],"genre_scores_gemma":[0.9760832,0.021283487,0.0016320705,0.00018608882,0.000022330907,0.00014473501,0.00014238502,0.00010320698,0.00040250522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99422026,0.0004851625,0.0016158342,0.0016951717,0.00077253376,0.0012110367],"domain_scores_gemma":[0.9969076,0.0009493535,0.00026128348,0.00081038475,0.00034268064,0.00072871987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091116136,0.000717294,0.0017047971,0.00090337184,0.0005310367,0.00020973253,0.00021381301,0.0006997259,0.00034757864],"category_scores_gemma":[0.0018411491,0.0006451373,0.0006590183,0.0030835893,0.0008543906,0.0003622504,0.00052679697,0.0009783572,0.000025094374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013245937,0.0010567878,0.92411286,0.00012691581,0.003012093,0.000098351346,0.0015268398,0.0002888978,0.03677526,0.0000055620167,0.00009668072,0.031575177],"study_design_scores_gemma":[0.013803346,0.000561723,0.89355975,0.00046270047,0.00071027933,0.000031924923,0.0010771186,0.08883953,0.00012610944,0.000020546562,0.00016794012,0.0006390477],"about_ca_topic_score_codex":0.002286415,"about_ca_topic_score_gemma":0.0022583317,"teacher_disagreement_score":0.088550635,"about_ca_system_score_codex":0.00015973714,"about_ca_system_score_gemma":0.00013340602,"threshold_uncertainty_score":0.9996},"labels":[],"label_agreement":null},{"id":"W3130955693","doi":"10.1016/j.msard.2021.102854","title":"Challenges in multiple sclerosis care: Results from an international mixed-methods study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Axdev Group (Canada)","funders":"Merck KGaA","keywords":"Medicine; Multiple sclerosis; Immunology","score_opus":0.11404897795377365,"score_gpt":0.3523979306294212,"score_spread":0.23834895267564754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130955693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97761196,0.012631938,0.000030770425,0.0038990243,0.00096549775,0.001297867,0.00027167765,0.00019874936,0.0030925302],"genre_scores_gemma":[0.9286159,0.06538986,0.0048815575,0.00008702406,0.000115191004,0.00020501234,0.0005286447,0.00008793171,0.00008884616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944591,0.0010216541,0.0011198208,0.0017896302,0.0008417072,0.0007680891],"domain_scores_gemma":[0.996509,0.0013288914,0.00021397407,0.0010823595,0.00041471096,0.00045104264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00111235,0.0005509903,0.00091804325,0.00043164694,0.00038756707,0.0001424416,0.0003548891,0.0003958565,0.00010888081],"category_scores_gemma":[0.004188481,0.0005030158,0.00024237741,0.00067026215,0.00032183048,0.00043695615,0.0005958489,0.00087986793,0.00002736098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010824398,0.0031976867,0.29792166,0.000056056684,0.0007214379,0.000039411516,0.0207029,0.00023872765,0.018724492,0.000010424495,0.00013793718,0.65716684],"study_design_scores_gemma":[0.02308774,0.00046754183,0.9028691,0.0005008527,0.00011442378,0.000003884995,0.06384575,0.005030902,0.0016507651,0.00004012036,0.0019016807,0.0004872258],"about_ca_topic_score_codex":0.002730828,"about_ca_topic_score_gemma":0.015929805,"teacher_disagreement_score":0.65667963,"about_ca_system_score_codex":0.00022369715,"about_ca_system_score_gemma":0.00012069019,"threshold_uncertainty_score":0.99974215},"labels":[],"label_agreement":null},{"id":"W3131487333","doi":"10.1016/j.msard.2021.102844","title":"Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; Allergan; EMD Serono; MedDay Pharmaceuticals; Innosuisse - Schweizerische Agentur für Innovationsförderung; Schweizerische Multiple Sklerose Gesellschaft; Eisai; Alexion Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Multiple Sclerosis Society; Ministerstvo Školství, Mládeže a Tělovýchovy; Atara Biotherapeutics; Mylan; Baxalta; TG Therapeutics; National Research Foundation; F. Hoffmann-La Roche; Novartis; Celgene; Bayer; Pfizer; Biogen; Roche; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Multiple Sclerosis International Federation; Sanofi; Genentech; National Multiple Sclerosis Society; Merck; CSL Behring; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; MedDRA; Population; Adverse effect; Placebo; Clinical trial; Incidence (geometry); Phases of clinical research; Pathology; Pharmacovigilance","score_opus":0.08706421045346827,"score_gpt":0.316655371971675,"score_spread":0.22959116151820672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131487333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97622377,0.008707675,0.00005454823,0.009704413,0.0007334454,0.0024712207,0.00012432042,0.0003266737,0.0016539475],"genre_scores_gemma":[0.961123,0.030857783,0.006293359,0.00042338966,0.00011644658,0.0002528209,0.0004989777,0.00009294907,0.000341308],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934587,0.0007753646,0.002213406,0.0015435457,0.00091088045,0.0010981096],"domain_scores_gemma":[0.9948754,0.0030186772,0.0003487421,0.000985205,0.00030540227,0.00046657602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019997635,0.00059239386,0.0010755241,0.00017077583,0.0009003007,0.00017688777,0.00032464732,0.00057796837,0.00009760161],"category_scores_gemma":[0.007647123,0.00042927862,0.0003972374,0.0011353587,0.0007125281,0.00021304157,0.0006513299,0.0015940263,0.00006877775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025519417,0.0026680978,0.3790484,0.000056492125,0.0009968074,0.000031427713,0.004161922,0.00015102248,0.00553243,0.000010964814,0.0018566314,0.6029339],"study_design_scores_gemma":[0.027196016,0.00020763316,0.9427237,0.0020803232,0.00015688481,0.0000048920556,0.0035447786,0.007474152,0.00056361774,0.00003889984,0.0154962605,0.00051284354],"about_ca_topic_score_codex":0.0011531016,"about_ca_topic_score_gemma":0.0065478478,"teacher_disagreement_score":0.60242105,"about_ca_system_score_codex":0.00022357586,"about_ca_system_score_gemma":0.00043633935,"threshold_uncertainty_score":0.9998159},"labels":[],"label_agreement":null},{"id":"W3133335727","doi":"10.1016/j.msard.2021.102840","title":"Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerische Multiple Sklerose Gesellschaft; ZonMw; Health~Holland; European Commission; EU Joint Programme – Neurodegenerative Disease Research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Weston Brain Institute","keywords":"Medicine; Multiple sclerosis; Biomarker; Immunoassay; Internal medicine; Gastroenterology; Cerebrospinal fluid; Expanded Disability Status Scale; Pathology; Amyotrophic lateral sclerosis; Oncology; Immunology; Disease; Antibody; Biology","score_opus":0.06168818904227556,"score_gpt":0.2546800506918796,"score_spread":0.19299186164960402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133335727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873509,0.0064627845,0.000040951443,0.0030947183,0.00030997265,0.0013758391,0.000121206525,0.000099085024,0.0011445569],"genre_scores_gemma":[0.97327113,0.025553003,0.0005748097,0.00019152524,0.000026690926,0.000113628914,0.000057737074,0.000081624254,0.00012985471],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99509525,0.00046223434,0.0011678141,0.0010304789,0.0013077535,0.0009364415],"domain_scores_gemma":[0.9975112,0.0005376813,0.0002589492,0.00069171557,0.00064254535,0.00035790948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010294862,0.00054378307,0.0011060772,0.00038316523,0.0003139648,0.000053149553,0.00016218628,0.00031542423,0.00017683786],"category_scores_gemma":[0.0023068779,0.00049209304,0.00039808615,0.0010348934,0.0005454566,0.00018536106,0.00030960803,0.00075476465,0.000021550713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007394854,0.0020126104,0.3013724,0.00032183094,0.00077732676,0.000035100413,0.0021422373,0.00047843368,0.64080834,0.000018260052,0.0002887337,0.05100525],"study_design_scores_gemma":[0.012763688,0.00034886829,0.9003327,0.0015819607,0.00013479685,0.000011032708,0.0034564615,0.003639888,0.07691706,0.000018504836,0.00035686046,0.00043819248],"about_ca_topic_score_codex":0.0010362777,"about_ca_topic_score_gemma":0.0021266823,"teacher_disagreement_score":0.5989603,"about_ca_system_score_codex":0.00028226446,"about_ca_system_score_gemma":0.00022800958,"threshold_uncertainty_score":0.99975306},"labels":[],"label_agreement":null},{"id":"W3134164674","doi":"10.1016/j.msard.2021.102882","title":"Fulminant ADEM treated with cyclophosphamide: Case report and review of the literature","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Acute disseminated encephalomyelitis; Medicine; Fulminant; Multiple sclerosis; Cyclophosphamide; Pediatrics; Intensive care unit; Intensive care medicine; Immunology; Internal medicine; Chemotherapy","score_opus":0.038288022934512285,"score_gpt":0.3028962195589655,"score_spread":0.26460819662445323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134164674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022752327,0.9935201,5.7457765e-7,0.00042953354,0.00010333341,0.003101689,0.00015913637,0.00004754151,0.00036286868],"genre_scores_gemma":[0.0015434835,0.99670553,0.00009677038,0.000068915666,0.000027440678,0.00028449876,0.00028308065,0.000104836196,0.0008854422],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960634,0.0006049105,0.0013320684,0.000912614,0.00058775255,0.0004992296],"domain_scores_gemma":[0.9969505,0.0005262294,0.0008141174,0.0010683106,0.0003615286,0.0002792809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007307262,0.000779452,0.0031648802,0.00017670395,0.00047781118,0.00005452399,0.00016091442,0.0005824601,0.000049537284],"category_scores_gemma":[0.0017055059,0.00038742003,0.00070852006,0.0016332802,0.00072011707,0.00008326939,0.0003697191,0.00163804,0.0000016789193],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034959536,0.00027955257,0.0014834333,0.17192777,0.0017366605,0.0042312606,0.00037361713,3.2354055e-7,0.0000069034522,0.0000040693635,0.0011780441,0.8187434],"study_design_scores_gemma":[0.0020558317,0.00023487948,0.003275527,0.67473894,0.004004469,0.030749438,0.00032318398,0.000009709898,0.0000065539534,0.0000013943202,0.28405976,0.0005403164],"about_ca_topic_score_codex":0.00029372433,"about_ca_topic_score_gemma":0.00010010991,"teacher_disagreement_score":0.8182031,"about_ca_system_score_codex":0.000085900654,"about_ca_system_score_gemma":0.00027884467,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W3134385846","doi":"10.1016/j.msard.2021.102883","title":"Corpus callosum lesions are not inextricably linked to CNS symptoms in reported cases of susac syndrome","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Corpus callosum; Encephalopathy; Disease; Presentation (obstetrics); Pediatrics; Multiple sclerosis; Pathology; Surgery; Internal medicine","score_opus":0.037418966524798807,"score_gpt":0.2536817145676341,"score_spread":0.2162627480428353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134385846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942129,0.00096981716,0.000019129313,0.003608522,0.00013827356,0.00040982306,0.00006484575,0.00004884253,0.000527831],"genre_scores_gemma":[0.9968286,0.0013145751,0.00021136829,0.00019039538,0.000007860131,0.00003692925,0.00011011642,0.000023991794,0.0012761465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984217,0.000053918768,0.00062311237,0.00039960846,0.00022550525,0.0002761286],"domain_scores_gemma":[0.9988734,0.0002594868,0.00016126853,0.00031437047,0.00016093842,0.00023050242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011486676,0.00018169737,0.00048727126,0.00024649233,0.000113828646,0.000015818136,0.00005527088,0.00019555913,0.00016454009],"category_scores_gemma":[0.0009910276,0.00015673053,0.00014296062,0.0009294419,0.00012236733,0.00005224367,0.00007808993,0.00028271336,0.00001223076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003761467,0.0018527654,0.9084261,0.00022363508,0.00044814555,0.0019957984,0.0009659046,0.0005509461,0.06940664,0.0001481262,0.00055577187,0.015050025],"study_design_scores_gemma":[0.0031015289,0.00029372086,0.99241596,0.00084942277,0.00018331064,0.000456217,0.0009065811,0.0007176692,0.0003919102,0.000047656726,0.0004382656,0.00019777825],"about_ca_topic_score_codex":0.0007396419,"about_ca_topic_score_gemma":0.0008274875,"teacher_disagreement_score":0.08398985,"about_ca_system_score_codex":0.000039999308,"about_ca_system_score_gemma":0.000100325145,"threshold_uncertainty_score":0.63912857},"labels":[],"label_agreement":null},{"id":"W3134686384","doi":"10.1016/j.msard.2021.102884","title":"Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; University of Victoria","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Medicine; Relapsing remitting; Depressive symptoms; Beck Depression Inventory; Population; Placebo; Cognition; Internal medicine; Clinical psychology; Psychiatry; Anxiety","score_opus":0.057897969849158765,"score_gpt":0.26517419472930365,"score_spread":0.20727622488014488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134686384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772264,0.010351485,0.000049759452,0.0006363737,0.000060956474,0.0006335587,0.000037312868,0.00007661535,0.0004312877],"genre_scores_gemma":[0.98274684,0.015540677,0.0013954578,0.000024827204,0.000027390746,0.000060587365,0.000052149113,0.00005796277,0.000094114715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996893,0.00022843364,0.0007725442,0.0008851415,0.0005886009,0.00063228776],"domain_scores_gemma":[0.9976674,0.0011926289,0.0002596004,0.0004020935,0.00019073523,0.000287568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004227087,0.00042618442,0.0010067003,0.00032692964,0.00035116542,0.000079107114,0.00012559936,0.00031967947,0.000036815618],"category_scores_gemma":[0.0012006334,0.0003186376,0.00013166305,0.00073246757,0.00080193346,0.0002570554,0.000327111,0.00057843036,0.000002337515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018830886,0.00026901247,0.9056651,0.0003084598,0.00029714088,0.0000060163366,0.0012939208,0.000026314434,0.027077738,0.0000062840772,0.0000117250265,0.06484999],"study_design_scores_gemma":[0.008074258,0.0002688373,0.9762877,0.004546718,0.00015270311,0.000009114034,0.0033401346,0.0020641768,0.0048513254,0.00002246025,0.000025696585,0.00035683237],"about_ca_topic_score_codex":0.000577541,"about_ca_topic_score_gemma":0.0007864515,"teacher_disagreement_score":0.07062265,"about_ca_system_score_codex":0.00005165074,"about_ca_system_score_gemma":0.00008070461,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W3138262194","doi":"10.1016/j.msard.2021.102911","title":"A mixed-methods study of cognitive performance in persons with multiple sclerosis: Association between neuropsychological test performance and interviews about daily cognitive functioning","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Multiple Sclerosis Society","keywords":"Neuropsychology; Cognition; Clinical psychology; Psychology; Neuropsychological assessment; Neuropsychological test; Thematic analysis; Effects of sleep deprivation on cognitive performance; Test (biology); Qualitative research; Medicine; Developmental psychology; Psychiatry","score_opus":0.06402109757871173,"score_gpt":0.31462114225491045,"score_spread":0.25060004467619873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138262194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954454,0.001906601,0.00010675326,0.00021600643,0.00010600465,0.0015235717,0.00007312137,0.00006996713,0.0005525827],"genre_scores_gemma":[0.98669845,0.012133983,0.0004952322,0.00006565425,0.000031352385,0.0002871015,0.00007510878,0.000054366385,0.00015877021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626046,0.0007266024,0.00083160005,0.00096552016,0.0005766051,0.0006391895],"domain_scores_gemma":[0.9954721,0.0031759199,0.00039954897,0.00024188479,0.00048190603,0.00022869153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011976514,0.00044705553,0.0009794228,0.0003276625,0.0004817511,0.000076046534,0.00010004543,0.00027476723,0.000037681257],"category_scores_gemma":[0.0044716643,0.00035768174,0.00011278382,0.0011091772,0.00040983254,0.00031873345,0.00027053518,0.0010095172,0.0000055552628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006536672,0.0014960516,0.82954973,0.00019489485,0.0005231384,0.000003998127,0.0074330913,0.000026957787,0.002203409,1.5118954e-7,0.000019516681,0.1578954],"study_design_scores_gemma":[0.018623838,0.0030435976,0.9315144,0.003727674,0.0004316962,0.00000766273,0.036567368,0.0051374887,0.00056349876,7.090643e-7,0.000026582507,0.00035552957],"about_ca_topic_score_codex":0.00020392875,"about_ca_topic_score_gemma":0.0007250261,"teacher_disagreement_score":0.15753987,"about_ca_system_score_codex":0.0001074881,"about_ca_system_score_gemma":0.000067667315,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W3138588637","doi":"10.1016/j.msard.2021.102910","title":"Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Sucampo Pharmaceuticals; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Optic neuritis; Leptin; Body mass index; Logistic regression; Multiple sclerosis; Obesity; Estrogen; Sex hormone-binding globulin; Endocrinology; Hormone; Testosterone (patch); Gastroenterology; Immunology; Androgen","score_opus":0.023611548390920726,"score_gpt":0.22450663378391855,"score_spread":0.20089508539299783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138588637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245393,0.0012248886,0.000012854733,0.0038273986,0.000083703155,0.0014430006,0.00016421115,0.00010902734,0.0006809552],"genre_scores_gemma":[0.9947466,0.0035128072,0.00029164532,0.00045018355,0.00001725227,0.0001709216,0.00019242021,0.00008507103,0.0005330934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962228,0.00033326427,0.00052551524,0.0009972793,0.0009754163,0.00094574015],"domain_scores_gemma":[0.99753654,0.0007075916,0.00020231279,0.00065274636,0.0005772934,0.00032349635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039890502,0.00052506855,0.00080172723,0.00017920857,0.0007301826,0.000132727,0.00020969548,0.0002991014,0.00025006142],"category_scores_gemma":[0.0012271072,0.0003408359,0.00015885019,0.00161874,0.00073878735,0.00027582992,0.00028946795,0.0009432491,0.000019200472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004937913,0.0017517444,0.9860554,0.000080569596,0.00054490526,0.000034009387,0.0015514717,0.00011786192,0.0009225956,0.0000033269214,0.0010322784,0.007412083],"study_design_scores_gemma":[0.017629586,0.0004163404,0.9749429,0.001044321,0.0001769186,0.000010766734,0.0012488747,0.0034284012,0.00034891305,0.0000066509897,0.0002815781,0.0004647196],"about_ca_topic_score_codex":0.00095079833,"about_ca_topic_score_gemma":0.006037947,"teacher_disagreement_score":0.017135793,"about_ca_system_score_codex":0.00018939652,"about_ca_system_score_gemma":0.00015714203,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W3149959926","doi":"10.1016/j.msard.2021.102931","title":"Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; McDonald criteria; Medical diagnosis; Cerebrospinal fluid; Magnetic resonance imaging; Lumbar; Lumbar puncture; Pathology; Radiology; Psychiatry","score_opus":0.04665116888110507,"score_gpt":0.2674648555797023,"score_spread":0.22081368669859722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149959926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96985704,0.020347157,0.000019321898,0.006243644,0.00017156091,0.002839106,0.00015995746,0.00013396134,0.00022825228],"genre_scores_gemma":[0.9677789,0.029195769,0.0018895966,0.000039871007,0.000114275914,0.00072825793,0.000037224232,0.00009724805,0.000118854616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603945,0.00025481603,0.0008726364,0.0009866132,0.00088826835,0.00095821026],"domain_scores_gemma":[0.9975117,0.00070639217,0.00037282452,0.0005847567,0.0004159844,0.00040836813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005657117,0.0005662461,0.0009122633,0.00021713309,0.0010022457,0.00016242091,0.00020326188,0.0003631731,0.00006433737],"category_scores_gemma":[0.0013030604,0.00041339247,0.0003027195,0.00089199457,0.001346316,0.00024163333,0.0006288977,0.00073387387,0.0000036325105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035199642,0.00046604106,0.7880293,0.00077784795,0.00097369775,0.000023262994,0.0037946578,0.000072185416,0.12053875,0.00004057957,0.00015490157,0.08477678],"study_design_scores_gemma":[0.0096999975,0.00056616747,0.862436,0.0052566347,0.00036283888,0.00002955198,0.009380212,0.001577911,0.10949606,0.00013260853,0.00040389804,0.00065809576],"about_ca_topic_score_codex":0.0007312507,"about_ca_topic_score_gemma":0.00058985944,"teacher_disagreement_score":0.08411869,"about_ca_system_score_codex":0.00013444253,"about_ca_system_score_gemma":0.00017356109,"threshold_uncertainty_score":0.9998318},"labels":[],"label_agreement":null},{"id":"W3154761299","doi":"10.1016/j.msard.2021.102945","title":"A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cladribine; Medicine; Alemtuzumab; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Adverse effect; Regimen; Clinical trial; Transplantation; Immunology","score_opus":0.061552138367007236,"score_gpt":0.279093176129514,"score_spread":0.21754103776250677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154761299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893481,0.004386151,0.00015367103,0.0029280123,0.00014918741,0.0014792853,0.00044323617,0.00013242869,0.000979895],"genre_scores_gemma":[0.9734147,0.021752836,0.0030253334,0.000100467616,0.000035705954,0.000118156015,0.00043676424,0.000078448655,0.0010375514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637514,0.00016725605,0.000998669,0.0010841455,0.00057906273,0.0007957301],"domain_scores_gemma":[0.9967038,0.0013263816,0.00031538476,0.00063912215,0.0005686,0.00044669173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004285467,0.00048886327,0.0014425815,0.00085630256,0.0004358487,0.00007805221,0.00013335371,0.00028969537,0.00019259438],"category_scores_gemma":[0.0016869738,0.0004342444,0.00063485384,0.0024730114,0.00060826546,0.00016560595,0.00029399776,0.00035396838,0.000003508978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011184262,0.0018731316,0.6539809,0.00063438196,0.008558126,0.0000066678826,0.0021714966,0.00043309812,0.25525415,0.000113231625,0.0013672139,0.074489154],"study_design_scores_gemma":[0.015453113,0.0003806567,0.9192259,0.0008678272,0.0035150426,0.0000022998458,0.0022673714,0.046443485,0.00937382,0.000042370717,0.0018685681,0.0005595499],"about_ca_topic_score_codex":0.0009049164,"about_ca_topic_score_gemma":0.009322015,"teacher_disagreement_score":0.26524496,"about_ca_system_score_codex":0.00013918217,"about_ca_system_score_gemma":0.000106623884,"threshold_uncertainty_score":0.99981093},"labels":[],"label_agreement":null},{"id":"W3155780952","doi":"10.1016/j.msard.2021.102966","title":"Longitudinal analysis of disability outcomes among young people with MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Cognition; Physical medicine and rehabilitation; Longitudinal study; Physical therapy; Expanded Disability Status Scale; Gait; Young adult; Pediatrics; Gerontology; Psychiatry","score_opus":0.029299423419740667,"score_gpt":0.27336809062288925,"score_spread":0.24406866720314857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155780952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958463,0.0007558624,0.00010841441,0.0012296352,0.00006739365,0.00048219206,0.00006439367,0.00007299805,0.0013728428],"genre_scores_gemma":[0.9963172,0.0027848694,0.00042914448,0.000018963443,0.000008897492,0.00006339297,0.00013007961,0.000030848758,0.00021659202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744695,0.0001344569,0.0005759367,0.0007163543,0.0006546069,0.00047171046],"domain_scores_gemma":[0.99815696,0.0004499123,0.00017507566,0.00063056103,0.0002725212,0.00031499294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003262364,0.00031380294,0.001118187,0.0002315971,0.00027722534,0.000040246014,0.00010246502,0.00016802,0.00037002368],"category_scores_gemma":[0.00086364447,0.00022016506,0.00044848933,0.0021349394,0.0009979212,0.00014403944,0.0001835122,0.0003379234,0.000003022111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001816367,0.0007505437,0.9882252,0.00013106754,0.0054226047,0.000004077422,0.0011718491,0.00056366564,0.001101448,0.000018271143,0.00004372213,0.0023858855],"study_design_scores_gemma":[0.0038809166,0.00014528442,0.9854177,0.000120848796,0.0021272432,0.000003232891,0.0016053588,0.006209313,0.00020903906,0.000010644065,0.000024732108,0.00024568482],"about_ca_topic_score_codex":0.005427858,"about_ca_topic_score_gemma":0.043369614,"teacher_disagreement_score":0.037941758,"about_ca_system_score_codex":0.00008959189,"about_ca_system_score_gemma":0.00006583762,"threshold_uncertainty_score":0.9740864},"labels":[],"label_agreement":null},{"id":"W3155910301","doi":"10.1016/j.msard.2021.102967","title":"Socioeconomic status and access to multiple sclerosis treatment in Mexico","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Neurology; Neurosurgery; Pediatrics; Expanded Disability Status Scale; Internal medicine; Physical therapy; Surgery; Population; Environmental health; Immunology","score_opus":0.05984559780417387,"score_gpt":0.2989172757336982,"score_spread":0.23907167792952433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155910301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847002,0.0057620197,0.000016060616,0.0068065696,0.00018859749,0.0014997422,0.000097404365,0.00010925259,0.0008201607],"genre_scores_gemma":[0.93879896,0.059314072,0.0005576234,0.00046928655,0.000032136995,0.0003415321,0.000084885556,0.00007362012,0.00032786152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966589,0.00017393926,0.0006836179,0.0011269463,0.00032320942,0.0010333427],"domain_scores_gemma":[0.99800897,0.0005485369,0.000110502006,0.00049582985,0.00012229472,0.0007138926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026572504,0.00049926015,0.000885465,0.0004075494,0.00039054564,0.00021239107,0.00013526539,0.00028327055,0.00023668927],"category_scores_gemma":[0.00068796135,0.00043639273,0.0001971303,0.00053848315,0.00032846097,0.0003160511,0.0004667884,0.00038018578,0.000058193935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032606183,0.00070205855,0.86736244,0.00008278259,0.00036408662,0.000010480391,0.0024886085,0.0002994201,0.018345222,0.000011078481,0.0004412734,0.10956646],"study_design_scores_gemma":[0.013322783,0.00035648746,0.9724059,0.0003748461,0.000091901326,0.0000050809226,0.0023062208,0.00349514,0.003895669,0.000048095044,0.0032393923,0.0004584604],"about_ca_topic_score_codex":0.0022687505,"about_ca_topic_score_gemma":0.008570991,"teacher_disagreement_score":0.109108,"about_ca_system_score_codex":0.00041285367,"about_ca_system_score_gemma":0.00017982813,"threshold_uncertainty_score":0.9998088},"labels":[],"label_agreement":null},{"id":"W3157740433","doi":"10.1016/j.msard.2021.102990","title":"A pilot trial of autologous hematopoietic stem cell transplant in neuromyelitis optic spectrum disorder","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Neuromyelitis optica; Rituximab; Multiple sclerosis; Spectrum disorder; Expanded Disability Status Scale; Hematopoietic stem cell transplantation; Cyclophosphamide; Pediatrics; Internal medicine; Transplantation; Surgery; Lymphoma; Immunology; Chemotherapy; Psychiatry","score_opus":0.03200563233889158,"score_gpt":0.24937753894676243,"score_spread":0.21737190660787084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157740433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970836,0.0051439707,0.000025603333,0.00203909,0.00029510862,0.0012777544,0.000046434674,0.00007725764,0.0013863869],"genre_scores_gemma":[0.98020643,0.019005,0.00016823733,0.00003802402,0.000021946033,0.00011167832,0.000037783895,0.00005522861,0.00035567966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969744,0.00025784902,0.00087897934,0.0007114718,0.00050921674,0.0006681005],"domain_scores_gemma":[0.9985867,0.0004907274,0.00015378192,0.00046335903,0.00007491506,0.00023051737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030313668,0.00035734702,0.0009054214,0.00027362473,0.00015123714,0.000030711195,0.00013209619,0.00016931088,0.0001347403],"category_scores_gemma":[0.00016062244,0.0003099833,0.00024795943,0.0007271,0.00036671,0.00009111564,0.0001247994,0.0005604736,0.000013561503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08282693,0.029324623,0.4499796,0.0070203976,0.0022155906,0.0011526508,0.035507564,0.0018612924,0.26652378,0.0008103399,0.00052615185,0.12225108],"study_design_scores_gemma":[0.26290277,0.0047045304,0.70716625,0.0018758074,0.00037592664,0.00009876027,0.0058852825,0.008949427,0.006511615,0.00019802304,0.00042519066,0.0009063971],"about_ca_topic_score_codex":0.0006115489,"about_ca_topic_score_gemma":0.00081041665,"teacher_disagreement_score":0.26001215,"about_ca_system_score_codex":0.00005325004,"about_ca_system_score_gemma":0.00014119054,"threshold_uncertainty_score":0.9999352},"labels":[],"label_agreement":null},{"id":"W3161653279","doi":"10.1016/j.msard.2021.103009","title":"Transcutaneous spinal cord stimulation improves postural stability in individuals with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Glenrose Rehabilitation Hospital; Alberta Health Services; Women and Children’s Health Research Institute; University of Alberta Hospital; University of Alberta","funders":"Houston Methodist Hospital","keywords":"Medicine; Multiple sclerosis; Stimulation; Center of pressure (fluid mechanics); Physical medicine and rehabilitation; Proprioception; Spinal cord; Functional electrical stimulation; Internal medicine","score_opus":0.040851118059993086,"score_gpt":0.29294306247146235,"score_spread":0.25209194441146926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161653279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526256,0.0015935316,0.00007770277,0.00073799584,0.00037213898,0.0013028238,0.000103564365,0.0001371117,0.0004125422],"genre_scores_gemma":[0.99656415,0.0019600794,0.0007047272,0.00015667074,0.000032564407,0.00013390786,0.00026578413,0.000048016933,0.00013409316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683124,0.0006009582,0.00082729233,0.00072631135,0.000327411,0.0006867783],"domain_scores_gemma":[0.99862546,0.00041845543,0.00027026486,0.00034937798,0.00015527503,0.00018117859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005177044,0.00033679893,0.0004879554,0.00013154627,0.00072797696,0.000041367086,0.00012939637,0.00047578217,0.000051872703],"category_scores_gemma":[0.00022035949,0.0002831008,0.0001266884,0.00057376764,0.0001929008,0.00031059442,0.000078762656,0.0008599238,0.000022744054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010196936,0.00094530615,0.84191644,0.00024299203,0.000117047806,0.0000041371122,0.0029039807,0.00003630546,0.11285652,0.00003584698,0.000043137745,0.039878584],"study_design_scores_gemma":[0.008944324,0.00047951523,0.9806364,0.0007911233,0.00007584747,0.0000034474067,0.004695257,0.0035498128,0.000051841176,0.0002323492,0.00016056158,0.0003794767],"about_ca_topic_score_codex":0.0011531629,"about_ca_topic_score_gemma":0.0077505982,"teacher_disagreement_score":0.13871999,"about_ca_system_score_codex":0.00011883516,"about_ca_system_score_gemma":0.00014798863,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W3162915930","doi":"10.1016/j.msard.2021.103012","title":"The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Université de Montréal; Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; Centre Hospitalier Universitaire de Rennes; Sanofi Genzyme; Multiple Sclerosis Society; Centre Hospitalier Universitaire de Nice; Sanofi; Université Claude Bernard Lyon 1; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Toulouse; Multiple Sclerosis Society of Canada; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; Merck; Teva Pharmaceutical Industries; Université de Lorraine; Centre Hospitalier Universitaire de Bordeaux; Hospices Civils de Lyon; Agence Nationale de la Recherche; Roche","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Hazard ratio; Internal medicine; Immunology; Confidence interval","score_opus":0.04998136824734042,"score_gpt":0.33259484200560463,"score_spread":0.28261347375826423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162915930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970509,0.02591199,0.000023826524,0.001207066,0.00037636558,0.0004174495,0.00003835917,0.000027630158,0.001488349],"genre_scores_gemma":[0.961756,0.03782242,0.00015671414,0.000009830348,0.000015628639,0.00004220721,0.000033278793,0.000018384668,0.00014552168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810815,0.0002820084,0.000549268,0.0003230165,0.0004897536,0.00024778204],"domain_scores_gemma":[0.9966742,0.002106524,0.00022398215,0.000376209,0.00054601347,0.000073099356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006579405,0.00017741606,0.0006011491,0.000083059196,0.00025096728,0.000019791143,0.00015875947,0.00011692996,0.000015751142],"category_scores_gemma":[0.004179392,0.0001199606,0.0001860234,0.00031700186,0.0008526454,0.00006278203,0.00029056685,0.00027697993,0.0000017983236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030845786,0.0010742713,0.83331114,0.001560646,0.004216113,0.0000055033765,0.0028756256,0.0004093745,0.104674906,0.0006929745,0.0011029731,0.046991866],"study_design_scores_gemma":[0.006220549,0.0002536659,0.945301,0.0015783156,0.0001282967,0.000005591298,0.0073425155,0.0027986157,0.034414068,0.0001603393,0.0016387398,0.00015828859],"about_ca_topic_score_codex":0.000119210694,"about_ca_topic_score_gemma":0.00012779293,"teacher_disagreement_score":0.11198985,"about_ca_system_score_codex":0.000056957477,"about_ca_system_score_gemma":0.000070831265,"threshold_uncertainty_score":0.5003425},"labels":[],"label_agreement":null},{"id":"W3162935255","doi":"10.1016/j.msard.2021.103006","title":"Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; University of British Columbia; Memorial University of Newfoundland","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Biomarker; Interleukin 1 receptor antagonist; Microglia; Receptor antagonist; Expanded Disability Status Scale; Immunology; Cerebrospinal fluid; Interleukin; Pathology; Internal medicine; Receptor; Antagonist; Inflammation; Cytokine; Biology","score_opus":0.05859214145914149,"score_gpt":0.25994149441028497,"score_spread":0.20134935295114348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162935255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331766,0.0037100327,0.00002112017,0.0010142965,0.0002366739,0.001267862,0.00005486842,0.00022516378,0.00015232865],"genre_scores_gemma":[0.9823148,0.01558424,0.0013461083,0.000113755035,0.000038113783,0.0002457441,0.00020043517,0.00009936794,0.000057415513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522424,0.000701519,0.0008666035,0.0016922131,0.00060573267,0.00090966496],"domain_scores_gemma":[0.99711615,0.0011532786,0.0002605902,0.0006923676,0.00021792197,0.00055969146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006222235,0.00070849765,0.0010840436,0.00022405224,0.0007155675,0.00019963732,0.00018196803,0.0005366146,0.000069329166],"category_scores_gemma":[0.0015777948,0.00051787467,0.00018797962,0.0007981205,0.002000719,0.0006861824,0.00047802314,0.0010489939,0.000010965792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020000834,0.001358744,0.7544481,0.00024641686,0.0002531124,0.0000222761,0.0043101837,0.000051613402,0.19090037,0.000009526045,0.000069460075,0.046330124],"study_design_scores_gemma":[0.01204496,0.00083480135,0.9459811,0.002297582,0.00011031245,0.000020123569,0.015857527,0.016848803,0.004987439,0.00006323364,0.00020407345,0.00075008254],"about_ca_topic_score_codex":0.0003060125,"about_ca_topic_score_gemma":0.0026224263,"teacher_disagreement_score":0.19153297,"about_ca_system_score_codex":0.0002218115,"about_ca_system_score_gemma":0.00012500687,"threshold_uncertainty_score":0.9997273},"labels":[],"label_agreement":null},{"id":"W3163139312","doi":"10.1016/j.msard.2021.103016","title":"A mindfulness group intervention in newly diagnosed persons with multiple sclerosis: A pilot study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Parkwood Institute; London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Lawson Health Research Institute","keywords":"Medicine; Physical therapy; Mindfulness; Anxiety; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Psychological intervention; Repeated measures design; Coping (psychology); Clinical psychology; Psychiatry","score_opus":0.048685031934047635,"score_gpt":0.2722002085374608,"score_spread":0.22351517660341316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163139312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206233,0.0030968818,0.00019969982,0.0011608043,0.0001984198,0.0026740916,0.000051037674,0.00018188356,0.000374862],"genre_scores_gemma":[0.99665093,0.0010134826,0.000465462,0.000100562356,0.00004158823,0.0011951744,0.00011351129,0.00011239216,0.00030688703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995487,0.0005155717,0.0008756289,0.001318246,0.0008373489,0.0009662485],"domain_scores_gemma":[0.99781984,0.0006382258,0.00021010416,0.0006779018,0.00023157903,0.00042235467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006875828,0.0006085553,0.0009859297,0.0005050015,0.0004977681,0.00016163144,0.00020431347,0.00019247795,0.00020217744],"category_scores_gemma":[0.0012429958,0.0004986736,0.00023516237,0.0014995264,0.00043323697,0.0003413673,0.00033601237,0.0008983807,0.000026008054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029309602,0.015780885,0.85546136,0.00029081467,0.0010344371,0.00017349952,0.005385881,0.00020302141,0.010329946,0.000011778353,0.0003524375,0.108044975],"study_design_scores_gemma":[0.04999822,0.00414247,0.91042966,0.0019329947,0.0002475869,0.000017914863,0.027607772,0.00394498,0.0009276044,0.00001670584,0.00015850403,0.0005755846],"about_ca_topic_score_codex":0.004128092,"about_ca_topic_score_gemma":0.034894932,"teacher_disagreement_score":0.10746939,"about_ca_system_score_codex":0.00019804378,"about_ca_system_score_gemma":0.00010186655,"threshold_uncertainty_score":0.9997465},"labels":[],"label_agreement":null},{"id":"W3163435887","doi":"10.1016/j.msard.2021.103003","title":"Cross-sectional analysis of peripheral blood mononuclear cells in lymphopenic and non-lymphopenic relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate.","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Government of Alberta; Biogen","keywords":"Immunophenotyping; Medicine; Peripheral blood mononuclear cell; CD8; Multiple sclerosis; Population; Immunology; Monocyte; Internal medicine; CD16; Immune system; Flow cytometry; Gastroenterology; CD3; Biology; In vitro","score_opus":0.023190131559225682,"score_gpt":0.24941706729005644,"score_spread":0.22622693573083075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163435887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958221,0.0022586866,0.000017044606,0.0000842972,0.000097652024,0.000963796,0.00015190488,0.000071020746,0.0005335457],"genre_scores_gemma":[0.98641175,0.011819055,0.0007712502,0.000056565616,0.000017412445,0.00009008392,0.00027506196,0.0001029429,0.00045585143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953627,0.00028696458,0.0012614401,0.0013821052,0.00082595274,0.00088082685],"domain_scores_gemma":[0.99740505,0.00061073736,0.00042513167,0.00060313486,0.00055649685,0.0003994249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058735587,0.0006194663,0.0014191474,0.000822082,0.0005468513,0.00018425068,0.00018483096,0.00045523542,0.00025959164],"category_scores_gemma":[0.0006545564,0.00052580395,0.00041918308,0.0029945648,0.00078107504,0.0003735782,0.00036984374,0.00055214064,0.0000062404392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010880727,0.0013323714,0.9105214,0.00013469078,0.0032924223,0.000009048533,0.0010183656,0.0029392103,0.072996855,0.0000011438958,0.000016001854,0.0066504427],"study_design_scores_gemma":[0.025053525,0.00047239807,0.937035,0.00056488975,0.0011553307,0.0000047188323,0.0006532902,0.029108845,0.0054028514,0.00000186757,0.000027376027,0.0005198774],"about_ca_topic_score_codex":0.0028714533,"about_ca_topic_score_gemma":0.0017304114,"teacher_disagreement_score":0.067594,"about_ca_system_score_codex":0.00023114693,"about_ca_system_score_gemma":0.00016641973,"threshold_uncertainty_score":0.9997194},"labels":[],"label_agreement":null},{"id":"W3164228261","doi":"10.1016/j.msard.2021.103041","title":"Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Corporation; American University of Beirut","keywords":"Fingolimod; Medicine; Multiple sclerosis; Retinal; Montreal Cognitive Assessment; Cognition; Cognitive decline; Internal medicine; Audiology; Ophthalmology; Disease; Immunology; Cognitive impairment; Psychiatry; Dementia","score_opus":0.048822441238611604,"score_gpt":0.2905171473254759,"score_spread":0.2416947060868643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164228261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940976,0.0034386674,0.00000795943,0.00038332702,0.00010213636,0.00084634736,0.000018046814,0.00002825709,0.0010776736],"genre_scores_gemma":[0.99317837,0.0064711706,0.000017220895,0.000039322502,0.000011809982,0.000101989805,0.000046358906,0.000025226145,0.00010854216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983084,0.00026497702,0.00033638082,0.00047493255,0.0003124131,0.00030284768],"domain_scores_gemma":[0.99901134,0.0005211012,0.00008162812,0.0001645363,0.00009562228,0.00012574703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030117983,0.00026024773,0.0005389425,0.00020235764,0.000112324204,0.000019237601,0.000028244884,0.00014589484,0.000043807486],"category_scores_gemma":[0.0007285914,0.00018895481,0.000111206486,0.0002870352,0.00018571207,0.000065849905,0.00006845899,0.0002147711,0.000006330076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007858117,0.0011109293,0.5372424,0.00034996183,0.0010359413,0.0000072277794,0.0017426378,0.00006311568,0.055722266,0.0000036409858,0.000044598404,0.39481917],"study_design_scores_gemma":[0.02536109,0.008880095,0.9224524,0.0018733441,0.00036087076,0.000003153917,0.00083356793,0.0016179263,0.038337383,0.000010162223,0.00006669393,0.00020330836],"about_ca_topic_score_codex":0.0003078089,"about_ca_topic_score_gemma":0.00040143268,"teacher_disagreement_score":0.39461586,"about_ca_system_score_codex":0.00008642486,"about_ca_system_score_gemma":0.0000311227,"threshold_uncertainty_score":0.7705354},"labels":[],"label_agreement":null},{"id":"W3166952808","doi":"10.1016/j.msard.2021.103249","title":"Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Nova Scotia Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Dalhousie Medical Research Foundation; U.S. Department of Defense","keywords":"Discontinuation; Comorbidity; Medicine; Glatiramer acetate; Internal medicine; Proportional hazards model; Hazard ratio; Physical therapy; Disease; Psychiatry; Pediatrics; Confidence interval","score_opus":0.12828306854256744,"score_gpt":0.2860483914292349,"score_spread":0.15776532288666745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166952808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830789,0.014380344,0.000035318662,0.001246924,0.00014435142,0.00075096946,0.000051512583,0.00008086963,0.00023080145],"genre_scores_gemma":[0.9015879,0.0965914,0.0014535219,0.00010344949,0.000020833268,0.000045641907,0.000044743396,0.00005695666,0.00009553115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967149,0.00030523835,0.0007951225,0.0009316598,0.00057706115,0.0006760337],"domain_scores_gemma":[0.99735284,0.0012079148,0.0002282535,0.0005370103,0.00025960288,0.00041439303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062150025,0.00040382365,0.00079420535,0.0003014796,0.00045403175,0.00010170173,0.00012166783,0.000240916,0.00004899863],"category_scores_gemma":[0.0034962525,0.0003660078,0.00024463178,0.0008059353,0.0006957575,0.0003889375,0.00031678897,0.00065043394,0.0000028298286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006317037,0.00052861864,0.85382366,0.0002627109,0.00020872698,0.000012214509,0.0019372731,0.00020033604,0.09515173,0.000011865814,0.00006738783,0.047163792],"study_design_scores_gemma":[0.009780329,0.0001288381,0.96572363,0.0024853204,0.00007929874,0.000006154911,0.0030765058,0.015474233,0.0026282892,0.000033976896,0.00021409163,0.0003693557],"about_ca_topic_score_codex":0.0009780364,"about_ca_topic_score_gemma":0.00068057526,"teacher_disagreement_score":0.111899965,"about_ca_system_score_codex":0.00010010747,"about_ca_system_score_gemma":0.00011619341,"threshold_uncertainty_score":0.9998792},"labels":[],"label_agreement":null},{"id":"W3170288888","doi":"10.1016/j.msard.2021.103050","title":"A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Armand-Frappier Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Internal medicine; Confounding; Logistic regression; Propensity score matching; Hazard ratio; Proportional hazards model; Interferon beta-1a; Interferon beta-1b; Interferon beta; Immunology; Confidence interval","score_opus":0.0967418744945849,"score_gpt":0.3135608160988775,"score_spread":0.21681894160429258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170288888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936158,0.0008999575,0.00042904558,0.00087589584,0.00031036494,0.00360088,0.0001008695,0.00006059978,0.000106576124],"genre_scores_gemma":[0.9963076,0.0013903114,0.001485709,0.000069333924,0.000028466931,0.0003283058,0.000072355135,0.00008671245,0.0002312073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964362,0.00027266817,0.0010643668,0.00082422805,0.00071106397,0.0006915158],"domain_scores_gemma":[0.9940752,0.003937518,0.0005243941,0.00083184097,0.00041173407,0.00021932577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009283155,0.0005678312,0.0015988216,0.00033546187,0.00044783286,0.000063686035,0.0002953562,0.00026286548,0.000059218346],"category_scores_gemma":[0.005344227,0.00031708094,0.0006036452,0.0010870354,0.00077853777,0.00014462163,0.00040678174,0.00058124686,0.0000072395555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031075915,0.0005616162,0.8900963,0.0013201358,0.0014483428,0.0000035019439,0.0006983317,0.0009268693,0.030036693,0.0000024443145,0.00014249065,0.07165569],"study_design_scores_gemma":[0.014902404,0.0026694387,0.9057997,0.0022943863,0.00051009096,0.0000045957263,0.00020116448,0.032724395,0.04056201,0.0000040538603,0.000008046659,0.00031972368],"about_ca_topic_score_codex":0.00026157987,"about_ca_topic_score_gemma":0.00035224273,"teacher_disagreement_score":0.071335964,"about_ca_system_score_codex":0.00007845928,"about_ca_system_score_gemma":0.00010007566,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W3173562773","doi":"10.1016/j.msard.2021.103088","title":"Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; St. Francis Xavier University; University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Research Manitoba","keywords":"Medicine; Brain size; Framingham Risk Score; Framingham Heart Study; Percentile; Internal medicine; Multiple sclerosis; Cardiology; Disease; Magnetic resonance imaging","score_opus":0.030160773771186908,"score_gpt":0.23914466033544274,"score_spread":0.20898388656425582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173562773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934209,0.0026112886,0.000014565448,0.0020720807,0.0001290558,0.0009265269,0.00029788588,0.00014111803,0.00038660684],"genre_scores_gemma":[0.9926686,0.003993289,0.00030127531,0.00018272588,0.00003389129,0.00010563761,0.00017112943,0.0001248506,0.002418557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956555,0.00045760957,0.0009172645,0.0010829855,0.0009122556,0.0009744242],"domain_scores_gemma":[0.99712896,0.0009618765,0.0004938519,0.0006708601,0.00039906672,0.00034539192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006235926,0.00059927866,0.0012689898,0.00042488793,0.00035596002,0.00007865308,0.00019553362,0.00053174305,0.0008020057],"category_scores_gemma":[0.0029615222,0.0004800174,0.00030715019,0.0013946852,0.00092530757,0.00025595192,0.00030954508,0.00092695764,0.00004264371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006236,0.001029259,0.9752609,0.00013693157,0.0009417062,0.000038456197,0.0010787861,0.0003572905,0.014015126,0.00000285458,0.0018267554,0.0046883146],"study_design_scores_gemma":[0.017108466,0.00035502028,0.96886927,0.0025611168,0.00020863688,0.0000038331004,0.0004617886,0.007981701,0.0016016,0.000024554065,0.00028323883,0.0005407899],"about_ca_topic_score_codex":0.0012829087,"about_ca_topic_score_gemma":0.0023037505,"teacher_disagreement_score":0.016484866,"about_ca_system_score_codex":0.00018795312,"about_ca_system_score_gemma":0.00011459472,"threshold_uncertainty_score":0.99976516},"labels":[],"label_agreement":null},{"id":"W3173632496","doi":"10.1016/j.msard.2021.103105","title":"Cannabinoids and bladder symptoms in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Department of Obstetrics and Gynecology, University of Wisconsin-Madison","keywords":"Cannabis; Medicine; Logistic regression; Cross-sectional study; Environmental health; Consumption (sociology); Psychiatry; Internal medicine","score_opus":0.024350194998976758,"score_gpt":0.24067593192462036,"score_spread":0.2163257369256436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173632496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726857,0.011177436,0.000009909781,0.013766577,0.00019683987,0.000588951,0.000034016448,0.00008243227,0.0014581332],"genre_scores_gemma":[0.9824689,0.011697769,0.000108802175,0.0004095124,0.000037073525,0.00011103566,0.00007035452,0.000067150904,0.005029391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974004,0.00012237969,0.0005201529,0.00081740675,0.00042308692,0.00071655185],"domain_scores_gemma":[0.9988371,0.00005746754,0.000075258606,0.00041439643,0.00015949183,0.00045627978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029908275,0.0003440205,0.00054324075,0.00029213197,0.0002870226,0.00011181239,0.00009158697,0.00038232811,0.0002978424],"category_scores_gemma":[0.000412345,0.00030692964,0.00016626029,0.0008189399,0.0004434779,0.00015606907,0.00020551003,0.0006449827,0.000016796193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048371928,0.0012035333,0.6914116,0.00031304173,0.00042802835,0.000087998334,0.0023855295,0.0001444685,0.0787305,0.00019097228,0.012246601,0.212374],"study_design_scores_gemma":[0.011845699,0.0002496609,0.96583706,0.00042509663,0.0001067385,0.00005432861,0.001849559,0.0054473584,0.0024265705,0.00013431914,0.011150142,0.00047345657],"about_ca_topic_score_codex":0.0014914646,"about_ca_topic_score_gemma":0.002074144,"teacher_disagreement_score":0.27442545,"about_ca_system_score_codex":0.00009436512,"about_ca_system_score_gemma":0.00019361256,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W3174727609","doi":"10.1016/j.msard.2021.103124","title":"Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research; Alberta Innovates - Health Solutions; Multiple Sclerosis Society of Canada; Canada Foundation for Innovation; Canadian Institutes of Health Research","keywords":"Susceptibility weighted imaging; Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Spinal cord; Pathology; Magnetic resonance imaging; White matter; Immunology; Radiology","score_opus":0.0739931107559621,"score_gpt":0.276170572251512,"score_spread":0.20217746149554988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174727609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927715,0.00080469064,0.00015169613,0.0008707499,0.00007844738,0.004861972,0.00015897649,0.00016680972,0.00013513224],"genre_scores_gemma":[0.994844,0.001688723,0.002434183,0.000037216076,0.000018633766,0.0007098168,0.000052479474,0.00010917562,0.00010575095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944646,0.00051332684,0.001191808,0.0016403495,0.0011164144,0.001073554],"domain_scores_gemma":[0.99690044,0.00076054916,0.0003279803,0.0011371042,0.00040593275,0.00046797798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009802675,0.0007187353,0.0013944227,0.0002667165,0.00037593461,0.00008133084,0.00026521157,0.00016487401,0.000098671364],"category_scores_gemma":[0.0017956266,0.0005152041,0.0002199907,0.0010873993,0.001130587,0.0003609185,0.00053665077,0.00083033164,0.0000039972456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008049419,0.011511214,0.8326227,0.00049000257,0.00043697818,0.000016443686,0.00273493,0.00057488465,0.13557863,0.0000013725454,0.000014814181,0.007968602],"study_design_scores_gemma":[0.023285683,0.0034456784,0.8265657,0.0011368679,0.00021073049,0.00000877715,0.0066373716,0.13158357,0.0065973713,0.000023026627,0.000003785319,0.0005014826],"about_ca_topic_score_codex":0.0035708765,"about_ca_topic_score_gemma":0.060164127,"teacher_disagreement_score":0.13100868,"about_ca_system_score_codex":0.00039532938,"about_ca_system_score_gemma":0.00035288738,"threshold_uncertainty_score":0.99972993},"labels":[],"label_agreement":null},{"id":"W31758784","doi":"10.1016/j.msard.2011.07.002","title":"Multiple sclerosis in children","year":2011,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Neuroimaging; Pediatrics; Epidemiology; Psychiatry; Family medicine; Pathology","score_opus":0.0325694220883064,"score_gpt":0.25639660886621696,"score_spread":0.22382718677791055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31758784","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46619523,0.036542945,0.000024133366,0.0012211405,0.47322667,0.011152351,0.002191947,0.001244046,0.008201546],"genre_scores_gemma":[0.7511682,0.1745154,0.00056617643,0.00008125751,0.06868534,0.0007844566,0.0021109295,0.0005073793,0.00158089],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9923825,0.00034616297,0.0016027937,0.002169653,0.0017398006,0.0017590577],"domain_scores_gemma":[0.9956461,0.0014690752,0.0005190958,0.0012456494,0.00038382923,0.0007362067],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0009908783,0.0013746443,0.0021893692,0.0011969353,0.0005323872,0.00014782969,0.0006035918,0.0028501775,0.00035699064],"category_scores_gemma":[0.005454113,0.001208233,0.0006889908,0.0010971072,0.0010259657,0.00030011058,0.0007841086,0.003742077,0.0002005996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011008573,0.0016406438,0.36730084,0.00045238883,0.0017150289,0.000010674565,0.0013570037,0.000026917265,0.0013648068,0.000005216769,0.57545364,0.049571984],"study_design_scores_gemma":[0.02523023,0.0006689555,0.88122624,0.0035871486,0.0005317356,0.0000059587223,0.0003950825,0.0008011405,0.00015424554,0.000059053553,0.08564219,0.0016980049],"about_ca_topic_score_codex":0.007222952,"about_ca_topic_score_gemma":0.002541164,"teacher_disagreement_score":0.51392543,"about_ca_system_score_codex":0.00037538577,"about_ca_system_score_gemma":0.00035961022,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W3179310843","doi":"10.1016/j.msard.2021.103130","title":"Cognitive fatigability in multiple sclerosis: How does performance decline over time on the Paced Auditory Serial Addition Test?","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Carleton University; Ottawa Hospital","funders":"Multiple Sclerosis Society of Canada; University of Ottawa","keywords":"Paced Auditory Serial Addition Test; Audiology; Cognition; Analysis of variance; Neuropsychology; Mixed-design analysis of variance; Stimulus (psychology); Task (project management); Multiple sclerosis; Neuropsychological test; Medicine; Repeated measures design; Psychology; Effects of sleep deprivation on cognitive performance; Developmental psychology; Physical medicine and rehabilitation; Cognitive psychology; Psychiatry; Statistics","score_opus":0.0385241016422043,"score_gpt":0.25206659613563487,"score_spread":0.21354249449343057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179310843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874219,0.0005472525,0.0000063053703,0.008952686,0.00042344487,0.0016541962,0.00036944516,0.00014304684,0.00048174185],"genre_scores_gemma":[0.98930836,0.008649301,0.00011629647,0.00044154102,0.00020151668,0.00041746142,0.00029756894,0.00006976754,0.0004981807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625707,0.00045265714,0.0006229406,0.001020077,0.00085082545,0.0007964261],"domain_scores_gemma":[0.9950585,0.0035168487,0.0002227996,0.00057266286,0.00035491824,0.0002743151],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083944737,0.0005300705,0.0007223065,0.00020364346,0.00071581267,0.0001444642,0.00017467613,0.00038429745,0.00083793094],"category_scores_gemma":[0.008370884,0.0003351463,0.00026452995,0.00071504567,0.0008419334,0.00032128528,0.0003333671,0.0010003799,0.00009287265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025151605,0.0032360223,0.702593,0.00037453836,0.00067072955,0.000015606063,0.002482023,0.00023003775,0.20815843,0.000009860522,0.005961645,0.0737529],"study_design_scores_gemma":[0.012218027,0.00044922915,0.9566927,0.0018121862,0.00010182033,0.0000024062172,0.0018323873,0.016242443,0.009639211,0.00003809564,0.00052800635,0.00044348775],"about_ca_topic_score_codex":0.00015202863,"about_ca_topic_score_gemma":0.0009105036,"teacher_disagreement_score":0.25409967,"about_ca_system_score_codex":0.00019011149,"about_ca_system_score_gemma":0.0001512388,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W3182293793","doi":"10.1016/j.msard.2021.103149","title":"Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital; University of British Columbia; McGill University","funders":"National Institutes of Health; Fonds de recherche du Québec; Government of South Australia; National Institute of Allergy and Infectious Diseases; Immune Tolerance Network","keywords":"Medicine; Multiple sclerosis; White matter; Transplantation; Immunosuppression; Brain size; Nuclear medicine; Grey matter; Hematopoietic cell; Internal medicine; Magnetic resonance imaging; Oncology; Stem cell; Haematopoiesis; Radiology; Immunology; Biology","score_opus":0.03345681017649542,"score_gpt":0.2550159212055808,"score_spread":0.22155911102908538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182293793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97453034,0.016138451,0.0003985869,0.005976931,0.000403391,0.0020150552,0.0002050171,0.00020854258,0.00012367574],"genre_scores_gemma":[0.9653852,0.029163579,0.003216901,0.0003671976,0.00007685202,0.0007704577,0.00033455444,0.000116646675,0.0005686347],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965214,0.00023570305,0.00077520905,0.0010985174,0.00048211173,0.0008870159],"domain_scores_gemma":[0.99770284,0.0009879073,0.00022388765,0.00047410864,0.00025232034,0.00035895445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005064558,0.0005358509,0.000811646,0.0002525807,0.0007802921,0.00013652748,0.00011865249,0.00049637066,0.00011615115],"category_scores_gemma":[0.00092563836,0.00047904442,0.0002811628,0.00044706542,0.00041910209,0.00034521092,0.00019904252,0.00055786164,0.000015416597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003429118,0.0014583542,0.3429747,0.0035221255,0.0006630385,0.000054019732,0.01599398,0.00009021274,0.42889458,0.000022104712,0.002022172,0.2008756],"study_design_scores_gemma":[0.018093972,0.00040003302,0.95595276,0.002403138,0.00036800845,0.00004215896,0.0021482902,0.010041284,0.008969368,0.00007314625,0.0008638331,0.00064397854],"about_ca_topic_score_codex":0.0004592721,"about_ca_topic_score_gemma":0.00025898498,"teacher_disagreement_score":0.6129781,"about_ca_system_score_codex":0.000092593786,"about_ca_system_score_gemma":0.00007154365,"threshold_uncertainty_score":0.9997661},"labels":[],"label_agreement":null},{"id":"W3186473405","doi":"10.1016/j.msard.2021.103159","title":"High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Relative risk; Placebo; MEDLINE; Meta-analysis; Internal medicine; Systematic review; Multiple sclerosis; Pathology; Confidence interval; Psychiatry; Alternative medicine","score_opus":0.13169344900408472,"score_gpt":0.33982951166033093,"score_spread":0.2081360626562462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186473405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023220904,0.98344094,0.000089422785,0.00024006251,0.00023683383,0.015472327,0.0004411476,0.000026137135,0.00002991087],"genre_scores_gemma":[0.0014702791,0.9927933,0.0005080689,0.00011936131,0.000033451888,0.0037880994,0.0006164561,0.000103393955,0.00056754],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9887805,0.004298363,0.00512036,0.0010811551,0.0002802337,0.00043936202],"domain_scores_gemma":[0.99105334,0.003892018,0.0038979137,0.0006809979,0.0003147479,0.00016095814],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006514998,0.0011365477,0.03287649,0.00023335387,0.00027333057,0.00008044823,0.0002743337,0.0012430042,0.000033486725],"category_scores_gemma":[0.018212758,0.0005848605,0.009517924,0.0003546597,0.0005325051,0.000008060422,0.0002413235,0.00035896222,0.0000020064954],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032910237,0.00039779113,0.0000013364363,0.6821309,0.30315158,8.688212e-7,0.00006960158,0.000011413286,0.0006289388,0.00005891422,0.0013410121,0.008916677],"study_design_scores_gemma":[0.14528649,0.00017542647,0.0000010424437,0.1386638,0.70917606,0.000009598435,0.00011843116,0.00005400415,0.00014648704,0.000018534398,0.0053835707,0.0009665503],"about_ca_topic_score_codex":0.000081433005,"about_ca_topic_score_gemma":0.000024444758,"teacher_disagreement_score":0.54346704,"about_ca_system_score_codex":0.000014776825,"about_ca_system_score_gemma":0.00010350062,"threshold_uncertainty_score":0.99966025},"labels":[],"label_agreement":null},{"id":"W3188046047","doi":"10.1016/j.msard.2021.103206","title":"Longitudinally extensive transverse myelitis with positive aquaporin-4 IgG associated with dengue infection: a case report and systematic review of cases","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Calgary; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Neuromyelitis optica; Medicine; Transverse myelitis; Dengue fever; Serology; Rituximab; Immunology; Multiple sclerosis; Pediatrics; Antibody","score_opus":0.05147709847104438,"score_gpt":0.3069706806845038,"score_spread":0.2554935822134594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188046047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003697934,0.98906267,0.000018274366,0.00014209868,0.00006745684,0.0064992337,0.00028110656,0.00008065853,0.00015057113],"genre_scores_gemma":[0.016460033,0.98179585,0.000106474654,0.000038787108,0.000020903233,0.0007004893,0.00055730477,0.00013105915,0.0001891288],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948166,0.0007871882,0.001804508,0.0011811071,0.0008252655,0.0005853459],"domain_scores_gemma":[0.99440974,0.0018033262,0.0014358341,0.0007369495,0.0012195692,0.00039455952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086435623,0.0009665839,0.0058839996,0.00038079591,0.00039270346,0.00006141343,0.00008651967,0.00048364542,0.000045047585],"category_scores_gemma":[0.0045778467,0.0006119668,0.0006448776,0.0013200593,0.00077105075,0.00015949397,0.00012532211,0.0009227104,0.0000022676702],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006797987,0.00049466826,0.0010815415,0.90996176,0.010927694,0.04871037,0.0005546713,0.0000020588177,0.0000018689834,0.0000062865183,0.000109231056,0.028081851],"study_design_scores_gemma":[0.0028864925,0.0007511376,0.002246764,0.8868332,0.019057978,0.08606265,0.00070293486,0.000018853983,0.0000016002923,4.933361e-7,0.0007717117,0.00066617056],"about_ca_topic_score_codex":0.0014468355,"about_ca_topic_score_gemma":0.0017620933,"teacher_disagreement_score":0.03735228,"about_ca_system_score_codex":0.00021292927,"about_ca_system_score_gemma":0.0004454905,"threshold_uncertainty_score":0.9996332},"labels":[],"label_agreement":null},{"id":"W3192175397","doi":"10.1016/j.msard.2021.103165","title":"The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Physical disability; Physical therapy; Cohort; Physical medicine and rehabilitation; Cross-sectional study; Internal medicine; Pathology; Psychiatry","score_opus":0.24547990116250468,"score_gpt":0.3614456529966943,"score_spread":0.11596575183418961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192175397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871768,0.006805619,0.00049387536,0.0019149936,0.00042605118,0.0029866162,0.00007844582,0.00010109542,0.00001653188],"genre_scores_gemma":[0.9801124,0.012447845,0.006559167,0.00009827866,0.000031924465,0.00052471337,0.000059081067,0.00008416888,0.00008245551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944244,0.0006252209,0.002267935,0.0010185073,0.00080676994,0.00085717137],"domain_scores_gemma":[0.9939267,0.003529153,0.0006450099,0.0007726398,0.00062030315,0.0005061749],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016199322,0.0004469161,0.0009516892,0.0002118278,0.00084114115,0.00011249482,0.0001546343,0.0003216635,0.000009404268],"category_scores_gemma":[0.026755517,0.00030799306,0.00062327407,0.00071252586,0.00078934693,0.00020443236,0.00036516815,0.0007098343,0.0000021284886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015531308,0.0011609904,0.7085537,0.00015954254,0.00034953293,0.000012683631,0.00048273863,0.00022856855,0.009946137,0.000003974778,0.00013124147,0.2774178],"study_design_scores_gemma":[0.014481888,0.00034382188,0.9443296,0.001333983,0.00017762031,0.0000037373102,0.0016744052,0.033001415,0.0011368339,0.000026794589,0.0031233984,0.00036645815],"about_ca_topic_score_codex":0.0002516296,"about_ca_topic_score_gemma":0.0016034867,"teacher_disagreement_score":0.27705136,"about_ca_system_score_codex":0.000109914974,"about_ca_system_score_gemma":0.00019032475,"threshold_uncertainty_score":0.99993724},"labels":[],"label_agreement":null},{"id":"W3193852454","doi":"10.1016/j.msard.2021.103213","title":"Cognitive fatigue interventions for people with multiple sclerosis: A scoping review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Mary's University; Queen's University; Dalhousie University","funders":"","keywords":"CINAHL; Psychological intervention; PsycINFO; Medicine; MEDLINE; Randomized controlled trial; Cognition; Physical therapy; Systematic review; Intervention (counseling); Physical medicine and rehabilitation; Psychiatry","score_opus":0.19057575724056594,"score_gpt":0.38981919471859955,"score_spread":0.1992434374780336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193852454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000710495,0.98042303,0.00072016614,0.00047453455,0.00025044638,0.016938783,0.0006685561,0.000227849,0.00022560309],"genre_scores_gemma":[0.0011771829,0.98589265,0.0010619017,0.00013692655,0.000087161156,0.008773607,0.0022595334,0.00030754073,0.0003035107],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99340695,0.00054738205,0.0021359648,0.0018863335,0.0008055751,0.0012177848],"domain_scores_gemma":[0.99393296,0.002885063,0.0009886962,0.0008330551,0.0007632632,0.00059697195],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009225139,0.001327607,0.006098016,0.00057737826,0.0009018732,0.00018141571,0.00031815894,0.0007070782,0.00024564037],"category_scores_gemma":[0.004989599,0.0009812098,0.0026924019,0.0016373137,0.0005707145,0.00024741597,0.00046268632,0.0012649117,0.000032544347],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008964194,0.00065732974,0.00053564983,0.32467893,0.0028569445,0.0000047039,0.00023875899,0.0000025400186,0.0000040319323,0.0000054483635,0.0009801023,0.66994596],"study_design_scores_gemma":[0.007568733,0.00062481564,0.0014274349,0.96023273,0.0075935842,0.000037106223,0.00063102506,0.00015615186,0.0000033329704,0.0000021566418,0.02062909,0.0010938409],"about_ca_topic_score_codex":0.00019246747,"about_ca_topic_score_gemma":0.0017668925,"teacher_disagreement_score":0.6688521,"about_ca_system_score_codex":0.00020179854,"about_ca_system_score_gemma":0.0006779914,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W3194345549","doi":"10.1016/j.msard.2021.103152","title":"Corrigendum to “Does Age at Diagnosis Influence the Use of Health Services for Multiple Sclerosis?” [Multiple Sclerosis and Related Disorders 46 (2020), 102555]","year":2021,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; University of Manitoba; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Regret; Medicine; Pediatrics; Psychiatry; Statistics","score_opus":0.06268593145955087,"score_gpt":0.27863871155058934,"score_spread":0.21595278009103847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194345549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8190354,0.09849257,0.0001092796,0.02829361,0.017301368,0.024429165,0.01101813,0.00097114197,0.00034930083],"genre_scores_gemma":[0.6113268,0.36293846,0.0013241095,0.0013815534,0.0002410053,0.0031065242,0.0030948091,0.00060224294,0.015984518],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98655134,0.0011162139,0.0036173775,0.0036682237,0.0021454159,0.002901434],"domain_scores_gemma":[0.9892211,0.0037307953,0.0019915444,0.002522374,0.0010452253,0.0014889586],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0017176472,0.0023535595,0.004117305,0.000978597,0.0031762663,0.0004875234,0.0011311665,0.002118674,0.00022791814],"category_scores_gemma":[0.005318447,0.0017241461,0.0013822211,0.002436512,0.0022061265,0.00072346005,0.0024236997,0.002728775,0.000034801284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027753906,0.0031407883,0.39959198,0.010821039,0.0067804917,0.00002446949,0.016806753,0.0018956434,0.010620631,0.000021761807,0.4210025,0.12651855],"study_design_scores_gemma":[0.014287839,0.0013319472,0.71000683,0.014847536,0.0011048967,0.000012359465,0.0046854825,0.009038481,0.0003640444,0.000057665537,0.24210271,0.0021602304],"about_ca_topic_score_codex":0.012882517,"about_ca_topic_score_gemma":0.03911466,"teacher_disagreement_score":0.31041482,"about_ca_system_score_codex":0.000677981,"about_ca_system_score_gemma":0.00056988327,"threshold_uncertainty_score":0.999572},"labels":[],"label_agreement":null},{"id":"W3194500955","doi":"10.1016/j.msard.2021.103224","title":"In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"Janssen Pharmaceuticals; Ministero della Salute; University of Brighton; Wellcome Trust; University of Sussex; Academy of Medical Sciences; Motor Neurone Disease Association; Biogen","keywords":"Monoaminergic; Neuroscience; Ventral tegmental area; Raphe; Raphe nuclei; Medicine; Brainstem; Locus coeruleus; Multiple sclerosis; Default mode network; Thalamus; Dopaminergic; Internal medicine; Dopamine; Psychology; Serotonin; Serotonergic; Central nervous system; Functional magnetic resonance imaging","score_opus":0.06970972282189908,"score_gpt":0.27162528061441155,"score_spread":0.20191555779251247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194500955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857474,0.008036094,0.0002110792,0.0047553745,0.00019088048,0.0007945075,0.000029408906,0.000050732517,0.0001845336],"genre_scores_gemma":[0.9804493,0.018761039,0.00018471213,0.00014559615,0.000065573186,0.00009582705,0.000033470475,0.000052657102,0.0002117904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967076,0.00032819418,0.00095229625,0.00089080207,0.0004894546,0.0006316458],"domain_scores_gemma":[0.99694693,0.0020707757,0.00020128464,0.00037379662,0.00015149172,0.0002557105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076564273,0.00038648024,0.0008670798,0.0004721454,0.00022362392,0.000053295935,0.00010285021,0.00036799934,0.000113100556],"category_scores_gemma":[0.0022305374,0.00035670347,0.00017344035,0.0012691516,0.0004920556,0.0004602855,0.00028836538,0.0006674537,0.0000029625255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046772286,0.0004036576,0.8878115,0.00027612806,0.00019953313,0.000009225644,0.0010638176,0.004210772,0.088080786,0.000031317883,0.00046329235,0.016982276],"study_design_scores_gemma":[0.008649313,0.00022854874,0.9318658,0.0024974756,0.000059817536,0.000006452392,0.001701466,0.05280377,0.0016799133,0.000044932793,0.00013206647,0.00033045534],"about_ca_topic_score_codex":0.0009311374,"about_ca_topic_score_gemma":0.0034319544,"teacher_disagreement_score":0.086400874,"about_ca_system_score_codex":0.00014276103,"about_ca_system_score_gemma":0.00008369918,"threshold_uncertainty_score":0.9998885},"labels":[],"label_agreement":null},{"id":"W3194875566","doi":"10.1016/j.msard.2021.103221","title":"Vitamin D3 and estradiol alter PAD2 expression and activity levels in C6 glioma cells","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Iran University of Medical Sciences","keywords":"Multiple sclerosis; Endocrinology; Internal medicine; Citrullination; Vitamin D and neurology; Gene expression; Glioma; Medicine; Citrulline; Arginine; Biology; Cancer research; Immunology; Gene; Biochemistry","score_opus":0.03887625733290314,"score_gpt":0.27204124274272923,"score_spread":0.23316498540982608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194875566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428564,0.003105832,0.000026617216,0.0014488684,0.000087354616,0.00058889785,0.00004251758,0.000052643598,0.00036164734],"genre_scores_gemma":[0.9864359,0.012552859,0.00055818754,0.000059060483,0.000022704378,0.000049968192,0.000014766373,0.00003866701,0.0002678785],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978605,0.00020283973,0.00034879282,0.0007457565,0.000329048,0.0005130532],"domain_scores_gemma":[0.9988321,0.00041707585,0.000081965314,0.00029328978,0.000068382375,0.00030717734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003083162,0.00031705474,0.0005608753,0.00020846367,0.00025503847,0.00007620085,0.00005834825,0.0002686054,0.000088823355],"category_scores_gemma":[0.00037930312,0.00026199757,0.000080494545,0.0003704184,0.00038941676,0.00021728601,0.00026358775,0.00047975135,0.0000077630575],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014886478,0.00031982575,0.06062875,0.00016211584,0.00009081206,0.000032125183,0.0010770244,0.000016686654,0.88235134,0.0000022675038,0.00024371143,0.054926507],"study_design_scores_gemma":[0.008487349,0.00016270782,0.8730149,0.0007230314,0.00004759068,0.000024062036,0.0008187342,0.0059471685,0.11017867,0.000034916913,0.00024027076,0.00032054455],"about_ca_topic_score_codex":0.00019739427,"about_ca_topic_score_gemma":0.0001616007,"teacher_disagreement_score":0.8123862,"about_ca_system_score_codex":0.000046516925,"about_ca_system_score_gemma":0.000047480422,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W3196748365","doi":"10.1016/j.msard.2021.103253","title":"High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Multiple Sclerosis International Federation","keywords":"Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Optic neuritis; Immunology; Demyelinating disease; Titer; Immunoglobulin G; Antibody; Internal medicine; Experimental autoimmune encephalomyelitis","score_opus":0.05868217488618522,"score_gpt":0.3223163125145612,"score_spread":0.263634137628376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196748365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993287,0.002444121,0.000035738474,0.0024621792,0.00040305557,0.0011198554,0.00007919622,0.000058607846,0.000110194786],"genre_scores_gemma":[0.97274095,0.02474707,0.0017385825,0.00019533378,0.00008098443,0.000048070066,0.00011197279,0.000056302637,0.00028071195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962387,0.0003323864,0.0012566212,0.00085583015,0.00067324104,0.0006432352],"domain_scores_gemma":[0.99795234,0.00046604287,0.00027260766,0.0005717537,0.00030390467,0.00043333252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076611835,0.0003540628,0.0010321187,0.00035278377,0.00013560004,0.000019531284,0.0001874195,0.00038059245,0.00008612321],"category_scores_gemma":[0.0030206442,0.00031722814,0.00031486995,0.0012253989,0.00020320402,0.00011798565,0.00038405095,0.000692146,0.000039833998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007003162,0.0011400812,0.9668855,0.0003003927,0.00021052173,0.000029463106,0.00046834213,0.0001805201,0.01247496,0.000015817266,0.0002688432,0.017325258],"study_design_scores_gemma":[0.010349206,0.00034478688,0.9846357,0.00090397155,0.00009570217,0.0000047362882,0.00094195944,0.0006898601,0.0013573392,0.000036570877,0.00032596986,0.00031416118],"about_ca_topic_score_codex":0.00090502907,"about_ca_topic_score_gemma":0.0014981697,"teacher_disagreement_score":0.02230295,"about_ca_system_score_codex":0.00008808007,"about_ca_system_score_gemma":0.00020031497,"threshold_uncertainty_score":0.999928},"labels":[],"label_agreement":null},{"id":"W3200291571","doi":"10.1016/j.msard.2021.103269","title":"Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes","year":2021,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Biogen; Multiple Sclerosis Society of Canada; Roche; Sanofi Genzyme; VGH and UBC Hospital Foundation; Novartis","keywords":"Multiple sclerosis; Medicine; Immunology; Disease; Antigen; Clinically isolated syndrome; Internal medicine","score_opus":0.050564636669196625,"score_gpt":0.2591225114763988,"score_spread":0.20855787480720217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200291571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.843133,0.035174135,0.000031305106,0.09727665,0.0010558768,0.006980127,0.015215796,0.000560086,0.0005730247],"genre_scores_gemma":[0.9691169,0.0066317697,0.0010594382,0.016225701,0.00080052426,0.0007298495,0.0028794077,0.00053212047,0.0020242725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913983,0.00072259316,0.0018534345,0.0024752964,0.0018070661,0.0017433462],"domain_scores_gemma":[0.9944932,0.0010048457,0.0011761358,0.0016716846,0.0009400116,0.0007141209],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00047811007,0.0015566302,0.0025137358,0.0006018857,0.00071613374,0.00021910248,0.000613898,0.0018199313,0.0022911204],"category_scores_gemma":[0.0029954044,0.0013539125,0.0009931155,0.0010804735,0.0016511997,0.0002704856,0.0007916465,0.0037965516,0.000049629125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024301945,0.0032837486,0.5637161,0.0071412036,0.012842537,0.00083149254,0.003354145,0.000054700497,0.10290552,0.000009947834,0.20431831,0.09911211],"study_design_scores_gemma":[0.012471994,0.00034828443,0.92536604,0.010765944,0.0008366985,0.0000052615164,0.0005485525,0.0014509457,0.0044755517,0.000082994186,0.041914485,0.0017332344],"about_ca_topic_score_codex":0.0021682852,"about_ca_topic_score_gemma":0.00043550125,"teacher_disagreement_score":0.36164996,"about_ca_system_score_codex":0.00021088832,"about_ca_system_score_gemma":0.0006609393,"threshold_uncertainty_score":0.9997182},"labels":[],"label_agreement":null},{"id":"W3200387566","doi":"10.1016/j.msard.2021.103237","title":"Dietary intake and characteristics in persons with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut du Savoir Montfort; Niagara Health System; University of Ottawa","funders":"","keywords":"Medicine; Micronutrient; Vitamin B12; Dietary Reference Intake; Food group; Multiple sclerosis; Food science; Vitamin; Environmental health; Nutrient; Population; Physiology; Internal medicine; Biology","score_opus":0.0452704021666997,"score_gpt":0.253101953925558,"score_spread":0.2078315517588583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200387566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994553,0.0046654274,0.00001624029,0.0034448914,0.00012163244,0.0007754074,0.00010612569,0.00011279969,0.00081195764],"genre_scores_gemma":[0.9665402,0.031356037,0.0011581831,0.00023470602,0.000037788206,0.00011725745,0.00013994398,0.00007756624,0.00033830298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705935,0.00015520777,0.00059105206,0.0009363813,0.0004894935,0.0007685068],"domain_scores_gemma":[0.99836594,0.0004636734,0.0001343022,0.00044913363,0.00016521603,0.00042174885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030620716,0.00046570628,0.00083869783,0.00028562747,0.0004071033,0.00010446222,0.00010192051,0.0002852532,0.00010850377],"category_scores_gemma":[0.00090550544,0.0003778053,0.00013352076,0.0007996132,0.00066758663,0.00021468854,0.0002717538,0.0007684197,0.000013102111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055029884,0.0006423739,0.8565321,0.00023904501,0.0003706105,0.000049061335,0.0025282062,0.000017137894,0.03745042,0.000008326405,0.0002492842,0.10136317],"study_design_scores_gemma":[0.0098749595,0.0003319002,0.9766538,0.0011308147,0.0001353643,0.00003390168,0.004076031,0.005720606,0.00070137315,0.000012237849,0.00087184465,0.00045713026],"about_ca_topic_score_codex":0.00062776345,"about_ca_topic_score_gemma":0.0024391008,"teacher_disagreement_score":0.12012177,"about_ca_system_score_codex":0.0000909436,"about_ca_system_score_gemma":0.00011184118,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W3202953604","doi":"10.1016/j.msard.2021.103286","title":"Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Institute for Regenerative Medicine; Canadian Society of Nephrology; Rare Disease Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Incidence (geometry); Pediatrics; Exact test; Cohort; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunology; Internal medicine","score_opus":0.05706248991232948,"score_gpt":0.31724374599329713,"score_spread":0.26018125608096765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202953604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820959,0.005890222,0.000048507627,0.009329364,0.00007713919,0.0017372151,0.0001899585,0.00013842907,0.0004932767],"genre_scores_gemma":[0.9599367,0.039105743,0.00010532482,0.00029477244,0.00001900797,0.00011917391,0.00025934982,0.000074066724,0.00008589512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952787,0.00070320995,0.001012693,0.0009342076,0.0009379683,0.001133217],"domain_scores_gemma":[0.9974697,0.00042529835,0.00036941594,0.0005956859,0.00020653098,0.0009333173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011987356,0.00050999474,0.0011316218,0.00064626714,0.00040698473,0.0000623471,0.00020865384,0.000363446,0.00019479866],"category_scores_gemma":[0.0061852327,0.00042559768,0.00050153915,0.0016062475,0.00047166334,0.00015633431,0.00020915184,0.0008417612,0.000013948704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046159726,0.00239942,0.9136421,0.00013383666,0.0012787109,0.0000035919861,0.002014382,0.0012102909,0.0033512115,0.000028486698,0.0006583499,0.07481799],"study_design_scores_gemma":[0.01529971,0.0009646789,0.97991693,0.00042576608,0.0000402419,0.000007297996,0.0008622071,0.0015646969,0.00018027397,0.00006762755,0.00029256605,0.0003780057],"about_ca_topic_score_codex":0.01009111,"about_ca_topic_score_gemma":0.008649548,"teacher_disagreement_score":0.07443999,"about_ca_system_score_codex":0.0008049776,"about_ca_system_score_gemma":0.0012017816,"threshold_uncertainty_score":0.9998196},"labels":[],"label_agreement":null},{"id":"W3203041565","doi":"10.1016/j.msard.2021.103277","title":"Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Stockholms Läns Landsting; Kommunfullmäktige, Stockholms Stad","keywords":"Medicine; Fingolimod; Pandemic; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Disease; Family medicine; Pediatrics; Intensive care medicine; Infectious disease (medical specialty); Psychiatry; Internal medicine","score_opus":0.08959931482317973,"score_gpt":0.3420050974423322,"score_spread":0.2524057826191525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203041565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897112,0.0070262505,0.0000054921825,0.0019619097,0.00015807958,0.00075544906,0.00019427411,0.000019793508,0.00016750683],"genre_scores_gemma":[0.9460412,0.05354951,0.00003476194,0.000055423716,0.000023774788,0.000107711865,0.00012105831,0.000022592327,0.000043923574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973635,0.00037669085,0.0007517182,0.0004908673,0.00059846457,0.0004187219],"domain_scores_gemma":[0.9983842,0.0006007093,0.00023296375,0.0005268404,0.000104300605,0.00015102809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043565148,0.00031031625,0.0005950155,0.00041409297,0.00014628876,0.00002386978,0.0002775217,0.00015829112,0.00015076691],"category_scores_gemma":[0.0009903889,0.0001717046,0.0005191064,0.0013154043,0.000487657,0.00008293865,0.00013458474,0.00037853242,0.0000016546835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024015167,0.0022365355,0.8957018,0.000028916138,0.00036325684,0.0000010545973,0.003991986,0.0011335398,0.0052033467,0.000006005238,0.00018216747,0.09091124],"study_design_scores_gemma":[0.013568763,0.00029173822,0.9813471,0.00027178883,0.000077562065,0.000010727675,0.0009371174,0.002550381,0.0002578521,0.000021474712,0.00050993916,0.00015556935],"about_ca_topic_score_codex":0.003963768,"about_ca_topic_score_gemma":0.004274877,"teacher_disagreement_score":0.090755664,"about_ca_system_score_codex":0.00040852424,"about_ca_system_score_gemma":0.00018671906,"threshold_uncertainty_score":0.700191},"labels":[],"label_agreement":null},{"id":"W3203218405","doi":"10.1016/j.msard.2021.103309","title":"Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Mitacs","keywords":"Multiple sclerosis; Magnetization transfer; Medicine; Myelin; Saturation (graph theory); Differential (mechanical device); Nuclear magnetic resonance; Water saturation; Fraction (chemistry); Materials science; Chromatography; Magnetic resonance imaging; Chemistry; Composite material; Internal medicine; Central nervous system; Physics; Immunology; Thermodynamics; Porosity; Radiology","score_opus":0.040991019132828994,"score_gpt":0.297303901788054,"score_spread":0.256312882655225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203218405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84660006,0.00023124591,0.15157,0.0010242261,0.000036469046,0.0004611068,0.000009302576,0.00002421564,0.000043377408],"genre_scores_gemma":[0.9966876,0.00097654905,0.0019707526,0.000028427497,0.0000132123805,0.00003515972,0.00021606805,0.000015415939,0.000056824527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933267,0.00003945527,0.00023306768,0.00019572853,0.000080196674,0.00011888195],"domain_scores_gemma":[0.99967915,0.00010123254,0.000035086636,0.00009911132,0.000061730636,0.000023719977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010174365,0.00009388524,0.00015693603,0.000054524728,0.00017045997,0.000045311546,0.000013099662,0.00010098181,0.000015655207],"category_scores_gemma":[0.00003406276,0.00006333718,0.00003491882,0.00011182391,0.00008468791,0.00012301958,0.0000141425835,0.000120544624,1.7220007e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056975918,0.00012959616,0.0019105376,0.00009348118,0.000011898443,5.401309e-7,0.0015560715,0.0005212989,0.940188,0.00023784382,0.000008510014,0.05528527],"study_design_scores_gemma":[0.00452465,0.00018363664,0.33167824,0.0005493462,0.00020797484,0.000012035812,0.007071597,0.24205625,0.41190022,0.00055648875,0.000973509,0.00028605305],"about_ca_topic_score_codex":0.00005511705,"about_ca_topic_score_gemma":0.000120532124,"teacher_disagreement_score":0.52828777,"about_ca_system_score_codex":0.000013759685,"about_ca_system_score_gemma":0.000009883761,"threshold_uncertainty_score":0.25828153},"labels":[],"label_agreement":null},{"id":"W3204407904","doi":"10.1016/j.msard.2021.103283","title":"Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Merck","keywords":"Medicine; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Interferon beta; Interferon beta-1b; Interferon beta-1a; BETA (programming language); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Interferon; Virology; Immunology; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.0468734160230599,"score_gpt":0.27978921761934517,"score_spread":0.23291580159628528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204407904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963641,0.0007612604,0.00017591131,0.0005429232,0.00010943944,0.0014639216,0.00016294299,0.00012895591,0.00029053362],"genre_scores_gemma":[0.9967023,0.00021589767,0.0002573696,0.0022680813,0.000011807593,0.00017144241,0.00015644786,0.00008887462,0.00012775144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973496,0.00011483405,0.00066228135,0.0007698385,0.00050070643,0.0006027364],"domain_scores_gemma":[0.9979565,0.00070482056,0.00022891685,0.0005085709,0.00037482879,0.0002263358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020959796,0.00041909676,0.00084492215,0.0002723309,0.00029055725,0.00005544947,0.00016521443,0.00034931776,0.000037387344],"category_scores_gemma":[0.0007528419,0.0003146789,0.0003284055,0.00061030104,0.00046719232,0.00013840079,0.00012130217,0.00033112054,0.000007605524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032834592,0.0011031255,0.97045887,0.0003061753,0.0007520707,0.000015318696,0.0008472513,0.000029377348,0.013883869,0.000008593438,0.00017062134,0.009141245],"study_design_scores_gemma":[0.032799646,0.003572501,0.9270042,0.00050276145,0.00061038136,0.0000119885735,0.0015408259,0.0034830596,0.02671022,0.000037039757,0.0030831576,0.0006442162],"about_ca_topic_score_codex":0.001898776,"about_ca_topic_score_gemma":0.002016187,"teacher_disagreement_score":0.04345469,"about_ca_system_score_codex":0.00014630583,"about_ca_system_score_gemma":0.00020915481,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W3206377547","doi":"10.1016/j.msard.2021.103316","title":"Predictors of cognitive fatigue and fatigability in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Sanofi Genzyme; AbbVie; Roche; EMD Serono; Novartis","keywords":"Medicine; Anxiety; Cognition; Paced Auditory Serial Addition Test; Depression (economics); Effects of sleep deprivation on cognitive performance; Multiple sclerosis; Hospital Anxiety and Depression Scale; Physical therapy; Quality of life (healthcare); Audiology; Physical medicine and rehabilitation; Psychiatry; Cognitive impairment","score_opus":0.0680018828208656,"score_gpt":0.2814320459272793,"score_spread":0.21343016310641366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206377547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910614,0.0055604926,0.000048751033,0.0009942394,0.0001435893,0.0011252678,0.00014800565,0.00007360294,0.00084467937],"genre_scores_gemma":[0.977195,0.021968404,0.00039517815,0.000063743915,0.000020928968,0.000121471036,0.000104837396,0.000047509817,0.00008293196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967981,0.00028805094,0.0008624073,0.00089622854,0.00054799847,0.00060722866],"domain_scores_gemma":[0.99723905,0.0015136643,0.00018695211,0.00037706495,0.0003366895,0.00034655828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000526689,0.0003937392,0.0008892595,0.000297698,0.00024712784,0.00003942901,0.00009444006,0.0003297627,0.00009839001],"category_scores_gemma":[0.005404516,0.0003468375,0.00019316442,0.00087062776,0.0011190786,0.00020482639,0.00031829404,0.0005795148,0.0000046910714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000379435,0.0008638796,0.92871207,0.00030489528,0.00039643786,0.000005789012,0.0031122356,0.000045399407,0.028421171,0.000010606218,0.000082244,0.03766584],"study_design_scores_gemma":[0.012024135,0.00026927385,0.96945226,0.0017980183,0.00013627499,0.0000049170453,0.0051159086,0.004095504,0.006668567,0.00005272105,0.00006802416,0.00031439582],"about_ca_topic_score_codex":0.00080489623,"about_ca_topic_score_gemma":0.0015767142,"teacher_disagreement_score":0.040740192,"about_ca_system_score_codex":0.00007343778,"about_ca_system_score_gemma":0.00012143231,"threshold_uncertainty_score":0.9998984},"labels":[],"label_agreement":null},{"id":"W3206988781","doi":"10.1016/j.msard.2021.103322","title":"Age differences in trajectories of self-rated health of young people with Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; McGill University","funders":"Royal Children's Hospital Foundation","keywords":"Medicine; Multiple sclerosis; Prodrome; Young adult; Demography; Ordinal regression; Pediatrics; Gerontology; Psychiatry; Psychosis","score_opus":0.038346679308120094,"score_gpt":0.25835720257810446,"score_spread":0.22001052326998438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206988781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992864,0.0044730445,0.00003838498,0.0009016171,0.0001306944,0.0009867024,0.00009166241,0.000096663636,0.00041723961],"genre_scores_gemma":[0.9712669,0.026788171,0.0015767304,0.000027972772,0.000013717965,0.00009336661,0.000087462366,0.000055182394,0.00009046481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964996,0.00029932405,0.0010465856,0.00071710756,0.00073209254,0.000705316],"domain_scores_gemma":[0.99795485,0.0005523459,0.00038609424,0.00047805495,0.00034772468,0.00028096014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044024165,0.00042243287,0.0014711624,0.0003672852,0.00022849384,0.000033446337,0.00015780097,0.00023370085,0.00006867139],"category_scores_gemma":[0.0007064707,0.000327288,0.00019457529,0.00166535,0.0005312524,0.0001655803,0.00016175525,0.0004904843,0.0000019571203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046664407,0.0013822091,0.9502445,0.00070869096,0.0005372753,0.0000056162776,0.009419046,0.00007095706,0.03239122,0.000024516668,0.00007250232,0.0046768226],"study_design_scores_gemma":[0.009912234,0.00070163124,0.97324663,0.0015163744,0.00008159974,0.0000067137507,0.007630202,0.0022415798,0.004313678,0.000015394924,0.000027942182,0.000306014],"about_ca_topic_score_codex":0.0051589985,"about_ca_topic_score_gemma":0.025994878,"teacher_disagreement_score":0.02807754,"about_ca_system_score_codex":0.00011009106,"about_ca_system_score_gemma":0.00031169006,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W3207337634","doi":"10.1016/j.msard.2021.103338","title":"A systematic review of the effects of cannabis on cognition in people with multiple sclerosis","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Dalhousie University; Nova Scotia Health Authority","funders":"Dalhousie Medical Research Foundation","keywords":"Cannabis; Cognition; Medicine; Context (archaeology); Effects of cannabis; Multiple sclerosis; Cannabinoid; Psychiatry; Cannabidiol; Clinical psychology","score_opus":0.02089277612849307,"score_gpt":0.26244785426701756,"score_spread":0.24155507813852448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207337634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019791445,0.9893964,0.0000010626978,0.0005491954,0.00013924249,0.007680061,0.00008189107,0.000018594232,0.00015442347],"genre_scores_gemma":[0.008626286,0.98914117,0.000008830577,0.00010196372,0.000009964075,0.0012892719,0.00012605946,0.00009007982,0.00060640415],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960483,0.0006995439,0.0014402911,0.0006130356,0.0007873471,0.0004115297],"domain_scores_gemma":[0.9975488,0.00033073113,0.0008774183,0.0008180158,0.0002644595,0.00016058126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058522774,0.00054344547,0.0039083846,0.00034787387,0.0001076654,0.000020478108,0.0002320914,0.0004273945,0.000037202986],"category_scores_gemma":[0.0023327644,0.0003011737,0.00092691823,0.0017464068,0.00028698638,0.00004621472,0.00013588487,0.0008021095,0.0000032921034],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041484935,0.0005533954,0.00029481502,0.95923203,0.000657294,0.0000041916237,0.00019569164,0.0000017462705,0.000032238688,0.0000081354165,0.0010558722,0.037923127],"study_design_scores_gemma":[0.0028969178,0.0004593964,0.0029726387,0.9849344,0.0041151545,0.000022050359,0.00016227544,0.00003051413,0.00004728455,0.0000015205217,0.004041067,0.0003168138],"about_ca_topic_score_codex":0.0006173437,"about_ca_topic_score_gemma":0.0006345879,"teacher_disagreement_score":0.037606314,"about_ca_system_score_codex":0.00014328933,"about_ca_system_score_gemma":0.00047821054,"threshold_uncertainty_score":0.99994403},"labels":[],"label_agreement":null},{"id":"W3208607270","doi":"10.1016/j.msard.2021.103366","title":"Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; White matter; Multiple sclerosis; Fractional anisotropy; Myelin; Magnetic resonance imaging; Expanded Disability Status Scale; Pathology; Diffusion MRI; Lesion; Internal medicine; Radiology; Central nervous system","score_opus":0.021924225447769768,"score_gpt":0.2247373587507246,"score_spread":0.20281313330295483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208607270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94439226,0.045457277,0.00001893632,0.0076310355,0.00019720822,0.0012551388,0.000059415008,0.00013864196,0.00085007475],"genre_scores_gemma":[0.95560473,0.0421522,0.0009579538,0.00040020456,0.00003409816,0.00018175562,0.00004952062,0.00010370837,0.00051579915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582183,0.00028824675,0.00077441556,0.0013194297,0.0007212767,0.0010747878],"domain_scores_gemma":[0.9980587,0.00059624895,0.00015418766,0.000531019,0.00020092812,0.00045895085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051865703,0.0006114867,0.0008211975,0.0003783069,0.0005058715,0.00014583013,0.00015044092,0.00023565644,0.00018727953],"category_scores_gemma":[0.0008114794,0.00051225966,0.00015287285,0.0010018477,0.0006810589,0.0002512876,0.00038805016,0.0009025168,0.000017196595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085460226,0.00045949832,0.7988659,0.00015721883,0.00010363899,0.0000812904,0.0011547115,0.00011859389,0.028510967,0.000013465292,0.0004562756,0.16922383],"study_design_scores_gemma":[0.015246052,0.00036573326,0.94255555,0.0018538825,0.00010376497,0.000051456194,0.0029024752,0.033062268,0.0011519289,0.000023269153,0.0021098373,0.0005737784],"about_ca_topic_score_codex":0.00044525845,"about_ca_topic_score_gemma":0.0014270236,"teacher_disagreement_score":0.16865006,"about_ca_system_score_codex":0.00013202945,"about_ca_system_score_gemma":0.00013191771,"threshold_uncertainty_score":0.9997329},"labels":[],"label_agreement":null},{"id":"W3208727480","doi":"10.1016/j.msard.2021.103367","title":"Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Atrophy; Disease; Clinical trial; Pediatrics; Immunology","score_opus":0.0799425548653229,"score_gpt":0.33092033841724955,"score_spread":0.2509777835519267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208727480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958327,0.001523976,0.0000278463,0.0008568953,0.00008181013,0.0014139137,0.00014278379,0.000082545936,0.000037544094],"genre_scores_gemma":[0.9951627,0.0031959605,0.0010076294,0.00010036245,0.000013543495,0.00012684452,0.00009286695,0.000090064386,0.00020998085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563354,0.000544503,0.0011654189,0.0011726473,0.0007098854,0.00077398826],"domain_scores_gemma":[0.9958712,0.002151197,0.0005247113,0.0005958301,0.00047343152,0.00038364006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005718032,0.00061238225,0.0016802622,0.0004190731,0.00030266785,0.0000802269,0.00013487265,0.000294768,0.000017888213],"category_scores_gemma":[0.0031419122,0.00042299132,0.00024641378,0.00091073406,0.00059461064,0.00025495887,0.00021944715,0.00051707897,0.0000029696166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046562855,0.0023501494,0.9753296,0.000079301804,0.0015669916,0.0000138240985,0.0022883934,0.00013538158,0.002091058,7.793097e-7,0.000019550334,0.011468726],"study_design_scores_gemma":[0.025628997,0.0035240585,0.9637153,0.0034758842,0.00040358384,0.0000012871603,0.0019382733,0.00030685542,0.0005347904,0.0000014735612,0.000013160216,0.00045632073],"about_ca_topic_score_codex":0.00044231061,"about_ca_topic_score_gemma":0.0020996765,"teacher_disagreement_score":0.020972712,"about_ca_system_score_codex":0.00023213083,"about_ca_system_score_gemma":0.000105611216,"threshold_uncertainty_score":0.9998222},"labels":[],"label_agreement":null},{"id":"W3210963379","doi":"10.1016/j.msard.2021.103336","title":"The impact of brain lesions on sexual dysfunction in patients with multiple sclerosis: A systematic review of magnetic resonance imaging studies","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Cognitive Sciences and Technologies Council; Iran University of Medical Sciences","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Functional magnetic resonance imaging; Sexual dysfunction; Pathology; Radiology; Psychiatry","score_opus":0.059033434765610085,"score_gpt":0.3213234260537245,"score_spread":0.2622899912881144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210963379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047445893,0.98785585,0.0000010926175,0.00017393539,0.0001022107,0.00685745,0.00019280192,0.00003572963,0.000036343088],"genre_scores_gemma":[0.02180964,0.97686714,0.000037176145,0.00003458678,0.000013307025,0.00088580995,0.00014847735,0.00011088799,0.00009297615],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937712,0.0011837359,0.0023688183,0.0009173165,0.0010612844,0.0006976497],"domain_scores_gemma":[0.9929589,0.0038450519,0.0012423166,0.0010972298,0.00067404355,0.00018247748],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014174766,0.00087892695,0.0049362346,0.0004795598,0.00036140403,0.00003767776,0.00030274785,0.00025932415,0.000016624987],"category_scores_gemma":[0.0089657735,0.00045772945,0.0008117935,0.001632095,0.0008145069,0.00011414328,0.00029680462,0.0009078567,0.0000048100983],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023017042,0.00093965617,0.015246967,0.5358888,0.0014723485,0.0000026811178,0.00046229098,0.00001565041,0.000007517813,0.000003210646,0.00078724115,0.4449435],"study_design_scores_gemma":[0.00548213,0.0012180274,0.08789571,0.90103656,0.001773384,0.000003192351,0.0011133746,0.00018785687,7.8472607e-7,0.0000012037357,0.000849014,0.0004387604],"about_ca_topic_score_codex":0.00036698385,"about_ca_topic_score_gemma":0.00020125686,"teacher_disagreement_score":0.44450474,"about_ca_system_score_codex":0.0003790824,"about_ca_system_score_gemma":0.00031025583,"threshold_uncertainty_score":0.99978745},"labels":[],"label_agreement":null},{"id":"W3211797748","doi":"10.1016/j.msard.2021.103404","title":"Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Medicine; Multiple sclerosis; De-escalation; Family medicine; Psychiatry; Intensive care medicine","score_opus":0.07930803957407116,"score_gpt":0.29542118526838634,"score_spread":0.21611314569431517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211797748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687636,0.00019122861,0.000007141201,0.0010061311,0.00019459572,0.00081772235,0.00028338202,0.00010610302,0.00051733723],"genre_scores_gemma":[0.9961397,0.0020579472,0.00006876295,0.000042168485,0.00006944812,0.000043468877,0.0013468848,0.000037274007,0.00019432971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976132,0.00026615392,0.00047047992,0.0008303367,0.0004861165,0.00033372987],"domain_scores_gemma":[0.9986873,0.00035101786,0.00017834835,0.0003282587,0.00019298437,0.0002620691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019359801,0.00033428468,0.00048428093,0.0001273285,0.00031889026,0.00013401081,0.00007469988,0.00017129224,0.000067236324],"category_scores_gemma":[0.0010072812,0.00023056165,0.00008270552,0.0002538661,0.000327474,0.00023988671,0.000114670496,0.0002634957,0.0000013138468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005775328,0.00179859,0.98257804,0.00000333349,0.0009979546,0.000020943286,0.0038910275,0.00023520026,0.0021224027,0.0000035287292,0.00003456334,0.007736856],"study_design_scores_gemma":[0.016210325,0.0012275033,0.9702663,0.00008879536,0.00018635736,8.41885e-7,0.002005804,0.009381087,0.0002758509,0.000012400373,0.00011050914,0.00023423397],"about_ca_topic_score_codex":0.00385018,"about_ca_topic_score_gemma":0.014103178,"teacher_disagreement_score":0.015632791,"about_ca_system_score_codex":0.0001539591,"about_ca_system_score_gemma":0.00004922631,"threshold_uncertainty_score":0.94020313},"labels":[],"label_agreement":null},{"id":"W3211811792","doi":"10.1016/j.msard.2021.103384","title":"Relationship between lymphopenia and disease activity in persons with multiple sclerosis treated with dimethyl fumarate","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Memorial University of Newfoundland","funders":"","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Discontinuation; Adverse effect; Internal medicine; Mallinckrodt; Disease; Glatiramer acetate; Lymphocyte; Lymphocytopenia; Gastroenterology; Oncology; Immunology","score_opus":0.05995907752777968,"score_gpt":0.2702331384550504,"score_spread":0.21027406092727075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211811792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202925,0.0025650593,0.00006624665,0.0032894358,0.0000281724,0.0012884282,0.00016567633,0.00014685061,0.00042089875],"genre_scores_gemma":[0.99505407,0.0031226557,0.0007033702,0.0000752776,0.000025928197,0.00022538197,0.00016418239,0.0001035256,0.0005256324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964647,0.00038978524,0.0004735866,0.0012054443,0.0006318856,0.00083455],"domain_scores_gemma":[0.9967546,0.0013733248,0.00017573859,0.00058346515,0.00018907303,0.00092383125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038229857,0.0005904617,0.0008878895,0.0003861085,0.00068443484,0.00014721268,0.00011355185,0.00027521557,0.000049000093],"category_scores_gemma":[0.0013844486,0.00044047306,0.00013326571,0.0013919338,0.00081513,0.00041919,0.00020589077,0.00072960876,0.000011457954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021619645,0.0005108542,0.9789955,0.00020344381,0.00036723967,0.000041531523,0.00089571596,0.00012260096,0.0052184504,0.000009869293,0.000085542226,0.011387308],"study_design_scores_gemma":[0.018508935,0.0004153964,0.9743433,0.001045242,0.0003880546,0.000008959557,0.0011343424,0.0028113022,0.00063873234,0.000021207761,0.000113248076,0.000571296],"about_ca_topic_score_codex":0.001401315,"about_ca_topic_score_gemma":0.0025275368,"teacher_disagreement_score":0.01634697,"about_ca_system_score_codex":0.00017844618,"about_ca_system_score_gemma":0.00028601274,"threshold_uncertainty_score":0.9998047},"labels":[],"label_agreement":null},{"id":"W3211966991","doi":"10.1016/j.msard.2021.103395","title":"The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Multiple sclerosis; Simvastatin; Internal medicine; Statin; Meta-analysis; Randomized controlled trial; Odds ratio; Confidence interval; Clinically isolated syndrome; HMG-CoA reductase; Clinical trial; Oncology; Reductase; Immunology","score_opus":0.09112487645957563,"score_gpt":0.32131188854862053,"score_spread":0.2301870120890449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211966991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093173835,0.98693657,0.0000015214678,0.0009393758,0.000119476594,0.010708822,0.00027581412,0.000060227696,0.000026469315],"genre_scores_gemma":[0.040331375,0.95554936,0.000023779756,0.000093872506,0.00001684737,0.0035198976,0.00013571003,0.000121545934,0.00020758259],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99144864,0.002611264,0.0023204535,0.0015988896,0.0011400082,0.0008807196],"domain_scores_gemma":[0.9894217,0.006624353,0.0013238479,0.0017525412,0.00023901224,0.00063850346],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018812632,0.001287518,0.011677896,0.0008641476,0.00056759315,0.00012734903,0.00037970624,0.0005060655,0.000030715168],"category_scores_gemma":[0.011632596,0.0007263688,0.004244269,0.0030253157,0.00085688307,0.00014887132,0.0005135482,0.0013845091,0.000008573266],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121371915,0.0009933815,0.0001350732,0.838637,0.12932532,0.000020885249,0.00019553963,0.00000884432,0.00003070744,0.000009185794,0.00032599378,0.03019673],"study_design_scores_gemma":[0.002594324,0.0002684199,0.002036558,0.2938245,0.6981757,0.000004180711,0.00017054687,0.00020277954,0.000014580829,0.0000045831534,0.0018766817,0.0008271172],"about_ca_topic_score_codex":0.0003462271,"about_ca_topic_score_gemma":0.0003350389,"teacher_disagreement_score":0.5688504,"about_ca_system_score_codex":0.00020140491,"about_ca_system_score_gemma":0.00024204481,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W3212518353","doi":"10.1016/j.msard.2021.103389","title":"Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Pregnancy; Family medicine; Psychiatry","score_opus":0.07045415638180676,"score_gpt":0.30617203998382925,"score_spread":0.2357178836020225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212518353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904664,0.0035678837,0.00007632798,0.0008277296,0.0002404758,0.0038054737,0.0005274612,0.00005380113,0.0004344247],"genre_scores_gemma":[0.98148286,0.016632084,0.0007654509,0.000030733794,0.00010650025,0.0005972917,0.0001967145,0.00007772129,0.000110659756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962516,0.00030335475,0.0008901716,0.0011559905,0.00059182354,0.0008070486],"domain_scores_gemma":[0.99501026,0.0035009475,0.00018853304,0.0005721862,0.00021900536,0.00050907163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003452889,0.0006322605,0.001499084,0.0004361832,0.0004552067,0.000087064516,0.00016992817,0.00036426613,0.00004255581],"category_scores_gemma":[0.0026661071,0.00047529183,0.00036328455,0.0007675229,0.00038625294,0.000115940384,0.00023222831,0.0003086386,0.000007540124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010895152,0.0005327617,0.57735425,0.00034153802,0.00037663605,0.000008213938,0.0024492966,0.00005410671,0.009567147,0.000010910411,0.00009306968,0.40812254],"study_design_scores_gemma":[0.01796446,0.003294546,0.95781446,0.004722707,0.00026417966,0.000001322466,0.0005387534,0.0006302379,0.014034032,0.000046625268,0.00024844805,0.0004402459],"about_ca_topic_score_codex":0.0009930315,"about_ca_topic_score_gemma":0.003352975,"teacher_disagreement_score":0.4076823,"about_ca_system_score_codex":0.0002605651,"about_ca_system_score_gemma":0.00010451941,"threshold_uncertainty_score":0.99976987},"labels":[],"label_agreement":null},{"id":"W3216053749","doi":"10.1016/j.msard.2021.103408","title":"Response to treatment in NMOSD: the Australasian experience","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; University of British Columbia; University of Sydney; Brain Foundation; Multiple Sclerosis Australia; NIHR Oxford Biomedical Research Centre; Star Scientific Foundation; Petre Foundation; Guthy-Jackson Charitable Foundation","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.046378994448420155,"score_gpt":0.30434004320411007,"score_spread":0.2579610487556899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216053749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97089094,0.0011544497,0.0000073307356,0.026028164,0.00011185879,0.00085100305,0.000012451588,0.000049439772,0.00089436764],"genre_scores_gemma":[0.9926714,0.0046102777,0.00031287395,0.00031072364,0.00001572853,0.00029713288,0.000010033219,0.000026108557,0.0017457262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980107,0.00026849634,0.00035049403,0.0005331395,0.00032316192,0.0005140184],"domain_scores_gemma":[0.99872005,0.00045155198,0.00003964906,0.00045630793,0.000070339214,0.00026212703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032279847,0.00023759475,0.0003440868,0.00014523389,0.0002932342,0.00005542184,0.000100456724,0.0001227931,0.00015712141],"category_scores_gemma":[0.0011369698,0.0001520282,0.00012273015,0.0007562849,0.0002519285,0.00007063006,0.00013786834,0.00024509412,0.000041605468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003053693,0.0013811336,0.5642295,0.000041294898,0.00032657073,0.00009729185,0.039065335,0.00047410288,0.19038261,0.00003528482,0.0008651506,0.20004801],"study_design_scores_gemma":[0.0050887847,0.00035515855,0.9561337,0.00019502515,0.000025763391,0.000012084135,0.010874344,0.0006778894,0.0034925174,0.000013244359,0.022943644,0.00018783956],"about_ca_topic_score_codex":0.000612134,"about_ca_topic_score_gemma":0.0016029093,"teacher_disagreement_score":0.3919042,"about_ca_system_score_codex":0.00016261649,"about_ca_system_score_gemma":0.00010374411,"threshold_uncertainty_score":0.619953},"labels":[],"label_agreement":null},{"id":"W3216860585","doi":"10.1016/j.msard.2021.103426","title":"It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology","year":2021,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Clinical endpoint; Placebo; Multiple sclerosis; Frequentist inference; Holy Grail; Intensive care medicine; Clinical study design; Neurology; Physical therapy; Alternative medicine; Internal medicine; Psychiatry; Bayesian probability; Statistics; Pathology","score_opus":0.32618042834971345,"score_gpt":0.4114681794528889,"score_spread":0.08528775110317544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216860585","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11599008,0.005738699,0.0006246969,0.04828655,0.80000335,0.024660317,0.0014266982,0.00026043813,0.0030091794],"genre_scores_gemma":[0.02942877,0.10751988,0.0254283,0.008014251,0.8013534,0.005350093,0.0012119381,0.0011758227,0.020517522],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907235,0.0025323336,0.0024752764,0.001725142,0.0015988479,0.0009448979],"domain_scores_gemma":[0.97703046,0.019492906,0.00076873874,0.0011538732,0.0009024113,0.0006516324],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0056618685,0.0008062791,0.002885391,0.00048025645,0.00039546567,0.00011314822,0.0005857644,0.0016906932,0.0007428527],"category_scores_gemma":[0.06300761,0.00057490874,0.0010851561,0.0008359402,0.00073554687,0.00009244013,0.0009495338,0.0024682179,0.00015539119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14625776,0.00059025286,0.000041778443,0.00010434673,0.0024688644,0.0000075342327,0.003152814,0.000047479163,0.0016209868,7.9937126e-7,0.8020372,0.043670192],"study_design_scores_gemma":[0.4579022,0.008891716,0.0014311771,0.0023736055,0.001299484,0.0000025702896,0.0019458473,0.0006059359,0.00057275547,0.000108130436,0.5236962,0.0011703703],"about_ca_topic_score_codex":0.0005363458,"about_ca_topic_score_gemma":0.00018439713,"teacher_disagreement_score":0.31164443,"about_ca_system_score_codex":0.00015497906,"about_ca_system_score_gemma":0.00066990417,"threshold_uncertainty_score":0.9998331},"labels":[],"label_agreement":null},{"id":"W3217203738","doi":"10.1016/j.msard.2021.103422","title":"Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; White matter; Lesion; Pathology; Neurofilament; Parenchyma; Magnetic resonance imaging; Immunology; Radiology; Immunohistochemistry","score_opus":0.06470887912743513,"score_gpt":0.3081831803335818,"score_spread":0.24347430120614666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217203738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15751171,0.83762467,0.00000801102,0.00079993764,0.0001776566,0.0031597898,0.00038196085,0.00014987188,0.00018641348],"genre_scores_gemma":[0.20143814,0.7967007,0.0000683265,0.0002247968,0.000016098053,0.00026348676,0.0004929487,0.00018405149,0.00061141857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928895,0.0007818528,0.002249434,0.001851478,0.0008822794,0.0013454464],"domain_scores_gemma":[0.99666667,0.00096725964,0.0007762385,0.00074781204,0.0002572262,0.00058477913],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008116535,0.0012809582,0.0043536425,0.00065062294,0.00034360786,0.0002012395,0.0002777755,0.0012605118,0.0005246816],"category_scores_gemma":[0.00065327325,0.00093731144,0.0005563795,0.0015883589,0.00076713634,0.00020923855,0.000554248,0.0023571798,0.000049699458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009732186,0.0039455774,0.6399233,0.013621506,0.009783333,0.0013616432,0.0028741474,0.000029911467,0.00004094596,0.0000041830176,0.001727063,0.3257152],"study_design_scores_gemma":[0.01667662,0.0021300393,0.88676167,0.06718989,0.0024670095,0.00043252175,0.00038037743,0.0012797404,0.0000011111301,0.0000056992717,0.020712545,0.0019627789],"about_ca_topic_score_codex":0.00015911061,"about_ca_topic_score_gemma":0.00017487947,"teacher_disagreement_score":0.32375243,"about_ca_system_score_codex":0.00022925629,"about_ca_system_score_gemma":0.00032592812,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W34627003","doi":"10.1016/j.msard.2021.103286","title":"Mura urbane di Busca","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Ancient Mediterranean Archaeology and History","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Institute for Regenerative Medicine; Canadian Society of Nephrology; Rare Disease Foundation; Biogen","keywords":"Mura; Geography; Computer science","score_opus":0.022563031573890262,"score_gpt":0.18525322085241958,"score_spread":0.16269018927852932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34627003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93307906,0.0012229454,0.000012103902,0.0010903714,0.0034843755,0.000187687,0.000020937416,0.0001674801,0.06073506],"genre_scores_gemma":[0.99112856,0.0003242732,0.00003825394,0.0001980831,0.00016718614,0.000016437742,0.000038278984,0.0000223486,0.008066585],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909383,0.000027914888,0.00020886552,0.00027393855,0.00011468271,0.0002807948],"domain_scores_gemma":[0.999516,0.00008081126,0.0000700304,0.00018552782,0.000033643737,0.00011396821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013355356,0.00016137585,0.00016480328,0.00010900383,0.00072643114,0.00003525211,0.00012496904,0.00013938868,0.0028622376],"category_scores_gemma":[0.000049818922,0.00013338614,0.0000841158,0.000036694186,0.0015879762,0.00015576322,0.000052717915,0.0004677466,0.00018265113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030977748,0.0010518802,0.07237853,0.00014312787,0.00041900462,0.000018086981,0.42805532,0.000042507254,0.010168328,0.25388956,0.05035049,0.18317337],"study_design_scores_gemma":[0.0022273608,0.00012576203,0.06767619,0.00004447341,0.0000597343,0.000006083277,0.0033139894,0.0014130176,0.000036373316,0.0020119788,0.9226059,0.00047918558],"about_ca_topic_score_codex":0.00021999993,"about_ca_topic_score_gemma":0.0041407663,"teacher_disagreement_score":0.8722554,"about_ca_system_score_codex":0.000006860387,"about_ca_system_score_gemma":0.000014743505,"threshold_uncertainty_score":0.99804926},"labels":[],"label_agreement":null},{"id":"W4200360730","doi":"10.1016/j.msard.2021.103468","title":"Pandemic-associated mental health changes in youth with neuroinflammatory disorders","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; University of Toronto","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Pandemic; Mental health; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Neuroinflammation; Psychiatry; 2019-20 coronavirus outbreak; Virology; Immunology; Disease; Inflammation; Pathology","score_opus":0.01782153277906568,"score_gpt":0.24075697291892958,"score_spread":0.2229354401398639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200360730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97805405,0.003059878,0.000009013806,0.017096283,0.00019134875,0.0009840437,0.000044950262,0.000193994,0.0003664411],"genre_scores_gemma":[0.9871365,0.01076088,0.00007193077,0.0013826615,0.000014457328,0.00003048011,0.00034714807,0.00006742157,0.00018854394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979217,0.00021773543,0.00036715105,0.0005934229,0.00033614354,0.0005638575],"domain_scores_gemma":[0.9989606,0.00020626983,0.0001777028,0.0002971573,0.000038467293,0.00031976769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031301755,0.0003171045,0.0005332842,0.00019762252,0.00022901713,0.000038464394,0.00008040879,0.00021598171,0.00004427608],"category_scores_gemma":[0.00031407137,0.0002645319,0.00009733074,0.0005419619,0.00019380453,0.00011496741,0.00008147673,0.00046820956,0.000006701877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037204532,0.00057124364,0.9741378,0.00018767966,0.00020380369,0.00002142568,0.006271587,0.00010762356,0.002342927,0.000018195966,0.00024132278,0.015524371],"study_design_scores_gemma":[0.019028751,0.00073775544,0.9721695,0.0011733721,0.000100060744,0.000020116819,0.003799872,0.0015115528,0.00014256226,0.000062117666,0.0007969504,0.0004573899],"about_ca_topic_score_codex":0.0008220328,"about_ca_topic_score_gemma":0.017104572,"teacher_disagreement_score":0.018656706,"about_ca_system_score_codex":0.0001793939,"about_ca_system_score_gemma":0.00024314753,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W4200548123","doi":"10.1016/j.msard.2021.103467","title":"Feasibility of a theory-informed mobile app for changing physical activity in youth with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Social cognitive theory; Intervention (counseling); Medicine; Physical therapy; Cardiorespiratory fitness; Depression (economics); Psychology; Psychiatry; Developmental psychology","score_opus":0.061819206001710966,"score_gpt":0.2981677991008056,"score_spread":0.23634859309909462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200548123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492395,0.0007350225,0.00044555182,0.0002673443,0.000074423595,0.0028055357,0.00027486266,0.00010234075,0.0003709529],"genre_scores_gemma":[0.99627393,0.0020362367,0.0007982558,0.00003143481,0.000032350985,0.0005123742,0.000109135246,0.00006730952,0.00013894416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701405,0.00018883985,0.00047699627,0.0008405117,0.0005319192,0.00094767485],"domain_scores_gemma":[0.9973124,0.0013289015,0.0002181121,0.00057341554,0.00030813407,0.00025901414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007128068,0.00043019722,0.0010100055,0.00033381613,0.0003336197,0.000040629388,0.0001369416,0.00023066119,0.000027119391],"category_scores_gemma":[0.0016281327,0.00033271403,0.0003380819,0.0011242633,0.00060051074,0.00024173669,0.0002524552,0.00047202318,0.000002814237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009566558,0.007038196,0.61255145,0.0016915778,0.0011634901,0.000006386584,0.03284976,0.0012310619,0.1480968,0.00012682054,0.00005817621,0.18561973],"study_design_scores_gemma":[0.03131247,0.0010276502,0.8880234,0.0017368811,0.00030254506,0.0000037874931,0.02323228,0.025309373,0.028242722,0.000113618495,0.000059935242,0.0006353741],"about_ca_topic_score_codex":0.000272664,"about_ca_topic_score_gemma":0.0008173365,"teacher_disagreement_score":0.27547193,"about_ca_system_score_codex":0.00016456078,"about_ca_system_score_gemma":0.00021106978,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W4205747186","doi":"10.1016/j.msard.2021.103479","title":"Comparing diagnostic criteria for the diagnosis of neurocognitive disorders in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Eurostars; Amsterdam Neuroscience; ZonMw; Multiple Sclerosis Society of Canada; National Institutes of Health; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Atara Biotherapeutics; Celgene; Biogen; National Multiple Sclerosis Society; MedDay Pharmaceuticals; Sanofi","keywords":"McNemar's test; Medicine; Neurocognitive; Cognition; Multiple sclerosis; Cognitive impairment; Clinical psychology; Normative; Cognitive test; Psychiatry; Physical therapy","score_opus":0.08991184375142688,"score_gpt":0.2969553129104668,"score_spread":0.2070434691590399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205747186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417664,0.005562433,0.00012473346,0.0041662147,0.00043399647,0.0047663976,0.00031134102,0.000094784635,0.000363444],"genre_scores_gemma":[0.9680625,0.026280377,0.00020113548,0.00015887583,0.00003512762,0.0050247763,0.00009775222,0.000094540184,0.000044896104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963381,0.00037044348,0.00092677306,0.00083045254,0.0006811616,0.0008530395],"domain_scores_gemma":[0.9902194,0.008645728,0.0002859706,0.00049419707,0.00014781754,0.0002068917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000911014,0.0004556511,0.00087644265,0.00044202103,0.001232422,0.00005450465,0.00036623218,0.00013303816,0.00021651645],"category_scores_gemma":[0.005158968,0.00036796893,0.00039666507,0.0010250187,0.000751223,0.0001666496,0.00069006655,0.0007795956,0.0000041213816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010218741,0.0014153619,0.9245752,0.0002466842,0.00043624899,0.0000015846458,0.003068762,0.0027900997,0.0033212448,0.000027642589,0.0010279934,0.062067278],"study_design_scores_gemma":[0.013566973,0.0006790758,0.92859393,0.00040558956,0.0002291638,0.000002615179,0.0063215657,0.047309395,0.00042020794,0.00011459459,0.0019647225,0.00039215368],"about_ca_topic_score_codex":0.0021172084,"about_ca_topic_score_gemma":0.0027860182,"teacher_disagreement_score":0.061675124,"about_ca_system_score_codex":0.0001363916,"about_ca_system_score_gemma":0.00006787957,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W4205816563","doi":"10.1016/j.msard.2022.103516","title":"Wilcoxon-Mann-Whitney odds ratio: A statistical measure for ordinal outcomes such as EDSS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Manitoba","funders":"","keywords":"Ordinal Scale; Ordinal data; Medicine; Odds ratio; Expanded Disability Status Scale; Ordinal regression; Confidence interval; Wilcoxon signed-rank test; Odds; Statistics; Mann–Whitney U test; Ordered logit; Multiple sclerosis; Physical therapy; Internal medicine; Mathematics; Logistic regression; Psychiatry","score_opus":0.042497542601688205,"score_gpt":0.2986033938349913,"score_spread":0.2561058512333031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205816563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96084327,0.0042483374,0.0035573412,0.019471679,0.0010046884,0.0060639265,0.0011132217,0.00046272858,0.0032348249],"genre_scores_gemma":[0.994856,0.0009938381,0.0007402486,0.00040313898,0.00004892995,0.0011886583,0.00030640326,0.00008897758,0.0013738149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636424,0.00024085492,0.0006575357,0.0008317913,0.0010454952,0.0008601098],"domain_scores_gemma":[0.99772006,0.0010746194,0.0001526814,0.00040763416,0.00021967225,0.00042533912],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000806205,0.00043745467,0.0007909194,0.00027818792,0.0014906498,0.000075648604,0.00021973302,0.00017072169,0.00079435704],"category_scores_gemma":[0.0025564025,0.00036457798,0.00030510136,0.000496943,0.000357823,0.00013624017,0.00035896126,0.00076118973,0.000028052733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008078649,0.0054566544,0.69074816,0.00096888584,0.005537458,0.00005868178,0.007985709,0.0018505547,0.033547837,0.009109391,0.05141622,0.1852418],"study_design_scores_gemma":[0.029874371,0.0029311122,0.8970937,0.00021786177,0.00059037923,0.00004020643,0.006834632,0.040702295,0.00026873226,0.0010175728,0.01931522,0.001113915],"about_ca_topic_score_codex":0.0005293342,"about_ca_topic_score_gemma":0.00020859996,"teacher_disagreement_score":0.20634554,"about_ca_system_score_codex":0.00017852563,"about_ca_system_score_gemma":0.00018694531,"threshold_uncertainty_score":0.9998806},"labels":[],"label_agreement":null},{"id":"W4206195605","doi":"10.1016/j.msard.2022.103539","title":"Remyelination trial failures: Repercussions of ignoring neurorehabilitation and exercise in repair","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Memorial University of Newfoundland","funders":"","keywords":"Remyelination; Medicine; Psychological intervention; Clinical trial; Neuroscience; Multiple sclerosis; Physical medicine and rehabilitation; Bioinformatics; Internal medicine; Psychology; Immunology; Central nervous system; Biology","score_opus":0.07760768729359606,"score_gpt":0.3295857761311949,"score_spread":0.2519780888375988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206195605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012926215,0.9815956,0.0000012491632,0.00022757975,0.00024340804,0.0046594795,0.00004607518,0.000103378705,0.00019703816],"genre_scores_gemma":[0.011651875,0.98685044,0.00031252264,0.0000041085445,0.000023172697,0.0008370083,0.00015174226,0.00007427774,0.000094833085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962907,0.0004992746,0.0013834615,0.00088110904,0.00056700606,0.0003784783],"domain_scores_gemma":[0.9974493,0.0014166387,0.0004266195,0.00048207396,0.00007030098,0.00015509684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010236457,0.00044375454,0.0018487712,0.00088489783,0.00028361424,0.00002253535,0.00011678436,0.0003943384,0.00008060369],"category_scores_gemma":[0.0036725062,0.00034757255,0.0005454896,0.0009675927,0.0003302734,0.00013526264,0.00032354568,0.0009494849,0.000001848784],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012967893,0.0004407832,0.00065862195,0.01073758,0.00018069499,0.00000317627,0.0012000294,0.000010692976,0.000030361743,0.000013601544,0.000094139345,0.9853335],"study_design_scores_gemma":[0.10297197,0.003044614,0.04841711,0.10091828,0.00329556,0.000022005268,0.007287401,0.003305183,0.000003853151,0.00013480088,0.72886705,0.0017321932],"about_ca_topic_score_codex":0.00043560917,"about_ca_topic_score_gemma":0.000121160745,"teacher_disagreement_score":0.98360133,"about_ca_system_score_codex":0.00015613559,"about_ca_system_score_gemma":0.00014832737,"threshold_uncertainty_score":0.9998976},"labels":[],"label_agreement":null},{"id":"W4206552172","doi":"10.1016/j.msard.2022.103509","title":"Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Ocrelizumab; Retrospective cohort study; Population; Disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pediatrics; Internal medicine; Infectious disease (medical specialty); Immunology","score_opus":0.0455873167147681,"score_gpt":0.29016341688653996,"score_spread":0.24457610017177187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206552172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90576524,0.0026618298,0.0000050246617,0.08501565,0.000681293,0.0031562897,0.0023230978,0.000089088906,0.0003024694],"genre_scores_gemma":[0.92981434,0.021618936,0.00022354897,0.045739103,0.000104370076,0.00028464993,0.0017217036,0.00016991244,0.00032340962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940593,0.0005129908,0.0017082086,0.0013008441,0.0014544387,0.00096419663],"domain_scores_gemma":[0.995154,0.0025664037,0.0007479746,0.0007553631,0.00021326994,0.0005629901],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006639836,0.0008236306,0.0022375141,0.00027761087,0.00042198342,0.000046394412,0.00031336313,0.0008369151,0.0005816565],"category_scores_gemma":[0.0035173208,0.0006471002,0.00026028763,0.00037461563,0.00087996107,0.00014910307,0.0005670828,0.0025188748,0.0000012471587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006926384,0.00052448106,0.9273519,0.0006560232,0.0009094042,0.000028908213,0.00040695947,0.00000916094,0.000013575602,9.0498446e-7,0.058493998,0.010912056],"study_design_scores_gemma":[0.015519334,0.00063276204,0.9183914,0.0004532674,0.00027349804,0.000001736143,0.0007138935,0.0003496343,0.0000012357707,0.00000233125,0.06302882,0.00063206605],"about_ca_topic_score_codex":0.541343,"about_ca_topic_score_gemma":0.5878888,"teacher_disagreement_score":0.046545815,"about_ca_system_score_codex":0.0012351563,"about_ca_system_score_gemma":0.00094344874,"threshold_uncertainty_score":0.9997824},"labels":[],"label_agreement":null},{"id":"W4206573422","doi":"10.1016/j.msard.2022.103535","title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; University of Manitoba; Ottawa Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Biomarker; Proportional hazards model; Internal medicine; Oncology; McDonald criteria; Immunology","score_opus":0.04458607865476119,"score_gpt":0.26482515623061537,"score_spread":0.22023907757585418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206573422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120295,0.0026884843,0.000043068743,0.001945708,0.00048316122,0.0017912744,0.00082356366,0.0002516092,0.00077015045],"genre_scores_gemma":[0.9859939,0.011461366,0.0011329757,0.00022347532,0.000059303777,0.0003489193,0.00011891886,0.0001350765,0.00052603625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490887,0.00050940114,0.0011396648,0.0011087366,0.0013067658,0.0010265547],"domain_scores_gemma":[0.9967039,0.0014285449,0.000490897,0.0007046413,0.00023090235,0.00044107955],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011319437,0.0005991445,0.0011537885,0.000648922,0.0016234308,0.00006335607,0.00035662227,0.00026784933,0.0014983983],"category_scores_gemma":[0.0021258756,0.00049960957,0.00040855966,0.001381738,0.0007178786,0.00032481502,0.0011171771,0.0011195708,0.000015164419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009136474,0.002139729,0.7752137,0.0006134757,0.0026024305,0.00002282309,0.009913809,0.0019752742,0.12198769,0.000075901284,0.004518152,0.07180049],"study_design_scores_gemma":[0.018450785,0.001983203,0.9412578,0.00096736924,0.000456465,0.000041479503,0.012626359,0.01572159,0.006124794,0.00010187518,0.001508628,0.00075965235],"about_ca_topic_score_codex":0.0032083034,"about_ca_topic_score_gemma":0.00024329378,"teacher_disagreement_score":0.16604406,"about_ca_system_score_codex":0.00032149145,"about_ca_system_score_gemma":0.00018026319,"threshold_uncertainty_score":0.99974555},"labels":[],"label_agreement":null},{"id":"W4207014326","doi":"10.1016/j.msard.2022.103557","title":"Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Exercise and Physiological Responses","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Hyperthermia; Coronavirus; Disease; Thermoregulation; Coronavirus disease 2019 (COVID-19); Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.03433131098261919,"score_gpt":0.25183533815478676,"score_spread":0.21750402717216757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207014326","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52608526,0.47239074,8.2351266e-7,0.000012040598,0.00006524532,0.0013479049,0.0000284018,0.00003241959,0.000037138656],"genre_scores_gemma":[0.4771281,0.52253324,0.000006876622,0.000008351549,0.000007825895,0.00014216891,0.00011928403,0.000040140138,0.000014026997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977118,0.00032431717,0.00069395656,0.00051691366,0.00040179494,0.0003512137],"domain_scores_gemma":[0.9987487,0.00031513209,0.00042176148,0.00040403873,0.000049933566,0.000060390114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020442122,0.00045599526,0.0012150559,0.00026814544,0.00032671174,0.000027784856,0.00014998608,0.00036403176,0.00010358941],"category_scores_gemma":[0.00008396952,0.0002603618,0.00042092867,0.00069627486,0.00023266555,0.000103450744,0.00013486296,0.0006516351,0.0000053342724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019160534,0.0009306682,0.030916307,0.0018097311,0.00036916113,0.0000010331341,0.00033722198,0.00042398224,0.0014014645,0.0000031007385,0.000004983298,0.9618863],"study_design_scores_gemma":[0.005898279,0.0004909305,0.97445124,0.00875906,0.001403832,0.0000016637038,0.00012529947,0.00041509874,0.00011643236,0.000032740383,0.007820938,0.00048450276],"about_ca_topic_score_codex":0.00044421473,"about_ca_topic_score_gemma":0.00004329236,"teacher_disagreement_score":0.9614018,"about_ca_system_score_codex":0.00007949337,"about_ca_system_score_gemma":0.00007102659,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W4210367898","doi":"10.1016/j.msard.2022.103638","title":"Medical cannabis use in Canadians with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University Hospital Foundation; University of Alberta","keywords":"Multiple sclerosis; Medicine; Cannabis; Medical cannabis; Dermatology; Psychiatry","score_opus":0.02305351732865284,"score_gpt":0.23123587740021656,"score_spread":0.2081823600715637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210367898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675358,0.0011664333,0.000007709822,0.029324735,0.00016850836,0.000946682,0.00011986281,0.00008362748,0.0006466382],"genre_scores_gemma":[0.9917181,0.0011268555,0.00006569094,0.0010807895,0.00002363182,0.00045671422,0.000111658555,0.000082504645,0.0053340206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665844,0.00018554553,0.00047975345,0.00071184186,0.0011148275,0.0008495769],"domain_scores_gemma":[0.99854,0.00006349853,0.00008763948,0.00042231235,0.000084615975,0.00080197357],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053575524,0.0003142619,0.00048471577,0.00049357355,0.0005935508,0.00007130652,0.00021017788,0.00022055877,0.0014100398],"category_scores_gemma":[0.00043995696,0.00026397043,0.00014090845,0.0011556947,0.00040334088,0.0001520551,0.0002205782,0.0011759914,0.000008014584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012815949,0.0011207825,0.8992011,0.00010225194,0.00023801354,0.0002116119,0.002524722,0.0012634431,0.0015268626,0.00008604653,0.048483863,0.04395971],"study_design_scores_gemma":[0.013330915,0.0007887728,0.9087615,0.00024484054,0.00006886966,0.000100400015,0.003939505,0.011661965,0.00006665092,0.00001824002,0.060511444,0.0005069195],"about_ca_topic_score_codex":0.12028249,"about_ca_topic_score_gemma":0.17145045,"teacher_disagreement_score":0.05116796,"about_ca_system_score_codex":0.00035495078,"about_ca_system_score_gemma":0.0006527205,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W4212804224","doi":"10.1016/j.msard.2022.103689","title":"Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; University of Manitoba; Hospital for Sick Children; York University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Neurocognitive; Cognition; Disease; Pediatrics; Neurology; Immunology; Internal medicine; Psychiatry","score_opus":0.026719595333692538,"score_gpt":0.2718255498147476,"score_spread":0.24510595448105507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212804224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880617,0.0074002733,0.000047933285,0.0012595125,0.00037330354,0.0017971894,0.00022851638,0.00020840671,0.0006231346],"genre_scores_gemma":[0.98315614,0.01503533,0.000042603257,0.00019072325,0.000048132715,0.00043001253,0.00064000365,0.000082206025,0.0003748241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961479,0.0004881037,0.0007085698,0.0009027566,0.0009130637,0.0008396554],"domain_scores_gemma":[0.99842554,0.00046935477,0.0002433003,0.0002988022,0.00013723229,0.00042574338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008161815,0.00041557054,0.0005978988,0.00065511756,0.0010502267,0.000056805777,0.00014041443,0.00017694174,0.0003685161],"category_scores_gemma":[0.0017992997,0.000408815,0.00024183503,0.0014373473,0.00023632856,0.00020920228,0.00044259537,0.001212314,0.00003193846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004336755,0.0016768404,0.9713018,0.00017314842,0.00039756627,0.000060795428,0.0014110059,0.0007273773,0.0032400936,0.0000124683465,0.0006757644,0.015986418],"study_design_scores_gemma":[0.014874946,0.0005257143,0.9681957,0.00036805548,0.00038031637,0.0000053310027,0.0024378123,0.012285757,0.00004715013,0.00009081725,0.0003272732,0.00046112065],"about_ca_topic_score_codex":0.0006393722,"about_ca_topic_score_gemma":0.0003169787,"teacher_disagreement_score":0.015525298,"about_ca_system_score_codex":0.0002841701,"about_ca_system_score_gemma":0.00017579959,"threshold_uncertainty_score":0.9998364},"labels":[],"label_agreement":null},{"id":"W4220661846","doi":"10.1016/j.msard.2022.103761","title":"Progressive retinal changes in pediatric multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"Multiple Sclerosis Society of Canada; Ontario Institute for Regenerative Medicine; Stem Cell Network; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society","keywords":"Medicine; Optic neuritis; Nerve fiber layer; Retinal; Multiple sclerosis; Ophthalmology; Inner plexiform layer","score_opus":0.04306767492897136,"score_gpt":0.26523303964532513,"score_spread":0.22216536471635379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220661846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98112935,0.009655852,0.0000049810706,0.005277557,0.00034645663,0.0021270188,0.00010625552,0.00022354249,0.0011290071],"genre_scores_gemma":[0.97950757,0.017994778,0.00037188604,0.00019883199,0.00010324713,0.0012566503,0.000117483854,0.000098779106,0.00035079257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956677,0.0003781616,0.00068950397,0.0010835273,0.0010657564,0.0011153267],"domain_scores_gemma":[0.9981863,0.0005231524,0.00026580523,0.000514917,0.00012487487,0.0003849504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008404971,0.00050289684,0.0007599569,0.00083210744,0.0010346896,0.00006820543,0.0002956217,0.00021226765,0.0006849155],"category_scores_gemma":[0.0009995679,0.00046170043,0.00022643554,0.0016581251,0.00039237938,0.00015251036,0.0008166747,0.0012847809,0.000027728049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010499216,0.001413139,0.93613964,0.0002477981,0.0001971708,0.000047722675,0.0029927667,0.0004032862,0.008545733,0.00001913501,0.0019347699,0.047008917],"study_design_scores_gemma":[0.012507135,0.00091366615,0.97293925,0.00021541295,0.00013668125,0.000027065207,0.003502154,0.0067292233,0.00032814423,0.000041810214,0.0020836608,0.0005758078],"about_ca_topic_score_codex":0.00052969676,"about_ca_topic_score_gemma":0.0007268863,"teacher_disagreement_score":0.04643311,"about_ca_system_score_codex":0.0002741568,"about_ca_system_score_gemma":0.00011189013,"threshold_uncertainty_score":0.99978346},"labels":[],"label_agreement":null},{"id":"W4220761486","doi":"10.1016/j.msard.2022.103779","title":"Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; University of Manitoba; Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society of Canada","keywords":"Mesenchymal stem cell; Medicine; Multiple sclerosis; Clinical trial; Cognition; Stem-cell therapy; Cell therapy; Stem cell; Oncology; Internal medicine; Pathology; Immunology; Psychiatry; Biology","score_opus":0.10661464198893725,"score_gpt":0.3299668980979571,"score_spread":0.22335225610901985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220761486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990636,0.0051431833,0.0000042040747,0.00086034584,0.00027733616,0.0020290955,0.00006120925,0.00004844523,0.0009402191],"genre_scores_gemma":[0.9909092,0.007885331,0.0000606279,0.00012189624,0.00004271307,0.00021259469,0.00016784901,0.00003687614,0.00056287367],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973333,0.00045631774,0.0006886965,0.00064569333,0.00048988085,0.00038613644],"domain_scores_gemma":[0.9987417,0.00063594856,0.00011908163,0.00022310553,0.00003104301,0.00024915906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010237114,0.00021976898,0.00047337147,0.00021471856,0.00047434444,0.000032657284,0.00010336628,0.00022856006,0.00081169215],"category_scores_gemma":[0.00009905337,0.0001915007,0.00014048957,0.00035227442,0.00021378974,0.00009650241,0.00026861724,0.00091745576,0.000007436094],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2513166,0.017190715,0.13247792,0.00012980291,0.00048212757,0.00012698282,0.009510589,0.000056507564,0.032068737,0.00001955091,0.0021204602,0.5545],"study_design_scores_gemma":[0.7027232,0.033669516,0.2256847,0.00028132822,0.00021233843,0.000017841718,0.007011968,0.021914944,0.0010941956,0.00023267463,0.006464759,0.00069252675],"about_ca_topic_score_codex":0.0004225913,"about_ca_topic_score_gemma":0.000035058427,"teacher_disagreement_score":0.55380744,"about_ca_system_score_codex":0.000049074042,"about_ca_system_score_gemma":0.00008150716,"threshold_uncertainty_score":0.888746},"labels":[],"label_agreement":null},{"id":"W4220808026","doi":"10.1016/j.msard.2022.103745","title":"Structural visual metrics associate with moderate to vigorous physical activity in youth with pediatric onset neuroinflammatory disorders","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Mental Health Research Canada; Hospital for Sick Children","funders":"","keywords":"Medicine; Optic neuritis; Multiple sclerosis; Neuromyelitis optica; Retinal; Cohort; Myelin oligodendrocyte glycoprotein; Pediatrics; Ophthalmology; Internal medicine; Psychiatry; Experimental autoimmune encephalomyelitis","score_opus":0.02681956103543183,"score_gpt":0.2625453185428964,"score_spread":0.2357257575074646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220808026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964294,0.0002512662,0.000030976684,0.0010624902,0.00009768954,0.0016684366,0.00015110713,0.00014724184,0.00016138027],"genre_scores_gemma":[0.9985081,0.00079443696,0.000099839715,0.00008598878,0.000036150646,0.000230326,0.00006305035,0.00010337215,0.00007871617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962702,0.00036274426,0.00033864207,0.00093814556,0.0011691006,0.0009211708],"domain_scores_gemma":[0.9986195,0.00036472472,0.00019339669,0.0003377033,0.00009166353,0.000393012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036880007,0.0005075391,0.00076739787,0.0007190173,0.0008362557,0.00007707944,0.00018675665,0.00010812257,0.000026127684],"category_scores_gemma":[0.00028717416,0.0003863544,0.00013781055,0.0022892365,0.00022370764,0.00021724244,0.00040837558,0.0012172707,0.0000053735534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058598625,0.001428591,0.9296273,0.00010707095,0.00039261935,0.000029935674,0.008117423,0.026670977,0.00093526725,0.0000059306903,0.00008761611,0.026737427],"study_design_scores_gemma":[0.010528845,0.0019282213,0.9264321,0.000041857813,0.00019421849,0.0000068955155,0.0030235397,0.05715985,0.00008252901,0.000016388767,0.000026978576,0.0005585784],"about_ca_topic_score_codex":0.0012015076,"about_ca_topic_score_gemma":0.001372185,"teacher_disagreement_score":0.030488871,"about_ca_system_score_codex":0.00029652877,"about_ca_system_score_gemma":0.00016249125,"threshold_uncertainty_score":0.99985886},"labels":[],"label_agreement":null},{"id":"W4220867349","doi":"10.1016/j.msard.2022.103757","title":"The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"Multiple Sclerosis International Federation; Multiple Sclerosis Trust; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Patient-reported outcome; Agency (philosophy); Multiple sclerosis; Stakeholder; Public relations; Quality of life (healthcare); Nursing; Political science; Sociology; Psychiatry","score_opus":0.08853545093438485,"score_gpt":0.3245907632389557,"score_spread":0.23605531230457083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220867349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97749454,0.004259146,0.000029206476,0.010341398,0.00039839227,0.006286381,0.0006231827,0.00008046544,0.00048731072],"genre_scores_gemma":[0.9923129,0.0046656565,0.00052667264,0.00020064619,0.000010849276,0.0020679112,0.000046208355,0.000041596737,0.00012757542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694175,0.00036735713,0.0008339562,0.00062973594,0.00067374425,0.0005534467],"domain_scores_gemma":[0.9972835,0.0011204112,0.00051422836,0.0006372603,0.00027601738,0.00016854762],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0007737482,0.00033656828,0.00059461215,0.000080684295,0.0030042732,0.00013925451,0.00044599996,0.00010798865,0.000031163374],"category_scores_gemma":[0.0033901315,0.0001968514,0.0002609592,0.000724946,0.00097603985,0.00016280611,0.0017324153,0.00041473855,6.650384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970838,0.00080233515,0.9020898,0.00010625018,0.0010606918,0.0000012424116,0.0016201506,0.00010574964,0.0017937066,0.00015212515,0.0018380504,0.08973283],"study_design_scores_gemma":[0.0072906855,0.00060147844,0.976693,0.00022883502,0.00020768402,0.00000840902,0.004612464,0.0020026534,0.00038452342,0.0002921484,0.00742597,0.00025216283],"about_ca_topic_score_codex":0.0010876961,"about_ca_topic_score_gemma":0.0010657838,"teacher_disagreement_score":0.08948067,"about_ca_system_score_codex":0.00015179471,"about_ca_system_score_gemma":0.0001737915,"threshold_uncertainty_score":0.9982937},"labels":[],"label_agreement":null},{"id":"W4220874346","doi":"10.1016/j.msard.2021.103478","title":"Multimodal emotion perception in young and elderly patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Perception; Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology","score_opus":0.0218561860423329,"score_gpt":0.2332730679329121,"score_spread":0.21141688189057922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220874346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958404,0.0006401376,0.000037833477,0.0008480911,0.00016987363,0.0018918272,0.00009516184,0.00013018577,0.00034653457],"genre_scores_gemma":[0.9946546,0.00380008,0.00064567075,0.000070449656,0.000021817947,0.0003682412,0.00024541235,0.00008019808,0.00011350783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966825,0.00026457233,0.0005696022,0.0009201633,0.0008514399,0.0007117156],"domain_scores_gemma":[0.9988452,0.0002181489,0.0001683276,0.00034903947,0.0001344534,0.00028481323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045354484,0.0004289322,0.00057072693,0.0005097909,0.0009693702,0.00007370401,0.00012880044,0.00017782791,0.00021125282],"category_scores_gemma":[0.00032858178,0.00036776334,0.000117341806,0.00072605757,0.00040148833,0.0003117305,0.0003483947,0.0008452968,0.000008654389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009892703,0.00097828,0.8981766,0.00006986417,0.00013468169,0.000002009122,0.0032858015,0.00050784106,0.0063669113,0.0000032241298,0.00010965667,0.089375876],"study_design_scores_gemma":[0.020981753,0.0012111966,0.9524335,0.00024084227,0.0000629359,0.0000055039277,0.00497142,0.019473957,0.000025905458,0.000011816823,0.00016505302,0.00041606146],"about_ca_topic_score_codex":0.002500544,"about_ca_topic_score_gemma":0.0017332671,"teacher_disagreement_score":0.08895981,"about_ca_system_score_codex":0.0002753797,"about_ca_system_score_gemma":0.000045075456,"threshold_uncertainty_score":0.99987745},"labels":[],"label_agreement":null},{"id":"W4221056406","doi":"10.1016/j.msard.2022.103746","title":"Implications of Low-Titer MOG Antibodies","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Titer; Antibody; Immunology; Virology","score_opus":0.02598116198887592,"score_gpt":0.28753402267878825,"score_spread":0.26155286068991235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221056406","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11420424,0.045294344,0.000045854376,0.008533145,0.78936213,0.007781229,0.007758175,0.0008098718,0.026210979],"genre_scores_gemma":[0.5889499,0.30803806,0.000625566,0.00011093691,0.089519165,0.0011112253,0.0052995365,0.00045005066,0.0058955327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996267,0.00015346713,0.00091422565,0.0009177917,0.0011171324,0.0006303879],"domain_scores_gemma":[0.9968134,0.0012910226,0.00042378966,0.0008190285,0.00040316008,0.00024955595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004416306,0.0005433453,0.0011741791,0.0005084086,0.000558047,0.000045680237,0.00031721784,0.0007700822,0.0008796295],"category_scores_gemma":[0.002317798,0.0004669332,0.0004589686,0.00058546365,0.0007480619,0.00010723871,0.0006516513,0.0015802305,0.000019010555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029568016,0.00072576635,0.018248368,0.0011545123,0.0012535912,0.000002181328,0.0010619542,0.000044753742,0.0053648134,0.000017815171,0.953577,0.018253598],"study_design_scores_gemma":[0.008881173,0.0006201613,0.22538322,0.0014950004,0.0006087466,0.0000026391504,0.0011231365,0.00041038074,0.00017651897,0.00014134184,0.760276,0.0008816877],"about_ca_topic_score_codex":0.00050965446,"about_ca_topic_score_gemma":0.00014903238,"teacher_disagreement_score":0.699843,"about_ca_system_score_codex":0.00015363451,"about_ca_system_score_gemma":0.00024999422,"threshold_uncertainty_score":0.9997782},"labels":[],"label_agreement":null},{"id":"W4223433487","doi":"10.1016/j.msard.2022.103790","title":"Do we need more clinical trials in secondary progressive MS?","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Alliance; Medicine; Multiple sclerosis; Clinical trial; Disease; Progressive disease; Alternative medicine; Psychiatry; Internal medicine; Pathology; Political science; Law","score_opus":0.08613404031667447,"score_gpt":0.38649021531601185,"score_spread":0.30035617499933737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223433487","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03882294,0.15024476,0.000003812245,0.013923779,0.77809405,0.011856252,0.002496712,0.0005463793,0.0040113297],"genre_scores_gemma":[0.07522211,0.6807829,0.00045918455,0.0002089309,0.23345964,0.0030331735,0.0034366287,0.00058895047,0.002808497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874166,0.0033246276,0.003800479,0.0020147655,0.0022131044,0.0012304162],"domain_scores_gemma":[0.98219436,0.014254205,0.0014525282,0.0010745489,0.0003497978,0.00067454966],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0106531065,0.0010327408,0.004323016,0.0010010614,0.0005568961,0.00018231894,0.0005211156,0.0024484207,0.002669075],"category_scores_gemma":[0.047021855,0.00082321843,0.0013721685,0.0010378554,0.0011410003,0.00018900739,0.0010663262,0.0074225706,0.00003660032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020321293,0.0011232026,0.0127290115,0.00064321834,0.0015023181,0.00006368445,0.0013205857,0.0000180954,0.00009984084,0.0000028957807,0.76854426,0.21192075],"study_design_scores_gemma":[0.03289152,0.0011134726,0.07356824,0.0029725344,0.0006399642,0.000004268906,0.00446009,0.00066444965,0.000007861208,0.000077198216,0.8825551,0.0010452672],"about_ca_topic_score_codex":0.0005830848,"about_ca_topic_score_gemma":0.00021630523,"teacher_disagreement_score":0.5446344,"about_ca_system_score_codex":0.00035698217,"about_ca_system_score_gemma":0.0009934007,"threshold_uncertainty_score":0.9994219},"labels":[],"label_agreement":null},{"id":"W4224249334","doi":"10.1016/j.msard.2022.103792","title":"Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Medicine; Pregnancy; Ocrelizumab; Pediatrics; Retrospective cohort study; Live birth; Obstetrics; Prospective cohort study; Reproductive medicine; Surgery; Internal medicine","score_opus":0.05787079466661044,"score_gpt":0.2619896650254949,"score_spread":0.20411887035888449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224249334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571115,0.00092252844,0.000011089214,0.0003093368,0.000029950726,0.0014566088,0.001211552,0.000046074165,0.00030171344],"genre_scores_gemma":[0.9948996,0.003732737,0.00041899,0.000024475878,0.0000025059805,0.0003128657,0.00039807646,0.0000717645,0.00013901024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540585,0.00031802323,0.0010280374,0.0010449538,0.0012549239,0.0009482114],"domain_scores_gemma":[0.99689716,0.00068768335,0.0005999096,0.001254512,0.00022966674,0.0003310427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005110606,0.0005001382,0.0019659675,0.0013371165,0.00031603593,0.000017778873,0.000491114,0.00006788549,0.00018149342],"category_scores_gemma":[0.00037026676,0.00036347893,0.0001341687,0.0052685,0.0006234105,0.00020267004,0.0006552408,0.00057584944,3.9186793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027896736,0.00089965254,0.9693221,0.00012572372,0.0070038163,0.000014538606,0.0035560823,0.005106838,0.0014157206,0.000007664902,0.000064573615,0.009693617],"study_design_scores_gemma":[0.0121267475,0.0009771764,0.9469823,0.00054248096,0.00109953,0.0000010719214,0.01758395,0.020084966,0.00018009344,0.0000014834404,0.000038669317,0.00038153012],"about_ca_topic_score_codex":0.8913631,"about_ca_topic_score_gemma":0.95924443,"teacher_disagreement_score":0.06788135,"about_ca_system_score_codex":0.0014886946,"about_ca_system_score_gemma":0.0008621272,"threshold_uncertainty_score":0.99988174},"labels":[],"label_agreement":null},{"id":"W4224299660","doi":"10.1016/j.msard.2022.103816","title":"High efficacy treatment is not enough in MS: Socioeconomic factors are key to improving outcomes","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Fingolimod; Teriflunomide; Medicine; Multiple sclerosis; Clinical trial; Natalizumab; Internal medicine; Immunology","score_opus":0.03196315494529688,"score_gpt":0.2812564293762534,"score_spread":0.2492932744309565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224299660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8270107,0.0016113946,0.000001261314,0.004981167,0.16069692,0.0034374027,0.001881124,0.00021869082,0.00016134388],"genre_scores_gemma":[0.94133806,0.026230343,0.0002057685,0.0002650224,0.025935965,0.0010361102,0.0014308337,0.0003684415,0.003189471],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9943856,0.00022942011,0.0012326291,0.0018135243,0.001102117,0.0012366968],"domain_scores_gemma":[0.9955506,0.0024143434,0.0004962197,0.00087567844,0.00013092063,0.0005322463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044090083,0.001155303,0.0023146616,0.000849367,0.00070457556,0.00014251647,0.00038957814,0.0011193817,0.0009866669],"category_scores_gemma":[0.0023022217,0.00093018945,0.00069953053,0.00039584597,0.0002734024,0.00014827779,0.0006667392,0.0018268533,0.00009044978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002098416,0.0037598242,0.30394626,0.0007736827,0.0045023113,0.00003739825,0.02449306,0.0008595642,0.0015528899,0.00000529736,0.59589714,0.06207419],"study_design_scores_gemma":[0.021856176,0.0012830953,0.66439736,0.00049854117,0.00041395013,4.2731406e-7,0.004118556,0.00024290696,0.00016000812,0.000006075285,0.3058124,0.001210492],"about_ca_topic_score_codex":0.016458368,"about_ca_topic_score_gemma":0.0031187858,"teacher_disagreement_score":0.36045113,"about_ca_system_score_codex":0.0019207266,"about_ca_system_score_gemma":0.0003492653,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W4224980576","doi":"10.1016/j.msard.2022.103829","title":"The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; SickKids Foundation; University of Saskatchewan; Simon Fraser University; University of Manitoba; Saskatchewan Disease Control Laboratory; Public Health Agency of Canada; Hospital for Sick Children; University of British Columbia","funders":"Janssen Canada; Canadian Institutes of Health Research; Institute for Translational Neuroscience; National Institutes of Health; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; University of Manitoba; Emerald Publishing; Multiple Sclerosis Scientific Research Foundation; Takeda Canada; Immune Tolerance Network; Public Health Agency of Canada; Biogen; Patient-Centered Outcomes Research Institute; American Academy of Neurology; U.S. Department of Defense; Genome Canada; Novartis; Erasmus Medisch Centrum; National Multiple Sclerosis Society; Pfizer Canada; Alexion Pharmaceuticals; Roche; University of British Columbia","keywords":"Multiple sclerosis; Interquartile range; Medicine; Microbiome; Internal medicine; Feces; Physiology; Immunology; Gastroenterology; Biology; Bioinformatics; Microbiology","score_opus":0.010469934062647861,"score_gpt":0.19686297299030714,"score_spread":0.18639303892765927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224980576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98002744,0.016998876,0.00001762348,0.0013275654,0.0007302735,0.0005137061,0.0003040896,0.000016545267,0.000063890795],"genre_scores_gemma":[0.98605514,0.013037185,0.00006177767,0.00022879832,0.00003970555,0.00005792115,0.00011380373,0.00003670838,0.00036893785],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982211,0.0003024277,0.00043021413,0.00042356318,0.00018722349,0.00043544953],"domain_scores_gemma":[0.99903953,0.00005824606,0.0002500474,0.0005132656,0.00005250325,0.00008641162],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00040836137,0.00022566692,0.00022113173,0.00006152098,0.0015722218,0.000038756953,0.00045794938,0.00016202497,0.000041330302],"category_scores_gemma":[0.00009123487,0.00015006651,0.0002898368,0.00037988866,0.00033694712,0.0000058454584,0.0006224225,0.000311808,0.000003857929],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014473012,0.00018274221,0.0278897,0.000015145639,0.0001586959,1.6917758e-7,0.00022412113,0.00066137646,0.95904523,0.000020434516,0.0043237605,0.007333913],"study_design_scores_gemma":[0.0060617784,0.00032961485,0.84821206,0.000031076084,0.00022395774,0.00002709194,0.0019661714,0.0008234399,0.025135687,0.00009108263,0.11649104,0.000606992],"about_ca_topic_score_codex":0.00035744713,"about_ca_topic_score_gemma":0.00032025648,"teacher_disagreement_score":0.93390954,"about_ca_system_score_codex":0.000016842141,"about_ca_system_score_gemma":0.00009298669,"threshold_uncertainty_score":0.9997276},"labels":[],"label_agreement":null},{"id":"W4225165339","doi":"10.1016/j.msard.2022.103820","title":"Quality of life in pediatric-onset multiple sclerosis: Different disease course, different impact, different measurement approach needed","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Shriners Hospitals for Children - Canada; Montreal Children's Hospital; Santé Montérégie; McGill University; McGill University Health Centre","funders":"Fondation de l'Hôpital de Montréal pour enfants","keywords":"Medicine; Multiple sclerosis; Quality of life (healthcare); Disease; Pediatrics; Immunology; Internal medicine","score_opus":0.09692189695966878,"score_gpt":0.29395803414480987,"score_spread":0.19703613718514107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225165339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299456,0.010698465,0.00007838194,0.0014168122,0.00034031025,0.003326241,0.00083513017,0.00016919612,0.00014089225],"genre_scores_gemma":[0.9846079,0.013172431,0.00005048152,0.00012143276,0.0000667868,0.0013670033,0.0004266828,0.00013093666,0.00005635299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908361,0.0012718375,0.0020454773,0.0014251848,0.0030288852,0.00139251],"domain_scores_gemma":[0.9958541,0.0007169894,0.0006978271,0.0010983679,0.00028432565,0.0013483926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013623352,0.0010326528,0.0020912532,0.00072708604,0.00079835946,0.000079447746,0.0005044559,0.00024368701,0.0002613371],"category_scores_gemma":[0.0019699452,0.0007721008,0.0009047514,0.0009626177,0.00048363412,0.00015999416,0.0010473412,0.0014243565,0.000004347486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003912254,0.009894368,0.97029877,0.00078306254,0.0008081633,0.0000026196803,0.0015582086,0.0017066664,0.006333417,0.000011627758,0.0011196497,0.0035712104],"study_design_scores_gemma":[0.022219272,0.0006032765,0.9575075,0.0002542853,0.00035297172,0.0000013332317,0.0042170016,0.013901294,0.000117545045,0.000041905034,0.000022779897,0.0007608302],"about_ca_topic_score_codex":0.0018176156,"about_ca_topic_score_gemma":0.0008817134,"teacher_disagreement_score":0.018307017,"about_ca_system_score_codex":0.0007958641,"about_ca_system_score_gemma":0.00026788714,"threshold_uncertainty_score":0.999473},"labels":[],"label_agreement":null},{"id":"W4253778485","doi":"10.1016/j.msard.2019.06.025","title":"Reply to letter to the editor","year":2019,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Multiple sclerosis; Medicine; Scopus; Epidemiology; MEDLINE; Immunology; Pathology","score_opus":0.017770295909726338,"score_gpt":0.22855712090753286,"score_spread":0.21078682499780652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253778485","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01094931,0.00091435533,0.00001535165,0.9804328,0.0051280367,0.001480185,0.0000984258,0.000098271885,0.0008832293],"genre_scores_gemma":[0.029984867,0.00032903758,0.000045009987,0.95060885,0.009212321,0.00012870072,0.00023977917,0.000080481004,0.009370951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980271,0.000112770664,0.0003416351,0.0006992175,0.00031480307,0.00050450466],"domain_scores_gemma":[0.9987889,0.00020829006,0.00008675679,0.00070993445,0.000050369857,0.00015574902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001503785,0.00037750296,0.00047881214,0.00017376628,0.0002268586,0.000043741333,0.00021330362,0.00091551855,0.00024894296],"category_scores_gemma":[0.00031296333,0.00023585885,0.00024970534,0.00023540069,0.0001254395,0.000046433022,0.00014455641,0.0016141501,0.001476696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017908878,0.000049248945,0.0027859549,0.000075541684,0.00021128649,0.000013190712,0.00025061538,0.000029760575,0.00018468856,8.35287e-7,0.9935155,0.0027042767],"study_design_scores_gemma":[0.0012991069,0.0003517035,0.035198215,0.0002876518,0.00028570372,0.0000039496335,0.000037339447,0.0000518776,0.000010173102,0.00001302565,0.9621468,0.00031443665],"about_ca_topic_score_codex":0.00018257501,"about_ca_topic_score_gemma":0.000021655376,"teacher_disagreement_score":0.03241226,"about_ca_system_score_codex":0.000030991006,"about_ca_system_score_gemma":0.00004181998,"threshold_uncertainty_score":0.9993008},"labels":[],"label_agreement":null},{"id":"W4280505911","doi":"10.1016/j.msard.2022.103606","title":"Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physical medicine and rehabilitation; Gait; Cognition; Medicine; Treadmill; Preferred walking speed; Psychology; Physical therapy; Neuroscience","score_opus":0.020789962334015186,"score_gpt":0.24110602672869835,"score_spread":0.22031606439468315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280505911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996086,0.000559949,0.000018613639,0.00045656363,0.0002655276,0.0020378153,0.00017202322,0.00014046622,0.0002630127],"genre_scores_gemma":[0.9982372,0.0006284353,0.000114481794,0.0000964733,0.000030223491,0.0003720172,0.00031801622,0.000109061664,0.000094094816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610466,0.00028068703,0.0006985648,0.00093211007,0.0010200838,0.00096389424],"domain_scores_gemma":[0.9984988,0.0004326149,0.00027946354,0.00029133112,0.00018888134,0.00030890026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004903418,0.0005100834,0.00064935966,0.0006809241,0.001134091,0.00009873585,0.00014668395,0.00015502884,0.0002749265],"category_scores_gemma":[0.000743223,0.00045007063,0.00017894614,0.0010130798,0.00034966605,0.00042005916,0.0006560783,0.0010404487,0.0000108843515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038672271,0.0033462837,0.95391583,0.00012108546,0.00045722356,0.000015163603,0.0037427493,0.0002921462,0.0091248285,0.0000016612499,0.00008881209,0.025026977],"study_design_scores_gemma":[0.033163417,0.0019134751,0.9533025,0.001182773,0.00010966053,0.0000057340435,0.006288697,0.0028741353,0.00058775465,0.000003869026,0.000046418965,0.00052157324],"about_ca_topic_score_codex":0.0006162642,"about_ca_topic_score_gemma":0.0006010594,"teacher_disagreement_score":0.02929619,"about_ca_system_score_codex":0.00057992566,"about_ca_system_score_gemma":0.00006279367,"threshold_uncertainty_score":0.9997951},"labels":[],"label_agreement":null},{"id":"W4280506672","doi":"10.1016/j.msard.2022.103865","title":"Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Normative; Cognition; Multiple sclerosis; Cognitive impairment; Medicine; Clinical psychology; Discriminant function analysis; Discriminant validity; Cognitive Assessment System; Psychology; Audiology; Gerontology; Psychometrics; Psychiatry; Statistics","score_opus":0.12234202107696569,"score_gpt":0.3031837256084954,"score_spread":0.1808417045315297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280506672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908347,0.00083533797,0.0003989679,0.0019383974,0.00017102406,0.0022821522,0.0033494486,0.000018576544,0.00017140851],"genre_scores_gemma":[0.99467963,0.0041025314,0.0002762992,0.00011134142,0.000016699387,0.00026502408,0.0005009943,0.000030998573,0.000016487802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733335,0.0005313872,0.0006033699,0.00057573535,0.0004909706,0.00046518957],"domain_scores_gemma":[0.994586,0.00431022,0.0002687219,0.00044841674,0.0001980267,0.0001886424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022106585,0.00025769236,0.00059262523,0.0006017733,0.00070486614,0.000022099604,0.0001383528,0.000111293964,0.000062971194],"category_scores_gemma":[0.0019108282,0.00020607225,0.0001144543,0.00080728444,0.00061516894,0.0002019816,0.0005772312,0.0005185066,4.313775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015379796,0.00088932324,0.93003744,0.00035662536,0.0008470715,0.0000031239401,0.0036651504,0.0008892132,0.021561345,0.000018299512,0.0011019786,0.03909243],"study_design_scores_gemma":[0.0066960673,0.0004990578,0.84872824,0.0002697025,0.00025855334,0.0000032744363,0.01014775,0.13275278,0.0002215379,0.000011543971,0.00023557224,0.00017594919],"about_ca_topic_score_codex":0.067384206,"about_ca_topic_score_gemma":0.104637794,"teacher_disagreement_score":0.13186356,"about_ca_system_score_codex":0.00011663166,"about_ca_system_score_gemma":0.00021753751,"threshold_uncertainty_score":0.93882614},"labels":[],"label_agreement":null},{"id":"W4280577718","doi":"10.1016/j.msard.2022.103875","title":"Onset of multiple sclerosis is preventable – time to act now!","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Immunology","score_opus":0.027734226203240266,"score_gpt":0.269489485070087,"score_spread":0.24175525886684676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280577718","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3239247,0.02780764,0.00004498054,0.01237224,0.5629625,0.02532883,0.030378409,0.0017506242,0.015430127],"genre_scores_gemma":[0.57081956,0.19205417,0.0036797759,0.0011026518,0.11764565,0.0050004995,0.012575674,0.002260676,0.09486137],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914565,0.0004328331,0.001698555,0.0020329135,0.0028675492,0.0015116354],"domain_scores_gemma":[0.9936049,0.002707754,0.00071458233,0.0015204508,0.00056274567,0.0008895433],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012395926,0.0012276415,0.002493255,0.0010208234,0.0008873416,0.00012020012,0.0007781649,0.0014170015,0.0069948053],"category_scores_gemma":[0.0050107604,0.0011369067,0.00093111675,0.0014969234,0.0006093638,0.00023526946,0.0016335347,0.0024940893,0.00055453135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014534332,0.0012459386,0.0077339597,0.00074208796,0.0017536458,0.000006050577,0.0012743404,0.00011875977,0.007971313,3.2883037e-7,0.96003246,0.01766769],"study_design_scores_gemma":[0.013874551,0.0017937621,0.044385567,0.002709324,0.00085980864,0.0000039852316,0.00063827354,0.0016868862,0.0010813571,0.000013558189,0.93149436,0.0014585509],"about_ca_topic_score_codex":0.0016897167,"about_ca_topic_score_gemma":0.0003609022,"teacher_disagreement_score":0.44531682,"about_ca_system_score_codex":0.00050357886,"about_ca_system_score_gemma":0.0005819566,"threshold_uncertainty_score":0.99987936},"labels":[],"label_agreement":null},{"id":"W4280578607","doi":"10.1016/j.msard.2022.103596","title":"Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Alexithymia; Multiple sclerosis; Hospital Anxiety and Depression Scale; Psychiatry; Cohort; Hamilton Anxiety Rating Scale; Toronto Alexithymia Scale; Population; Neurology; Medical record; Internal medicine","score_opus":0.022328708602535434,"score_gpt":0.23295339039517837,"score_spread":0.21062468179264293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280578607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936695,0.0023942986,0.000012209159,0.0009886327,0.00012079131,0.0017306993,0.00012844686,0.00012721877,0.00082821806],"genre_scores_gemma":[0.9915809,0.006844306,0.0005259726,0.00020190234,0.000016727985,0.0004363364,0.00016027098,0.00009022005,0.00014335476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646235,0.000244153,0.0005848811,0.0010184271,0.00087914115,0.00081106747],"domain_scores_gemma":[0.9985286,0.00028216452,0.00017476753,0.0004900612,0.00010841734,0.00041598696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044378353,0.00046547956,0.00065301737,0.00043624948,0.0010516951,0.00006687002,0.00018822598,0.00017599313,0.00021318592],"category_scores_gemma":[0.00037174247,0.00037257947,0.00011734256,0.0008898658,0.0004953997,0.0002409083,0.00065966364,0.0009371541,0.0000059043473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010374486,0.0008721046,0.94193745,0.00008510353,0.00017528886,0.0000033623026,0.0015343974,0.00029556223,0.0019445866,0.000005549142,0.00046006666,0.051649056],"study_design_scores_gemma":[0.020053165,0.00046592072,0.9695973,0.0004228124,0.000067040695,0.0000060611414,0.002020716,0.005011439,0.00009461224,0.000018174062,0.0017878998,0.00045484872],"about_ca_topic_score_codex":0.0011035844,"about_ca_topic_score_gemma":0.0009211458,"teacher_disagreement_score":0.05119421,"about_ca_system_score_codex":0.00016635656,"about_ca_system_score_gemma":0.00006521517,"threshold_uncertainty_score":0.9998726},"labels":[],"label_agreement":null},{"id":"W4281636901","doi":"10.1016/j.msard.2022.103937","title":"Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Barts Charity","keywords":"Medicine; Seroconversion; Vaccination; Immunology; Multiple sclerosis; Immune system; Coronavirus disease 2019 (COVID-19); Booster dose; Booster (rocketry); Virology; Antibody; Immunization; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.044040016839496765,"score_gpt":0.2844411345669836,"score_spread":0.24040111772748685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281636901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96259815,0.00065405224,0.00017170278,0.032364327,0.00013718012,0.003211918,0.0002495326,0.0002079981,0.00040514395],"genre_scores_gemma":[0.99342054,0.0009984694,0.00087564474,0.0017659538,0.000016378815,0.0018703211,0.00010128897,0.00010427162,0.0008471533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953668,0.000809212,0.00070129696,0.0011298868,0.0010233541,0.00096944784],"domain_scores_gemma":[0.996452,0.0016875565,0.00017677924,0.00063581415,0.00016120891,0.00088665367],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0013866054,0.0005021412,0.00076417805,0.0010452288,0.0014659698,0.00008432344,0.00029059485,0.00016065761,0.00070732454],"category_scores_gemma":[0.0032253468,0.00043653967,0.00017162663,0.0024013433,0.00020724515,0.00023976767,0.0007199341,0.00093369535,0.000039639082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017332539,0.0018472801,0.8844278,0.00015271443,0.00050520466,0.000029072478,0.03080254,0.016244244,0.03256927,0.000027279411,0.005398981,0.010663071],"study_design_scores_gemma":[0.02009644,0.0014721683,0.9485435,0.00019185543,0.0000772891,0.000018464883,0.014759013,0.005864608,0.00024433882,0.000029829653,0.008122113,0.00058036787],"about_ca_topic_score_codex":0.0026645968,"about_ca_topic_score_gemma":0.0085849725,"teacher_disagreement_score":0.06411571,"about_ca_system_score_codex":0.0008295361,"about_ca_system_score_gemma":0.00034685238,"threshold_uncertainty_score":0.999834},"labels":[],"label_agreement":null},{"id":"W4281640815","doi":"10.1016/j.msard.2022.103932","title":"Multiple sclerosis incidence: A systematic review of change over time by geographical region","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Incidence (geometry); Demography; Medicine; Population; Multiple sclerosis; Scopus; McDonald criteria; Systematic review; Pediatrics; MEDLINE; Geography; Environmental health","score_opus":0.11160084349357316,"score_gpt":0.31332506919185044,"score_spread":0.20172422569827728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281640815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017040731,0.9860152,0.0000033276365,0.00037754752,0.00021577212,0.01230247,0.0005050662,0.00020596356,0.0002042241],"genre_scores_gemma":[0.0010988171,0.9918265,0.00005283646,0.00028577948,0.000056148474,0.0049733925,0.0011104485,0.00025809903,0.0003380316],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.990769,0.0014358412,0.00309552,0.0016404977,0.0019326865,0.0011263997],"domain_scores_gemma":[0.993413,0.0023338578,0.0018512567,0.0015724058,0.00022467751,0.0006048224],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0017625957,0.0013692067,0.007568015,0.00093120895,0.0006119516,0.00006537095,0.00070957374,0.0009333045,0.00084278866],"category_scores_gemma":[0.0047595534,0.0010270524,0.0023447152,0.0025152543,0.00086537085,0.00026026423,0.0009864027,0.00190519,0.000065398286],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060935883,0.00066857645,0.0005429904,0.84489685,0.0020297752,0.000007921165,0.00024371936,1.7927917e-7,0.000029080391,0.0000028467712,0.005927888,0.14558923],"study_design_scores_gemma":[0.0030847867,0.00047904125,0.0009553436,0.86538655,0.006845653,0.000049616603,0.000110252164,0.0003244835,0.0000015422291,0.000003783397,0.121703975,0.0010549994],"about_ca_topic_score_codex":0.00067118957,"about_ca_topic_score_gemma":0.000033627097,"teacher_disagreement_score":0.14453423,"about_ca_system_score_codex":0.00033793075,"about_ca_system_score_gemma":0.0001950912,"threshold_uncertainty_score":0.9999059},"labels":[],"label_agreement":null},{"id":"W4281926010","doi":"10.1016/j.msard.2022.103916","title":"Sick leave and occupational burnout among nurses caring for patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Sick leave; Burnout; Logistic regression; Family medicine; Cross-sectional study; Emotional exhaustion; Nursing; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.030450100461458858,"score_gpt":0.2552692186853468,"score_spread":0.22481911822388795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281926010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994659,0.001009813,0.000064056956,0.00047112297,0.00025733098,0.002733626,0.00037518953,0.00014088769,0.00028897266],"genre_scores_gemma":[0.9961342,0.0012282864,0.0007860786,0.00009615625,0.00004555096,0.0009312388,0.00038969237,0.00009466753,0.00029411196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969408,0.000116822295,0.0005196805,0.000878715,0.0008188427,0.00072517386],"domain_scores_gemma":[0.9981682,0.00067513646,0.00021906637,0.00034458117,0.0002525747,0.00034046287],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00031193875,0.00043805118,0.0006038218,0.0003140826,0.0016760736,0.00008820596,0.00015112774,0.00014221923,0.00010543643],"category_scores_gemma":[0.00063939247,0.0003628617,0.00017395137,0.0004431671,0.00062185235,0.0002460821,0.00035963583,0.0005215581,0.0000030522501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015980822,0.0007320021,0.96732086,0.000120755045,0.0004667712,9.2498425e-7,0.0017741588,0.00062294956,0.0010589584,0.00001785513,0.00069176155,0.025594916],"study_design_scores_gemma":[0.017919626,0.0010775505,0.9654347,0.00026145432,0.00018633265,0.0000019686097,0.002348952,0.010855299,0.0000942486,0.000021737142,0.0013456335,0.00045255618],"about_ca_topic_score_codex":0.0008552073,"about_ca_topic_score_gemma":0.00043435636,"teacher_disagreement_score":0.025142359,"about_ca_system_score_codex":0.00015972013,"about_ca_system_score_gemma":0.00007428261,"threshold_uncertainty_score":0.99988234},"labels":[],"label_agreement":null},{"id":"W4283516981","doi":"10.1016/j.msard.2022.103995","title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Sherbrooke; University of British Columbia; Memorial University of Newfoundland; Western University","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Dosing; Adverse effect; Intensive care medicine; Internal medicine; Immunology","score_opus":0.07109589134726166,"score_gpt":0.2656694784780308,"score_spread":0.19457358713076914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0097316075,0.9865528,0.000002137774,0.0000903507,0.00025465747,0.0020207064,0.0009839509,0.0001210574,0.0002427411],"genre_scores_gemma":[0.019778308,0.97788244,0.000120078126,0.000057286088,0.000018567149,0.00037029144,0.0011559776,0.00020703816,0.00041002512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959857,0.00032425203,0.001254488,0.0010786805,0.0006309732,0.00072589534],"domain_scores_gemma":[0.99759984,0.0005154502,0.0006792936,0.00076431053,0.00004311396,0.0003979797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024416018,0.0008732226,0.0024941496,0.0009049656,0.000325018,0.00005784578,0.0002647083,0.00075590017,0.0006964574],"category_scores_gemma":[0.00027790715,0.00063338905,0.0008255314,0.0015452364,0.0004926266,0.00023459204,0.0002750145,0.0014935667,0.000018824616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081670086,0.0017843981,0.0051969625,0.0074778395,0.002147076,0.00008781832,0.00050751725,0.00011781981,0.00002103995,0.00003237495,0.0010890315,0.9807214],"study_design_scores_gemma":[0.009454138,0.0007143983,0.004615321,0.030828789,0.004676375,0.000101223224,0.0007598922,0.00094325584,0.0000040141626,0.000007834959,0.9466426,0.0012522077],"about_ca_topic_score_codex":0.0014866401,"about_ca_topic_score_gemma":0.00036223148,"teacher_disagreement_score":0.97946924,"about_ca_system_score_codex":0.00019990021,"about_ca_system_score_gemma":0.00041653385,"threshold_uncertainty_score":0.99961174},"labels":[],"label_agreement":null},{"id":"W4283746622","doi":"10.1016/j.msard.2022.104007","title":"EBV as the “gluten of MS” hypothesis provides a rationale for trialing antiviral therapies","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Scopus; Multiple sclerosis; Medicine; Epstein–Barr virus; Web of science; Virus; MEDLINE; Immunology; Virology; Internal medicine; Meta-analysis; Law; Political science","score_opus":0.04901008463862364,"score_gpt":0.2853209897920375,"score_spread":0.23631090515341388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283746622","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23322359,0.06807162,0.00008192147,0.026282122,0.62764716,0.03339383,0.0056061894,0.0006364148,0.0050571635],"genre_scores_gemma":[0.6124532,0.18422313,0.0019710925,0.00027770986,0.18227977,0.0076531614,0.002411251,0.00066390564,0.008066738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603957,0.00034992537,0.00092261913,0.00078848423,0.001330001,0.0005693961],"domain_scores_gemma":[0.9904502,0.00805102,0.00043809926,0.00055357267,0.000396985,0.00011012268],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013807873,0.00052889297,0.0011456836,0.00030594858,0.000992865,0.00009646421,0.00036656126,0.0005878825,0.00022084973],"category_scores_gemma":[0.010724575,0.0003489289,0.00066988665,0.00041210902,0.0007259483,0.00012401599,0.00029233383,0.0010118212,0.000005039825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005734091,0.0009466993,0.0020055538,0.0014117978,0.005032356,0.0000021010374,0.00881173,0.0001019112,0.012606087,0.00006590795,0.8853705,0.07791129],"study_design_scores_gemma":[0.01835288,0.0014486136,0.0069407974,0.00084285904,0.000941175,0.0000012442855,0.0051957606,0.0016067383,0.000495483,0.0004576383,0.9630298,0.0006870046],"about_ca_topic_score_codex":0.0007170037,"about_ca_topic_score_gemma":0.00019733912,"teacher_disagreement_score":0.4453674,"about_ca_system_score_codex":0.000115923554,"about_ca_system_score_gemma":0.00046004393,"threshold_uncertainty_score":0.9998963},"labels":[],"label_agreement":null},{"id":"W4283797772","doi":"10.1016/j.msard.2022.104031","title":"Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"University of Bristol; Novartis Animal Health; Novartis","keywords":"Ocrelizumab; Medicine; Relapsing remitting; Ofatumumab; Multiple sclerosis; Internal medicine; Filgrastim; Oncology; Physical therapy; Dermatology; Rituximab; Immunology; Granulocyte colony-stimulating factor; Chemotherapy","score_opus":0.07481059588906752,"score_gpt":0.3151139462203904,"score_spread":0.24030335033132288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283797772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877119,0.0027351656,0.000026496024,0.0007958834,0.00024958458,0.007927489,0.00048156866,0.000044084292,0.00002784053],"genre_scores_gemma":[0.9942235,0.003406313,0.0005576387,0.000014424294,0.000010057919,0.00128749,0.0003295791,0.00008873294,0.00008231406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964815,0.00017723291,0.0012253809,0.000754551,0.0006227736,0.00073860324],"domain_scores_gemma":[0.99556965,0.0030695829,0.0004327973,0.00057397055,0.00021244172,0.00014155384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031971047,0.000545827,0.0014623445,0.00048691285,0.0010442333,0.00001866057,0.00021720734,0.0001705675,0.000043683667],"category_scores_gemma":[0.0006372107,0.00035257288,0.00044201873,0.0008063469,0.00037526333,0.000107400076,0.00019316075,0.0002708893,4.1552673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026235811,0.016846493,0.7904703,0.00012253043,0.0015984412,6.4554337e-7,0.016978491,0.06060003,0.0015117659,0.0000089558525,0.00006144982,0.08556505],"study_design_scores_gemma":[0.14351007,0.016146384,0.7559604,0.00029402954,0.000351861,1.3827729e-7,0.0041846363,0.07748957,0.0006222769,0.0000037994757,0.0011151626,0.00032169174],"about_ca_topic_score_codex":0.002181246,"about_ca_topic_score_gemma":0.0019302284,"teacher_disagreement_score":0.11727426,"about_ca_system_score_codex":0.0007444164,"about_ca_system_score_gemma":0.00011897264,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W4283813348","doi":"10.1016/j.msard.2022.104028","title":"COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"COVID-19 Impact on Reproduction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of British Columbia","funders":"Alvin J. Siteman Cancer Center; National Cancer Institute; National Multiple Sclerosis Society; National Center for Advancing Translational Sciences; Multiple Sclerosis Society of Canada; U.S. Department of Defense","keywords":"Medicine; Pregnancy; Postpartum period; Multiple sclerosis; Obstetrics; Coronavirus disease 2019 (COVID-19); Propensity score matching; Young adult; Internal medicine; Disease; Infectious disease (medical specialty); Immunology","score_opus":0.034685802608223265,"score_gpt":0.27349131730230974,"score_spread":0.23880551469408648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283813348","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14544086,0.004073401,0.0000034529767,0.84682304,0.0006445102,0.0025474918,0.00011843984,0.00013909076,0.00020973482],"genre_scores_gemma":[0.37513217,0.00945886,0.000022780727,0.6125524,0.00014618585,0.00041280405,0.00067567255,0.0001257835,0.0014733267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696004,0.00035582428,0.00060321006,0.00092803,0.0006285564,0.00052432064],"domain_scores_gemma":[0.99790376,0.0008401559,0.00027866304,0.0007413043,0.00002892494,0.0002071749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042800765,0.00048615586,0.0006663214,0.0004115906,0.00038512636,0.00007934576,0.0001749512,0.0005898831,0.0005763164],"category_scores_gemma":[0.0019576491,0.00028672523,0.00018485903,0.0005265009,0.0002946438,0.000102021375,0.00017812595,0.0020125296,0.00000626492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015222386,0.0009903986,0.41645056,0.0022502746,0.0009864778,0.00047650712,0.021375764,0.00024803763,0.00011889341,0.000016052707,0.50863504,0.04692973],"study_design_scores_gemma":[0.007173866,0.0012726662,0.18140359,0.00051815674,0.0004589519,0.00016500657,0.0017742526,0.0003761466,0.00000306325,0.00011466538,0.80609703,0.0006426308],"about_ca_topic_score_codex":0.002044062,"about_ca_topic_score_gemma":0.00026536657,"teacher_disagreement_score":0.29746193,"about_ca_system_score_codex":0.00029558945,"about_ca_system_score_gemma":0.00031324915,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W4284667846","doi":"10.1016/j.msard.2022.104030","title":"Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Innovative Medicines Canada; Dalhousie University","funders":"Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Regimen; Internal medicine; Oncology; Immunology; Transplantation","score_opus":0.02851383815231817,"score_gpt":0.24893150441573722,"score_spread":0.22041766626341905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284667846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152344,0.0018989639,0.000081707665,0.001133095,0.0005518337,0.0034326974,0.00006424081,0.00025303516,0.0010609624],"genre_scores_gemma":[0.9916308,0.005876416,0.00063572323,0.00022599657,0.000030624004,0.0008785186,0.0002053711,0.00015035301,0.0003662074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99441636,0.00065057765,0.0010210578,0.0013452887,0.0013300589,0.0012366559],"domain_scores_gemma":[0.99742824,0.0009088093,0.00034655805,0.0007327998,0.00016987647,0.00041374387],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008274508,0.0006599957,0.0009960191,0.0008930106,0.0015199531,0.000103292245,0.0003317611,0.00034787736,0.000116061754],"category_scores_gemma":[0.0012996811,0.0006085813,0.00032431853,0.0016826589,0.00038756584,0.0003553007,0.001163858,0.0016648554,0.000019213763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003912634,0.0035835581,0.6812693,0.000515956,0.0011226718,0.000031210096,0.007562343,0.0072685764,0.08550738,0.00004513821,0.0013640359,0.20781718],"study_design_scores_gemma":[0.030622154,0.0017819857,0.9324718,0.0011723394,0.00017862888,0.000006988737,0.0016810505,0.0302367,0.0005663256,0.00014587922,0.00034922306,0.00078690087],"about_ca_topic_score_codex":0.0010870792,"about_ca_topic_score_gemma":0.0003766835,"teacher_disagreement_score":0.25120252,"about_ca_system_score_codex":0.0008207151,"about_ca_system_score_gemma":0.00011685198,"threshold_uncertainty_score":0.99977994},"labels":[],"label_agreement":null},{"id":"W4285603485","doi":"10.1016/j.msard.2022.104062","title":"Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD)","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Biogen; Ministry of Health – Kingdom of Saudi Arabia; Merck","keywords":"Neuromyelitis optica; Medicine; Spectrum disorder; Multiple sclerosis; Demyelinating Disorder; Aquaporin 4; Immunology; Dermatology; Pathology; Psychiatry","score_opus":0.09081450929488182,"score_gpt":0.3154046180443192,"score_spread":0.22459010874943736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285603485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027269474,0.96456575,0.000005576063,0.013570806,0.0005669153,0.0048671523,0.00043062822,0.00013194162,0.01558851],"genre_scores_gemma":[0.003525411,0.9939208,0.00023361579,0.0000840581,0.00003096034,0.0008846239,0.00032467864,0.00014499258,0.0008508686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955805,0.0006030963,0.0012522506,0.0010040826,0.00080815726,0.0007519321],"domain_scores_gemma":[0.99588233,0.0022341397,0.0005661675,0.001047681,0.000034304816,0.00023540019],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067077065,0.00077845895,0.0018366562,0.0004332708,0.0009081146,0.000052572257,0.0004219052,0.00027709868,0.0015975146],"category_scores_gemma":[0.00037297912,0.0005088572,0.0009444448,0.0011206365,0.00075391843,0.00003599597,0.0006739336,0.0014799017,0.000048005768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007615288,0.000552206,0.00007480793,0.006172909,0.002873985,0.000007579854,0.00021297074,0.000020459149,0.0000013822145,0.0009414902,0.0034193422,0.9856467],"study_design_scores_gemma":[0.0022907527,0.0004693821,0.002266866,0.01040967,0.0015663331,0.000011412082,0.0010785076,0.00020461032,7.5961293e-7,0.00015904273,0.9810346,0.0005081102],"about_ca_topic_score_codex":0.00018838106,"about_ca_topic_score_gemma":0.00007473142,"teacher_disagreement_score":0.9851386,"about_ca_system_score_codex":0.00018226072,"about_ca_system_score_gemma":0.000103370614,"threshold_uncertainty_score":0.9997363},"labels":[],"label_agreement":null},{"id":"W4285678970","doi":"10.1016/j.msard.2022.104061","title":"Saudi consensus recommendations on the management of multiple sclerosis: MS management in children and adolescents","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ministry of Health – Kingdom of Saudi Arabia","keywords":"Glatiramer acetate; Medicine; Acute disseminated encephalomyelitis; Multiple sclerosis; Neuromyelitis optica; Pediatrics; Observational study; Demyelinating Disorder; Demyelinating disease; Randomized controlled trial; McDonald criteria; Intensive care medicine; Population; Disease; Pathology; Psychiatry","score_opus":0.08181320650427126,"score_gpt":0.3054345439414968,"score_spread":0.22362133743722556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285678970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0107900025,0.97696,0.0000023650064,0.0011632196,0.00025396395,0.0088145165,0.0004175294,0.00009528481,0.0015030997],"genre_scores_gemma":[0.05549582,0.9423194,0.00028723865,0.000077938144,0.000017633336,0.0011513961,0.00032874642,0.000117034615,0.00020480515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953398,0.00057366595,0.0013802431,0.0011723649,0.00078479125,0.0007491444],"domain_scores_gemma":[0.9976134,0.0006739507,0.00055351574,0.0008909619,0.000045136207,0.00022306558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009437815,0.00079927134,0.0017400291,0.00072940474,0.0006201068,0.00005954669,0.00039450405,0.00030371835,0.00022150636],"category_scores_gemma":[0.00017274417,0.00056655565,0.00048666584,0.0011409716,0.0005667107,0.00004961069,0.0010306636,0.0012634764,0.000018383867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001838219,0.0010093838,0.006801076,0.0070812204,0.003381398,0.000006004185,0.00023895976,0.000017580998,0.0000025739944,0.000087157685,0.0014863742,0.97970444],"study_design_scores_gemma":[0.017034313,0.0005031379,0.5748953,0.09804603,0.0036355606,0.00002225459,0.0027978236,0.0004947078,0.0000026033742,0.000047865153,0.3011371,0.0013833225],"about_ca_topic_score_codex":0.00028891582,"about_ca_topic_score_gemma":0.000088481385,"teacher_disagreement_score":0.97832114,"about_ca_system_score_codex":0.00024666486,"about_ca_system_score_gemma":0.000041358642,"threshold_uncertainty_score":0.9996786},"labels":[],"label_agreement":null},{"id":"W4288455360","doi":"10.1016/j.msard.2022.104080","title":"Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Biogen","keywords":"Dimethyl fumarate; Discontinuation; Medicine; Term (time); Multiple sclerosis; Family medicine; Pediatrics; Internal medicine; Physical therapy; Psychiatry","score_opus":0.04220681545848206,"score_gpt":0.2868115921861847,"score_spread":0.24460477672770262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288455360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945089,0.0009737357,8.6253124e-7,0.0017227109,0.0001388923,0.002211091,0.00013988571,0.000045407414,0.00025850028],"genre_scores_gemma":[0.9963582,0.0020341207,0.00006037047,0.0002325618,0.000014848517,0.00082159345,0.00035562608,0.000030433186,0.00009222028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977088,0.00022021389,0.0004118013,0.00061358936,0.0005064402,0.00053915527],"domain_scores_gemma":[0.9989651,0.00027736925,0.000112515816,0.00031622662,0.00006697888,0.0002618423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032118033,0.00025943478,0.0003348887,0.00020428702,0.00078688096,0.00009540117,0.00017174872,0.0001000406,0.0003653715],"category_scores_gemma":[0.00037388512,0.00019267104,0.00006840002,0.00048634288,0.00036624723,0.0001375793,0.00021403561,0.00051424024,0.000010047857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021961662,0.00053200446,0.8539764,0.000009899219,0.00008765095,0.0000024257781,0.003917998,0.000019076979,0.0006417289,0.0000036001504,0.00017968907,0.1404099],"study_design_scores_gemma":[0.004694836,0.0010166916,0.99054277,0.00014199706,0.000031730942,4.5153024e-7,0.0020881349,0.0007334669,0.00016132691,0.000017012988,0.00034367852,0.00022787944],"about_ca_topic_score_codex":0.061956592,"about_ca_topic_score_gemma":0.078034565,"teacher_disagreement_score":0.14018203,"about_ca_system_score_codex":0.00016231523,"about_ca_system_score_gemma":0.00010280998,"threshold_uncertainty_score":0.9442899},"labels":[],"label_agreement":null},{"id":"W4290098700","doi":"10.1016/j.msard.2022.104088","title":"Lessons learned from clinical trials of exercise and physical activity in people with MS – guidance for improving the quality of future research","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychological intervention; Randomized controlled trial; Fidelity; Physical medicine and rehabilitation; Multiple sclerosis; Physical therapy; Cognition; Applied psychology; Psychology; Nursing; Psychiatry","score_opus":0.4648288480510515,"score_gpt":0.508287043480823,"score_spread":0.04345819542977147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290098700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12582496,0.86641115,0.000011380967,0.001148833,0.00011906015,0.0056239488,0.0008102138,0.000019946952,0.00003052104],"genre_scores_gemma":[0.0964009,0.9021092,0.00015750922,0.0000029792916,0.00008927689,0.0010362949,0.00009908947,0.00006560317,0.000039142742],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.990876,0.0047057252,0.0018417336,0.0010515243,0.0009719614,0.0005530093],"domain_scores_gemma":[0.9758725,0.02161165,0.00132488,0.0008017869,0.00021355462,0.00017561002],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015780624,0.0004560372,0.0049698898,0.00029553584,0.00039327936,0.000032977303,0.00033213306,0.0004684735,0.000030378687],"category_scores_gemma":[0.012206139,0.00025666057,0.0008854024,0.0009851808,0.0011605717,0.00008460389,0.00057060184,0.0020741525,4.533982e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017090834,0.0010145919,0.0039067334,0.010997497,0.00062314235,4.185379e-7,0.0013703676,0.0000042240936,0.00021891452,0.000016913391,0.00007008902,0.980068],"study_design_scores_gemma":[0.0494413,0.0038845947,0.6953186,0.0613298,0.0057009966,0.0000028223603,0.015431157,0.0058141155,0.000096939366,0.00030862386,0.16070868,0.001962379],"about_ca_topic_score_codex":0.004897608,"about_ca_topic_score_gemma":0.0015454793,"teacher_disagreement_score":0.97810566,"about_ca_system_score_codex":0.00009428406,"about_ca_system_score_gemma":0.00043853789,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W4292166418","doi":"10.1016/j.msard.2022.104102","title":"Vaccine hesitancy in people with multiple sclerosis","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Virology; Dermatology; Immunology","score_opus":0.02122079986011625,"score_gpt":0.22079047415309308,"score_spread":0.19956967429297684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292166418","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3724204,0.012419825,0.000024695937,0.60039145,0.0014256464,0.002897636,0.00021264641,0.0005126383,0.009695103],"genre_scores_gemma":[0.9207421,0.026172519,0.00014872766,0.046670612,0.0005591793,0.00043428096,0.0004739329,0.00022655063,0.0045721233],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953434,0.000562384,0.00075977494,0.0011970664,0.000903677,0.0012337228],"domain_scores_gemma":[0.9980417,0.00070532,0.00039319394,0.0005738576,0.000090606976,0.00019531559],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005748002,0.000675997,0.00094582466,0.00055065367,0.0015731683,0.00022482163,0.0006123691,0.0011239066,0.002391936],"category_scores_gemma":[0.00027323663,0.00062390545,0.00027219785,0.001491365,0.000077133474,0.00044082396,0.00020961656,0.0026056,0.00004744665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002615798,0.00034371213,0.5466262,0.00015781494,0.00026941788,0.00008551642,0.01351213,0.00023886641,0.00004145024,0.00006284453,0.42972296,0.008677534],"study_design_scores_gemma":[0.00740964,0.00034182385,0.3857198,0.00064187194,0.00021195412,0.000004245277,0.0051391134,0.00025547933,0.000005228843,0.00031140086,0.5984031,0.001556319],"about_ca_topic_score_codex":0.015853953,"about_ca_topic_score_gemma":0.077896826,"teacher_disagreement_score":0.55372083,"about_ca_system_score_codex":0.00035550704,"about_ca_system_score_gemma":0.00025535526,"threshold_uncertainty_score":0.99972665},"labels":[],"label_agreement":null},{"id":"W4292805718","doi":"10.1016/j.msard.2022.104138","title":"Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Celgene; Teva Pharmaceutical Industries; Biogen; Sanofi; Heart and Stroke Foundation of Canada; Roche","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Mood; Physical therapy; Cohort; Quality of life (healthcare); Cognition; Disease; Pediatrics; Internal medicine; Psychiatry","score_opus":0.08463754628614457,"score_gpt":0.29193224968933223,"score_spread":0.20729470340318767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292805718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888994,0.0068463096,0.000017690541,0.0008013385,0.000117323354,0.0022644287,0.0003844737,0.00016892263,0.00050010777],"genre_scores_gemma":[0.979051,0.01888152,0.0002621269,0.00011992769,0.000025076457,0.0008738006,0.00018483285,0.00010357478,0.000498129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584216,0.0003761747,0.00076316117,0.0011155831,0.00074252667,0.001160378],"domain_scores_gemma":[0.9981537,0.00065837,0.00024219319,0.00031541658,0.00012961632,0.000500694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053184124,0.0005814139,0.0008462423,0.00061171886,0.0010979486,0.00012451301,0.000121119905,0.0001951803,0.00017226551],"category_scores_gemma":[0.0007498651,0.00050538033,0.00019316198,0.0010074723,0.00057376985,0.0002677412,0.0004529226,0.00077605643,0.00001030809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016251974,0.0012226554,0.7615639,0.00009518069,0.00041506562,0.000019773996,0.011985607,0.00026418507,0.0044428366,0.000005472491,0.000054593558,0.21830554],"study_design_scores_gemma":[0.02379464,0.0018690263,0.93699515,0.00041929874,0.00017174898,0.000007200677,0.013967719,0.020546736,0.0003007075,0.0000148258105,0.0013916751,0.00052124524],"about_ca_topic_score_codex":0.00803992,"about_ca_topic_score_gemma":0.0044033416,"teacher_disagreement_score":0.2177843,"about_ca_system_score_codex":0.00044093846,"about_ca_system_score_gemma":0.00016904563,"threshold_uncertainty_score":0.99973977},"labels":[],"label_agreement":null},{"id":"W4294842594","doi":"10.1016/j.msard.2022.104164","title":"Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Bruton's tyrosine kinase; Multiple sclerosis; Immunology; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Receptor; Cancer","score_opus":0.050399819930991664,"score_gpt":0.2694452851222424,"score_spread":0.21904546519125076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294842594","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76994854,0.2193215,0.0000018679112,0.0005787509,0.0004947206,0.009114365,0.00044334703,0.000045235694,0.000051681494],"genre_scores_gemma":[0.44881076,0.5505411,0.000028618262,0.00004972222,0.000016401793,0.0002622393,0.00009799395,0.00008441232,0.00010874169],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99405366,0.0009286786,0.00233033,0.00086775824,0.0011974233,0.0006221236],"domain_scores_gemma":[0.99134505,0.005563299,0.0014756551,0.0012777044,0.00016004141,0.0001782381],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0015403074,0.0006960482,0.0022899748,0.00026360713,0.00043221656,0.00008152537,0.0005332393,0.0005401996,0.000034284036],"category_scores_gemma":[0.00321578,0.0002360191,0.0007144574,0.0011519766,0.0029407786,0.00016102301,0.0008102651,0.0015966316,0.0000010526466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044813347,0.0023609546,0.47123316,0.008104494,0.0020196836,0.000011815033,0.003731825,0.00028142633,0.000019091538,0.000058164915,0.00027838562,0.50741965],"study_design_scores_gemma":[0.20575896,0.0019454465,0.653486,0.051466793,0.0051778336,0.000013762512,0.0022983085,0.004918775,0.00005535513,0.00007098848,0.07301684,0.0017909022],"about_ca_topic_score_codex":0.0052466705,"about_ca_topic_score_gemma":0.0011880673,"teacher_disagreement_score":0.50562876,"about_ca_system_score_codex":0.00091299246,"about_ca_system_score_gemma":0.0012609212,"threshold_uncertainty_score":0.99977267},"labels":[],"label_agreement":null},{"id":"W4296741057","doi":"10.1016/j.msard.2022.104190","title":"Linking X to MS: Immunity and demyelination on the X-chromosome in MS","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Immunity; X chromosome; Chromosome; Immunology; Neuroscience; Genetics; Immune system; Biology; Gene","score_opus":0.0246551719435279,"score_gpt":0.21571332701721382,"score_spread":0.19105815507368593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296741057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56339496,0.04687479,0.00000664225,0.38023975,0.0027189127,0.0025153267,0.00015888097,0.00012664859,0.0039640614],"genre_scores_gemma":[0.96968746,0.0031673345,0.0000069074913,0.024492389,0.000090149064,0.00026319915,0.0005276314,0.000056480585,0.0017084238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750096,0.0009491595,0.0004238056,0.00066988694,0.00007751892,0.00037867523],"domain_scores_gemma":[0.99872744,0.0005793201,0.00018587115,0.00046000304,0.00003124596,0.00001612043],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00061526714,0.00033046116,0.00040574325,0.00025983137,0.0006498099,0.000040734194,0.0002501175,0.000831355,0.0004891363],"category_scores_gemma":[0.00020653065,0.00023901493,0.00009539786,0.00029849436,0.00020281655,0.000061674684,0.00023101269,0.0023489203,0.00006942911],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082312326,0.001022233,0.10616089,0.0011700534,0.0028721993,0.0000644691,0.04822607,0.00094515755,0.08857247,0.00093709887,0.5817208,0.16748542],"study_design_scores_gemma":[0.0036321166,0.00069455884,0.16474149,0.0019191944,0.00012378367,0.000035414127,0.0014135805,0.000022354041,0.0005692018,0.0011494259,0.8246128,0.0010860938],"about_ca_topic_score_codex":0.00079679966,"about_ca_topic_score_gemma":0.00012323575,"teacher_disagreement_score":0.4062925,"about_ca_system_score_codex":0.00006035516,"about_ca_system_score_gemma":0.000023303568,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W4297311074","doi":"10.1016/j.msard.2022.104196","title":"The relationship between alexithymia, reading the mind in the eyes and cognition in patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Beck Depression Inventory; Cognition; Psychology; Trail Making Test; Anxiety; Clinical psychology; Verbal fluency test; Paced Auditory Serial Addition Test; Beck Anxiety Inventory; Medicine; Depression (economics); Psychiatry; Neuropsychology","score_opus":0.05847195435854977,"score_gpt":0.2659462954068055,"score_spread":0.2074743410482557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297311074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016106,0.0013966054,0.0000044335247,0.0057635535,0.000064082815,0.002167265,0.00007269456,0.000025095876,0.00034523738],"genre_scores_gemma":[0.99744236,0.0015850154,0.0000551764,0.00013375847,0.00002293435,0.00053765037,0.000119842385,0.000039611383,0.0000636515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968027,0.0007123992,0.00055762497,0.0005297317,0.00081212557,0.0005854493],"domain_scores_gemma":[0.9942284,0.0050004735,0.00018508353,0.00042005646,0.00006419536,0.000101790174],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016410497,0.00029595086,0.00035050954,0.00024005403,0.0022981274,0.00012947408,0.00026033737,0.000116154806,0.000020389829],"category_scores_gemma":[0.0015985353,0.00015376981,0.000081684884,0.0009845119,0.00073811284,0.00017269055,0.00027587172,0.0011852831,0.0000041952712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046167063,0.00023196544,0.9755628,0.000026685277,0.00009971687,9.3350735e-7,0.004863816,0.000109741355,0.00006680287,0.000025379884,0.00015131352,0.018399145],"study_design_scores_gemma":[0.008975104,0.00034960127,0.9783063,0.00036978672,0.000084495725,0.0000014252973,0.010142844,0.0009852772,0.000010194537,0.00012491606,0.0004399418,0.00021011311],"about_ca_topic_score_codex":0.000695551,"about_ca_topic_score_gemma":0.0018042646,"teacher_disagreement_score":0.018189033,"about_ca_system_score_codex":0.00011415824,"about_ca_system_score_gemma":0.00004233794,"threshold_uncertainty_score":0.9990007},"labels":[],"label_agreement":null},{"id":"W4303446350","doi":"10.1016/j.msard.2022.104229","title":"The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Carleton University; University of Ottawa; St. Francis Xavier University; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"Numerical digit; Medicine; Test (biology); Audiology; Modalities; Symbol (formal); Arithmetic; Computer science","score_opus":0.023670388049836406,"score_gpt":0.24430650171116794,"score_spread":0.22063611366133154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303446350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724713,0.005491045,0.0000033791764,0.017957393,0.00042528482,0.0021046887,0.00029506025,0.00018804154,0.0010637818],"genre_scores_gemma":[0.9896384,0.008362571,0.000023422304,0.0001705435,0.00019329206,0.00042169445,0.00010994504,0.00005566788,0.0010244786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974695,0.00022335997,0.000468519,0.0005121586,0.0007545779,0.000571879],"domain_scores_gemma":[0.9967028,0.0024021994,0.00021558633,0.00036651676,0.00013659617,0.00017631508],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006997669,0.00033460822,0.0004401636,0.000108092936,0.0036188774,0.00024707607,0.00020251606,0.000115697956,0.00006746459],"category_scores_gemma":[0.002453481,0.00019209053,0.00015470225,0.0004132174,0.0018723519,0.00019806086,0.0004860434,0.00076112105,0.000004163545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010785678,0.0033873369,0.435421,0.0013253324,0.0025864465,0.000027700778,0.085144155,0.0018851089,0.0639909,0.00036670078,0.051124793,0.34395486],"study_design_scores_gemma":[0.031495374,0.0010032938,0.7969901,0.00058690814,0.00037814627,0.000032985343,0.0948093,0.05966071,0.00039630686,0.0005793197,0.0132734645,0.00079407403],"about_ca_topic_score_codex":0.00039278629,"about_ca_topic_score_gemma":0.00022519141,"teacher_disagreement_score":0.36156914,"about_ca_system_score_codex":0.00011080431,"about_ca_system_score_gemma":0.000107987034,"threshold_uncertainty_score":0.9976783},"labels":[],"label_agreement":null},{"id":"W4303446370","doi":"10.1016/j.msard.2022.104230","title":"Discussing the potential for progression with patients newly diagnosed with multiple sclerosis: When, how, and why?","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Acknowledgement; Multiple sclerosis; Disease; Anxiety; Intensive care medicine; Progressive disease; Pediatrics; Psychiatry; Pathology","score_opus":0.053012340172682804,"score_gpt":0.28430436252011343,"score_spread":0.23129202234743063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303446370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006438462,0.9781209,0.00019400447,0.0017872227,0.00028773703,0.012469285,0.000431261,0.00020317857,0.00006791261],"genre_scores_gemma":[0.02848626,0.9644349,0.001328494,0.00010145905,0.00009629301,0.0042017023,0.0008627062,0.0003149037,0.00017326351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945156,0.00049710507,0.00087232003,0.0016397183,0.0012898579,0.0011854052],"domain_scores_gemma":[0.9962721,0.0013997613,0.00079045986,0.0008331655,0.00022490203,0.0004796038],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006104664,0.001237595,0.002318554,0.00039813554,0.002394614,0.0004345226,0.00039500016,0.0004889623,0.00005827609],"category_scores_gemma":[0.0008694363,0.00060213933,0.00055042387,0.00071953994,0.001234779,0.00032372237,0.000604095,0.0014077034,0.0000023736184],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093870325,0.0007792349,0.0074824453,0.005860132,0.0015874106,0.0000073534816,0.0011184674,0.000021804664,0.000011491534,0.0000027008205,0.0016698199,0.9805204],"study_design_scores_gemma":[0.039498713,0.0042532524,0.048415348,0.046478447,0.0058313725,0.000040180592,0.004078694,0.0025590807,0.0000035849139,0.000015402953,0.8467269,0.0020990297],"about_ca_topic_score_codex":0.00024034538,"about_ca_topic_score_gemma":0.00047447777,"teacher_disagreement_score":0.9784214,"about_ca_system_score_codex":0.00019907659,"about_ca_system_score_gemma":0.00023796331,"threshold_uncertainty_score":0.999643},"labels":[],"label_agreement":null},{"id":"W4306644982","doi":"10.1016/j.msard.2022.104250","title":"Trends in the environmental risks associated with earlier onset in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Margareta af Ugglas Foundation; Multiple Sclerosis Society; European Genomic Institute for Diabetes; Swedish Foundation for MS Research; HORIZON EUROPE Framework Programme; Multiple Sclerosis Society of Canada","keywords":"Medicine; Vitamin D and neurology; Age of onset; Body mass index; Disease; Cohort; Multiple sclerosis; Risk factor; Cohort study; vitamin D deficiency; Obesity; Pediatrics; Demography; Internal medicine; Immunology","score_opus":0.06341110857591195,"score_gpt":0.2640886501180761,"score_spread":0.20067754154216413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306644982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365884,0.0015089561,0.000002060964,0.0025792425,0.00008517593,0.0011029186,0.00024628328,0.00006995804,0.0007465792],"genre_scores_gemma":[0.9951235,0.003041249,0.000053380194,0.00031236495,0.0000134693,0.0006948796,0.00038178643,0.00007201622,0.00030733112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995833,0.00072665146,0.00063686795,0.00080722343,0.001086702,0.000909579],"domain_scores_gemma":[0.9983276,0.00078916276,0.0001825375,0.0005037633,0.000019296776,0.0001776067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012146465,0.00043956324,0.0006260213,0.00074119016,0.00085205806,0.000061330844,0.0003156007,0.00018514761,0.0005883358],"category_scores_gemma":[0.00039688795,0.00031468956,0.00019556891,0.001592321,0.0005849492,0.00015726939,0.00035472267,0.0014809867,0.000012082984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007273689,0.0020030695,0.9420664,0.000013088084,0.00024008744,0.000024649233,0.0054024085,0.0015165618,0.0019315918,0.0000028943266,0.0007863995,0.04528549],"study_design_scores_gemma":[0.015453934,0.0006504121,0.96592474,0.00017885023,0.00007665319,0.000010596539,0.00813015,0.008388223,0.00003970139,0.000011586731,0.00075458665,0.00038057868],"about_ca_topic_score_codex":0.0021236055,"about_ca_topic_score_gemma":0.004320146,"teacher_disagreement_score":0.04490491,"about_ca_system_score_codex":0.00040419403,"about_ca_system_score_gemma":0.000044191456,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W4306664528","doi":"10.1016/j.msard.2022.104238","title":"A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; International Collaboration On Repair Discoveries; University of British Columbia","funders":"University of British Columbia","keywords":"Multiple sclerosis; White matter; Myelin; Medicine; Nuclear medicine; Binding potential; Pathology; Magnetic resonance imaging; Internal medicine; Positron emission tomography; Central nervous system; Radiology; Immunology","score_opus":0.12081709891831649,"score_gpt":0.27647721004989095,"score_spread":0.15566011113157446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306664528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9117737,0.007044259,0.000007966334,0.07394849,0.0009227074,0.005293891,0.00031312072,0.0003210643,0.00037482483],"genre_scores_gemma":[0.9756862,0.008255742,0.000274286,0.012190847,0.00038767044,0.0011102732,0.0014513306,0.0003546515,0.0002890177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99000615,0.001129923,0.0019166652,0.0026974734,0.002227749,0.0020220252],"domain_scores_gemma":[0.99671453,0.0009983802,0.00040984896,0.001204117,0.00023339613,0.00043972477],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016043924,0.00149268,0.002442772,0.0012632285,0.0012757293,0.0003486752,0.0005965065,0.0003379825,0.0007306783],"category_scores_gemma":[0.0009137337,0.001232212,0.00034895202,0.0006880783,0.0007098722,0.00034836555,0.0018033971,0.005310349,0.000062435836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016641632,0.0025312507,0.91440874,0.00042754985,0.001870061,0.0002263981,0.005063243,0.00022693453,0.017836263,1.370866e-7,0.04544638,0.0102988975],"study_design_scores_gemma":[0.044893224,0.0019507315,0.9072505,0.0025372102,0.00095863,0.000019599414,0.0071419934,0.015381928,0.00021931622,0.00003424731,0.01744417,0.0021684465],"about_ca_topic_score_codex":0.025013654,"about_ca_topic_score_gemma":0.0066916887,"teacher_disagreement_score":0.0639125,"about_ca_system_score_codex":0.00056126807,"about_ca_system_score_gemma":0.00010552309,"threshold_uncertainty_score":0.99978226},"labels":[],"label_agreement":null},{"id":"W4306709142","doi":"10.1016/j.msard.2022.104256","title":"The biological rabbit hole: Only for the blind","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Rabbit (cipher); Medicine; Multiple sclerosis; Immunology; Statistics; Mathematics","score_opus":0.0712973415011136,"score_gpt":0.29138752437165694,"score_spread":0.22009018287054333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306709142","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016833445,0.025894865,0.000019667954,0.9506951,0.00084570923,0.0036005438,0.00032347967,0.000103572456,0.001683611],"genre_scores_gemma":[0.23084235,0.24813244,0.00013039685,0.45757443,0.0030421645,0.0032909552,0.0026112953,0.00048248845,0.053893477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743485,0.00017687661,0.0004680291,0.0006292554,0.0005382428,0.0007527595],"domain_scores_gemma":[0.9964502,0.0025799896,0.00016148736,0.0006168066,0.00008455352,0.00010699119],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00076732895,0.0003770697,0.00048593752,0.00012274145,0.002120507,0.00017917535,0.00042308087,0.00087376504,0.0007559541],"category_scores_gemma":[0.00044108674,0.00017880111,0.0004806951,0.0003513639,0.00074836035,0.000033239237,0.000275362,0.0033816944,0.00003496014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011163276,0.00010180442,0.0011929409,0.00007101493,0.0006337377,0.00001325433,0.00020551996,0.000016855229,0.0001646554,0.000050810508,0.8867388,0.10969433],"study_design_scores_gemma":[0.0045672567,0.00047195956,0.0046083843,0.000060219685,0.00019808202,0.000013809286,0.00035125547,0.0008991819,0.0000084572175,0.00015192735,0.98840415,0.00026531328],"about_ca_topic_score_codex":0.00032082552,"about_ca_topic_score_gemma":0.00015476308,"teacher_disagreement_score":0.49312067,"about_ca_system_score_codex":0.0000799728,"about_ca_system_score_gemma":0.00017678239,"threshold_uncertainty_score":0.9991786},"labels":[],"label_agreement":null},{"id":"W4309479795","doi":"10.1016/j.msard.2022.104421","title":"Association between multiple sclerosis and epilepsy: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Epilepsy; Meta-analysis; Incidence (geometry); Multiple sclerosis; Confidence interval; Observational study; Population; Internal medicine; Relative risk; Pediatrics; Psychiatry; Environmental health","score_opus":0.15728198384027198,"score_gpt":0.3312605183813784,"score_spread":0.1739785345411064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309479795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009338017,0.9881282,0.000008770446,0.0013571363,0.00006724025,0.008862215,0.0011367089,0.00018180531,0.00016458421],"genre_scores_gemma":[0.0020866252,0.9917504,0.00016553352,0.0002384453,0.00003467273,0.0034320946,0.0008550626,0.00018779181,0.0012493429],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990737,0.0020253814,0.0027888052,0.0019365915,0.0014550654,0.0010571388],"domain_scores_gemma":[0.99099207,0.005030357,0.0019443973,0.0011607886,0.00020467119,0.00066771335],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003324016,0.0014404706,0.015209211,0.0011464203,0.0010699223,0.00022665481,0.00036217514,0.000855458,0.0007322467],"category_scores_gemma":[0.005572208,0.0010197979,0.0036897685,0.002662623,0.0003729373,0.00023483198,0.00090827944,0.001767376,0.000027976052],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013973477,0.00021476393,0.0045868997,0.54825926,0.41189158,0.0000032313544,0.00028720257,0.0000017432396,0.0000014105099,0.0000030811093,0.0008145934,0.033922233],"study_design_scores_gemma":[0.001854367,0.00017764447,0.005302573,0.032166768,0.913153,0.000008413227,0.00020671144,0.00012670767,2.2122892e-7,0.0000065147783,0.045995906,0.0010011581],"about_ca_topic_score_codex":0.00054561783,"about_ca_topic_score_gemma":0.00023501432,"teacher_disagreement_score":0.5160925,"about_ca_system_score_codex":0.0004571538,"about_ca_system_score_gemma":0.000118630014,"threshold_uncertainty_score":0.99983454},"labels":[],"label_agreement":null},{"id":"W4310064348","doi":"10.1016/j.msard.2022.104433","title":"The nine hole peg test as an outcome measure in progressive MS trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"","keywords":"Medicine; Ambulatory; Clinical trial; Randomized controlled trial; Physical therapy; Test (biology); Surgery; Internal medicine","score_opus":0.08297419620756323,"score_gpt":0.33296610375509905,"score_spread":0.2499919075475358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310064348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96969575,0.010807105,0.0000029544017,0.013470741,0.00035381038,0.003178118,0.000084891224,0.00016049447,0.00224614],"genre_scores_gemma":[0.99349195,0.004068388,0.00007472451,0.00019527136,0.00005592962,0.00096198724,0.00006940485,0.000062481726,0.0010198889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565816,0.0008732531,0.0010343664,0.00068049907,0.0010057493,0.0007479664],"domain_scores_gemma":[0.9970654,0.00162279,0.0003106451,0.0005661019,0.00013561624,0.00029942679],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0035595256,0.00035513472,0.00084240147,0.00025127147,0.0015435267,0.00011080884,0.0003078463,0.00014952848,0.0003968573],"category_scores_gemma":[0.0086606415,0.00022888194,0.00025550654,0.00079544843,0.00042971552,0.00015186575,0.0004102542,0.0010903141,0.000021481057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001447972,0.0018668153,0.8397354,0.00006687701,0.00043400578,0.000031044594,0.0032730638,0.00047868144,0.009508963,0.00006282108,0.0020433317,0.14105105],"study_design_scores_gemma":[0.016581232,0.0015241548,0.95672894,0.00016859251,0.00013794351,0.000017026634,0.00947435,0.0062806276,0.00018001984,0.00013474855,0.008334638,0.00043771186],"about_ca_topic_score_codex":0.0007655516,"about_ca_topic_score_gemma":0.00067119754,"teacher_disagreement_score":0.14061333,"about_ca_system_score_codex":0.00016197989,"about_ca_system_score_gemma":0.00011621112,"threshold_uncertainty_score":0.99975634},"labels":[],"label_agreement":null},{"id":"W4310731794","doi":"10.1016/j.msard.2022.104444","title":"Stroke Outcomes and Hyperacute Treatment Utilization in Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Stroke (engine); Thrombolysis; Population; Odds ratio; Logistic regression; Multiple sclerosis; Emergency medicine; Internal medicine; Physical therapy; Myocardial infarction; Environmental health","score_opus":0.09061417699426802,"score_gpt":0.29001869555218024,"score_spread":0.19940451855791222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310731794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902161,0.0044295858,0.000013832672,0.0027585216,0.00020070033,0.0015849171,0.00020025733,0.00013706328,0.00045901645],"genre_scores_gemma":[0.96963644,0.02830162,0.0003147034,0.00017077543,0.000015881562,0.0005631354,0.0001396231,0.00006630258,0.00079149334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704933,0.0002411722,0.00062185305,0.0008244042,0.00059168413,0.0006715359],"domain_scores_gemma":[0.99864566,0.00048011358,0.0001389808,0.00038949322,0.00006154857,0.00028417542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003775463,0.00044065833,0.0007452391,0.00050978275,0.000916936,0.00006327351,0.000119428856,0.00015057035,0.00021341104],"category_scores_gemma":[0.00042548132,0.00036652596,0.0001936056,0.0005849487,0.00032195452,0.00018179676,0.0003711013,0.0004713356,0.000009178078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042122422,0.0010257585,0.86299,0.000040413448,0.00036384145,0.000006735413,0.0019883164,0.00038325172,0.013479394,0.000018745097,0.0001695109,0.11911276],"study_design_scores_gemma":[0.017017163,0.0007363143,0.95676845,0.00009568162,0.00011841795,0.000008116816,0.0033813987,0.018324973,0.00037513475,0.000019417657,0.002793834,0.00036107303],"about_ca_topic_score_codex":0.001481097,"about_ca_topic_score_gemma":0.00088668213,"teacher_disagreement_score":0.11875169,"about_ca_system_score_codex":0.00031750312,"about_ca_system_score_gemma":0.000064332846,"threshold_uncertainty_score":0.99987864},"labels":[],"label_agreement":null},{"id":"W4311086874","doi":"10.1016/j.msard.2022.104459","title":"Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Bayer Vital; EMD Serono; Deutsche Forschungsgemeinschaft; European Commission; Sanofi; Bayer HealthCare; Bristol-Myers Squibb; CSL Behring; Fresenius Medical Care North America; Biogen; Celgene; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Merck KGaA; Pfizer","keywords":"Cladribine; Medicine; Multiple sclerosis; Expert opinion; Term (time); Relapsing remitting; Dermatology; Systematic review; Alternative medicine; MEDLINE; Intensive care medicine; Medical physics; Immunology; Pathology; Internal medicine","score_opus":0.2194334906312244,"score_gpt":0.36579924789781365,"score_spread":0.14636575726658926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311086874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010674192,0.9813437,0.000011874369,0.0007311114,0.00051663676,0.016511457,0.00063334644,0.0000871836,0.000057968795],"genre_scores_gemma":[0.0011620593,0.9917058,0.00019227706,0.00022782736,0.000081433805,0.0053659473,0.0007685198,0.00021055368,0.00028561405],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99167633,0.0014955343,0.0031892913,0.0013223245,0.0014711339,0.0008453789],"domain_scores_gemma":[0.98327684,0.01174038,0.0022579457,0.0019148195,0.0005131007,0.0002969135],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002301935,0.0011829056,0.00552413,0.00079319533,0.0005793006,0.00010363845,0.00073100073,0.00052006077,0.0002027529],"category_scores_gemma":[0.0121061215,0.00070521235,0.0019880496,0.0022568356,0.00058001187,0.00030319905,0.0005866104,0.0013926767,0.00000636027],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027048247,0.000665912,0.00050318823,0.8374265,0.0019454865,0.0000028011707,0.0004502753,0.000006517648,0.00011503597,0.000036186164,0.0045500235,0.15402758],"study_design_scores_gemma":[0.0020218806,0.0006270421,0.0023678055,0.92810184,0.0012757959,0.000009690977,0.00009866099,0.00023242994,0.000016591264,0.0000017809562,0.06464639,0.0006000886],"about_ca_topic_score_codex":0.00022780022,"about_ca_topic_score_gemma":0.0001066474,"teacher_disagreement_score":0.1534275,"about_ca_system_score_codex":0.00032826926,"about_ca_system_score_gemma":0.00027159308,"threshold_uncertainty_score":0.9995399},"labels":[],"label_agreement":null},{"id":"W4312156836","doi":"10.1016/j.msard.2022.104482","title":"Cognitive reserve as a moderating factor between EDSS and cognition in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Cognitive reserve; Neuropsychology; Cognition; Medicine; Expanded Disability Status Scale; Population; Effects of sleep deprivation on cognitive performance; Clinical psychology; Physical medicine and rehabilitation; Audiology; Cognitive impairment; Psychiatry; Environmental health","score_opus":0.09531968446700659,"score_gpt":0.2968907295039255,"score_spread":0.2015710450369189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312156836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910829,0.0033080692,0.000031130516,0.0020548645,0.00009587775,0.0020264436,0.00041861302,0.0001472868,0.0008347865],"genre_scores_gemma":[0.9931711,0.005237812,0.00018758634,0.00019796759,0.00004527323,0.00064130063,0.00027015826,0.00008911341,0.00015968081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961136,0.0004525928,0.00076442084,0.0010101614,0.0008273251,0.00083191594],"domain_scores_gemma":[0.9975984,0.0014063274,0.0001825394,0.000271213,0.00015377931,0.00038773255],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006305048,0.00046850342,0.0007850042,0.0005475456,0.0014612123,0.00010807144,0.00014243912,0.00022411876,0.0003027224],"category_scores_gemma":[0.0020801192,0.00045040992,0.00017423456,0.000731443,0.0005062826,0.0002968085,0.00069286925,0.001233085,0.000016114365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001120736,0.0006635227,0.88572615,0.00017819936,0.0005711358,0.000013269885,0.0065426514,0.00020679785,0.0190219,0.000009605472,0.00017643243,0.08576962],"study_design_scores_gemma":[0.017980231,0.00080021046,0.94845575,0.00071522436,0.00016885095,0.000012164036,0.010770365,0.019339995,0.0009077675,0.00012637815,0.00016182124,0.0005612298],"about_ca_topic_score_codex":0.00904576,"about_ca_topic_score_gemma":0.003957475,"teacher_disagreement_score":0.08520839,"about_ca_system_score_codex":0.00019966798,"about_ca_system_score_gemma":0.00013140602,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W4312157419","doi":"10.1016/j.msard.2022.104477","title":"Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"Sanofi Genzyme; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Glatiramer acetate; Hazard ratio; Internal medicine; Confidence interval; Physical therapy; Immunology","score_opus":0.04864018171732619,"score_gpt":0.3034846335300865,"score_spread":0.2548444518127603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312157419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312925,0.0018092778,0.00006798907,0.00051982165,0.00014948897,0.0039881626,0.00016353677,0.000099555196,0.000072902825],"genre_scores_gemma":[0.9970625,0.0013228117,0.000098212215,0.000042623218,0.000015868069,0.0013287461,0.000030052985,0.000065550485,0.000033602395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995786,0.0010651767,0.0005901016,0.0010437553,0.00078736816,0.00072760857],"domain_scores_gemma":[0.99618465,0.0025078617,0.00020854984,0.00048711852,0.00008723418,0.0005245865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012512034,0.0005405758,0.0012846446,0.00058485905,0.00076739007,0.00005070803,0.00021889612,0.00013456606,0.000058321966],"category_scores_gemma":[0.0015705334,0.00042752866,0.00020509843,0.0011440859,0.00029938263,0.00024046242,0.0008949367,0.0008556321,0.0000032500564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05077597,0.0017414801,0.7151246,0.0017519989,0.0007347588,0.000022522823,0.008175602,0.0063021746,0.1383712,0.000013894553,0.00009073191,0.076895066],"study_design_scores_gemma":[0.018484365,0.0022235408,0.94678026,0.0011812838,0.00014671973,0.0000049881714,0.0010293254,0.025972344,0.0036518297,0.0000131089655,0.00007260706,0.00043963792],"about_ca_topic_score_codex":0.0023433005,"about_ca_topic_score_gemma":0.00087954855,"teacher_disagreement_score":0.23165564,"about_ca_system_score_codex":0.00027147867,"about_ca_system_score_gemma":0.00011484458,"threshold_uncertainty_score":0.99981767},"labels":[],"label_agreement":null},{"id":"W4315884145","doi":"10.1016/j.msard.2023.104519","title":"Cancer risk and mortality in multiple sclerosis: The need for vigilance","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Azathioprine; Multiple sclerosis; Cancer; Internal medicine; Population; Cyclophosphamide; Oncology; Disease; Chemotherapy; Immunology","score_opus":0.05518526377351195,"score_gpt":0.30802340309560955,"score_spread":0.2528381393220976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315884145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47651598,0.0448761,0.000047366364,0.0040898956,0.45761418,0.010505347,0.0055045765,0.00065798516,0.00018856356],"genre_scores_gemma":[0.51128596,0.43303093,0.00014642868,0.00007800644,0.049920876,0.003862687,0.00061134447,0.00033642224,0.0007273646],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99435544,0.0003349849,0.0011671452,0.0016089525,0.0012061967,0.0013272904],"domain_scores_gemma":[0.991038,0.006798309,0.00053748564,0.0008713186,0.00037243034,0.00038244232],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017547426,0.0009213372,0.0015977138,0.0004198103,0.0010225449,0.00018836976,0.000400735,0.0014328995,0.000022088392],"category_scores_gemma":[0.011319829,0.0006531303,0.0004333319,0.0009289463,0.0011258858,0.00017571637,0.00050413253,0.0024227775,0.0000140169295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013806914,0.0004521658,0.37017256,0.0016427246,0.0019823827,0.0000043763685,0.002120881,0.00038247832,0.001243435,0.000005019216,0.57305354,0.04755973],"study_design_scores_gemma":[0.020341642,0.00034053312,0.82530344,0.0041194675,0.00083852554,4.5313124e-7,0.0016035892,0.01590259,0.00005366085,0.00012530766,0.13035692,0.0010138621],"about_ca_topic_score_codex":0.013757354,"about_ca_topic_score_gemma":0.025763044,"teacher_disagreement_score":0.45513088,"about_ca_system_score_codex":0.00024839133,"about_ca_system_score_gemma":0.00027303514,"threshold_uncertainty_score":0.99987864},"labels":[],"label_agreement":null},{"id":"W4316035190","doi":"10.1016/j.msard.2023.104514","title":"Multiple sclerosis-related heat sensitivity linked to absence of DMT prescription and subjective hand impairment but not autonomic or corticospinal dysfunction","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Thermoregulation and physiological responses","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Depression (economics); Physical medicine and rehabilitation; Anxiety; Transcranial magnetic stimulation; Multiple sclerosis; Visual analogue scale; Physical therapy; Internal medicine; Cardiology; Psychiatry; Stimulation","score_opus":0.040208404117657075,"score_gpt":0.25003616870786555,"score_spread":0.20982776459020847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316035190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755913,0.00016358454,0.00013682818,0.0005656865,0.00022176658,0.0010944549,0.00006173216,0.0001754837,0.000021350952],"genre_scores_gemma":[0.998355,0.0008602231,0.00009175841,0.000109487555,0.000016431077,0.00004631895,0.00006361567,0.000029033761,0.00042815498],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998246,0.00018442828,0.0004875134,0.0005279206,0.00022424376,0.00032990085],"domain_scores_gemma":[0.99884593,0.00045115806,0.00012741488,0.00021886264,0.00010223405,0.0002543757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035221825,0.0002586603,0.00044999536,0.00021193916,0.00028622177,0.00003737081,0.00003939253,0.00025829746,0.00007021786],"category_scores_gemma":[0.00059729785,0.00019432874,0.00011778211,0.0004732726,0.0003277482,0.00011597615,0.00008801504,0.00023123196,0.000028241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009894435,0.00027538938,0.028369877,0.000058492762,0.00014453102,0.000003844972,0.0012462576,0.0029699802,0.9308676,0.000013401258,0.000041211424,0.026114974],"study_design_scores_gemma":[0.0049999105,0.0011749356,0.92309594,0.0003601594,0.00008062225,0.000008358537,0.0006917641,0.063715234,0.0055774846,0.00003547841,0.000042546235,0.00021758456],"about_ca_topic_score_codex":0.00084079837,"about_ca_topic_score_gemma":0.00020688963,"teacher_disagreement_score":0.9252901,"about_ca_system_score_codex":0.00008848458,"about_ca_system_score_gemma":0.00006208334,"threshold_uncertainty_score":0.7924496},"labels":[],"label_agreement":null},{"id":"W4318672184","doi":"10.1016/j.msard.2023.104542","title":"Specific alterations in NKG2D+ T lymphocytes in relapsing-remitting and progressive multiple sclerosis patients","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Medicine; Relapsing remitting; Multiple sclerosis; NKG2D; Immunology; Cytotoxic T cell; Genetics","score_opus":0.04567342888861846,"score_gpt":0.2677340634801948,"score_spread":0.22206063459157632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318672184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914218,0.0045431736,0.0000050618487,0.001214811,0.0002509033,0.00180877,0.000048567064,0.00020553255,0.00050138304],"genre_scores_gemma":[0.9706247,0.028109495,0.00045815928,0.000064407825,0.00004045382,0.00032718168,0.00017305514,0.00007978849,0.00012275235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963346,0.00021076274,0.0009254493,0.000992301,0.00056555116,0.0009713403],"domain_scores_gemma":[0.99811935,0.00087196735,0.00019090765,0.0003747513,0.00014583378,0.00029718428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006330568,0.00045227402,0.0006962126,0.0009917555,0.0004938536,0.00013293562,0.00013968744,0.000317336,0.000044116074],"category_scores_gemma":[0.001824148,0.000405454,0.00012942652,0.0018302182,0.0005031579,0.0003405489,0.0003388926,0.00061227207,0.000042357602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003230379,0.00052792253,0.9146292,0.00012472179,0.00008845346,0.000009905444,0.0038385245,0.0003378033,0.0062407255,0.000010495861,0.0004789633,0.07339021],"study_design_scores_gemma":[0.015744768,0.00019690857,0.9560046,0.00200569,0.000025933676,0.0000022999568,0.0021207333,0.022765948,0.00043161685,0.000053804477,0.00024657327,0.00040108425],"about_ca_topic_score_codex":0.00065541005,"about_ca_topic_score_gemma":0.0007427082,"teacher_disagreement_score":0.07298912,"about_ca_system_score_codex":0.00024103046,"about_ca_system_score_gemma":0.00006381932,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W4319915130","doi":"10.1016/j.msard.2023.104561","title":"Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Medicine; Natalizumab; Dosing; Expanded Disability Status Scale; Physical therapy; Multiple sclerosis; Rating scale; Randomized controlled trial; Clinical trial; Internal medicine; Clinical endpoint; Progressive multifocal leukoencephalopathy; Disease","score_opus":0.08653767171726767,"score_gpt":0.30270793263833595,"score_spread":0.21617026092106828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364484,0.006985613,0.00005425871,0.0002669535,0.001659599,0.006820349,0.000112371716,0.000382978,0.0000730114],"genre_scores_gemma":[0.9951618,0.0037435326,0.00030124144,0.00007536532,0.000052373958,0.00029201197,0.00019993821,0.00013983142,0.0000339379],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99378264,0.0006760222,0.0030359176,0.0011429455,0.0006026558,0.0007598078],"domain_scores_gemma":[0.9880949,0.009173215,0.0014276244,0.00056370243,0.00026960834,0.00047092696],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014712184,0.00069106894,0.0035155553,0.0004899427,0.0006491837,0.000118588294,0.00014966281,0.0006013455,0.000025538944],"category_scores_gemma":[0.009097072,0.0005194973,0.0009213252,0.0006800793,0.000711704,0.00022495228,0.00019204547,0.0006296592,0.000005978685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6817317,0.014307449,0.12352564,0.00021998302,0.018381406,0.00007002939,0.020166142,0.00047153188,0.012051483,0.000013523186,0.0003480913,0.12871301],"study_design_scores_gemma":[0.8101828,0.0022600072,0.15350896,0.0014484851,0.0049231453,0.0000029843686,0.012408026,0.014403501,0.00019055414,0.00003806608,0.000029706885,0.0006037195],"about_ca_topic_score_codex":0.0011459215,"about_ca_topic_score_gemma":0.00014549676,"teacher_disagreement_score":0.12845112,"about_ca_system_score_codex":0.00006156588,"about_ca_system_score_gemma":0.00013214395,"threshold_uncertainty_score":0.99972564},"labels":[],"label_agreement":null},{"id":"W4320921451","doi":"10.1016/j.msard.2023.104578","title":"Vascular function and cognition in persons with multiple sclerosis: Preliminary examination","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Cognition; Arterial stiffness; Multiple sclerosis; Population; Internal medicine; Trail Making Test; Comorbidity; Cardiology; Physical therapy; Cognitive impairment; Blood pressure; Psychiatry","score_opus":0.04080956677154136,"score_gpt":0.24474924242258678,"score_spread":0.20393967565104543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320921451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422336,0.0020858508,0.00009953642,0.0010474925,0.000102107726,0.0015757469,0.000032927794,0.00030877982,0.0005241789],"genre_scores_gemma":[0.98318106,0.015664045,0.0001843884,0.00006279881,0.000029729386,0.00039978864,0.0002358559,0.00006935294,0.00017295552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974327,0.00019622908,0.00041873858,0.0007782818,0.00056339946,0.000610668],"domain_scores_gemma":[0.9988339,0.0004178211,0.00011131236,0.00027953976,0.000117945434,0.00023946525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067354826,0.00036070254,0.00046372574,0.00069380645,0.00045874843,0.00007036637,0.00006849005,0.0002766449,0.000037167734],"category_scores_gemma":[0.0005255089,0.0002980962,0.000103547514,0.001123203,0.0004265848,0.00033640835,0.00013825193,0.00047854922,0.000032893015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001942873,0.00090813794,0.71927434,0.0005867726,0.00075640687,0.000014446415,0.004812199,0.00065741997,0.045894127,0.000025844376,0.00067067565,0.22445676],"study_design_scores_gemma":[0.012828077,0.0009541824,0.9454615,0.0010780123,0.00021444028,0.000005437989,0.005625272,0.033090852,0.00018607725,0.000042021205,0.00017700715,0.00033712227],"about_ca_topic_score_codex":0.0003311698,"about_ca_topic_score_gemma":0.0005681667,"teacher_disagreement_score":0.22618717,"about_ca_system_score_codex":0.00007585413,"about_ca_system_score_gemma":0.000037959548,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W4322011926","doi":"10.1016/j.msard.2023.104590","title":"Are we ready for CD19-targeted CAR T-cell therapies in MS?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chimeric antigen receptor; CD19; Medicine; Immunology; B cell; Antigen; T cell; Cancer research","score_opus":0.0493028518859097,"score_gpt":0.29498792866946655,"score_spread":0.24568507678355683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322011926","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07356178,0.036452398,0.000011639489,0.004531894,0.87439793,0.0069522033,0.0018125282,0.00071604043,0.0015636084],"genre_scores_gemma":[0.08442077,0.5024886,0.00036799422,0.0001808935,0.2864042,0.002693304,0.009598346,0.0018420045,0.11200386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964526,0.00015787261,0.000708297,0.0009936347,0.00081635,0.00087121245],"domain_scores_gemma":[0.9965168,0.0020551733,0.00034221154,0.00058701535,0.00025191015,0.00024686172],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00067405036,0.0005946582,0.0011121093,0.000605679,0.0002118658,0.00008458742,0.00024905382,0.0019256099,0.0003260976],"category_scores_gemma":[0.001162562,0.0005055359,0.0003689599,0.0006553906,0.00025956242,0.000073977506,0.00010963329,0.0016853871,0.000047021138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016872018,0.00046107444,0.0029254525,0.00097043405,0.0005696581,0.000017506423,0.0017303515,0.00005077089,0.014804237,0.0000018339002,0.9622247,0.01455673],"study_design_scores_gemma":[0.017266935,0.00054630917,0.004679954,0.0014286039,0.00020386116,5.98094e-7,0.002058189,0.0009496216,0.0002616496,0.00013960003,0.97178507,0.00067960005],"about_ca_topic_score_codex":0.0011610796,"about_ca_topic_score_gemma":0.0022207326,"teacher_disagreement_score":0.5879937,"about_ca_system_score_codex":0.00019990976,"about_ca_system_score_gemma":0.0002115634,"threshold_uncertainty_score":0.99973965},"labels":[],"label_agreement":null},{"id":"W4323275977","doi":"10.1016/j.msard.2023.104606","title":"Mapping two decades of multiple sclerosis rehabilitation trials: A systematic scoping review and call to action to advance the study of race and ethnicity in rehabilitation research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Humber River Regional Hospital; Queen's University","funders":"","keywords":"Medicine; Multiple sclerosis; Rehabilitation; Ethnic group; Call to action; Race (biology); Physical medicine and rehabilitation; Physical therapy; Systematic review; Clinical trial; MEDLINE; Pathology; Gender studies; Psychiatry","score_opus":0.1981652630258297,"score_gpt":0.43172721773072936,"score_spread":0.23356195470489965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323275977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626518,0.014952819,0.00004193272,0.006210919,0.000056427445,0.016012177,0.000015188626,0.00004830864,0.00001046594],"genre_scores_gemma":[0.9557555,0.04145579,0.0009933637,0.00004410484,0.000009761346,0.0016840008,0.000005702491,0.000032835673,0.000018986584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932034,0.002966253,0.0017643714,0.0007448124,0.0008502784,0.00047089212],"domain_scores_gemma":[0.9812452,0.017045982,0.0003716977,0.00052680867,0.0006070519,0.00020321194],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013980445,0.00026756187,0.0015997426,0.0009992254,0.00035701014,0.000035312514,0.00014653856,0.0001227235,0.0000039992105],"category_scores_gemma":[0.07797791,0.0001903795,0.000104499864,0.0035974423,0.0003974782,0.00020181455,0.00034550336,0.00045540516,0.0000033300694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001732377,0.0016299315,0.5070252,0.18853498,0.000613971,0.0000011681566,0.123636484,0.0027200722,0.11797264,0.00001721412,0.0005067782,0.05560919],"study_design_scores_gemma":[0.005728178,0.0014434162,0.80473703,0.13297965,0.00013626588,6.7954574e-7,0.0516448,0.002966003,0.00014654954,0.000029125064,0.000006302235,0.00018198152],"about_ca_topic_score_codex":0.0019575928,"about_ca_topic_score_gemma":0.005287872,"teacher_disagreement_score":0.29771188,"about_ca_system_score_codex":0.000121665966,"about_ca_system_score_gemma":0.00005919633,"threshold_uncertainty_score":0.92978865},"labels":[],"label_agreement":null},{"id":"W4323658077","doi":"10.1016/j.msard.2023.104612","title":"Multiple sclerosis in Indigenous Peoples of the Americas: A systematic review of incidence, prevalence, and outcomes","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Indigenous; Epidemiology; Multiple sclerosis; Demography; Confounding; Prevalence; Gerontology; Internal medicine; Immunology","score_opus":0.06653528153400365,"score_gpt":0.32205837874927107,"score_spread":0.25552309721526745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323658077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009574116,0.9793617,9.1616823e-7,0.0001603104,0.00013645257,0.010352123,0.00029738946,0.000068648835,0.000048315815],"genre_scores_gemma":[0.021574534,0.9766699,0.00007177045,0.000049465096,0.000009737246,0.0012346925,0.000040369392,0.00012994581,0.00021959086],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930543,0.0009696851,0.0031704344,0.0009469803,0.0011293219,0.0007292894],"domain_scores_gemma":[0.99239916,0.00400988,0.001930883,0.0011966155,0.00023759321,0.00022585616],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016282151,0.0008869888,0.006630439,0.000799473,0.00025071486,0.000031708143,0.0006085491,0.0005202215,0.00002069479],"category_scores_gemma":[0.011396489,0.0005163301,0.0011497604,0.0026181675,0.00112331,0.00012519286,0.00084979925,0.0009431335,0.000011526807],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017841625,0.00028539874,0.05427364,0.9109961,0.0011500716,0.0000018563873,0.0012828368,0.0000015672807,0.000011873386,0.000002810592,0.000056423207,0.031919625],"study_design_scores_gemma":[0.0016226422,0.00014433781,0.14419417,0.8494164,0.0031925878,0.000009861132,0.00057167263,0.00005322827,0.0000021677333,0.000004694912,0.00036132493,0.00042696035],"about_ca_topic_score_codex":0.0010779165,"about_ca_topic_score_gemma":0.000837632,"teacher_disagreement_score":0.08992053,"about_ca_system_score_codex":0.00014755708,"about_ca_system_score_gemma":0.00038491568,"threshold_uncertainty_score":0.99972886},"labels":[],"label_agreement":null},{"id":"W4323980898","doi":"10.1016/j.msard.2023.104614","title":"Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Spinal cord; Multiple sclerosis; Lesion; Corticospinal tract; Central nervous system disease; Demyelinating disease; Pathology; Magnetic resonance imaging; Radiology; Surgery","score_opus":0.06543710682518092,"score_gpt":0.3088262401795518,"score_spread":0.24338913335437087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323980898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913264,0.0014940917,0.000014631042,0.004234547,0.00011216936,0.0021931122,0.00012210896,0.00035377083,0.00014916073],"genre_scores_gemma":[0.9915163,0.007280752,0.00019939395,0.00010944115,0.000026170477,0.00039367913,0.000124953,0.000101933394,0.00024739603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960281,0.00026827643,0.0007050578,0.0010720592,0.0008402188,0.001086237],"domain_scores_gemma":[0.99766856,0.0009036458,0.00033833657,0.00037070437,0.00020275734,0.0005160073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067692134,0.0005703311,0.00091412675,0.00067282724,0.0007066688,0.00010849321,0.0001502406,0.0003981081,0.000039323786],"category_scores_gemma":[0.0031915791,0.00043662993,0.0001676266,0.001577574,0.00080041995,0.00030894074,0.0002595646,0.00095390866,0.00002314708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037059048,0.0012307091,0.83410656,0.00015972187,0.00035977113,0.000053932697,0.0007923123,0.00006435611,0.031019624,0.0000045286442,0.00040031882,0.12810229],"study_design_scores_gemma":[0.013385854,0.0028262842,0.96283364,0.004031478,0.00011423777,0.000010164903,0.0030500856,0.012835561,0.0002604164,0.000021770102,0.000121154364,0.0005093322],"about_ca_topic_score_codex":0.0005191222,"about_ca_topic_score_gemma":0.0010577843,"teacher_disagreement_score":0.12872712,"about_ca_system_score_codex":0.00019450538,"about_ca_system_score_gemma":0.00010095762,"threshold_uncertainty_score":0.99980855},"labels":[],"label_agreement":null},{"id":"W4328097996","doi":"10.1016/j.msard.2023.104626","title":"The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"Bristol-Myers Squibb","keywords":"Multiple sclerosis; Medicine; Cognitive impairment; Disease; Cognition; Physical medicine and rehabilitation; Psychiatry; Internal medicine","score_opus":0.03516307136005028,"score_gpt":0.3039537774814197,"score_spread":0.26879070612136946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328097996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451995,0.00024443716,0.000012558041,0.00026887207,0.00004462493,0.00454289,0.00018738332,0.00011492951,0.00006437409],"genre_scores_gemma":[0.9976855,0.001541793,0.000011720789,0.00001299999,0.000016935708,0.00045654457,0.0001451368,0.00007199284,0.000057378486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968385,0.0002220197,0.0006591651,0.0006762688,0.00091361214,0.0006904393],"domain_scores_gemma":[0.9970801,0.0016050362,0.00022320906,0.0004513673,0.00029755078,0.00034275698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052840303,0.00046756092,0.0005954188,0.00045804234,0.0004998844,0.000055908124,0.00015653139,0.00011516708,0.000012027227],"category_scores_gemma":[0.0019852584,0.00025750787,0.0002434582,0.0013244917,0.00036735903,0.00017023613,0.00020281172,0.0004276287,0.000014929509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006420097,0.0023941656,0.7281251,0.00003671164,0.00046114728,0.0000021845176,0.0034605418,0.25129497,0.000103184684,5.0037414e-7,0.000033861717,0.007667515],"study_design_scores_gemma":[0.016858367,0.0013603718,0.58887994,0.00057905144,0.0000656255,3.9277495e-8,0.0017340414,0.39033395,0.0000021150602,0.000014939682,4.5534443e-7,0.00017110651],"about_ca_topic_score_codex":0.00086472806,"about_ca_topic_score_gemma":0.00048599223,"teacher_disagreement_score":0.13924517,"about_ca_system_score_codex":0.00016719867,"about_ca_system_score_gemma":0.000110023604,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W4328110099","doi":"10.1016/j.msard.2023.104630","title":"Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Depression (economics); Medicine; Cognition; Anxiety; Physical therapy; Beck Depression Inventory; Physical medicine and rehabilitation; Audiology; Psychiatry","score_opus":0.0759929165356866,"score_gpt":0.2966199833045948,"score_spread":0.22062706676890823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328110099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917903,0.0041546426,0.00005061639,0.0010887493,0.00008610824,0.0021305499,0.00021479432,0.00019768365,0.00028658097],"genre_scores_gemma":[0.95664865,0.042367805,0.00012541338,0.00010337833,0.000046928937,0.00033491588,0.0001221594,0.00008609846,0.00016464047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962151,0.0002172424,0.00071838486,0.0012501212,0.00060552265,0.0009936444],"domain_scores_gemma":[0.99747825,0.0012869384,0.00018902663,0.0003758425,0.00014465257,0.00052531407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005723329,0.0006035847,0.0009415869,0.0005816655,0.00066306,0.00013154258,0.00015413604,0.0004536812,0.000052822703],"category_scores_gemma":[0.00094446214,0.00048257248,0.00015061567,0.0009672727,0.00073129125,0.00024700456,0.0005563375,0.00077808194,0.000021786058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036445988,0.00023903597,0.9231707,0.00025854143,0.0003191409,0.000007445805,0.005909012,0.000013011107,0.008384858,0.0000011919572,0.00031935325,0.061013278],"study_design_scores_gemma":[0.01504972,0.00037058906,0.9599898,0.0029461193,0.00015062596,0.000002456644,0.0061198026,0.013673664,0.0010735714,0.00007582097,0.00003360776,0.0005142185],"about_ca_topic_score_codex":0.0017292238,"about_ca_topic_score_gemma":0.0007770398,"teacher_disagreement_score":0.06049906,"about_ca_system_score_codex":0.00006573389,"about_ca_system_score_gemma":0.000052234845,"threshold_uncertainty_score":0.9997626},"labels":[],"label_agreement":null},{"id":"W4353048131","doi":"10.1016/j.msard.2023.104655","title":"Inequality in accessing healthcare for people with MS","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Referral; Health care; Family medicine; Library science; Political science; Law; Computer science","score_opus":0.05714403381001097,"score_gpt":0.33444627715734765,"score_spread":0.27730224334733666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353048131","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21083742,0.010838179,0.0001581851,0.014733717,0.74754816,0.011766081,0.0024737734,0.0010941691,0.00055030675],"genre_scores_gemma":[0.76230294,0.0887014,0.0012051059,0.00011644041,0.13693793,0.0034274294,0.005387284,0.0007904668,0.0011310176],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9954137,0.00019593904,0.0009233863,0.0012423281,0.0011200488,0.0011045738],"domain_scores_gemma":[0.99478614,0.0034963116,0.0003424741,0.0005681999,0.00044343586,0.00036346048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010831273,0.00065432425,0.0015578474,0.0005674677,0.00046608207,0.00013052353,0.0002367153,0.0012836945,0.000019612915],"category_scores_gemma":[0.00564348,0.00050176214,0.00024974725,0.0010665972,0.0003106951,0.00016534326,0.00026575557,0.0017141732,0.000012144359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038022508,0.0008351145,0.17789558,0.0083320085,0.0011783073,0.000014132257,0.004764384,0.00017733185,0.00034255505,0.000010084721,0.7430708,0.059577446],"study_design_scores_gemma":[0.037192006,0.001843461,0.7569939,0.011218257,0.00044389605,0.0000015332113,0.002736368,0.005875069,0.00003311177,0.00014462588,0.1817862,0.0017315682],"about_ca_topic_score_codex":0.009118511,"about_ca_topic_score_gemma":0.03780221,"teacher_disagreement_score":0.61061025,"about_ca_system_score_codex":0.00028797382,"about_ca_system_score_gemma":0.00045555667,"threshold_uncertainty_score":0.9997434},"labels":[],"label_agreement":null},{"id":"W4360999432","doi":"10.1016/j.msard.2023.104677","title":"Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Paced Auditory Serial Addition Test; Medicine; Neurocognitive; Depression (economics); Confidence interval; Population; Mallinckrodt; Expanded Disability Status Scale; Physical therapy; Cognition; Neuropsychology; Physical medicine and rehabilitation; Psychiatry; Internal medicine; Multiple sclerosis","score_opus":0.09938648461708932,"score_gpt":0.3662454622970719,"score_spread":0.26685897767998257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360999432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929051,0.00039505571,0.000066184584,0.0014330229,0.00025941286,0.0033206036,0.000066886365,0.00017776275,0.0013759659],"genre_scores_gemma":[0.99256253,0.0057684984,0.0009099764,0.00006728903,0.000048582973,0.00033549292,0.00016331406,0.000097053264,0.000047241767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931965,0.0010699491,0.0022101277,0.0013867966,0.0011794469,0.00095718424],"domain_scores_gemma":[0.9934794,0.0044919252,0.0007361186,0.00054724864,0.00047359,0.0002717532],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040626856,0.00054085755,0.001280496,0.0010436398,0.00038685073,0.00007647467,0.0001740937,0.0003202085,0.000020971707],"category_scores_gemma":[0.009475067,0.00045610542,0.00020246163,0.0032681245,0.00041616548,0.0005744283,0.00040011774,0.0016116088,0.0000119958495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049774037,0.003466921,0.958037,0.00013745722,0.0005834911,0.000048153062,0.0040955427,0.0018773766,0.0010800577,0.000004636788,0.00008712565,0.025604788],"study_design_scores_gemma":[0.04137666,0.003200131,0.8897779,0.0017789919,0.0003405875,0.000006808011,0.023886906,0.039169762,0.000026491434,0.000007971074,0.000032434782,0.00039535828],"about_ca_topic_score_codex":0.003402457,"about_ca_topic_score_gemma":0.010073394,"teacher_disagreement_score":0.06825915,"about_ca_system_score_codex":0.00019558454,"about_ca_system_score_gemma":0.00025160745,"threshold_uncertainty_score":0.99978906},"labels":[],"label_agreement":null},{"id":"W4361268560","doi":"10.1016/j.msard.2023.104676","title":"ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Mayo Clinic","keywords":"Medicine; Multiple sclerosis; Therapeutic plasma exchange; Neuroscience; Internal medicine; Immunology","score_opus":0.12041235679416369,"score_gpt":0.33011883432682204,"score_spread":0.20970647753265836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361268560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046576,0.0002580097,0.000020130437,0.0060090045,0.0004107003,0.0019347778,0.00025064524,0.00043599913,0.00021495316],"genre_scores_gemma":[0.99296695,0.004893491,0.00042522614,0.0003267057,0.00005454985,0.00024132825,0.00012495102,0.00013589105,0.0008308828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945619,0.00064853043,0.0012647501,0.0011834744,0.0012346659,0.0011066607],"domain_scores_gemma":[0.99488646,0.0029250672,0.00037308774,0.0007030148,0.00031179565,0.00080056384],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023191278,0.0005610096,0.0012222489,0.00087171013,0.0005964325,0.00006922742,0.0002549407,0.00057080673,0.0001006225],"category_scores_gemma":[0.010281414,0.00046005874,0.00057600206,0.0028396915,0.00045100343,0.00024218103,0.0004086072,0.00077864726,0.00010831342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013937196,0.0012251724,0.883601,0.00019337988,0.0023786211,0.000025293548,0.0049638283,0.00047717913,0.044960212,0.0000024307083,0.015651973,0.032583676],"study_design_scores_gemma":[0.01971055,0.0018283603,0.9578328,0.0016921597,0.0002905638,0.000001681653,0.0017285893,0.01366133,0.0013456815,0.000003665529,0.0013941104,0.00051048765],"about_ca_topic_score_codex":0.0005034483,"about_ca_topic_score_gemma":0.00065815257,"teacher_disagreement_score":0.07423178,"about_ca_system_score_codex":0.00017862419,"about_ca_system_score_gemma":0.000169042,"threshold_uncertainty_score":0.9997851},"labels":[],"label_agreement":null},{"id":"W4362472116","doi":"10.1016/j.msard.2022.104322","title":"Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Confidence interval; Magnetic resonance imaging; Cladribine; Clinical endpoint; Nuclear medicine; Lesion; Internal medicine; Poisson regression; Expanded Disability Status Scale; McDonald criteria; Clinical trial; Surgery; Radiology; Population","score_opus":0.04682843048370224,"score_gpt":0.2871072259003992,"score_spread":0.24027879541669697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362472116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951956,0.00032962725,9.3547715e-7,0.0009912135,0.00013937133,0.0029772753,0.00019998525,0.000072468756,0.00009347008],"genre_scores_gemma":[0.9927237,0.00672503,0.000072301016,0.000004508916,0.000011190481,0.000108645625,0.000036285186,0.000054723158,0.00026360608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965515,0.00034875632,0.0011746536,0.0006842683,0.00066651107,0.00057431334],"domain_scores_gemma":[0.997347,0.0011363513,0.0005316965,0.00061789935,0.00021678704,0.0001502751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059789687,0.0004131116,0.0010597301,0.00063297414,0.00028881978,0.000021396163,0.00016390807,0.00023075657,0.000008487065],"category_scores_gemma":[0.0019158035,0.00028273492,0.00024824357,0.0014418087,0.0005616125,0.00018766681,0.00032356282,0.0004044412,0.0000019431652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049531674,0.002184604,0.8911305,0.00027319085,0.0008238098,0.00000422735,0.010921079,0.00065869716,0.08231987,0.0000024484657,0.000037190664,0.0066911923],"study_design_scores_gemma":[0.04211721,0.0011363068,0.9275674,0.0009972233,0.00021227417,0.000001035021,0.01522242,0.001236839,0.01127887,0.000008150204,0.000009715916,0.0002125375],"about_ca_topic_score_codex":0.0064592278,"about_ca_topic_score_gemma":0.002374307,"teacher_disagreement_score":0.071041,"about_ca_system_score_codex":0.00017889944,"about_ca_system_score_gemma":0.00008397957,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W4362472973","doi":"10.1016/j.msard.2022.104360","title":"MRI and Clinical Outcomes of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, in Relapsing Multiple Sclerosis Over 2.5 Years of the Open-Label Extension to a Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Multiple sclerosis; Double blind; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Tolerability; Gastroenterology; Adverse effect; Pathology; Immunology; Radiology","score_opus":0.09464708955712986,"score_gpt":0.3631750525634793,"score_spread":0.26852796300634946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362472973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502456,0.0007330254,0.000005358643,0.0009681535,0.00048702105,0.0026285935,0.00004858636,0.000044270084,0.00006042728],"genre_scores_gemma":[0.9962267,0.0029713593,0.0003004294,0.00013397704,0.000027360866,0.000053684664,0.0000213267,0.000058130536,0.00020700302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967665,0.0002653679,0.0011867569,0.000697175,0.000589124,0.0004950463],"domain_scores_gemma":[0.9974162,0.0012649907,0.00027635228,0.0006662681,0.000104998326,0.000271217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014791386,0.00026545854,0.0009089527,0.00035292952,0.00013837662,0.00004159841,0.00027678206,0.0003615995,0.000024475938],"category_scores_gemma":[0.003681182,0.00019830988,0.000191835,0.0014398746,0.00054393086,0.00014513258,0.00084722403,0.00047579466,0.000007040914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09947557,0.0128456205,0.52206886,0.00054436293,0.0010418791,0.000067277244,0.005382166,0.00049795,0.13741322,0.000092079346,0.0056809816,0.21489005],"study_design_scores_gemma":[0.4390409,0.0013580158,0.5294228,0.0016276204,0.00014835625,0.0000036756064,0.00045718,0.026532205,0.0008566288,0.00003985237,0.00027223447,0.00024052264],"about_ca_topic_score_codex":0.0037661365,"about_ca_topic_score_gemma":0.0007242692,"teacher_disagreement_score":0.3395653,"about_ca_system_score_codex":0.0004290936,"about_ca_system_score_gemma":0.0007148393,"threshold_uncertainty_score":0.8086842},"labels":[],"label_agreement":null},{"id":"W4362474564","doi":"10.1016/j.msard.2022.104348","title":"Nurses' Knowledges on Multiple Sclerosis Disease in the Béni-Mellal Khénifra Region, Morocco","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Multiple sclerosis; Quarter (Canadian coin); Family medicine; Informed consent; Alternative medicine; Physical therapy; Internal medicine; Psychiatry; Pathology","score_opus":0.06290453222756454,"score_gpt":0.2853350518812402,"score_spread":0.22243051965367566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362474564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772261,0.004549071,0.000007663553,0.011366526,0.0006376745,0.0022139587,0.00007180644,0.0004332643,0.0034939284],"genre_scores_gemma":[0.95893306,0.038601443,0.000029174804,0.00042489675,0.00012722917,0.00052077055,0.00014328718,0.00010827266,0.001111868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995428,0.0004167807,0.00078646524,0.0011347673,0.0010182118,0.0012157524],"domain_scores_gemma":[0.996372,0.0017789346,0.00017028059,0.0009833811,0.00015968544,0.0005357494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008021581,0.0006181747,0.000697445,0.0007289049,0.0008171844,0.00013822682,0.00044250014,0.00032554613,0.00011274774],"category_scores_gemma":[0.0033824835,0.0004360632,0.00039700803,0.0020892532,0.0008158439,0.00023478267,0.00026509957,0.0009924402,0.0003791691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018001008,0.0019915763,0.8358363,0.00039127137,0.0003718912,0.000085153006,0.0077341734,0.0013150288,0.0024818243,0.0001329616,0.03545005,0.112409666],"study_design_scores_gemma":[0.008612912,0.00035484866,0.9578367,0.0010987123,0.000121944955,0.0000037730665,0.004012935,0.01805936,0.00013700593,0.00013427685,0.009113654,0.0005138613],"about_ca_topic_score_codex":0.00051306083,"about_ca_topic_score_gemma":0.0005832222,"teacher_disagreement_score":0.12200041,"about_ca_system_score_codex":0.00012181403,"about_ca_system_score_gemma":0.000100512465,"threshold_uncertainty_score":0.9998091},"labels":[],"label_agreement":null},{"id":"W4362583702","doi":"10.1016/j.msard.2023.104699","title":"Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarate","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dimethyl fumarate; Multiple sclerosis; Adverse effect; Internal medicine; Eosinophil; Lymphocyte; Population; Blood count; Leukopenia; Complete blood count; Immunology; Toxicity; Asthma","score_opus":0.020948136710343533,"score_gpt":0.23896932388904996,"score_spread":0.21802118717870642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362583702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953364,0.0012236662,0.000010213646,0.0003891027,0.000044482767,0.002365448,0.00016342511,0.00028906093,0.00017815964],"genre_scores_gemma":[0.9886383,0.010052727,0.00030214916,0.000077595265,0.0000146830525,0.00029330683,0.00043969144,0.00010069286,0.00008089775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967144,0.00023178148,0.0005022698,0.0010307513,0.00063325535,0.0008875059],"domain_scores_gemma":[0.997369,0.0014674226,0.0001607734,0.0004838868,0.00009557124,0.00042333087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003331046,0.0005664183,0.0009945466,0.00043284608,0.00036903287,0.000072906165,0.00014062732,0.00023116644,0.00003690672],"category_scores_gemma":[0.00036993652,0.0003903842,0.00010144154,0.0014528856,0.0006221049,0.0002009333,0.00019461392,0.00046334448,0.000030044252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021613606,0.0006800136,0.9728851,0.00020785908,0.0012493168,0.00006462571,0.0019388446,0.0011669158,0.011706779,0.0000019512652,0.0001242624,0.0078129815],"study_design_scores_gemma":[0.038706336,0.0013632046,0.94093275,0.00092020346,0.0004478362,0.0000073544757,0.00078165747,0.01561472,0.0005733989,0.000009196285,0.00017062148,0.0004727121],"about_ca_topic_score_codex":0.009796094,"about_ca_topic_score_gemma":0.0053756335,"teacher_disagreement_score":0.036544975,"about_ca_system_score_codex":0.000087414955,"about_ca_system_score_gemma":0.00007518966,"threshold_uncertainty_score":0.9998548},"labels":[],"label_agreement":null},{"id":"W4372311940","doi":"10.1016/j.msard.2023.104749","title":"Equity, diversity and inclusion in academic publishing: Can we move the needle?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Equity (law); Medicine; Inclusion (mineral); Diversity (politics); Publishing; Social science; Sociology; Law; Political science","score_opus":0.05346566508976891,"score_gpt":0.2849824706272839,"score_spread":0.23151680553751497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372311940","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.065362684,0.007934596,0.0000018705127,0.06349801,0.85222906,0.0010234993,0.0003188805,0.00026985403,0.009361511],"genre_scores_gemma":[0.72987276,0.20826955,0.0000039685087,0.00034954335,0.05892691,0.000014400459,0.00021862361,0.000041625146,0.0023026431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960992,0.0003432638,0.00029167839,0.00051778695,0.0021662356,0.0005818581],"domain_scores_gemma":[0.9974084,0.0018597967,0.00019274178,0.00018740323,0.000106816355,0.00024483705],"candidate_categories":["sts","open_science","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0042768847,0.0002540577,0.00035922776,0.00024312199,0.00789911,0.0003384743,0.0013914009,0.0018461074,0.000028752462],"category_scores_gemma":[0.004675203,0.00020165642,0.000089838155,0.0007895642,0.0011367227,0.0004574774,0.03486344,0.0024978633,0.0000046442574],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041014842,0.00003326787,0.008629401,0.00005692394,0.00006310193,0.0000041649346,0.17649452,0.000018775765,0.0000035355133,0.0001835398,0.76744866,0.047023077],"study_design_scores_gemma":[0.0039238846,0.00008081046,0.011143005,0.0011553647,0.00023617786,1.2496541e-7,0.13787583,0.00020696591,6.276926e-7,0.019327018,0.82538766,0.0006625524],"about_ca_topic_score_codex":0.06642477,"about_ca_topic_score_gemma":0.045277264,"teacher_disagreement_score":0.7933022,"about_ca_system_score_codex":0.00021592702,"about_ca_system_score_gemma":0.00018760061,"threshold_uncertainty_score":0.9998034},"labels":[],"label_agreement":null},{"id":"W4377826726","doi":"10.1016/j.msard.2023.104769","title":"Migraine and multiple sclerosis: The final answer?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Migraine; Dermatology; Neuroscience; Physical medicine and rehabilitation; Psychiatry; Psychology","score_opus":0.043647720067425656,"score_gpt":0.2545502412882075,"score_spread":0.21090252122078187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377826726","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17858967,0.13046692,0.000023940302,0.030448657,0.64778334,0.005863555,0.001832615,0.0016697493,0.0033215734],"genre_scores_gemma":[0.36841297,0.3616462,0.00023428678,0.00050137355,0.23626128,0.00042325215,0.0019930375,0.0005776565,0.029949922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965314,0.00012830722,0.0007537142,0.0010201205,0.00077503506,0.00079141645],"domain_scores_gemma":[0.9961772,0.0024574716,0.00027474813,0.0005963634,0.00020364141,0.00029060402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006314875,0.0007530007,0.001094383,0.00025921073,0.0009332235,0.000116186224,0.00021715023,0.0012430558,0.000051450945],"category_scores_gemma":[0.003230505,0.00050061237,0.00042586104,0.0005455779,0.0007870646,0.00009046793,0.00032771882,0.0018000837,0.00006175436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028983457,0.00016059616,0.00406583,0.000375696,0.0008203644,0.000006821961,0.0021145865,0.000008015426,0.00028109172,0.0000069529915,0.9852946,0.00657561],"study_design_scores_gemma":[0.009477525,0.00053675304,0.05851208,0.0020787593,0.0011253172,0.0000048226466,0.002926069,0.0012263393,0.0000144347205,0.00009739399,0.9232285,0.0007719983],"about_ca_topic_score_codex":0.0021246183,"about_ca_topic_score_gemma":0.0033059567,"teacher_disagreement_score":0.41152203,"about_ca_system_score_codex":0.000054585755,"about_ca_system_score_gemma":0.00014160866,"threshold_uncertainty_score":0.99974453},"labels":[],"label_agreement":null},{"id":"W4378978155","doi":"10.1016/j.msard.2023.104786","title":"Beyond the B-cell as a treatment target in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Ofatumumab; Internal medicine; Natalizumab; Dermatology; CD20; Rituximab; Immunology; Lymphoma","score_opus":0.03763177313008521,"score_gpt":0.2723908189235822,"score_spread":0.234759045793497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378978155","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18649547,0.029536659,0.0000072960042,0.009045452,0.7511647,0.011291705,0.0021657264,0.0012339416,0.0090590855],"genre_scores_gemma":[0.49450016,0.38089338,0.00040654995,0.00021909019,0.10233073,0.0035559572,0.0033507184,0.00094621244,0.013797204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923893,0.00040978615,0.0014488269,0.0019676315,0.0019628135,0.0018216305],"domain_scores_gemma":[0.9915586,0.0056807143,0.00047895196,0.0013530296,0.00032501027,0.0006036556],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0011054791,0.0014023175,0.0019732034,0.00083847775,0.0010135577,0.00024028732,0.00059075677,0.001976101,0.00020548902],"category_scores_gemma":[0.005079564,0.00094288995,0.0008317916,0.001541672,0.0010527993,0.00018686026,0.00063779,0.0025493489,0.00053602754],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013624014,0.0022465028,0.017644728,0.00054794084,0.0014903586,0.000047793204,0.0039540795,0.00034139096,0.0030783855,0.0000056603326,0.94355947,0.025721317],"study_design_scores_gemma":[0.05796708,0.0028751558,0.09685921,0.0032260183,0.001079275,0.0000039893384,0.0051018917,0.0076867836,0.00085089676,0.00031376077,0.8215487,0.0024872625],"about_ca_topic_score_codex":0.008721777,"about_ca_topic_score_gemma":0.0054578274,"teacher_disagreement_score":0.64883393,"about_ca_system_score_codex":0.00074412377,"about_ca_system_score_gemma":0.00058115955,"threshold_uncertainty_score":0.9998727},"labels":[],"label_agreement":null},{"id":"W4379375212","doi":"10.1016/j.msard.2023.104787","title":"Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier de l'Université Laval; Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Ottawa; McGill University Health Centre; Montreal Neurological Institute and Hospital; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Ottawa Hospital","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Medicine; Multiple sclerosis; Pathological; Myelin; Oligodendrocyte; Demyelinating disease; Disease; Pathology; Glycoprotein; Antibody; Immunology; Central nervous system; Internal medicine; Biology; Experimental autoimmune encephalomyelitis","score_opus":0.03267765359218974,"score_gpt":0.32343469081794196,"score_spread":0.2907570372257522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379375212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97932506,0.018068355,0.0000033648737,0.0012342113,0.00010504279,0.0008365954,0.00023102699,0.000119653734,0.00007670935],"genre_scores_gemma":[0.8343411,0.16521011,0.00011611607,0.000045146266,0.00003489539,0.000032293538,0.00009797127,0.00003251331,0.000089853114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725693,0.00026231827,0.00082297914,0.00065752974,0.00049920403,0.0005010368],"domain_scores_gemma":[0.99774325,0.00092335657,0.00031641457,0.00029426423,0.00027456429,0.00044812835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070567976,0.0003214569,0.0008534895,0.00026754924,0.00022349342,0.000025721663,0.00010307244,0.00025569397,0.000018186454],"category_scores_gemma":[0.0046936967,0.00024577545,0.00020289823,0.00064728135,0.0011163331,0.00009754812,0.00032291355,0.00048832444,0.0000032229896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065974914,0.0005560752,0.9636676,0.00037747447,0.00021490901,0.000050549057,0.00030161027,0.000008088361,0.003378386,0.000016022062,0.0008208895,0.029948652],"study_design_scores_gemma":[0.0071667614,0.00040929433,0.9875013,0.00042528423,0.00036357422,0.0000095620135,0.0006923036,0.0029891212,0.000112695205,0.000050532417,0.00003918613,0.00024037214],"about_ca_topic_score_codex":0.00039287127,"about_ca_topic_score_gemma":0.00010674517,"teacher_disagreement_score":0.14714175,"about_ca_system_score_codex":0.000014347529,"about_ca_system_score_gemma":0.00007204569,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W4379742832","doi":"10.1016/j.msard.2023.104788","title":"Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; Novartis Animal Health; Novartis","keywords":"Clinical trial; Medicine; Protocol (science); Selection (genetic algorithm); Multiple sclerosis; Medical physics; MEDLINE; Alternative medicine; Pathology; Artificial intelligence; Psychiatry; Computer science","score_opus":0.42181555034574436,"score_gpt":0.4818763018958606,"score_spread":0.060060751550116254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379742832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042089324,0.9021958,0.0009964559,0.0018393348,0.0016024472,0.047323752,0.0032529493,0.00058772665,0.00011217452],"genre_scores_gemma":[0.019604376,0.9741619,0.0012530452,0.000038902424,0.00011876345,0.0029659944,0.001450347,0.0001679708,0.00023866675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869816,0.0040240264,0.0061546564,0.0015370806,0.00071783096,0.0005848127],"domain_scores_gemma":[0.9876462,0.008167145,0.00222077,0.0005976034,0.0007082072,0.0006600785],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019620415,0.00070067897,0.005731163,0.0008417554,0.00043483733,0.00013446767,0.00017964192,0.00090365985,0.000046089383],"category_scores_gemma":[0.08072482,0.0005274254,0.0010779583,0.001202234,0.00014090864,0.00019888114,0.00023159831,0.00044568436,0.000004645995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004180596,0.00033727995,0.0012079992,0.0038937659,0.0022071656,2.6689156e-7,0.0016744646,0.000015347716,0.00016817146,0.0000021736173,0.008054551,0.98202074],"study_design_scores_gemma":[0.020491162,0.0062332056,0.011006256,0.04333722,0.011934127,0.000010691016,0.0072295186,0.0018274488,0.00006488685,0.000037335576,0.89567995,0.0021482187],"about_ca_topic_score_codex":0.00015921159,"about_ca_topic_score_gemma":0.00051463814,"teacher_disagreement_score":0.9798725,"about_ca_system_score_codex":0.00017939942,"about_ca_system_score_gemma":0.000194486,"threshold_uncertainty_score":0.9997177},"labels":[],"label_agreement":null},{"id":"W4382518072","doi":"10.1016/j.msard.2023.104862","title":"Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Meta-analysis; Medicine; Serology; Chlamydia; Internal medicine; Odds ratio; Confidence interval; Subgroup analysis; Chlamydophila pneumoniae; Logistic regression; Chlamydial infection; Multiple sclerosis; Immunology; Chlamydiales; Antibody","score_opus":0.13226761442951052,"score_gpt":0.31441393158809,"score_spread":0.18214631715857948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382518072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01790785,0.97915286,0.000026228325,0.00003262114,0.0003544343,0.0016196924,0.00059712166,0.00020336991,0.000105817926],"genre_scores_gemma":[0.04751684,0.95047,0.000024634366,0.0000021906744,0.000013362794,0.0005390229,0.00041660853,0.000107765416,0.00090960035],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949035,0.0015864738,0.001367011,0.0013851565,0.00014333584,0.0006145424],"domain_scores_gemma":[0.99606776,0.0017373514,0.0010233152,0.00090489344,0.00018214672,0.00008451959],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013982857,0.0007688241,0.0039621578,0.001730452,0.0006334804,0.0000694954,0.0002395234,0.0013677088,0.00028744517],"category_scores_gemma":[0.0013044598,0.00057164003,0.00278666,0.0028103094,0.00086506526,0.00018707437,0.00031568113,0.0015996706,0.00024998139],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005280644,0.0006024291,0.019102648,0.0031384865,0.51031464,9.63244e-7,0.000395802,0.00020246199,0.00070527877,0.000024909414,0.00015707317,0.4653025],"study_design_scores_gemma":[0.0028510008,0.00037122652,0.13509771,0.0014984926,0.69849503,0.000029749988,0.00019217897,0.0001330161,0.00011835523,0.000110935776,0.15952498,0.0015773133],"about_ca_topic_score_codex":0.00766385,"about_ca_topic_score_gemma":0.0021115306,"teacher_disagreement_score":0.46372518,"about_ca_system_score_codex":0.000065826054,"about_ca_system_score_gemma":0.000089409885,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W4382883108","doi":"10.1016/j.msard.2023.104869","title":"Assessing the utility of magnetic resonance imaging-based “SuStaIn” disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"International Progressive MS Alliance; Biogen","keywords":"Subtyping; Natalizumab; Medicine; Multiple sclerosis; Magnetic resonance imaging; Oncology; Clinical trial; Disease; Internal medicine; Placebo; Progressive disease; Pathology; Immunology; Radiology","score_opus":0.04748384130623075,"score_gpt":0.3108504081322997,"score_spread":0.26336656682606896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382883108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332513,0.055214558,0.00015689376,0.007452263,0.00019619183,0.0032869347,0.000079330464,0.00016877045,0.00019372902],"genre_scores_gemma":[0.99294853,0.005602363,0.00065383187,0.00013446582,0.000042840038,0.0003946736,0.000092133276,0.00007627038,0.000054885943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961765,0.00033902004,0.0010258768,0.00096127606,0.0006445906,0.00085275224],"domain_scores_gemma":[0.99483705,0.003618547,0.0003446621,0.0005607856,0.00032511467,0.0003138468],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021546537,0.0004367846,0.00076479523,0.0005123087,0.0007761387,0.0000948418,0.00021120388,0.00017732078,0.000055948243],"category_scores_gemma":[0.008670644,0.0003094821,0.00018465008,0.0012758835,0.0015817704,0.00031590398,0.00029616387,0.0006380925,0.0000014670385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008544981,0.00020895792,0.60955894,0.0007140263,0.0000429509,0.0000064318506,0.0014829134,0.00011139075,0.005697369,0.0000065953896,0.00067725516,0.38063866],"study_design_scores_gemma":[0.009051198,0.0001513012,0.7143855,0.003986404,0.00009477022,0.0000012804176,0.003564074,0.2679464,0.00017579526,0.00013858218,0.00028363193,0.00022105763],"about_ca_topic_score_codex":0.00038542092,"about_ca_topic_score_gemma":0.00012291365,"teacher_disagreement_score":0.38041762,"about_ca_system_score_codex":0.00008118339,"about_ca_system_score_gemma":0.00019241631,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W4383164035","doi":"10.1016/j.msard.2023.104873","title":"Is using ChatGPT to help write papers and grants is useful, and ethical?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Spelling; Chatbot; Entertainment; Style (visual arts); Loneliness; Computer science; Singing; Grammar; Artificial intelligence; Psychology; Linguistics; Visual arts; Management; Social psychology","score_opus":0.12853420959720097,"score_gpt":0.37138628447698757,"score_spread":0.2428520748797866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383164035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60371816,0.005223854,0.000011248487,0.022319425,0.36706987,0.0011980687,0.00020667494,0.00015326272,0.00009944808],"genre_scores_gemma":[0.73501176,0.16594048,0.0003125669,0.0036652044,0.09310895,0.00010791796,0.00038105095,0.0002923613,0.0011797401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975411,0.000074194395,0.0006031377,0.0008206989,0.0004753394,0.00048547683],"domain_scores_gemma":[0.9980107,0.00089233584,0.0001513287,0.00028754456,0.00018664499,0.00047146672],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004471426,0.00037263497,0.0005762764,0.00021228782,0.00047450323,0.00010180872,0.00007254159,0.0021074936,0.000068203306],"category_scores_gemma":[0.0014018278,0.00033252113,0.000099545934,0.00041231475,0.00025914668,0.00005840074,0.00010169289,0.0017118626,0.000035373247],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042788484,0.00012532207,0.023900324,0.0010935571,0.0003667178,0.000006497101,0.02686129,0.000013336401,0.0013981794,0.0000063633547,0.74155074,0.20424977],"study_design_scores_gemma":[0.0022884547,0.0014526392,0.038473155,0.011640658,0.0013400159,0.000011729106,0.016876375,0.007004831,0.00080477097,0.00084211444,0.9170521,0.0022131787],"about_ca_topic_score_codex":0.005902705,"about_ca_topic_score_gemma":0.00071500806,"teacher_disagreement_score":0.27396092,"about_ca_system_score_codex":0.000067423425,"about_ca_system_score_gemma":0.00016312195,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W4384565171","doi":"10.1016/j.msard.2023.104894","title":"Beyond the simplicity of theory of mind deficit in multiple sclerosis: from kinetic perception to socio-emotional abstraction and mentalizing","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Personality Disorders and Psychopathology","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Mentalization; Theory of mind; Psychology; Social cognition; Intentionality; Cognition; Cognitive psychology; Perception; Cognitive deficit; Attribution; Developmental psychology; Neuroscience; Social psychology; Cognitive impairment","score_opus":0.04956715884096193,"score_gpt":0.27536030130426203,"score_spread":0.2257931424633001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384565171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631554,0.00089703983,0.00008982456,0.001067053,0.00031452297,0.00044801916,0.00020787625,0.000025882702,0.00063423265],"genre_scores_gemma":[0.99865127,0.0008652178,0.000095349205,0.00013098138,0.000017401517,0.000051414925,0.00010841827,0.000024029116,0.000055929835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998244,0.00029302147,0.0005188222,0.000460939,0.00018534432,0.00029790227],"domain_scores_gemma":[0.99889034,0.00059111643,0.00018915196,0.0002250658,0.000033924593,0.00007041861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057897496,0.00019933505,0.0003097103,0.00021682327,0.00018061613,0.000015943488,0.00012696572,0.00026824145,0.00033536108],"category_scores_gemma":[0.00008481929,0.00016749278,0.00010722229,0.0004233301,0.00034792646,0.000075333606,0.00006635963,0.0002426558,0.00003047965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007000325,0.00071313395,0.68581325,0.000049435122,0.00021806879,0.0000011753621,0.0400981,0.00091637735,0.121272996,0.00076971477,0.0005207201,0.148927],"study_design_scores_gemma":[0.002516722,0.000109436456,0.96275663,0.000104406216,0.00004582337,0.0000016039867,0.030034615,0.00073485053,0.000051793104,0.0034129273,0.00006224358,0.00016891959],"about_ca_topic_score_codex":0.0024017652,"about_ca_topic_score_gemma":0.0010485987,"teacher_disagreement_score":0.27694342,"about_ca_system_score_codex":0.000023955636,"about_ca_system_score_gemma":0.000009898543,"threshold_uncertainty_score":0.6830157},"labels":[],"label_agreement":null},{"id":"W4385298954","doi":"10.1016/j.msard.2023.104911","title":"Is it ethical to use teriflunomide as an active comparator in phase 3 trials?","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Teriflunomide; Medicine; Clinical trial; Amyotrophic lateral sclerosis; Multiple sclerosis; Family medicine; Disease; Oncology; Fingolimod; Internal medicine; Psychiatry","score_opus":0.3638427763101612,"score_gpt":0.47076212204114004,"score_spread":0.10691934573097883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385298954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03685805,0.9403046,0.00001043768,0.0058930623,0.0007317169,0.013802996,0.0014476582,0.0004196917,0.00053179986],"genre_scores_gemma":[0.006714615,0.9897999,0.00016025356,0.0007315467,0.00009927696,0.0011101299,0.00048659722,0.00022708069,0.00067058805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992342,0.0016098215,0.002423903,0.0016831431,0.00085939106,0.001081758],"domain_scores_gemma":[0.9936571,0.0036874597,0.0005418137,0.00090172165,0.00017808663,0.0010337855],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022662594,0.0010560724,0.0056514987,0.0012786124,0.0003346102,0.00022837461,0.00037192216,0.0018101757,0.00033085578],"category_scores_gemma":[0.009661461,0.0007914468,0.00102401,0.0017466617,0.0004214507,0.00025465607,0.00044813027,0.003112074,0.0006601436],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015336162,0.0013950474,0.000477446,0.005054127,0.0018495405,0.00004251527,0.0038865055,0.000007568337,0.0001503706,0.000013452824,0.010107401,0.9754824],"study_design_scores_gemma":[0.020494407,0.001639502,0.011309492,0.03991539,0.0018334128,0.000017904775,0.0018401656,0.0008168079,0.000019554403,0.000027854168,0.9205735,0.0015120077],"about_ca_topic_score_codex":0.0014463234,"about_ca_topic_score_gemma":0.0014439301,"teacher_disagreement_score":0.9739704,"about_ca_system_score_codex":0.0003404086,"about_ca_system_score_gemma":0.0004386512,"threshold_uncertainty_score":0.9994857},"labels":[],"label_agreement":null},{"id":"W4385694372","doi":"10.1016/j.msard.2023.104934","title":"Iron in multiple sclerosis – Neuropathology, immunology, and real-world considerations","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Excitotoxicity; Multiple sclerosis; Neurotoxicity; Neuropathology; Medicine; Oxidative stress; Ferritin; Deferoxamine; Immunology; Immune system; Neuroprotection; Innate immune system; Central nervous system; Physiology; Neuroscience; Glutamate receptor; Toxicity; Pathology; Disease; Biology; Pharmacology; Endocrinology; Internal medicine","score_opus":0.05634555039097719,"score_gpt":0.2756353304680608,"score_spread":0.21928978007708363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385694372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03294378,0.96481556,0.000004503678,0.00020478421,0.00033096108,0.0010540145,0.00019254361,0.00008788323,0.00036596967],"genre_scores_gemma":[0.06606013,0.9322281,0.00006857659,0.00006467832,0.000035360426,0.00018269148,0.00068320683,0.00010183295,0.00057545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973641,0.0003971121,0.0007702094,0.00093500735,0.00010752151,0.00042602478],"domain_scores_gemma":[0.9988176,0.00021496053,0.00028291126,0.00047175965,0.0000378042,0.00017491299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002408522,0.00051154074,0.00085533987,0.00040601508,0.00029984038,0.0000787821,0.0001360966,0.00069415144,0.000027894133],"category_scores_gemma":[0.0004184855,0.00046916847,0.0002703862,0.0004045176,0.0005154662,0.000012435274,0.00028184775,0.00036410659,0.00002943158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021929812,0.0008727303,0.034347445,0.0048303613,0.0009259176,0.00004789041,0.00037024586,0.0003445815,0.0069397306,0.000740288,0.004046698,0.9463148],"study_design_scores_gemma":[0.014740752,0.0006220578,0.3912375,0.010667201,0.0017851058,0.00009511633,0.00058370543,0.001410952,0.00006040184,0.0007086569,0.5739281,0.004160403],"about_ca_topic_score_codex":0.0004132565,"about_ca_topic_score_gemma":0.0030290498,"teacher_disagreement_score":0.9421544,"about_ca_system_score_codex":0.00002670427,"about_ca_system_score_gemma":0.00011075184,"threshold_uncertainty_score":0.999776},"labels":[],"label_agreement":null},{"id":"W4385708421","doi":"10.1016/j.msard.2023.104933","title":"Randomized controlled trial of the behavioral intervention for physical activity in multiple sclerosis project: Social cognitive theory variables as mediators","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Randomized controlled trial; Medicine; Intervention (counseling); Social cognitive theory; Cognition; Physical therapy; Clinical psychology; Physical medicine and rehabilitation; Psychotherapist; Psychiatry; Psychology; Internal medicine","score_opus":0.06775457892095482,"score_gpt":0.3381902637466798,"score_spread":0.270435684825725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385708421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819677,0.00017580503,0.000034786586,0.0006552425,0.00044423863,0.01625624,0.0001443112,0.000111689995,0.0002099999],"genre_scores_gemma":[0.99302864,0.0012141123,0.00002288975,0.000017374161,0.00009627758,0.005266962,0.000061881634,0.000061203034,0.00023066136],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958333,0.00138596,0.0008517787,0.0006128022,0.0006942646,0.00062193425],"domain_scores_gemma":[0.9932014,0.0057061836,0.0005138391,0.0002311277,0.00024294632,0.00010453829],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028408023,0.00041286804,0.0020529279,0.00043183987,0.00049824355,0.000042242587,0.00018014149,0.00032463187,0.000022860335],"category_scores_gemma":[0.008771443,0.0002616116,0.0014553944,0.0010008017,0.001203587,0.00012971087,0.00025110482,0.00053275866,0.0000052355845],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9449963,0.003649789,0.0041150963,0.00019864675,0.0011343324,6.4660605e-7,0.005739909,0.00002172076,0.00717628,0.00012403364,0.00010637393,0.03273689],"study_design_scores_gemma":[0.91683954,0.00072013895,0.06106597,0.0007070566,0.00082466594,3.2012235e-7,0.0040496443,0.013621897,0.0014031869,0.0004998353,0.000007906803,0.00025981778],"about_ca_topic_score_codex":0.0008969459,"about_ca_topic_score_gemma":0.0003266153,"teacher_disagreement_score":0.056950875,"about_ca_system_score_codex":0.00008811327,"about_ca_system_score_gemma":0.00014410423,"threshold_uncertainty_score":0.9999836},"labels":[],"label_agreement":null},{"id":"W4385973218","doi":"10.1016/j.msard.2023.104937","title":"CNS resilience in the progression of MS","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Scopus; Genome-wide association study; Genomics; Genetics; Epigenetics; Resilience (materials science); Genome; Medicine; Biology; Computational biology; MEDLINE; Gene; Genotype; Psychiatry; Single-nucleotide polymorphism","score_opus":0.03206027442023911,"score_gpt":0.3117704720261226,"score_spread":0.2797101976058835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385973218","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14048643,0.018002056,0.000009812987,0.0067910156,0.8194963,0.00776867,0.0006153495,0.0004500814,0.0063803312],"genre_scores_gemma":[0.7742221,0.16366804,0.00018526359,0.000034351906,0.059304066,0.0007192305,0.0006554483,0.00021329905,0.0009982161],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9958365,0.0002945858,0.0008088128,0.0007410624,0.0016686536,0.00065037736],"domain_scores_gemma":[0.99528325,0.0034105815,0.00031070347,0.00064681686,0.00021307553,0.00013560537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013652657,0.00042387546,0.00085081195,0.00042021496,0.00024442977,0.00004509784,0.0004074964,0.00093244936,0.000028105907],"category_scores_gemma":[0.008279525,0.0002592164,0.00024341309,0.0010911814,0.0008040095,0.00008149668,0.0003062238,0.0017019041,0.000024550644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004970166,0.0006092216,0.014645136,0.0009433486,0.00025709977,0.000013973659,0.0033015923,0.000053605945,0.0015651912,0.0000070410306,0.9284959,0.04961092],"study_design_scores_gemma":[0.0154024325,0.0017118823,0.5325237,0.011653721,0.0003880827,0.0000022648685,0.0059982915,0.0030942746,0.00016798377,0.000099800716,0.42795736,0.0010002174],"about_ca_topic_score_codex":0.0010364737,"about_ca_topic_score_gemma":0.0010083644,"teacher_disagreement_score":0.7601922,"about_ca_system_score_codex":0.000054044503,"about_ca_system_score_gemma":0.00018726634,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W4386012957","doi":"10.1016/j.msard.2023.104945","title":"Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Merck; Merck Healthcare KGaA","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Regimen; Randomization; Placebo; Incidence (geometry); Internal medicine; Randomized controlled trial; Cumulative incidence; Surgery; Gastroenterology; Pediatrics; Cohort; Immunology","score_opus":0.06369443365532455,"score_gpt":0.3053357887524003,"score_spread":0.24164135509707574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386012957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138564,0.00044457108,0.00025874772,0.0026009765,0.00013119102,0.0050176405,0.000015656464,0.000042316533,0.000103237755],"genre_scores_gemma":[0.9975097,0.0014353484,0.00010123728,0.00013190843,0.00002667317,0.00066898356,0.000012478662,0.000035871184,0.000077781006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976541,0.0001413197,0.0006091309,0.00044466855,0.0007897336,0.00036107848],"domain_scores_gemma":[0.99845695,0.0003213568,0.00024117742,0.0007405545,0.0001647725,0.00007517059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011145811,0.00024574934,0.00038148934,0.00013007608,0.00047965892,0.000064542415,0.00025155736,0.00009589923,0.000011246627],"category_scores_gemma":[0.00029426088,0.0001062943,0.00016311444,0.0009875569,0.0003335693,0.00008231382,0.0003809698,0.00032901196,0.0000031625773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095342094,0.002756975,0.3000413,0.0002183705,0.0009378593,7.9723117e-7,0.025859347,0.0011455129,0.542799,0.000012072835,0.0002785675,0.124996796],"study_design_scores_gemma":[0.004426642,0.00034148706,0.9784104,0.00018719716,0.00008909238,5.493842e-7,0.009950852,0.0037513082,0.0026873134,0.000005651547,0.000027588747,0.00012192317],"about_ca_topic_score_codex":0.00021476924,"about_ca_topic_score_gemma":0.00018193443,"teacher_disagreement_score":0.6783691,"about_ca_system_score_codex":0.000036327223,"about_ca_system_score_gemma":0.000056940014,"threshold_uncertainty_score":0.43345556},"labels":[],"label_agreement":null},{"id":"W4386257877","doi":"10.1016/j.msard.2023.104969","title":"Delayed oculomotor response associates with optic neuritis in youth with demyelinating disorders","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University","funders":"Ontario Institute for Regenerative Medicine; Stem Cell Network","keywords":"Optic neuritis; Medicine; Nerve fiber layer; Pupillary response; Optic nerve; Ophthalmology; Audiology; Retinal ganglion cell; Saccade; Visual acuity; Multiple sclerosis; Neuroscience; Pupil; Psychology; Eye movement","score_opus":0.02686891349310801,"score_gpt":0.25811592960853746,"score_spread":0.23124701611542944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386257877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267024,0.00076354115,0.000018098803,0.0041505992,0.000064735425,0.0014285236,0.00007456354,0.00037204532,0.00045762822],"genre_scores_gemma":[0.99224263,0.00643371,0.0005080836,0.00006447298,0.00001883462,0.00020531782,0.00011817242,0.000117535776,0.0002912508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965353,0.00032448838,0.0005499841,0.0008258752,0.0007371391,0.0010272291],"domain_scores_gemma":[0.9980408,0.0009911046,0.00016781552,0.00036052376,0.0001297646,0.00031000027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009775755,0.00045946537,0.0006648491,0.0006324201,0.00048578068,0.00008668094,0.00015600736,0.00025039783,0.000030148345],"category_scores_gemma":[0.0013687625,0.00033544525,0.00012445019,0.0019692644,0.0005039926,0.00021927485,0.00016967284,0.0007125549,0.000029444778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008748931,0.0006732364,0.93422365,0.00018183893,0.00088909833,0.00008124641,0.012199646,0.0022430706,0.0062206914,0.000016406866,0.00021953105,0.034302674],"study_design_scores_gemma":[0.0143738035,0.0014945996,0.9551625,0.0008482079,0.00013902584,0.000008011856,0.010713317,0.01655181,0.00008700022,0.000029743862,0.00009924603,0.0004926966],"about_ca_topic_score_codex":0.0012671411,"about_ca_topic_score_gemma":0.00302412,"teacher_disagreement_score":0.03380998,"about_ca_system_score_codex":0.00013714415,"about_ca_system_score_gemma":0.00010955252,"threshold_uncertainty_score":0.99990976},"labels":[],"label_agreement":null},{"id":"W4386401846","doi":"10.1016/j.msard.2023.104966","title":"Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Expanded Disability Status Scale; Depression (economics); Quality of life (healthcare); Medicine; Multiple sclerosis; Cognition; Beck Depression Inventory; Physical disability; Executive dysfunction; Physical therapy; Physical medicine and rehabilitation; Clinical psychology; Psychiatry; Anxiety; Neuropsychology","score_opus":0.06909068961577618,"score_gpt":0.2983099691224767,"score_spread":0.2292192795067005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386401846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174184,0.0030796225,0.0000151861905,0.0010805906,0.00008622591,0.002946496,0.00065669237,0.000115954,0.00027739242],"genre_scores_gemma":[0.98285943,0.01623367,0.00014791642,0.00010352102,0.000025342217,0.0003665806,0.00012484097,0.000096300486,0.0000423858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99328,0.0009470148,0.0022169815,0.0010904224,0.0014958323,0.00096973963],"domain_scores_gemma":[0.9909065,0.0061258897,0.0010745171,0.00082883984,0.0005486922,0.00051558897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026761375,0.0006900633,0.0021007673,0.00067133905,0.00041135843,0.000039308776,0.00033005778,0.0004049722,0.00005851614],"category_scores_gemma":[0.008184689,0.00048218732,0.00040911316,0.0021551861,0.0017474885,0.0002161883,0.0005087942,0.00078260404,0.000009806286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061085946,0.0018835575,0.9220206,0.0007759296,0.0009278469,3.956713e-7,0.00798453,0.0005302165,0.04912096,0.000043674787,0.000083936844,0.010519751],"study_design_scores_gemma":[0.023830757,0.0011978004,0.93798876,0.0024437136,0.00014469911,3.952129e-7,0.023478156,0.0057673957,0.0046237796,0.000033543416,0.000016806978,0.00047422407],"about_ca_topic_score_codex":0.017205583,"about_ca_topic_score_gemma":0.011354828,"teacher_disagreement_score":0.044497177,"about_ca_system_score_codex":0.00010081829,"about_ca_system_score_gemma":0.00023334146,"threshold_uncertainty_score":0.99976295},"labels":[],"label_agreement":null},{"id":"W4386630159","doi":"10.1016/j.msard.2023.104998","title":"Are we there yet? The holy grail: A biomarker for Multiple Sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Holy Grail; Medicine; Multiple sclerosis; Biomarker; Immunology; World Wide Web; Genetics","score_opus":0.08516344769704169,"score_gpt":0.3031964610574046,"score_spread":0.2180330133603629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386630159","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037168097,0.0430243,0.00010828707,0.028957615,0.8658812,0.014400012,0.007788122,0.0019602142,0.0007121464],"genre_scores_gemma":[0.36878526,0.46052006,0.00056856364,0.0003569815,0.14474921,0.00771149,0.003548565,0.0018429257,0.011916962],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919066,0.00040741265,0.0014596786,0.0021491041,0.0021030593,0.0019741335],"domain_scores_gemma":[0.9843114,0.011534498,0.0010801998,0.0015929495,0.0008434404,0.0006375162],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0016416393,0.0014900551,0.0020696693,0.00064601435,0.0018829608,0.0003892094,0.0008732198,0.0024322628,0.000106169675],"category_scores_gemma":[0.017127335,0.0009970356,0.0013671604,0.0013851403,0.0014912407,0.00021686629,0.0008304278,0.0025155763,0.00016030596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012532125,0.00047809508,0.005700619,0.001125992,0.002573883,0.000008382444,0.0008387704,0.000034268836,0.0026494549,0.0000040363634,0.9484219,0.03691138],"study_design_scores_gemma":[0.018857183,0.00048535469,0.20884281,0.006008788,0.0011265929,0.00000188468,0.0035337077,0.004884971,0.00006502692,0.00013592604,0.7546091,0.0014486352],"about_ca_topic_score_codex":0.0011022342,"about_ca_topic_score_gemma":0.00196103,"teacher_disagreement_score":0.721132,"about_ca_system_score_codex":0.0002850047,"about_ca_system_score_gemma":0.00029688675,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W4386851210","doi":"10.1016/j.msard.2023.105008","title":"Admission and discharge profiles of people with MS accessing in-patient rehabilitation in Canada","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital; University of British Columbia; McGill University; McGill University Health Centre","funders":"","keywords":"Rehabilitation; Medicine; Odds; Cohort; Quality of life (healthcare); Latent class model; Functional Independence Measure; Stroke (engine); Multiple sclerosis; Logistic regression; Physical therapy; Acute care; Cognition; Odds ratio; Physical medicine and rehabilitation; Ordered logit; Gerontology; Health care; Psychiatry; Internal medicine","score_opus":0.019474239279034418,"score_gpt":0.2548042655903164,"score_spread":0.23533002631128197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386851210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630237,0.0006494164,0.0000014312791,0.002003228,0.00003855068,0.000838261,0.000016275553,0.00002253798,0.00012790898],"genre_scores_gemma":[0.996841,0.0027799858,0.000200705,0.000013404319,0.0000031366474,0.00009461467,0.000031008985,0.000020275751,0.000015832049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985305,0.000080803606,0.00038865453,0.00033576295,0.00034678268,0.00031750143],"domain_scores_gemma":[0.9991961,0.00038749343,0.000093749644,0.00014256641,0.000053630567,0.0001264394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021918453,0.00015430647,0.00035341232,0.00030220067,0.00009700589,0.000012682688,0.000041769275,0.000066047556,0.000018891893],"category_scores_gemma":[0.0006384857,0.00011029304,0.00002575298,0.00087951374,0.00012248821,0.00012462071,0.000096400465,0.00021151264,6.5037034e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025344235,0.00010692635,0.9634421,0.0002933579,0.000027097705,0.0000024111118,0.0043931985,0.00029937935,0.0060854703,0.0000038553467,0.000084113126,0.025008649],"study_design_scores_gemma":[0.0035374132,0.00023929535,0.9739911,0.0011536296,0.000011503385,9.4220303e-7,0.0073080286,0.0132288085,0.0003438308,0.000015585136,0.000044787324,0.00012506945],"about_ca_topic_score_codex":0.43625396,"about_ca_topic_score_gemma":0.7384475,"teacher_disagreement_score":0.30219352,"about_ca_system_score_codex":0.00012738974,"about_ca_system_score_gemma":0.00022109336,"threshold_uncertainty_score":0.56750005},"labels":[],"label_agreement":null},{"id":"W4386989266","doi":"10.1016/j.msard.2023.105025","title":"Sleep, physical activity, and psychological outcomes in children and adolescents with pediatric onset multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Queen's University; University of Toronto; Hospital for Sick Children","funders":"National Multiple Sclerosis Society","keywords":"Actigraphy; Medicine; Sleep onset latency; Sleep onset; Sleep (system call); Depression (economics); Physical therapy; Population; Quality of life (healthcare); Pediatrics; Psychiatry; Insomnia","score_opus":0.04539463137848946,"score_gpt":0.29314293247238826,"score_spread":0.2477483010938988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386989266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621546,0.0005300223,0.0000058196224,0.0013158829,0.000061063365,0.0015065651,0.000086196225,0.00023409177,0.000044893543],"genre_scores_gemma":[0.9834898,0.016016563,0.0000949437,0.000059017595,0.000040274932,0.00014424272,0.000039542014,0.00006797128,0.00004763462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969612,0.00017278238,0.00035333273,0.0010906062,0.0005753144,0.0008467897],"domain_scores_gemma":[0.99865144,0.00037051228,0.00012327111,0.00037186322,0.000058049292,0.0004248499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031050097,0.0005168937,0.0008642631,0.0005375559,0.00038013933,0.00008788162,0.0001343183,0.000285855,0.0000096736085],"category_scores_gemma":[0.0005123427,0.00036735804,0.00012595528,0.0010572028,0.0006364512,0.0002118517,0.00039915458,0.0007698842,0.00002255478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005447834,0.0015949635,0.96435195,0.00010376293,0.00017642608,0.0000055861324,0.0005538007,0.00003518994,0.0017926524,0.0000018031734,0.00013092383,0.030708129],"study_design_scores_gemma":[0.014549267,0.0006757682,0.97720957,0.00028934414,0.0001329042,0.000012444296,0.00026570633,0.006355544,0.000056208013,0.000020167856,0.0000051150037,0.00042798885],"about_ca_topic_score_codex":0.000544575,"about_ca_topic_score_gemma":0.0003100267,"teacher_disagreement_score":0.03028014,"about_ca_system_score_codex":0.00004578303,"about_ca_system_score_gemma":0.000017666443,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W4387101856","doi":"10.1016/j.msard.2023.105023","title":"A Canadian case control study investigating demographic and environmental factors associated with MOGAD","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of New Brunswick; Public Health Ontario; Western University; University of Toronto; Ottawa Hospital; Health Sciences Centre; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; University of Manitoba; University of British Columbia; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Odds ratio; Logistic regression; Case-control study; Young adult; Pediatrics; Surgery; Internal medicine","score_opus":0.03753921952861682,"score_gpt":0.24289865967890595,"score_spread":0.20535944015028912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387101856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658674,0.0005125086,0.0000013884678,0.00071374426,0.000044057822,0.0016332265,0.00026495729,0.00016698218,0.00007638789],"genre_scores_gemma":[0.99861795,0.0009392785,0.000012239355,0.00007007599,0.0000086117125,0.000099595854,0.00011700236,0.00005626038,0.000078999736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782306,0.00018943453,0.0003320608,0.00056497304,0.0003911382,0.00069934083],"domain_scores_gemma":[0.9983941,0.00050499476,0.00009636762,0.00021992001,0.00003219991,0.00075244374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044287133,0.00033428945,0.0004674304,0.0005067927,0.00092303945,0.00006457282,0.000060495233,0.00017357997,0.00003498001],"category_scores_gemma":[0.000719663,0.00025103704,0.000075338554,0.00075574825,0.0004915609,0.000114274866,0.00007847655,0.00044648885,0.000004149452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003593467,0.00018090331,0.98862815,0.000018957335,0.0008866192,0.00013865133,0.003811353,0.000094734016,0.0013288349,7.9319693e-7,0.00006773645,0.004807315],"study_design_scores_gemma":[0.009558469,0.0005512202,0.9510265,0.00015606561,0.00025000976,0.000020818079,0.023283426,0.014835389,0.000012628258,0.000007089473,0.00002223676,0.00027613717],"about_ca_topic_score_codex":0.033377703,"about_ca_topic_score_gemma":0.17530979,"teacher_disagreement_score":0.14193209,"about_ca_system_score_codex":0.000128009,"about_ca_system_score_gemma":0.000075045136,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W4387108150","doi":"10.1016/j.msard.2023.105029","title":"The role of autophagy protein Atg5 in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Autophagy; ATG5; Multiple sclerosis; Biology; Cell biology; Immunology; Genetics; Apoptosis","score_opus":0.05367112339667342,"score_gpt":0.27502037442032273,"score_spread":0.22134925102364933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387108150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013401794,0.9824857,0.0000011658085,0.00008399214,0.00020120222,0.003183566,0.00009790859,0.00016392997,0.00038071806],"genre_scores_gemma":[0.046678115,0.9516176,0.000034667133,0.00001622931,0.000040332015,0.00068613753,0.0001378027,0.00016883627,0.00062029425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966123,0.000272582,0.0013428167,0.00071383215,0.00041939918,0.00063907454],"domain_scores_gemma":[0.99779046,0.0006402251,0.0005596003,0.0007304864,0.000053666765,0.00022558168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000506966,0.0006329142,0.0018466857,0.0003668119,0.0003264712,0.000047489462,0.00032991168,0.00077555777,0.000051904866],"category_scores_gemma":[0.0003759269,0.00041119417,0.0008207776,0.0010925136,0.00045135274,0.00007896613,0.00016842637,0.00083172723,0.00007966844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011817503,0.00036386802,0.0004946659,0.003189692,0.0007901181,0.000006360728,0.000269275,0.0000071227564,0.00019016863,0.00012919541,0.00006105552,0.9943803],"study_design_scores_gemma":[0.013265335,0.0006431934,0.019311612,0.09248642,0.0025325057,0.000015990763,0.0014001972,0.002724158,0.00041204068,0.0018031102,0.8636355,0.0017699522],"about_ca_topic_score_codex":0.00048734978,"about_ca_topic_score_gemma":0.00021723432,"teacher_disagreement_score":0.99261034,"about_ca_system_score_codex":0.0000937425,"about_ca_system_score_gemma":0.00023929961,"threshold_uncertainty_score":0.999834},"labels":[],"label_agreement":null},{"id":"W4387189999","doi":"10.1016/j.msard.2023.105021","title":"Association between limbic system lesions and anxiety in persons with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Robarts Clinical Trials; Western University","funders":"American Academy of Neurology","keywords":"Medicine; Multiple sclerosis; Association (psychology); Anxiety; Limbic system; Pathology; Psychiatry; Internal medicine; Central nervous system; Psychotherapist; Psychology","score_opus":0.04590942316197807,"score_gpt":0.2575910237112579,"score_spread":0.21168160054927984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387189999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319816,0.0010798293,0.000015573443,0.0029556134,0.000100443154,0.0014121449,0.00014546416,0.00045365334,0.000639102],"genre_scores_gemma":[0.98130226,0.017335365,0.00024614576,0.000037388167,0.00004950268,0.00023830037,0.00013287537,0.000083311716,0.00057486095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666387,0.00021792851,0.0005834766,0.0008627604,0.0007282977,0.0009436676],"domain_scores_gemma":[0.9979559,0.00095065264,0.00020090483,0.00036173058,0.00012957255,0.0004012203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008579513,0.000427519,0.0007821411,0.00060181215,0.0006778819,0.00010098426,0.00012442745,0.00042092477,0.000018861432],"category_scores_gemma":[0.00087035814,0.00034304964,0.00014936095,0.0015846718,0.0002831337,0.00022552397,0.0002303653,0.00071424246,0.000047075853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015971993,0.00014109981,0.9665289,0.00026475,0.00052032236,0.000004177847,0.0019640944,0.000107713204,0.0062257457,0.000008197211,0.00096578826,0.023109488],"study_design_scores_gemma":[0.009172952,0.00026651376,0.9691601,0.0013627874,0.00023255107,0.0000031218233,0.006795245,0.011784413,0.0001699414,0.0000054436805,0.0006621651,0.00038479918],"about_ca_topic_score_codex":0.0014616591,"about_ca_topic_score_gemma":0.0017165766,"teacher_disagreement_score":0.022724688,"about_ca_system_score_codex":0.00034620822,"about_ca_system_score_gemma":0.000066379354,"threshold_uncertainty_score":0.9999021},"labels":[],"label_agreement":null},{"id":"W4387363470","doi":"10.1016/j.msard.2023.105046","title":"Social network size and mental health outcomes in youth with neuroinflammatory disorders","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Anxiety; Depression (economics); Medicine; Mental health; Quality of life (healthcare); Psychiatry; Clinical psychology; Social support; Psychology","score_opus":0.015182002121924663,"score_gpt":0.25342710331180957,"score_spread":0.2382451011898849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387363470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713729,0.0006875587,0.00000451138,0.026116582,0.00016030153,0.0012130017,0.000020052288,0.00024324015,0.00018187313],"genre_scores_gemma":[0.99564064,0.0031476058,0.00006667216,0.00080408785,0.000028563874,0.00003131768,0.00007765202,0.000063276304,0.00014020588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981675,0.00012840512,0.0003651555,0.00047613803,0.0002804529,0.0005823332],"domain_scores_gemma":[0.99902767,0.00041424035,0.0001284222,0.00017444283,0.000012049957,0.00024320283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003359382,0.00030203315,0.0005377141,0.0001557391,0.0004009396,0.000039225793,0.00006976728,0.00015954714,0.000010157564],"category_scores_gemma":[0.00017679416,0.0002289661,0.000093435665,0.00052507996,0.0002878332,0.00012309379,0.00009746276,0.00034891002,0.000008480405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003958275,0.00012980842,0.9852735,0.00017212512,0.0001323289,0.0000070052783,0.005606923,0.00031048295,0.000091418726,0.000050642957,0.0007708337,0.007059135],"study_design_scores_gemma":[0.01064588,0.00036709415,0.9849588,0.00022648876,0.00004005629,0.0000029980665,0.0016238163,0.0013250827,0.0000015883996,0.00018616715,0.00035672158,0.00026529355],"about_ca_topic_score_codex":0.00054990296,"about_ca_topic_score_gemma":0.0014745244,"teacher_disagreement_score":0.025312494,"about_ca_system_score_codex":0.00005924951,"about_ca_system_score_gemma":0.00008362512,"threshold_uncertainty_score":0.9336967},"labels":[],"label_agreement":null},{"id":"W4387521237","doi":"10.1016/j.msard.2023.105066","title":"MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Neuroscience; Pathology; Immunology; Biology","score_opus":0.08503298338119988,"score_gpt":0.28026724385968815,"score_spread":0.19523426047848827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937658,0.0009793094,0.000032081818,0.0028355257,0.00032284236,0.0013395787,0.00013892209,0.00024643124,0.00033954126],"genre_scores_gemma":[0.9766106,0.022181667,0.00063356524,0.00007558899,0.000020799174,0.00018156553,0.00009614457,0.00008385166,0.00011622482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559355,0.0002953419,0.0010575565,0.0010712555,0.0008984792,0.0010837917],"domain_scores_gemma":[0.9972891,0.0011756673,0.00032336067,0.00060476037,0.00019417697,0.0004129132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009853458,0.0005553507,0.001080658,0.0011426089,0.00033924458,0.00005253425,0.00028666662,0.0004101566,0.00008801357],"category_scores_gemma":[0.0021866586,0.00048326486,0.00046424672,0.0024560043,0.0011173409,0.00023992917,0.00038847575,0.0011997403,0.00004545867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001238468,0.00061463943,0.96320766,0.0003284388,0.00042430923,0.000013873878,0.0006676477,0.0010653174,0.010478843,0.000012067786,0.0018915507,0.020057179],"study_design_scores_gemma":[0.008886744,0.0004185695,0.96940273,0.0012288163,0.00009900375,0.0000036438419,0.0026286931,0.015876334,0.0007829425,0.00009680269,0.00014377656,0.00043195597],"about_ca_topic_score_codex":0.0021411944,"about_ca_topic_score_gemma":0.0016922476,"teacher_disagreement_score":0.021202357,"about_ca_system_score_codex":0.00011478075,"about_ca_system_score_gemma":0.000078581485,"threshold_uncertainty_score":0.9997619},"labels":[],"label_agreement":null},{"id":"W4387643059","doi":"10.1016/j.msard.2023.105060","title":"Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Retrospective cohort study; Cohort; Dementia; Cognition; Cognitive reserve; Multiple sclerosis; Audiology; Risk factor; Cohort study; Amyotrophic lateral sclerosis; Disease; Pediatrics; Physical therapy; Psychiatry; Internal medicine","score_opus":0.053211491535602604,"score_gpt":0.3083231252297077,"score_spread":0.25511163369410506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387643059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774399,0.0004537817,0.000008379963,0.0010370604,0.00035493044,0.018803816,0.00059049815,0.00068537676,0.00062629406],"genre_scores_gemma":[0.988104,0.0062124175,0.000037731872,0.00013862032,0.00008676041,0.004451787,0.00027859627,0.00020992139,0.00048019795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918749,0.0008853389,0.0013509266,0.0024078975,0.0017237149,0.0017572249],"domain_scores_gemma":[0.9953615,0.0020464982,0.0004327555,0.00064881437,0.00083507306,0.0006753238],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016336525,0.0010877112,0.0017392978,0.0013362099,0.0010897832,0.00017906746,0.00031026715,0.0005610047,0.00015811127],"category_scores_gemma":[0.010543899,0.000761107,0.00049266027,0.0027193313,0.0009904902,0.00046846797,0.00079594704,0.0018488301,0.00017711731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033246027,0.0034437303,0.9359498,0.0001558329,0.0019742895,0.00009318687,0.026703987,0.000038362774,0.0050099017,0.0000011262346,0.00008879428,0.023216402],"study_design_scores_gemma":[0.031466715,0.0019663025,0.90585,0.0022965532,0.00024575894,0.0000028283516,0.050047506,0.005938352,0.0012125926,0.00004943783,0.00003192934,0.0008920336],"about_ca_topic_score_codex":0.022463758,"about_ca_topic_score_gemma":0.030360896,"teacher_disagreement_score":0.030099789,"about_ca_system_score_codex":0.00081479124,"about_ca_system_score_gemma":0.00033913885,"threshold_uncertainty_score":0.999484},"labels":[],"label_agreement":null},{"id":"W4387653819","doi":"10.1016/j.msard.2023.105075","title":"Characteristics and predictors of disease course in children initially presenting with ADEM","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Disease; Pediatrics; Dermatology; Internal medicine; Immunology","score_opus":0.030131592056845766,"score_gpt":0.30371395674451623,"score_spread":0.27358236468767044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387653819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730885,0.0009785296,0.0000014237602,0.00028594193,0.00009607162,0.000847837,0.00022952324,0.00009815788,0.0001536398],"genre_scores_gemma":[0.9928601,0.0066886935,0.00000827007,0.00011311358,0.00006263256,0.00008225215,0.00009370889,0.000027034874,0.00006422452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982927,0.00023826955,0.00052773755,0.00028857964,0.00018755026,0.0004652016],"domain_scores_gemma":[0.99887913,0.00032595743,0.00022121568,0.0001274078,0.00004468986,0.00040160716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003246592,0.00015561159,0.0002667034,0.0001718891,0.0003716459,0.000007355452,0.000071827315,0.00017112594,0.00002426316],"category_scores_gemma":[0.0003350258,0.00011905906,0.000032022366,0.00044466954,0.00017832806,0.000099817924,0.000090602975,0.0003629225,0.00000858054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015540596,0.00010138651,0.99670833,0.00028054244,0.000036928912,0.0000029527316,0.00060446525,0.000031835876,0.0000126605655,0.000009840915,0.00021715631,0.0018384665],"study_design_scores_gemma":[0.0026345025,0.00005649949,0.995264,0.00026598334,0.0000731298,2.125604e-7,0.0006189056,0.00078418455,4.7100127e-7,0.00002805536,0.00013702264,0.00013706092],"about_ca_topic_score_codex":0.00017965818,"about_ca_topic_score_gemma":0.000037557198,"teacher_disagreement_score":0.005710164,"about_ca_system_score_codex":0.000012979767,"about_ca_system_score_gemma":0.0002487881,"threshold_uncertainty_score":0.48550877},"labels":[],"label_agreement":null},{"id":"W4387767261","doi":"10.1016/j.msard.2023.105086","title":"Can we improve outcomes in MS around the world? Access and global considerations across income strata","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Intervention (counseling); Intensive care medicine; Disease; Clinical Practice; Physical therapy; Pathology; Psychiatry","score_opus":0.04662434464144772,"score_gpt":0.3469727916802097,"score_spread":0.300348447038762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387767261","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34592786,0.008393487,0.000004041796,0.05339189,0.5724107,0.007210909,0.01081698,0.00061471376,0.0012294098],"genre_scores_gemma":[0.9115247,0.055636287,0.000057532972,0.00012393435,0.029160978,0.00066768494,0.00056593993,0.00017238347,0.0020905444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953213,0.0002467147,0.0010158807,0.001197527,0.0011070551,0.0011115428],"domain_scores_gemma":[0.993291,0.005027037,0.00031915755,0.00076720136,0.00024190311,0.00035369702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083555275,0.0007632541,0.0013124758,0.00027899697,0.0009791309,0.00072666135,0.0003821322,0.0008924444,0.00003752626],"category_scores_gemma":[0.0060717934,0.0005153583,0.0002416515,0.0009684721,0.0012864732,0.00026289152,0.0011430725,0.0020616986,0.000012976784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047336586,0.0006559805,0.5237272,0.0010691411,0.0026710993,0.000052182048,0.003130481,0.00015861634,0.00028166658,0.000098410754,0.44742027,0.020261621],"study_design_scores_gemma":[0.016674554,0.0003107241,0.9363105,0.001969261,0.0003888121,0.0000032343498,0.003400722,0.0019349481,0.00001568315,0.0019522854,0.035860844,0.0011783871],"about_ca_topic_score_codex":0.010316253,"about_ca_topic_score_gemma":0.19700317,"teacher_disagreement_score":0.5655969,"about_ca_system_score_codex":0.0003157444,"about_ca_system_score_gemma":0.00038182657,"threshold_uncertainty_score":0.9997298},"labels":[],"label_agreement":null},{"id":"W4387802367","doi":"10.1016/j.msard.2023.105093","title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Genentech","keywords":"Multiple sclerosis; Medicine; Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Spectrum disorder; Optic neuritis; Expanded Disability Status Scale; Relapsing remitting; Internal medicine; Gastroenterology; Immunology; Psychiatry; Experimental autoimmune encephalomyelitis","score_opus":0.02772519443667449,"score_gpt":0.2795204740821587,"score_spread":0.2517952796454842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387802367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878349,0.0049459413,0.000034356308,0.0030983556,0.00022486717,0.0029721165,0.0002788966,0.00034993762,0.00026065693],"genre_scores_gemma":[0.9313054,0.06740015,0.0002185691,0.00003901744,0.000037559934,0.00022892916,0.00039928048,0.00013726126,0.00023383323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942725,0.0004164177,0.0013035304,0.001418288,0.001249529,0.0013397852],"domain_scores_gemma":[0.9972953,0.0007377391,0.0004364969,0.00062790466,0.00019406842,0.0007084841],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082911237,0.0007643729,0.0012909507,0.0009734926,0.0005594907,0.000101921265,0.00027294309,0.00046193926,0.00006938268],"category_scores_gemma":[0.00248394,0.0006608307,0.00032657883,0.0020355284,0.0009873906,0.0003675586,0.00071960286,0.0009519202,0.000036729132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002125246,0.0014766448,0.9003186,0.00059294427,0.0006119981,0.00008054645,0.0017825061,0.0006848373,0.060836844,0.000054974003,0.00016025067,0.03127461],"study_design_scores_gemma":[0.013705578,0.0007937092,0.9514755,0.0031043394,0.00018656383,0.000005495885,0.001610163,0.026018022,0.00222115,0.00013193388,0.0001214423,0.00062607846],"about_ca_topic_score_codex":0.002078794,"about_ca_topic_score_gemma":0.0011714357,"teacher_disagreement_score":0.06245421,"about_ca_system_score_codex":0.00016900565,"about_ca_system_score_gemma":0.00013798627,"threshold_uncertainty_score":0.9995843},"labels":[],"label_agreement":null},{"id":"W4387817166","doi":"10.1016/j.msard.2023.105091","title":"Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of Toronto; St. Michael's Hospital; Centre for Advancing Health Outcomes; University of British Columbia; Foothills Medical Centre; University of Calgary","funders":"Alberta Health; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Government of Alberta; Biogen Idec; Biogen; Roche","keywords":"Medicine; Interquartile range; Population; Hazard ratio; Cancer; Internal medicine; Confidence interval; Cohort study; Environmental health","score_opus":0.06565235849740345,"score_gpt":0.3007560240838869,"score_spread":0.23510366558648346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387817166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936814,0.0038013372,0.000005951022,0.0009589385,0.00018760763,0.00507395,0.00016540174,0.00036593978,0.0000727551],"genre_scores_gemma":[0.9598721,0.038005188,0.0000717696,0.00008461528,0.000043851673,0.0015788545,0.00014878048,0.00010629641,0.00008853621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587005,0.00039364357,0.00072796777,0.0012767542,0.0008613419,0.00087022793],"domain_scores_gemma":[0.99795395,0.0006723126,0.0002250359,0.0005465941,0.00013455488,0.0004675267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001024509,0.0005418964,0.0009240695,0.0007245073,0.0008607056,0.00012486543,0.00015428083,0.00022311229,0.000042177675],"category_scores_gemma":[0.0016146331,0.00045678532,0.00019541327,0.0015772717,0.00035450188,0.00021070117,0.0002055669,0.000796737,0.000024273917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008142437,0.0008279024,0.9772543,0.00008690215,0.00048178062,0.000022490434,0.0019867206,0.001556696,0.0009901879,0.000002657479,0.00014218235,0.015833983],"study_design_scores_gemma":[0.016648665,0.0002830375,0.9364769,0.00062239927,0.00015227967,3.7112522e-7,0.0023614482,0.042892713,0.000017391387,0.000057108555,0.000024824558,0.0004629022],"about_ca_topic_score_codex":0.020723125,"about_ca_topic_score_gemma":0.012427846,"teacher_disagreement_score":0.04133602,"about_ca_system_score_codex":0.00028365874,"about_ca_system_score_gemma":0.00008341222,"threshold_uncertainty_score":0.9997884},"labels":[],"label_agreement":null},{"id":"W4388378419","doi":"10.1016/j.msard.2023.105125","title":"A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Ministerstvo Zdravotnictví Ceské Republiky","keywords":"Medicine; Kappa; Multiple sclerosis; Measles; Immunoglobulin light chain; Rubella; Virology; Immunology; Antibody; Vaccination","score_opus":0.04717166000694903,"score_gpt":0.2645785332423748,"score_spread":0.21740687323542576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388378419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167067,0.0034645125,0.000018882733,0.0030649905,0.00024257947,0.0006910864,0.0001157342,0.00015814295,0.00057340134],"genre_scores_gemma":[0.9949339,0.0042033135,0.000054798973,0.00020103419,0.00004842444,0.00007788228,0.00017977177,0.000058217327,0.0002426399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972984,0.00014316395,0.0008307642,0.00071045395,0.00041536833,0.00060183584],"domain_scores_gemma":[0.9986467,0.00026919675,0.00023486227,0.00043451396,0.00008917769,0.00032554628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033901137,0.000415266,0.00082969776,0.0005602055,0.00030657338,0.000028062736,0.00016527166,0.00054941553,0.00007447995],"category_scores_gemma":[0.00041387483,0.00036453962,0.00020875869,0.0008490523,0.00048203216,0.00018331142,0.00020869846,0.00057610875,0.000028188564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001318565,0.0009328649,0.94515646,0.00018586424,0.00029106459,0.000008973276,0.0016975248,0.00015387443,0.03711058,0.00008175055,0.0022348624,0.010827602],"study_design_scores_gemma":[0.011834084,0.00039852055,0.96553934,0.0005777804,0.00019733634,0.000007732352,0.0012150912,0.017659824,0.0011646199,0.0002635982,0.0007614856,0.00038059574],"about_ca_topic_score_codex":0.0006591251,"about_ca_topic_score_gemma":0.0012737866,"teacher_disagreement_score":0.035945956,"about_ca_system_score_codex":0.000044557724,"about_ca_system_score_gemma":0.000065403096,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W4388561368","doi":"10.1016/j.msard.2023.105123","title":"Brain volume increase after discontinuing natalizumab therapy: Evidence for reversible pseudoatrophy","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of British Columbia Hospital; Montreal Neurological Institute and Hospital","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Placebo; Anesthesia; Brain size; Internal medicine; Magnetic resonance imaging; Pathology; Radiology; Immunology","score_opus":0.05864502814502363,"score_gpt":0.30231301892333684,"score_spread":0.24366799077831322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388561368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97803354,0.0077053374,0.00009345996,0.011148203,0.00023731418,0.0021151125,0.000103905906,0.00035149857,0.00021164885],"genre_scores_gemma":[0.96378845,0.0314441,0.0004775353,0.00030039067,0.000083956205,0.000669564,0.00009135621,0.00008490829,0.0030597318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972864,0.00013226864,0.00048464077,0.0007921476,0.00048703948,0.0008175081],"domain_scores_gemma":[0.99767536,0.0012509676,0.00011797714,0.00047640706,0.00015425202,0.0003250086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005952775,0.0003696038,0.00054167496,0.00038220503,0.0004771152,0.00010120396,0.00017430632,0.00022076131,0.00016974463],"category_scores_gemma":[0.0033099432,0.00029793533,0.0003501244,0.0008845547,0.00038954464,0.0003566053,0.00024857037,0.00033591004,0.0000980818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069794785,0.0006575661,0.5774683,0.0012229965,0.0012497264,0.000036146695,0.0060079475,0.00017086457,0.08908444,0.000042170333,0.07188029,0.24520007],"study_design_scores_gemma":[0.011724493,0.00064176705,0.95800185,0.0016613895,0.0001145289,0.0000057755237,0.0012697212,0.013604145,0.00036731616,0.00012799363,0.011957614,0.0005234087],"about_ca_topic_score_codex":0.0005694028,"about_ca_topic_score_gemma":0.0002000007,"teacher_disagreement_score":0.38053355,"about_ca_system_score_codex":0.000084814215,"about_ca_system_score_gemma":0.00008272791,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W4388818948","doi":"10.1016/j.msard.2023.105144","title":"Long term effects of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea syndrome in multiple sclerosis patients","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Randomized controlled trial; Continuous positive airway pressure; Obstructive sleep apnea; Physical therapy; Hypopnea; Apnea–hypopnea index; Epworth Sleepiness Scale; Quality of life (healthcare); Depression (economics); Internal medicine; Apnea; Polysomnography","score_opus":0.020100198729553237,"score_gpt":0.240616953517221,"score_spread":0.22051675478766777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388818948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922147,0.0032787044,0.0000114351815,0.00017700715,0.00031470117,0.0034429075,0.00029210706,0.00012353333,0.00014490393],"genre_scores_gemma":[0.9902662,0.008756902,0.00011203857,0.000010705507,0.000016108432,0.00034480778,0.00023329252,0.000088913905,0.0001710221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629384,0.0002608739,0.0010062372,0.0008738204,0.0007160914,0.0008491221],"domain_scores_gemma":[0.99718124,0.0012891389,0.0004141507,0.000525265,0.0003014854,0.0002887326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021217471,0.0005823482,0.0014630747,0.0007428736,0.00023206015,0.000024254698,0.000187917,0.00038717617,0.00002645538],"category_scores_gemma":[0.0009573793,0.0004774385,0.00039438473,0.0012658504,0.00075149315,0.00020591516,0.0002250734,0.0003251496,0.00001599507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007961722,0.002164716,0.8720872,0.00071940117,0.001395141,0.000020844063,0.0043630074,0.00025557174,0.020140944,0.0000035100459,0.000029010967,0.0980245],"study_design_scores_gemma":[0.023102703,0.0023732635,0.95710945,0.0015609005,0.00037287307,0.0000030324054,0.00073841756,0.0031572345,0.011173063,0.000011104629,0.000013401371,0.00038457688],"about_ca_topic_score_codex":0.0011638744,"about_ca_topic_score_gemma":0.00028485336,"teacher_disagreement_score":0.097639926,"about_ca_system_score_codex":0.00014411245,"about_ca_system_score_gemma":0.0000415799,"threshold_uncertainty_score":0.9997677},"labels":[],"label_agreement":null},{"id":"W4388818964","doi":"10.1016/j.msard.2023.105141","title":"Is multiple sclerosis a glymphaticopathy?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Immunology","score_opus":0.031941161554268196,"score_gpt":0.24692528136007705,"score_spread":0.21498411980580884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388818964","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068735786,0.047680765,0.000013924588,0.001424291,0.8744321,0.0028158496,0.0018984991,0.0016123739,0.0013864185],"genre_scores_gemma":[0.4817911,0.31027013,0.00020311214,0.00044107542,0.1914374,0.0008495744,0.003980128,0.0012283417,0.009799133],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99244326,0.00024053811,0.0018366065,0.0021572574,0.001914091,0.0014082562],"domain_scores_gemma":[0.99369633,0.0026329318,0.0008170853,0.001355056,0.00044665238,0.0010519183],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00068238244,0.001411359,0.002133905,0.0007715085,0.0007461629,0.00027991633,0.00047116878,0.0039904662,0.0003719023],"category_scores_gemma":[0.004051561,0.0011782781,0.0012498422,0.0013190707,0.0005902267,0.0002247074,0.0003935425,0.0016494817,0.0009587941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005276824,0.00066104316,0.006344655,0.00089001,0.001644752,0.000023389603,0.0010477081,0.000033386103,0.0019665675,0.0000036813412,0.9663232,0.020533899],"study_design_scores_gemma":[0.069923304,0.0019147701,0.080211714,0.05980922,0.009256784,0.000033941964,0.0050138296,0.01334807,0.00081706623,0.0002518682,0.7531766,0.006242819],"about_ca_topic_score_codex":0.0015433228,"about_ca_topic_score_gemma":0.00014005296,"teacher_disagreement_score":0.6829947,"about_ca_system_score_codex":0.00031149326,"about_ca_system_score_gemma":0.00053468684,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W4388947332","doi":"10.1016/j.msard.2023.105138","title":"The influence of personality in persons with MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ontario Shores Centre for Mental Health Sciences; Lawson Health Research Institute; Western University","funders":"","keywords":"Conscientiousness; Neuroticism; Extraversion and introversion; Big Five personality traits; Personality; Clinical psychology; Psychological intervention; Anxiety; Medicine; Depression (economics); Psychology; Psychiatry; Social psychology","score_opus":0.034968413135310496,"score_gpt":0.27477086957793667,"score_spread":0.23980245644262618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388947332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936314,0.0008660588,0.0000012746241,0.0038336401,0.000029179217,0.0006123873,0.000019775845,0.000073280375,0.0009329525],"genre_scores_gemma":[0.9884312,0.011073105,0.000048762045,0.000032273634,0.000007922954,0.000085409185,0.000010969917,0.00002308447,0.00028724372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983199,0.000095366195,0.00032773436,0.0003405301,0.0004504951,0.00046597075],"domain_scores_gemma":[0.99881554,0.0005878587,0.000088221415,0.00028832414,0.00009404071,0.00012604348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056736736,0.00018110426,0.00032149648,0.00017086901,0.0003384561,0.000023589391,0.00012164745,0.0001059233,0.000017631117],"category_scores_gemma":[0.0006947422,0.000105826744,0.00008865702,0.0010390013,0.0008358382,0.00008593633,0.00011359767,0.00036385556,0.000012770137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004698621,0.00016283902,0.9681228,0.00013213615,0.00023310384,0.000004556374,0.0043118494,0.0013386898,0.01105407,0.00005054306,0.00039448944,0.013725079],"study_design_scores_gemma":[0.003514818,0.00019135077,0.98774797,0.00036066875,0.000028908158,0.0000020830828,0.0031008944,0.004082847,0.00010608736,0.000029294551,0.00070655334,0.00012852119],"about_ca_topic_score_codex":0.0019302589,"about_ca_topic_score_gemma":0.002246775,"teacher_disagreement_score":0.01962519,"about_ca_system_score_codex":0.000038938793,"about_ca_system_score_gemma":0.000059447582,"threshold_uncertainty_score":0.43154895},"labels":[],"label_agreement":null},{"id":"W4389340890","doi":"10.1016/j.msard.2023.105356","title":"Exercise ventilatory (in)efficiency in multiple sclerosis: The missing factor?","year":2023,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Multiple sclerosis; Physical medicine and rehabilitation; Physical therapy; Immunology","score_opus":0.07526556728994567,"score_gpt":0.27366635115196103,"score_spread":0.19840078386201537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389340890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5134506,0.039135464,0.000012757559,0.4341602,0.0025098103,0.008475126,0.00034797748,0.00084444234,0.0010636025],"genre_scores_gemma":[0.916804,0.06515028,0.00007914511,0.014958304,0.0003693207,0.00072918774,0.0002953528,0.00038485002,0.001229553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929179,0.00035654986,0.0015618104,0.0017500571,0.0014506229,0.0019630769],"domain_scores_gemma":[0.9965928,0.0013756219,0.00040752455,0.0012021449,0.00014351333,0.00027839406],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00097594265,0.0010939528,0.0016717939,0.0013691873,0.0007222305,0.00021020598,0.00065339817,0.0017344509,0.0001264638],"category_scores_gemma":[0.0013810062,0.0008127568,0.00061647577,0.0019803552,0.0011117092,0.00022283432,0.0005824978,0.0053020553,0.00016615307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009949036,0.0018638727,0.3873965,0.0034201,0.0010953713,0.00050117535,0.012423626,0.0010035238,0.0077850237,0.0000037204659,0.36036298,0.2231492],"study_design_scores_gemma":[0.010776001,0.00019205533,0.9262352,0.012422712,0.00022332066,0.0000068742493,0.0017123395,0.012855445,0.0001582821,0.00006243226,0.034093082,0.0012622805],"about_ca_topic_score_codex":0.002232094,"about_ca_topic_score_gemma":0.001439682,"teacher_disagreement_score":0.5388387,"about_ca_system_score_codex":0.0004237003,"about_ca_system_score_gemma":0.00022472277,"threshold_uncertainty_score":0.9995615},"labels":[],"label_agreement":null},{"id":"W4389476706","doi":"10.1016/j.msard.2023.105365","title":"Comorbidity in the multiple sclerosis and neuromyelitis optica spectrum disorders population: findings from an underserved, low income country, Zambia","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of AIDS Research; Fogarty International Center; National Institute on Aging; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; American Academy of Neurology; National Multiple Sclerosis Society","keywords":"Neuromyelitis optica; Medicine; Multiple sclerosis; Spectrum disorder; Comorbidity; Population; Pediatrics; Environmental health; Psychiatry","score_opus":0.04766772374554182,"score_gpt":0.27204752992369746,"score_spread":0.22437980617815564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389476706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845963,0.00085926225,0.000015162252,0.011683105,0.0003228506,0.0017092605,0.00027355264,0.00031354112,0.00022694828],"genre_scores_gemma":[0.97127587,0.027104441,0.00012718175,0.00032457334,0.00007937916,0.0001749898,0.0007530596,0.000103069346,0.000057424964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99542624,0.000457052,0.0008470734,0.0012179158,0.0009500773,0.0011016491],"domain_scores_gemma":[0.99715364,0.0013997399,0.0001665041,0.00081145973,0.00005406383,0.00041458342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009053401,0.0006290522,0.0008386454,0.0004922383,0.0010243272,0.00029712456,0.00039395023,0.00040052462,0.00012095594],"category_scores_gemma":[0.00097246474,0.0004920761,0.00019941032,0.0016763533,0.0007772029,0.0004973921,0.0004009533,0.0010036753,0.00004283238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035220574,0.00046816753,0.9825213,0.00013896954,0.00020520971,0.000014200766,0.003114818,0.0004107302,0.0018752053,0.00009033641,0.00045241116,0.010356457],"study_design_scores_gemma":[0.008529602,0.0003451087,0.94778836,0.00051744323,0.0000997795,0.0000050317535,0.0035193933,0.037459884,0.000041011124,0.0007505328,0.00042123624,0.00052259176],"about_ca_topic_score_codex":0.021411117,"about_ca_topic_score_gemma":0.030490534,"teacher_disagreement_score":0.037049156,"about_ca_system_score_codex":0.00013048553,"about_ca_system_score_gemma":0.000047923037,"threshold_uncertainty_score":0.9997531},"labels":[],"label_agreement":null},{"id":"W4389513800","doi":"10.1016/j.msard.2023.105364","title":"Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.051789653677591994,"score_gpt":0.2849057615460464,"score_spread":0.2331161078684544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389513800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51011145,0.0012484518,0.000012711706,0.0011385494,0.4806989,0.005674345,0.0006339713,0.00026418082,0.0002174372],"genre_scores_gemma":[0.8476875,0.051014762,0.000080599326,0.000056919394,0.09019554,0.0007116859,0.001256699,0.00054652663,0.008449791],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99306077,0.00057348196,0.001715812,0.0013522936,0.002138392,0.0011592493],"domain_scores_gemma":[0.9936494,0.003913527,0.0006014215,0.0011529169,0.00035002464,0.00033268592],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017173612,0.00086449087,0.002008943,0.0008010627,0.0003866658,0.0001610263,0.0006804959,0.0023526212,0.00066015887],"category_scores_gemma":[0.005255115,0.0005801004,0.00084070466,0.0013335801,0.00083506684,0.00014154581,0.00045961293,0.0026766509,0.000079309175],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2536035,0.0031604276,0.004174686,0.001193098,0.0038316334,0.00010086952,0.005238567,0.0006665186,0.11752067,0.0000036904623,0.54659957,0.063906774],"study_design_scores_gemma":[0.71341807,0.006045176,0.06225534,0.00845828,0.002393038,0.0000048557517,0.005401664,0.015024002,0.002391133,0.00006918699,0.18132795,0.003211278],"about_ca_topic_score_codex":0.004193571,"about_ca_topic_score_gemma":0.006538642,"teacher_disagreement_score":0.4598146,"about_ca_system_score_codex":0.00020895666,"about_ca_system_score_gemma":0.0006629899,"threshold_uncertainty_score":0.999665},"labels":[],"label_agreement":null},{"id":"W4389866816","doi":"10.1016/j.msard.2023.105288","title":"Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Patient-Reported Vitality and Mental Health in Patients with Relapsing Multiple Sclerosis in a Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Multiple sclerosis; Vitality; Internal medicine; Mental health; Tyrosine kinase; Oncology; Psychiatry; Genetics; Receptor","score_opus":0.022203950507527145,"score_gpt":0.2817896169211643,"score_spread":0.2595856664136371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389866816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944931,0.000552049,8.40639e-7,0.00046209325,0.00020632535,0.0040737814,0.00008723532,0.000083088016,0.000041464133],"genre_scores_gemma":[0.9983999,0.0009518485,0.000031448115,0.00005037354,0.0000121045105,0.00011331604,0.00036091637,0.00006382999,0.000016246582],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99644774,0.00040392444,0.0010198565,0.0007701258,0.0006674336,0.00069094263],"domain_scores_gemma":[0.9983491,0.0005567701,0.00033641825,0.00039427716,0.00006014367,0.00030332917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010621357,0.00038325047,0.00089754077,0.000640582,0.00017592945,0.000029573897,0.00007271417,0.0002517263,0.000012934165],"category_scores_gemma":[0.0008922026,0.00029599373,0.000110932575,0.00140108,0.0003506673,0.00015116148,0.00013568868,0.0004762911,0.0000035480655],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26756877,0.006688151,0.5332818,0.000871801,0.00032357534,0.000040685907,0.004626908,0.0002678993,0.0053674118,0.0000044013677,0.00041019623,0.18054841],"study_design_scores_gemma":[0.7099938,0.015178771,0.2543282,0.0033055667,0.000053860018,0.0000036957601,0.0003545328,0.014732007,0.0016548219,0.0000055603764,0.000050164723,0.00033907112],"about_ca_topic_score_codex":0.003047093,"about_ca_topic_score_gemma":0.00051084696,"teacher_disagreement_score":0.44242498,"about_ca_system_score_codex":0.0016813827,"about_ca_system_score_gemma":0.0005259979,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W4389878096","doi":"10.1016/j.msard.2023.105237","title":"Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple sclerosis; Medicine; Lymphocyte; Lymphocyte subsets; Immunology; Internal medicine; Pathology; Immune system; CD8","score_opus":0.05672076094658816,"score_gpt":0.2584236059101785,"score_spread":0.20170284496359034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389878096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945131,0.0005160362,6.836938e-7,0.0039824955,0.000040009178,0.00066468865,0.000011718006,0.000023247318,0.00024802354],"genre_scores_gemma":[0.99535406,0.004359446,0.000018562683,0.000085133724,0.000003949901,0.00009591103,0.000022511535,0.000012646409,0.000047801197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993322,0.0000784217,0.00017235443,0.00017041739,0.0001300139,0.00011659157],"domain_scores_gemma":[0.99932206,0.00043386893,0.00005839549,0.00014025223,0.000016639331,0.000028804658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003388874,0.00009905335,0.00018270822,0.00018469754,0.000050466835,0.000010321001,0.00004269683,0.00007186745,0.000013798102],"category_scores_gemma":[0.000071609604,0.000058343096,0.000015205302,0.0005812658,0.000115873736,0.000041633954,0.000018177701,0.00012134041,0.0000038595763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044006763,0.000059539852,0.99051356,0.000036868125,0.000025880556,0.0000012463023,0.007693745,0.00005182077,0.0000486264,0.0000130305125,0.00016535452,0.0013463325],"study_design_scores_gemma":[0.003281401,0.00016408136,0.9890812,0.00018377467,0.00002788522,9.773016e-7,0.00617084,0.0007907155,0.000044308596,0.000104315426,0.00008212051,0.00006834736],"about_ca_topic_score_codex":0.00061198487,"about_ca_topic_score_gemma":0.0069719506,"teacher_disagreement_score":0.0063599655,"about_ca_system_score_codex":0.000026080108,"about_ca_system_score_gemma":0.00002346231,"threshold_uncertainty_score":0.3890512},"labels":[],"label_agreement":null},{"id":"W4389883767","doi":"10.1016/j.msard.2023.105329","title":"Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Bruton's tyrosine kinase; Open label; Term (time); Extension (predicate logic); Tyrosine kinase; Pharmacology; Oncology; Adverse effect; Internal medicine; Receptor; Cancer; Computer science","score_opus":0.047042485512655066,"score_gpt":0.33179932538169954,"score_spread":0.2847568398690445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389883767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962403,0.001692318,0.000006746505,0.00045523528,0.00017148867,0.0011128047,0.00010014004,0.000115252624,0.00010570393],"genre_scores_gemma":[0.99184316,0.0071348203,0.00010203676,0.00015793608,0.00004205193,0.000019658564,0.00048749617,0.00007403092,0.00013883333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99768543,0.0001163288,0.00051334273,0.0007583802,0.00045748753,0.00046905794],"domain_scores_gemma":[0.9984915,0.00034985182,0.00014718223,0.00058529474,0.00006844871,0.00035767755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004194383,0.00028164563,0.00053195254,0.00025598306,0.0002035559,0.000077170385,0.00017874119,0.00027068652,0.00012414921],"category_scores_gemma":[0.0003236676,0.00024375944,0.000060033646,0.0006061093,0.00033288266,0.00021831597,0.0003805571,0.00035942975,0.000038954142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024750592,0.008741388,0.028023105,0.00043804367,0.0008612264,0.00043690598,0.0037593008,0.00043148108,0.29691187,0.00012308864,0.0027658292,0.6327572],"study_design_scores_gemma":[0.25456262,0.0019260375,0.69083685,0.0022852465,0.00022625121,0.000014257879,0.00022226007,0.045476545,0.0034043116,0.00005481157,0.00051867496,0.00047213276],"about_ca_topic_score_codex":0.0014003585,"about_ca_topic_score_gemma":0.0001575478,"teacher_disagreement_score":0.6628137,"about_ca_system_score_codex":0.00045671946,"about_ca_system_score_gemma":0.0003788315,"threshold_uncertainty_score":0.99402213},"labels":[],"label_agreement":null},{"id":"W4389893007","doi":"10.1016/j.msard.2023.105328","title":"Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Internal medicine; Relapsing remitting; Clinical trial; Physical therapy; Oncology; Immunology; Fingolimod","score_opus":0.1882112032418722,"score_gpt":0.3692451553097669,"score_spread":0.18103395206789472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389893007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224293,0.0033872658,0.00032894805,0.0004643256,0.0001813235,0.0032788075,0.00004450286,0.000042925807,0.000028946472],"genre_scores_gemma":[0.98202205,0.016925639,0.000740028,0.000013497914,0.000028193577,0.000092133225,0.000081815815,0.0000438492,0.00005280174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963925,0.00078989257,0.0014346956,0.0005312437,0.0004205671,0.00043110902],"domain_scores_gemma":[0.9897241,0.009135425,0.00048598647,0.00033018895,0.0001390681,0.00018521203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070666526,0.00029530897,0.001061707,0.00032926732,0.00023945665,0.00004616565,0.00009529606,0.0002649551,0.000019950212],"category_scores_gemma":[0.0077090603,0.0002106126,0.00010641411,0.00067049236,0.0007288088,0.00012429216,0.00017532031,0.00034824925,0.0000013516094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59555346,0.00078024884,0.0060812896,0.00060725876,0.00068550964,0.0000063736998,0.0059291925,0.0014154651,0.18952657,0.000016085432,0.000089065965,0.19930945],"study_design_scores_gemma":[0.614617,0.0008820172,0.027715016,0.0010734134,0.000386362,0.0000066854486,0.0007270349,0.35339215,0.0009789187,0.000014680134,0.000020470028,0.00018627718],"about_ca_topic_score_codex":0.0006331498,"about_ca_topic_score_gemma":0.000041554944,"teacher_disagreement_score":0.3519767,"about_ca_system_score_codex":0.00036125738,"about_ca_system_score_gemma":0.00059650274,"threshold_uncertainty_score":0.9229022},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4390084405","doi":"10.1016/j.msard.2023.105399","title":"Physical activity together for MS (PAT-MS): Secondary outcomes of a randomized controlled feasibility trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; McMaster University; University of Ottawa","funders":"","keywords":"Randomized controlled trial; Psychological intervention; Medicine; Coping (psychology); Multiple sclerosis; Clinical psychology; Context (archaeology); Caregiver burden; Physical therapy; Quality of life (healthcare); Psychiatry; Disease; Nursing; Internal medicine","score_opus":0.05611424981829161,"score_gpt":0.32623630047423813,"score_spread":0.2701220506559465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390084405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98283464,0.00037041795,0.00007470457,0.0022671747,0.00033952412,0.012732731,0.00014280017,0.00019779881,0.0010402004],"genre_scores_gemma":[0.99514514,0.0018076416,0.00015366854,0.000038539074,0.00006907652,0.0018642038,0.0000488549,0.000057091504,0.0008157769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967547,0.000534263,0.00082966813,0.0006672617,0.0006093058,0.0006047933],"domain_scores_gemma":[0.9938607,0.0048543904,0.00037290773,0.0004598297,0.0002272973,0.00022484701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022990736,0.0004150155,0.003512545,0.00028468313,0.00028689543,0.00003404913,0.00013576113,0.00025988385,0.000097160155],"category_scores_gemma":[0.008096956,0.0002648133,0.0017535621,0.00045505897,0.0008352166,0.00012574259,0.00015951258,0.00043345193,0.000012374658],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9304571,0.002272293,0.020883517,0.00032527174,0.003964114,9.755678e-7,0.0017278525,0.000046428184,0.014877689,0.00006495118,0.00076160114,0.024618201],"study_design_scores_gemma":[0.7780784,0.0005425917,0.19586214,0.000105724925,0.0005239049,2.7006806e-7,0.0003147547,0.023461295,0.00054797105,0.00026275718,0.00007178991,0.00022839557],"about_ca_topic_score_codex":0.00041607773,"about_ca_topic_score_gemma":0.00013411808,"teacher_disagreement_score":0.17497863,"about_ca_system_score_codex":0.00005733974,"about_ca_system_score_gemma":0.000113063026,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W4390817041","doi":"10.1016/j.msard.2024.105444","title":"In the era of antiviral trials for MS, the answer lies in the details","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Massachusetts General Hospital","keywords":"Multiple sclerosis; Epstein–Barr virus; Medicine; Virus; Disease; Immunology; Prodrug; Virology; Internal medicine; Pharmacology","score_opus":0.06197284138430743,"score_gpt":0.33140479392944644,"score_spread":0.269431952545139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390817041","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16625938,0.1180475,0.000029928377,0.100572534,0.57599145,0.031620245,0.0031923824,0.00016968687,0.0041168984],"genre_scores_gemma":[0.8260517,0.10453207,0.00007880753,0.00032676567,0.06592971,0.0020258739,0.0003810658,0.00013562482,0.0005383867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945655,0.0013389002,0.0014357613,0.0006896222,0.0012877558,0.00068249676],"domain_scores_gemma":[0.981335,0.017294433,0.00038129365,0.00074665726,0.00019267508,0.00004995448],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008239591,0.00054717856,0.0014696013,0.0002962403,0.00031778973,0.00017919419,0.0006909557,0.00083734933,0.000026437874],"category_scores_gemma":[0.013904519,0.00022892069,0.00065977516,0.0009006631,0.00088729925,0.00012253971,0.00018661635,0.0027913342,0.0000088202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009059724,0.00046991176,0.0016881587,0.0007810181,0.0006870829,0.0000056264653,0.014825543,0.000020541247,0.0005701826,0.000055053184,0.9631459,0.016844995],"study_design_scores_gemma":[0.017272474,0.0010051614,0.05585539,0.004139114,0.0011527326,0.000002453724,0.018770779,0.0015259281,0.000110404384,0.0009071608,0.8985587,0.00069974497],"about_ca_topic_score_codex":0.0018514956,"about_ca_topic_score_gemma":0.0037878952,"teacher_disagreement_score":0.6597923,"about_ca_system_score_codex":0.00006369355,"about_ca_system_score_gemma":0.0002219151,"threshold_uncertainty_score":0.9995093},"labels":[],"label_agreement":null},{"id":"W4390837701","doi":"10.1016/j.msard.2024.105434","title":"Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta; London Health Sciences Centre; University of Calgary; Ottawa Hospital; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Manitoba; University of Ottawa; University of Toronto; Western University","funders":"European Genomic Institute for Diabetes; Roche Canada","keywords":"Medicine; Serology; Neuromyelitis optica; Cohort; Ethnic group; Pediatrics; Cohort study; Spectrum disorder; Internal medicine; Demography; Multiple sclerosis; Antibody; Immunology; Psychiatry","score_opus":0.09374377842453142,"score_gpt":0.3560968428491834,"score_spread":0.262353064424652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390837701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938691,0.0013465446,0.00000894446,0.0034477657,0.00011203623,0.00088202686,0.00012419527,0.000085028456,0.00012433965],"genre_scores_gemma":[0.99657136,0.0029065688,0.00014915325,0.00019283708,0.000024774528,0.000050592793,0.000021400076,0.000037035068,0.00004626343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739337,0.00027304093,0.0009460089,0.00055535266,0.000416211,0.00041600064],"domain_scores_gemma":[0.99787295,0.0014589989,0.00018902228,0.00019365142,0.00007644671,0.00020895994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010590866,0.00026386997,0.00090604177,0.00028713388,0.00023047868,0.000022544287,0.000088421446,0.00023769066,0.000088891706],"category_scores_gemma":[0.0011382918,0.00018927948,0.00022584248,0.00038299023,0.00043031017,0.000060418242,0.00013378925,0.00038299809,0.000009953727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021328314,0.00036893197,0.89127034,0.0005137861,0.0001757755,0.0000011880948,0.0012282298,0.000041357125,0.00058057235,0.000001740327,0.00056556065,0.10503922],"study_design_scores_gemma":[0.0023275919,0.0020340746,0.9652751,0.0012055266,0.000079942394,4.8259915e-7,0.00043715772,0.027857311,0.0003184121,0.000006542229,0.000306432,0.00015139084],"about_ca_topic_score_codex":0.00043291217,"about_ca_topic_score_gemma":0.00009072421,"teacher_disagreement_score":0.10488783,"about_ca_system_score_codex":0.000041292365,"about_ca_system_score_gemma":0.000090073976,"threshold_uncertainty_score":0.77185935},"labels":[],"label_agreement":null},{"id":"W4391036856","doi":"10.1016/j.msard.2024.105457","title":"What is the role of diet for multiple sclerosis? Why epidemiological studies don't give the full answer","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Epidemiology; Disease; Vitamin D and neurology; Immune system; Immunology; Environmental health; Gerontology; Internal medicine","score_opus":0.060783286783141495,"score_gpt":0.3166874655476032,"score_spread":0.2559041787644617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391036856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022243228,0.5131447,0.000038918814,0.042451676,0.4077252,0.010939656,0.0027512303,0.00040390427,0.00030155428],"genre_scores_gemma":[0.18653598,0.7410294,0.0003062268,0.00073499844,0.06642556,0.0028360009,0.0006111761,0.00032802724,0.0011926404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924388,0.0007015481,0.0018579504,0.0018845139,0.0016803714,0.0014368336],"domain_scores_gemma":[0.9752443,0.021019943,0.00077447615,0.0014260958,0.0012034911,0.0003316856],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.0030256547,0.0013272219,0.0026219015,0.0003211222,0.001327601,0.000315626,0.000899854,0.0018021218,0.000084194704],"category_scores_gemma":[0.015618611,0.0006569372,0.0016035506,0.00080254447,0.0033833673,0.00032967475,0.0011903173,0.00294033,0.00003661557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033196725,0.00044399968,0.0013523067,0.0012040301,0.005770513,0.00000180446,0.0072509353,0.00006417358,0.002231566,0.00003179401,0.95549846,0.022830723],"study_design_scores_gemma":[0.0076295612,0.0026268603,0.004087566,0.0067088166,0.0021235552,0.0000023050736,0.03343508,0.0057332795,0.0003777549,0.0016222005,0.9346346,0.0010184045],"about_ca_topic_score_codex":0.0006753035,"about_ca_topic_score_gemma":0.0009907358,"teacher_disagreement_score":0.34129962,"about_ca_system_score_codex":0.00022032349,"about_ca_system_score_gemma":0.00021360483,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W4391058228","doi":"10.1016/j.msard.2024.105454","title":"Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Saffron Plant Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Kashan University of Medical Sciences","keywords":"Medicine; Multiple sclerosis; Crocin; Double blinded; Randomized controlled trial; Clinical trial; Mental health; Physical therapy; Internal medicine; Psychiatry; Alternative medicine; Pathology; Pharmacology; Placebo","score_opus":0.03698428820916453,"score_gpt":0.30468759778925714,"score_spread":0.2677033095800926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391058228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380417,0.008605944,0.0000043530536,0.0009900527,0.00036379122,0.006044308,0.0000517237,0.00007905526,0.000056599943],"genre_scores_gemma":[0.97897494,0.02047081,0.000108314016,0.00006974654,0.000019878342,0.00020951455,0.00008166421,0.00004223019,0.00002289522],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968429,0.00043979328,0.0009761618,0.000639831,0.00055082206,0.00055047567],"domain_scores_gemma":[0.99731606,0.0019228123,0.00019867932,0.00019000526,0.000054125576,0.00031834035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001233662,0.00033686322,0.0011336037,0.00047091994,0.00015701477,0.00004604868,0.00006338114,0.00022604622,0.000007791179],"category_scores_gemma":[0.0006156527,0.00022351694,0.00019618428,0.00041261595,0.00073248503,0.00012179273,0.00009577712,0.0005293247,0.0000038322055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68276894,0.00114202,0.28938895,0.0007372241,0.001208418,0.000003995666,0.0013126391,0.0000061690685,0.00014570123,0.000018567238,0.00040408358,0.022863314],"study_design_scores_gemma":[0.5743721,0.0017259604,0.4202823,0.002177496,0.00008672411,3.763844e-7,0.00024112329,0.00082678057,0.00005327057,0.000007371281,0.00007458228,0.00015186582],"about_ca_topic_score_codex":0.0007019715,"about_ca_topic_score_gemma":0.00038469755,"teacher_disagreement_score":0.13089338,"about_ca_system_score_codex":0.000102452475,"about_ca_system_score_gemma":0.00017113207,"threshold_uncertainty_score":0.9114756},"labels":[],"label_agreement":null},{"id":"W4391289135","doi":"10.1016/j.msard.2024.105477","title":"Milk and multiple sclerosis: A possible link?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Milk Quality and Mastitis in Dairy Cows","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Immune system; Immunology; Vitamin D and neurology; Myelin oligodendrocyte glycoprotein; Myelin; Pathology; Endocrinology; Central nervous system","score_opus":0.03901879050953096,"score_gpt":0.21533598422582662,"score_spread":0.17631719371629567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391289135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736869,0.019156847,0.000011093395,0.004526651,0.0004922583,0.0003426692,0.00012746241,0.0003260597,0.0013301065],"genre_scores_gemma":[0.9832425,0.0155439805,0.00011603421,0.0002081934,0.00010493473,0.00002561137,0.00007481172,0.000004946393,0.00067899976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831116,0.0001020702,0.0003492398,0.0006290733,0.00019873955,0.00040973388],"domain_scores_gemma":[0.99916875,0.00045722042,0.00005124801,0.000088538734,0.000027940305,0.00020630717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031256682,0.00026315518,0.00025092793,0.000038350183,0.0005093595,0.00029491886,0.0001612658,0.00029266038,0.00032079895],"category_scores_gemma":[0.0001346098,0.000118277574,0.00013141139,0.0004402118,0.00025565646,0.0002622867,0.00015753054,0.0003172968,0.00005600241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071357914,0.00014290825,0.016604496,0.000107795204,0.00012179796,0.000005277144,0.0012039436,0.00004681515,0.0925471,0.00097533,0.0025104496,0.88566273],"study_design_scores_gemma":[0.0033136916,0.0008454022,0.78088975,0.0020563845,0.00020302333,0.000034283697,0.0037919579,0.031100744,0.0021316234,0.007886908,0.16593501,0.001811227],"about_ca_topic_score_codex":0.000881104,"about_ca_topic_score_gemma":0.0017417416,"teacher_disagreement_score":0.8838515,"about_ca_system_score_codex":0.000015837468,"about_ca_system_score_gemma":0.000009407676,"threshold_uncertainty_score":0.48232195},"labels":[],"label_agreement":null},{"id":"W4391430005","doi":"10.1016/j.msard.2024.105473","title":"The effect of exercise on mental health and health-related quality of life in individuals with multiple sclerosis: A Systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Medicine; Multiple sclerosis; Meta-analysis; Quality of life (healthcare); Mental health; Health related quality of life; Physical medicine and rehabilitation; Physical therapy; Psychiatry; Disease; Internal medicine; Nursing","score_opus":0.14298506852616397,"score_gpt":0.37479585313740427,"score_spread":0.2318107846112403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391430005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016008939,0.97984904,6.406541e-7,0.002645088,0.00004001544,0.01515753,0.0006384941,0.000053865457,0.0000144038295],"genre_scores_gemma":[0.035363268,0.96234035,0.000044435037,0.00009850422,0.0000032593841,0.0017433268,0.00021891644,0.00010737139,0.00008054445],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9888281,0.003221468,0.004689333,0.0012896798,0.0011835246,0.0007878618],"domain_scores_gemma":[0.9926116,0.002884936,0.0027115725,0.0010431355,0.00011230566,0.0006364662],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0080065895,0.0011659275,0.017250327,0.0009977986,0.0004448028,0.00008021653,0.00029696085,0.0004212986,0.000015944866],"category_scores_gemma":[0.001963612,0.0005596973,0.0018943776,0.0026485545,0.0009168454,0.00009489712,0.00036711717,0.0012126882,0.0000041786307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015813086,0.000249245,0.0037803273,0.86485726,0.11236914,5.957674e-7,0.0011209737,0.000004635611,6.6984404e-7,0.000008039861,0.00028218757,0.017168809],"study_design_scores_gemma":[0.0072223567,0.0025837955,0.008146192,0.5811078,0.3983777,0.0000073698848,0.00096523133,0.00020344793,9.2182285e-7,0.0000047763815,0.0005436394,0.00083677203],"about_ca_topic_score_codex":0.002443471,"about_ca_topic_score_gemma":0.0010576331,"teacher_disagreement_score":0.28600854,"about_ca_system_score_codex":0.00018168181,"about_ca_system_score_gemma":0.00031330777,"threshold_uncertainty_score":0.99968547},"labels":[],"label_agreement":null},{"id":"W4392202594","doi":"10.1016/j.msard.2024.105525","title":"Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Hotchkiss Brain Institute","keywords":"Medicine; Multiple sclerosis; Relapsing remitting; Domperidone; Lesion; Randomized controlled trial; Clinical trial; Expanded Disability Status Scale; Clinically isolated syndrome; Internal medicine; Oncology; Pathology; Psychiatry","score_opus":0.2042149628265359,"score_gpt":0.39370540783067104,"score_spread":0.18949044500413514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392202594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702618,0.0034934012,0.000042580887,0.0010870171,0.0011089661,0.023190109,0.00006278917,0.00040970606,0.00034364403],"genre_scores_gemma":[0.9855532,0.011223369,0.0005811534,0.00006870841,0.00014015027,0.0020458603,0.00003060358,0.00010969842,0.00024727974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9896952,0.0028520583,0.0036043867,0.0018362886,0.0011404945,0.00087157084],"domain_scores_gemma":[0.987624,0.0101984935,0.0004348019,0.0009716366,0.00024757112,0.00052352395],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0088404985,0.0008249017,0.0046413788,0.0008771609,0.00034298399,0.000101385434,0.00021194253,0.0003353373,0.000068624904],"category_scores_gemma":[0.01724947,0.00053307094,0.0016858564,0.0011713093,0.0006416957,0.00018061853,0.00027391748,0.0009652931,0.00002603615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8578894,0.018595502,0.088026285,0.00020796696,0.0026438423,0.000017853461,0.0033109162,0.00035961572,0.0051939683,0.000012410618,0.00025905442,0.02348315],"study_design_scores_gemma":[0.76645374,0.011627092,0.19374052,0.0029706403,0.0007546582,0.000001367015,0.002506542,0.021342201,0.00012746664,0.00001800091,0.000049917795,0.00040782493],"about_ca_topic_score_codex":0.0015371776,"about_ca_topic_score_gemma":0.0014017435,"teacher_disagreement_score":0.10571423,"about_ca_system_score_codex":0.00046205972,"about_ca_system_score_gemma":0.00024494194,"threshold_uncertainty_score":0.9997121},"labels":[],"label_agreement":null},{"id":"W4392302729","doi":"10.1016/j.msard.2024.105530","title":"Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Student Research Committee, Tabriz University of Medical Sciences; Tabriz University of Medical Sciences","keywords":"Medicine; Montreal Cognitive Assessment; Confounding; Cognition; Multiple sclerosis; Meta-analysis; Neuropsychology; Critical appraisal; Systematic review; Sample size determination; Bioinformatics; Clinical psychology; Internal medicine; MEDLINE; Psychiatry; Pathology; Cognitive impairment; Alternative medicine; Biology","score_opus":0.15382993898698422,"score_gpt":0.35155969091624795,"score_spread":0.19772975192926373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392302729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024373255,0.98646396,0.000004772665,0.0011849202,0.00008915648,0.010738105,0.0009937963,0.00016751728,0.00011402386],"genre_scores_gemma":[0.018025218,0.9769406,0.000087838016,0.00029903077,0.000016327827,0.0032085136,0.00022644516,0.00020015697,0.0009959261],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920015,0.0011183198,0.0028106146,0.0021440291,0.00088036794,0.0010452047],"domain_scores_gemma":[0.99484885,0.002700181,0.0007448469,0.000886211,0.00020883698,0.0006110475],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018163247,0.0017363643,0.016501006,0.0017950997,0.00038470238,0.0002635242,0.00027072924,0.00086421135,0.00014232444],"category_scores_gemma":[0.0035656574,0.0010528207,0.00341138,0.002861733,0.00082229107,0.00022696178,0.00080667884,0.0017156311,0.000060111986],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020884523,0.00031019485,0.0017855625,0.7259425,0.2492108,0.000013934547,0.00044778388,7.1922807e-7,0.0000011409998,0.000006251914,0.00013002698,0.022130199],"study_design_scores_gemma":[0.002295506,0.00015277095,0.005327781,0.17688675,0.81203425,0.000020875554,0.00045990158,0.00031190354,2.4671274e-7,0.000008936233,0.0015174622,0.0009836217],"about_ca_topic_score_codex":0.00043266403,"about_ca_topic_score_gemma":0.0010599057,"teacher_disagreement_score":0.5628234,"about_ca_system_score_codex":0.00013935177,"about_ca_system_score_gemma":0.00012791785,"threshold_uncertainty_score":0.99953824},"labels":[],"label_agreement":null},{"id":"W4392545642","doi":"10.1016/j.msard.2024.105544","title":"Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background","year":2024,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Medical diagnosis; Inclusion and exclusion criteria; Intensive care medicine; Pathology; Alternative medicine","score_opus":0.045978867747604145,"score_gpt":0.2726277596016084,"score_spread":0.22664889185400425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392545642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76065296,0.0068720123,0.00000430939,0.2273589,0.0009027476,0.0020134936,0.00030899292,0.000015485222,0.0018711073],"genre_scores_gemma":[0.9642048,0.009462889,0.000017386714,0.0242387,0.000078863515,0.00021267332,0.00026293282,0.000070822585,0.0014509202],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99762136,0.00028081666,0.00062507414,0.00047778737,0.00064946833,0.00034550924],"domain_scores_gemma":[0.9980751,0.0006960262,0.0004073714,0.0007427682,0.000042245,0.00003646905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031301987,0.0004341591,0.00065438985,0.00013371768,0.00021360935,0.000039103863,0.00044094145,0.0004329763,0.00015071969],"category_scores_gemma":[0.00004355854,0.0001865417,0.0004273942,0.00033594135,0.000607627,0.00005646622,0.00031755934,0.00087287975,0.000014823603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009899538,0.0025910747,0.04803375,0.002694138,0.0044015157,0.00010890493,0.03755395,0.00007588367,0.001666495,0.00011619387,0.8914228,0.0103453025],"study_design_scores_gemma":[0.030126432,0.0015200827,0.7260315,0.035994478,0.0035817027,0.000101266094,0.02409875,0.005420592,0.0010490161,0.006798636,0.16368283,0.0015947392],"about_ca_topic_score_codex":0.0029832735,"about_ca_topic_score_gemma":0.0009496982,"teacher_disagreement_score":0.72774,"about_ca_system_score_codex":0.000085808395,"about_ca_system_score_gemma":0.00003650876,"threshold_uncertainty_score":0.760695},"labels":[],"label_agreement":null},{"id":"W4392596335","doi":"10.1016/j.msard.2024.105542","title":"OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Nerve fiber layer; Subclinical infection; Multiple sclerosis; Retina; Inner plexiform layer; Ganglion; Optic nerve; Ophthalmology; Optical coherence tomography; Retinal; Optical coherence tomography angiography; Neuromyelitis optica; Ganglion cell layer; Pathology; Neuroscience; Anatomy; Immunology","score_opus":0.03709265859973692,"score_gpt":0.31035083546337,"score_spread":0.2732581768636331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392596335","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38709465,0.06390655,0.00006687841,0.0013489758,0.54166275,0.004149411,0.0006196719,0.0003914678,0.0007596906],"genre_scores_gemma":[0.7090418,0.033674434,0.00070502184,0.00011782746,0.24635547,0.00027262265,0.0022908484,0.0008525314,0.0066894535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501324,0.00025230367,0.0012136084,0.0013621106,0.0012718636,0.0008868599],"domain_scores_gemma":[0.9964935,0.0018150584,0.00024176652,0.00059773587,0.00014008753,0.00071185577],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00079970167,0.0006805406,0.0012423734,0.0012505979,0.00018221706,0.00018957074,0.00024404541,0.0016974316,0.000092479284],"category_scores_gemma":[0.0024962719,0.0005778292,0.0010291332,0.0014323627,0.00031594036,0.00014008471,0.0002947896,0.002433929,0.00008025973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022730364,0.0006351038,0.171427,0.00304083,0.002144582,0.00038448413,0.002920791,0.00010915301,0.00030789728,0.000022933653,0.8102247,0.006509503],"study_design_scores_gemma":[0.114742704,0.0025451686,0.07905728,0.20743531,0.0132260155,0.00050704414,0.007633479,0.06828596,0.000053267737,0.0031233681,0.49400538,0.009385027],"about_ca_topic_score_codex":0.0014649486,"about_ca_topic_score_gemma":0.00021314895,"teacher_disagreement_score":0.32194716,"about_ca_system_score_codex":0.00033305533,"about_ca_system_score_gemma":0.0010337158,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W4393386030","doi":"10.1016/j.msard.2024.105603","title":"Assessing multimodal emotion recognition in multiple sclerosis with a clinically accessible measure","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Carleton University; Ottawa Hospital; The Scarborough Hospital; University of Ottawa","funders":"","keywords":"Cognition; Mood; Multiple sclerosis; Social cognition; Emotion recognition; Psychology; Clinical psychology; Medicine; Developmental psychology; Psychiatry; Neuroscience","score_opus":0.114061484896842,"score_gpt":0.32434569209159947,"score_spread":0.2102842071947575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393386030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887218,0.0038586599,0.0006685559,0.0023369454,0.000362656,0.0017248706,0.000047009864,0.00049980415,0.0017797122],"genre_scores_gemma":[0.9824984,0.013225447,0.003409097,0.00011393196,0.00009310092,0.00026490478,0.00016489073,0.0001325155,0.00009771881],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954966,0.00031551128,0.0010858645,0.00130721,0.0008856577,0.00090920826],"domain_scores_gemma":[0.99774337,0.0009892753,0.00017758696,0.0004354295,0.00025932354,0.00039503942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012956397,0.0005701995,0.0008091333,0.0007571114,0.0004853028,0.00055878947,0.0001750468,0.0005182259,0.00014892934],"category_scores_gemma":[0.0014418232,0.00043679422,0.0002738259,0.0015497248,0.0005505922,0.0011759435,0.00017703316,0.0013092941,0.00008049884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011553923,0.00088677416,0.33053356,0.000504117,0.00048637288,0.000030708958,0.0017370563,0.00030262742,0.030581418,0.00000459969,0.00023464639,0.6335427],"study_design_scores_gemma":[0.011558628,0.00063685735,0.8907374,0.007313964,0.00018202202,0.00001557758,0.0026573401,0.08535792,0.00057445274,0.00008322248,0.00024212366,0.00064047636],"about_ca_topic_score_codex":0.00090975384,"about_ca_topic_score_gemma":0.00083836546,"teacher_disagreement_score":0.63290226,"about_ca_system_score_codex":0.00022915268,"about_ca_system_score_gemma":0.00021411726,"threshold_uncertainty_score":0.9998084},"labels":[],"label_agreement":null},{"id":"W4393931160","doi":"10.1016/j.msard.2024.105599","title":"Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Public Health Agency of Canada; University of Manitoba; University of British Columbia","funders":"Hospital for Sick Children; University of Toronto; Multiple Sclerosis Society of Canada; McGill University; University of Pennsylvania","keywords":"Multiple sclerosis; Medicine; Pediatrics; Immunology","score_opus":0.032469404543208645,"score_gpt":0.269323689514796,"score_spread":0.23685428497158736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983621,0.013166512,0.000029258581,0.001103801,0.00018634123,0.001278678,0.00014287254,0.00014710873,0.0003244329],"genre_scores_gemma":[0.96009856,0.03885376,0.0005677774,0.000034333305,0.000051995947,0.00015550658,0.00005609878,0.00007958081,0.00010239767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691004,0.00016264868,0.0007179071,0.0008677842,0.0006815469,0.00066006917],"domain_scores_gemma":[0.9986202,0.00048175987,0.0001315981,0.00031470138,0.0001199951,0.00033175157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052534323,0.0004654216,0.0007307339,0.00071644696,0.0002530698,0.000084799554,0.00013216173,0.0002919858,0.00007365665],"category_scores_gemma":[0.00027947355,0.00036008086,0.00018083908,0.00088854856,0.0004200068,0.00030961062,0.00025097522,0.00083981734,0.0000068202703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004049421,0.00053344783,0.9488575,0.001365285,0.0005901729,0.00003912483,0.002054539,0.0004634969,0.030989869,0.000024087905,0.00031344162,0.01436409],"study_design_scores_gemma":[0.0060199206,0.00051668513,0.9324744,0.0011650821,0.00027259855,0.0000137292045,0.0018052192,0.057049766,0.00019801129,0.00001079889,0.000098440265,0.00037538994],"about_ca_topic_score_codex":0.00045836213,"about_ca_topic_score_gemma":0.0007612095,"teacher_disagreement_score":0.05658627,"about_ca_system_score_codex":0.00010675053,"about_ca_system_score_gemma":0.00018438611,"threshold_uncertainty_score":0.99988514},"labels":[],"label_agreement":null},{"id":"W4394836657","doi":"10.1016/j.msard.2024.105625","title":"Open access publishing and the future of scientific communication","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Download; Publishing; Medicine; Scientific publishing; Scholarly communication; Internet privacy; World Wide Web; Library science; Computer science; Law; Political science","score_opus":0.11987495043826121,"score_gpt":0.44152962579027005,"score_spread":0.32165467535200887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394836657","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016020913,0.0404669,0.0000030349079,0.0436078,0.8887816,0.0034252969,0.00026102297,0.000057092155,0.007376346],"genre_scores_gemma":[0.45115596,0.30332467,0.00026696295,0.00048621287,0.22201952,0.0018722358,0.0031699697,0.0001616659,0.017542789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634445,0.0011882522,0.0007299282,0.0005525379,0.0006914611,0.000493381],"domain_scores_gemma":[0.99418443,0.004043977,0.00046685783,0.0006488727,0.00043743136,0.0002184568],"candidate_categories":["sts","scholarly_communication","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0076291217,0.00018679824,0.0003957991,0.00028143998,0.002997529,0.0027539532,0.002223353,0.0008981122,0.00012499122],"category_scores_gemma":[0.0035253176,0.000111352696,0.000059352296,0.0010356948,0.0012087037,0.0017991941,0.0029647828,0.0028119371,0.000021146188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008908912,0.000029037488,0.000976002,0.00062086975,0.000033516626,3.7423288e-8,0.007285579,0.0000017755247,0.0000033011188,0.0004923138,0.9711426,0.01932587],"study_design_scores_gemma":[0.0022269846,0.000021646249,0.004062294,0.0014698429,0.00003951005,6.423131e-8,0.0088757975,0.0010409547,3.7471744e-7,0.004558511,0.9775631,0.00014092047],"about_ca_topic_score_codex":0.010235187,"about_ca_topic_score_gemma":0.007882519,"teacher_disagreement_score":0.66676205,"about_ca_system_score_codex":0.00008637556,"about_ca_system_score_gemma":0.0016743556,"threshold_uncertainty_score":0.9994886},"labels":[],"label_agreement":null},{"id":"W4396656463","doi":"10.1016/j.msard.2024.105645","title":"Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parkwood Institute; London Health Sciences Centre; Western University; St Joseph's Health Centre; University Health Network","funders":"Sanofi Genzyme; EMD Serono; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Cognition; Multiple sclerosis; Depression (economics); Mood; Mediation; Cognitive skill; Medicine; Clinical psychology; Effects of sleep deprivation on cognitive performance; Psychology; Psychiatry","score_opus":0.06891309897790426,"score_gpt":0.2852530187343158,"score_spread":0.21633991975641154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396656463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161745,0.013085702,0.0002749781,0.0016941559,0.0001823886,0.0022006514,0.00013069047,0.0003661812,0.0004477928],"genre_scores_gemma":[0.9924091,0.006259153,0.00012269121,0.00007578308,0.000074709984,0.00050146313,0.00027862118,0.00009285896,0.00018558564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661916,0.00028940086,0.00065291894,0.00097476697,0.0006721327,0.0007916398],"domain_scores_gemma":[0.9934958,0.005585117,0.00015752431,0.00021992919,0.00019588381,0.00034573433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007432176,0.00048828847,0.00054765336,0.00053208973,0.00091589533,0.00022847777,0.00006447268,0.0002860258,0.00004780193],"category_scores_gemma":[0.0022001953,0.0003268303,0.00013715104,0.0012632216,0.00072718615,0.0003906625,0.00014453758,0.0011221044,0.000021671478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064434856,0.00020815128,0.9569081,0.00020225755,0.0019082171,0.00000731949,0.0069984617,0.0000222914,0.0002900874,0.000020677624,0.000075627075,0.03271447],"study_design_scores_gemma":[0.008213165,0.0006643716,0.9666801,0.0027520112,0.00163644,0.000008554786,0.014098349,0.0052109794,0.000065275475,0.000056029574,0.00022020999,0.00039451488],"about_ca_topic_score_codex":0.0010655342,"about_ca_topic_score_gemma":0.0016887368,"teacher_disagreement_score":0.03231996,"about_ca_system_score_codex":0.00014190539,"about_ca_system_score_gemma":0.0001540657,"threshold_uncertainty_score":0.9999184},"labels":[],"label_agreement":null},{"id":"W4396767444","doi":"10.1016/j.msard.2024.105643","title":"Effects of virtual reality-based rehabilitation on cognitive function and mood in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Multiple sclerosis; Medicine; Meta-analysis; Mood; Randomized controlled trial; Cognition; Rehabilitation; Physical medicine and rehabilitation; Cognitive rehabilitation therapy; Virtual reality; Physical therapy; Systematic review; MEDLINE; Clinical psychology; Psychiatry; Artificial intelligence; Internal medicine; Computer science","score_opus":0.105504400862463,"score_gpt":0.35057669958630444,"score_spread":0.24507229872384145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396767444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058999367,0.96270055,0.000053035084,0.00038366742,0.000069635586,0.035696477,0.00042654475,0.000052220334,0.000027896933],"genre_scores_gemma":[0.14061192,0.84996444,0.00004290142,0.000058815513,0.000007176677,0.008974855,0.00022568576,0.00007616719,0.00003806051],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9805863,0.010406684,0.0063569434,0.0012487641,0.0009748317,0.0004264895],"domain_scores_gemma":[0.9324419,0.06326689,0.0031256846,0.0005188678,0.0004224141,0.00022428058],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0149881365,0.001123885,0.046359148,0.00258465,0.0001330133,0.000059745274,0.00012148466,0.0006571828,0.000028744153],"category_scores_gemma":[0.0807381,0.000609235,0.008147102,0.0022199696,0.0009838553,0.00010331764,0.00012938802,0.0007962514,0.0000027791996],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013327938,0.0006415751,0.0000178915,0.65939766,0.32028073,8.677376e-7,0.00033091128,0.000027501901,0.00001961241,0.00003214389,0.000018996792,0.0059041795],"study_design_scores_gemma":[0.11179139,0.0006251422,0.0003243148,0.23122902,0.65329105,4.5843618e-7,0.00019243029,0.002208654,0.0000019006826,0.000016562839,0.000009725656,0.0003093501],"about_ca_topic_score_codex":0.00036335815,"about_ca_topic_score_gemma":0.00019576283,"teacher_disagreement_score":0.42816862,"about_ca_system_score_codex":0.00009068185,"about_ca_system_score_gemma":0.00014309921,"threshold_uncertainty_score":0.9996359},"labels":[],"label_agreement":null},{"id":"W4396789160","doi":"10.1016/j.msard.2024.105660","title":"Carotid intima media thickness in multiple sclerosis: A CLSA study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation; Government of Canada","keywords":"Medicine; Intima-media thickness; Multiple sclerosis; Internal medicine; Cardiology; Carotid arteries; Immunology","score_opus":0.05744580231679806,"score_gpt":0.2832099185957511,"score_spread":0.22576411627895307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396789160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814012,0.010031008,0.000038032304,0.002578872,0.0009173959,0.003310972,0.000077617115,0.0005764805,0.0010684452],"genre_scores_gemma":[0.9838933,0.014443754,0.0003091794,0.00011204373,0.00011585047,0.00067137304,0.00007099041,0.00015670848,0.00022679994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946566,0.00039597545,0.0011392693,0.0015337935,0.001092243,0.0011820941],"domain_scores_gemma":[0.9970919,0.0013709781,0.000112118694,0.0007377396,0.0001789278,0.0005083444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013505811,0.0007268623,0.0011001613,0.0010292645,0.00046872944,0.0002636599,0.00031953852,0.0004745931,0.00021002536],"category_scores_gemma":[0.002092677,0.0005888127,0.0003407754,0.001930437,0.00068230415,0.0004186324,0.00048580594,0.001626673,0.00015920645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006313358,0.0028017703,0.8569506,0.0007329492,0.00092614564,0.000075106705,0.022877133,0.00027851315,0.021537622,0.000052365413,0.0015829898,0.09155349],"study_design_scores_gemma":[0.0121481195,0.0005376768,0.95578873,0.002337358,0.00023910751,0.000015007805,0.012432514,0.014737245,0.00028625762,0.00007908484,0.0007162376,0.00068267377],"about_ca_topic_score_codex":0.0021216145,"about_ca_topic_score_gemma":0.0053872694,"teacher_disagreement_score":0.098838136,"about_ca_system_score_codex":0.0002437028,"about_ca_system_score_gemma":0.00017463436,"threshold_uncertainty_score":0.9996563},"labels":[],"label_agreement":null},{"id":"W4396791055","doi":"10.1016/j.msard.2024.105631","title":"Cognitive impairment and its impact on employment: A qualitative interview-based study involving healthcare professionals and people living with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"Merck KGaA; Merck Healthcare KGaA","keywords":"Multiple sclerosis; Medicine; Health professionals; Cognition; Cognitive impairment; Qualitative research; Health care; Gerontology; Physical medicine and rehabilitation; Nursing; Psychiatry","score_opus":0.0787477139017309,"score_gpt":0.37515488283548515,"score_spread":0.29640716893375424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396791055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97248816,0.018674776,0.000027330083,0.0036574511,0.000112617825,0.004551259,0.00022239878,0.00023508981,0.000030906933],"genre_scores_gemma":[0.9921475,0.00635041,0.00009174197,0.00025321502,0.000030380177,0.00085686654,0.000057243833,0.00012010585,0.00009254758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952926,0.0010544824,0.0007029525,0.0012839884,0.00083745643,0.00082851463],"domain_scores_gemma":[0.9949953,0.003658199,0.00017563447,0.0002727089,0.00029638983,0.0006017482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015297633,0.0007161971,0.00096823927,0.0005806856,0.00080910104,0.00022628735,0.00010172997,0.00021498537,0.0000716485],"category_scores_gemma":[0.0010463293,0.00046796494,0.00018737011,0.0007978364,0.00028476046,0.0003208514,0.00031544315,0.000872015,0.000012018632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021993984,0.0039954316,0.77541244,0.0024932537,0.0027839977,0.000020082329,0.17997456,0.00006936494,0.0022889683,0.000020747199,0.00022776016,0.030513978],"study_design_scores_gemma":[0.008911684,0.0053617693,0.8564129,0.016923595,0.00027557882,0.000005082278,0.09384638,0.01762077,0.0001192336,0.0000106771095,0.0000072967937,0.0005050647],"about_ca_topic_score_codex":0.0012041718,"about_ca_topic_score_gemma":0.0021008574,"teacher_disagreement_score":0.086128175,"about_ca_system_score_codex":0.00022485737,"about_ca_system_score_gemma":0.0001847014,"threshold_uncertainty_score":0.9997772},"labels":[],"label_agreement":null},{"id":"W4396827426","doi":"10.1016/j.msard.2024.105675","title":"Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Arthritis Society; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Bristol-Myers Squibb; Celgene; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Cognition; Quality of life (healthcare); Cognitive impairment; Association (psychology); Gerontology; Health Utilities Index; Clinical psychology; Health related quality of life; Psychiatry; Disease; Psychology; Pathology","score_opus":0.051828196535997934,"score_gpt":0.2894996284383571,"score_spread":0.23767143190235915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235076,0.004612804,0.000021512662,0.0010164983,0.000087245855,0.0015531628,0.00011372343,0.00007077004,0.00017354416],"genre_scores_gemma":[0.98927224,0.010182755,0.00018649266,0.000038082617,0.000009706201,0.00014573333,0.000050873157,0.00004228366,0.000071816365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967964,0.00023359185,0.0011269882,0.00060589163,0.00079395593,0.00044315666],"domain_scores_gemma":[0.997734,0.0011496856,0.0004002433,0.00021588223,0.00027061766,0.00022957192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008390327,0.0003122568,0.00081785757,0.00038908346,0.00011631244,0.000033579257,0.000054232132,0.00022330017,0.000042554555],"category_scores_gemma":[0.0016990007,0.0002381209,0.00015059065,0.0007099123,0.00037839107,0.00016325367,0.00013750645,0.00038048712,0.0000020887258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013450461,0.000919328,0.94761497,0.0006491132,0.0014526827,0.0000026099524,0.0042287707,0.0000644158,0.014869887,0.0000089676305,0.00012132633,0.02872289],"study_design_scores_gemma":[0.011072281,0.00091529416,0.9762223,0.0024643359,0.00019431104,0.000001189755,0.0041498346,0.00279336,0.0018716477,0.000018274714,0.000046787285,0.00025041067],"about_ca_topic_score_codex":0.0026268854,"about_ca_topic_score_gemma":0.001763052,"teacher_disagreement_score":0.02860731,"about_ca_system_score_codex":0.00016071195,"about_ca_system_score_gemma":0.00012498502,"threshold_uncertainty_score":0.97102886},"labels":[],"label_agreement":null},{"id":"W4397292099","doi":"10.1016/j.msard.2024.105689","title":"Allied health professionals knowledge and clinical practice in telehealth exercise behavioural change for multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Perron Institute for Neurological and Translational Science; Department of Health, Government of Western Australia; Multiple Sclerosis Australia","keywords":"Multiple sclerosis; Medicine; Telehealth; Clinical Practice; Health professionals; Physical therapy; Physical medicine and rehabilitation; Telemedicine; Health care; Psychiatry","score_opus":0.162108875601603,"score_gpt":0.4109342839831743,"score_spread":0.24882540838157127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397292099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7871049,0.16046245,0.000059232098,0.039857194,0.0013360338,0.010200263,0.0002783791,0.0004255254,0.00027603816],"genre_scores_gemma":[0.80880433,0.18669881,0.0021562758,0.00059544866,0.00012095668,0.0011358216,0.00014277347,0.00010520994,0.00024038742],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952127,0.00043199208,0.0014248026,0.0012947418,0.0005106852,0.0011251313],"domain_scores_gemma":[0.9950308,0.0033492355,0.00024097675,0.00040485561,0.0002254471,0.00074864714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027425545,0.00052631967,0.0011631442,0.0005236661,0.00059532555,0.00012054024,0.0001558552,0.00048529648,0.000030158106],"category_scores_gemma":[0.0026408785,0.00042267173,0.0003061821,0.00075786107,0.000485721,0.0005087606,0.00029980147,0.001132419,0.000022693735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001254015,0.0033421593,0.18208006,0.0017930702,0.0003936888,0.000008151712,0.0092794215,0.000002784724,0.00036357075,0.00006553947,0.007225204,0.7941923],"study_design_scores_gemma":[0.013174743,0.0010866469,0.9410325,0.0070666466,0.00024102707,0.000010830762,0.00412396,0.019218028,0.0000335786,0.000042875872,0.013431003,0.0005381508],"about_ca_topic_score_codex":0.0017420177,"about_ca_topic_score_gemma":0.0021192813,"teacher_disagreement_score":0.7936542,"about_ca_system_score_codex":0.0002066225,"about_ca_system_score_gemma":0.0003410937,"threshold_uncertainty_score":0.9998225},"labels":[],"label_agreement":null},{"id":"W4399051864","doi":"10.1016/j.msard.2024.105696","title":"Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; London Health Sciences Centre; Western University","funders":"","keywords":"Cognition; Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Psychology; Cognitive psychology; Neuroscience; Psychiatry","score_opus":0.12781204335563132,"score_gpt":0.2903082156520533,"score_spread":0.16249617229642196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399051864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984087,0.0047170306,0.00018734361,0.0025309357,0.00015715127,0.0018924815,0.0002281527,0.00023785622,0.0002081969],"genre_scores_gemma":[0.991365,0.0073391683,0.0001546039,0.000056654935,0.00007967011,0.0005860703,0.0001968785,0.00008785166,0.00013406723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969345,0.00027479476,0.00059747964,0.000996614,0.00051245,0.00068416155],"domain_scores_gemma":[0.99508005,0.004080912,0.00010030904,0.00027986974,0.00013324743,0.0003256189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070485787,0.00048822834,0.0005886117,0.0004903347,0.0010411298,0.0002706185,0.000091350885,0.00021781861,0.000018284618],"category_scores_gemma":[0.0017812907,0.00034895257,0.00011426294,0.000971852,0.0007776187,0.00074571377,0.00024500795,0.0011226595,0.00002251682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048151994,0.0001850237,0.95494,0.00033693382,0.00034878167,0.0000055780815,0.005409374,0.00004394788,0.0015309812,0.000016954336,0.00006737952,0.036633484],"study_design_scores_gemma":[0.007163945,0.00037155848,0.967826,0.002790574,0.000407833,0.000014905359,0.012895014,0.0077901883,0.00012993939,0.00006461346,0.0001233163,0.00042208255],"about_ca_topic_score_codex":0.0011819745,"about_ca_topic_score_gemma":0.004183969,"teacher_disagreement_score":0.0362114,"about_ca_system_score_codex":0.000089506335,"about_ca_system_score_gemma":0.00006731069,"threshold_uncertainty_score":0.9998962},"labels":[],"label_agreement":null},{"id":"W4399206876","doi":"10.1016/j.msard.2024.105698","title":"Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Placebo; Intensive care medicine; Phase (matter); Clinical trial; Physical therapy; Alternative medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.10588300343890747,"score_gpt":0.35221963479255064,"score_spread":0.24633663135364317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399206876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93634266,0.04016298,0.00004828929,0.016540637,0.0006213154,0.004746337,0.00025650422,0.0003589671,0.0009223276],"genre_scores_gemma":[0.93000454,0.06803417,0.00009518113,0.00023405718,0.00011042435,0.0007137894,0.00013418289,0.00008880576,0.0005848679],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956021,0.00065677415,0.0012924521,0.00095198414,0.00067116355,0.0008255337],"domain_scores_gemma":[0.99600434,0.0027644606,0.00015892855,0.0004359561,0.00008863342,0.00054765516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00271598,0.00052876543,0.0016710995,0.0007001228,0.0002707559,0.00020900028,0.00015534036,0.0002639977,0.00032217876],"category_scores_gemma":[0.004790177,0.00036711825,0.00060980825,0.0007592521,0.00036159586,0.00018441967,0.00011007603,0.0007817362,0.000018291017],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0725932,0.004170998,0.031191682,0.0015789043,0.005269944,0.00024566654,0.014358179,0.001497535,0.11773899,0.00036364442,0.007572053,0.74341923],"study_design_scores_gemma":[0.49522623,0.0015177146,0.16272847,0.005586737,0.0014129236,0.000012461549,0.004506446,0.29388675,0.000949795,0.00072055997,0.031481855,0.001970054],"about_ca_topic_score_codex":0.0007831614,"about_ca_topic_score_gemma":0.00043173894,"teacher_disagreement_score":0.7414492,"about_ca_system_score_codex":0.00015739402,"about_ca_system_score_gemma":0.00020867331,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W4399849991","doi":"10.1016/j.msard.2024.105741","title":"Weak grip strength among persons with multiple sclerosis having minimal disability is not related to agility or integrity of the corticospinal tract","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Outaouais; Royal Ottawa Mental Health Centre; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Research and Development Corporation of Newfoundland and Labrador; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Medicine; Multiple sclerosis; Corticospinal tract; Physical medicine and rehabilitation; Grip strength; Pyramidal tracts; Structural integrity; Physical therapy; Psychiatry; Diffusion MRI; Magnetic resonance imaging","score_opus":0.05279707826570282,"score_gpt":0.2902823528825687,"score_spread":0.2374852746168659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399849991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832214,0.0009317601,0.000027724705,0.0066565196,0.00036031348,0.0024720985,0.00044421197,0.00026432626,0.0005209093],"genre_scores_gemma":[0.9969415,0.0013355537,0.0005962505,0.000105019404,0.000033418615,0.00017337575,0.000032058033,0.00010362339,0.00067918637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947286,0.00035256502,0.0012287201,0.0014765182,0.0012056339,0.0010079237],"domain_scores_gemma":[0.99654514,0.0012670651,0.0002487066,0.0010521368,0.00028700108,0.0005999463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096051896,0.0007169513,0.0010686017,0.00022119928,0.00069767574,0.00017319403,0.00041220497,0.0004764335,0.00037714915],"category_scores_gemma":[0.0028619487,0.00041726642,0.00058726576,0.001716002,0.0024906653,0.00040327365,0.00045540527,0.0018677283,0.000020029931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019377089,0.0015770704,0.9259715,0.0006590248,0.0008787194,0.000006230996,0.006242161,0.000085690364,0.019058617,0.000018706605,0.0006715763,0.04289301],"study_design_scores_gemma":[0.0045047477,0.000976754,0.96412784,0.0030707829,0.0004553619,0.000012619928,0.005274468,0.018252606,0.0023434325,0.000012540636,0.000450121,0.0005187227],"about_ca_topic_score_codex":0.0037999735,"about_ca_topic_score_gemma":0.0037311027,"teacher_disagreement_score":0.042374287,"about_ca_system_score_codex":0.0003241956,"about_ca_system_score_gemma":0.00024023608,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W4399914800","doi":"10.1016/j.msard.2024.105736","title":"DigiTRAC: Qualitative insights from knowledge users to inform the development of a Digital Toolkit for enhancing resilience among multiple sclerosis caregivers","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Kingston General Hospital; Queen's University","funders":"Social Sciences and Humanities Research Council of Canada","keywords":"Multiple sclerosis; Medicine; Resilience (materials science); Qualitative research; Psychological resilience; Knowledge management; Data science; Psychology; Psychotherapist; Psychiatry; Computer science; Sociology","score_opus":0.06006168724553255,"score_gpt":0.3100294550447945,"score_spread":0.24996776779926197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399914800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966587,0.0033217592,0.0017841106,0.0008189831,0.0003312351,0.0025418997,0.00027245312,0.0001784157,0.0010852738],"genre_scores_gemma":[0.99641705,0.00083073153,0.0015622035,0.000029608409,0.00004219466,0.00048722498,0.00013273914,0.000073241004,0.00042499654],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99664843,0.00009194936,0.0010465533,0.0008702482,0.0006617985,0.0006810464],"domain_scores_gemma":[0.9953546,0.0032971466,0.00016755729,0.00044913855,0.000343553,0.0003880343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049087283,0.0004911228,0.0006919614,0.00041449923,0.0008048196,0.00027382548,0.0003253674,0.00023996393,0.000022713066],"category_scores_gemma":[0.002424574,0.00033757463,0.00032989524,0.0011537009,0.00074565643,0.0006692677,0.0003676788,0.00044648873,0.000036926547],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013066406,0.00064329925,0.031311978,0.0010164386,0.0025482227,0.0000026553969,0.6349962,0.0005142259,0.059149794,0.00014639886,0.0018224476,0.26654175],"study_design_scores_gemma":[0.010531762,0.0009340444,0.6571582,0.007757997,0.00043667865,0.0000014219837,0.26153648,0.019372169,0.02410489,0.00028532933,0.01637539,0.0015056318],"about_ca_topic_score_codex":0.00044478185,"about_ca_topic_score_gemma":0.0055453153,"teacher_disagreement_score":0.6258462,"about_ca_system_score_codex":0.00025452682,"about_ca_system_score_gemma":0.00029379083,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W4399926650","doi":"10.1016/j.msard.2024.105746","title":"Web scraping of user-simulated online nutrition information for people with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Trust; Multiple Sclerosis Australia; Multiple Sclerosis Society of Canada; Australian Government","keywords":"Multiple sclerosis; Medicine; The Internet; World Wide Web; Computer science; Immunology","score_opus":0.044057160769325796,"score_gpt":0.3289406019038564,"score_spread":0.28488344113453057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399926650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885573,0.0008777993,0.004152006,0.0012168733,0.00060362613,0.0031146181,0.0008458284,0.0003321331,0.0002998619],"genre_scores_gemma":[0.99308777,0.0024881435,0.0023571004,0.00042769182,0.000041155996,0.00026751697,0.0012296789,0.000031885964,0.00006908272],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970225,0.00018035152,0.0017427087,0.00029645435,0.00025947206,0.00049850094],"domain_scores_gemma":[0.99767685,0.0009953346,0.00048315825,0.00026908825,0.00039989335,0.00017567717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086915976,0.0002532245,0.0004235419,0.00037481225,0.00084580685,0.00006901468,0.00013045018,0.00040004193,0.00013758316],"category_scores_gemma":[0.00045626666,0.00019516985,0.00012019989,0.00084468233,0.00010240374,0.002355146,0.000062723964,0.0005540979,0.000032877022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036591676,0.0016947495,0.6279944,0.03221724,0.00062237994,3.4333792e-7,0.05746489,0.0059756152,0.004295361,0.0017724854,0.009803305,0.25450006],"study_design_scores_gemma":[0.011289939,0.00032617914,0.28934294,0.005956452,0.00008894118,6.811669e-7,0.008137722,0.63862336,0.0000886042,0.00020145602,0.045514494,0.00042925111],"about_ca_topic_score_codex":0.0005922897,"about_ca_topic_score_gemma":0.00077318243,"teacher_disagreement_score":0.63264775,"about_ca_system_score_codex":0.0000968792,"about_ca_system_score_gemma":0.00022069644,"threshold_uncertainty_score":0.79587954},"labels":[],"label_agreement":null},{"id":"W4400156306","doi":"10.1016/j.msard.2024.105749","title":"Impact of sex on clinical outcome in early Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chugai Pharmaceutical; Berlin Institute of Health; Stiftung Charité; Sanofi; Bayer HealthCare; European Commission; British Society for Immunology; Alexion Pharmaceuticals; Novartis Pharma; Novartis; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Bayer; Biogen; Arthur Arnstein Stiftung; Guthy-Jackson Charitable Foundation","keywords":"Multiple sclerosis; Medicine; Stage (stratigraphy); Pediatrics; Internal medicine; Immunology","score_opus":0.11221178175556924,"score_gpt":0.36798536385621233,"score_spread":0.2557735821006431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400156306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930639,0.0028757106,0.0000158012,0.0007806799,0.00038859938,0.001237376,0.00011519549,0.00020685703,0.001315874],"genre_scores_gemma":[0.98599243,0.013131994,0.0001937541,0.00005546578,0.000067636756,0.000089764595,0.000036668323,0.000101803955,0.00033046634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558264,0.00028105357,0.001564174,0.0010336946,0.00070094987,0.00083746057],"domain_scores_gemma":[0.99695426,0.00173146,0.00015956852,0.0006112973,0.00010949123,0.00043393805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011777654,0.00052988017,0.0011956425,0.0007586824,0.00016453037,0.00008821802,0.00021279295,0.00049722975,0.00015041564],"category_scores_gemma":[0.0017895258,0.00038791573,0.0008879557,0.0010845262,0.000673725,0.00021233739,0.00021681204,0.0012724004,0.00009909425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006185482,0.0009906113,0.8931718,0.0001900277,0.00072270125,0.000011789926,0.0011970764,0.00023205133,0.0053814393,0.000017648632,0.0005108521,0.09695544],"study_design_scores_gemma":[0.008096768,0.0018240514,0.9733296,0.001417516,0.000100986246,0.0000029066757,0.00035838413,0.014056322,0.00015624959,0.000035631358,0.00024910353,0.00037248633],"about_ca_topic_score_codex":0.0022048384,"about_ca_topic_score_gemma":0.00028878765,"teacher_disagreement_score":0.09658295,"about_ca_system_score_codex":0.00019633354,"about_ca_system_score_gemma":0.00012615543,"threshold_uncertainty_score":0.99985725},"labels":[],"label_agreement":null},{"id":"W4400324635","doi":"10.1016/j.msard.2024.105758","title":"Depression and anxiety in MS: symptoms or comorbidity?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Comorbidity; Depression (economics); Anxiety; Multiple sclerosis; Psychiatry; Clinical psychology","score_opus":0.023569432671295663,"score_gpt":0.28552906913611664,"score_spread":0.26195963646482096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400324635","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28516904,0.09869748,0.000009591336,0.0027242152,0.60114926,0.0055791545,0.0010675323,0.00083332264,0.004770383],"genre_scores_gemma":[0.3753441,0.55610085,0.00019895486,0.000060034017,0.06359337,0.0004406056,0.0007602224,0.00029555205,0.0032062975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957116,0.00017418418,0.00080599455,0.0014341437,0.0010676609,0.0008064211],"domain_scores_gemma":[0.9975106,0.0012496588,0.00016489504,0.00052816304,0.00014732598,0.00039934495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006179235,0.0007385197,0.0012116649,0.0005853102,0.00028476777,0.00017114685,0.00019338052,0.001704797,0.00013496254],"category_scores_gemma":[0.0026216838,0.0005150864,0.00022158887,0.0006516567,0.0006090545,0.00016243756,0.0006666718,0.002653796,0.000039845345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011852307,0.00044290043,0.042568706,0.0020332008,0.00074829406,0.000042363088,0.0013493297,0.000011974025,0.0008574937,0.000003220298,0.8316963,0.11906102],"study_design_scores_gemma":[0.014039394,0.0005733138,0.124862544,0.0088961655,0.00050697825,0.000010516084,0.0006403182,0.004922141,0.000053731666,0.00007912202,0.8443563,0.0010595049],"about_ca_topic_score_codex":0.0015988698,"about_ca_topic_score_gemma":0.0022499617,"teacher_disagreement_score":0.53755593,"about_ca_system_score_codex":0.00018925381,"about_ca_system_score_gemma":0.00022927475,"threshold_uncertainty_score":0.99973005},"labels":[],"label_agreement":null},{"id":"W4400686863","doi":"10.1016/j.msard.2024.105761","title":"An analytical review on the use of artificial intelligence and machine learning in diagnosis, prediction, and risk factor analysis of multiple sclerosis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Multiple sclerosis; Artificial intelligence; Machine learning; Risk factor; Computer science; Pathology; Immunology","score_opus":0.21523875060423991,"score_gpt":0.3527226711326643,"score_spread":0.1374839205284244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400686863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027949102,0.96773577,0.00003498965,0.00030560762,0.000069399095,0.0023059556,0.0015333543,0.00005855881,0.000007281949],"genre_scores_gemma":[0.13044518,0.8688801,0.00009100279,0.000023938808,0.000017480663,0.0002462991,0.00021074025,0.00007056424,0.000014705751],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99463254,0.0010359308,0.002009706,0.0011492615,0.00068311766,0.00048943097],"domain_scores_gemma":[0.9943271,0.0038457343,0.00068630197,0.00066954276,0.0001731794,0.0002980924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012156131,0.00073815126,0.0033646934,0.0013739176,0.00026624976,0.000092625516,0.0002073244,0.00048456,0.00009810815],"category_scores_gemma":[0.0056739445,0.00044626204,0.00074024615,0.003022116,0.0009977706,0.00015953001,0.00029071013,0.0017148639,0.000003465285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008674384,0.0004974468,0.10538124,0.012312197,0.0046726787,0.0000018238594,0.00047363996,0.00025935724,0.000010442395,0.0000246877,0.000069207315,0.8762105],"study_design_scores_gemma":[0.0014717162,0.0018171127,0.38681182,0.18961501,0.05148959,0.000006136843,0.0007091236,0.3284702,0.000018993385,0.000028686576,0.038243398,0.0013181913],"about_ca_topic_score_codex":0.0014886756,"about_ca_topic_score_gemma":0.0013766356,"teacher_disagreement_score":0.87489235,"about_ca_system_score_codex":0.00008489817,"about_ca_system_score_gemma":0.00008218435,"threshold_uncertainty_score":0.9997989},"labels":[],"label_agreement":null},{"id":"W4400735818","doi":"10.1016/j.msard.2024.105759","title":"A preliminary investigation of sex differences in cognitive and fMRI changes following 28 days of cannabis abstinence","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"EGIDE; Multiple Sclerosis Society; University of Cambridge; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; Johns Hopkins University","keywords":"Abstinence; Cannabis; Medicine; Effects of cannabis; Multiple sclerosis; Cognition; Clinical psychology; Psychiatry; Cannabidiol","score_opus":0.03241972114625091,"score_gpt":0.26504211280508844,"score_spread":0.23262239165883752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400735818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304826,0.011423448,0.0000069467415,0.0047461344,0.0000723849,0.00045955234,0.000024957197,0.000022783415,0.00019552885],"genre_scores_gemma":[0.9958195,0.0034606925,0.00002587328,0.000024346935,0.000008837559,0.000057330766,0.000020687705,0.000015926735,0.0005668039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989485,0.00004948312,0.0002777479,0.0003012526,0.00022871068,0.000194288],"domain_scores_gemma":[0.9996366,0.000071236725,0.000055858272,0.00008467392,0.000049984355,0.00010167802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025437912,0.00013568436,0.00030944886,0.00027694248,0.00005074786,0.000018487664,0.000039911014,0.00012958847,0.000020229603],"category_scores_gemma":[0.00018271367,0.00010700035,0.00006365702,0.0004357802,0.00034027055,0.00007447037,0.00005907225,0.00021591736,3.9437467e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036501477,0.00017575524,0.79277927,0.0016297665,0.00026930965,0.000019289611,0.021218797,0.000010202095,0.06174474,0.000044902714,0.00077457586,0.12096838],"study_design_scores_gemma":[0.0019322654,0.0006987654,0.97576094,0.0028468508,0.00011080759,0.000005550145,0.0054931226,0.008054085,0.004730716,0.00015474382,0.0000666865,0.0001454935],"about_ca_topic_score_codex":0.001309331,"about_ca_topic_score_gemma":0.00032515684,"teacher_disagreement_score":0.18298164,"about_ca_system_score_codex":0.00001672952,"about_ca_system_score_gemma":0.0000763532,"threshold_uncertainty_score":0.43633476},"labels":[],"label_agreement":null},{"id":"W4400766065","doi":"10.1016/j.msard.2024.105772","title":"Cross-prevalence of multiple sclerosis and stroke evaluated on cohorts of four independent specialty medical centers","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Multiple sclerosis; Specialty; Stroke (engine); Physical therapy; Physical medicine and rehabilitation; Family medicine; Immunology","score_opus":0.053556102475798936,"score_gpt":0.3081797112060037,"score_spread":0.25462360873020473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400766065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886497,0.0071530733,0.00003742693,0.00097312155,0.00048266223,0.0014363183,0.00036533998,0.00013415703,0.0007681644],"genre_scores_gemma":[0.9498476,0.04929662,0.00013764155,0.000058054862,0.000059152877,0.00007311771,0.000036525595,0.00007406567,0.00041724538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476737,0.00024972355,0.0011817906,0.001047247,0.0020497579,0.0007040932],"domain_scores_gemma":[0.99720657,0.0011365277,0.00024281711,0.0005423583,0.00029613025,0.0005756243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001385996,0.00050439866,0.000992023,0.0005367834,0.0002589056,0.00007745909,0.00026023918,0.00049638806,0.00065955194],"category_scores_gemma":[0.0027108798,0.00040136836,0.00034619667,0.0005894007,0.0014929068,0.0002041361,0.00039748626,0.00087684917,0.000015956464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017223374,0.0008728131,0.85327697,0.0026173403,0.0013089458,0.000021876192,0.0013877853,0.00027206162,0.053411387,0.00004670435,0.00054999633,0.08451176],"study_design_scores_gemma":[0.009811475,0.0007419778,0.9495488,0.004629745,0.0002734403,0.000012272163,0.00038487656,0.029579043,0.0044282773,0.000021938875,0.00022308182,0.00034510583],"about_ca_topic_score_codex":0.0006606328,"about_ca_topic_score_gemma":0.0003052817,"teacher_disagreement_score":0.09627177,"about_ca_system_score_codex":0.000118171105,"about_ca_system_score_gemma":0.00018610073,"threshold_uncertainty_score":0.99984384},"labels":[],"label_agreement":null},{"id":"W4401261205","doi":"10.1016/j.msard.2024.105794","title":"Mr. Machiavelli's Choice for Treatment of MOG Antibody Disease: Do the benefits of long-term corticosteroids justify the means?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Term (time); Multiple sclerosis; Intensive care medicine; Disease; Immunology; Dermatology; Pathology","score_opus":0.022044323290798095,"score_gpt":0.276277553475545,"score_spread":0.2542332301847469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401261205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50016487,0.19796233,0.000033328903,0.00323173,0.29008085,0.005044596,0.003118596,0.00012398475,0.00023972586],"genre_scores_gemma":[0.79147446,0.17832245,0.000022504388,0.000070269365,0.026575275,0.00030669573,0.0014881134,0.00021927606,0.0015209327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735284,0.00009510229,0.00081665744,0.00068921194,0.00061311555,0.0004330972],"domain_scores_gemma":[0.99733675,0.0011412958,0.00040657952,0.00073485036,0.00019353774,0.0001869928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016685254,0.0005828992,0.00089778216,0.00011849667,0.0002795336,0.000071340124,0.00026822655,0.0005289111,0.00003847198],"category_scores_gemma":[0.00044015792,0.00030573967,0.00059319416,0.00030327376,0.00058110734,0.00005488578,0.00010102964,0.00039862425,0.0000031538448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010386074,0.0067058336,0.07559211,0.013375334,0.0079326,0.00003453346,0.0065936972,0.0028913077,0.0064596916,0.0002609699,0.4849905,0.38477737],"study_design_scores_gemma":[0.03533587,0.008150552,0.33588627,0.008888637,0.017372472,0.0000085643815,0.0014416599,0.008177729,0.0003133649,0.0001839834,0.58233124,0.0019096769],"about_ca_topic_score_codex":0.0003803827,"about_ca_topic_score_gemma":0.000384974,"teacher_disagreement_score":0.38286766,"about_ca_system_score_codex":0.00005280937,"about_ca_system_score_gemma":0.00015866096,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W4401284098","doi":"10.1016/j.msard.2024.105799","title":"Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stillwater Medical Foundation; Providence Health Care","keywords":"Melatonin; Medicine; Multiple sclerosis; Urine; Quality of life (healthcare); Internal medicine; Physiology; Endocrinology; Immunology","score_opus":0.06940536701506027,"score_gpt":0.2887385039214035,"score_spread":0.2193331369063432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401284098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945434,0.0037351197,0.000056892764,0.00044214612,0.00010213004,0.00059211033,0.0002845143,0.000059102847,0.00018463733],"genre_scores_gemma":[0.99517024,0.0044660396,0.00019492392,0.000030229867,0.000006305579,0.000026761969,0.000020065523,0.000041443494,0.00004397556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978119,0.0002464565,0.0006152657,0.000627043,0.00032246823,0.0003768596],"domain_scores_gemma":[0.9987473,0.00064592453,0.00018372166,0.00018826404,0.000031676198,0.00020312831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000387553,0.00029979504,0.00044537528,0.00033643865,0.00023072422,0.00009556566,0.00007233841,0.00017301449,0.00004460818],"category_scores_gemma":[0.00035792784,0.00024214374,0.00010844102,0.0006435529,0.00050476607,0.0003680821,0.00004677141,0.000345466,0.0000017229742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041118526,0.00024929564,0.79591787,0.00013448979,0.00013049324,0.0000027836609,0.007448134,0.0019795818,0.18081439,0.0038761175,0.00003660397,0.008999057],"study_design_scores_gemma":[0.006751219,0.0005001364,0.9408432,0.00091725105,0.00008013825,0.000008128451,0.00178815,0.015888859,0.03271092,0.00006136636,0.00005679697,0.00039383027],"about_ca_topic_score_codex":0.0014243522,"about_ca_topic_score_gemma":0.0010588795,"teacher_disagreement_score":0.14810346,"about_ca_system_score_codex":0.0000611237,"about_ca_system_score_gemma":0.00010685284,"threshold_uncertainty_score":0.9874335},"labels":[],"label_agreement":null},{"id":"W4401344157","doi":"10.1016/j.msard.2024.105802","title":"Clinical characteristics and disease burden of African, Caribbean, and Black people with multiple sclerosis in Toronto, Canada","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"St. Michael's Hospital Foundation","keywords":"Multiple sclerosis; Medicine; Ethnic group; Disease; Caribbean region; Caribbean island; Gerontology; Immunology; Internal medicine; Latin Americans; Anthropology","score_opus":0.027578733667065702,"score_gpt":0.26870655399230087,"score_spread":0.24112782032523516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401344157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826549,0.0112684565,0.000015032174,0.0041154344,0.0001673095,0.0010919246,0.0003174089,0.00006453757,0.00030499458],"genre_scores_gemma":[0.9550594,0.044305485,0.00019876834,0.00006211442,0.000054150274,0.00007419071,0.00006625809,0.00006400339,0.0001156051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970505,0.00015319158,0.00083235605,0.0008545254,0.00053220574,0.00057719165],"domain_scores_gemma":[0.9976794,0.00092617073,0.00013370921,0.0003611064,0.00013136472,0.00076824497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045884764,0.000408397,0.00089819694,0.00014642293,0.0001693513,0.000078664954,0.00010750269,0.00019274796,0.000058947873],"category_scores_gemma":[0.001165736,0.00031408406,0.00010136117,0.00040041248,0.00082031585,0.0001958939,0.00023660774,0.00050750846,0.0000014268493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085107115,0.00022782835,0.94988924,0.00089322805,0.00044780402,0.00002338111,0.0024813556,0.00003601711,0.0010797526,0.000031402156,0.0008308906,0.043208044],"study_design_scores_gemma":[0.004754601,0.000295859,0.9528236,0.0014197769,0.00022797684,0.0000034541383,0.0042507355,0.034292314,0.00001588173,0.000010695507,0.0015561606,0.00034893988],"about_ca_topic_score_codex":0.4288915,"about_ca_topic_score_gemma":0.63448924,"teacher_disagreement_score":0.20559774,"about_ca_system_score_codex":0.00021247099,"about_ca_system_score_gemma":0.0004310366,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W4401432774","doi":"10.1016/j.msard.2024.105804","title":"The association between vitamin D deficiency and multiple sclerosis: an updated systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Queensland; Cancer Australia","keywords":"Medicine; Multiple sclerosis; Meta-analysis; vitamin D deficiency; Vitamin D and neurology; Systematic review; Internal medicine; Vitamin; MEDLINE; Immunology; Biochemistry","score_opus":0.09829691247237747,"score_gpt":0.32712717454418394,"score_spread":0.22883026207180646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401432774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021553155,0.99273485,0.0000043116793,0.0011366601,0.000059875674,0.005256217,0.0003829379,0.00013714799,0.00007244861],"genre_scores_gemma":[0.012917535,0.98439676,0.000038503167,0.000070708746,0.000018226741,0.0006990395,0.0004978135,0.00010454611,0.0012568872],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99413717,0.0012390753,0.0018277222,0.0012269992,0.00084462424,0.00072440226],"domain_scores_gemma":[0.9960479,0.001623606,0.000881053,0.0008495298,0.00022577183,0.00037214512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031130854,0.0009258807,0.0073908176,0.0005503778,0.00093242124,0.00037374886,0.00028623582,0.0006500444,0.000024989964],"category_scores_gemma":[0.0019772637,0.00046938699,0.0017146855,0.0021428806,0.000399447,0.00018176851,0.00040221534,0.0011229857,0.000030324602],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054682314,0.00017352749,0.0010377974,0.62872916,0.3464668,0.0000044016474,0.00042811254,0.0000010473241,0.000002253915,0.00001793071,0.0012733298,0.021860164],"study_design_scores_gemma":[0.00066966534,0.00014928498,0.002075706,0.037115492,0.9527546,0.000007324446,0.00035857808,0.00017430604,2.1003378e-7,0.000014685253,0.006132798,0.00054731756],"about_ca_topic_score_codex":0.00015644707,"about_ca_topic_score_gemma":0.00023901183,"teacher_disagreement_score":0.60628784,"about_ca_system_score_codex":0.00019901215,"about_ca_system_score_gemma":0.00008675508,"threshold_uncertainty_score":0.99977577},"labels":[],"label_agreement":null},{"id":"W4401445542","doi":"10.1016/j.msard.2024.105798","title":"Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Effects of Vibration on Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology","score_opus":0.07077334335299279,"score_gpt":0.32056169809344953,"score_spread":0.24978835474045674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401445542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996298,0.0009345056,0.00009865489,0.0011831484,0.000050783176,0.0011320628,0.00012759965,0.00016293561,0.000012319744],"genre_scores_gemma":[0.998481,0.0006674357,0.00018960059,0.00002735451,0.00003876335,0.000065487504,0.00047044427,0.00005255084,0.000007410888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984465,0.00014966485,0.0003186776,0.0005217028,0.0002461535,0.00031729724],"domain_scores_gemma":[0.9989602,0.00042989463,0.00010721612,0.00015647385,0.00005347415,0.0002927342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017008357,0.0002788627,0.0004413258,0.00024401932,0.00023578723,0.00018390994,0.000038364553,0.00017953439,0.00000714988],"category_scores_gemma":[0.00016617945,0.00020278679,0.00005992672,0.00047539538,0.00014525226,0.0010313032,0.000035136447,0.00042444558,0.000001411872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006961709,0.00025699343,0.97727793,0.000072178635,0.00007886923,0.0000023909536,0.0080304565,0.00014315608,0.0022498136,0.000012664502,0.000016676511,0.011789243],"study_design_scores_gemma":[0.002873333,0.0011622744,0.9659635,0.00050812715,0.00013894874,0.000002555555,0.0011695884,0.027650287,0.00025025374,0.000052840674,0.0000024730239,0.000225852],"about_ca_topic_score_codex":0.0012535193,"about_ca_topic_score_gemma":0.0010471785,"teacher_disagreement_score":0.027507132,"about_ca_system_score_codex":0.00008142014,"about_ca_system_score_gemma":0.0000761088,"threshold_uncertainty_score":0.82694054},"labels":[],"label_agreement":null},{"id":"W4401494334","doi":"10.1016/j.msard.2024.105815","title":"Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Vysoká Škola Bánská - Technická Univerzita Ostrava; Ministerstvo Zdravotnictví Ceské Republiky; Department of Clinical Neurosciences, University of Calgary; U.S. Embassy in The Czech Republic","keywords":"Multiple sclerosis; Medicine; Gold standard (test); Immunoglobulin light chain; Internal medicine; Immunology","score_opus":0.09904735862879491,"score_gpt":0.30376459555054264,"score_spread":0.20471723692174773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401494334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462228,0.040385026,0.00016283235,0.00922015,0.00033779262,0.0029687386,0.000092684575,0.00039816683,0.00021184768],"genre_scores_gemma":[0.9790969,0.019653566,0.0006492339,0.000031599506,0.000019108104,0.00041003895,0.000019292727,0.00007028942,0.000049972892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674124,0.00009689745,0.00090400374,0.00087658735,0.000681025,0.00070023874],"domain_scores_gemma":[0.9985912,0.0005421849,0.0001404737,0.00039318434,0.00017375097,0.00015920801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082766573,0.0004397957,0.0009179174,0.00064241706,0.00026229597,0.000082157596,0.00016422235,0.0003386554,0.000013939702],"category_scores_gemma":[0.0014602363,0.00035593368,0.0002088647,0.00072391774,0.00049718027,0.0001500951,0.0002876794,0.0005531855,0.0000044270823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006449962,0.0010797118,0.37509915,0.0019925695,0.00067097077,0.00000416843,0.0038315384,0.00028602357,0.29843056,0.00011956138,0.0013672883,0.31647345],"study_design_scores_gemma":[0.012003843,0.0014327646,0.8115035,0.004617171,0.00026788746,0.0000034197508,0.009003518,0.1158191,0.0392688,0.000186033,0.0052074525,0.0006864606],"about_ca_topic_score_codex":0.00022797025,"about_ca_topic_score_gemma":0.00067293184,"teacher_disagreement_score":0.4364044,"about_ca_system_score_codex":0.00016037305,"about_ca_system_score_gemma":0.00006998524,"threshold_uncertainty_score":0.99988925},"labels":[],"label_agreement":null},{"id":"W4401537539","doi":"10.1016/j.msard.2024.105806","title":"Psychometric properties of the modified reaching performance scale in persons with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universiteit Hasselt","keywords":"Multiple sclerosis; Physical medicine and rehabilitation; Scale (ratio); Medicine; Psychometrics; Stroke (engine); Physical therapy; Clinical psychology; Psychiatry; Cartography","score_opus":0.049952284528896454,"score_gpt":0.2662689274115954,"score_spread":0.21631664288269897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401537539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117297,0.0050345818,0.000047682297,0.00064492336,0.000531591,0.0010055976,0.00002380564,0.0001118066,0.0014270516],"genre_scores_gemma":[0.99420923,0.0047792005,0.00007992992,0.00006252685,0.000025399231,0.00016983128,0.000009732819,0.000045085813,0.000619034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980462,0.00025753333,0.00054312724,0.0004302246,0.00026628983,0.0004565895],"domain_scores_gemma":[0.99926573,0.00014706216,0.00015765807,0.0003095323,0.000044789642,0.000075252734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056690467,0.0002293315,0.00031054253,0.0003218219,0.00068699976,0.00002844875,0.00019669389,0.00027377953,0.000008102298],"category_scores_gemma":[0.000089713365,0.00013646795,0.000114539296,0.0014418184,0.00022988656,0.00027672687,0.00009479621,0.0008925119,0.000013845055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034739464,0.0006829777,0.8561768,0.0014890847,0.0001550771,1.9623681e-7,0.025195811,0.00048117372,0.06654535,0.00006759344,0.0003398907,0.048518647],"study_design_scores_gemma":[0.0029354747,0.00007893467,0.92947805,0.0052831606,0.000050924795,7.521185e-7,0.0041949796,0.05747703,0.00007046535,0.00002918055,0.00018226562,0.00021879777],"about_ca_topic_score_codex":0.0014290273,"about_ca_topic_score_gemma":0.0015515031,"teacher_disagreement_score":0.073301226,"about_ca_system_score_codex":0.000079460835,"about_ca_system_score_gemma":0.000075763055,"threshold_uncertainty_score":0.55650014},"labels":[],"label_agreement":null},{"id":"W4401799250","doi":"10.1016/j.msard.2024.105838","title":"Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche España","keywords":"Multiple sclerosis; Medicine; Immunoglobulin light chain; Immunology; Neuroscience; Antibody","score_opus":0.06777445580225774,"score_gpt":0.2766102397854492,"score_spread":0.20883578398319144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401799250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645995,0.016696686,0.00009916042,0.014309496,0.0008553124,0.002428075,0.000054820735,0.00043495063,0.00052201306],"genre_scores_gemma":[0.957349,0.041269623,0.00020354457,0.0003606437,0.000056869074,0.00038880354,0.000017312874,0.00011373083,0.00024045834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948171,0.00028491844,0.0010233725,0.0013280738,0.0014256467,0.0011209046],"domain_scores_gemma":[0.9977267,0.0007648924,0.0001119095,0.0007033976,0.00022458332,0.0004685422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012256405,0.00064669026,0.00077755615,0.00075800973,0.0005119389,0.00025319445,0.00029096814,0.00034430387,0.00011539372],"category_scores_gemma":[0.0015602747,0.0004020806,0.00033188623,0.0013217103,0.00042234207,0.00035932515,0.00034927676,0.001051286,0.00010671516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058128283,0.0013410876,0.33977407,0.00044176992,0.00095331995,0.00004862253,0.004897773,0.0011316584,0.28586838,0.0001231728,0.0008149271,0.36402395],"study_design_scores_gemma":[0.006104453,0.0003392099,0.9537142,0.003909115,0.00014698121,0.0000057941916,0.0013014636,0.022626545,0.003445366,0.00021217692,0.007592737,0.0006019879],"about_ca_topic_score_codex":0.00056170556,"about_ca_topic_score_gemma":0.0017772,"teacher_disagreement_score":0.6139401,"about_ca_system_score_codex":0.00037213252,"about_ca_system_score_gemma":0.0001661151,"threshold_uncertainty_score":0.9998431},"labels":[],"label_agreement":null},{"id":"W4401827972","doi":"10.1016/j.msard.2024.105833","title":"Head and neck cooling enhance exercise tolerance in individuals with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Head and neck; Physical medicine and rehabilitation; Core (optical fiber); Core temperature; Physical therapy; Internal medicine; Surgery; Psychiatry","score_opus":0.03095472140387017,"score_gpt":0.278468067140693,"score_spread":0.24751334573682282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401827972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589096,0.036739916,0.000059001388,0.0016813263,0.00018342232,0.0016337205,0.000067816225,0.00028021645,0.0004450376],"genre_scores_gemma":[0.9289644,0.06862596,0.0015237522,0.00010532856,0.00004353447,0.00032004179,0.000041658124,0.00010453347,0.0002708123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963747,0.00010204102,0.0007055618,0.0012281989,0.00064582186,0.00094362604],"domain_scores_gemma":[0.9984012,0.0005560416,0.0001009977,0.0004336146,0.00010330177,0.00040480937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005204407,0.00056938163,0.0008868685,0.0005390041,0.00039150787,0.00023852693,0.0001578364,0.00032258691,0.00006394139],"category_scores_gemma":[0.00038376515,0.00044422096,0.00013744697,0.001182163,0.0006484688,0.00042952204,0.00022900308,0.00090808043,0.000032017306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008620246,0.0005654368,0.76683867,0.0010351173,0.00043163178,0.000027760927,0.0056247064,0.0007602218,0.015590727,0.000026055903,0.00059340335,0.20764422],"study_design_scores_gemma":[0.008669796,0.00039414706,0.944348,0.010403621,0.00014217522,0.00001366649,0.0011453631,0.030969433,0.0014714221,0.00003723589,0.0017845882,0.0006205913],"about_ca_topic_score_codex":0.0010231221,"about_ca_topic_score_gemma":0.001280221,"teacher_disagreement_score":0.20702364,"about_ca_system_score_codex":0.00010258297,"about_ca_system_score_gemma":0.000094558665,"threshold_uncertainty_score":0.999801},"labels":[],"label_agreement":null},{"id":"W4401946086","doi":"10.1016/j.msard.2024.105853","title":"The risks and benefits of using AI for diagnosis: beware of unconscious bias","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Unconscious mind; Multiple sclerosis; Psychiatry; Psychoanalysis; Psychology","score_opus":0.19861925603613798,"score_gpt":0.38231120890751324,"score_spread":0.18369195287137527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401946086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5745747,0.08817636,0.000017240156,0.0022394133,0.3329094,0.0015450865,0.00047589504,0.000036415324,0.000025482717],"genre_scores_gemma":[0.86940473,0.10211718,0.00009632296,0.000026387406,0.027886968,0.00014595735,0.0001664239,0.00006471468,0.00009132514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984305,0.00004476274,0.00069988426,0.0003339517,0.00026033228,0.00023056143],"domain_scores_gemma":[0.99649525,0.0025174087,0.00029311175,0.00021362033,0.00038716468,0.00009343471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004299066,0.0002068533,0.00044377652,0.0001347937,0.0002563524,0.000033709035,0.0000717602,0.0007216529,0.00000500578],"category_scores_gemma":[0.0021153747,0.00014246468,0.00014917452,0.00020773924,0.00032878178,0.00004123821,0.00004529484,0.0004700543,9.067172e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068306737,0.00036816465,0.0680803,0.004446602,0.0008714734,5.554622e-7,0.007136219,0.0006843102,0.000112352725,0.00007326082,0.41956624,0.49797744],"study_design_scores_gemma":[0.0049468004,0.0055535045,0.022496792,0.04990729,0.010210216,0.000012456645,0.04132187,0.03770917,0.0102266185,0.014475154,0.8004813,0.0026588081],"about_ca_topic_score_codex":0.004515214,"about_ca_topic_score_gemma":0.001617574,"teacher_disagreement_score":0.49531865,"about_ca_system_score_codex":0.000039960767,"about_ca_system_score_gemma":0.0002773287,"threshold_uncertainty_score":0.6825683},"labels":[],"label_agreement":null},{"id":"W4402022965","doi":"10.1016/j.msard.2024.105854","title":"Physiological fitness in people with advanced multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Royal Ottawa Mental Health Centre","funders":"","keywords":"Cardiorespiratory fitness; Multiple sclerosis; Medicine; Quality of life (healthcare); Expanded Disability Status Scale; Psychological intervention; Gerontology; Physical therapy; Physical medicine and rehabilitation; Psychiatry","score_opus":0.03983157544512982,"score_gpt":0.2699278608351425,"score_spread":0.23009628539001264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402022965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862853,0.0080074845,0.00007137514,0.0024749886,0.000244239,0.0014938344,0.000051358533,0.00042519698,0.00094618194],"genre_scores_gemma":[0.9749361,0.023300748,0.00070766854,0.00010851969,0.00004750037,0.00041475502,0.00008842168,0.00009750411,0.0002987637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965077,0.00014343555,0.0006111323,0.0011838838,0.0006014761,0.00095234177],"domain_scores_gemma":[0.99837255,0.00062578585,0.00007840468,0.00046345068,0.00010748293,0.00035233106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000363477,0.0005464025,0.0008529959,0.0004464869,0.0003211779,0.00012545574,0.00018570549,0.0003325276,0.00018844407],"category_scores_gemma":[0.0005669714,0.00037732846,0.0002277537,0.0014695422,0.000565765,0.00033253146,0.00022953816,0.0009188132,0.00006979537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021266765,0.0016945394,0.5270995,0.0011142894,0.0009188888,0.000063250016,0.0046616853,0.002893596,0.14206867,0.00013064899,0.0015693761,0.31565887],"study_design_scores_gemma":[0.0088038845,0.00070390076,0.9513184,0.0021778,0.0000913313,0.0000120374,0.0015875509,0.032755654,0.00066284044,0.00005256505,0.0012864254,0.0005476288],"about_ca_topic_score_codex":0.0005824025,"about_ca_topic_score_gemma":0.0016779306,"teacher_disagreement_score":0.4242189,"about_ca_system_score_codex":0.00016056234,"about_ca_system_score_gemma":0.000099802826,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W4402127373","doi":"10.1016/j.msard.2024.105865","title":"Social network characteristics and their relationships with physical activity in children with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Epilepsy Society; National Institutes of Health; Ontario Institute for Regenerative Medicine; Multiple Sclerosis Society of Canada; Hospital for Sick Children; Multiple Sclerosis Society; Biogen; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Physical activity; Social network (sociolinguistics); Developmental psychology; Physical medicine and rehabilitation; Psychiatry; Psychology; World Wide Web","score_opus":0.04408072786230595,"score_gpt":0.26040377454005886,"score_spread":0.21632304667775293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402127373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949062,0.0012379115,0.00011093113,0.0019268859,0.000050590712,0.0012894751,0.00006866828,0.00021862352,0.00019072798],"genre_scores_gemma":[0.99558264,0.0036071513,0.00021056882,0.000030432926,0.00015632174,0.00017153396,0.000080688274,0.000097784454,0.00006290018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975498,0.0002091143,0.00030374748,0.0008422189,0.00038353322,0.00071158743],"domain_scores_gemma":[0.9986805,0.0006412761,0.000098876306,0.0002601149,0.00007560126,0.00024366788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038559895,0.00049315754,0.00070925057,0.00023491506,0.00071313634,0.00016754707,0.00009494009,0.00025424338,0.000009081173],"category_scores_gemma":[0.00019578535,0.0003213154,0.00011619943,0.0009222471,0.00076158036,0.00029425204,0.00014983515,0.0012415007,0.000008415383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067770353,0.00046329154,0.9224963,0.000111270514,0.00070710655,0.000003452554,0.0028419117,0.00010386036,0.0022993444,0.000057154528,0.00017824546,0.07006032],"study_design_scores_gemma":[0.00465859,0.00033338898,0.96618426,0.0009480042,0.00014954584,0.000014058254,0.0005540711,0.026454892,0.00009995762,0.00005106685,0.0001421034,0.00041009203],"about_ca_topic_score_codex":0.0003216806,"about_ca_topic_score_gemma":0.0008135599,"teacher_disagreement_score":0.069650225,"about_ca_system_score_codex":0.0000970617,"about_ca_system_score_gemma":0.00008148404,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W4402293007","doi":"10.1016/j.msard.2024.105866","title":"Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health; National Institutes of Health; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Mendelian randomization; Depression (economics); Medicine; Psychiatry; Internal medicine; Clinical psychology; Genetics; Gene; Genetic variants; Genotype","score_opus":0.09936946771651545,"score_gpt":0.3235954973378941,"score_spread":0.22422602962137866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402293007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755814,0.01551099,0.0021813451,0.00062728423,0.0003103672,0.005404961,0.00010472904,0.00018648901,0.000092424845],"genre_scores_gemma":[0.98023564,0.01748346,0.0012736282,0.00002287291,0.000054852495,0.0007456021,0.000053695196,0.00007910234,0.000051155508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963152,0.00028841093,0.0010920792,0.0010208976,0.00066152785,0.0006218829],"domain_scores_gemma":[0.995504,0.0034005514,0.0001705043,0.00048080634,0.00021916632,0.00022497484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014380253,0.00042630875,0.00092049513,0.00066300156,0.00031013263,0.00010287693,0.00019132084,0.00020860553,0.00007053953],"category_scores_gemma":[0.0037889876,0.0003374645,0.0003022998,0.0010777982,0.00029478827,0.00037906016,0.00020801618,0.00045005514,0.0000071036357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056459564,0.0018341278,0.78699327,0.0010057688,0.00065016735,0.0000037193558,0.005911965,0.0021609005,0.089535445,0.000022854943,0.00033750848,0.10589832],"study_design_scores_gemma":[0.042748313,0.00089494145,0.7684176,0.007963397,0.00032125652,0.0000021293092,0.004323021,0.17110032,0.0034479743,0.00012806493,0.00017319366,0.00047979224],"about_ca_topic_score_codex":0.002035831,"about_ca_topic_score_gemma":0.0020696935,"teacher_disagreement_score":0.16893943,"about_ca_system_score_codex":0.00015143302,"about_ca_system_score_gemma":0.00009642123,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W4402737724","doi":"10.1016/j.msard.2024.105905","title":"Alexithymia in radiologically isolated syndrome","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Multiple sclerosis; Medicine; Feeling; Clinically isolated syndrome; Clinical psychology; Psychiatry; Psychology","score_opus":0.01929018110445789,"score_gpt":0.23806913239692842,"score_spread":0.21877895129247055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402737724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97333634,0.017344028,0.000066580586,0.001473787,0.0003037475,0.00052511954,0.000009906979,0.00022031927,0.006720189],"genre_scores_gemma":[0.9864615,0.0123957,0.0001945283,0.00012665999,0.0000064089704,0.000046078392,0.00004534954,0.00003399406,0.0006897622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871385,0.00004029438,0.0003504506,0.0004407429,0.00013199597,0.00032265834],"domain_scores_gemma":[0.99953794,0.000093300674,0.000031539126,0.00018984773,0.00001040601,0.00013697473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012152487,0.00022755325,0.00034297397,0.00021305562,0.000069210575,0.000047383066,0.00006110178,0.00023298193,0.0002460903],"category_scores_gemma":[0.000037460373,0.00016070403,0.00012682127,0.0004765503,0.00012465879,0.00009681184,0.000029203675,0.00027314678,0.00010539097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010106328,0.0027589465,0.7958336,0.0007494782,0.002046446,0.0009347639,0.0042550275,0.00013453327,0.0032952747,0.0014496611,0.0022918356,0.18523979],"study_design_scores_gemma":[0.008076227,0.0010720718,0.94549817,0.004854144,0.00013608152,0.00032146726,0.00055361853,0.033003688,0.000010621895,0.0036676587,0.0023679126,0.00043835866],"about_ca_topic_score_codex":0.00010537608,"about_ca_topic_score_gemma":0.000034200675,"teacher_disagreement_score":0.18480143,"about_ca_system_score_codex":0.00003973745,"about_ca_system_score_gemma":0.000026414536,"threshold_uncertainty_score":0.655332},"labels":[],"label_agreement":null},{"id":"W4403012968","doi":"10.1016/j.msard.2024.105916","title":"FROM BENCH TO BEDSIDE: A SNAIL IN TREACLE?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Healthcare Systems and Challenges","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Snail; Bench to bedside; Multiple sclerosis; Medical physics; Immunology; Biology; Ecology","score_opus":0.05157816051834184,"score_gpt":0.3563943231415693,"score_spread":0.30481616262322747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403012968","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063113116,0.022020606,0.0000029707485,0.009438586,0.8965876,0.0023252943,0.001412936,0.00029921895,0.004799669],"genre_scores_gemma":[0.3779216,0.04793066,0.0001105251,0.00039739374,0.55850136,0.0018226348,0.0017925703,0.00048736442,0.011035889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949743,0.0006986255,0.0014426329,0.0012501718,0.0006291598,0.0010051181],"domain_scores_gemma":[0.99625814,0.002312285,0.00026368667,0.00056103844,0.0001398743,0.00046499673],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00089194323,0.0005958555,0.0010737726,0.00046164528,0.0004927447,0.000047480153,0.0002906767,0.004113052,0.00033368432],"category_scores_gemma":[0.00096762495,0.00050045404,0.00018660004,0.00052588177,0.000069191374,0.00008712629,0.00030952352,0.0043839538,0.00085969735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006355366,0.00008121239,0.0014527314,0.0008092044,0.0001279927,0.000008616047,0.024433874,0.000007836063,0.000032890934,0.00002148448,0.94963247,0.023328114],"study_design_scores_gemma":[0.0022611732,0.00012926056,0.005252112,0.006857288,0.00006670398,8.961878e-8,0.014079425,0.00013862559,5.964162e-7,0.0007278442,0.9698943,0.00059259776],"about_ca_topic_score_codex":0.076302536,"about_ca_topic_score_gemma":0.103707395,"teacher_disagreement_score":0.33808625,"about_ca_system_score_codex":0.0003511649,"about_ca_system_score_gemma":0.00059409003,"threshold_uncertainty_score":0.9999182},"labels":[],"label_agreement":null},{"id":"W4403432250","doi":"10.1016/j.msard.2024.105941","title":"New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; London Health Sciences Centre; Memorial University of Newfoundland; Western University","funders":"","keywords":"Medicine; Plasmapheresis; Multiple sclerosis; Dermatology; Pediatrics; Immunology; Antibody","score_opus":0.03988222858740705,"score_gpt":0.25247804793571266,"score_spread":0.2125958193483056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403432250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982216,0.01340697,0.0000438473,0.003382318,0.00006428917,0.0007382513,0.000010062351,0.000050809245,0.00008742921],"genre_scores_gemma":[0.9658442,0.032904122,0.0008054501,0.000057973513,0.000013310701,0.000037035992,0.000008601666,0.000035860292,0.0002934143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847084,0.000088240355,0.00033967887,0.00048872974,0.00031093456,0.00030156216],"domain_scores_gemma":[0.9987606,0.00068221125,0.000057506895,0.00024384784,0.000044049477,0.0002118038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001229351,0.00025715178,0.00041058916,0.00023901218,0.0001912213,0.00011012465,0.00006273283,0.00014862436,0.000026738564],"category_scores_gemma":[0.0002587525,0.00014759073,0.00005320117,0.000525957,0.00061665836,0.00022836206,0.00015618891,0.00040399175,0.0000020434593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018811977,0.00036544763,0.41748485,0.00094843976,0.0014395802,0.000038378526,0.051296942,0.00042322103,0.024630738,0.0003309013,0.002319971,0.49884033],"study_design_scores_gemma":[0.006556,0.0005462465,0.96667457,0.001524214,0.00019174964,0.00001006441,0.003043586,0.01811247,0.0003032503,0.0001199842,0.002665574,0.00025228938],"about_ca_topic_score_codex":0.0066716294,"about_ca_topic_score_gemma":0.007091044,"teacher_disagreement_score":0.54918975,"about_ca_system_score_codex":0.00003388734,"about_ca_system_score_gemma":0.00006786355,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W4403563718","doi":"10.1016/j.msard.2024.105943","title":"Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver Hospital and Health Sciences Centre; University of Manitoba; Health Sciences Centre; Manitoba Health; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Multiple sclerosis; Association (psychology); Population; Psychiatry; Environmental health; Psychotherapist","score_opus":0.09448837981055583,"score_gpt":0.31349351624689004,"score_spread":0.2190051364363342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403563718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017048753,0.9889989,0.0000014711849,0.0036846467,0.0002072871,0.0046531665,0.00027276773,0.00014484381,0.00033203218],"genre_scores_gemma":[0.02428517,0.9732128,0.00005957692,0.0003172876,0.000059851925,0.0011265803,0.0004744459,0.00013789814,0.00032641165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528396,0.00076165673,0.0013061521,0.0010443473,0.0008451355,0.0007587262],"domain_scores_gemma":[0.9962052,0.0022552647,0.0005447092,0.00067715603,0.00012269412,0.00019498274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016149264,0.001034457,0.0032690284,0.0004985051,0.0004534501,0.00022268071,0.00028632535,0.000602817,0.000052864827],"category_scores_gemma":[0.0014431736,0.00050725776,0.0006710195,0.001225118,0.0003312721,0.00019802182,0.00026493956,0.001664783,0.000030485222],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004522038,0.00034776272,0.037714195,0.043697923,0.0022379376,0.0000075071107,0.0013902533,0.0000014621932,0.000002775853,0.000016862308,0.0044971853,0.9100409],"study_design_scores_gemma":[0.0059432248,0.00056730444,0.18010055,0.26254284,0.0058181034,0.000056664416,0.0020491781,0.00039140353,8.0735686e-7,0.000043706594,0.54096466,0.0015215243],"about_ca_topic_score_codex":0.00079750066,"about_ca_topic_score_gemma":0.0010469592,"teacher_disagreement_score":0.9085194,"about_ca_system_score_codex":0.00032629914,"about_ca_system_score_gemma":0.00011565266,"threshold_uncertainty_score":0.9997379},"labels":[],"label_agreement":null},{"id":"W4404195695","doi":"10.1016/j.msard.2024.106151","title":"The multiple sclerosis gut microbiome and disease activity: A systematic review","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Gut microbiome; Microbiome; Disease; Immunology; Gut flora; Bioinformatics; Biology; Pathology","score_opus":0.03280516436373126,"score_gpt":0.2700931285437865,"score_spread":0.2372879641800552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404195695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037245319,0.9946669,0.0000055725504,0.0006215604,0.0003742318,0.0035222904,0.0003550922,0.000051079493,0.000030864245],"genre_scores_gemma":[0.0031826831,0.994635,0.000019062312,0.0002118413,0.000047583988,0.0005102769,0.0003690986,0.0001388333,0.00088565575],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99676734,0.00046097313,0.0009334948,0.0010768607,0.00016207443,0.00059924874],"domain_scores_gemma":[0.998039,0.0001757469,0.00045937396,0.0008530572,0.000052281768,0.00042050966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058878446,0.0007893155,0.0016850809,0.00012149597,0.0006318727,0.00022763043,0.0003547419,0.00057439075,0.0000059350327],"category_scores_gemma":[0.00047166494,0.0004793306,0.00072569965,0.00036412236,0.00036016718,0.000010277671,0.00044278108,0.00054348394,0.000055884942],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034261902,0.00011957171,0.00001334472,0.8783635,0.0011067853,0.000002691911,0.000046789275,2.9544705e-7,0.0019081922,0.000013596528,0.0066759516,0.111715],"study_design_scores_gemma":[0.00081838813,0.00012721223,0.00009906583,0.5208369,0.0067468225,0.00003560633,0.00004585127,0.000043849777,0.0000044709013,0.000018049997,0.4702405,0.0009832726],"about_ca_topic_score_codex":0.000056624885,"about_ca_topic_score_gemma":0.00012252606,"teacher_disagreement_score":0.46356454,"about_ca_system_score_codex":0.000047969825,"about_ca_system_score_gemma":0.00025000868,"threshold_uncertainty_score":0.9997658},"labels":[],"label_agreement":null},{"id":"W4404412901","doi":"10.1016/j.msard.2024.106175","title":"Multiple Sclerosis and biological definitions in neurodegenerative diseases","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Amyotrophic lateral sclerosis; Neuroscience; Disease; Immunology; Pathology; Biology","score_opus":0.09696491196284833,"score_gpt":0.2809746982330748,"score_spread":0.18400978627022646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404412901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689961,0.024740186,0.000043574255,0.003620263,0.0002417135,0.0010447815,0.00027096475,0.00030355825,0.0007388801],"genre_scores_gemma":[0.9068974,0.09202265,0.0003315179,0.00016211814,0.00004915877,0.00026676196,0.00012946951,0.000054428703,0.0000864453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722105,0.00021218181,0.00055283715,0.0010056195,0.0003429597,0.0006653458],"domain_scores_gemma":[0.99812144,0.0010674373,0.000052978612,0.00028657657,0.00007295406,0.0003985984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025511964,0.00042947917,0.0005976584,0.00046811302,0.00041905668,0.00016578776,0.000103097635,0.00027312041,0.000110683424],"category_scores_gemma":[0.0012394655,0.0003249369,0.00019729517,0.00081046973,0.0008308554,0.00023399416,0.00026027477,0.0006523322,0.00003879577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005042183,0.0011194452,0.8356388,0.00039808016,0.00054462795,0.000050482093,0.0025361003,0.00021808226,0.04329074,0.0007597214,0.001839099,0.1131006],"study_design_scores_gemma":[0.004578699,0.0003494086,0.96394926,0.00092608173,0.00010957048,0.00001121861,0.0010506222,0.026938481,0.0002445464,0.00034891916,0.001084332,0.0004088563],"about_ca_topic_score_codex":0.0003653926,"about_ca_topic_score_gemma":0.0004297168,"teacher_disagreement_score":0.12831047,"about_ca_system_score_codex":0.000076876735,"about_ca_system_score_gemma":0.000065594184,"threshold_uncertainty_score":0.99992025},"labels":[],"label_agreement":null},{"id":"W4404421191","doi":"10.1016/j.msard.2024.106167","title":"Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Manitoba; Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University; International Collaboration On Repair Discoveries; University of British Columbia; University of Saskatchewan","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Prodrome; Pharmacotherapy; Cohort; Cohort study; Population; Oncology; Internal medicine; Psychiatry; Environmental health","score_opus":0.0406043648057078,"score_gpt":0.2996232106483462,"score_spread":0.2590188458426384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404421191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98516643,0.005687085,0.000017736833,0.0033103505,0.00023742202,0.0051830104,0.00003414746,0.00022847166,0.00013537487],"genre_scores_gemma":[0.98951995,0.009027248,0.00013351483,0.00023861759,0.000047002373,0.00077042804,0.00007755001,0.00009192655,0.0000937534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961532,0.00043073992,0.00079197634,0.0010614882,0.00084827206,0.0007143597],"domain_scores_gemma":[0.99814963,0.00094008626,0.00010488549,0.00050647353,0.00008406772,0.00021487597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014498088,0.0005129275,0.000743712,0.0005231453,0.0004966886,0.00031252284,0.0002130343,0.00019408282,0.0001458028],"category_scores_gemma":[0.00041080322,0.00034524058,0.00019324043,0.001147983,0.0003334955,0.00023731081,0.00011802929,0.0008011939,0.000020052621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021523226,0.0012746445,0.9578758,0.00026660218,0.00047754325,0.00001841522,0.0033838789,0.0000959397,0.016083322,0.0000074212608,0.00019276139,0.020108433],"study_design_scores_gemma":[0.009261935,0.00037455058,0.9424324,0.0006861278,0.00024503408,0.0000072432335,0.002698056,0.043450817,0.00023424864,0.00002385431,0.00020785662,0.00037790078],"about_ca_topic_score_codex":0.0026128464,"about_ca_topic_score_gemma":0.00074699725,"teacher_disagreement_score":0.043354876,"about_ca_system_score_codex":0.000102268496,"about_ca_system_score_gemma":0.000072066,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W4404704377","doi":"10.1016/j.msard.2024.106182","title":"Incorporation of the central vein sign into the McDonald criteria","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; Idorsia Pharmaceuticals; National Multiple Sclerosis Society; Horizon Therapeutics; Genentech; Multiple Sclerosis Society; Race to Erase MS; Multiple Sclerosis Society of Canada; Atara Biotherapeutics; University of California, San Francisco; MedDay Pharmaceuticals; NGM Biopharmaceuticals; TG Therapeutics; Biogen; Celgene; EMD Serono; University of Pennsylvania; Greenwich Biosciences; Alexion Pharmaceuticals; Eli Lilly and Company; U.S. Department of Defense; Sanofi; National Institute of Mental Health; Sanofi Genzyme; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Sign (mathematics); Multiple sclerosis; Psychiatry","score_opus":0.030716744617864514,"score_gpt":0.2739191439737593,"score_spread":0.24320239935589483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404704377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96510524,0.008584672,0.000088276895,0.022833752,0.00069554395,0.0011159435,0.00002472013,0.00010218098,0.0014496824],"genre_scores_gemma":[0.9935401,0.005660126,0.00011667512,0.00012633056,0.000057516256,0.00005503548,0.00001779142,0.00002956445,0.00039682508],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99835956,0.00016336713,0.00038937715,0.0003327205,0.0004377331,0.00031726583],"domain_scores_gemma":[0.9990775,0.0003285014,0.000075701915,0.00033751997,0.000082397535,0.00009837549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039490074,0.00019276756,0.0002510698,0.00009406391,0.00036724564,0.00007464405,0.00016423743,0.00013192321,0.00011100813],"category_scores_gemma":[0.00047801706,0.00009715827,0.00019726234,0.00057482667,0.00063351664,0.000119961616,0.00018480378,0.000399393,0.000011640492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055089104,0.0006458423,0.16215065,0.0010565371,0.0014818509,0.0000054511315,0.028763255,0.00035592561,0.41198495,0.0015805732,0.020934893,0.37048918],"study_design_scores_gemma":[0.0018505373,0.00018250225,0.95473826,0.00087620114,0.00015832538,0.0000038008243,0.0019218221,0.02696407,0.0032321198,0.0007416424,0.009139898,0.00019079793],"about_ca_topic_score_codex":0.0007513481,"about_ca_topic_score_gemma":0.00038689523,"teacher_disagreement_score":0.79258764,"about_ca_system_score_codex":0.000057353118,"about_ca_system_score_gemma":0.0000850101,"threshold_uncertainty_score":0.39619994},"labels":[],"label_agreement":null},{"id":"W4404768579","doi":"10.1016/j.msard.2024.106194","title":"Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Physical medicine and rehabilitation; Psychiatry","score_opus":0.07449494065826186,"score_gpt":0.2949737730690436,"score_spread":0.22047883241078176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404768579","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109157994,0.20102245,0.000050128005,0.025550066,0.6429392,0.01305288,0.00085762603,0.0025300442,0.0048395954],"genre_scores_gemma":[0.74334705,0.2256296,0.00007045452,0.00012764627,0.027019365,0.0007731562,0.0004053416,0.00046061524,0.002166799],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99169135,0.00057243067,0.0016283838,0.0020806515,0.0020643598,0.0019628499],"domain_scores_gemma":[0.99263245,0.0049993154,0.00048916484,0.0011347486,0.00031324528,0.0004310661],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001798194,0.0014502922,0.0019888538,0.0010282268,0.0010178079,0.0005878917,0.0007275964,0.002157969,0.00018873866],"category_scores_gemma":[0.0051031485,0.0009581492,0.00072602957,0.0018933773,0.00092595606,0.00032958147,0.00099112,0.005508159,0.00011328029],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038152493,0.0027057142,0.011543886,0.0036151018,0.00871942,0.00019889687,0.01952685,0.0006647164,0.003767741,0.00003240612,0.5406865,0.40472353],"study_design_scores_gemma":[0.052748285,0.00257307,0.12510657,0.045424253,0.0037659348,0.000015468804,0.02115896,0.100928575,0.000117060525,0.000623248,0.6417339,0.0058046663],"about_ca_topic_score_codex":0.0028314479,"about_ca_topic_score_gemma":0.011027824,"teacher_disagreement_score":0.634189,"about_ca_system_score_codex":0.00071424904,"about_ca_system_score_gemma":0.0003873131,"threshold_uncertainty_score":0.9998247},"labels":[],"label_agreement":null},{"id":"W4405350116","doi":"10.1016/j.msard.2024.105975","title":"14. An Algorithm for Assessment and Correction of Walking in Patients with Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Algorithm; Physical therapy; Immunology; Computer science","score_opus":0.034792556029690794,"score_gpt":0.2855962218951882,"score_spread":0.2508036658654974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405350116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944902,0.0015118269,0.001050382,0.00022643158,0.00039125947,0.0019731862,0.00010034496,0.00011442587,0.00014196626],"genre_scores_gemma":[0.99064285,0.003491558,0.005312661,0.000022478152,0.000026130267,0.00022479742,0.00014662294,0.00006896301,0.00006395183],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776095,0.00009525617,0.00051939447,0.00070476695,0.00045080812,0.00046879333],"domain_scores_gemma":[0.9987335,0.0005193946,0.0001037922,0.00024668933,0.00019342262,0.00020319963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004666009,0.00031836057,0.00054279267,0.00043678487,0.0002292995,0.00008088777,0.000073637355,0.0002042076,0.000019723957],"category_scores_gemma":[0.00021620195,0.00024360174,0.000102817045,0.00053593254,0.00030750042,0.0003263403,0.000091075104,0.00039592272,0.0000010359767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029001664,0.0005419514,0.42584237,0.00022241741,0.00023184642,6.434714e-7,0.00097117154,0.00012715012,0.0022455954,0.0000047237354,0.00009758888,0.5694245],"study_design_scores_gemma":[0.0088360505,0.0010535717,0.7587853,0.0012727213,0.00010028313,7.3444437e-7,0.00081529893,0.22852086,0.00021603309,0.000012773808,0.00016278362,0.00022358574],"about_ca_topic_score_codex":0.0004922157,"about_ca_topic_score_gemma":0.0005089384,"teacher_disagreement_score":0.56920093,"about_ca_system_score_codex":0.00012815943,"about_ca_system_score_gemma":0.000068492525,"threshold_uncertainty_score":0.99337906},"labels":[],"label_agreement":null},{"id":"W4405364891","doi":"10.1016/j.msard.2024.106123","title":"162. Long-term Effectiveness of Cladribine Tablets over 4 years in Relapsing Multiple Sclerosis: Results from the MAGNIFY-MS Extension Study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Term (time); Dermatology; Internal medicine; Immunology","score_opus":0.044570029649524924,"score_gpt":0.28541333648339096,"score_spread":0.24084330683386604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806978,0.014371722,0.00002940974,0.0005185455,0.00063814595,0.0031587787,0.00023865633,0.00018496886,0.00016199182],"genre_scores_gemma":[0.9853401,0.013882138,0.00009985999,0.000040380502,0.0000718116,0.00017264826,0.000193288,0.000116209296,0.00008352151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948962,0.0008015396,0.0011891417,0.0013812577,0.00095081725,0.0007810732],"domain_scores_gemma":[0.994576,0.0038999757,0.00020599898,0.0009290248,0.00015911063,0.00022993237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021458748,0.0005572062,0.0010023902,0.00044205124,0.0003139757,0.00015417887,0.00029593328,0.00036473275,0.000074464304],"category_scores_gemma":[0.0022633052,0.00039544082,0.0003084617,0.0013545154,0.00058042974,0.00032990778,0.0004756773,0.0011524587,0.00002838355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004017912,0.0018196249,0.80872214,0.0004127833,0.0008918526,0.00007665132,0.0053967913,0.00048355988,0.13042517,0.000006275403,0.00041788688,0.047329344],"study_design_scores_gemma":[0.019674605,0.0005845578,0.95978296,0.008581633,0.00027684247,0.0000037486634,0.0012557114,0.008536179,0.0007993965,0.000036130594,0.000069121226,0.00039913194],"about_ca_topic_score_codex":0.006278887,"about_ca_topic_score_gemma":0.0027517707,"teacher_disagreement_score":0.15106079,"about_ca_system_score_codex":0.00019647839,"about_ca_system_score_gemma":0.00009932098,"threshold_uncertainty_score":0.99984974},"labels":[],"label_agreement":null},{"id":"W4405364903","doi":"10.1016/j.msard.2024.106137","title":"176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ocrelizumab; Multiple sclerosis; Pregnancy; Obstetrics; Pediatrics; Internal medicine; Immunology","score_opus":0.03299971466051489,"score_gpt":0.26735213029988897,"score_spread":0.2343524156393741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354673,0.012503343,0.0001092365,0.0010556313,0.000098868775,0.0018665837,0.00019933347,0.00020876952,0.0004114875],"genre_scores_gemma":[0.9654135,0.032278556,0.00131729,0.00006477074,0.000008856095,0.00059366977,0.000034550736,0.00009136508,0.00019744979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586797,0.00015018543,0.0010044761,0.0012176519,0.00073777715,0.001021957],"domain_scores_gemma":[0.9977558,0.00082418247,0.00016758869,0.0006312293,0.00015536374,0.00046578993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005669672,0.00060506584,0.001558551,0.0017897043,0.0002541683,0.0001615769,0.00021232852,0.0002604927,0.00008965371],"category_scores_gemma":[0.0009007748,0.00043734544,0.0002121888,0.0033083856,0.00054242346,0.00036411273,0.0003893818,0.0005490668,0.0000068292584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010297261,0.000515466,0.86734575,0.0009877064,0.0043547694,0.00001424012,0.014662971,0.0012814399,0.016119104,0.00002201847,0.000071515344,0.09359531],"study_design_scores_gemma":[0.0047534965,0.0006229168,0.95799947,0.007332526,0.0006226727,0.0000027765855,0.0031913838,0.024252959,0.00043818055,0.000013474492,0.00025869047,0.0005114664],"about_ca_topic_score_codex":0.0022343374,"about_ca_topic_score_gemma":0.0024458282,"teacher_disagreement_score":0.09308384,"about_ca_system_score_codex":0.00014371517,"about_ca_system_score_gemma":0.00008334896,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W4405364924","doi":"10.1016/j.msard.2024.106115","title":"154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Phase (matter); Internal medicine; Oncology; Fingolimod; Immunology","score_opus":0.06294736156404931,"score_gpt":0.3237788504028992,"score_spread":0.2608314888388499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699559,0.024446841,0.000017079032,0.0027919004,0.0004675685,0.0010627831,0.00058102753,0.0000624461,0.0006144569],"genre_scores_gemma":[0.9816458,0.017540181,0.00032654955,0.000055635883,0.000043518266,0.000038156515,0.00024020928,0.000033368855,0.00007653919],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980625,0.00015475311,0.0008435201,0.0005326459,0.00016126261,0.00024535618],"domain_scores_gemma":[0.9969381,0.0024824871,0.00016551724,0.00025751587,0.000029353665,0.00012702966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006177825,0.00024448577,0.00055763556,0.000121640514,0.00019787264,0.00007931483,0.000056854544,0.00018635324,0.000025018619],"category_scores_gemma":[0.0012124556,0.00015969016,0.00010581098,0.0002957285,0.0002702287,0.00013367711,0.00006442597,0.00026959006,0.0000025748377],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03234661,0.0013679196,0.05162851,0.00022482827,0.0024694533,0.000023180972,0.02907837,0.00025774367,0.037827343,0.00013963849,0.0016589666,0.84297746],"study_design_scores_gemma":[0.2144304,0.0011799535,0.7472004,0.00653977,0.0023621735,0.000007803375,0.006078707,0.012451281,0.0011048476,0.00014873946,0.007963703,0.00053216197],"about_ca_topic_score_codex":0.0020074078,"about_ca_topic_score_gemma":0.00046532752,"teacher_disagreement_score":0.84244525,"about_ca_system_score_codex":0.0000596522,"about_ca_system_score_gemma":0.00007834289,"threshold_uncertainty_score":0.65119755},"labels":[],"label_agreement":null},{"id":"W4405364934","doi":"10.1016/j.msard.2024.106114","title":"153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Placebo; Relapsing remitting; Internal medicine; Pathology; Immunology; Alternative medicine","score_opus":0.03891098586633257,"score_gpt":0.2788187953834719,"score_spread":0.2399078095171393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96930987,0.023054255,0.00001695668,0.0017060835,0.0012085158,0.0026391263,0.00058144826,0.00010187776,0.0013818658],"genre_scores_gemma":[0.9896395,0.009095225,0.0003193617,0.00013530649,0.00012618094,0.00009230773,0.00045075698,0.00006664058,0.00007468128],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996892,0.00020566337,0.0011346175,0.0009139643,0.00035628496,0.0004974694],"domain_scores_gemma":[0.99647063,0.0025386102,0.0002453809,0.00046782324,0.00005701794,0.00022055353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006507599,0.00044649284,0.0007485379,0.00020508564,0.00029371295,0.00011201963,0.00017232455,0.00040085037,0.00017147814],"category_scores_gemma":[0.0007248787,0.00032403134,0.00022708636,0.0005087633,0.0005980095,0.0002791408,0.00014313075,0.0009407832,0.000008784837],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.371079,0.0011183523,0.0026659225,0.000279444,0.0012486194,0.00004389282,0.013866543,0.00030241878,0.0147426175,0.000022995098,0.0018300661,0.59280014],"study_design_scores_gemma":[0.82134414,0.0025447235,0.11265946,0.0061765015,0.0007306149,0.000010508718,0.0063729393,0.042544387,0.0013360772,0.000049115693,0.0053987713,0.00083277584],"about_ca_topic_score_codex":0.0012714755,"about_ca_topic_score_gemma":0.0005587736,"teacher_disagreement_score":0.59196734,"about_ca_system_score_codex":0.000115468254,"about_ca_system_score_gemma":0.00026169154,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4405364984","doi":"10.1016/j.msard.2024.106120","title":"159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Pediatrics; Physical therapy; Internal medicine; Immunology","score_opus":0.02897219515397852,"score_gpt":0.24743764614453437,"score_spread":0.21846545099055584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945893,0.0013204049,0.00009070999,0.0009784342,0.00031109716,0.0019519628,0.000489798,0.00018324085,0.000085027204],"genre_scores_gemma":[0.99377537,0.0019306804,0.0024499283,0.00020553183,0.000030384304,0.00028202496,0.0009173745,0.00010080675,0.00030789492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969478,0.00008739091,0.000668974,0.0010578147,0.00054639624,0.0006915865],"domain_scores_gemma":[0.99830943,0.0006954246,0.000087130946,0.00039770768,0.00006869726,0.00044159888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022148843,0.00043915282,0.000587722,0.0004163354,0.00018167422,0.00027619733,0.00008656967,0.0003095397,0.00003465839],"category_scores_gemma":[0.00040944203,0.0003395926,0.000119210585,0.00099292,0.00014213631,0.0003954261,0.0001361732,0.00035552797,0.000025172983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054219323,0.0017725548,0.768049,0.00019143091,0.0016177568,0.00047111858,0.046417408,0.0009436627,0.008749466,0.000012135965,0.0019972527,0.16435629],"study_design_scores_gemma":[0.05212638,0.0026786525,0.86650646,0.0020672951,0.00050196773,0.000030327845,0.0059691304,0.06392753,0.0007163759,0.000011535117,0.004636645,0.00082770165],"about_ca_topic_score_codex":0.009766504,"about_ca_topic_score_gemma":0.010691065,"teacher_disagreement_score":0.16352859,"about_ca_system_score_codex":0.00056702585,"about_ca_system_score_gemma":0.00030937535,"threshold_uncertainty_score":0.9999056},"labels":[],"label_agreement":null},{"id":"W4405364989","doi":"10.1016/j.msard.2024.106117","title":"156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Immune system; Immunology; Neuroscience; Biology","score_opus":0.029046992068251305,"score_gpt":0.26654000800382216,"score_spread":0.23749301593557084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825917,0.014664,0.000025569418,0.00050218636,0.00033981,0.0010739121,0.00018690273,0.00021123292,0.00040467642],"genre_scores_gemma":[0.9876841,0.010966272,0.00024870248,0.00004320583,0.000023573235,0.000097451135,0.0004556183,0.000090766196,0.00039035836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622405,0.00010956941,0.0012428302,0.00084107654,0.00067308574,0.00090937124],"domain_scores_gemma":[0.99805605,0.00082802796,0.00013622851,0.0005029445,0.00010162193,0.00037513013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006709563,0.00041105907,0.00074744585,0.00034525746,0.0002320244,0.000071043905,0.00019518494,0.00039596844,0.00025043156],"category_scores_gemma":[0.00082875,0.00034481226,0.00025088838,0.0011408806,0.0005530049,0.0002040938,0.00029447998,0.00054228853,0.00006987721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060942625,0.0035139832,0.43479452,0.0049309083,0.0023419433,0.00038919243,0.034507994,0.0013518375,0.08028888,0.00011273269,0.0021311839,0.42954257],"study_design_scores_gemma":[0.049322337,0.0002949175,0.86095554,0.0062896246,0.00019120425,0.000042878302,0.0035304332,0.06271354,0.0068592867,0.000065249485,0.008839595,0.00089542073],"about_ca_topic_score_codex":0.0016134616,"about_ca_topic_score_gemma":0.00056735676,"teacher_disagreement_score":0.42864716,"about_ca_system_score_codex":0.0021427535,"about_ca_system_score_gemma":0.0021761535,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W4405365057","doi":"10.1016/j.msard.2024.106121","title":"160. Low Rate of Progression Independent of Relapse Activity (PIRA) in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Internal medicine; Oncology; Immunology","score_opus":0.023856342820409163,"score_gpt":0.25097005933029176,"score_spread":0.2271137165098826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405365057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479824,0.0018621463,0.00005647142,0.00032887506,0.00010536407,0.002352052,0.00010487426,0.00014666948,0.0002453144],"genre_scores_gemma":[0.9953127,0.0036635986,0.0005169595,0.000014557791,0.000012855505,0.00013937752,0.00011310975,0.00012194594,0.00010488355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613327,0.0002833579,0.00087397674,0.0010198961,0.00092749216,0.0007620096],"domain_scores_gemma":[0.9978994,0.000529014,0.00036891,0.0005663789,0.0003508246,0.00028545485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006535935,0.0005896942,0.0011160717,0.00075107976,0.00021559556,0.000059243543,0.00016585542,0.00039031848,0.00005841292],"category_scores_gemma":[0.0004674603,0.00039187167,0.00017956377,0.0017213534,0.00076672,0.00045742514,0.00020338644,0.0009070114,0.0000047843887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067198835,0.001936928,0.8683046,0.0010374042,0.0007203691,0.000012715133,0.0009867745,0.000744492,0.068696894,0.000006306287,0.000080521815,0.050753098],"study_design_scores_gemma":[0.021392489,0.00212962,0.9376017,0.011849474,0.00023317247,0.0000020871364,0.00034381505,0.013194356,0.012771608,0.000006742192,0.000040498908,0.00043444594],"about_ca_topic_score_codex":0.0011723932,"about_ca_topic_score_gemma":0.00074662047,"teacher_disagreement_score":0.069297075,"about_ca_system_score_codex":0.00024238143,"about_ca_system_score_gemma":0.00017314116,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W4405365084","doi":"10.1016/j.msard.2024.106138","title":"177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Open label; Disease; Extension (predicate logic); Relapsing remitting; Clinical trial; Physical medicine and rehabilitation; Internal medicine; Immunology","score_opus":0.06102225189578062,"score_gpt":0.3068371326029154,"score_spread":0.24581488070713478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405365084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97617245,0.008733718,0.00006295758,0.009949019,0.0011787479,0.0027514594,0.000524502,0.00017080129,0.00045633502],"genre_scores_gemma":[0.9919276,0.0062202383,0.000253438,0.00029931724,0.00009928068,0.0002148719,0.0004378813,0.00007408611,0.00047328166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745345,0.00020209012,0.00057523634,0.00097575266,0.00032717147,0.00046630285],"domain_scores_gemma":[0.99818605,0.00072481175,0.00013176823,0.00060833263,0.000051955947,0.00029705005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045056612,0.00036462196,0.00043905788,0.00014226531,0.00054454984,0.00033424975,0.00020039933,0.00022796758,0.0000376579],"category_scores_gemma":[0.0006508696,0.00024473248,0.0001430554,0.00061174145,0.00020924093,0.00038232404,0.0002076601,0.0005567919,0.00002886859],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2085454,0.012412597,0.031353917,0.0003139451,0.0029888146,0.00026586282,0.015225444,0.002173127,0.042469155,0.000371016,0.015768243,0.66811246],"study_design_scores_gemma":[0.32213795,0.00090944994,0.5749069,0.0073845633,0.0014393177,0.0000040691466,0.0020494624,0.08547664,0.00021955055,0.0008109752,0.0038750174,0.0007861578],"about_ca_topic_score_codex":0.0057729273,"about_ca_topic_score_gemma":0.0017440196,"teacher_disagreement_score":0.66732633,"about_ca_system_score_codex":0.00024174865,"about_ca_system_score_gemma":0.0002672253,"threshold_uncertainty_score":0.9979901},"labels":[],"label_agreement":null},{"id":"W4405663833","doi":"10.1016/j.msard.2024.106245","title":"Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Psychotherapist; Psychiatry; Psychology","score_opus":0.04155354934755087,"score_gpt":0.2807413214089716,"score_spread":0.23918777206142075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405663833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851099,0.009089287,0.000322774,0.0017647236,0.00031813097,0.0026465466,0.00014235509,0.00034926232,0.00025697442],"genre_scores_gemma":[0.9621296,0.03528167,0.00089075917,0.00017512369,0.00005904133,0.0005500537,0.000080587044,0.00016954803,0.0006636305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622566,0.000119423494,0.000766385,0.001224409,0.00063623005,0.0010278805],"domain_scores_gemma":[0.9975636,0.0013070985,0.0001242432,0.0004902838,0.0001566459,0.0003581557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048262975,0.0006428493,0.0009509836,0.0007302148,0.00043389993,0.00021303096,0.00020537162,0.00037680744,0.00009003264],"category_scores_gemma":[0.00045904532,0.00047184053,0.00031797538,0.0013209973,0.00040810058,0.00045750287,0.00006876112,0.0007347762,0.00001539952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002165116,0.00045704594,0.87601787,0.0008649995,0.0010035147,0.0000047920976,0.01535639,0.0005995209,0.059651427,0.00003858901,0.0017271771,0.04211358],"study_design_scores_gemma":[0.010556668,0.0006973121,0.9603561,0.0030790865,0.0001246681,0.000004190319,0.0032065245,0.016602047,0.0021682202,0.0000535109,0.0025099244,0.0006417314],"about_ca_topic_score_codex":0.0014150942,"about_ca_topic_score_gemma":0.0048197177,"teacher_disagreement_score":0.08433826,"about_ca_system_score_codex":0.00019915595,"about_ca_system_score_gemma":0.00015281055,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W4406364993","doi":"10.1016/j.msard.2025.106269","title":"Potential mechanisms of how B-cell depletion works in MOGAD","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Massachusetts General Hospital","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.006078453973629121,"score_gpt":0.18570506113522695,"score_spread":0.1796266071615978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406364993","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05864469,0.045298748,0.000867036,0.0006779706,0.89165604,0.0011811659,0.00031202624,0.00018517248,0.0011771485],"genre_scores_gemma":[0.9602207,0.027284069,0.00007850704,0.00001752809,0.0033323655,0.0000634389,0.0018231601,0.000059489954,0.007120738],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974969,0.000362015,0.00066452,0.0007794145,0.000106398256,0.00059075136],"domain_scores_gemma":[0.9985219,0.00048620204,0.0004403342,0.00041207293,0.0001106222,0.00002883762],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00030664462,0.0005187034,0.00090235466,0.00050310424,0.00021369325,0.000037048827,0.00038238455,0.0041987333,0.00015840246],"category_scores_gemma":[0.0002350091,0.0004801251,0.0002874697,0.0003556034,0.00041116457,0.000102053775,0.0002624107,0.0018735714,0.000038497314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005282208,0.0007481709,0.00015230535,0.00021429884,0.00044076733,0.000003833409,0.00025244927,0.000095567266,0.74925375,0.00006453059,0.23848505,0.009761039],"study_design_scores_gemma":[0.08793771,0.002336351,0.0020510375,0.006163259,0.0021300798,0.000013533121,0.0052250964,0.000566292,0.16047326,0.005097172,0.72349435,0.004511835],"about_ca_topic_score_codex":0.0010689038,"about_ca_topic_score_gemma":0.00042870914,"teacher_disagreement_score":0.901576,"about_ca_system_score_codex":0.00005767934,"about_ca_system_score_gemma":0.00014250378,"threshold_uncertainty_score":0.99976504},"labels":[],"label_agreement":null},{"id":"W4406598422","doi":"10.1016/j.msard.2025.106280","title":"A glass half empty","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Aging, Elder Care, and Social Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Psychiatry","score_opus":0.032898406992676966,"score_gpt":0.32177722284827126,"score_spread":0.2888788158555943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406598422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.909772,0.003886476,0.00020726451,0.0038449294,0.0015476799,0.00073239853,0.000013229874,0.00029433228,0.07970172],"genre_scores_gemma":[0.9869071,0.0025604141,0.00006579169,0.0014700934,0.000042769403,0.000082761566,0.000022556122,0.000022148473,0.008826314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843204,0.00023973455,0.00040297405,0.00033879056,0.00013256639,0.00045391978],"domain_scores_gemma":[0.99914825,0.00034355206,0.00011160861,0.00021751606,0.0000733808,0.000105663086],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00027539092,0.000181548,0.00029433955,0.00011075362,0.0014878964,0.000020582633,0.0001251726,0.0004062694,0.00019669464],"category_scores_gemma":[0.0002081741,0.00015555961,0.000106902,0.0003365301,0.00016136777,0.00009467013,0.00012058905,0.0005722448,0.000089894216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011423591,0.0002511547,0.83312756,0.00035513754,0.00039507615,0.0000023235577,0.067510724,0.00002811791,0.0006798619,0.0077552167,0.02313522,0.0666454],"study_design_scores_gemma":[0.008770397,0.00009004533,0.70556974,0.0015746102,0.00021973078,2.602548e-7,0.12404646,0.0024100738,0.000054407737,0.012700064,0.1438031,0.00076110003],"about_ca_topic_score_codex":0.0029380613,"about_ca_topic_score_gemma":0.0025925024,"teacher_disagreement_score":0.1275578,"about_ca_system_score_codex":0.000057834008,"about_ca_system_score_gemma":0.00008935678,"threshold_uncertainty_score":0.999812},"labels":[],"label_agreement":null},{"id":"W4406753778","doi":"10.1016/j.msard.2025.106287","title":"A retrospective evaluation of patient characteristics and recommendations of a novel multidisciplinary clinic for persons with advanced disability from multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Parkwood Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Multiple sclerosis; Multidisciplinary approach; Retrospective cohort study; Physical therapy; Physical medicine and rehabilitation; Pediatrics; Internal medicine; Psychiatry","score_opus":0.06388904227221708,"score_gpt":0.32901153694359403,"score_spread":0.26512249467137694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406753778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914611,0.0009792738,0.00044671915,0.0017578821,0.00014061974,0.0035432335,0.001484583,0.000041224746,0.00014536659],"genre_scores_gemma":[0.9889841,0.0029726722,0.0070649716,0.0000193707,0.00001079202,0.0006036517,0.0002823027,0.000034053177,0.000028065648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737096,0.00015725098,0.0008849906,0.00073861383,0.0005091143,0.0003390443],"domain_scores_gemma":[0.99704087,0.0011813993,0.0004562304,0.00045895422,0.0007198619,0.0001427106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007079188,0.0003204069,0.00083561946,0.000181133,0.00036549475,0.000019306292,0.00009338378,0.0002025432,0.000032746484],"category_scores_gemma":[0.0028446573,0.00025862403,0.00019035292,0.00048878806,0.0009411366,0.00015552808,0.00019269256,0.0002942987,4.32352e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002889843,0.002914838,0.79503644,0.000370633,0.0010923552,7.796148e-8,0.0053778007,0.00010786263,0.043214887,0.00002373851,0.00009491498,0.14887659],"study_design_scores_gemma":[0.019229686,0.00091626303,0.9149589,0.0016528572,0.0006685356,3.061556e-7,0.007422348,0.05369923,0.0011084069,0.00007844767,0.00003995706,0.00022508134],"about_ca_topic_score_codex":0.00049643323,"about_ca_topic_score_gemma":0.0005279488,"teacher_disagreement_score":0.14865151,"about_ca_system_score_codex":0.00018265139,"about_ca_system_score_gemma":0.00012977378,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4406821385","doi":"10.1016/j.msard.2025.106300","title":"Is there truly no progression in NMOSD and MOGAD?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.013108387348026395,"score_gpt":0.25726935662227357,"score_spread":0.24416096927424719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406821385","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17646149,0.29356703,0.0000030087228,0.002549823,0.510249,0.0040354733,0.00061073474,0.0004161032,0.012107299],"genre_scores_gemma":[0.4051997,0.51964504,0.00017754671,0.00037411222,0.05986079,0.00042355902,0.0012136293,0.00027849386,0.012827155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965975,0.00014800894,0.0008973147,0.0011363417,0.0006757565,0.00054507446],"domain_scores_gemma":[0.99793667,0.00073596556,0.00031744462,0.00050525717,0.0001862114,0.00031844754],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034115242,0.0006559136,0.0010983559,0.00041785708,0.00023686349,0.00010124822,0.00016094433,0.002567745,0.00015911263],"category_scores_gemma":[0.0011210245,0.00048522695,0.00028357955,0.0004848708,0.00028882123,0.00010409277,0.00018194993,0.0013883653,0.000034686676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000711781,0.0005884931,0.034190323,0.0014625055,0.0005735445,0.00001576911,0.000776945,0.0000054459256,0.00032961296,0.000005801632,0.90849674,0.052843012],"study_design_scores_gemma":[0.034476336,0.00093543355,0.11807244,0.0700113,0.0017368061,0.000008664924,0.0015476566,0.002857069,0.00008924577,0.00015745116,0.76835424,0.0017533713],"about_ca_topic_score_codex":0.0005796411,"about_ca_topic_score_gemma":0.00006906379,"teacher_disagreement_score":0.45038825,"about_ca_system_score_codex":0.000104653955,"about_ca_system_score_gemma":0.00028408846,"threshold_uncertainty_score":0.9997599},"labels":[],"label_agreement":null},{"id":"W4407164742","doi":"10.1016/j.msard.2025.106318","title":"Progressive unilateral tremor associated with large confluent perirolandic juxtacortical lesions in multiple sclerosis","year":2025,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Multiple sclerosis; Pathology; Immunology","score_opus":0.02539278073944422,"score_gpt":0.23385080626685661,"score_spread":0.20845802552741238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407164742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90964407,0.004525353,0.000012128562,0.0810623,0.00043276532,0.0027440477,0.00086845824,0.00026939015,0.0004414735],"genre_scores_gemma":[0.95258456,0.0014823964,0.000059114107,0.039837908,0.00013206556,0.00033415091,0.003369746,0.00014858204,0.002051499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570537,0.00024350842,0.0008917343,0.0012465351,0.0006570295,0.0012558197],"domain_scores_gemma":[0.99813795,0.0003720063,0.00035775057,0.0005758534,0.00018825682,0.000368184],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00018815763,0.00087822054,0.0013599013,0.0005586038,0.00044379348,0.000121662684,0.00021121732,0.0016445743,0.00025355135],"category_scores_gemma":[0.0004472992,0.0006693802,0.00045297903,0.00074589904,0.0004277437,0.00012083489,0.00016612951,0.0024079194,0.000017857967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006395829,0.00886125,0.55149525,0.0024327,0.007907544,0.017791428,0.0041532246,0.00026573395,0.0015483234,0.000046833284,0.3741053,0.024996543],"study_design_scores_gemma":[0.052618027,0.001371734,0.847191,0.013266112,0.0036622486,0.0001548763,0.00093096576,0.009402245,0.00006043961,0.000038512382,0.069090486,0.002213352],"about_ca_topic_score_codex":0.0004448554,"about_ca_topic_score_gemma":0.00036257278,"teacher_disagreement_score":0.30501482,"about_ca_system_score_codex":0.00025008933,"about_ca_system_score_gemma":0.00031005248,"threshold_uncertainty_score":0.99989355},"labels":[],"label_agreement":null},{"id":"W4407165175","doi":"10.1016/j.msard.2025.106322","title":"Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Aging","keywords":"Multiple sclerosis; Medicine; Cognition; Physical medicine and rehabilitation; Psychiatry","score_opus":0.03191505425122631,"score_gpt":0.2782034890622853,"score_spread":0.246288434811059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407165175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960272,0.0007060393,0.00006300691,0.00073179684,0.00020502244,0.0015106958,0.000091697315,0.00009360456,0.000570993],"genre_scores_gemma":[0.98021054,0.01862853,0.00006266724,0.0002193077,0.000035012934,0.00035647303,0.00009535926,0.00002485993,0.0003672177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974084,0.00072086893,0.0005325866,0.0005897823,0.00017021087,0.00057813915],"domain_scores_gemma":[0.99810153,0.0012568835,0.00023439598,0.00022905049,0.00007561387,0.00010255024],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00059739157,0.00031010667,0.00046562683,0.00012666176,0.0015400317,0.000032456766,0.00015914367,0.0003975928,0.000014176304],"category_scores_gemma":[0.0002559016,0.00015766673,0.0000745013,0.00045919206,0.00038510354,0.00021110724,0.00017358271,0.0010829024,0.000016449458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026263276,0.00022240146,0.9778152,0.0001438237,0.00010712627,1.9625502e-7,0.0052874573,0.000012386864,0.0018966631,0.000020601148,0.00011254879,0.014118956],"study_design_scores_gemma":[0.00747736,0.0001438737,0.9715083,0.0017529865,0.00010520948,1.347188e-7,0.014384662,0.004042836,0.0000055502514,0.00022398525,0.000094730145,0.000260368],"about_ca_topic_score_codex":0.0016760379,"about_ca_topic_score_gemma":0.007437608,"teacher_disagreement_score":0.01792249,"about_ca_system_score_codex":0.000049249462,"about_ca_system_score_gemma":0.00005585279,"threshold_uncertainty_score":0.99975985},"labels":[],"label_agreement":null},{"id":"W4407281743","doi":"10.1016/j.msard.2025.106335","title":"Associations between fronto-limbic white matter connections and internalizing symptoms in pediatric demyelinating disease","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; McGill University; Mental Health Research Canada; Hospital for Sick Children","funders":"","keywords":"Medicine; White matter; Multiple sclerosis; Demyelinating disease; Disease; Demyelinating Disorder; Neuroscience; Limbic system; Psychiatry; Pathology; Psychology; Magnetic resonance imaging; Internal medicine; Central nervous system","score_opus":0.023671289854620543,"score_gpt":0.2787222330779737,"score_spread":0.2550509432233532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407281743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843922,0.0063884673,0.0001172727,0.006502841,0.00014690479,0.00072338845,0.00009354946,0.00008546063,0.0015498648],"genre_scores_gemma":[0.98957527,0.009242761,0.00015358355,0.00016445963,0.00004734716,0.00008689842,0.00007828373,0.000027408812,0.00062396395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810255,0.00013260808,0.0005662768,0.0005114121,0.00024304501,0.00044413764],"domain_scores_gemma":[0.99882185,0.00054429675,0.00012432081,0.00019607297,0.00008727815,0.00022618443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003520019,0.00024087443,0.00045402988,0.0005550816,0.0004276549,0.000082423736,0.00008441993,0.00016323532,0.00005554953],"category_scores_gemma":[0.00089026714,0.00022105873,0.000113087284,0.0006361533,0.00015864304,0.00016418262,0.0002143831,0.00048893073,0.00001377875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004063649,0.0001251418,0.98444766,0.00010553768,0.00019738427,0.0000015288547,0.0005789431,0.000054095042,0.000100599435,0.000016943464,0.00044381185,0.01388771],"study_design_scores_gemma":[0.0041844803,0.000039445295,0.99051815,0.00042966692,0.00026033755,4.2773866e-7,0.0003714413,0.0036425528,0.0000055824653,0.0001576682,0.0001930298,0.00019718694],"about_ca_topic_score_codex":0.0005321312,"about_ca_topic_score_gemma":0.00054394425,"teacher_disagreement_score":0.013690523,"about_ca_system_score_codex":0.00012736309,"about_ca_system_score_gemma":0.000054582022,"threshold_uncertainty_score":0.90145135},"labels":[],"label_agreement":null},{"id":"W4407635963","doi":"10.1016/j.msard.2025.106337","title":"Infectious mononucleosis is a more realistic target for preventing multiple sclerosis","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mononucleosis; Multiple sclerosis; Medicine; Virology; Immunology; Virus","score_opus":0.0192967379330133,"score_gpt":0.2624359087893843,"score_spread":0.243139170856371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407635963","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08548473,0.011477151,0.0010801736,0.001964978,0.8717742,0.011700623,0.0088015925,0.0015708747,0.006145652],"genre_scores_gemma":[0.7814179,0.04870692,0.0041469764,0.00048553795,0.13459167,0.0042651314,0.009160992,0.00082641013,0.016398456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625987,0.0001022374,0.0009954338,0.0013116386,0.00052215613,0.0008086496],"domain_scores_gemma":[0.9967785,0.0013551916,0.00046473442,0.00069972465,0.0003754053,0.00032645458],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034729732,0.00086788833,0.0012781366,0.0005396637,0.00096611347,0.0001631184,0.00016782817,0.0019854498,0.00010933463],"category_scores_gemma":[0.002148649,0.00079014443,0.00080850883,0.0006435892,0.00022909918,0.00014778021,0.00016950021,0.0010658002,0.00002445791],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048438358,0.0016254425,0.015951796,0.0013766733,0.0034900466,0.0000047087096,0.00075406005,0.00011102652,0.00012778633,0.000007682201,0.8957273,0.08033912],"study_design_scores_gemma":[0.020122899,0.00075289473,0.0057726223,0.003923237,0.0032028558,0.000002949182,0.00023108769,0.0060464498,0.00019719204,0.00021302815,0.958466,0.0010687814],"about_ca_topic_score_codex":0.0034284636,"about_ca_topic_score_gemma":0.00045953068,"teacher_disagreement_score":0.73718256,"about_ca_system_score_codex":0.00030381134,"about_ca_system_score_gemma":0.00031550069,"threshold_uncertainty_score":0.999455},"labels":[],"label_agreement":null},{"id":"W4408535100","doi":"10.1016/j.msard.2025.106394","title":"Magnetic resonance imaging characteristics of myelin oligodendrocyte glycoprotein antibody positive patients -validation of current diagnostic criteria","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Magnetic resonance imaging; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Antibody; Myelin; Oligodendrocyte; Pathology; Nuclear magnetic resonance; Immunology; Radiology; Internal medicine; Central nervous system; Experimental autoimmune encephalomyelitis","score_opus":0.016212178922580346,"score_gpt":0.29155721240324456,"score_spread":0.2753450334806642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408535100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98393667,0.013402606,0.00015252046,0.00026316906,0.00029647117,0.0012952306,0.00024902454,0.000034608714,0.00036970412],"genre_scores_gemma":[0.9783412,0.021055458,0.00019024566,0.000022138329,0.000015256146,0.00006106194,0.00024628092,0.000025110168,0.000043255193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978519,0.0001405256,0.00081266445,0.00043846338,0.00040066184,0.00035578976],"domain_scores_gemma":[0.9983743,0.00050356745,0.0002602679,0.00030542247,0.0004531716,0.00010329028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023645755,0.00026538444,0.00060627353,0.000323833,0.00015342965,0.000022755074,0.00012078587,0.00010323805,0.00004758994],"category_scores_gemma":[0.002285497,0.00023764164,0.00013718753,0.00050142437,0.00043936053,0.000116942385,0.00019113175,0.000273203,0.000004034409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045349414,0.00074987987,0.68302953,0.00054261443,0.00007424186,0.0000010455653,0.0005910576,0.0000043218038,0.046167098,0.00003825506,0.00012852477,0.26821992],"study_design_scores_gemma":[0.0054214867,0.00025271077,0.9721125,0.0034455648,0.00014696358,4.6348805e-7,0.00016995941,0.0022771596,0.015663492,0.000034193425,0.0002924833,0.00018302535],"about_ca_topic_score_codex":0.00028305277,"about_ca_topic_score_gemma":0.000011757788,"teacher_disagreement_score":0.28908294,"about_ca_system_score_codex":0.000057568806,"about_ca_system_score_gemma":0.00006411538,"threshold_uncertainty_score":0.9690744},"labels":[],"label_agreement":null},{"id":"W4408760219","doi":"10.1016/j.msard.2025.106392","title":"Comparison of vision-related quality of life in NMOSD and MOGAD","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Western University; University of Toronto; Dalhousie University; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Manitoba; Ottawa Hospital; University of Ottawa; Public Health Ontario; Toronto Public Health","funders":"Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; Roche; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Dermatology; Quality of life (healthcare); Optometry; Immunology","score_opus":0.0663735583943237,"score_gpt":0.36057487976407016,"score_spread":0.29420132136974647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408760219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844461,0.0110048875,0.000016437903,0.0015784827,0.0000915471,0.0007190073,0.000021794858,0.000034720022,0.002087019],"genre_scores_gemma":[0.98997164,0.009582561,0.00020986941,0.00003650867,0.0000030001358,0.00002321367,0.000017493681,0.000016209775,0.0001394869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741876,0.00020903257,0.0012724329,0.00042581582,0.00035799324,0.0003159479],"domain_scores_gemma":[0.9983764,0.0007445212,0.000274073,0.00031055458,0.00014250504,0.00015188845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069746404,0.00022457114,0.0010865985,0.00041784896,0.00011383373,0.000011648338,0.00009937983,0.00027130265,0.000046396235],"category_scores_gemma":[0.0020271621,0.00018590632,0.00013214668,0.0007990658,0.0007152901,0.00008494563,0.00021443749,0.00041528043,0.0000017753867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054934033,0.0008248475,0.9306422,0.000581794,0.000321651,2.383073e-7,0.0016124324,0.00016077541,0.031880032,0.00019801996,0.00028533535,0.03294332],"study_design_scores_gemma":[0.009588642,0.00021249929,0.97531825,0.00095430546,0.000055189565,1.5680023e-7,0.0025495114,0.010220268,0.0007033983,0.00014696887,0.00010419965,0.00014660202],"about_ca_topic_score_codex":0.00215416,"about_ca_topic_score_gemma":0.0007739981,"teacher_disagreement_score":0.044676043,"about_ca_system_score_codex":0.000034588717,"about_ca_system_score_gemma":0.00007419177,"threshold_uncertainty_score":0.75810397},"labels":[],"label_agreement":null},{"id":"W4408787704","doi":"10.1016/j.msard.2025.106403","title":"IS MULTIPLE SCLEROSIS A MICROGLIOPATHY?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Immunology","score_opus":0.030279936535247572,"score_gpt":0.2327744734025983,"score_spread":0.20249453686735072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408787704","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05067004,0.00167374,0.00024438996,0.0024083965,0.9366182,0.0023569732,0.002162438,0.0011824624,0.0026833676],"genre_scores_gemma":[0.6334113,0.144135,0.0008378784,0.006183592,0.16076729,0.0010360344,0.0012503894,0.00097304914,0.051405463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946709,0.00044201626,0.0010710354,0.002028898,0.0010226171,0.0007644886],"domain_scores_gemma":[0.9963203,0.0018295486,0.00054470415,0.0008514221,0.00015616955,0.00029783105],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00030885692,0.0008888011,0.0007875711,0.0006024245,0.0010191913,0.0004788818,0.0006575901,0.0014153328,0.0002618382],"category_scores_gemma":[0.0036362906,0.0008686002,0.0004397887,0.0008974135,0.00029763128,0.0003257012,0.00038519592,0.0015224501,0.00022758362],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010832952,0.00018546518,0.000039460458,0.00012100749,0.000033473996,0.000005710064,0.00035675865,0.00006550215,0.37686226,0.00008643254,0.61488956,0.0072460314],"study_design_scores_gemma":[0.006514483,0.00020485396,0.00016192139,0.00070488016,0.00017846786,0.0000033535073,0.00008856818,0.006847844,0.30964163,0.00034678364,0.6739155,0.0013917432],"about_ca_topic_score_codex":0.00010158808,"about_ca_topic_score_gemma":0.000105921834,"teacher_disagreement_score":0.7758509,"about_ca_system_score_codex":0.00007486263,"about_ca_system_score_gemma":0.00021862991,"threshold_uncertainty_score":0.999881},"labels":[],"label_agreement":null},{"id":"W4409203845","doi":"10.1016/j.msard.2025.106410","title":"The utility of serum neurofilament light chain in MOGAD: Current insights and future directions","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Canadian Electricity Association; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunoglobulin light chain; Current (fluid); Pathology; Neuroscience; Immunology; Antibody","score_opus":0.042141862273776684,"score_gpt":0.31035300168288665,"score_spread":0.26821113940910996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409203845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009890887,0.99338627,7.4219946e-7,0.0012235091,0.00072630175,0.0026036256,0.00009398285,0.000049216906,0.0009272349],"genre_scores_gemma":[0.007747487,0.9915761,0.000012814822,0.000010814415,0.0000626949,0.0003218483,0.00003957114,0.0000378994,0.00019077296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967714,0.00048267998,0.0010596204,0.0007712507,0.0004151348,0.0004999275],"domain_scores_gemma":[0.99791324,0.0009053066,0.00031042367,0.00057580945,0.00010405627,0.00019115885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004483829,0.0005600092,0.0016984775,0.00048656014,0.0005088846,0.000047289934,0.00018995084,0.00040870995,0.00002462262],"category_scores_gemma":[0.0005433773,0.00033190762,0.0004135918,0.0010943193,0.00045423058,0.000062208754,0.00040019173,0.0012151849,0.00000236661],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036182966,0.00031339843,0.0012638676,0.0088951485,0.00032336556,0.0000011303648,0.0005569777,2.4793925e-7,0.0000027954222,0.000031178137,0.00040769132,0.988168],"study_design_scores_gemma":[0.00174824,0.00008933543,0.055023495,0.015121306,0.00043554843,0.0000022138515,0.00043727946,0.00034728803,0.0000020576624,0.000023428314,0.92650557,0.00026424183],"about_ca_topic_score_codex":0.00011812974,"about_ca_topic_score_gemma":0.0006477647,"teacher_disagreement_score":0.9879038,"about_ca_system_score_codex":0.00007871938,"about_ca_system_score_gemma":0.000199375,"threshold_uncertainty_score":0.9999133},"labels":[],"label_agreement":null},{"id":"W4409342705","doi":"10.1016/j.msard.2025.106439","title":"Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literature","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Multiple sclerosis; Medicine; Observational study; MEDLINE; Dermatology; Psychiatry; Pathology; Biology","score_opus":0.05250570815092951,"score_gpt":0.29305104643914787,"score_spread":0.24054533828821836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409342705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031280185,0.99055964,0.0000036802153,0.00021848218,0.00022285093,0.0052843196,0.00028716866,0.00007000442,0.00022584766],"genre_scores_gemma":[0.003588424,0.99403185,0.00016133027,0.00030075604,0.00003272127,0.00052933174,0.00088039937,0.00008615227,0.00038903556],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99619323,0.00035411687,0.0013921607,0.0010918741,0.0005602889,0.00040834374],"domain_scores_gemma":[0.99753535,0.00069091,0.0004621396,0.00078545714,0.00021236806,0.00031377395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002729423,0.000812143,0.0027752237,0.00039087332,0.00020910229,0.000066996916,0.0002266936,0.0005236644,0.00014890355],"category_scores_gemma":[0.0013400515,0.00063460966,0.0010019832,0.0011894231,0.00027366375,0.000076820754,0.0002165927,0.00055382936,0.000009607176],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042510474,0.0012401084,0.0153598925,0.12966105,0.0015611248,0.000005783541,0.000245992,0.0000026658,0.0000013839821,0.000005361263,0.0010468364,0.8508273],"study_design_scores_gemma":[0.009491349,0.0007032562,0.21743341,0.5756123,0.014524492,0.00002912943,0.00044500118,0.000078146964,5.042095e-7,0.00006302168,0.18054822,0.001071175],"about_ca_topic_score_codex":0.00017272354,"about_ca_topic_score_gemma":0.000072456736,"teacher_disagreement_score":0.8497561,"about_ca_system_score_codex":0.000042980817,"about_ca_system_score_gemma":0.00041527968,"threshold_uncertainty_score":0.99961054},"labels":[],"label_agreement":null},{"id":"W4409451847","doi":"10.1016/j.msard.2025.106449","title":"Identifying axonal injury through the eye: can the cornea provide new clues to axonal injury in MS?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Cornea; Neuroscience; Ophthalmology; Psychology; Psychiatry","score_opus":0.034366259848986454,"score_gpt":0.3169360836789767,"score_spread":0.28256982382999024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409451847","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.069635436,0.031643137,0.00024691923,0.10879545,0.75282323,0.023713302,0.0038340476,0.00091647333,0.008392007],"genre_scores_gemma":[0.48445076,0.17264758,0.0016256637,0.0046272143,0.28936005,0.0041798004,0.0025098785,0.00082415214,0.039774906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99314064,0.00053312787,0.0013817844,0.0015101766,0.002090104,0.0013441814],"domain_scores_gemma":[0.99522656,0.0024468377,0.00040022837,0.0011587676,0.00037476126,0.0003928164],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012301232,0.0010033781,0.0013533286,0.0004861593,0.0011604327,0.00038228594,0.0009730189,0.001250237,0.00014573036],"category_scores_gemma":[0.007238033,0.00060445187,0.00050573784,0.0015747328,0.0009187727,0.00022123502,0.0013227079,0.0040130154,0.000040559684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012604363,0.00025902322,0.006466485,0.00036827908,0.0008345612,0.000004982873,0.004026092,0.00007256215,0.0006177076,0.000029281651,0.940743,0.045317534],"study_design_scores_gemma":[0.0055786897,0.00045597742,0.07233288,0.00405016,0.0004270851,0.0000011150214,0.0022590857,0.00043553556,0.00011387185,0.0003580341,0.9131144,0.0008731194],"about_ca_topic_score_codex":0.016616523,"about_ca_topic_score_gemma":0.010243057,"teacher_disagreement_score":0.4634632,"about_ca_system_score_codex":0.00047936817,"about_ca_system_score_gemma":0.0014131254,"threshold_uncertainty_score":0.9996407},"labels":[],"label_agreement":null},{"id":"W4409785659","doi":"10.1016/j.msard.2025.106459","title":"Results from a multiple sclerosis relapse clinic","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.05545720594714648,"score_gpt":0.29005607205315964,"score_spread":0.23459886610601316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605647,0.007930681,0.00011627608,0.010296046,0.0009900035,0.0021864576,0.0005618902,0.0005864559,0.016767506],"genre_scores_gemma":[0.95638955,0.036355905,0.0014019944,0.0005844933,0.000080297534,0.00020104331,0.00036137548,0.00008745116,0.004537893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476165,0.00029531357,0.0015233706,0.0016164571,0.0007323126,0.001070899],"domain_scores_gemma":[0.995658,0.002046592,0.00031239088,0.0011987452,0.00026766976,0.00051664485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008587301,0.00068678835,0.0011444945,0.0005845105,0.0008537356,0.00014398035,0.0003564594,0.0006758586,0.00030090986],"category_scores_gemma":[0.0060288925,0.00058494334,0.00052890345,0.0012894067,0.00086076325,0.0002630857,0.0005638275,0.0011787607,0.00028267034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009957492,0.003364594,0.4551586,0.00038470927,0.004195168,0.000025126337,0.00435058,0.00019195717,0.0905804,0.00009506756,0.06522892,0.36646742],"study_design_scores_gemma":[0.034955557,0.0003585064,0.93373376,0.0021041073,0.0004299084,0.0000019183278,0.0018894684,0.0085042985,0.0016043896,0.00031836794,0.015412894,0.0006868077],"about_ca_topic_score_codex":0.0029855531,"about_ca_topic_score_gemma":0.0011135129,"teacher_disagreement_score":0.4785752,"about_ca_system_score_codex":0.0001834252,"about_ca_system_score_gemma":0.00017728152,"threshold_uncertainty_score":0.9996602},"labels":[],"label_agreement":null},{"id":"W4410064939","doi":"10.1016/j.msard.2025.106502","title":"Evaluating the impact of systematic reporting of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"Sanofi Genzyme; University Hospital Foundation; University of Alberta","keywords":"Medicine; Multiple sclerosis; Randomized controlled trial; Depression (economics); Anxiety; Physical therapy; Psychiatry; Physical medicine and rehabilitation; Clinical psychology; Internal medicine","score_opus":0.10643477191936601,"score_gpt":0.3578644694380102,"score_spread":0.2514296975186442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410064939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996634,0.0037994415,0.000045633195,0.00019972272,0.00010703032,0.015621161,0.00001166205,0.00004523557,0.00020377203],"genre_scores_gemma":[0.9960156,0.0019561206,0.00020670256,0.000018447015,0.000008073416,0.0017151559,0.000007565043,0.00003706128,0.000035257],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9916527,0.0013966196,0.0047652693,0.0006688083,0.0010299343,0.000486639],"domain_scores_gemma":[0.9898971,0.0050293826,0.0037789533,0.00066945876,0.00049085956,0.00013425124],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0072404947,0.00049134466,0.004179763,0.00050904474,0.00031527763,0.000048298127,0.00013923323,0.00024109843,0.000010204248],"category_scores_gemma":[0.048945855,0.00023612773,0.00076906243,0.0008576846,0.00053826405,0.000110420966,0.0001629771,0.00053291756,2.6523753e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46236882,0.0007281449,0.50657004,0.0021865699,0.0025299033,0.0000011601509,0.0027592154,0.0030747727,0.015191708,0.0000039219726,0.0000062668814,0.004579468],"study_design_scores_gemma":[0.53064185,0.0007618823,0.4162703,0.011134204,0.00068861846,0.0000030831497,0.0014892183,0.0384683,0.00037746006,0.000013876887,7.712255e-8,0.00015114238],"about_ca_topic_score_codex":0.0024801814,"about_ca_topic_score_gemma":0.0004348495,"teacher_disagreement_score":0.090299785,"about_ca_system_score_codex":0.000113007096,"about_ca_system_score_gemma":0.00021609484,"threshold_uncertainty_score":0.96290094},"labels":[],"label_agreement":null},{"id":"W4410091341","doi":"10.1016/j.msard.2025.106499","title":"Vitamin D- should we all take it?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Vitamin D and neurology; Intensive care medicine; Immunology; Internal medicine","score_opus":0.03766777249667159,"score_gpt":0.2990125943421173,"score_spread":0.2613448218454457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410091341","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024576,0.04638897,0.00002610948,0.03514043,0.89102393,0.0031124214,0.00085214153,0.0005493373,0.020449076],"genre_scores_gemma":[0.0523185,0.6385852,0.00043843494,0.0006310819,0.1954522,0.00062664005,0.0028802387,0.00035621677,0.10871148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586344,0.00014990337,0.0007346214,0.001101056,0.0012737724,0.00087717955],"domain_scores_gemma":[0.99685746,0.0016153972,0.00020126517,0.0006819897,0.00030293094,0.0003409695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00051619177,0.00072759436,0.0012091695,0.0005042804,0.00037713913,0.00009565735,0.00029575688,0.0021229067,0.00016405668],"category_scores_gemma":[0.004052501,0.00056906923,0.00041774663,0.0005164131,0.0005584459,0.000091446556,0.00047405195,0.0026105365,0.0000663827],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014915313,0.0003298493,0.000610644,0.0009542731,0.001456765,0.000018571045,0.00062826864,0.000008123299,0.00031101992,0.000005487015,0.9738305,0.02169734],"study_design_scores_gemma":[0.007134217,0.0003739118,0.0036406685,0.0032471763,0.0007464005,0.0000014255517,0.0009118469,0.00031758123,0.000031069885,0.000060999268,0.98296785,0.000566838],"about_ca_topic_score_codex":0.0004102081,"about_ca_topic_score_gemma":0.00046359765,"teacher_disagreement_score":0.6955717,"about_ca_system_score_codex":0.00018241831,"about_ca_system_score_gemma":0.00035052028,"threshold_uncertainty_score":0.9996905},"labels":[],"label_agreement":null},{"id":"W4410220931","doi":"10.1016/j.msard.2025.106511","title":"High-intensity resistance training in people with multiple sclerosis-related fatigue – experiences from a randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Montreal Neurological Institute and Hospital","keywords":"Multiple sclerosis; Medicine; Randomized controlled trial; Physical therapy; Resistance training; Physical medicine and rehabilitation; Intensity (physics); Internal medicine; Psychiatry","score_opus":0.03343611215203489,"score_gpt":0.2630462221543362,"score_spread":0.2296101100023013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410220931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791527,0.004774825,0.00018494124,0.0034472607,0.0008839339,0.009683192,0.00003542381,0.00026638477,0.0015713461],"genre_scores_gemma":[0.9874033,0.0065616085,0.0009930916,0.00018046454,0.000048349022,0.0037564388,0.00010285827,0.00006842832,0.0008854707],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993932,0.00080101826,0.0019270523,0.0013970599,0.0008924507,0.0010503888],"domain_scores_gemma":[0.99411595,0.004049354,0.00052112073,0.00066436426,0.0003144465,0.00033476556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016454638,0.0007924151,0.004448711,0.0007075317,0.0006677871,0.00015792828,0.00030379262,0.0005251411,0.0001714447],"category_scores_gemma":[0.0059385635,0.00054858706,0.00064851163,0.0015365245,0.0014110443,0.00028724482,0.00020346553,0.0010192859,0.000008169338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9379238,0.0008158419,0.022226466,0.000084836895,0.00233414,0.000010481405,0.02830432,0.00037272042,0.0030746611,0.00011175959,0.0003197589,0.0044212444],"study_design_scores_gemma":[0.862863,0.00028740053,0.09958832,0.0023060665,0.00047491357,0.0000010187324,0.02175564,0.011601098,0.0002855286,0.0002371206,0.000057801743,0.00054210256],"about_ca_topic_score_codex":0.0048186784,"about_ca_topic_score_gemma":0.013438408,"teacher_disagreement_score":0.07736185,"about_ca_system_score_codex":0.00019351902,"about_ca_system_score_gemma":0.00031784482,"threshold_uncertainty_score":0.99969655},"labels":[],"label_agreement":null},{"id":"W4410616544","doi":"10.1016/j.msard.2025.106544","title":"Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Demyelinating disease; Paradigm shift; Low and middle income countries; Neuroscience; Developing country; Immunology; Economic growth; Psychology; Economics","score_opus":0.03399252837059849,"score_gpt":0.2637806442357036,"score_spread":0.22978811586510509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410616544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945679,0.001848983,0.000008514932,0.0023932727,0.000120629345,0.00066354015,0.00003905694,0.00004219659,0.00031592403],"genre_scores_gemma":[0.9964158,0.0030863043,0.000014251671,0.00034475073,0.000005029497,0.00011054447,0.0000068742024,0.000012370233,0.000004062298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803483,0.0003808598,0.0005261104,0.00048401256,0.00019964468,0.0003745093],"domain_scores_gemma":[0.997985,0.0016221533,0.00011186663,0.00022648531,0.000004826256,0.000049665792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015568321,0.00021966461,0.00030522374,0.00009519143,0.00017384454,0.000037257476,0.0002372426,0.0001326795,0.000012813904],"category_scores_gemma":[0.00064864085,0.00014957355,0.00009280148,0.001041898,0.00029962006,0.00012015887,0.000044010638,0.0003073998,0.0000023931177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002175105,0.002733429,0.9385917,0.00014207182,0.000026411311,0.000035915484,0.008744274,0.00491098,0.0024311778,0.0024131841,0.0000059607864,0.039747372],"study_design_scores_gemma":[0.004399866,0.0003709338,0.965578,0.00057357544,0.00003140493,0.0000012529307,0.0012946598,0.018462865,0.00020960488,0.008689767,0.00016034859,0.00022769225],"about_ca_topic_score_codex":0.00072729005,"about_ca_topic_score_gemma":0.000998703,"teacher_disagreement_score":0.03951968,"about_ca_system_score_codex":0.000040273586,"about_ca_system_score_gemma":0.00002771293,"threshold_uncertainty_score":0.6099432},"labels":[],"label_agreement":null},{"id":"W4410720609","doi":"10.1016/j.msard.2025.106553","title":"Multiple sclerosis is associated with worse body composition across compartments: Results from a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Meta-analysis; Composition (language); MEDLINE; Internal medicine; Immunology; Biology","score_opus":0.11377070512439319,"score_gpt":0.3423688427167629,"score_spread":0.2285981375923697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410720609","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035392275,0.97633004,0.000023902356,0.0009484983,0.00006585084,0.011348646,0.01054106,0.000252377,0.00013567787],"genre_scores_gemma":[0.015369041,0.9739307,0.0002039079,0.00054851396,0.000015188023,0.0025057658,0.006408135,0.00014610274,0.0008726365],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9897767,0.0016694422,0.0034864,0.002486088,0.0013579548,0.0012234492],"domain_scores_gemma":[0.9902964,0.0045983796,0.0021389718,0.00178344,0.00054995983,0.0006328478],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001707116,0.0018588555,0.01664294,0.00078355166,0.0010553767,0.0003237477,0.00047913837,0.0009532468,0.00015382754],"category_scores_gemma":[0.0028901012,0.0011884926,0.003574128,0.003590444,0.0007767879,0.00026767212,0.00062535575,0.0014113225,0.000036051133],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026029506,0.0012804222,0.0003778264,0.3964862,0.59259295,0.000012404873,0.0009159715,0.000013326119,0.000006738546,0.0000016891403,0.0016135948,0.0064386004],"study_design_scores_gemma":[0.006460987,0.00022082661,0.0021267391,0.23593314,0.7514006,0.0000048581282,0.00025461474,0.0005635569,0.0000020340035,0.0000028100992,0.0019555858,0.0010742618],"about_ca_topic_score_codex":0.0011468068,"about_ca_topic_score_gemma":0.0009785515,"teacher_disagreement_score":0.16055305,"about_ca_system_score_codex":0.00035299442,"about_ca_system_score_gemma":0.00017070521,"threshold_uncertainty_score":0.9994156},"labels":[],"label_agreement":null},{"id":"W4410845152","doi":"10.1016/j.msard.2025.106557","title":"Mental health as an unmet medical need in NMOSD: how can we do better?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Mental health; Psychiatry; Family medicine","score_opus":0.012416499943067115,"score_gpt":0.2603885103566481,"score_spread":0.247972010413581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410845152","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18138881,0.109043725,0.0000048886914,0.07822246,0.62372434,0.004209982,0.0015279244,0.000553696,0.0013241852],"genre_scores_gemma":[0.48550013,0.42437652,0.00011085176,0.0019315279,0.076509,0.0003111683,0.007868672,0.00033407708,0.0030580652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938224,0.0005213969,0.001277219,0.0014988729,0.0018784758,0.0010016678],"domain_scores_gemma":[0.996784,0.0005629854,0.0005068598,0.0007701198,0.00012892917,0.0012471089],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008777265,0.00089840346,0.0017831465,0.0007998955,0.00041428843,0.00018388299,0.00041959138,0.0032079984,0.00027107372],"category_scores_gemma":[0.0013396259,0.00073144346,0.00044232447,0.00089360826,0.00039700634,0.00014494652,0.00022409952,0.002416825,0.000017311748],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056345604,0.0012302125,0.009318089,0.0008626179,0.0008079188,0.000030604042,0.0022486271,0.000007961651,0.00010031484,0.000020391413,0.880219,0.1045908],"study_design_scores_gemma":[0.066841565,0.0028071739,0.022408966,0.076224335,0.001250938,0.000049526116,0.016996259,0.002866169,0.000037595,0.00041448887,0.80692077,0.0031822263],"about_ca_topic_score_codex":0.004325893,"about_ca_topic_score_gemma":0.0015349906,"teacher_disagreement_score":0.54721534,"about_ca_system_score_codex":0.00046717832,"about_ca_system_score_gemma":0.0018125842,"threshold_uncertainty_score":0.99988467},"labels":[],"label_agreement":null},{"id":"W4410935111","doi":"10.1016/j.msard.2025.106560","title":"Informative patterns of health care utilization preceding the recognition of adult-onset multiple sclerosis: A population-based study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Nova Scotia Health Authority; Dalhousie University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Medicine; Cohort; Multiple sclerosis; Population; Confounding; Health care; Medical prescription; Cohort study; Pediatrics; Demography; Gerontology; Internal medicine; Psychiatry; Environmental health","score_opus":0.0663916041363021,"score_gpt":0.31105685961666474,"score_spread":0.24466525548036264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410935111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932142,0.0013622782,0.00041452178,0.0009778802,0.0001544323,0.0033911176,0.00024721952,0.000076660785,0.00016171898],"genre_scores_gemma":[0.9964235,0.0024579305,0.00020306047,0.00014060503,0.0000083965515,0.00026368428,0.00045758605,0.000027962104,0.000017295566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970433,0.00039977455,0.0012117686,0.00040595653,0.0005554538,0.0003837052],"domain_scores_gemma":[0.9975435,0.00072454696,0.0005811572,0.0004130684,0.0006403339,0.00009738717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056551804,0.00030367103,0.0006909187,0.00040763972,0.0008146541,0.0000507129,0.000155935,0.00015836679,0.00002167973],"category_scores_gemma":[0.0016988758,0.00022132919,0.00019104837,0.00088003394,0.00016828615,0.00018057352,0.00013096111,0.00034107384,0.0000017402297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039918156,0.0006250879,0.8803713,0.0007968472,0.00036211289,7.666263e-8,0.010604643,0.00041104195,0.00033687826,0.0000044113817,0.00007781198,0.10601062],"study_design_scores_gemma":[0.008485241,0.00056756334,0.9306014,0.002696928,0.00014987124,1.9177907e-7,0.047026403,0.009362817,0.00091227615,0.000013565366,0.000016678066,0.00016705095],"about_ca_topic_score_codex":0.005423674,"about_ca_topic_score_gemma":0.003628278,"teacher_disagreement_score":0.105843574,"about_ca_system_score_codex":0.00014671907,"about_ca_system_score_gemma":0.00015937047,"threshold_uncertainty_score":0.9025542},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4411050228","doi":"10.1016/j.msard.2025.106543","title":"Multiple Sclerosis in the Greenlandic population. A nationwide cohort study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Nunatsinni Ilisimatusarnermik Siunnersuisoqatigiit; Eli Lilly and Company","keywords":"Medicine; Incidence (geometry); Danish; Demography; Population; Epidemiology; Cohort; Multiple sclerosis; Cohort study; Prevalence; Pediatrics; Environmental health; Internal medicine; Immunology","score_opus":0.036859660648470634,"score_gpt":0.28351488243103456,"score_spread":0.24665522178256394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411050228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870839,0.0017251034,0.0000414114,0.0039511877,0.00022464199,0.0044139344,0.000023363194,0.00013238007,0.0024040882],"genre_scores_gemma":[0.9939618,0.004230084,0.00013191969,0.00036203733,0.000029811814,0.0007573644,0.000091987495,0.000038004073,0.00039695075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964053,0.00046400315,0.0008455835,0.0008273551,0.00082642975,0.0006313031],"domain_scores_gemma":[0.9978166,0.0010810358,0.00014948519,0.00066664076,0.00014766681,0.0001385201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014601367,0.00040704152,0.0006786198,0.00068663125,0.0007455469,0.00012580797,0.00029810224,0.00023259329,0.00006091391],"category_scores_gemma":[0.0019754171,0.00028300498,0.00020176647,0.0017139007,0.000284082,0.0002001283,0.00021545522,0.0007148341,0.000021669039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023242932,0.001332239,0.97491896,0.00006631678,0.00039909597,0.000003796538,0.0018309233,0.00017447058,0.0005291463,0.00003995839,0.0007209686,0.019751666],"study_design_scores_gemma":[0.01093413,0.00021050211,0.9763259,0.00039546206,0.00018982876,0.0000020792786,0.0044143186,0.006742464,0.000018438897,0.00011240391,0.00038757693,0.0002668714],"about_ca_topic_score_codex":0.0060382793,"about_ca_topic_score_gemma":0.007863018,"teacher_disagreement_score":0.019484794,"about_ca_system_score_codex":0.00013677776,"about_ca_system_score_gemma":0.00006191106,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W4411251236","doi":"10.1016/j.msard.2025.106561","title":"Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia; Public Health Ontario; Centre for Advancing Health Outcomes; St. Michael's Hospital; Queen's University; McMaster University; University of Toronto; SickKids Foundation; University of Calgary; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Mental health; Physical health; Psychiatry; Gerontology","score_opus":0.051390492235226334,"score_gpt":0.3133559377619772,"score_spread":0.26196544552675083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411251236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866209,0.007870953,0.00001209122,0.002808198,0.00017770728,0.001688029,0.00019530127,0.00008943785,0.0005374031],"genre_scores_gemma":[0.9804355,0.018863482,0.0001909069,0.000104660015,0.000009162149,0.00010787954,0.00012162249,0.000037770456,0.00012904119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642617,0.00053779926,0.0012127832,0.0007204695,0.0004990131,0.0006037431],"domain_scores_gemma":[0.9974549,0.0012656712,0.0003889038,0.00043440377,0.00011146387,0.00034469116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083483296,0.00040552704,0.0015037454,0.00062010903,0.0003411849,0.0000270545,0.00014033409,0.0002687079,0.000019805877],"category_scores_gemma":[0.0016126292,0.0003597364,0.0002864128,0.0012334553,0.0010036567,0.00015005496,0.0003024788,0.0005793243,0.0000022709564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010236127,0.0021428617,0.86600006,0.0010253185,0.0008865522,0.0000011766625,0.005258777,0.00009246402,0.09752297,0.00008224677,0.0005299797,0.025434006],"study_design_scores_gemma":[0.013319064,0.000381089,0.9755174,0.0017770538,0.00008980732,0.0000010469306,0.0018359473,0.00539681,0.001264649,0.000059445672,0.000093030816,0.00026469395],"about_ca_topic_score_codex":0.007333009,"about_ca_topic_score_gemma":0.0029522215,"teacher_disagreement_score":0.10951733,"about_ca_system_score_codex":0.0001391556,"about_ca_system_score_gemma":0.00014998933,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W4411605538","doi":"10.1016/j.msard.2025.106593","title":"Comment on the use of AI-based protein design for autoimmune encephalitis: exciting possibilities and practical considerations","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"Autoimmune encephalitis; Medicine; Multiple sclerosis; Encephalitis; Immunology; Virology; Neuroscience; Virus; Biology","score_opus":0.13681636538055222,"score_gpt":0.3397781609027335,"score_spread":0.20296179552218127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411605538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9046527,0.00064985076,0.007566505,0.08353684,0.000049251645,0.0033234202,0.000027756454,0.000052978412,0.00014069327],"genre_scores_gemma":[0.97261935,0.000022487004,0.0022977653,0.024662493,0.0000038347875,0.0003451309,0.000003943735,0.00001190548,0.00003307898],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988932,0.00019301352,0.00031525706,0.0002371505,0.00015902164,0.000202366],"domain_scores_gemma":[0.996123,0.0034585877,0.00006568371,0.00020820428,0.000121627316,0.000022899432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004614794,0.0001256529,0.00021669811,0.000105190455,0.0003397942,0.00007711325,0.000023708813,0.00011151236,0.000008769012],"category_scores_gemma":[0.0028024658,0.00008474303,0.000068127156,0.0001458683,0.0003992784,0.00007744729,0.000031924093,0.0002525108,5.8777704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012264624,0.007393575,0.107671395,0.0034717866,0.003049909,0.000036439622,0.011807137,0.0010441788,0.57855976,0.19804837,0.025877655,0.05077515],"study_design_scores_gemma":[0.038835008,0.004237416,0.07503319,0.007304572,0.0007118867,0.000023008686,0.010985251,0.46860653,0.31828365,0.032024845,0.042945936,0.0010086986],"about_ca_topic_score_codex":0.000400259,"about_ca_topic_score_gemma":0.00003193951,"teacher_disagreement_score":0.46756238,"about_ca_system_score_codex":0.00002945119,"about_ca_system_score_gemma":0.0002219164,"threshold_uncertainty_score":0.34557205},"labels":[],"label_agreement":null},{"id":"W4411644443","doi":"10.1016/j.msard.2025.106595","title":"Heterogeneity in health care pathways preceding the classical recognition of adult-onset multiple sclerosis: A multichannel state sequence analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Nova Scotia Health Authority; Vancouver Coastal Health; University of British Columbia; BC Centre for Disease Control; Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; European Genomic Institute for Diabetes; European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Cohort; Health care; Neurology; Population; Cohort study; Disease; Pediatrics; Physical therapy; Psychiatry; Internal medicine","score_opus":0.07206775663767315,"score_gpt":0.30274204998045173,"score_spread":0.23067429334277859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411644443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879886,0.0043943455,0.00028568698,0.003527908,0.00016443802,0.0021017655,0.00045597187,0.0001176369,0.00015342022],"genre_scores_gemma":[0.9779268,0.020393876,0.0006987715,0.0002873044,0.000014054056,0.0003520915,0.00024076448,0.00004048895,0.0000458338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955319,0.00059662235,0.0013582613,0.0009797149,0.0006349671,0.0008985335],"domain_scores_gemma":[0.99718976,0.0010159474,0.0004075819,0.0006428832,0.00046123052,0.0002826063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084018434,0.00048418582,0.0011411648,0.00079705776,0.0008859474,0.000108126405,0.00027561604,0.00027792258,0.000014828984],"category_scores_gemma":[0.0022382732,0.00036098505,0.00048988796,0.0027115564,0.0007510883,0.00018271604,0.00030979957,0.0008200594,0.0000059930026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015361803,0.0011707773,0.7486215,0.0013786271,0.0030240244,0.0000039551237,0.01434146,0.0034798086,0.023659216,0.000012663204,0.00033361424,0.20243816],"study_design_scores_gemma":[0.009748284,0.00038504996,0.886875,0.0026260805,0.00048494406,0.0000017063268,0.010835429,0.084082685,0.004374407,0.00007679909,0.000085926826,0.00042371405],"about_ca_topic_score_codex":0.0042935046,"about_ca_topic_score_gemma":0.021201178,"teacher_disagreement_score":0.20201445,"about_ca_system_score_codex":0.000334704,"about_ca_system_score_gemma":0.00022766342,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W4412441076","doi":"10.1016/j.msard.2025.106616","title":"Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Actelion Pharmaceuticals; Janssen Research and Development; Johnson and Johnson","keywords":"Medicine; Dimethyl fumarate; Multiple sclerosis; Placebo; Clinical endpoint; Randomized controlled trial; Clinical trial; Internal medicine; Phases of clinical research; Oncology; Immunology; Alternative medicine; Pathology","score_opus":0.04708319287789179,"score_gpt":0.3306873086080997,"score_spread":0.2836041157302079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412441076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978506,0.0009642684,0.00011454046,0.0018755771,0.00062011386,0.015512534,0.00007431446,0.00017299349,0.0021596313],"genre_scores_gemma":[0.98891336,0.0073193926,0.0002678599,0.0003126081,0.000057176654,0.002044856,0.00016559772,0.00010408129,0.0008150992],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992748,0.001681615,0.0020297875,0.0015776666,0.00087241636,0.0010904644],"domain_scores_gemma":[0.99100953,0.006869558,0.00057821564,0.00078212656,0.00029041377,0.00047013373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018640874,0.0009907348,0.003405992,0.00095276267,0.0006322796,0.00013197606,0.00021287048,0.0006337849,0.00014177937],"category_scores_gemma":[0.005394424,0.0006356173,0.0009774448,0.001039392,0.001074637,0.0002944836,0.00018274653,0.0010729254,0.00004284278],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86903405,0.010026707,0.019098476,0.00004608175,0.0035522196,0.000005563345,0.00077449076,0.00037487518,0.0002456222,0.00003936457,0.0001818604,0.09662071],"study_design_scores_gemma":[0.87199616,0.005884904,0.10920291,0.0014496561,0.00096831034,4.4667777e-7,0.00093383976,0.008632551,0.00018416636,0.0000980034,0.000104554696,0.0005444861],"about_ca_topic_score_codex":0.0011054022,"about_ca_topic_score_gemma":0.00078220665,"teacher_disagreement_score":0.09607622,"about_ca_system_score_codex":0.00058038,"about_ca_system_score_gemma":0.00033804998,"threshold_uncertainty_score":0.99960953},"labels":[],"label_agreement":null},{"id":"W4412441085","doi":"10.1016/j.msard.2025.106606","title":"The P42 epitope in MOG associated disorders: Understanding regional variations and predictive value","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Predictive value; Epitope; Value (mathematics); Immunology; Internal medicine; Antibody; Machine learning; Computer science","score_opus":0.012913026590431873,"score_gpt":0.22860285113822063,"score_spread":0.21568982454778876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412441085","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07804984,0.11860227,0.013315513,0.01916707,0.74638176,0.008283365,0.005226412,0.00039387145,0.010579906],"genre_scores_gemma":[0.89476264,0.085528575,0.000040701143,0.000100487145,0.012214415,0.00017161733,0.0040816893,0.000079563244,0.0030203178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981424,0.00023657558,0.00040201575,0.0006045117,0.00029091796,0.00032356384],"domain_scores_gemma":[0.9988374,0.0004945325,0.00021378594,0.00026795716,0.00007127944,0.00011502006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033553166,0.0003143251,0.00025893535,0.00012165234,0.00058823434,0.00016428261,0.00016851148,0.0009986933,0.0000041316885],"category_scores_gemma":[0.0013192066,0.00026106433,0.00013248112,0.00024887038,0.0003090176,0.00001696291,0.00015479488,0.00042415145,6.663462e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010812384,0.0006827698,0.021691369,0.00013359069,0.0015396264,0.0000014268714,0.00061468186,0.0042830934,0.00086935447,0.0031757215,0.95921487,0.0067122853],"study_design_scores_gemma":[0.022931324,0.0007219114,0.16721454,0.0014767124,0.00082257565,0.0000010108921,0.0033923879,0.04743958,0.000020627625,0.020289848,0.733354,0.0023355212],"about_ca_topic_score_codex":0.00023976322,"about_ca_topic_score_gemma":0.0017422695,"teacher_disagreement_score":0.8167128,"about_ca_system_score_codex":0.000096083364,"about_ca_system_score_gemma":0.00022472494,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4412467872","doi":"10.1016/j.msard.2025.106620","title":"Automated multiple sclerosis lesion segmentation from 3D-FLAIR MRI using R2AUNet: A deep learning approach with recurrent residual and attention mechanisms","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Fluid-attenuated inversion recovery; Medicine; Multiple sclerosis; Segmentation; Lesion; Magnetic resonance imaging; Residual; Radiology; Neuroscience; Artificial intelligence; Pathology; Computer science; Psychology","score_opus":0.042766705810173444,"score_gpt":0.27687851875551867,"score_spread":0.23411181294534522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412467872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794452,0.0034293989,0.013409755,0.000579369,0.00018653013,0.002021789,0.000036483645,0.00060578366,0.00028568527],"genre_scores_gemma":[0.96085715,0.011705134,0.026527004,0.000058015037,0.000024701576,0.0001702303,0.0004659193,0.00007816292,0.000113684866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963537,0.00037385485,0.00071459287,0.001171044,0.000692614,0.0006942081],"domain_scores_gemma":[0.99851894,0.00035496516,0.00029185464,0.00035548696,0.00021327724,0.0002654905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050186133,0.00056098774,0.00073302776,0.00051397143,0.001169091,0.00017686037,0.00012609444,0.00038690498,0.00002740366],"category_scores_gemma":[0.00036889315,0.00045836272,0.00013219932,0.0008516262,0.00040632492,0.0003326661,0.00028775985,0.00072279753,0.0000059901427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028007692,0.0012441396,0.22603485,0.0005880188,0.001813833,0.0000057278994,0.003742716,0.009668811,0.5456789,0.000040783594,0.00026249638,0.20811896],"study_design_scores_gemma":[0.010552016,0.00037363698,0.49637634,0.001489448,0.0003913576,0.0000035580713,0.003962805,0.48522925,0.0011482851,0.000035208133,0.000051636787,0.00038646525],"about_ca_topic_score_codex":0.0015188715,"about_ca_topic_score_gemma":0.00054093305,"teacher_disagreement_score":0.54453063,"about_ca_system_score_codex":0.00021885346,"about_ca_system_score_gemma":0.00007093303,"threshold_uncertainty_score":0.9997868},"labels":[],"label_agreement":null},{"id":"W4412529008","doi":"10.1016/j.msard.2025.106631","title":"Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Medicine; Watchful waiting; Multiple sclerosis; Pediatrics; Surgery; Dermatology; Psychiatry; Internal medicine; Cancer","score_opus":0.019271919074710903,"score_gpt":0.26887356785321725,"score_spread":0.24960164877850635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412529008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930383,0.0012290457,0.0000056968274,0.003934348,0.00015697561,0.0010679835,0.000025862597,0.00007563861,0.0004661825],"genre_scores_gemma":[0.99375993,0.00542392,0.00015712014,0.00020166597,0.000006491283,0.00015999495,0.000029693536,0.000027736607,0.00023346867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975885,0.00016103641,0.0006531344,0.00068193587,0.00035942806,0.00055592996],"domain_scores_gemma":[0.9984469,0.00086409756,0.00009313153,0.00034513965,0.00006250359,0.00018824935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004063248,0.0003300309,0.0005944774,0.00022476877,0.0002803329,0.000060765615,0.00008745584,0.00022299157,0.000030819818],"category_scores_gemma":[0.0022555331,0.00026121957,0.0001311364,0.00042706853,0.00054112443,0.00018525559,0.00039924105,0.00051750406,0.000005226156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003509116,0.0006303478,0.9720686,0.00020757155,0.00017692673,0.0000024795381,0.0010407036,0.000019540392,0.00015186354,0.0000078767835,0.000089869645,0.025253309],"study_design_scores_gemma":[0.009858217,0.000117459145,0.9848624,0.0008204022,0.00006929769,5.589063e-7,0.00148384,0.002193149,0.00003086121,0.00020264137,0.00012303371,0.00023814423],"about_ca_topic_score_codex":0.000982957,"about_ca_topic_score_gemma":0.0037941523,"teacher_disagreement_score":0.025015166,"about_ca_system_score_codex":0.0002064874,"about_ca_system_score_gemma":0.00004801754,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W4412702645","doi":"10.1016/j.msard.2025.106637","title":"Serum neurofilament light chain as a biomarker in multiple sclerosis: A cross-sectional observation in real-world clinical practice","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"Canadian Institutes of Health Research; University Hospital Foundation; Roche","keywords":"Multiple sclerosis; Medicine; Biomarker; Cross-sectional study; Clinical Practice; Immunology; Oncology; Pathology; Physical therapy","score_opus":0.11615171406844582,"score_gpt":0.37339559586724697,"score_spread":0.25724388179880114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412702645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97561026,0.001591283,0.00001894413,0.013012492,0.0007630934,0.0023962415,0.000030536896,0.00017304055,0.0064041154],"genre_scores_gemma":[0.97457045,0.021438234,0.0007170926,0.0012473841,0.000045036417,0.00045297126,0.0000748625,0.00006394123,0.0013900421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409616,0.0007174195,0.0020096016,0.0013978013,0.00082110334,0.0009579332],"domain_scores_gemma":[0.99624115,0.002153801,0.00035654817,0.00062173104,0.00031844806,0.00030833148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026598242,0.00053621153,0.00089862436,0.0012173547,0.00043104767,0.00017949856,0.00025095925,0.00053606613,0.00010945269],"category_scores_gemma":[0.0078323,0.00048929814,0.0003212732,0.0026200213,0.0005106633,0.0005390407,0.00040072022,0.0013203808,0.0000463063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022971532,0.0019425597,0.96128976,0.00015464505,0.0003317484,0.00001843236,0.00052708667,0.00021153383,0.0077873077,0.00011967433,0.0009992863,0.024320787],"study_design_scores_gemma":[0.018224807,0.00025663487,0.9531508,0.0010095665,0.0000651306,0.0000034532459,0.0007063575,0.020664234,0.00016845435,0.0000932709,0.005261505,0.0003957708],"about_ca_topic_score_codex":0.0056587798,"about_ca_topic_score_gemma":0.009874721,"teacher_disagreement_score":0.023925016,"about_ca_system_score_codex":0.0004475453,"about_ca_system_score_gemma":0.00028234135,"threshold_uncertainty_score":0.99975586},"labels":[],"label_agreement":null},{"id":"W4412713513","doi":"10.1016/j.msard.2025.106617","title":"Real-world change in annualized relapse rate and healthcare resource utilization following initiation of ofatumumab in people with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Quebec Population Health Research Network","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Multiple sclerosis; Health care; Ofatumumab; Natalizumab; Resource (disambiguation); Physical medicine and rehabilitation; Physical therapy; Environmental health; Intensive care medicine; Internal medicine; Economic growth; Psychiatry","score_opus":0.06405300285565096,"score_gpt":0.3130705169597751,"score_spread":0.24901751410412415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412713513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959327,0.0036883494,0.00002114707,0.0034883427,0.00008849603,0.0022864328,0.000040334242,0.00008312021,0.0007105335],"genre_scores_gemma":[0.9745769,0.024280274,0.00029527114,0.000176042,0.000011325019,0.00034720168,0.00014328228,0.000050984785,0.00011872516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968844,0.000449635,0.0009038921,0.0007559872,0.00040981665,0.00059628254],"domain_scores_gemma":[0.9983706,0.0006839945,0.00024869668,0.0003754831,0.0001493696,0.00017189569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009120834,0.00037767368,0.00091513235,0.001294775,0.00025008558,0.000040139617,0.000108372384,0.0002736634,0.000012205441],"category_scores_gemma":[0.00092262024,0.000330189,0.00011531476,0.002605862,0.0002518146,0.00033579374,0.0001784207,0.0005310873,0.0000010399707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014611582,0.00038380423,0.96236223,0.00056372146,0.00014350851,0.0000039026504,0.007406593,0.000103361635,0.004001859,0.00008286284,0.000055459037,0.02343157],"study_design_scores_gemma":[0.018651104,0.00025581592,0.9593423,0.0042071366,0.000080804835,6.236133e-7,0.0035744556,0.012982774,0.00045013093,0.000039376428,0.00014042572,0.00027504237],"about_ca_topic_score_codex":0.015254702,"about_ca_topic_score_gemma":0.07374499,"teacher_disagreement_score":0.058490288,"about_ca_system_score_codex":0.00021342572,"about_ca_system_score_gemma":0.000110494046,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W4412856400","doi":"10.1016/j.msard.2025.106619","title":"Systematic review on the wearing-off phenomenon of disease-modifying therapies in managing multiple sclerosis","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Regimen; Psychological intervention; Confidence interval; Disease; Physical therapy; Systematic review; Pediatrics; Internal medicine; MEDLINE; Psychiatry","score_opus":0.0776087536671738,"score_gpt":0.30965766634740216,"score_spread":0.23204891268022837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412856400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029153278,0.98614174,0.000005935209,0.0013460045,0.00018648102,0.010954579,0.00011290889,0.00011262993,0.00084821146],"genre_scores_gemma":[0.015456898,0.9812684,0.000042912787,0.00023294688,0.000026334921,0.002333926,0.00010447939,0.00013751918,0.00039657205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9931103,0.0012081759,0.0025034605,0.0012352717,0.0010168465,0.00092593994],"domain_scores_gemma":[0.9924279,0.0045707957,0.0010186976,0.0015318559,0.0001579007,0.00029287935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019294651,0.0011476466,0.0052650617,0.0009773349,0.0004925536,0.000094497365,0.0006705251,0.00040212288,0.00007116575],"category_scores_gemma":[0.0047250576,0.0006875451,0.0013261813,0.0018580185,0.00055801607,0.00012546006,0.00054743065,0.0014308707,0.00003317217],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009199655,0.00042835623,0.00043434565,0.77750915,0.001738923,0.0000034232792,0.00042017456,0.000016989166,0.000008825671,0.000058543596,0.00020364183,0.2190856],"study_design_scores_gemma":[0.0022669272,0.00013757848,0.0022932524,0.9849063,0.0035225975,0.0000011828191,0.00062594184,0.0006976722,0.0000011846055,0.000034992587,0.004876055,0.00063629827],"about_ca_topic_score_codex":0.00019179795,"about_ca_topic_score_gemma":0.00008710527,"teacher_disagreement_score":0.21844931,"about_ca_system_score_codex":0.0003096526,"about_ca_system_score_gemma":0.00024132617,"threshold_uncertainty_score":0.99955755},"labels":[],"label_agreement":null},{"id":"W4413049549","doi":"10.1016/j.msard.2025.106665","title":"Treatment of First and Subsequent Attacks in Multiple Sclerosis","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Psychiatry","score_opus":0.02823803753599192,"score_gpt":0.2574638461557841,"score_spread":0.2292258086197922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413049549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79397595,0.023295915,0.0000109436105,0.00071000407,0.1751266,0.0032425146,0.001090675,0.00016954316,0.002377863],"genre_scores_gemma":[0.86499655,0.12708847,0.00013104001,0.0000090127805,0.0056591216,0.00027049702,0.00063366705,0.00007197083,0.0011396938],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976038,0.00007922499,0.00076624943,0.0007880958,0.0003346065,0.00042802555],"domain_scores_gemma":[0.99823374,0.00077754905,0.00023766526,0.00044445624,0.00011037281,0.00019620793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000120545614,0.000577892,0.0011189338,0.00048651794,0.00024795573,0.000038892467,0.000070242415,0.0012138694,0.00005608247],"category_scores_gemma":[0.00035044822,0.0004659896,0.00027635053,0.00044159213,0.00029512684,0.000074434836,0.000073499716,0.00043483212,0.0000069147763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013908559,0.007416502,0.64671314,0.0013349423,0.0032460755,0.000038642644,0.0021060181,0.00014296005,0.00023474147,0.000014541679,0.07102505,0.26633656],"study_design_scores_gemma":[0.048946667,0.0020943384,0.17192587,0.0047619394,0.0016937874,0.000004701021,0.0004321086,0.001938347,0.00031741548,0.000047764446,0.7669286,0.00090842845],"about_ca_topic_score_codex":0.008120152,"about_ca_topic_score_gemma":0.006356266,"teacher_disagreement_score":0.6959036,"about_ca_system_score_codex":0.00035058378,"about_ca_system_score_gemma":0.00016391299,"threshold_uncertainty_score":0.99977916},"labels":[],"label_agreement":null},{"id":"W4413323873","doi":"10.1016/j.msard.2025.106697","title":"Gaps and discordance in assessment of PIRA identified between HCPs and people with MS: Results of international surveys","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Sanofi Genzyme; EMD Serono; National Institutes of Health; Genentech; Multiple Sclerosis Society; Moderna; Kiniksa Pharmaceuticals; Biogen; Merck KGaA; Sanofi; Fondation Brain Canada; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Vir Biotechnology; Eli Lilly and Company; Multiple Sclerosis Society of Canada; Amgen","keywords":"Medicine; Multiple sclerosis; Family medicine; Psychiatry","score_opus":0.02734716556446047,"score_gpt":0.303696548193095,"score_spread":0.2763493826286345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413323873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949547,0.0014198034,0.00017554141,0.0015189582,0.000061175495,0.00059742917,0.00011906229,0.0000149971065,0.0011383102],"genre_scores_gemma":[0.9853432,0.013872655,0.0005158715,0.00000960463,0.00000653631,0.000033120676,0.00006368799,0.000013128722,0.00014218279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825984,0.00017008257,0.0005905504,0.0004199283,0.00033596333,0.00022362781],"domain_scores_gemma":[0.99883443,0.00056167913,0.00018171898,0.00020914945,0.000131214,0.000081786246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008837015,0.00018081334,0.0005434128,0.00033584458,0.00008199728,0.000024284966,0.00008842773,0.00009962678,0.0000057466527],"category_scores_gemma":[0.00049806875,0.00013787043,0.000043912944,0.00046224124,0.0004581829,0.00010129052,0.00019987099,0.0002556801,1.4106405e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002810788,0.00020345305,0.9722368,0.00028448997,0.0003315985,6.7539725e-7,0.0007248428,0.000034735815,0.006965288,0.00003999123,0.000041430794,0.018855574],"study_design_scores_gemma":[0.010635677,0.00023623783,0.9839797,0.0012497662,0.00006544527,5.876776e-7,0.0009083349,0.002225677,0.00047321594,0.000042992866,0.000063758096,0.000118602315],"about_ca_topic_score_codex":0.0024678456,"about_ca_topic_score_gemma":0.00549092,"teacher_disagreement_score":0.018736972,"about_ca_system_score_codex":0.00003461135,"about_ca_system_score_gemma":0.000058021207,"threshold_uncertainty_score":0.5622193},"labels":[],"label_agreement":null},{"id":"W4413682646","doi":"10.1016/j.msard.2025.106696","title":"Correlations of myelin, axon, and inflammation metrics from multi echo T2 relaxation and multi-shell diffusion imaging in multiple sclerosis and healthy controls","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; International Collaboration On Repair Discoveries","funders":"Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Myelin; Diffusion MRI; Diffusion imaging; Axon; White matter; Neuroscience; Inflammation; Echo (communications protocol); Shell (structure); Diffusion; Nuclear magnetic resonance; Magnetic resonance imaging; Pathology; Anatomy; Immunology; Central nervous system; Physics; Internal medicine; Biology; Radiology; Materials science","score_opus":0.04339920880491238,"score_gpt":0.2789367482793924,"score_spread":0.23553753947448003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413682646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97471476,0.017675046,0.0025623534,0.0023576985,0.00016039415,0.0022375456,0.000116897805,0.000094432035,0.00008085716],"genre_scores_gemma":[0.9362466,0.05862523,0.004602859,0.00012003554,0.0000206583,0.00012734448,0.00013895499,0.000043442207,0.0000749268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966758,0.00029004432,0.0011915118,0.00090021593,0.0004136124,0.00052885496],"domain_scores_gemma":[0.9968613,0.0017844914,0.00042318838,0.0003610051,0.00028431378,0.0002857054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007555606,0.00045175926,0.0008708293,0.0010723786,0.0005742873,0.00009831716,0.00009817278,0.00038282073,0.000013002498],"category_scores_gemma":[0.003796228,0.0004105865,0.0001032241,0.0009932988,0.0006621283,0.00041156408,0.00032053745,0.0006399212,0.0000022574807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053059834,0.0003542838,0.7875345,0.00022298188,0.00013863014,9.68063e-7,0.0021862944,0.00016132112,0.070176035,0.00002021561,0.000044707904,0.1386295],"study_design_scores_gemma":[0.019241657,0.00010155969,0.67458904,0.0010858402,0.0001256919,9.790814e-7,0.0018829203,0.3021938,0.0004002554,0.000054506974,0.000091274036,0.00023247555],"about_ca_topic_score_codex":0.004446828,"about_ca_topic_score_gemma":0.0029031974,"teacher_disagreement_score":0.30203247,"about_ca_system_score_codex":0.0001311065,"about_ca_system_score_gemma":0.000073515555,"threshold_uncertainty_score":0.9998346},"labels":[],"label_agreement":null},{"id":"W4413903534","doi":"10.1016/j.msard.2025.106720","title":"Subjective cognitive fatigability is associated with worse patient-reported physical disability in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Psychological Association","keywords":"Multiple sclerosis; Medicine; Cognition; Physical disability; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.042468346747391035,"score_gpt":0.28022884915920115,"score_spread":0.23776050241181013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413903534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992795,0.00052587164,0.000029685463,0.0015477227,0.00012452595,0.003402269,0.00017976649,0.00023081384,0.0011643416],"genre_scores_gemma":[0.9979962,0.0007636616,0.00007953001,0.00021570081,0.0000150189535,0.00058696675,0.0001382678,0.00006302739,0.00014162541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950817,0.0004982958,0.0010005705,0.0015492006,0.0008301881,0.001040014],"domain_scores_gemma":[0.9957673,0.002392813,0.00032228287,0.00064368994,0.0005130887,0.0003608143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006161719,0.00069525465,0.001288457,0.0003325658,0.0005923919,0.000079193014,0.0001641335,0.00041152266,0.00008340494],"category_scores_gemma":[0.0059877206,0.0005446468,0.00034937367,0.0019860517,0.0022094406,0.00030669261,0.0003125145,0.0011333048,0.000011911815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020401785,0.004345602,0.9303196,0.00012210592,0.0012650398,0.000007110789,0.004736012,0.000054993798,0.0037793072,0.000006325258,0.000079977166,0.05324375],"study_design_scores_gemma":[0.017185852,0.0006059485,0.96244955,0.002092298,0.00033678795,0.0000013817906,0.0054547708,0.008995574,0.0021652372,0.00015399263,0.000026214146,0.00053239363],"about_ca_topic_score_codex":0.002361991,"about_ca_topic_score_gemma":0.004054942,"teacher_disagreement_score":0.052711353,"about_ca_system_score_codex":0.00051063346,"about_ca_system_score_gemma":0.00018327446,"threshold_uncertainty_score":0.9997005},"labels":[],"label_agreement":null},{"id":"W4413923643","doi":"10.1016/j.msard.2025.106718","title":"When does multiple sclerosis start?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.028666343054551614,"score_gpt":0.26593867714112135,"score_spread":0.23727233408656973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413923643","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028761918,0.030458704,0.000114446404,0.009769328,0.90441966,0.008922858,0.0051480494,0.0018692729,0.010535758],"genre_scores_gemma":[0.3223755,0.40014362,0.00306846,0.00053129357,0.22524507,0.0021581622,0.006303009,0.0009411374,0.03923374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99093145,0.0004212221,0.001751502,0.002549104,0.0024629387,0.0018837595],"domain_scores_gemma":[0.99176097,0.0042183585,0.00059414934,0.00166938,0.00089384237,0.0008633237],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0008756062,0.0016398712,0.0025697981,0.0010885966,0.0012150679,0.0003623908,0.0007201308,0.0030267339,0.00055438257],"category_scores_gemma":[0.010501685,0.0012183841,0.0010131683,0.00089811685,0.0012628463,0.00034077864,0.0011679655,0.0037019828,0.00012634916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010474833,0.00083469594,0.009793926,0.0014416195,0.0022867688,0.0000106862035,0.0010925421,0.00002593556,0.0029264335,0.0000075367284,0.9258626,0.05466975],"study_design_scores_gemma":[0.021042507,0.00060695346,0.039886072,0.006855357,0.0012566585,0.000001436134,0.001216824,0.0019721664,0.00039456124,0.00021170388,0.92473006,0.0018256702],"about_ca_topic_score_codex":0.0033452455,"about_ca_topic_score_gemma":0.0028336793,"teacher_disagreement_score":0.6791746,"about_ca_system_score_codex":0.00048492363,"about_ca_system_score_gemma":0.0007160705,"threshold_uncertainty_score":0.99963486},"labels":[],"label_agreement":null},{"id":"W4414298417","doi":"10.1016/j.msard.2025.106761","title":"Machine learning using clinical variables to screen for depression and anxiety in people with early multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; St. Michael's Hospital; Centre for Advancing Health Outcomes; University of British Columbia; University of Toronto; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Mach-Gaensslen Foundation of Canada; University of Calgary","keywords":"Depression (economics); Multiple sclerosis; Anxiety; Identification (biology); MEDLINE","score_opus":0.04901473421761774,"score_gpt":0.3064524261605053,"score_spread":0.2574376919428875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414298417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990499,0.0029729998,0.0024059897,0.0010250198,0.00011305816,0.0025193866,0.00005963143,0.00011971417,0.0002851696],"genre_scores_gemma":[0.97840625,0.011702479,0.00914907,0.00017146995,0.000030202496,0.00021476674,0.00005234638,0.00006778596,0.00020565056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679536,0.00023044096,0.0007882429,0.0010665015,0.00036291155,0.0007565562],"domain_scores_gemma":[0.9977937,0.0011378416,0.00015172934,0.00035905538,0.00018383721,0.00037386987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010311124,0.00043082994,0.000908031,0.00048906094,0.000668271,0.00010833655,0.00014630766,0.00036276708,0.000016531438],"category_scores_gemma":[0.002045357,0.0003361519,0.00015908446,0.0009954465,0.0003016364,0.0002020983,0.00037747427,0.0007398158,0.0000022695533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020380937,0.00034407162,0.91511935,0.00016774649,0.0002857211,7.9679927e-7,0.00069921,0.001462919,0.009171218,0.000012077635,0.00008674617,0.07061203],"study_design_scores_gemma":[0.01541345,0.00048130905,0.86407983,0.0017145663,0.00016443878,0.0000019245056,0.0006208591,0.11595912,0.0002432526,0.000020188798,0.00096325367,0.00033779672],"about_ca_topic_score_codex":0.005114815,"about_ca_topic_score_gemma":0.004099086,"teacher_disagreement_score":0.1144962,"about_ca_system_score_codex":0.00009439583,"about_ca_system_score_gemma":0.00009671739,"threshold_uncertainty_score":0.99990904},"labels":[],"label_agreement":null},{"id":"W4414804539","doi":"10.1016/j.msard.2025.106783","title":"A conceptual approach to comprehensive interdisciplinary cognitive rehabilitation: A description using the TIDieR-rehab framework","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Educational and Psychological Assessments","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Ottawa; Memorial University of Newfoundland; McGill University; Queen's University","funders":"Multiple Sclerosis Society; International Progressive MS Alliance","keywords":"Cognition; Rehabilitation; Cognitive rehabilitation therapy; Intervention (counseling); Occupational therapy; Cognitive skill; Checklist; Process (computing); Cognitive Intervention","score_opus":0.07745267860194258,"score_gpt":0.35883785864246953,"score_spread":0.2813851800405269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414804539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96882993,0.0012758595,0.010006621,0.0051274085,0.0013776906,0.0009465876,0.000026526697,0.000055090233,0.012354283],"genre_scores_gemma":[0.99504286,0.000033189826,0.0029823398,0.001015547,0.000037567224,0.00025330822,0.000034831974,0.000013267789,0.00058707775],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9984474,0.00032374694,0.00032825387,0.0005086942,0.00013160064,0.00026030192],"domain_scores_gemma":[0.9982792,0.0012278244,0.000086212465,0.00020836537,0.000115093644,0.00008329781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016800978,0.0001930523,0.00020795135,0.00011459731,0.00051696145,0.0000527389,0.00015125114,0.00022764476,0.00016302575],"category_scores_gemma":[0.00013790955,0.00013459085,0.00010508882,0.00059321115,0.00053270935,0.00007803004,0.00015740597,0.0003928511,0.000037781156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033098846,0.009149028,0.25099438,0.00014554567,0.002709586,0.0000026801492,0.36702824,0.0019649635,0.0031297181,0.20476992,0.03177483,0.12502122],"study_design_scores_gemma":[0.0017825087,0.0003124438,0.7978513,0.00039076206,0.000101658414,0.000003218112,0.17969507,0.0007716474,0.0000030655708,0.017067363,0.001757329,0.0002636228],"about_ca_topic_score_codex":0.00008806483,"about_ca_topic_score_gemma":0.000007635085,"teacher_disagreement_score":0.54685694,"about_ca_system_score_codex":0.000041342595,"about_ca_system_score_gemma":0.000022204367,"threshold_uncertainty_score":0.5488456},"labels":[],"label_agreement":null},{"id":"W4414804578","doi":"10.1016/j.msard.2025.106784","title":"Rehabilitation interventions for improving gait for people with multiple sclerosis: A scoping review of reviews","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University of Saskatchewan; University Health Network","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Saskatchewan Health Research Foundation; University of Saskatchewan","keywords":"Rehabilitation; Psychological intervention; Gait; International Classification of Functioning, Disability and Health; Systematic review; MEDLINE; Multiple sclerosis","score_opus":0.09290883554640164,"score_gpt":0.36568992787326343,"score_spread":0.27278109232686176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414804578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017149929,0.959994,0.0021734915,0.00052226975,0.00022709278,0.0363119,0.00058002135,0.00010640673,0.00006767365],"genre_scores_gemma":[0.00016601078,0.96842974,0.011604748,0.000067230045,0.00005020908,0.018388335,0.0009057325,0.00014842686,0.00023954822],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99382573,0.0004321183,0.0031047245,0.0013635936,0.00047108307,0.0008027466],"domain_scores_gemma":[0.9907472,0.005622577,0.0016983188,0.0009480393,0.00072204595,0.00026181695],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002230881,0.00094699854,0.0058718845,0.0007396697,0.00053779565,0.000060821483,0.00033072493,0.00052143144,0.00003871936],"category_scores_gemma":[0.017935075,0.0006833937,0.0030602887,0.0013120332,0.0003900101,0.0002079615,0.00026516351,0.00057738344,0.000004424726],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010041004,0.00026618433,0.00013760627,0.5317148,0.0004253869,6.0555514e-8,0.0001313053,0.0000014404656,0.000013786142,0.00000745167,0.00076499034,0.46643656],"study_design_scores_gemma":[0.0055264644,0.0011857128,0.000588535,0.9453014,0.0049803616,0.0000023190057,0.00017978257,0.000295083,0.000003365321,0.000009449845,0.041315496,0.0006120284],"about_ca_topic_score_codex":0.00014573708,"about_ca_topic_score_gemma":0.00081501564,"teacher_disagreement_score":0.4658245,"about_ca_system_score_codex":0.00021120279,"about_ca_system_score_gemma":0.0005686676,"threshold_uncertainty_score":0.9995617},"labels":[],"label_agreement":null},{"id":"W4415224678","doi":"10.1016/j.msard.2025.106799","title":"The influence of manual dexterity on processing speed assessment in multiple sclerosis: A comparison of the PST and oral SDMT","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"Biogen Idec; Biogen","keywords":"Multiple sclerosis; Test (biology); Cohort; Expanded Disability Status Scale; Cognition; Correlation","score_opus":0.049759915345642676,"score_gpt":0.33300855357191367,"score_spread":0.283248638226271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415224678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933413,0.002504798,0.0000106976195,0.0022838723,0.00008836618,0.0013055291,0.000021804182,0.000027839498,0.00041575002],"genre_scores_gemma":[0.9953461,0.004200401,0.00021820208,0.000075218006,0.000005787217,0.0000611297,0.0000047342696,0.000020146985,0.00006824035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736774,0.00026647287,0.00087505556,0.00047694333,0.0005610279,0.00045275423],"domain_scores_gemma":[0.99818134,0.0007737252,0.00031372058,0.0004458798,0.00018816913,0.00009714479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007575701,0.00029624786,0.000671433,0.0002024195,0.000598062,0.00005705135,0.0002596691,0.00018739812,0.0000041589597],"category_scores_gemma":[0.0011549458,0.00017601102,0.00013294266,0.00078885484,0.001329565,0.00011911123,0.00038240838,0.0007067963,6.503223e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005495562,0.00068601535,0.88089925,0.0003479053,0.00015938016,3.021627e-7,0.0014705306,0.001415767,0.04975378,0.00006300025,0.00007655859,0.06457797],"study_design_scores_gemma":[0.005652954,0.00022748945,0.95867956,0.0027048711,0.00007636938,6.019466e-7,0.0031133147,0.026954105,0.0022804716,0.00007171839,0.00008668588,0.00015189183],"about_ca_topic_score_codex":0.0009501671,"about_ca_topic_score_gemma":0.0013449817,"teacher_disagreement_score":0.07778029,"about_ca_system_score_codex":0.00008857466,"about_ca_system_score_gemma":0.0001352928,"threshold_uncertainty_score":0.7177521},"labels":[],"label_agreement":null},{"id":"W4415610478","doi":"10.1016/j.msard.2025.106819","title":"Validity of model for predicting risk of relapse in MOGAD","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Incidence (geometry); Antibody; Disease; Autoimmune disease; Central nervous system; Optic neuritis; Immunopathology","score_opus":0.0355798650009472,"score_gpt":0.2633935466127812,"score_spread":0.227813681611834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415610478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452347,0.00069369894,0.0025331306,0.0004926826,0.0001228945,0.0007541867,0.00008823769,0.00003141862,0.00076030794],"genre_scores_gemma":[0.99525243,0.0022611811,0.0019738148,0.000020944643,0.0000036818508,0.000034826873,0.00002193137,0.000015086679,0.0004161192],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99889284,0.00004406475,0.0005139084,0.0002456713,0.00012223778,0.00018127258],"domain_scores_gemma":[0.99910074,0.0003756601,0.00017352261,0.00022124534,0.000080703794,0.000048126778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003421785,0.00012486144,0.0003611672,0.00018888463,0.000054326614,0.0000031865661,0.000062797924,0.00020111338,0.0000053665813],"category_scores_gemma":[0.0011878505,0.00011071979,0.00012850226,0.00029488647,0.00013898897,0.000055363616,0.00004505655,0.00021847457,3.0092394e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004274717,0.0004703248,0.95702434,0.00054009305,0.00016302805,2.1751237e-7,0.00198287,0.0177773,0.004607448,0.00009669381,0.00037121435,0.016538998],"study_design_scores_gemma":[0.008376022,0.00014760184,0.3209781,0.0009185441,0.00019058668,3.206961e-7,0.00047972982,0.6663143,0.0013462974,0.0011334362,0.00003011773,0.000084937965],"about_ca_topic_score_codex":0.0005162791,"about_ca_topic_score_gemma":0.00037041542,"teacher_disagreement_score":0.648537,"about_ca_system_score_codex":0.000026204612,"about_ca_system_score_gemma":0.00005265077,"threshold_uncertainty_score":0.4515022},"labels":[],"label_agreement":null},{"id":"W4415613121","doi":"10.1016/j.msard.2025.106816","title":"A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; St. Michael's Hospital; McMaster University; Queen's University; University of British Columbia; Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Multiple sclerosis; Association (psychology); Age of onset; Quality of life (healthcare); Young adult; MEDLINE","score_opus":0.03992407663709352,"score_gpt":0.29889150811099796,"score_spread":0.25896743147390444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415613121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994374,0.002283202,0.000009313833,0.00021690792,0.00010893635,0.0021970898,0.000054294014,0.00013084785,0.0006254597],"genre_scores_gemma":[0.9936557,0.0048258943,0.0005562124,0.000032618318,0.000012289707,0.00026619513,0.00004594374,0.000038373168,0.0005668104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972862,0.00019660592,0.00070213975,0.00077852095,0.00055605196,0.00048046876],"domain_scores_gemma":[0.9983564,0.0006185036,0.00025456992,0.0002564,0.00028599007,0.00022814053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084918586,0.00037405675,0.0006111375,0.0004441969,0.00068067556,0.000121009194,0.00010399264,0.0002452654,0.000015045025],"category_scores_gemma":[0.00070728385,0.00031144978,0.000089762994,0.00076597766,0.0003401412,0.00019579212,0.00036858683,0.00046671613,0.0000025189133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023334127,0.0012470153,0.98416775,0.00044104687,0.0011790367,0.0000025601885,0.0029921425,0.00003675117,0.0053886143,0.000015727286,0.00006765571,0.004228382],"study_design_scores_gemma":[0.014065072,0.0005115796,0.9783081,0.00070845365,0.00040307592,0.0000018658665,0.0020925412,0.0031286993,0.0004074104,0.000013739092,0.00008572587,0.00027373945],"about_ca_topic_score_codex":0.00044956908,"about_ca_topic_score_gemma":0.00080426125,"teacher_disagreement_score":0.013831731,"about_ca_system_score_codex":0.00017761828,"about_ca_system_score_gemma":0.0000604805,"threshold_uncertainty_score":0.9999338},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4415613154","doi":"10.1016/j.msard.2025.106818","title":"Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Guthy-Jackson Charitable Foundation","keywords":"Quality of life (healthcare); Neuromyelitis optica; Disease burden; Multiple sclerosis; Multidisciplinary approach; Spectrum disorder; Disease; Burden of disease","score_opus":0.023110452325815392,"score_gpt":0.28165877251881116,"score_spread":0.2585483201929958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415613154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961452,0.0010636015,0.00003568645,0.0011073037,0.00005666883,0.0010996237,0.00013106392,0.000052236297,0.0003086544],"genre_scores_gemma":[0.99663395,0.0028236366,0.00010606546,0.000058125093,0.000008120749,0.000093019364,0.00016445483,0.00002538179,0.00008723739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968155,0.00020797495,0.0010397529,0.0008216656,0.0006417767,0.00047332208],"domain_scores_gemma":[0.99827147,0.0003921332,0.00027405613,0.0004340073,0.00023220593,0.00039611594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028536032,0.00034311885,0.0008546601,0.0007070143,0.0002782039,0.00006187586,0.00009278465,0.00015034863,0.000078970785],"category_scores_gemma":[0.0016671236,0.00026498374,0.00023400506,0.0014825542,0.00070113246,0.00014065941,0.00019406184,0.00036106948,8.622216e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020944746,0.00071464654,0.9896302,0.0002056063,0.0017175078,0.0000022394645,0.0005553118,0.0009714868,0.00028720015,0.000037172766,0.000007638434,0.003776505],"study_design_scores_gemma":[0.01110366,0.00026158773,0.982068,0.00018382467,0.0003262541,1.8976225e-7,0.000513096,0.005187672,0.0000042410247,0.000064233296,0.000035511326,0.00025173795],"about_ca_topic_score_codex":0.003733814,"about_ca_topic_score_gemma":0.0017591596,"teacher_disagreement_score":0.009009185,"about_ca_system_score_codex":0.000069146605,"about_ca_system_score_gemma":0.00013331261,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W4416168561","doi":"10.1016/j.msard.2025.106800","title":"Examining diagnostic performance of the 2023 MOGAD criteria: Lessons learned and future directions","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation; Academic Medical Organization of Southwestern Ontario","keywords":"Multiple sclerosis; MEDLINE; Disease; Perspective (graphical); Health professionals","score_opus":0.030559806083246436,"score_gpt":0.262967079254824,"score_spread":0.23240727317157756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416168561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97792196,0.006482748,0.0000043320406,0.011150566,0.0005714211,0.00045109523,0.000008049914,0.00003793505,0.0033718862],"genre_scores_gemma":[0.9134146,0.08563756,0.000044520883,0.00016656103,0.000025292251,0.000040781255,0.000006346265,0.000012308731,0.00065200974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99916023,0.00004585579,0.00023526147,0.00026306274,0.000110317786,0.00018525514],"domain_scores_gemma":[0.99940944,0.0001953686,0.00007339694,0.00023268422,0.00003573961,0.00005339128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013872872,0.0001410456,0.0002954867,0.00010734551,0.00034728952,0.000022905106,0.00006505814,0.000119444645,0.000047941878],"category_scores_gemma":[0.00017416333,0.000098550336,0.000063178515,0.00037989573,0.00018417492,0.000060327166,0.00012603545,0.00019616379,0.0000020029124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114452305,0.0011054599,0.46536434,0.00083855225,0.00092467567,0.000001694605,0.0037289343,0.00023588892,0.006359371,0.0015435608,0.005666189,0.5141169],"study_design_scores_gemma":[0.0016518139,0.000118503405,0.9801594,0.0006358482,0.00032961194,0.0000012832567,0.0017443106,0.0014510435,0.00019141242,0.000058888076,0.013553755,0.000104137056],"about_ca_topic_score_codex":0.00042234146,"about_ca_topic_score_gemma":0.00019276582,"teacher_disagreement_score":0.51479506,"about_ca_system_score_codex":0.000016959946,"about_ca_system_score_gemma":0.0000288224,"threshold_uncertainty_score":0.4018766},"labels":[],"label_agreement":null},{"id":"W4416230718","doi":"10.1016/j.msard.2025.106859","title":"Adherence and compliance with exercise training in progressive multiple sclerosis: Rates and correlates from the CogEx trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Compliance (psychology); Multiple sclerosis; Clinical trial; Cognition; Patient compliance; Affect (linguistics); Exercise therapy","score_opus":0.07941670029547286,"score_gpt":0.2997765516977942,"score_spread":0.22035985140232134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416230718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603787,0.033392355,0.000023417344,0.0023445415,0.00017401524,0.0032678999,0.00006234363,0.000094637595,0.00026210543],"genre_scores_gemma":[0.969158,0.029390553,0.0004639918,0.00015300389,0.000026934273,0.0006098685,0.000043075215,0.00004009147,0.00011449024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726075,0.00018635616,0.00061076455,0.0009211875,0.00037347132,0.00064744544],"domain_scores_gemma":[0.99736387,0.0017159833,0.00019535421,0.00037751082,0.00013105142,0.00021626409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043955064,0.0004716139,0.00084109284,0.0001833467,0.00065677805,0.00017997794,0.00018027991,0.00026505042,0.000029741357],"category_scores_gemma":[0.0009880523,0.00030229185,0.00008418128,0.0006757731,0.001478449,0.00021378667,0.00026879675,0.00076480897,0.0000037565799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01637328,0.00044649083,0.70842105,0.0002018308,0.00057163666,0.00001022047,0.010352811,0.0000641778,0.0032200858,0.000036173482,0.00033973533,0.25996253],"study_design_scores_gemma":[0.08454025,0.000619435,0.8766727,0.008090711,0.00023751357,0.00000349564,0.013143058,0.015663182,0.00026463455,0.00019427174,0.00016554254,0.00040524855],"about_ca_topic_score_codex":0.0013288241,"about_ca_topic_score_gemma":0.0016866637,"teacher_disagreement_score":0.25955728,"about_ca_system_score_codex":0.000045907917,"about_ca_system_score_gemma":0.0001232172,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W4416589642","doi":"10.1016/j.msard.2025.106878","title":"Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"Multiple Sclerosis International Federation","keywords":"Rituximab; Multiple sclerosis; MEDLINE; Relapsing remitting; Fingolimod; Natalizumab","score_opus":0.10129630030901161,"score_gpt":0.30766157208512906,"score_spread":0.20636527177611746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416589642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8930306,0.023672767,0.0022423167,0.06366047,0.0004962737,0.0152810635,0.0013922137,0.000110347304,0.00011398531],"genre_scores_gemma":[0.9422822,0.052648295,0.002364307,0.00025885808,0.000023274391,0.0016478401,0.00011374771,0.000047171405,0.0006143087],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99773777,0.000112889255,0.0008876179,0.00048886356,0.0002622276,0.00051064877],"domain_scores_gemma":[0.99012035,0.008673309,0.0002798865,0.00058124703,0.0002637855,0.00008142248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051530125,0.00032602352,0.00070477126,0.0002824375,0.0006086385,0.000043746608,0.00021332625,0.0001941218,0.00001770466],"category_scores_gemma":[0.0020635645,0.00019130837,0.0003692431,0.0006917006,0.0006178864,0.00010988519,0.00010532771,0.00020667836,9.5202313e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002601252,0.005135062,0.05474608,0.00054259755,0.002085499,1.6276654e-7,0.004870413,0.0016892143,0.011876722,0.000117129326,0.011123561,0.9052123],"study_design_scores_gemma":[0.06963281,0.0014841681,0.35796833,0.0028867754,0.001056235,6.543402e-7,0.007380752,0.38499123,0.005655208,0.000061570034,0.16843748,0.00044477524],"about_ca_topic_score_codex":0.0010606706,"about_ca_topic_score_gemma":0.0013050357,"teacher_disagreement_score":0.9047675,"about_ca_system_score_codex":0.00011867117,"about_ca_system_score_gemma":0.00008019183,"threshold_uncertainty_score":0.7801329},"labels":[],"label_agreement":null},{"id":"W4416642664","doi":"10.1016/j.msard.2025.106886","title":"Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Novartis Pharma; Novartis Animal Health; Novartis","keywords":"Multiple sclerosis; Ofatumumab; Natalizumab; Relapsing remitting; MEDLINE; Fingolimod","score_opus":0.02454122563384652,"score_gpt":0.2534625429958049,"score_spread":0.22892131736195837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416642664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909223,0.0018213699,0.000053105032,0.0028837207,0.00014137974,0.0031522864,0.000113337395,0.00016801021,0.0007445047],"genre_scores_gemma":[0.96249986,0.03568118,0.0008624985,0.00012424555,0.000013042558,0.00019765957,0.00018246431,0.00009061226,0.00034842014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963051,0.00017592509,0.0008196067,0.0011821528,0.0005895788,0.0009276153],"domain_scores_gemma":[0.9968451,0.0017498006,0.00023074092,0.00059706875,0.00022719325,0.00035009094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025983658,0.0007461779,0.0012270324,0.0005996296,0.00073448545,0.00010476216,0.00015248184,0.00032770162,0.000046381152],"category_scores_gemma":[0.0013289336,0.0004958479,0.0001643088,0.0011391058,0.00072513474,0.0002752517,0.00020509599,0.0005770178,0.000008764628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053108092,0.002145815,0.9348648,0.00015263056,0.00092977146,0.000007781078,0.0014928045,0.00045573106,0.00018058863,0.000012697665,0.000107979395,0.054338586],"study_design_scores_gemma":[0.0805835,0.0014476394,0.91078174,0.0028821758,0.00029923793,8.689991e-7,0.0010379024,0.0015655353,0.00009134595,0.000008041242,0.0008047283,0.00049728435],"about_ca_topic_score_codex":0.0017013078,"about_ca_topic_score_gemma":0.008022436,"teacher_disagreement_score":0.07527269,"about_ca_system_score_codex":0.0003858233,"about_ca_system_score_gemma":0.00012573123,"threshold_uncertainty_score":0.9997493},"labels":[],"label_agreement":null},{"id":"W4416756928","doi":"10.1016/j.msard.2025.106874","title":"Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; St. Michael's Hospital","funders":"","keywords":"Cannabis; Cognition; Metacognition; Effects of cannabis; Multiple sclerosis; Association (psychology)","score_opus":0.031053396506899845,"score_gpt":0.24001979167926155,"score_spread":0.2089663951723617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416756928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926519,0.0025225787,0.000018089344,0.0030163496,0.000043452197,0.001090826,0.000086388354,0.000038378035,0.00053205906],"genre_scores_gemma":[0.99706846,0.0019408792,0.000042573367,0.000039506453,0.000012672217,0.0003562048,0.000027282287,0.000028875002,0.00048351262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984182,0.00012193247,0.00033160628,0.0004609878,0.00027702708,0.00039024564],"domain_scores_gemma":[0.99924093,0.00015862433,0.00009402241,0.00023624077,0.00014891638,0.0001212364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027219832,0.0002427776,0.00042474575,0.00033737204,0.00031851965,0.00006417972,0.00007750988,0.00013322139,0.00000725449],"category_scores_gemma":[0.00034703696,0.00016144315,0.00009685047,0.0007689707,0.0006617562,0.00027177183,0.00010620579,0.00046297218,5.7391196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007825698,0.00021292338,0.9469466,0.00009754328,0.0003561555,0.0000014241971,0.007163865,0.000049343624,0.008529806,0.0000938776,0.00012888,0.03563697],"study_design_scores_gemma":[0.0045622187,0.00029953345,0.9598218,0.0008864702,0.00020692704,0.0000023807252,0.028226683,0.0008454312,0.004271382,0.00013418829,0.00055918936,0.00018379366],"about_ca_topic_score_codex":0.010058151,"about_ca_topic_score_gemma":0.0066236737,"teacher_disagreement_score":0.035453174,"about_ca_system_score_codex":0.00008013488,"about_ca_system_score_gemma":0.00012370167,"threshold_uncertainty_score":0.99653393},"labels":[],"label_agreement":null},{"id":"W4416795925","doi":"10.1016/j.msard.2025.106891","title":"Brain Age","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"","score_opus":0.01295941292726513,"score_gpt":0.2317520241208852,"score_spread":0.21879261119362006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416795925","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010930536,0.0071947114,0.000011355461,0.0007219078,0.97021204,0.0010593941,0.0020109296,0.0008508968,0.016845701],"genre_scores_gemma":[0.043882992,0.039082397,0.0005352923,0.00037712627,0.7813468,0.0007075091,0.019482935,0.001816629,0.112768345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557626,0.00032457433,0.00085831364,0.0014147932,0.00095006503,0.00087600236],"domain_scores_gemma":[0.9959473,0.0023971107,0.00041454058,0.0008242142,0.00015586342,0.00026097422],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00067852094,0.000925321,0.0010229768,0.00062435283,0.0005273581,0.00027698826,0.0005766833,0.0032151558,0.00021139554],"category_scores_gemma":[0.0042355936,0.00087667146,0.0004419202,0.00093075074,0.0005162554,0.0001762619,0.00039257275,0.0023535816,0.0007172889],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012872889,0.00019910987,0.00014736783,0.00017227595,0.00050998485,0.00000789711,0.00038140017,0.0000762267,0.00048004827,0.000034233017,0.9873439,0.0105188],"study_design_scores_gemma":[0.0055937087,0.00008090054,0.0010044608,0.0010353867,0.00029482233,2.8060978e-7,0.0001533751,0.00042494095,0.000010636912,0.00044401,0.98996234,0.0009951394],"about_ca_topic_score_codex":0.0013108794,"about_ca_topic_score_gemma":0.0015982741,"teacher_disagreement_score":0.18886527,"about_ca_system_score_codex":0.00018886986,"about_ca_system_score_gemma":0.00027846653,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W4417400612","doi":"10.1016/j.msard.2025.106936","title":"The association between antimicrobial exposure and subsequent multiple sclerosis risk: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Antimicrobial; Risk factor; Prospective cohort study; Antibiotics; Association (psychology); MEDLINE","score_opus":0.05041545858430147,"score_gpt":0.2793820052663783,"score_spread":0.22896654668207683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417400612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5438698,0.42339316,0.0001428701,0.022982927,0.00013233461,0.008365649,0.0005348493,0.00023600206,0.00034240313],"genre_scores_gemma":[0.73155147,0.26691198,0.000119428434,0.0003055653,0.0000096105205,0.00034676297,0.000044916156,0.000027049526,0.00068321556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957584,0.0008891033,0.001233284,0.00085159746,0.000597987,0.0006695961],"domain_scores_gemma":[0.99539334,0.002747229,0.00062658155,0.00066301174,0.00031202147,0.00025781585],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0025687234,0.0005225654,0.0027802323,0.00035642757,0.0014217127,0.0002484225,0.00019555977,0.0003281876,0.000023944118],"category_scores_gemma":[0.0047288616,0.00031943133,0.00088527345,0.0013691068,0.0004250633,0.000163254,0.00033033776,0.0006717155,0.000006471795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010109443,0.00024225721,0.661368,0.034802854,0.29800305,0.0000011992978,0.0009352479,0.000029742181,0.0011890585,0.00003068642,0.0015255267,0.0017712702],"study_design_scores_gemma":[0.0031407697,0.00009528198,0.60028267,0.0027105107,0.39195257,0.0000010805732,0.0004588153,0.0007705729,0.00010245671,0.00002386424,0.000120495504,0.00034088653],"about_ca_topic_score_codex":0.0007915884,"about_ca_topic_score_gemma":0.0011073895,"teacher_disagreement_score":0.18768166,"about_ca_system_score_codex":0.00015385401,"about_ca_system_score_gemma":0.00004946718,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W7116845950","doi":"10.1016/j.msard.2025.106945","title":"Large language models in academic writing","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Academic writing; Language model; Content (measure theory); On Language; English language","score_opus":0.08925431665325552,"score_gpt":0.365534011795231,"score_spread":0.2762796951419755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116845950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596245,0.0056673307,0.00025324445,0.004161258,0.00019243422,0.00030989753,0.0000028891175,0.00005032917,0.0034001586],"genre_scores_gemma":[0.99455667,0.0043544616,0.00007045676,0.0005297793,0.000018693829,0.000026440342,0.000020478063,0.000009575063,0.00041345498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990787,0.00003295902,0.00034788542,0.00021181842,0.00007747086,0.00025118954],"domain_scores_gemma":[0.99964076,0.00011820017,0.00003762355,0.000112829104,0.000027032665,0.00006357472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000270881,0.000088179375,0.00015307534,0.00017956417,0.000112844384,0.000010542868,0.000039522736,0.0002202943,0.0000323966],"category_scores_gemma":[0.00016545536,0.000080387326,0.000039690076,0.00035699367,0.000044944867,0.00009191284,0.000026226635,0.0004087777,0.000010328351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014528507,0.0003235521,0.57140976,0.00022784628,0.000047410358,0.0000030433957,0.02106881,0.0006504122,0.004765013,0.002925695,0.00056968536,0.39786348],"study_design_scores_gemma":[0.0025680868,0.00017862499,0.50163704,0.0037741119,0.00013687831,0.000006733778,0.1370573,0.3258298,0.004435609,0.022268722,0.0015203651,0.00058673375],"about_ca_topic_score_codex":0.00091426814,"about_ca_topic_score_gemma":0.00044186774,"teacher_disagreement_score":0.39727676,"about_ca_system_score_codex":0.000043337717,"about_ca_system_score_gemma":0.000055147768,"threshold_uncertainty_score":0.32781002},"labels":[],"label_agreement":null}]}